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Introduction: Ageing is associated with declines in skeletal muscle mass, strength and 
physical function, reductions in components of energy expenditure (EE), and deterioration of 
metabolic and cognitive function. Two interventions that may mitigate these adverse health 
outcomes are resistance exercise (RE) and increased dietary protein intake. However, further 
work is required to determine the synergistic effects compared to each intervention alone. 
Broadly, the aim of this thesis was to examine the individual and combined effects of RE and 
whey protein supplementation on components of 24-h energy metabolism, parameters of 
sarcopenia, and metabolic and cognitive function in healthy older men. Additionally, this thesis 
aimed to examine potential mechanisms of action.  
General methods: Thirty-six healthy older men [(mean ± standard error (SE)) age: 66.9 ± 0.7 
y; body mass index (BMI) 25.5 ± 0.4 kg/m2] participated in a 12-week, 4-arm, double-blind, 
randomised controlled trial (RCT). Participants were randomised to either control (CON, n = 
9), whey protein supplementation (PRO, n = 9), RE + control (EX+CON, n = 9), or RE + whey 
protein supplementation (EX+PRO, n = 9). Resistance exercise was performed twice weekly 
by participants in the EX+CON and EX+PRO groups. Supplements (PRO, 25 g whey protein 
isolate; CON, 23.75 g maltodextrin) were consumed twice daily. For the primary analysis, the 
four intervention groups were compared. Exploratory analyses were also conducted between 
pooled exercise (EX+CON + EX+PRO, n = 18) and non-exercise groups (CON + PRO, n = 
18), and between pooled whey protein (PRO + EX+PRO, n = 18) and control supplement 
groups (CON + EX+CON, n = 18). Three individual study chapters were derived from the 12-
week RCT. 
Study specific methods and results: 
Study 1: Investigated the individual and combined effects of RE and whey protein 
supplementation on 24-h EE, substrate oxidation, metabolic flexibility, subjective appetite and 
glucose homeostasis. Participants (n = 33) resided in respiration chambers for 24 h pre- and 
post-intervention. Resistance exercise significantly increased fat-free mass (FFM), resting 
metabolic rate (RMR), sedentary EE, and 24-h metabolic flexibility compared to non-exercise. 
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Additionally, RE also elicited within-group increases in insulin sensitivity and subjective 
hunger, and within-group decreases in the energy cost of step exercise and spontaneous 
activity. Whey protein supplementation aided maintenance of body mass and reduced FM 
compared to control supplement groups pooled. Within-group decreases in the energy cost of 
both spontaneous activity and step exercise in the fasted state were also observed following 
whey protein supplementation. No negative effects of whey protein supplementation were 
observed for either total protein or energy intake (EI), or 24-h subjective appetite. However, 
whey protein supplementation did result in an increase in overnight protein oxidation, resulting 
in a reduced 24-h protein balance. Consequently, this may be a caveat to longitudinal high 
protein diets in the elderly. Combined RE and whey protein supplementation did not 
significantly augment changes in body composition, 24-h EE, substrate oxidation or metabolic 
flexibility, or glucose homeostasis compared to either RE or whey protein supplementation 
alone. 
Study 2: Examined the individual and combined effects of RE and whey protein 
supplementation on skeletal muscle/FFM, muscle strength, physical function, and hormonal 
and inflammatory biomarkers related to sarcopenia. Resistance exercise significantly 
increased FFM, muscle strength and physical function, and decreased markers of systemic 
inflammation compared to non-exercise. Whey protein supplementation increased physical 
function (4 m gait speed) and muscle strength [leg press one repetition maximum (1RM)]. No 
synergistic effects occurred for any parameter of sarcopenia compared to RE or whey protein 
supplementation alone. Furthermore, changes in hormonal and inflammatory markers did not 
correlate with changes in skeletal muscle mass, strength, or physical function. Diurnal salivary 
cortisol secretion did, however, significantly correlate with multiple parameters of sarcopenia 
at baseline. 
Study 3: Tested the individual and combined effects of RE and whey protein supplementation 
on cognitive function and explored mechanisms of action. At baseline, parameters of 
sarcopenia (muscle strength and physical performance) positively correlated with several 
domains of cognitive function. Following the intervention, RE and whey protein 
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supplementation alone and combined did not elicit any significant benefits compared to 
control. However, whey protein supplementation per se elicited within-group improvements in 
global cognitive function, working memory and executive function. When whey protein 
supplement groups were pooled, there was also a trend towards a greater increase in global 
cognitive function compared to control supplement groups pooled. Resistance exercise alone 
elicited within-group improvements in multitasking efficiency but worsened processing speed. 
No significant additive effects of combined intervention were observed compared to either RE 
or whey protein supplementation alone. Moreover, changes in cognitive function were not 
correlated with changes in any neurobiological, inflammatory or insulin sensitivity marker, nor 
blood pressure or salivary cortisol indices. In contrast, an association was observed between 
changes in SMI and episodic memory. 
Conclusions: Overall, this body of work supports the use of RE as the primary intervention 
to mitigate age-related declines in EE and parameters of sarcopenia. Increased dietary protein 
intake via whey protein supplementation may also be recommended as a safe method for 
older adults to mitigate age-related declines in muscle strength, physical function and 
sarcopenic obesity, and aid aspects of cognitive functioning. Finally, data presented in this 
thesis does not support the need for combined RE and whey protein supplementation to curb 
sarcopenia or age-related declines in metabolic or cognitive function. 
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1.1 Rationale  
Globally, the population is ageing, with demographic projections indicating individuals aged 
>60 years will represent 21.3% of the human population by 2050 (Office for National Statistics 
2018). Of note, ageing is associated with progressive declines in skeletal muscle mass (SMM), 
strength and physical function, a phenomenon termed sarcopenia (Cruz-Jentoft et al. 2019). 
In terms of human health, sarcopenia is associated with an increased risk of falls, 
hospitalisation, physical disability and poor quality of life (Beaudart et al. 2014). Sarcopenia is 
also linked with reductions in components of energy expenditure (EE) (Manini 2010, Soysal 
et al. 2019), which could lead to increased fat mass (FM), sarcopenic obesity and metabolic 
disease (Wannamethee and Atkins 2015, Westerterp 2018a). Additionally, declines in 
cognitive function, which may progress to mild cognitive impairment (MCI) and dementia (most 
commonly Alzheimer’s disease) (Alzheimer’s Society 2014), has likewise been associated 
with sarcopenic muscle loss (Chang et al. 2016, Cipolli, Yassuda, and Aprahamian 2019, 
Peng et al. 2020). As a longer life brings many opportunities at both an individual and societal 
level, there is a critical need to identify strategies to maintain muscle function and overall 
health in older adults (Witard et al. 2016).   
 
Resistance exercise (RE) is an effective countermeasure to age-related chronic disease 
(Mcleod, Stokes, and Phillips 2019). In older adults, meta-analyses have reported increases 
in fat-free mass (FFM) (Buch et al. 2017, Csapo and Alegre 2016, Peterson, Sen, and Gordon 
2011, Yoshimura et al. 2017), muscle strength (Buch et al. 2017, Csapo and Alegre 2016, 
Martins et al. 2013, Peterson et al. 2010, Yoshimura et al. 2017), and physical function 
following RE training (Yoshimura et al. 2017). Metabolically, increases in resting metabolic 
rate (RMR) and 24-h fat oxidation (Hunter, McCarthy, and Bamman 2004, Treuth et al. 1995), 
reductions in the energetic cost of performing activities of daily living (ADL) (Valenti, Bonomi, 
and Westerterp 2016), improvements in skeletal muscle glucose metabolism, metabolic 
flexibility and glucose homeostasis (Bell et al. 2017, Bucci et al. 2016, Consitt, Dudley, and 
Saxena 2019, Consitt et al. 2016, Flack et al. 2011, Holwerda et al. 2018, Iglay et al. 2007, 
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Leenders et al. 2013, Miller et al. 1994), and reductions in FM have also been reported 
(Westcott 2012). On a cognitive level, prior work has demonstrated favourable effects of RE 
training on executive functioning (Anderson-Hanley, Nimon, and Westen 2010, Best, 
Nagamatsu, and Liu-Ambrose 2014, Ikudome et al. 2017, Liu-Ambrose et al. 2010, Yoon, Lee, 
and Song 2018), memory (Best et al. 2015, Cassilhas et al. 2007, Coelho-Júnior et al. 2020, 
Ikudome et al. 2017, Marston et al. 2019a), and global cognitive function (Coelho-Júnior et al. 
2020, Smolarek et al. 2016, Singh et al. 2014).  
 
In addition to RE, increased dietary protein intake may also attenuate sarcopenia and aid body 
weight management (Drummen et al. 2018, Phillips and Martinson 2019). Meta-analyses have 
reported reductions in FM (Clifton, Condo, and Keogh 2014, Kim et al. 2016b), and several 
intervention studies have reported increases in FFM in older adults consuming higher intakes 
of dietary protein (Bauer et al. 2015, Bell et al. 2017, Bo et al. 2019, Kang et al. 2020, Mitchell 
et al. 2017, Negro et al. 2019, Norton et al. 2016, ten Haaf et al. 2019). Furthermore, some 
studies also report improvements in muscle function (Bo et al. 2019, Mitchell et al. 2017, Negro 
et al. 2019); however, these improvements have not been observed by all (Björkman et al. 
2020, Cramer et al. 2016, de Carvalho Bastone et al. 2020, Kim et al. 2012, Kirk et al. 2020, 
Kukuljan et al. 2009, Verreijen et al. 2017, Zhu et al. 2015). Discrepant findings may be 
explained by differences in participant health status (i.e., healthy vs. sarcopenic/functionally 
impaired), habitual protein intake [i.e., inadequate (<1 g/kg/d) vs. adequate (>1 g/kg/d)], and 
the magnitude of protein deviation from baseline (i.e., ≥0.4 vs. <0.4 g/kg/d).  
 
Regarding the effects on EE, studies in young adults have reported increases in sleeping 
metabolic rate (SMR) and diet-induced thermogenesis (DIT) (Bray et al. 2015, Martens et al. 
2015a, Sutton et al. 2016), RMR (Bray et al. 2012), and total energy expenditure (TEE) (Bray 
et al. 2012, 2015) following chronic consumption of a high protein diet [25-30% of energy 
intake (EI)]. However, the effects in older adults is contradictory, with one study reporting 
increases in RMR and a consequent negative energy balance (Drummen et al. 2018), whilst 
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others have not reported such effects (Luger et al. 2013, Negro et al. 2019). Disparities might 
be explained by an insufficient deviation of dietary protein from baseline, as highlighted above. 
In addition to EE, studies in both young (Bray et al. 2015, Robinson et al. 1990, Pannemans 
et al. 1995, Martens et al. 2015b), and middle- and older-aged adults (Campbell et al. 1995, 
Drummen et al. 2020, Hays et al. 2009, Pannemans, Halliday, and Westerterp 1995, 
Pannemans et al. 1998) have observed increases in 24-h protein oxidation and improved 
protein balance. Two of these studies also demonstrated decreases in 24-h respiratory 
quotient (RQ), indicative of increased fat oxidation (Drummen et al. 2020, Martens et al. 
2015a).  
 
The effects of dietary protein on glucose homeostasis is controversial with some studies 
reporting improvements (Acheson et al. 2011, Amirani et al. 2020, Luger et al. 2013, Pal, Ellis, 
and Dhaliwal 2010, Promintzer and Krebs 2006), whilst others have reported either no 
changes (Leenders et al. 2011) or an increase in whole-body insulin resistance (Linn et al. 
2000, Hattersley et al. 2014, Weickert et al. 2011). Contradictory findings may be explained 
by differences in the source of dietary protein (Drummen et al. 2018) and protein-induced 
changes in FM and systemic inflammation (Weickert 2012). Regrettably, data on the effects 
of dietary protein on metabolic flexibility is limited to one study that reported no effects of 
increased dairy consumption (Eelderink et al. 2019); however, these findings could have 
occurred due to an insufficient intervention period.  
 
Alongside increased muscle function and improved body weight management, dietary protein 
may also assist in curbing age-related declines in cognitive function (van de Rest, van der 
Zwaluw, and De Groot 2013). Intervention studies of 12-24 weeks in duration have reported 
protein-induced improvements in reaction time (van der Zwaluw et al. 2014), memory 
(Charlton et al. 2016) and emotion identification (Charlton et al. 2016, Crichton et al. 2012b, 
Jakobsen et al. 2011, Lefferts et al. 2020, van der Zwaluw et al. 2014). Conversely, others 
have not reported improvements, possibly due to an insufficient duration of intervention (Bell 
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et al. 2019, Zajac et al. 2019) and an inadequate dose of protein supplemented (Moran et al. 
2018).  
 
Based on the totality of aforementioned literature, it may be hypothesised that RE combined 
with dietary protein could synergistically aid attenuation of sarcopenia and sarcopenic obesity, 
improve metabolic health, and enhance cognitive function in older adults. Indeed, meta-
analyses (Cermak et al. 2012, Finger et al. 2015, Liao et al. 2017, Morton et al. 2018a) and 
randomised controlled trials (RCTs) (Bell et al. 2017, Daly et al. 2014, Junior et al. 2018, 
Rondanelli et al. 2016, 2020, Tieland et al. 2012b, Verreijen et al. 2015, Yamada et al. 2019, 
Zdzieblik et al. 2015) have reported augmented effects of dietary protein on the adaptive 
skeletal muscle response to RE. Additionally, data from a recent meta-analysis suggests RE 
combined with protein supplementation might also elicit greater decreases in absolute and 
%FM compared to RE alone (Liao et al. 2017), whilst RCTs have likewise reported synergistic 
effects on glucose homeostasis (Bell et al. 2017) and cognitive function (Bell et al. 2019, 
Rondanelli et al. 2020).  
 
However, in contrast to the above, opposing findings have also been reported. For example, 
several studies have reported no synergistic effects on FFM or muscle function (Arnarson et 
al. 2013, Candow et al. 2012, Chalé et al. 2013, de Carvalho Bastone et al. 2020, Dulac et al. 
2020, Englund et al. 2018, Fielding et al. 2017, Gryson et al. 2014, Hofmann et al. 2016, Holm 
et al. 2008, Holwerda et al. 2018, Kim et al. 2012, Kirk et al. 2019, 2020, Kukuljan et al. 2009, 
Leenders et al. 2013, Oesen et al. 2015, Shahar et al. 2013, Thomson et al. 2016, Verreijen 
et al. 2017), components of EE (Amamou et al. 2017, Campbell et al. 1994, Maltais et al. 
2016, Weinheimer et al. 2012), glucose homeostasis (Holwerda et al. 2018, Iglay et al. 2007, 
Leenders et al. 2013, Maltais et al. 2016, Weinheimer et al. 2012, Verdijk et al. 2009a), or 
cognitive function (Formica et al. 2020, van de Rest et al. 2014). Similar to that previously 
mentioned, inconsistent findings may be explained by the population studied, habitual protein 
intake of participants, and characteristics of the protein intervention. 
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Whilst numerous studies have investigated the combined effects of RE and dietary protein on 
multiple aspects of health in older adults, several recurrent methodological limitations warrant 
further discussion. Firstly, the majority of the aforementioned studies employed a daily protein 
intake which was less than the required dose (1.6 g/kg/d) reported to maximally accrete 
skeletal muscle during RE training (Morton et al. 2018a). Secondly, the bulk of studies (31/39 
previously cited) failed to include a protein only group. As not older adults are willing or able 
to perform RE (Dismore et al. 2020), collection of such data is vital to determine the 
effectiveness of this nutrient compared to both RE alone, and combined with dietary protein. 
Lastly, only two (Gryson et al. 2014, van de Rest et al. 2014) of the eight studies that  
investigated the synergistic effects of RE and dietary protein compared to each intervention 
alone supplemented participants in control groups with either a placebo or energy-matched 
control supplement. Consequently, the remainder of these studies are at a risk of experimental 
bias. For this reason, an expert working group has recommended the double-blind RCT as 
the mainstay of research design for trials investigating the effectiveness of interventions to 
treat or prevent sarcopenia (Reginster et al. 2016). Based on the abovementioned limitations, 
a 4-arm (control, protein, RE + control, RE + protein), double-blind RCT is warranted to 
robustly investigate the effects of RE and dietary protein (at a daily intake of 1.6 g/kg/d) in 
older adults. 
 
Further to the methodological limitations highlighted above, several unanswered questions 
also remain regarding the combined effects of RE and dietary protein. For instance, several 
biochemical pathways are involved in the pathogenesis of sarcopenia, including chronic 
systemic inflammation [e.g., increases in interleukin-6 (IL-6), C-reactive protein (CRP) and 
tumor necrosis factor alpha (TNF-α)] and changes in hormonal function [e.g., reductions in 
insulin-like growth factor 1 (IGF-1), flattened diurnal cortisol secretion, and increases in 
myostatin]. Additionally, systemic inflammation, declines in growth and neurotrophic factors 
[e.g., IGF-1 and brain-derived neurotrophic factor (BDNF)], dysregulation of the hypothalamic 
pituitary adrenal (HPA) axis, insulin resistance and hypertension are all purported to contribute 
 7 
to cognitive decline with age (De Felice, Lourenco, and Ferreira 2014, Maass et al. 2016, 
Macaulay, Fisher, and Schroeder 2020, Walker, Power, and Gottesman 2017). However, the 
effects of RE and dietary protein on these biomarkers compared to each intervention alone, 
and the relationship with changes in muscle and cognitive function is relatively unknown. 
Collection of such data is vital to further understand the mechanisms of how these 
interventions may synergistically attenuate sarcopenia and cognitive decline. 
 
Moreover,  prior studies investigating the combined effects of RE and dietary protein on energy 
metabolism only captured EE in the resting state (i.e., RMR) (Amamou et al. 2017, Campbell 
et al. 1994, Maltais et al. 2016, Weinheimer et al. 2012). Twenty-four-hour EE is not constant, 
and is regulated by numerous factors such as time of day and food intake (Schoffelen and 
Plasqui 2018); therefore, analysis of solely RMR does not provide a comprehensive analysis 
of the effects of these interventions on 24-h energy metabolism. Hence, analysis of multiple 
components of 24-h EE [i.e., RMR, SMR, activity energy expenditure (AEE), DIT and TEE] is 
warranted. Finally, no study has investigated the synergistic effects on 24-h metabolic 
flexibility or appetite compared to each intervention alone in older adults. The addition of this 
data may have important clinical implications for attenuating metabolic dysfunction and aiding 
energy balance in older adults.  
 
1.2 Aims of the thesis  
This thesis aimed to investigate the individual and combined effects of twice weekly RE and 
twice daily whey protein supplementation (25 g/serving, including 3 g leucine/serving) for 12 
weeks in healthy older men. Specifically, this thesis was designed to examine the individual 
and combined effects on body composition, 24-h energy metabolism, subjective appetite, 
metabolic flexibility, glucose homeostasis, and muscle and cognitive function. Secondary aims 
were to explore mechanisms of action relating to sarcopenia and cognitive function. 
Accordingly, this thesis is comprised of three research studies which contribute novel data 
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and provide insight into the effects of RE and dietary protein on the abovementioned 
outcomes.  
 
Study 1 (Chapter 4): Investigated the individual and combined effects of RE and whey protein 
supplementation on 24-h EE, substrate oxidation and metabolic flexibility, body composition, 
subjective appetite, and glucose homeostasis. 
Study 2 (Chapter 5): Examined the individual and combined effects of RE and whey protein 
supplementation on skeletal muscle mass, strength, physical function, and hormonal and 
inflammatory biomarkers related to sarcopenia. 
Study 3 (Chapter 6): Tested the individual and combined effects of RE and whey protein 




































2.1 Chapter overview 
This literature review is partitioned into three parts. Firstly, age-related declines in SMM, 
strength and physical function; secondly, changes in body composition, reductions in EE and 
metabolic dysfunction with age; and finally, age-related declines in cognitive function. 
Subsequently, the individual and combined effects of RE and dietary protein on these 
outcomes will be reviewed.  
 
2.1.1 Introduction 
The world’s population is ageing. By 2050, demographics indicate the number of individuals 
aged >60 years will increase 2-fold from 900 million reported in 2015, to >2 billion (World 
Health Organisation 2018). Population ageing – the increasing percentage of elderly 
individuals within a population, is developing into a global phenomenon and is poised to 
become one of the most significant social transformations of recent times (World Health 
Organisation 2018). The considerable demographic shift towards a more elderly population 
has been driven by an increase in longevity (Office for National Statistics 2018); however, this 
has not been accompanied by a concomitant reduction in morbidity (Seals, Justice, and 
LaRocca 2016). Therefore, whilst population ageing is a success of mankind, older adults 
today are living with greater burden of chronic disease than their ancestors (World Health 
Organisation 2018). The consequences of population ageing coupled with an increase in 
morbidity are far-reaching, and incorporate significant societal and healthcare economic 
burdens (Tolea and Galvin 2015).  
 
2.2 Part 1: Sarcopenia  
 
 
2.2.1 Skeletal muscle  
Skeletal muscle is the largest organ in the human body, accounting for ~45% of FFM (Geisler 
and Müller 2017). From a mechanical point of view, the main function of skeletal muscle is to 
exert force, and it does so by attempting to shorten (Winter and Fowler 2009). Metabolically, 
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skeletal muscle contributes to basal energy metabolism, serves as a reservoir of amino acid 
(AA) storage, and aids maintenance of glycaemic control (Evans 1995, Wolfe 2006). 
Furthermore, from a structural perspective, it is important to note that all myofibers are not 
created equal. Different fibre types are grouped according to the predominant isoform of the 
myosin heavy chain that they express (Welch, Hayhoe, and Cameron 2020). These include 
either type I (slow-twitch oxidative), type IIa (fast-twitch oxidative-glycolytic fibres), or type II x 
(fast-twitch glycolytic) (Welch, Hayhoe, and Cameron 2020). 
 
2.2.2 Origin of sarcopenia    
Advancing age is accompanied by a progressive decline in SMM. In 1931, British neurologist 
Dr MacDonald Critchley wrote that ageing was coupled with a progressive loss of SMM, most 
noticeably in the hands and feet (Critchley 1931). Several years later in 1989, Dr Irwin 
Rosenberg stated, “no decline with age is more dramatic, or potentially more functionally 
significant, than the decline in muscle mass” (Rosenberg 1989). Rosenberg coined the loss 
of SMM ‘sarcopenia’, derived from the Greek words ‘sarx’ and ‘penia’, which translates in 
English to ‘loss or poverty of flesh’ (Rosenberg 1989). 
 
2.2.3 Definition and diagnosis  
Following its inception by Rosenberg in 1989, defining and classifying a diagnosis of 
sarcopenia has been at the forefront of research to aid clinical needs. In 2010, The European 
Working Group of Sarcopenia in Older People (EWGSOP) defined sarcopenia as a syndrome 
characterized by progressive and generalised loss of skeletal muscle mass and strength with 
a risk of adverse outcomes, such as physical disability, poor quality of life, and death (Cruz-
Jentoft et al. 2010). Sarcopenia can be classified as either ‘primary’ (or age-related) or 
‘secondary’ when developed depending on other factors such as chronic disease (Cruz-
Jentoft et al. 2010). In 2019, based on research demonstrating a stronger relationship between 
loss of muscle strength and adverse health outcomes as opposed to declines in SMM, the 
EWGSOP published a revised criteria of sarcopenia (EWGSOP2), highlighting muscle 
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strength as the primary parameter of sarcopenia (Cruz-Jentoft et al. 2019). For diagnosis of 
sarcopenia, the EWGOSP2 recommends firstly screening individuals using the SARC-F 
questionnaire. If sarcopenia is likely, muscle strength, mass and physical function should be 
measured to confirm diagnosis using the following cut-offs: 
 
• Low muscle strength: grip strength <27 kg for men and <16 kg for women, or chair 
stand >15 s for five raises 
• Low muscle quantity: appendicular skeletal muscle mass (ASMM) <20 kg for men 
and <15 kg for women, or ASM/height2 <7.0 kg/m2 for men and <5.5 kg/m2 for women 
• Low physical performance: either gait speed ≤0.8 m/s, short physical performance 
battery (SPPB) score ≤8, timed-up and go (TUG) score of ≥20 s, or ≥6 min to complete 
a 400 m walk. 
 
These cut-offs are also supported by the Australian and New Zealand Society for Sarcopenia 
and Frailty Research (ANZSSFR) (Zanker et al. 2019). Additionally, alternative definitions of 
sarcopenia have been proposed by the Asian Working Group for Sarcopenia (Chen et al. 
2020) and the International Working Group on Sarcopenia (Fielding et al. 2011). Importantly, 
although these definitions are different, whereby utilising different criteria and cut-offs, there 
is agreement in that sarcopenia is defined as a loss of SMM, strength and physical function 
by all.  
 
2.2.4 Age-related declines in skeletal muscle mass and strength 
Cross-sectional studies using bioelectrical impedance analysis (BIA) (Janssen et al. 2000b), 
dual x-ray absorptiometry (DXA) (Gallagher and Heymsfield 1998, Lynch et al. 1999) and 
computed tomography (CT) (Borkan et al. 1983, Overend et al. 1992) have demonstrated 
SMM is relatively well preserved until the fifth decade of life, with notable decreases observed 
after ~45 years. Longitudinal data has also revealed declines in SMM occur at a rate of ~6% 
per decade (~0.5-1% per annum) after mid-life (Janssen and Ross 2005), which arises at a 
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greater rate in men (Delmonico et al. 2009, Goodpaster et al. 2006) and in muscles of the 
lower extremities (Janssen and Ross 2005). The latter of these findings is of clinical 
significance, as the lower limbs possess muscles involved in performing ADL (Janssen and 
Ross 2005).  
 
It is now well-recognised that age-related declines in SMM and strength are not linear, with 
the decline in muscle strength occurring 2-5 times faster (Manini and Clark 2012). 
Histologically, these findings may be partly explained by the predominant loss of type II muscle 
fibres with ageing (Nilwik et al. 2013). Further, age-related declines in muscle strength have 
been reported to occur earlier than declines in SMM, arising as early as the 4th decade of life 
(Manini and Clark 2012). However, prominent declines are typically not observed until around 
~50 years of age, with more rapid decreases observed after 65 years (Beenakker et al. 2010). 
Longitudinal studies in older adults, as reviewed by Manini and Clark (2012), have reported 
strength losses of ~1-3% per annum after mid-life. 
 
2.2.5 Prevalence  
The reported prevalence of sarcopenia is varied, ranging from 1-50% (Cruz-Jentoft et al. 2014, 
Fielding et al. 2011, Patel et al. 2013, Shafiee et al. 2017, Su et al. 2019). Heterogeneity 
between studies might be explained by differences in the population studied, criteria definition 
of sarcopenia employed, age of participants, and methods of measuring indices of sarcopenia. 
In a comprehensive meta-analysis of 35 studies conducted by Shafiee and colleagues (2017) 
(including 58,404 participants aged ≥60 years), it was estimated that the global prevalence of 
sarcopenia in both older men and women was 10%. More specifically in the United Kingdom, 
it has been reported that 4.6% of older men and 7.9% of elderly women met the criteria for 
sarcopenia (Patel et al. 2013). Taking into account the global prevalence of sarcopenia 
reported by Shafiee et al. (2017) and a conservative estimate of the current population aged 
>60 years (~900 million) (World Health Organisation 2018), sarcopenia currently affects ~90 
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million people worldwide, with the figure likely to rise to ~200 million by 2050 (Cruz-Jentoft et 
al. 2019).  
 
2.2.6 Clinical implications  
Sarcopenia is associated with several adverse health effects, including an increased risk of 
falls, hospitalisation visits, morbidity and mortality, and poor quality of life (Beaudart et al. 
2014). A meta-analysis conducted by Beaudart and colleagues (2017) reported a higher risk 
of mortality in sarcopenic compared to non-sarcopenic individuals. Beaudart et al. (2017) also 
reported an association between sarcopenia and incidence of functional disability, and others 
have observed a higher risk of recurrent falls in sarcopenic compared to healthy older adults 
(Cawthon et al. 2015). Moreover, sarcopenia has also been associated with cognitive and 
metabolic dysfunction, leading to increased risk of type 2 diabetes mellitus (T2DM) and 
Alzheimer’s disease (Chang et al. 2016, Scott, de Courten, and Ebeling 2016). These 
relationships will be reviewed in parts 2 (section 2.3) and 3 (section 2.4.3.2) of this literature 
review. Sarcopenia has been recognised as a disease since September 2016, having been 
awarded an internal classification of disease (ICD-10-CM) code (M62.84) (Cao and Morley 
2016). 
 
2.2.7 Clinical cost  
The economic burden of sarcopenia to healthcare services globally is highly significant. In the 
first published economic analysis, it was estimated that the direct cost of sarcopenia to 
healthcare services in the United States was $18.5 billion in the year 2000 (Janssen et al. 
2004). A follow up analysis conducted in 2014 reported an increased expenditure of $40.4 
billion (Goates et al. 2019). Likewise, economic analyses conducted in The Netherlands 
(Mijnarends et al. 2016), Porto (Sousa et al. 2016) and Portugal (Antunes et al. 2017) 
consistently report ≥50% hospitalisation costs in sarcopenic compared to non-sarcopenic 
older adults. In the United Kingdom, Pinedo‑Villanueva et al. (2019) reported an annual £2.5 
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billion estimated healthcare expenditure as a consequence of low muscle strength in older 
adults.  
 
2.2.8 Mechanisms  
The aetiology of sarcopenia is multifactorial, with neurological, immunological, 
endocrinological, nutritional and physical activity changes all described (Ali and Garcia 2014). 
Whilst significant research has been undertaken over recent years, a major barrier in the 
effective management of sarcopenia is the current inadequate understanding of many of these 
mechanisms (Sakuma, Aoi, and Yamaguchi 2017). The subsequent sections will review the 
current understanding of the mechanisms of sarcopenia which are directly related to this 
thesis.   
 
2.2.8.1 Physical inactivity/muscle disuse 
Homeostasis of skeletal muscle is maintained through the regulated balance between rates 
of muscle protein synthesis (MPS) and muscle protein breakdown (MPB) (Kumar et al. 2009a). 
For muscle hypertrophy to occur, rates of MPS must exceed MPB, whereas when MPB 
exceeds MPS, muscle atrophy arises (Kumar et al. 2009a). In healthy young individuals, 
muscle protein turnover occurs at a rate of 1-2% per day (Wilkinson et al. 2014); however, 
older adults display disturbances in muscle protein turnover, whereby rates of MPB are 
chronically increased and rates of MPS are chronically decreased, consequently leading to 
muscle atrophy (Rennie et al. 2004). Two key factors driving this disturbance are age-related 
declines in levels of physical activity and an increase in sedentariness (Wall, Dirks, and van 
Loon 2013). To add, only 10% of older women and 15% of older men have reported complying 
with current physical activity guidelines (Jefferis et al. 2014), whilst others have shown older 
adults remain sedentary for ~9.4 hours per day (Harvey, Chastin, and Skelton 2015).  
 
Following muscle disuse, studies have reported up to 40% declines in MPS in older adults 
(Drummond et al. 2012, Wall et al. 2016). Bed rest studies of 10-42 days have also reported 
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notable reductions in SMM (~0.5-0.6%) and more variable reductions in muscle strength (0.3-
4.2%) (Wall, Dirks, and van Loon 2013). Importantly, substantial muscle atrophy (1.4% and 
10% decreases in muscle CSA and myofiber size, respectively) has also been observed 
following just 4-5 days of disuse (Wall et al. 2014, Suetta et al. 2012). These findings are of 
clinical significance, as 5-6 days is the typical duration of acute hospitalisation in older adults 
(Fisher et al. 2010). Further, other circumstances which may lead to muscle disuse of <10 
days such as illness that does not require hospitalisation and minor injuries are also likely to 
occur in the elderly population (Wall, Dirks, and van Loon 2013). Anecdotally, elderly 
individuals may therefore experience numerous periods of short-term muscle disuse 
throughout their later years, which could lead to substantial muscle atrophy and sarcopenia if 
SMM and strength are not preserved.  
 
2.2.8.2 Protein malnutrition  
Another factor which contributes to muscle protein imbalance in the elderly is protein 
malnutrition. Protein ingestion transiently increases MPS and supresses MPB via the effects 
of insulin, resulting in a positive net protein balance (Rennie et al. 2004). Protein 
recommendations for adults aged ≥19 years are set according to the recommended dietary 
allowance (RDA) of 0.8 g/kg body mass/d (Institute of Medicine 2005). However, this “one-
size fits all” advice does not take into account age-related changes in protein metabolism, 
hormone concentrations, immunity or progressing frailty (Clegg et al. 2013). More recent data 
employing the indicator AA oxidation technique has established the current RDA for protein is 
insufficient for older adults (Rafii et al. 2015, Tang et al. 2014). These findings are supported 
by a number of consensus groups, who reason that healthy older adults require 1.0-1.2 g 
protein/kg/d to attenuate sarcopenic muscle loss (Bauer et al. 2013, Deutz et al. 2014). 
Though, many older adults find consuming dietary protein challenging, with 33% and 67% 
reported incapable of consuming the RDA and 1.2 g/kg/d, respectively (ten Haaf et al. 2018b, 
Wolfe and Miller 2008). As a result, a large proportion of older adults do not consume sufficient 
dietary protein to maintain muscle protein balance. 
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2.2.8.3 Anabolic resistance  
Previous work has demonstrated that older adults display a blunted muscle protein synthetic 
response to anabolic stimuli (i.e., RE and protein ingestion) compared to their younger 
counterparts (Breen and Phillips 2011, Burd, Gorissen, and van Loon 2013). For example, 
Moore et al. (2015) established the dose of dietary protein required to maximally stimulate 
MPS in younger adults was 0.25 g/kg; however, the same effect was not observed in older 
adults until 0.4 g/kg was ingested. Likewise, others have shown the MPS response to an acute 
bout of RE is impaired in the elderly compared to younger adults (Drummond et al. 2008, 
Kumar et al. 2009b). These blunted responses to anabolic stimuli have been coined anabolic 
resistance (Burd, Gorissen, and van Loon 2013), which is a multifactorial process 
incorporating reductions in protein digestion and absorption, postprandial AA delivery and 
availability, and impairments in the signalling of anabolic proteins (Wilkinson, Piasecki, and 
Atherton 2018).  
 
2.2.8.4 Hormone function  
Declines in circulating concentrations of hormones of the HPA axis are observed with 
advancing age (Vitale, Cesari, and Mari 2016). From the fourth decade of life, testosterone 
concentration in healthy men decline by 1% per annum (Feldman et al. 2002, Morley and 
Perry 2003), and concentrations of growth hormone (GH) and IGF-1 decline at a rate of ~1.4% 
per annum (Giustina and Veldhuis 1998, Ryall, Schertzer, and Lynch 2008, Veldhuis et al. 
1995). Insulin-like growth factor 1 is a key protein involved in the stimulation of MPS via 
activation of the mammalian target of rapamycin (mTOR) signalling pathway (Sakuma, Aoi, 
and Yamaguchi 2017, Sattler 2013). Low concentration has been associated with decreased 
gait speed, low ASMM and increased sarcopenia risk (Gielen et al. 2015, Volpato et al. 2014). 
Dysfunction of the HPA axis with age has been shown to increase secretion of glucocorticoids 
from the adrenal cortex (Vitale, Salvioli, and Franceschi 2013). In skeletal muscle, 
glucocorticoids inhibit MPS and increase MPB through activation of two target genes, REDD1 
and KLF15 (Figure 2.1). Glucocorticoid exposure is governed by 11β-hydroxysteroid 
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dehydrogenase type 1 (11β-HSD1), which converts inactive corticoids into their active form 
(i.e., cortisone into cortisol) (Vitale, Cesari, and Mari 2016). Generally, the diurnal cycle of 
cortisol secretion is characterised by a surge of 50-60% 30-40 min upon awakening [known 
as the cortisol awakening response (CAR)], followed by a decline in the hours subsequent 
until reaching a nadir in the late evening (Adam et al. 2017). However, in sarcopenic older 
adults, elevated cortisol production has been observed compared to healthy elderly individuals 
(Waters et al. 2008). Atypical circadian cortisol secretion (i.e., attenuated morning and 
elevated pre-sleep concentration) has also been associated with poor physical performance 


















Figure 2.1 Pathways involved in skeletal muscle atrophy. Taken from Bonaldo and Sandri 
(2013). 
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Increased circulating myostatin concentration has also been purported to contribute to 
sarcopenia (Elliott et al. 2012). First characterised by McPherron, Lawler, and Lee (1997), 
myostatin, a transforming growth factor β (TGF-β) family member, is a potent negative 
regulator of skeletal muscle. Myostatin promotes protein degradation via phosphorylation of 
Smad2 and Smad3 by activin-like kinase (ALK) 4 and ALK5 (Figure 2.1). Activation of these 
genes is also thought to blunt MPS via inhibition of the IGF-1/Akt/mTOR pathway (Goodman 
et al. 2013). Several studies have reported a relationship between increased myostatin 
concentration and decreased SMM (Léger et al. 2008, Schulte and Yarasheski 2001, 
Yarasheski et al. 2002) and strength (Han et al. 2011, Patel et al. 2014). In contrast, others 
have not observed a relationship between myostatin and sarcopenia (Hofmann et al. 2015, 
Ratkevicius et al. 2011). These discrepancies may be explained in part by measurement 
difficulties, as myostatin has a close homology with other TGF-β members, making antibody 
specificity problematic (Consitt and Clark 2018). Nonetheless, as the role of myostatin in the 
pathogenesis of sarcopenia is still unclear (Consitt and Clark 2018), ongoing research is 
required to determine methods of disrupting the activity of myostatin and its relation to 
sarcopenia.  
 
2.2.8.5 Systemic inflammation  
Ageing is associated with chronic, low-grade, systemic inflammation, a phenomenon termed 
inflammaging (Franceschi et al. 2006, Piber et al. 2019). Most notably, circulating 
concentrations of CRP, IL-6 and TNF-α have been reported to increase with age and have 
been associated with a greater risk of sarcopenia (Bano et al. 2017, Schaap et al. 2006, 2009, 
Wang et al. 2017b, Wilson et al. 2017). Previous work has demonstrated chronic systemic 
inflammation negatively affects skeletal muscle via both direct and indirect pathways 
(Sakuma, Aoi, and Yamaguchi 2017). Indirectly, TNF-α supresses the expression of GH and 
IGF-1, inhibiting MPS (Fernández-Celemín et al. 2002). Directly, proinflammatory cytokines 
potently activate nuclear-factor kappa-light-chain-enhancer of activated B cells (NF-κB) 
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signalling (Kumar et al. 2004), promoting protein degradation and muscle atrophy (Li, 
Malhotra, and Kumar 2008).  
 
2.2.9 Measurement of skeletal muscle mass, strength, and physical function  
Measurement of SMM, strength and physical function can be performed by a range of 
methods. These methods have specific advantages and disadvantageous for use in clinical 
research (Table 2.1). For measurement of SMM, methods include body imaging techniques 
[e.g., magnetic resonance imaging (MRI), CT, DXA, BIA], anthropometry (e.g., skinfold 
thickness and leg circumference), biochemical markers [e.g., total or partial body potassium, 
deuterated creatine (D3-creatine) dilution method], and alternative methods such as neutron 
activation analysis (NAA) and electrical impedance myography (EIM) (Tosato et al. 2017).  
Both MRI and CT are considered the ‘gold standard’, predominately due to the ability to 
measure both SMM and fat infiltration simultaneously (Cesari et al. 2012). Additionally, 
although not considered gold standard, DXA is also often used as a reference method for 
identifying low SMM in older adults (Mijnarends et al. 2013). However, whilst CT, MRI and 
DXA accurately and reliably measure FFM/SMM, they are expensive, not widely available and 
expose participants to radiation (CT and DXA only) (Heymsfield et al. 2015). As an alternative, 
BIA is a relatively inexpensive, simple measurement technique, which estimates SMM based 
on measured impedance (Ω) using the equation of Janssen (2002): 
 
Whole body SMM (kg) = [(height(cm)2 / Ω x 0.401) + (sex x 3.825) + (age x -0.071)] + 5.102. 
 
Bioelectrical impedance analysis is based on the concept that fluid and electrolyte rich-tissues, 
particularly skeletal muscle, pose the least impedance to the passage of electrical current 
compared to those enriched with lipid (e.g., adipose tissue) (Tosato et al. 2017). Prediction 
equations have been validated for multiple groups including the elderly (Cruz-Jentoft et al. 
2010), and measurement of SMM has been cross-validated against MRI in older adults 
(Janssen et al. 2000a). For these reasons, several expert groups accept measurement of 
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SMM by BIA in the diagnosis of sarcopenia (Fielding et al. 2011, Chen et al. 2020, Cruz-
Jentoft et al. 2019). However, it is important to note that BIA has several limitations, such as 
nutrition and hydration status besides recent physical activity influencing measurement 
accuracy (Bauer and Morley 2020). Therefore, control of these factors prior to measurement 
is essential.  
 
Muscle strength is typically measured by either isometric, isokinetic or isotonic [one repetition 
maximum (1RM)] testing (Buckner et al. 2017). Isokinetic dynamometry is considered the gold 
standard; however, its use is limited due to cost and equipment availability (Cooper et al. 
2013). Measurement of 1RM offers a reliable alternative, and is strongly correlated with 
measurement of maximal strength by isokinetic dynamometry (Verdijk et al. 2009b). 
Furthermore, during 1RM tests, both eccentric and concentric actions are performed, thereby 
reflecting muscle actions performed during ADL (Grgic et al. 2020). This contrasts with other 
laboratory tests. Consequently, while testing can be time consuming, many researchers 
consider 1RM as the gold standard method of determining dynamic strength (Kraemer et al. 
2006). Furthermore, handgrip strength, which is an accepted method for diagnosing 
sarcopenia by numerous working groups including the EWGSOP2 (Cruz-Jentoft et al. 2019), 
is a simple, inexpensive and non-invasive measure of muscle strength. Low grip strength is 
also a strong predictor of a number of adverse health outcomes, such as poor quality of life, 
impaired functional capacity and mortality (Ibrahim et al. 2016, Leong et al. 2015). However, 
as highlighted by Tieland and colleagues (2015), handgrip strength poorly reflects changes in 
muscle strength measured by 1RM following RE training. Its use as an outcome measure in 
RE RCTs is therefore questionable. 
 
Physical performance can be defined as an objectively measured whole-body function related 
to locomotion (Cruz-Jentoft et al. 2019). This concept is multifaceted, involving muscle and 
neurological function (Beaudart et al. 2019). Physical function can be assessed by various 
methods, including measures of balance, gait speed and performance of ADL (Mijnarends et 
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al. 2013). One of the most widely used tests in the literature is the SPPB, which has been 
shown to be a reliable and valid method of measuring physical function (Mijnarends et al. 
2013), strongly predicts all-cause mortality (Pessini, Barbosa, and Trindade 2016), and is 
supported for diagnosis of sarcopenia by the EWGSOP2 (Cruz-Jentoft et al. 2019). The SPPB 
is a composite test including measures of gait speed, standing balance, and standing and 
sitting chair performance to make up a 12-point scoring system (Guralnik et al. 2000). Of note, 
a significant limitation of the SPPB is the potential ceiling effect, with 20% of respondents 
reported achieving the highest or lowest possible score (Bergland and Strand 2019).  
 
In addition to the SPPB, measurement of gait speed, which is also supported by the 
EWGSOP2, is a quick, safe and reliable test widely used in clinical practice (Bruyère et al. 
2016). Gait speed strongly predicts likelihood of numerous adverse outcomes such as falls, 
mortality and cognitive dysfunction (Cruz-Jentoft et al. 2019). Furthermore, the 6-minute walk 
test (6MWT) is a timed maximal walking exercise capacity test that requires participants to 
cover as much distance as possible in six minutes (Crapo et al. 2002). Test-retest reliability 
has been confirmed in older adults (Rikli and Jones 1998), and poor performance has been 
associated with an impaired ability to perform ADL (Enright et al. 2003). 
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Table 2.1 Methods of measuring skeletal muscle mass, strength, and physical function. Adapted from Cruz-Jentoft et al. (2019), Heymsfield et 
al. (2015), Meijers et al. (2013), Tieland et al. (2015) and Tosato et al. (2017) 
Method Measurement(s) Advantages Disadvantages 
Skeletal muscle mass    
Anthropometry  Skinfold thickness, circumference (e.g., 
leg) 
Non-invasive, low cost, applicable for 
large cohort studies 
Imprecise, assessor experience and training 
required, not applicable in the elderly due to 
increases in intramuscular fat infiltration with age 
 
Bioelectrical impedance 
analysis (BIA)  
Whole-body and segmental impedance, 
resistance and reactance, phase angle 
Relatively inexpensive, portable, and 
simple to conduct  
Measurement specific to participant conditions 
(e.g., food consumption, hydration status and 





Cross-sectional area, muscle attenuation  Three-dimensional reconstruction, high 
resolution, whole-body/regional 
measurements of lean tissue, fat, and 
bone mineral content  
 
Participant exposed to radiation, cost, participant 






D3-creatinine quantification from urine  Excellent agreement with MRI for 
measurement of SMM in humans 
Laborious processing (urinary sample processing 
and D3-creatinine determination), requires 
sophisticated equipment  
Dual X-ray 
absorptiometry (DXA) 
Lean tissue, fat, and bone mineral 
content  
 
Low radiation, whole-body/segmental 
measurement  
Size restrictions (height and body mass), 




Resistance and reactance  Non-invasive, many parameters can be 
captured (e.g., reductions in myocyte 
number or size) 
 




Cross-sectional area, fat infiltration  Three-dimensional reconstruction, high 
resolution, skeletal muscle quality can 
be measured using multiple measures 




Table 2.1 continued 
Method Measurement(s) Advantages Disadvantages 
Neutron activation 
analysis (NAA) 
Identification and quantification of elements 
in a given sample. The measurement relies 
on atom excitation by neutrons, so the 
treated sample emits gamma rays  
 
Very accurate estimation of overall 
SMM 
High cost, radiation exposure and technical 
difficulty   
 
Total or partial body 
potassium 
Elemental potassium (K) by either whole- or 
partial-body scintillation counter, body cell 
mass can then be derived from total body 
potassium (TBK) using standard equations 
 
 
Safe and relatively inexpensive  Equations rely on several assumptions (e.g., 
nitrogen content, hydration content of FFM) 
Ultrasonography  Muscle width and area  Safe, non-invasive, widely available  Technical training and skill required. Measurement 
of muscle size may be influenced by excess 
transducer pressure and orientation. Identifying 
exact location for reproducible measurements 
critical. Hydration status important 
 
24-h urinary creatinine  24-h urinary creatinine  Safe, non-invasive, reflects muscle 
cell mass, relatively inexpensive 
Requires participant cooperation for accurate 
results, multiple 24-h samples whilst ingesting a 
meat-free diet may be required 
Muscle strength     
One repetition 
maximum (1RM) 
Maximal weight that can be lifted once 
whilst maintaining correct form  
Strong correlation with isokinetic 
peak torque in older adults, safe and 
inexpensive, excellent test-retest 
reliability. Strongly reflects dynamic 
muscle actions required for ADL 
 
Potential learning effect if participants are not 
familiarised with procedures, time consuming  
Handgrip dynamometry Maximum isometric strength of the 
hand and forearm muscles 
Non-invasive, widely used in the 
literature, strongly associated with 
adverse health outcomes 
Does not strongly reflect changes in strength 
following RE training  
 
 25 
Table 2.1 continued  
Method Measurement(s) Advantages Disadvantages 
Isokinetic dynamometry Maximal strength at a constant 
predetermined velocity throughout a 
selected joints range of motion 
Gold standard for measurement of 
muscle function, high test-retest 
reliability 
High cost of equipment, generally single joint tests, 
many familiarisation sessions needed in older 
adults    
Physical function    
3D accelerometery Walking speed, step and stride time, step-
time asymmetry, mediolateral and 
craniocaudal acceleration  
 
Non-invasive portable method, 
accurately assesses multiple gait 
parameters  
Regular calibration needed, positioning of the 
accelerometer introduces bias 
400 m walk test Cover 400 m as quickly as possible with 
up to two rest stops during the test 
(endurance and walking capacity) 
 
Can be used to assess sarcopenia 
according to the EWGSOP2, high 
reproducibility in older adults  
Not applicable for older adults with significant 
functional limitations, number of stops may 
influence outcome  
6 min walk test (6MWT) Total distance covered in 6 minutes  High construct and concurrent 
reliability, simple to administer, well-
established method of establishing 
exercise capacity  
 
Walkway length significantly affects performance 
due to differences in directional changes 
Gait speed Timed walk at habitual or maximal walking 
speed over a set distance (typically 4 m) 
 
 
Quick, safe and highly reliable method 
to assess sarcopenia, widely used in 
clinical practice  
Differences in test distance influences result due to 
acceleration. Static or moving start also influences 
outcome 
Physical performance 
test (4- or 7-item) 
Measurement of typical ADL (e.g., lifting a 
book, simulated dressing, chair raise) 
High construct and concurrent validity, 
scores correlate well with disability 
and loss of independence  
 
 
Potential ceiling effect in healthy older adults 
Sit-to-stand test Time to complete either 5 or 10 repetitions, 
or maximal number of repetitions over 30 
seconds  
Simple to administer, reliable, high 
construct validity  
Frail/functionally limited older adults may not be 
able to complete the required repetitions, no 
consistent chair height used in the literature 
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Table 2.1 continued  








Widely used test in in the literature, 
strongly predicts adverse health 
outcomes, simple to administer, high 
test-retest reliability 
 
Potential ceiling effect in healthy older adults  
Stair climb test Ascend a flight of stairs as quickly as 
possible (measures stair climb power)  
 
 
Clinically feasible and low cost 
(minimal equipment required), 
excellent test-retest reliability, high 
concurrent validity  
Stair length may influence what is being measured 
(e.g., a longer flight of stairs may place greater 
demand on cardiovascular capacity as opposed to 
leg power) 
 
Standing balance Standing balance tests under different 
conditions (e.g., feet together on firm 
surface eyes open), balance 
accelerometery measured during each 
condition for measurement of postural sway 
 
High test-retest reliability, simple to 
administer, correlates with adverse 
physical outcomes  
Poor construct validity, does not correlate well with 
dynamic balance  
Timed-up-and-go 
(TUG) test 
Time to stand up from a standard chair, 
walk to a marker 3 m away, turn around, 
walk back, and sit down again 
Simple to administer, high construct 
validity for measurement of physical 
function, extensively used in geriatric 
medicine  
Prediction of future falls in older adults is limited, 
performance dependent on type of chair used   
 
ADL, activities of daily living; EWGSOP2, European Working Group of Sarcopenia in Older People 2; FFM, fat-free mass; SMM, skeletal muscle mass. 
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2.2.10 Treatment and prevention  
Despite an upsurge of research activity over the last decade, no approved pharmacological 
interventions are available for treatment or prevention of sarcopenia. Several have been 
tested, but these have generally been unsuccessful (Borst 2004, Onder, Della Vedova, and 
Landi 2009). Therefore, effective and safe lifestyle interventions are needed. As briefly 
highlighted previously, two potent stimulators of MPS are RE and protein ingestion (Wilkinson, 
Piasecki, and Atherton 2018). The subsequent sections will review the individual and 
combined effects of RE and dietary protein for the prevention and treatment of sarcopenia and 
identify areas for further research. 
 
2.2.10.1 Resistance exercise 
Although ageing adversely affects skeletal muscle, previous work has demonstrated skeletal 
muscle can be trained even in older age (Martone et al. 2015). Resistance exercise, which 
involves the voluntary contraction of targeted skeletal muscle against an external resistance 
(e.g., body weight, resistance machine, free weights, cables or bands) (Winett and Carpinelli 
2001), has been shown to increase SMM, strength and physical function in both old (Hakkinen 
et al. 1998), and the oldest of old (>90 years) individuals (Fiatarone et al. 1994). However, the 
effects are attenuated with advancing age (Straight et al. 2020), highlighting the need for 
earlier prevention to curb sarcopenia. Importantly, RE is well tolerated in both healthy and frail 
older adults with very few adverse events reported in the literature (Fragala et al. 2019). As a 
result, RE is considered the most effective preventative treatment of sarcopenia (Phillips and 
Martinson 2019). 
 
2.2.10.1.1 Effects of resistance exercise on muscle protein turnover  
Resistance exercise is a powerful anabolic stimulus for skeletal muscle tissue. A single bout 
of RE elevates MPS by 40-150%, with rates remaining elevated for up to 48 h post-exercise 
(Chesley et al. 1992, Phillips et al. 1997). At the molecular level, RE increases rates of MPS 
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via activation of mTOR complex 1 (mTORC1), phosphorylating several downstream kinases 
such as ribosomal protein S6 kinase 1 (S6K1), augmenting translational efficiency and 
capacity (Hodson et al. 2019). Resistance exercise also increases rates of MPB, which remain 
negative in the absence of food ingestion (Biolo et al. 1995, Phillips et al. 1997). Nevertheless, 
the concurrent increase in MPS and MPB following RE improves net muscle protein balance 



















Figure 2.2 Current understanding of changes in muscle protein turnover with resistance 
exercise training. Taken from Joanisse et al. (2020). 
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2.2.10.1.2 Effects of resistance exercise on fat-free mass, muscle strength and 
physical performance 
Over time, increases in whole-muscle size (~4.6%), hypertrophy of type I (6.7%), type IIa 
(12.1%) and type IIx muscle fibres (18.4%), increases in whole-muscle (43.3%) and individual 
muscle fibre isotonic strength (19.5%), hyperplasia, and an increase in satellite cell content 
have been reported following RE training (Dankel et al. 2019, Folland and Williams 2007). 
Increases in muscle strength may be explained, at least in part, by neurological adaptions 
(Carroll, Riek, and Carson 2001). Such adaptions include an increase in motor unit recruitment 
and firing frequency, decreased antagonist co-activation, and increased motor unit 
synchronisation (Folland and Williams 2007).  
 
In older adults, there is a plethora of evidence supporting the positive effects of RE on muscle 
function (Beckwée et al. 2019). Several meta-analyses, as displayed in Table 2.2, have 
reported increases in FFM (Buch et al. 2017, Csapo and Alegre 2016, Peterson, Sen, and 
Gordon 2011, Yoshimura et al. 2017), muscle strength (Buch et al. 2017, Csapo and Alegre 
2016, Martins et al. 2013, Peterson et al. 2010, Yoshimura et al. 2017) and physical function 
(Yoshimura et al. 2017). Of note, pooled increases in FFM of 1.1 kg (Peterson, Sen, and 
Gordon 2011), muscular strength of 25-35% (Peterson et al. 2010), and usual and maximum 
gait speed of 0.11 m/s and 0.26 m/s, respectively, have been reported following 12-20 weeks 
of RE (Yoshimura et al. 2017). To add to these findings, a systematic review conducted by 
Papa, Dong, and Hassan (2017) reported increased TUG and functional reach performance, 
reporting small to very large effects (Cohen’s d = 0.49-5.28).  
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Table 2.2 Summary of meta-analyses investigating the effects of resistance exercise on fat-free mass, muscle strength and physical function in 
older adults 
Study Measured outcome Studies (n) and participant/RE characteristics Key findings 
 
 FFM/SMM Strength Physical 
function 
  
Buch et al. 
(2017) 
x   4 studies (103 participants; age: 64.5 ± 7.4 y); training 
duration: 39.8 ± 18.1 sessions (~13 weeks); training 
frequency: 3 ± 1.2 times/week; intensity: 40% 1RM-6RM 
 
↑ upper (1.14 kg overall effect) and lower body 
strength (11.99 kg overall effect); ↑ FFM (2 kg 
overall effect) 
Csapo and 
Alegre (2016)  
x x  FFM (7 studies, 213 participants); muscle strength (15 
studies, 448 participants; age: 67.8 y); training duration: 154 
± 100 days; training frequency: 3 times/week (all studies); 
intensity: 40-80% 1RM 
 
↑ muscle size and strength which was greater 
training at higher (11% and 43%, respectively) than 
lower intensities (9% and 35%, respectively) 
Martens et al. 
(2013) 
 x  11 studies (834 participants; age: 60-79 y); training duration: 
6-24 weeks (mean: 14.1 ± 7.0 weeks); training frequency: 1-5 
times/week (mean: 3.2 ± 0.9); intensity: all resistant band 
studies, based on target repetitions (6-12) 
 
↑ muscle strength: healthy elderly (SMD: 1.30); 
older adults with some functional incapacity (SMD: 
1.01); older adults with pathology (SMD 0.54) 
Peterson et 
al. (2010) 
 x  47 studies, 1,079 participants (age: 67.4 ± 6.3 y); training 
duration: 6-52 weeks (mean: 17.6 ± 8.6 weeks); training 
frequency: 1-3 times/week (mean: 2.7 ± 0.5 days/week); 
intensity: 40-50% 1RM (mean: 70 ± 12.7% 1RM) 
 
↑ maximal strength of leg press (29 ± 2%), chest 
press (24 ± 2%), knee extension (33 ± 3%) and 
lateral pull (25 ± 2%). ↑ intensity was associated 





x   49 studies, 1,328 participants (age: 65.5 ± 6.5 y); training 
duration: 10-52 weeks (mean: 20.5 ± 9.1 weeks); training 
frequency: 2-3 times/week (mean: 2.8 ± 0.4 times/week); 
intensity: 50-80% 1RM (mean: 74.6 ± 6.9 %1RM) 
 
↑ FFM (1.1 kg pooled estimate). ↑ volume 
interventions resulted in greater ↑ in FFM 
Yoshimura et 
al. (2017) 
x x x 3 studies (397 participants with sarcopenia; age: >65 y); 
training duration: 12 weeks; training frequency: 2 times/week; 
training intensity: not reported 
↑ appendicular SMM (0.38 kg), knee extension 
strength (0.11 Nm/kg), and usual (0.11 m/s) and 
maximum walking speed (0.26 m/s) 
1RM, one repetition maximum; 6RM, six repetition maximum; FFM, fat-free mass; SMD; standardised mean difference; SMM, skeletal muscle mass. 
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2.2.10.1.3 Resistance exercise recommendations for older adults 
For health-related outcomes, the American College of Sports Medicine (ACSM) recommend 
older adults should perform RE twice weekly, at a volume of 8-12 repetitions per exercise, and 
at a moderate-vigorous intensity (60-80% 1RM) (Chodzko-Zajko et al. 2009). However, whilst 
these guidelines are still applicable, the evidence published by the ACSM in 2009 is somewhat 
outdated. The following sections will briefly review the current evidence for optimisation of 
training outcomes in older adults.  
 
2.2.10.1.3.1 Intensity  
Resistance exercise intensity is typically prescribed as a percentage relative to maximal 
strength (Fragala et al. 2019). For optimisation of muscular strength, two meta-analyses have 
reported RE performed at 70-79% 1RM elicits the largest effects (Borde, Hortobágyi, and 
Granacher 2015, Steib, Schoene, and Pfeifer 2010). Conversely, for muscle hypotrophy, 
similar gains have been reported between high (~80% 1RM) and low-moderate intensities 
(~45% 1RM) when mechanical work (sets x repetitions x intensity) is matched (Borde, 
Hortobágyi, and Granacher 2015, Csapo and Alegre 2016). More recently, a perhaps 
surprising finding from a recent meta-analysis by Straight and colleagues (2020) reported low 
intensity RE resulted in greater increases in type II muscle fibre size. Despite these 
controversial effects on muscle hypertrophy, as muscle weakness is considered the main 
determinant of sarcopenia by the EWGSOP2 (Cruz-Jentoft et al. 2019), RE intensities aimed 
to optimise muscle strength should be utilised. In support, the National Strength and 
Conditioning Association (NSCA) suggest in healthy adults, RE intensity should achieve 70-
85% 1RM to augment strength gains (Fragala et al. 2019).  
 
2.2.10.1.3.2 Volume 
Training volume signifies the total amount of weight lifted per session (Fragala et al. 2019). In 
a meta-analysis by Borde, Hortobàgyi, and Granacher (2015), 2-3 sets per exercise and 7-9 
repetitions per set elicited the greatest effects on muscle hypertrophy and strength. The 
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previously cited meta-analysis by Peterson and colleagues (2010) also reported a greater 
number of sets per session was associated with superior increases in FFM. Furthermore, 
training to muscle failure (or very close to) has been suggested to optimise gains in SMM 
(Schoenfeld and Grgic 2019). However, older adults may experience slower post-exercise 
recovery compared to that of younger adults, suggesting training to failure for every set of 
each exercise may be detrimental for this population (Schoenfeld and Grgic 2019). This theory 
is supported by the NCSA (Fragala et al. 2019).  
 
2.2.10.1.3.3 Frequency  
Training frequency represents the total number of sessions per week (Fragala et al. 2019). 
Results from two meta-analyses suggest 2-3 sessions per week elicits the greatest 
improvements in muscle strength (Steib, Schoene, and Pfeifer 2010, Borde, Hortobágyi, and 
Granacher 2015). Additionally, Borde, Hortobàgyi, and Granacher (2015) also reported no 
additional benefit of training three times per week versus twice-weekly on muscle strength. 
These findings are supported by more recent studies that reported similar effects on muscle 
hypertrophy, strength and physical function (Grgic, Schoenfeld, and Latella 2019, da Silva et 
al. 2017, Kneffel et al. 2020, Stec et al. 2017). Furthermore, out of 94 older adults, a substantial 
difference has been reported for preference of training frequency, with 26% of older adults 
preferring to train twice per week, compared to only 1% preferring thrice weekly training (Foley, 
Hillier, and Barnard 2011). Based on these findings, twice weekly RE may be optimal to aid 
long-term adherence in this population. 
 
2.2.10.2 Dietary protein  
Proteins are essential nutrients for the human body and have an integral role in the growth 
and repair of all cells and tissues (British Nutrition Foundation 2018). They are natural 
polymers made up of different monomers called amino acids (AA), linked together by peptide 
bonds (Litwack 2018). There are 20 AA in total, which can be partitioned into either essential 
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(EAA, n = 9) or non-essential AA (NEAA, n = 11). Essential amino acids must be consumed 
exogenously and are critical to prevent protein malnutrition. Non-essential amino acids are 
synthesised endogenously predominately from glucose (Litwack 2018).  
 
2.2.10.2.1 Types of dietary protein  
Protein occurs in a wide range of foods, including both animal (e.g., meat, fish, dairy products) 
and plant-based sources (e.g., soy, tofu, lentils) (Devries and Phillips 2014). Of importance, 
protein derived from dairy products (e.g., milk, yoghurt, cheese) are considered the highest 
quality of proteins (Devries and Phillips 2015). Whey protein, a by-product of cheese 
production, contains all nine EAA and is rich in the branched-chain amino acid (BCAA) leucine 
(~3 g/25 g whey protein), the key AA responsible for stimulation of MPS (Anthony et al. 2000). 
Following ingestion, whey protein results in a marked increase in blood AA, which are 
transported across the sarcolemma into the intramyocellular space (West et al. 2011). The 
increase in intramyocellular EAA concentrations, in particular leucine, subsequently stimulates 
mTORC1 and ribosomal protein S6 kinase (p70S6K), triggering a cascade of molecular events 
resulting in elevated rates of MPS (Katsanos et al. 2006). In older adults, acute ingestion of 
whey protein stimulates MPS [myofibrillar fractional synthetic rate (FSR)] to a greater extent 
than isonitrogenous amounts (20 g) of casein and soy at both rest (whey: 0.04%/h; casein: 
0.02%/h; soy: ~0.03%/h), and following RE (whey: 0.059%/h; casein: 0.035%/h; soy: 0.04%/h) 
(Burd et al. 2012, Yang et al. 2012b).  
 
2.2.10.2.2 Per meal protein recommendations and protein distribution  
As previously mentioned in section 2.2.8.2, to attenuate sarcopenia, protein intakes of 1.0-
1.2 g/kg/d (Bauer et al. 2013, Deutz et al. 2014), and even up to 1.6 g/kg/d (Phillips, Chevalier, 
and Leidy 2016) have been recommended. In addition to the total amount of dietary protein, 
a growing body of evidence also suggests the per meal dose and daily distribution may also 
be of importance (Murphy, Oikawa, and Phillips 2016). Prior studies have demonstrated a 
dose-response relationship between dietary protein ingestion and rises in MPS, at least up to 
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a maximally effective dose (Cuthbertson et al. 2005, Moore et al. 2009a, 2015, Yang et al. 
2012a). Beyond this dose, the muscle becomes refractory, and surplus ingestion of AA does 
not further stimulate MPS (Atherton et al. 2010). In older adults, Moore et al. (2015) 
established 0.4 g protein/kg (~32 g protein for an 80 kg individual) maximally stimulated 
myofibrillar FSR (~0.05%/h). 
 
Several studies have examined the pattern in which older adults consume their daily protein 
intake (Bollwein et al. 2013, Farsijani et al. 2016, 2017, Tieland et al. 2012a, Smeuninx, Greig, 
and Breen 2020). In agreement, these studies consistently report older adults consume their 
daily protein intake in a skewed pattern (i.e., high amounts consumed in the evening meal and 
smaller amounts consumed at breakfast and lunch). For example, Smeuninx, Greig, and 
Breen (2020) recently published data demonstrating older adults consume ~8, 12 and 75% 
(or ~0.2, ~0.3 and ~0.5 g/kg) of their daily dietary protein intake at breakfast, lunch and dinner, 
respectively (Figure 2.3). Taking into consideration the previously mentioned findings of 
Moore and colleagues (2015), these findings suggest the majority of older adults only 
consume optimal amounts of dietary protein once daily.  
 
Cross-sectional studies have reported an association between evenly distributed daily dietary 
protein intake and greater retention of leg and appendicular FFM (Jyväkorpi et al. 2020, 
Loenneke et al. 2016), increases in muscle strength (Loenneke et al. 2016), and improved 
physical function (ten Haaf et al. 2018a). In contrast, results from RCTs do not support these 
findings (Arnal et al. 1999, Bouillanne et al. 2013). An inadequate protein intake (0.22-0.33 
g/kg) provided at each meal compared to the recommended 0.4 g/kg/meal in older adults may 
explain these findings. In support, data in young adults providing the recommended dose per 
meal to stimulate MPS (0.24 g/kg) for 12 weeks resulted in a greater accretion of FFM 
compared to protein consumed in a skewed fashion (Yasuda et al. 2020). Therefore, although 
further RCTs are needed to confirm the clinical relevance in older adults, data thus far 














Figure 2.3 Meal-specific relative protein intakes in young, middle and older adults. T1, 
breakfast; T2, lunch; T3, dinner; T4, snack. Taken from Smeunix, Greig, and Breen (2020). 
 
2.2.10.2.3 Adverse effects of high protein diets  
Although high protein diets (>1.0-1.2 g/kg/d) have been recommended to attenuate 
sarcopenia, they are often discouraged due to purported harmful effects on renal function 
(Devries et al. 2018). The basis of this hypothesis stems from data demonstrating lower protein 
diets (0.6-0.8 g/kg/d) improved outcomes and delayed mortality in patients with chronic kidney 
disease (CKD) (Fouque et al. 2000, Levey et al. 1999). However, these findings do not provide 
direct evidence that high protein diets affect renal function in healthy adults. Therefore, 
Devries and colleagues (2018) conducted a comprehensive meta-analysis and meta-
regression (28 studies; 1358 participants) to answer this research question. The findings 
reported no effect on change in glomerular filtration rate (GFR), suggesting high protein diets 
do not adversely affect renal function in healthy adults.  
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Opponents of high protein diets are also apprehensive about the effects on calcium 
homeostasis and bone health (Phillips, Chevalier, and Leidy 2016). This theory originated from 
the acid-ash hypothesis, coined from findings demonstrating that diets high in protein and 
grains yield a greater dietary acid load (Eisenstein et al. 2002, Fenton et al. 2009). According 
to the hypothesis, large protein-induced acid loads increase urinary calcium excretion, 
resulting in the release of skeletal calcium (Fenton et al. 2009). However, no casual 
association between acid load and osteoporotic bone disease has been reported (Fenton et 
al. 2009, 2011). In fact, recent research suggests dietary protein may aid bone health when 
sufficient calcium is consumed (Mangano, Sahni, and Kerstetter 2014). Hence, based on 
literature cited in this section, evidence supports the safe consumption of high protein diets in 
healthy older adults. 
 
2.2.10.2.4 Effects of dietary protein on fat-free mass, muscle strength and physical 
function  
Observational data over a 3-year period has reported an association between increased 
dietary protein intake and a greater retention of FFM (Houston et al. 2008). Others have shown 
consumption of >1 g protein/kg/d can preserve grip strength (McLean et al. 2016, Mishra et 
al. 2018) and physical function (Mustafa et al. 2018). In support of epidemiological studies, 
several RCTs ranging from 6-24 weeks in duration, as shown in Table 2.3, have established 
beneficial effects of dietary protein on FFM, muscle strength and physical function (Bauer et 
al. 2015, Bell et al. 2017, Bo et al. 2019, Sardeli et al. 2018, Kang et al. 2020, Mitchell et al. 
2017, Negro et al. 2019, Norton et al. 2016, Park, Choi, and Hwang 2018, Shahar et al. 2013, 
ten Haaf et al. 2019, Tieland et al. 2012c). However, not all studies have observed such effects 
(Björkman et al. 2020, Cramer et al. 2016, de Carvalho Bastone et al. 2020, Kim et al. 2012, 
Kirk et al. 2020, Kukuljan et al. 2009, Verreijen et al. 2017, Zhu et al. 2015). The lack of protein-
induced effects in these studies, with the exception of de Carvalho Bastone et al. (2020), may 
be partially explained by participants habitually consuming ample amounts (~1.0-1.2 g/kg/d) 
of dietary protein at baseline (Bauer et al. 2013, Deutz et al. 2014). Consequently, this may 
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have masked any additional effects of supplementation. Nonetheless, it must be noted that 
declines in FFM have been reported in older adults consuming 1.2 g/kg/d of dietary protein 
(Norton et al. 2016). Of note, Norton et al. (2016) also demonstrated a significant increase in 
FFM following protein supplementation in older adults habitually consuming this level of 
dietary protein. These findings suggest that some healthy older adults may still be sensitive to 
the anabolic properties of protein supplementation whilst already consuming adequate dietary 
protein. Consequently, increased dietary protein may still be a promising strategy to attenuate 
sarcopenia in these individuals.  
 
As a result of the hypothesis proposed above, the lack of protein-induced effects reported in 
several studies may be explained by an insufficient increase in dietary protein from baseline. 
Reported deviations in these studies ranged from 0-0.35 g/kg/d (Björkman et al. 2020, Cramer 
et al. 2016). In contrast, other studies that reported beneficial effects deviated dietary protein 
by ≥0.4 g/kg/d (Bauer et al. 2015, Bell et al. 2017, Mitchell et al. 2017, Norton et al. 2016, 
Park, Choi, and Hwang 2018, ten Haaf et al. 2019). As previously mentioned, Moore et al. 
(2015) demonstrated a dose of 0.4 g protein/kg might be required to maximally stimulate MPS 
in older adults. Hypothetically, a deviation of ≥0.4 g protein/kg/d may therefore be required to 
stimulate muscle hypertrophy in older adults. This theory is supported by others (Park, Choi, 
and Hwang 2018). 
 
Whilst numerous studies have reported advantageous effects of dietary protein in older adults, 
the majority report effects on only FFM (Bauer et al. 2015, Bell et al. 2017, Sardeli et al. 2018, 
Kang et al. 2020, Mitchell et al. 2017, Negro et al. 2019, Norton et al. 2016, Park, Choi, and 
Hwang 2018, Shahar et al. 2013, ten Haaf et al. 2019, Tieland et al. 2012c). Several of these 
studies that also examined muscle strength and physical function observed no effect on either 
one or both of these outcomes (Bauer et al. 2015, Bell et al. 2017, Kang et al. 2020, ten Haaf 
et al. 2019). These findings are supported by a recent meta-analysis that reported a positive 
effect of increased dietary protein on FFM, but not muscle strength (Wirth, Hillesheim, and 
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Brennan 2020). As the EWGSOP2 highlights muscle strength as the primary index of 
sarcopenia (Cruz-Jentoft et al. 2019), further work is required to establish a mechanism of 
how dietary protein may increase muscle strength and physical function. Although, it may be 
that to obtain clinically significant improvements in these parameters in older adults, dietary 





Table 2.3 Summary of intervention studies investigating the effects of dietary protein on fat-free mass, muscle strength and physical function in 
older adults  
Study Participants, duration, 
and design 





380 sarcopenic older 






Active: 20 g whey protein-based 
supplement (twice daily) 
Control: isocaloric carbohydrate 
supplement (twice daily) 
Active: 1.0 (0-9-1.2) 
Control: 1.0 (0.8-1.2) 
Active group ↑ appendicular FFM and chair stand test 
performance greater than control group. No 
differences observed between groups for handgrip 
strength or SPPB. Protein intake ↑ to 1.5 g/kg/d (0.5 
g/kg/d deviation from baseline) in the active group 
 
Bell et al. 
(2017) 
49 healthy older men 
(age: 73 ± 1 y) 
 
20-week double-blind 
RCT split into 2 phases: 
(6-weeks nutrition and 
12-weeks exercise + 
nutrition) 
 
SUPP: 30 g whey protein, 1500 mg n−3 
PUFA, 2.5 g creatine, 500 IU vitamin D 
and 400 mg calcium (twice daily) 
CON: 22 g maltodextrin (twice daily) 
SUPP: 1.1 ± 0.3 
Control: 1.2 ± 0.3 
SUPP group ↑ FFM and strength greater than the 
control group. No differences in physical function 
observed between groups. Key findings from the 





dwelling adults with 




Whey protein: 20 g whey protein 
(twice daily)  
Placebo: isocaloric placebo (twice 
daily) 
Control: no supplement 
Whey protein: 1.1 ± 0.5 
Placebo: 1.0 ± 0.4 
Control: 1.0 ± 0.3 
No differences between groups for SMM or physical 
performance (SPPB). No changes in protein intake 
occurred during the intervention in the whey protein 
group 
Bo et al. 
(2019) 
60 sarcopenic older 




Protein: 22 g protein supplement (twice 
daily) 
Placebo: isocaloric carbohydrate 
supplement (twice daily) 
 
Protein: 0.76 ± 0.32 
Placebo: 0.71 ± 0.36 
Skeletal muscle index and handgrip strength ↑ greater 
in the protein than the placebo group. Protein intake ↑ 
by 0.25 g/kg/d in the protein group 
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Table 2.3 continued 
Study Participants, duration, 
and design 












Experimental: 330 kcal supplement 
(20 g protein; 499 IU vitamin D3; 1.5 g 
CaHMB) 
Control: 330 kcal supplement (14 g 
protein; 147 IU vitamin D3) 
 
 
Experimental: 0.94 (95% 
CI 0.70, 1.20) 
Control: 0.97 (95% CI 0.73, 
1.30) 
No differences in isokinetic peak torque, muscle 
quality, grip strength or gait speed occurred between 
groups. In participants with mild-moderate sarcopenia, 
strength ↑ greater in experimental compared to control 
group. Protein intake ↑ to ~1.3 g/kg/d in the 





(2020)         
69 older adults with 




RE + supplement: home-based RE 3 
times/week (80% 1RM, 3 sets of 8 
repetitions) + 40 g protein 
supplementation once daily 
RE: home-based RE 3 times/week 
(80% 1RM, 3 sets of 8 repetitions) 
Supplement: 40 g protein 
supplementation once daily 
Control: maintained habitual diet and 
physical activity  
 
<1.0 for all participants No significant differences between supplement and 
control groups occurred for any outcome. Results of 








Intervention: 20 g leucine-enriched 
protein supplement 
Control: isocaloric carbohydrate 
supplement  
 
~0.93 for both groups FFM ↑ greater in the intervention compared to control 
group. No differences occurred between groups for 
grip strength or physical function. Protein intake did 








Table 2.3 continued  
Study Participants, duration, 
and design 
Groups Habitual protein intake 
(g/kg/d) 
Key findings 
Kim et al. 
(2012) 
151 sarcopenic older 
women (age: >75 y) 
 
12-week RCT 
Exercise + AA: strength training twice 
weekly (8 repetitions; intensity: 12-14 on 
Borg scale) + 3 g EAA twice daily 
Exercise: strength training twice weekly (8 
repetitions; intensity: 12-14 on Borg scale) 
AA: 3 g EAA twice daily 
Control (health education): health 
education once a month 
 
Not reported  No effect of EAA on SMM, strength or physical 
function. Results of exercise + EAA are 
reported in Table 2.4  
Kirk et al. 
(2020) 
100 community-
dwelling healthy older 
adults (52% women; 
age: 69 ± 6 y) 
 
16-week RCT 
Exercise + protein: twice weekly RE, once 
weekly functional performance + 
individualised whey protein supplementation 
to achieve 0.5 g/kg/meal  
Exercise: twice weekly RE, once weekly 
functional performance 
Protein: individualised whey protein 
supplementation to achieve 0.5 g/kg/meal  
Control: maintained habitual dietary and 
physical activity levels 
 
Exercise + protein: 1.16 ± 
0.4 
Exercise: 1.10 ± 0.4 
Protein: 0.99 ± 0.2 
Control: 0.98 ± 0.3 
No effects of protein supplementation without 
exercise on SMM, strength or physical function. 










Exercise + milk: RE 3 days/week (2 sets x 
8-12 repetitions at 80-85% 1RM) + 2 x 200 
mL/d fortified milk  
Exercise: 3 days/week (2 sets x 8-12 
repetitions at 80-85% 1RM) 
Milk: 2 x 200 mL/d fortified milk  
Control: Maintain habitual physical activity 
and diet  
Exercise + milk: 1.26 ± 0.32 
Exercise: 1.32 ± 0.32 
Milk: 1.23 ± 0.28 
Control: 1.33 ± 0.31 
Milk had no effect on SMM, strength or physical 
function. Protein intake ↑ by 0.16 g/kg/d (to 1.39 
g/kg/d) at 12 months but did not change at 18 
months in the milk group. Results of exercise + 







Table 2.3 continued 
Study Participants, duration, 
and design 




29 men (age: >70 y) 
 
10-week RCT 
2 x RDA protein: diet containing 1.6 
g/kg/d protein  
RDA protein: diet containing 0.8 g/kg/d 
protein 
 
2 x RDA: 1.1 ± 0.3 
RDA: 1.2 ± 0.4 
2 x RDA group ↑ whole-body and appendicular 




38 healthy elderly 





SUPP: EAA-based multi-ingredient 
supplement containing ~10 g protein (5 g 
EAA, 1.4 g leucine, 1500 mg creatine, 
1000 IU vitamin D) twice daily 
Placebo: maltodextrin (twice daily)  
 
 
Not reported  SUPP group ↑ appendicular FFM, maximal 




60 healthy older men 






Protein: 0.165 g/kg of median body 
mass protein supplement (twice daily) 
Con: isoenergetic maltodextrin 
supplement (twice daily) 
Protein: 1.2 ± 0.3 
Con: 1.2 ± 0.3 
Total and appendicular FFM ↑ greater in the 
protein compared to control group. Protein 
intake ↑ to 1.6 ± 0.3 g/kg/d in the protein group 






120 prefrail and frail 





Diet containing 1.5 g/kg/d protein  
Diet containing 1.2 g/kg/d protein  
Diet containing 0.8 g/kg/d protein 
 
 
1.5 g/kg/d: 0.80 ± 0.21 
1.2 g/kg/d: 0.77 ± 0.24 
0.8 g/kg/d: 0.84 ± 0.28 
Appendicular FFM, SMI and gait speed ↑ in the 
1.5 g/kg/d group greater than the 0.8 g/kg/d 
group 





Table 2.3 continued 
Study Participants, duration, 
and design 






65 sarcopenic older 
adults (age: 60-74 y) 
 
12-week RCT 
Exercise + protein: resistance band 
exercise twice weekly at moderate 
intensity + soy protein drink (20 g/d for 
men and 40 g/d for women) to achieve 
1.5 g/kg/d protein 
Exercise: resistance band exercise 
twice weekly at moderate intensity 
Protein: soy protein drink (20 g/d for 
men and 40 g/d for women) to achieve 
1.5 g/kg/d protein 
Control: relaxation programme twice 
weekly 
 




Protein supplementation alone ↑ upper body 
strength greater than control. Results of 




116 physically active 





Protein: 31 g milk protein supplement 
(twice daily) 
Placebo: isocaloric carbohydrate 
placebo (twice daily)  
 
Protein: 0.86 ± 0.23 
Placebo: 0.92 ± 0.24 
FFM ↑ in the protein group greater than placebo 
group. No differences between groups for 




65 frail elderly 





Protein: 15 g milk protein supplement 
(twice daily) 
Placebo: energy-matched placebo (no 
protein; twice daily) 
 
 
Protein: 1.0 ± 0.0 
Placebo: 1.0 ± 0.0 
No differences occurred between groups for SMM 
but physical performance ↑ in the protein group 
greater than the placebo group. Muscle strength 
also tended to ↑ greater in the protein group 







Table 2.3 continued  
Study Participants, duration, 
and design 






100 older adults who 
were overweight or with 
obesity (55–80 year) 
 
10-week RCT 
Exercise + protein: RE 3 days/week (2-
3 sets of 50 s per exercise) + dietary 
advice to achieve 1.3 g protein/kg/d 
Exercise: RE 3 days/week (2-3 sets of 
50 s per exercise) + dietary advice to 
achieve 0.8 g protein/kg/d 
Protein: dietary advice to achieve 1.3 g 
protein/kg/d 
Control: dietary advice to achieve 0.8 g 
protein/kg/d 




Exercise + protein: 1.00 ± 0.31 
Exercise: 0.93 ± 0.30 
Protein: 0.92 ± 0.34 
Control: 0.95 ± 0.36 
No effect of dietary protein on FFM, handgrip 
strength or gait speed. Protein intake during the 
intervention was lower than targeted (1.02 ± 0.36 
and 1.02 ± 0.35 g/kg/d in the protein and exercise 
plus protein groups respectively). Results of 




Zhu et al. 
(2015)  
181 postmenopausal 
older women (age: 74.3 




Protein: 30 g/d milk-based protein 
supplement  
Placebo: skimmed milk-based 
supplement (2.1 g protein)  
Protein: 1.2 ± 0.3 
Placebo: 1.1 ± 0.3 
No differences between groups for SMM, strength 
or physical function. Protein intake ↑ by 20 g/d to 
~1.47 g/kg/d (0.27 g/kg/d deviation from baseline) 
in the protein group 
 
↑, increased; CaHMB, calcium β-hydroxy-β-methylbutyrate; EAA, essential amino acids; FFM, fat-free mass; n-3 PUFA, omega 3 polyunsaturated fatty acids; 
RE, resistance exercise; RCT, randomised controlled trial; SMM, skeletal muscle mass; SPPB, short physical performance battery.
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2.2.10.3 Resistance exercise combined with dietary protein 
Previous work has shown acute ingestion of dietary protein during recovery of RE stimulates 
a greater and more sustained increase in rates of MPS (Moore et al. 2009b, Pennings et al. 
2011), and mitigates post-exercise MPB to a greater extent than RE without protein ingestion 
(Biolo et al. 1995, 1997). Resistance exercise also sensitises skeletal muscle to the anabolic 
properties of protein ingestion for up to 24 h post exercise (Burd et al. 2012). Accordingly, 
older adults chronically participating in RE training and consuming higher amounts of dietary 
protein may habitually increase their net muscle protein balance, resulting in a greater 
attenuation of sarcopenia. The synergistic effects of RE and dietary protein will be 
subsequently reviewed.   
 
2.2.10.3.1 Effects of resistance exercise combined with dietary protein on fat-free 
mass, muscle strength and physical function 
The findings of the majority (Cermak et al. 2012, Finger et al. 2015, Liao et al. 2017, Morton 
et al. 2018a), but not all meta-analyses (Thomas et al. 2016) including both younger and older 
adults suggest dietary protein may augment the adaptive response of skeletal muscle to RE. 
In contrast, whilst several individual RCTs in older adults have reported significantly greater 
increases in FFM, muscle strength and physical function following RE combined with dietary 
protein compared to RE alone (Bell et al. 2017, Daly et al. 2014, Kang et al. 2019, Junior et 
al. 2018, Rondanelli et al. 2016, 2020, Tieland et al. 2012b, Verreijen et al. 2015, Yamada et 
al. 2019, Zdzieblik et al. 2015), the majority of studies, as displayed in Table 2.4, have not 
observed such effects (Arnarson et al. 2013, Candow et al. 2006, Chalé et al. 2013, de 
Carvalho Bastone et al. 2020, Dulac et al. 2020, Englund et al. 2018, Fielding et al. 2017, 
Gryson et al. 2014, Hofmann et al. 2016, Holm et al. 2008, Holwerda et al. 2018, Kim et al. 
2012, Kirk et al. 2019, 2020, Kukuljan et al. 2009, Leenders et al. 2013, Maltais, Ladouceur, 
and Dionne 2016, Oesen et al. 2015, Ottestad et al. 2017, Shahar et al. 2013, Thomson et al. 
2016, Verdijk et al. 2009a, Verreijen et al. 2017).  
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Disparities between the aforementioned studies might be explained in part by differences in 
the population studied and habitual protein intake of participants. To elucidate, several studies 
that observed synergistic effects included sarcopenic or frail older adults with habitual protein 
intakes ≤1 g/kg/d (Kang et al. 2019, Rondanelli et al. 2016, 2020, Tieland et al. 2012b, Yamada 
et al. 2019, Zdzieblik et al. 2015). Contrary to these studies, others that failed to observe 
augmented effects included healthy older adults whom habitually consumed ≥1 g protein/kg/d 
(Arnarson et al. 2013, Candow et al. 2006, Dulac et al. 2020, Holm et al. 2008, Holwerda et 
al. 2018, Hofmann et al. 2016, Kirk et al. 2019, 2020, Kukuljan et al. 2009, Leenders et al. 
2013, Oesen et al. 2015, Thomson et al. 2016, Verdijk et al. 2009a). These findings imply a 
relatively good health status and an adequate habitual dietary protein intake may mask the 
supplemental effects in older adults performing RE. Differential effects between 
sarcopenic/frail and healthy older adults may be related to the higher chronic systemic 
inflammatory activity observed in frail older adults, resulting in dietary protein augmenting a 
greater anti-inflammatory effect in these individuals (Breen and Phillips 2011, Degens 2010, 
Toth et al. 2005).  
 
In opposition of the health status and habitual protein intake hypotheses above, augmented 
effects have been observed in healthy older adults habitually consuming both adequate (1.0-
1.1 g/kg/d) (Bell et al. 2017, Daly et al. 2014) and inadequate (0.85 ± 0.10 g/kg/d) amounts of 
dietary protein (Junior et al. 2018). Furthermore, no effects have also been reported in 
sarcopenic/functionally impaired older adults (Chalé et al. 2013, de Carvalho Bastone et al. 
2020, Englund et al. 2018, Fielding et al. 2017, Kim et al. 2012, Maltais, Ladouceur, and 
Dionne 2016, Ottestad et al. 2017, Shahar et al. 2013). Similar to that of the effects of dietary 
protein alone, these findings indicate participant health status and/or habitual protein intake 
do not fully explain the discrepancies between studies.  
 
Accordingly, inconsistent findings within the literature may also be explained by the 
characteristics of the protein intervention. Specifically, the magnitude of a) protein deviation 
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from baseline, and b) daily protein intake. In support, as frequently reported in this thesis, the 
breakpoint for maximal protein-induced stimulation of MPS in older adults has been 
established at 0.4 g/kg (Moore et al. 2015), suggesting this dietary modification may be 
required to augment the adaptive response to RE in older adults (Park, Choi, and Hwang 
2018). Indeed, two studies that demonstrated synergistic effects in healthy older adults 
deviated dietary protein by 0.5-0.55 g/kg/d (Bell et al. 2017, Junior et al. 2018). This is in 
contrast to those that failed to observe additive effects, of whom deviated dietary protein by 
≤0.3 g/kg/d (Arnarson et al. 2013, Dulac et al. 2020, Gryson et al. 2014, Holwerda et al. 2018, 
Kirk et al. 2019, 2020, Kukuljan et al. 2009, Leenders et al. 2013, Maltais, Ladouceur, and 
Dionne 2016, Verdijk et al. 2009a).  
 
Furthermore, studies in sarcopenic/functionally impaired older adults that reported null 
findings also deviated dietary protein intake by ≤0.4 g/kg/d (Chalé et al. 2013, Maltais, 
Ladouceur, and Dionne 2016, Ottestad et al. 2017), or those studies where dietary intake data 
was not reported, supplemented dietary protein either only post-exercise on training days 
(Englund et al. 2018, Fielding et al. 2017), or daily at a dose of ≤20 g/d [Kim et al. 2012, Shahar 
et al. 2013 (for men only)]. These dosing regimens were likely insufficient to elicit synergistic 
effects. A meta-regression conducted by Morton and colleagues (2016) also reported the dose 
of dietary protein required for maximal accretion of SMM during RE training in healthy adults 
to be 1.6 g/kg/d. This level of dietary protein was only achieved by healthy participants in the 
study by Bell et al. (2017). Taking together the totality of evidence, a dietary modification of 
≥0.4 g protein/kg/d and a protein intake of 1.6 g/kg/d may be required to elicit synergistic 
effects in healthy older adults. Further research is required to confirm this theory.  
 
Limitations of many of the aforementioned studies was the failure to include a protein only 
group. In fact, only 7/33 studies cited investigated the synergistic effects compared to both RE 
and dietary protein alone over a ≥10-week period (de Carvalho Bastone et al. 2020, Gryson 
et al. 2014, Kim et al. 2012, Kukuljan et al. 2009, Shahar et al. 2013, Kirk et al. 2020, Verreijen 
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et al. 2017). Since dietary protein was increased by ≤0.3 g/kg/d in these studies, the 
synergistic effects compared to each intervention alone utilising the optimal protein dose is 
currently unknown. Recently, it has been reported not all older adults are willing or able to 
perform RE (Dismore et al. 2020); thus, collection of such data is vital to determine the 
effectiveness of this nutrient in these groups. Furthermore, only one of the abovementioned 
4-arm RCTs included a placebo or energy-matched control product (Gryson et al. 2014), which 
has been recommended by an expert working group for trials investigating the effectiveness 
of interventions to treat or prevent sarcopenia (Reginster et al. 2016). Lack of such 
experimental control significantly increased the risk of bias in these studies (i.e., participants 
in the non-protein groups potentially increasing their dietary protein intake). A 4-arm, double-
blind, RCT is therefore warranted to robustly investigate the synergistic effects of RE and 
dietary protein (at a daily intake of 1.6 g/kg/d) compared to RE alone, dietary protein alone, 







Table 2.4 Summary of intervention studies investigating the effects of resistance exercise combined with dietary protein on skeletal muscle/fat-
free mass, muscle strength and physical function in older adults  
Study Participants, duration, 
and design 










Whey protein: 20 g protein, 20 g carbohydrate, 1 g 
fat (after each RE session only) 
Carbohydrate: 40 g carbohydrate, 1 g fat (after 
each RE session only) 
Both groups performed: RE 3 times/week (75-80% 
1RM, 6-8 repetitions per set) 
 
Whey protein: 1.0 ± 0.3 
Carbohydrate: 0.9 ± 0.3  
FFM, maximal strength and physical 
function ↑ after RE but whey protein did not 
provide an additive effect. Protein deviation 
from baseline was 0.06 g/kg/d in the whey 
protein group 
Bell et al. 
(2017) 
49 healthy older men 
(age: 73 ± 1 y) 
 
20-week, double-blind 
RCT split into 2 phases: 
6-weeks nutrition only + 
12-weeks exercise + 
nutrition 
 
SUPP: 30 g whey protein, 1500 mg n−3 PUFA, 2.5 g 
creatine, 500 IU vitamin D and 400 mg calcium 
(twice daily) 
CON: 22 g maltodextrin (twice daily) 
Both groups performed: twice weekly RE at 80% 
1RM (8 repetitions per set) + HIIT training once 
weekly (10 x 60 s intervals at 90% max HR) 
SUPP: 1.1 ± 0.3 




No augmented effect of whey protein 
supplementation on FFM in phase 2 
(exercise). Upper-body strength ↑ following 
12-weeks exercise greater in the SUPP 
group compared to the CON group. 
Protein intake during the intervention ↑ to 
1.6 ± 0.4 g/kg/d in the SUPP group (0.5 
g/kg/d deviation from baseline) 
Candow et 
al. (2006)  





Protein before training: 0.3 g/kg protein before 
training + 0.63 g/kg maltodextrin after training 
Protein after training: 
0.63 g/kg maltodextrin before training + 0.3 g/kg 
protein after training  
Placebo before and after training:  
0.63 g/kg maltodextrin before and after training  
All groups performed: 
3 days/week RE (3 x 10 repetitions at 70% 1RM) 
Not reported Protein supplementation before or after RE 




Table 2.4 continued  
 
Study Participants, 
duration, and design 






adults (age: 70–85 y) 
 
24-week RCT 
Whey protein: 20 g whey protein, 25 g maltodextrin, 1 g fat 
(twice daily) 
Control: isocaloric supplement containing 45 g maltodextrin 
and 1 g fat (twice daily) 
Both groups performed: RE (3 sets of 12 repetitions at 
80%1RM) 3 times/week 
 
Whey protein: ~0.97  
Control: ~1.0  
FFM, muscle CSA and stair climbing 
performance ↑ in both groups. Whey 
protein did not elicit additional benefits. 
Protein intake ↑ to 1.17 g/kg/d (0.2 
g/kg/d spread from baseline) in the 
whey protein group. 
Daly et al. 
(2014) 
100 women living in 
retirement villages 






Meat: 160 g (cooked) lean red meat 6 days/week 
Control: 1 serving of pasta or rice per day 
Both groups performed: RE twice weekly (14-16 ‘somewhat 
hard’ on Borg scale, 3 sets of 8-12 repetitions) 
Meat: ~1.04  
Control: ~1.11  
Greater ↑ in FFM and muscle strength 
were observed in the meat compared to 
the control group. Protein intake during 
the intervention was 1.29 ± 0.30 g/kg/d 
(deviation from baseline of ~0.25 





69 older adults with 
dynapenia (age: 75.9 
± 6.7 y) 
 
12-week RCT 
RE + supplement: home-based RE 3 times/week (80% 1RM, 
3 sets of 8 repetitions) + 40 g protein supplementation once 
daily 
RE: home-based RE 3 times/week (80% 1RM, 3 sets of 8 
repetitions 
Supplement: 40 g protein supplementation once daily 
Control: maintained habitual diet and physical activity 
  
<1.0 for all 
participants 
RE ↑ handgrip strength, gait speed and 
sit-to-stand test performance, but no 






60 elderly men (age: 




Fast protein supplementation: 10 g whey 3 times/day 
Slow protein supplementation: 10 g casein 3 times/day 
Placebo: isocaloric amount of maltodextrin  
All groups performed: mixed power training: RE: 3 
times/week (80% 1RM, 3 sets of 10-12 repetitions) and 
functional exercises (3 sets of 10 repetitions, 8 intensity on 
Borg scale) 
Fast protein: 1.40 ± 
0.31 
Slow protein: 1.34 ± 
0.45 
Placebo: 1.48 ± 0.36 
All groups ↑ FFM, MQ and functional 
capacity but no differences were 
observed between groups. 
Protein intake ↓ in both the fast and 
slow protein groups during the 
intervention (1.24 ± 0.40 and 1.22 ± 
0.40 g/kg/d at 12 weeks, respectively) 
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Table 2.4 continued  
 
Study Participants, duration, 
and design 





149 mobility limited 
(SPPB ≤9) older adults 





Supplement: 20 g whey protein, 800 IU vitamin D and 350 
mg of calcium post-exercise on training days 
Placebo: non-nutritive sweetened drink providing 30 kcal per 
serving 
Both groups performed: strength exercises 3 times/week 
(intensity: 15–17 on Borg Scale) 
Not reported  Both groups ↑ muscle strength, FFM and 
thigh composition. No differences 
occurred between groups 
Fielding et 
al. (2017) 
*Same as above 
 
*Same as above 
 
Not reported  No differences in physical function (SPPB 




48 healthy sedentary 




Exercise + leucine enriched fortified milk:  
RE + AE 3 times/week (RE: 50-80% 1RM, 3 sets of 8-12 
repetitions; AE: 80% max HR) + fortified drink containing 10 g 
soluble milk proteins rich in leucine 
Exercise + fortified milk: RE + AE 3 times/week (RE: 50-
80% 1RM, 3 sets of 8-12 repetitions; AE 80% max HR) + 
fortified drink containing 10 g milk protein 
Exercise + placebo: RE + AE 3 times/week (RE: 50-80% 
1RM, 3 sets of 8-12 repetitions; AE 80% max HR) + placebo 
drinking containing 4 g milk protein 
Fortified milk: Fortified milk containing 10 g soluble milk 
proteins rich in leucine  
Placebo: placebo drink containing 4 g milk protein 
 
Not reported ↑ in appendicular and dominant leg FFM, 
and quadricep strength occurred in both 
the RE + fortified milk and RE + placebo 
groups. No differences were observed 
between groups 
Holm et al. 
(2008)  





Nutrient: supplement containing 10 g whey protein, 31 g 
carbohydrate, 1 g fat, 200 IU vitamin D and 250 mg calcium 
after RE 
Placebo: 6 g carbohydrate and 12 mg calcium after RE 
Both groups performed:  
RE 3 times/week (3-5 sets x 8-15 reps at 8-10RM) 
Nutrient: ~1.04  
Placebo: ~0.89  
FFM, muscle fibre CSA and strength ↑ in 
both groups but no significant differences 
occurred between groups. The nutrient 
supplement was ineffective at increasing 
dietary protein intake  
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Table 2.4 continued  
 
 
Study Participants, duration, 
and design 






41 healthy older men 




Protein: 21 g whey protein (twice daily) 
Placebo: Energy matched placebo (24.5 g carbohydrate, 
5.8 g fat) (twice daily) 
Both groups performed: RE 3 times/week at 80% 1RM 
(10 repetitions per set) 
Protein: 1.14 ± 0.05 
Placebo: 1.19 ± 0.06 
Maximal strength and FFM ↑ after RE but 
protein supplementation did not augment 
the effects. Protein intake during the 
intervention was 1.43 ± 0.04 g/kg/d (0.29 










RE + nutritional supplementation: RE twice/week at 
moderate-high intensity using TheraBand®, 2 x 15 
repetitions per exercise) + 20.7 g protein every morning 
and after each session 
RE: RE twice/week at moderate-high intensity using 
TheraBand®, 2 x 15 repetitions per exercise)   
Control: cognitive training twice weekly 
 
Not reported  MQ and physical performance ↑ following 









Protein: 35 g whey protein after each RE session 
Placebo: 35 g maltodextrin after each RE session 
Both groups performed: RE 3 times/week (3 sets x 8-12 
RM) 
Protein: 0.85 ± 0.1 
Placebo: 0.81 ± 0.1 
Greater ↑ in SMM and total strength were 
observed in the protein group. Protein 
intake ↑ to 1.4 ± 0.1 g/kg/d at 12 weeks in 
the protein group (0.55 g/kg/d deviation 
from baseline) 
 
Kang et al. 
(2019) 
115 pre-frail and frail 





Active: home-based RE (no intensity or frequency 
reported) + 32.4 g whey protein daily 
Control: home-based RE (no intensity or frequency 
reported) 
Not reported  Active group ↑ handgrip strength, gait 
speed and chair raise performance greater 
than the control group. 
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Table 2.4 continued 
Study Participants, 
duration, and design 
Groups Habitual protein 
intake (g/kg/d) 
Key findings 
Kim et al. 
(2012) 
151 sarcopenic older 
women (age: >75 y) 
12-week RCT 
Exercise + AA: exercise including strength training twice 
weekly (8 repetitions, 12-14 Borg scale intensity) + 3 g EAA 
twice daily 
Exercise: exercise including strength training twice weekly (8 
repetitions, 12-14 Borg scale intensity) 
AA: 3 g EAA twice daily 
Control (health education): health education once a month 
 
Not reported  Exercise ↑ leg muscle mass, usual and 
maximum gait speed, and knee extension 
strength but no additive effects were 
observed following EAA 
Kirk et al. 
(2019) 
46 community-
dwelling healthy older 
adults (age: 68 ± 5 y)  
16-week RCT 
 
Exercise + protein: twice weekly RE, once weekly functional 
exercise + individualised whey protein supplementation to 
achieve 0.5 g/kg/meal protein (supplement 3 times/d) 
Exercise: twice weekly RE, once weekly functional exercise 
Exercise + protein: 
1.2 ± 0.4  
Exercise: 1.10 ± 0.4 
 
Maximal strength and physical function ↑ 
following RE but no additive effects were 
observed following protein supplementation. 
Protein intake during the intervention ↑ to 
1.5 ± 0.7 g/kg/d (0.3 g/kg/d deviation from 
baseline) in the protein group 
Kirk et al. 
(2020) 
100 community-
dwelling healthy older 
adults (age: 69 ± 6 y) 
 
16-week RCT 
Exercise + protein: twice weekly RE, once weekly functional 
exercise + individualised whey protein supplementation to 
achieve 0.5 g protein/kg/meal   
Exercise: twice weekly RE, once weekly functional exercise 
Protein: individualised whey protein supplementation to 
achieve 0.5 g protein/kg/meal  
Control: maintained habitual dietary and physical activity 
levels 
 
Exercise + protein: 
1.16 ± 0.4 
Exercise: 1.10 ± 0.4 
Protein: 0.99 ± 0.2 
Control: 0.98 ± 0.3 
Exercise ↑ myoelectrical muscle fatigue but 
not SMM. Protein supplementation had no 
additive effects. Protein intake during the 
intervention ↑ to 1.5 ± 0.7 g/kg/d (0.3 g/kg/d 






dwelling older men 
(age: 50-79 y) 
 
18-month RCT 
Exercise + milk: RE 3 days/week (2 sets x 8-12 repetitions 
at 80-85% 1RM) + 2 x 200 mL/d fortified milk 
Exercise: RE 3 days/week (2 sets x 8-12 repetitions at 80-
85% 1RM) 
Milk: 2 x 200 mL/d fortified milk  
Control: maintained habitual physical activity and diet  
Exercise + milk: 
1.26 ± 0.32 
Exercise: 1.32 ± 
0.32 
Milk: 1.23 ± 0.28 
Control: 1.33 ± 0.31 
RE ↑ muscle strength, gait speed and 
muscle CSA. Milk did not elicit 
supplemental effects. Protein intake ↑ by 
0.26 g/kg/d (to 1.52 g/kg/d) at 12 months 
but did not change at 18 months in the 
exercise + milk group 
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Table 2.4 continued 
 
 
Study Participants, duration, and 
design 






53 healthy older adults (age: 70 
± 1 y)  
 
24-week double-blind RCT 
 
 
Protein: 15 g milk protein supplement daily after 
breakfast 
Placebo: 7.13 g lactose (not isocaloric) daily after 
breakfast 
Both groups performed: RE 3 times/week at 75-
80% 1RM (8-10 repetitions) 
 
1.2 ± 0.1 in women 
and 1.1 ± 0.0 in men 
Maximal strength, FFM and physical 
performance ↑ in both groups with no 
differences between groups. Protein intake 






26 sarcopenic elderly men (age: 
60-75 y) 
 
12-week double-blind RCT 
Milk protein: 13.53 g protein, 7 g EAA, 37.5 g 
carbohydrate, 3.8 g fat (270 kcal) after each 
exercise session 
EAA: soy beverage enriched with EAA powder 
(12 g protein, 7 g EAA – 3.5 g from leucine, 39 g 
carbohydrate, 5.3 g fat - 252 kcal) after each 
exercise session 
Control: rice milk (59.5 g carbohydrate, 3.75 g fat 
– 290 kcal) after each exercise session 
All groups performed: 
RE 3 times/week (80% 1RM, 8 repetitions per set, 
3 sets per exercise) 
 
Milk: 1.04 ± 0.20 
EAA: 1.26 ± 0.20 
Control: 1.32 ± 0.45 
FFM and maximal strength ↑ in all groups 
with no differences between groups. Protein 
intake did not change over the duration of 
the study in the EAA group (week 12:1.21 ± 
0.3 g/kg/d – deviation from baseline, -0.05 
g/kg/d) or the milk group (week 12: 0.95 ± 









RE + nutrient supplementation: elastic band RE 
2 times/week (1 set x 15 repetitions) + 20.7 g 
protein supplement every morning and after each 
training session 
RE only: elastic band RE 2 times/week (1 set x 
15 repetitions) 
Control: cognitive training twice weekly 
Not reported  RE ↑ physical function compared to control. 
No differences were observed between 
groups  
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Table 2.4 continued  
Study Participants, duration, and 
design 






36 healthy, community-dwelling 
older adults with reduced strength 
and gait speed (age: ≥70 y) 
 
12-week double-blind RCT 
Protein-enriched milk: 2 x 0.4 L/d milk (2 x 20 
g/d protein) 
Control: isocaloric carbohydrate drink (2 x 0.4 
L/d) 
Both groups: performed 30 min/d physical 
activity including strength exercises 
 
Protein-enriched 
milk: 1.0 ± 0.3 
Control: 1.0 ± 0.3 
No additive effect of milk supplementation 
on SMM, strength or physical function 
occurred. Protein intake ↑ to 1.4 ± 0.5 
g/kg/d at 12 weeks (0.4 g/kg/d deviation 





130 sarcopenic older adults (age: 
80.3 y) 
 
12-week double-blind RCT 
Intervention: 22 g whey protein, 10.9 g EAA and 
100 IU vitamin D (once daily) 
Placebo: isocaloric amount of maltodextrin (once 
daily) 
Both groups performed: 
20 min moderate intensity (12-14 on Borg scale) 




Placebo: ~0.97  
Whole-body FFM, relative SMM and 
handgrip strength ↑ greater in the 








140 sarcopenic older adults (81 ± 6 
y) 
 
4-8-week RCT (minimum 4 weeks, 
maximum 8 weeks) 
 
Experimental: 20 g whey protein, 2.8 g of 
leucine, 9 g of carbohydrate, 3 g of fat, 800 IU of 
vitamin D 
Control: isocaloric amount of maltodextrin 
Both groups: completed a physical rehabilitation 




Control: 0.75  
Whey protein resulted in greater ↑ in gait 
speed, SMM, SPPB, chair stand test 
performance and handgrip strength 
compared to control 
Shahar et 
al. (2013) 




Exercise + protein: resistance band exercise 
twice weekly at moderate intensity + soy protein 
drink (20 g/d for men and 40 g/d for women) to 
achieve 1.5 g protein/kg/d 
Exercise: resistance band exercise twice weekly 
at moderate intensity 
Protein: soy protein drink (20 g/d for men and 40 
g/d for women) to achieve 1.5 g protein/kg/d  






No additive effect of protein 
supplementation was observed for FFM or 
muscle strength   
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Table 2.4 continued  
Study Participants, 
duration, and design 





62 frail older adults 





Protein: 15 g milk protein supplement (twice daily)  
Placebo: energy matched placebo (no protein – twice daily) 
Both groups performed: twice weekly RE at 75% 1RM (8-





FFM ↑ greater in the protein compared to 
placebo group. Maximal strength ↑ in both 
groups but no additive effect was observed 




179 healthy older 




High dairy protein diet: 1.0 g/kg/d protein diet + ~27 g/d 
dairy based protein shake 
High non-dairy protein diet: 1.0 g/kg/d protein diet + ~27 
g/d soy protein shake 
Usual protein diet: 1.0 g/kg/d protein diet + carbohydrate 
energy matched foods 
All groups performed: RE 3 days/week (3 sets of 8-12 
repetitions at 8-12RM) 
 
~1.0 maintenance in 
all diets 
Additional protein (from dairy or soy) did not 
provide additive benefits on strength, FFM 
or physical function. Protein intake ↑ to 1.42 
± 0.14 and 1.45 ± 0.14 g/kg/d in the high 




26 healthy older men 




Protein: 10 g protein pre- and post-session)  
Placebo: water only (pre- and post-session) 
Protein: 1.1 ± 0.1  
Placebo: 1.1 ± 0.1 
Maximal strength and muscle mass ↑ in 
both groups but protein supplementation 
provided no augmented effects. Protein 
intake did not change over the intervention 






80 older adults with 




Intervention: high whey-protein- (20.7g), leucine- (2.8g) 
and vitamin D-enriched supplement once daily on non-
exercise days + 3 times/day on exercise days 
Control: isocaloric carbohydrate supplement   
Both groups: received a hypocaloric diet (-600 kcal/d) and 
performed RE 3 times/week (3 sets x 20 repetitions – 
intensity not reported) 
N/a Appendicular FFM ↑ greater in the 
intervention compared to the control group. 
Muscle strength and physical performance 
↑ in both groups without differences 
between groups. Protein intake during the 
intervention was 1.11 ± 0.28 g/kg/d in the 
intervention group and 0.85 ± 0.24 g/kg/d in 
the control group 
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Table 2.4 continued 
Study Participants, duration, 
and design 






100 older adults who were 
overweight or with obesity 
(age: 55–80 year) 
 
10-week RCT 
Exercise + Protein: RE 3 days/week (2-3 sets of 50 s 
per exercise) + dietary advice to achieve 1.3 g 
protein/kg/d 
Exercise: RE 3 days/week (2-3 sets of 50 s per 
exercise) + dietary advice to achieve 0.8 g 
protein/kg/d 
Protein: dietary advice to achieve 1.3 g protein/kg/d 
Control: dietary advice to achieve 0.8 g protein/kg/d 
All groups: followed a hypocaloric diet (-600 kcal/d) 
 
Exercise + protein: 1.00 ± 
0.31 
Exercise: 0.93 ± 0.30 
Protein: 0.92 ± 0.34 
Control: 0.95 ± 0.36 
No differences in FFM, handgrip 
strength or gait speed occurred 
between groups. Protein intake 
during the intervention was lower 
than targeted (1.02 ± 0.36 and 1.02 
± 0.35 g/kg/d in the protein and 





112 older adults with 
sarcopenia or dynapenia 
(age: 84.2 ± 5.5 y) 
 
12-week RCT 
Exercise + Nutrition supplementation: supervised 
body weight RE twice weekly + instructed to perform 
daily exercise at home (3 sets of 30 repetitions) + 10 g 
whey protein and 800 IU vitamin D once daily  
Exercise: supervised body weight resistance exercise 
twice weekly + instructed to perform daily exercise at 
home (3 sets of 30 repetitions)  
Nutrition supplementation: 10 g whey protein and 
800 IU vitamin D once daily 
Control: maintained habitual diet and physical activity  
 
Not reported  Exercise + nutrition supplementation 
↑ muscle quality greater than 





53 older men with class I or 
class II sarcopenia (age: 
72.2 ± 4.7 y) 
 
12-week double-blind RCT 
Treatment: 15 g/d collagen peptides  
Placebo: silicon dioxide  
Both groups performed: RE 3 times/week, 8-10 RM 
Mean sample: 0.91 Treatment group ↑ FFM, isokinetic 
quadriceps strength and ↓ FM 
greater than the placebo group 
 
 
↑, increased; ↓, decreased; AE, aerobic exercise; FFM, fat-free mass; HIIT, high intensity interval training; HR, heart rate; MQ, muscle quality; n-3 PUFA, 
omega 3 polyunsaturated fatty acids; RCT, randomised controlled trial; RE, resistance exercise; SMM, skeletal muscle mass; SPPB, short physical 
performance battery. 
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2.2.10.4 Effects of resistance exercise and dietary protein on hormone function and 
systemic inflammation  
It has been proposed that the sarcopenic attenuating effects of RE and dietary protein may be 
partially explained by changes in circulating hormones and reductions in systemic 
inflammation (Xia et al. 2017, Ziaaldini et al. 2017). The following sections will review the 
effects of these interventions on endocrine and inflammatory markers related to this thesis.  
 
2.2.10.4.1 Insulin-like growth factor 1 
Studies conducted on both young (Borst et al. 2001, Gregory et al. 2013, Kraemer et al. 1990) 
and older adults (Cassilhas et al. 2010, de Souza Vale et al. 2009, Singh et al. 1999, Formica 
et al. 2020) have observed increases in circulating IGF-1 concentration following RE. Acutely, 
RE has been shown to increase serum IGF-1 concentration by ~15% (Gregory et al. 2013, 
Tsai et al. 2018). These findings are supported by a recent meta-analysis of longitudinal 
studies in older adults (Jiang et al. 2020). However, there is also evidence demonstrating 
either no change (Walsh et al. 2015) or a decrease in IGF-1 following RE in older adults 
(Arnarson et al. 2015, Ogawa et al. 2010). The lack of increase in two of these studies might 
be explained by an insufficient RE intensity (<70% 1RM) (Ogawa et al. 2010, Walsh et al. 
2015), as studies that have reported increases in IGF-1 have generally employed a high 
intensity RE intervention (75-85% 1RM) (Stein et al. 2018). In the other study, the authors 
hypothesised that the decrease in circulating IGF-1 was due to a redistribution of IGF-1 into 
skeletal muscle (Arnarson et al. 2015). 
 
In addition to RE, several RCTs in older adults have observed increases of 7-12% in circulating 
IGF-1 concentration following increased dietary protein intake (Bauer et al. 2015, Bo et al. 
2019, Mehlsen et al. 2017, Zhu et al. 2011). Furthermore, when combined with RE, some 
(Daly et al. 2014, Rondanelli et al. 2016), but not all studies (Formica et al. 2020, Holwerda et 
al. 2018, Shahar et al. 2013), have reported supplemental increases compared to RE alone. 
Disparities in these studies may be explained by synergistic (or lack thereof) effects on SMM, 
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as studies that reported greater increases in IGF-1 also reported additive effects on SMM 
(Daly et al. 2014, Rondanelli et al. 2016). This is in contrast to studies that did not observe 
additive increases in IGF-1 (Formica et al. 2020, Holwerda et al. 2018, Shahar et al. 2013).    
 
Whilst evidence demonstrates an increase in IGF-1 following RE alone and combined with 
dietary protein, recent studies suggest these increases may not be required nor reflect the 
incremental activation of intracellular muscle signalling and the subsequent adaptive response 
of skeletal muscle (Morton et al. 2016, West et al. 2012). For example, in healthy young adults, 
changes in IGF-1 were not related to changes in muscle hypertrophy or strength following RE 
training, but muscle androgen receptor content was (Morton et al. 2018b). Data from this study 
suggests the relative increase in SMM following RE training may be underpinned by local 
intramuscular factors. Nevertheless, as the above study was conducted in young adults, 
further work in older adults is required to determine whether muscle hypertrophy following RE 
is related to changes in circulating IGF-1 concentration. 
 
2.2.10.4.2 Cortisol 
The effects of RE on the adaptative cortisol response in older adults is ambiguous. Kraemer 
et al. (1999) reported declines in fasting cortisol concentration after 3 and 10 weeks of RE. In 
agreement, two studies reported decreases in fasting cortisol during RE training in older adults 
(Häkkinen et al. 2002, Izquierdo et al. 2003). However, it is important to note these decreases 
were observed only during the intervention [i.e., after 16 but not 24 weeks post-intervention 
(Häkkinen et al. 2002), and only in the final 8 weeks of RE (Izquierdo et al. 2003)], but no 
significant differences were observed between pre- and post-intervention concetrations. The 
lack of pre-post intervention change is consistent with other studies in older adults (Ahn and 
Kim 2018, Häkkinen et al. 2000, 2001). Equivocal findings may be explained by methological 
issues, particularly the timing of cortisol measurement (Hayes et al. 2016). As preivously 
discussed in section 2.2.8.4, cortisol secretion rises 50-60% 30-40 min after awakening, 
known as the CAR (Anderson and Wideman 2017). Thus, minor differences in the timing of 
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cortisol measurement between studies might have resulted in a different component of the 
CAR being analysed.  
 
In addition to RE, the macronutrient composition of the diet may also influence cortisol 
secretion. Data from two acute studies suggests dietary protein may increase cortisol 
concentration (Slag et al. 1981, Gibson et al. 1999). In contrast, others have demonstrated 
either no differences (Lemmens et al. 2011) or a lower cortisol concentration following a high 
protein compared to a high carbohydrate meal/diet (Vicennati et al. 2002, Martens et al. 2010). 
Additionally, longitudinal data has reported no effects of oral AA supplementation, or RE plus 
protein supplementation, on fasting cortisol concentration (Chaborski et al. 2015, Park et al. 
2019). Although further longitudinal research is needed, particularly in older adults, available 
data thus far suggests dietary protein does not negatively affect the HPA axis.  
 
A significant limitation of studies investigating the effects of RE and dietary protein on the 
adaptive cortisol response is the sole measurement of fasting cortisol concentration. It is well-
known cortisol secretion follows a diurnal rhythm, and recent studies have shown elevated 
evening (2000 h) cortisol concentration in particular is associated with sarcopenia prevalence 
(Gonzalez et al. 2018). Further, increases in the magnitude of the fasting CAR may actually 
be beneficial for health-related outcomes in older adults (Anderson and Wideman 2017). 
Therefore, further research examining the diurnal cortisol response following RE and dietary 
protein is warranted to fully understand the physiological response to these interventions.  
 
2.2.10.4.3 Myostatin  
Several studies have reported decreases in fasting concentrations of both plasma and serum 
myostatin following RE training in middle- and older-aged adults (Bagheri et al. 2019, 2020, 
Binns et al. 2017, Negaresh et al. 2019, Shabani and Izaddoust 2018). For example, serum 
myostatin has been shown to decrease by 0.36 ng/mL in middle-aged adults following 8 weeks 
of RE (Bagheri et al. 2019). The same research group also reported decreases in sarcopenic 
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older men following RE over the same timeframe (Bagheri et al. 2020). However, not all 
studies have observed reductions in myostatin (Hofmann et al. 2016, Kim et al. 2007, Planella-
Farrugia et al. 2019), which may be explained by an insufficient RE intensity (Hofmann et al. 
2016, Planella-Farrugia et al. 2019), and due to extreme pre-post test myostatin variability 
amongst participants (Kim et al. 2007).  
 
Following an acute bout of RE, protein supplementation has been shown to hinder the 
decrease in myostatin messenger RNA (mRNA) in middle and older-aged men (Hulmi et al. 
2008). Another study by the same research group confirmed these findings in young adults 
(Hulmi et al. 2009). More recently, Sniijders et al. (2014) demonstrated acute dietary protein 
restriction decreased myostatin mRNA expression for a longer duration following a single bout 
of RE compared to when ample protein was consumed. The authors speculated these findings 
may signify a compensatory mechanism to allow sufficient muscle reconditioning during times 
of protein restriction. In addition to acute studies, longitudinal RCTs in both young (Paoli et al. 
2015) and older adults (Planella-Farrugia et al. 2019) have reported either increases or no 
change in plasma and serum concentrations following increased dietary protein intake during 
RE training, respectively. Taken together, when dietary protein is sufficient, current evidence 
suggests that the mechanistic reduction in myostatin concentration may not be required 
because whey protein aids net protein balance following RE (Tipton et al. 2007). Further 
longitudinal studies in older adults are required to confirm this hypothesis.  
 
2.2.10.4.5 Systemic inflammation 
The effects of RE on markers of systemic inflammation, particularly in the elderly, is 
controversial. Intervention studies (Nahas, Maestá, and Burini 2014, Nunes et al. 2016, 
Ogawa et al. 2010, Tomeleri et al. 2016) and a recent meta-analysis (Sardeli et al. 2018) have 
reported significant decreases; however, others have not observed these effects (Azizbeigi et 
al. 2015, Bell et al. 2018, Grosicki et al. 2020, Hangelbroek et al. 2018). Inconsistent findings 
might be explained by differences in participant characteristics (i.e., age, sex, health status 
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and baseline inflammatory profile), the RE training protocol (i.e., training intensity, volume and 
duration) and changes in body composition components (i.e., increases in SMM and 
reductions in FM). In support of the latter, a sub-analysis in the meta-analysis by Sardeli et al. 
(2018) reported a larger effect size (-1.26 vs. -0.32) for decreased CRP when skeletal muscle 
hypertrophy occurred compared to when it was maintained. Several studies have also 
reported associations between RE-induced changes in SMM and markers of systemic 
inflammation (Mavros et al. 2014, Ogawa et al. 2010, Tomeleri et al. 2018). Furthermore, 
others have reported a relationship between reductions in FM and markers of systemic 
inflammation following RE (Mavros et al. 2014, Tomeleri et al. 2016, Wanderley et al. 2013), 
and only studies that observed a reduction in FM in the meta-analysis by Sardeli et al. (2018) 
also observed reductions in TNF-α. Based on these findings, RE may be a potent stimulus to 
reduce systemic inflammation, but the effects may be mediated by changes in body 
composition.  
 
Several studies have investigated the independent effects of dietary protein on markers of 
systemic inflammation in older adults (Bell et al. 2018, de Aguilar-Nascimento, Silveira, and 
Dock-Nascimento 2011, Liberman et al. 2019, Sugawara et al. 2012, Solerte et al. 2008, 
Wright et al. 2018). All but one of these studies reported a reduction in inflammatory markers 
(Wright et al. 2018). For example, twice daily consumption of a vitamin D- and leucine-
enriched whey protein supplement for 13 weeks attenuated age-related increases in 
inflammation in sarcopenic older adults (Liberman et al. 2019). Furthermore, Bell and 
colleagues (2018) reported modest (~1-3%), but significant reductions in IL-6 and TNF-α 
following 6 weeks consumption of a multi-ingredient whey protein-based supplement. 
Mechanistically, protein-induced reductions in MPB and the subsequent anti-inflammatory 
effect may decipher these beneficial effects (Bordoni et al. 2017).  
 
Regrettably, the combined effects of RE and dietary protein on markers of systemic 
inflammation has not been well studied in older adults. Nevertheless, studies that have been 
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conducted have reported synergistic reductions in both healthy (Bell et al. 2017, Daly et al. 
2014) and sarcopenic older adults (Rondanelli et al. 2016). Although, one recent study did not 
report augmented effects (Formica et al. 2020). The authors hypothesised this null finding may 
have been due to a high habitual protein intake (1.24 g/kg/d) of participants. Therefore, based 
on the abovementioned evidence, RE and dietary protein may synergistically attenuate age-
related systemic inflammation. However, whilst synergistic effects have been observed 
compared to RE alone, these studies did not include a protein only group, highlighting an area 
for further research. 
 
2.3 Part 2: Body composition, energy metabolism and metabolic health 
 
2.3.1 Introduction 
As reported in part 1 of this literature review (section 2.2.4), ageing is associated with 
sarcopenic muscle loss, which occurs at a rate of ~0.5-1% per annum after ~45 years of age 
(Janssen 2010). In addition to declines in SMM, ageing is accompanied by an increase in FM 
(St-Onge 2005), particularly visceral and intramuscular adiposity (Demerath et al. 2007, 2011). 
From around 20 years of age, %FM increases at a rate of ~0.2% per annum until the seventh 
decade of life and decreases thereafter (Imboden et al. 2017, Westerterp 2018a). Since 1980, 
obesity prevalence has increased by ~35-60% in middle- and older-aged adults (Flegal et al. 
2012, Gutiérrez-Fisac et al. 2012, Howel 2012, Oreopoulos et al. 2009). Subsequently, the 
prevalence of metabolic disease has also risen (Wannamethee and Atkins 2015), which has 
resulted in a 30% increase in healthcare expenditure (König et al. 2015, Withrow and Alter 
2011). The coexistence of sarcopenia and obesity, termed sarcopenic obesity (Baumgartner 
2000), is of great concern for the health of the elderly population as they act synergistically, 
exacerbating the negative effects of one another (Batsis et al. 2015, Lee et al. 2016, Scott et 
al. 2018).  Hence, preventative interventions that preserve SMM and attenuate adiposity are 
of critical importance for public health. 
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2.3.2 Energy balance 
Body composition changes with age are ascribed to alterations in energy balance (St-Onge 
and Gallagher 2010). Obeying the first law of thermodynamics, energy balance [or rate of 
energy storage (ES)] is equal to the difference between rates of EI and EE (Shook et al. 2018). 
Energy intake comprises the chemical energy from food and drink consumption, which 
incorporates the three major macronutrients with the following energy densities: carbohydrate 
(~4 kcal/g), protein (~4 kcal/g) and fat (~9 kcal/g), and alcohol, which has an energy density 
of ~7 kcal/g (Hall et al. 2012). Energy expenditure refers to energy used for any work 
performed and heat lost via conductive, radiant, convective and evaporation processes (Hall 
et al. 2012). Maintenance of energy balance and a healthy body mass throughout the ageing 
process is key, as a major drawback of significant weight loss is a concomitant loss of SMM, 
subsequently accelerating the development of sarcopenia (Houston, Nicklas, and Zizza 2009, 
Waters, Ward, and Villareal 2013). Additionally, weight loss leads to adaptive thermogenesis, 
that is, a reduction in EE greater than predicted based on reductions in body composition, 
thereby making long-term weight maintenance difficult (Müller, Enderle, and Bosy-Westphal 
2016, Camps, Verhoef, and Westerterp 2013). Age-related declines in EE has been implicated 
as a significant risk factor for energy imbalance and increased FM with age (Trouwborst et al. 
2018, Westerterp 2018a). The subsequent sections will review the effects of age on 
components of EE.  
 
2.3.3 Total Energy Expenditure  
Total energy expenditure is comprised of three major constituents: RMR, AEE and DIT 
(Figure 2.4). Resting metabolic rate consists of both the energy expended during sleep and 
through arousal (Manini 2010, Schoffelen and Westerterp 2008). Activity EE is subdivided into 
the energy expended through both volitional exercise (e.g., walking or jogging) and 
spontaneous physical activity (SPA) (e.g., fidgeting) (Manini 2010). Diet-induced 
thermogenesis is defined as the metabolic cost of processing food (Westerterp, Wilson, and 
Rolland 1999). Over the human lifespan, TEE increases 2-fold in the first two decades of life, 
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plateaus between 17-40 years of age, and dramatically decreases by ~160 kcal/decade in 
men and by ~100 kcal/decade in women following ~40 years of age. Age-related declines in 
TEE is a consequence of a decline in all components of TEE (Roberts and Rosenberg 2006); 
however, age-related declines in AEE explains the vast majority of the decrease (Roberts et 
al. 1995, Westerterp and Meijer 2001).  
 
 
Figure 2.4 Constituents of TEE. Resting metabolic rate accounts for 60-80%, DIT uses ~10%, 
and AEE, which is divided into SPA and volitional exercise, is the most variable component, 
comprising 20-50%. Adapted from Manini (2010). 
 
2.3.4 Resting metabolic rate   
Resting metabolic rate is defined as the energy required for maintenance of organismal 
homeostasis and is the largest component of TEE, accounting for 60-80% (Manini 2010). 
Declines in RMR begin around the third decade of life and occur at a rate of 1-2% per decade 
(Geisler et al. 2016a, Geisler and Müller 2017). Fat-free mass accounts for 50-70% of the 
variance in RMR (Bosy-Westphal et al. 2003, Gallagher et al. 2000). Metabolically, FFM is 
heterogeneous, comprised of both chemical (mineral content, glycogen, protein and water) 
and anatomical (organ/tissue level) aspects (Geisler and Müller 2017). Historically, it was 
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adulthood (Elia 1992). This assumption has more recently been shown to be incorrect, as both 
the chemical and anatomical components of FFM decline with age (He et al. 2009, Müller et 
al. 2013). This led to age-predicted, organ-specific equations to be developed (Wang et al. 
2010). Recently, Geisler and Müller (2017) published data demonstrating SMM accounts for 
46.5% and 43.3% of FFM in young and older adults, respectively, accounting for ~20% of 
RMR. Interestingly, RMR normalised to FFM was lower in older compared to younger adults 
(Geisler and Müller 2017). Age-related changes in the chemical as opposed to anatomical 
components of FFM explained this difference. When anatomical and chemical components of 
FFM were combined, the variance increased to 82.7%; however, 17.3% was still unexplained 
(Geisler and Müller 2017). Differences in rates of MPS, thyroid hormones, body temperature, 
heart rate, sympathetic nervous system activity and sleep quality may explain the remaining 
variance (Geisler and Müller 2017). Thus, current evidence suggests age-related declines in 
RMR can mostly be explained by FFM quality, which includes both anatomical and chemical 
aspects. 
 
2.3.5 Activity energy expenditure  
Activity-induced EE is the most variable component of TEE, comprising 20-50% (Manini 
2010). Spontaneous physical activity contributes the majority of AEE (Westerterp 2013). 
Typically, physical activity EE is measured as a physical activity level (PAL), calculated by 
dividing TEE by RMR (Westerterp 2018a). As previously stated in part 1 of this literature 
review (section 2.2.8.1), physical activity levels decline with age, whereas sedentary 
behaviour increases (Westerterp 2000, Meijer et al. 2001). Between the ages of 15-50, PAL 
has been reported to be between ~1.7-1.8, with gradual decreases observed from 50-80 years 
to ~1.4 (Westerterp 2018a). Of concern, a lower PAL has been associated with reduced 
mobility and a higher mortality risk in elderly individuals (Xue et al. 2012). Furthermore, whilst 
PAL decreases with age, the energetic cost of ADL increases (Schrack, Simonsick, and 
Ferrucci 2010, Schrack et al. 2012, 2016a). For example, Schrack et al. (2016b) established 
advancing age was associated with an increased metabolic cost of walking, which contributed 
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to declines in gait speed. Problematically, an increased metabolic cost of ADL contributes to 
less body movement, resulting in less AEE (Westerterp 2013), and weight gain (Schoeller, 
Shay, and Kushner 1997, Weinsier et al. 2002).  
 
2.3.6 Diet-induced thermogenesis  
Diet-induced thermogenesis represents the metabolic cost of digestion, absorption, transport, 
metabolism and storage of food (Westerterp, Wilson, and Rolland 1999). Food ingestion 
therefore increases EE above basal metabolism, with DIT representing ~10-15% of total daily 
EI in healthy young individuals consuming a typical Western diet in energy balance 
(Westerterp 2004). In elderly individuals, several (Du et al. 2014, Hawley et al. 2020, Jones et 
al. 2004, Morgan and York 1983, Schwartz, Jaeger, and Veith 1990), but not all studies 
(Bloesch et al. 1988, Vaughan, Zurlo, and Ravussin 1991, Visser et al. 1995) have reported 
decreases in DIT. Discrepancies might be explained by difficulties in measuring DIT and lack 
of statistical power. It is well-known that inter-individual variation in measurement of DIT is 
high [coefficient of variation (CV) 30-48%] (Tataranni et al. 1995, Weststrate 1993); thus, 
studies with small sample sizes were likely underpowered to detect changes between young 
and older adults. Additionally, differences in the duration of DIT measurement and 
macronutrient composition of the meal may also explain inconsistencies between studies (Du 
et al. 2014). Whilst age-related declines in DIT may be small (Du et al. 2014), the thermogenic 
implications may significantly contribute to increased FM. To explain, based on the findings of 
Du and colleagues (2014), consumption of 2,500 kcal/d would yield a DIT deficit of 22.5 kcal/d 
in older compared to younger adults. Extrapolated over a year, EE would be ~8,000 kcal less 
from purely DIT if activity and FFM were matched.  
 
2.3.7 Substrate oxidation  
In comparison to EE, age-related changes in substrate oxidation has received little research 
attention (Welch, Hayhoe, and Cameron 2020). This is perhaps surprising considering skeletal 
muscle is essential to the metabolism and oxidation of carbohydrate, fat and protein (Welch, 
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Hayhoe, and Cameron 2020). Nevertheless, research groups that have examined the effects 
of age on substrate oxidation have reported age-related reductions in basal and 24-h fat 
oxidation (Calles-Escandon et al. 1995, Levadoux et al. 2001, Solomon et al. 2008), 
decreases in exercise-induced carbohydrate oxidation and glucose utilisation (Dubé et al. 
2016, Malone et al. 2019, Sial et al. 1996), and increases in 24-h protein oxidation and 
declines in protein balance (Davy et al. 2001). In contrast, others have reported either higher 
(Melanson et al. 2007) or no age-related declines in basal or 24-h fat oxidation (Davy et al. 
2001, Siervo et al. 2016).  
 
Inconsistencies may be explained by differences in participant body composition 
characteristics. In particular, FM, which is associated with reductions in 24-h fat oxidation 
(Siervo et al. 2016, Zurlo et al. 1990), was notably higher in elderly compared to younger 
participants in two studies that observed age-related declines (Levadoux et al. 2001, Solomon 
et al. 2008). Contrary to these studies, others that did not observe differences matched body 
composition variables between groups (Davy et al. 2001, Melanson et al. 2007). Further, 
although Calles-Escandon et al. (1995) reported declines in basal fat oxidation with age, this 
study also reported an association between fat oxidation and FFM. These findings suggest 
ageing per se does not cause declines in fat oxidation, but age-related changes in body 
composition, especially increases in intramuscular fat infiltration which has been shown to 
increase with age (Delmonico et al. 2009) and impair mitochondrial fatty acid oxidation (Batsis 
and Villareal 2018), may. 
 
Age-related declines in exercise-induced carbohydrate oxidation and glucose utilisation might 
be explained declines in glucose transporter type 4 (GLUT-4) protein and adenosine 5'-
monophosphate-activated protein kinase (AMPK) activity, which have been reported in older 
adults with reduced insulin sensitivity (Dela et al. 1994, Morris, Rivas, and Fielding 2010, 
Qiang et al. 2007). The increased protein oxidation reported by Davy and colleagues (2001) 
could be due to diminished AA uptake with age as a consequence of declines in SMM, 
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resulting in greater amounts of exogenous dietary protein being oxidised (Welch, Hayhoe, and 
Cameron 2020).  
 
2.3.8 Metabolic flexibility 
Metabolic flexibility is defined as the ability to adjust rates of substrate oxidation to changes in 
fuel availability (Kelley and Mandarino 2000). It represents the ability to switch between high 
rates of fat oxidation (or low RQ) under fasted resting conditions, to supressing fat oxidation 
and increasing carbohydrate oxidation (higher RQ) under insulin- and exercise-stimulated 
conditions (Goodpaster and Sparks 2017). Metabolic inflexibility has been linked with a 
number of health risks and pathologies such as obesity, insulin resistance and T2DM, 
cardiovascular disease (CVD) and cancer (Goodpaster and Sparks 2017, Rynders et al. 2018, 
Smith et al. 2018). Although data is limited, recent work suggests metabolic flexibility is 
impaired in the elderly (Smith et al. 2018). At present, the mechanisms are not fully 
understood; however, it is thought a more sedentary lifestyle, deleterious changes in body and 
muscle fibre composition, mitochondrial dysfunction, systemic inflammation and 
endocrinological changes with age all contribute towards metabolic inflexibility (Calçada et al. 
2014, Smith et al. 2018).  
 
2.3.9 Glucose homeostasis  
Impairments in glucose homeostasis have been frequently observed with age (DeFronzo 
1981, Ferrannini et al. 1996, Shimokata et al. 1991). Elevations in 2-h post oral glucose 
tolerance test (OGTT) glucose concentrations (Dubowitz et al. 2014), increased glycated 
haemoglobin (HbA1c) (Davidson and Schriger 2010, Dubowitz et al. 2014), reduced insulin 
sensitivity following a mixed meal (Basu et al. 2003) and during a hyperinsulinemic-euglycemic 
clamp (DeFronzo 1979), and increased 24-h glucose variability (Wijsman et al. 2013) have all 
been associated with age. However, these impairments cannot be explained by ageing per se 
(Chee et al. 2016). Similar to that of metabolic flexibility, unfavourable changes in body 
composition, including decreases in SMM, increases in visceral adiposity which produces 
 70 
proinflammatory cytokines such as IL-6 and TNF-a, and adipokines such as leptin, all of which 
are associated with insulin resistance and sarcopenic muscle loss (Batsis and Buscemi 2011, 
Coon et al. 1992, Karakelides et al. 2010, Manoy et al. 2017), and physical inactivity (Flack et 
al. 2011), collectively contribute towards age-related impairments in glucose homeostasis.  
 
2.3.10 Measurement of energy metabolism 
Energy expenditure can be measured by either direct calorimetry (rate of heat loss from the 
body); indirect calorimetry [measuring the rate of oxygen consumption (V̇O2) and/or carbon 
dioxide production (V̇CO2) and converting to EE using formulae, e.g., Brouwer (1957), with or 
without measurement of urinary nitrogen excretion]; or non-calometric techniques (predicting 
EE from extrapolation of physiological measurements and observations) (Levine 2005). The 
variability of such methods with regards to the accuracy, reproducibility and reliability of 
measurement is extensive (Westerterp 2019). Likewise, cost and complexity of methods differ 
substantially. A summary of methods used to measure EE within the literature is provided in 
Table 2.5.
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Table 2.5 Summary of methods used to measure energy expenditure. Adapted from Lam and Ravussin (2016) and Westerterp (2019) 
Method Measurement Duration of use Advantages Disadvantages 
Direct calorimetry Direct measurement of heat 
production  
Hours to several days Researcher able to completely 
control environmental factors, 
high accuracy, and precision 
 
High cost, technically demanding, participant 
refined to a small area, requires substantial 





Indirectly measures EE via 
breath-by-breath collection of O2 
consumption and CO2 production 
Hours  Fast response time, easy to 
operate in clinical settings, high 
precision for RMR 
Facemask and mouthpiece can only be 
tolerated for a limited amount of time. 
Ventilated hood only applicable whilst supine, 
restricts participant mobility  
 
Douglas bag Indirectly measures EE by 
collection of expired O2 
consumption and CO2 production 
 
Hours High accuracy and precision, low 
cost  
Laborious method, each bag can only collect a 
certain volume, rapid changes in ventilation 
cannot be measured 
Respiration 
chamber  
Indirectly measures EE by 
collection of expired O2 
consumption and CO2 production 
Hours to several days  Minute-by-minute measurement 
in real time, allows measurement 
of multiple components of 24-h 
EE and substrate oxidation, high 
accuracy, and precision 
 
Participant restricted to a confined 




Indirectly measures EE by CO2 
production  
4-21 days  Able to assess habitual free-living 
TEE, high accuracy, and 
precision 
High cost due to isotope expense, no time-
course of data, different components of EE 




EE calculated by multiplying 
energy equivalent values for 
activities undertaken (estimated 
from prediction equations) 
3-7 days Simple administration, low cost Underreporting likely, data quality poor due to 





Table 2.5 continued  
Method Measurement Duration of use Advantages Disadvantages 
Kinematic 
measures 
Activity counts translated into EE 
using specific equations  
Flexible  Able to assess habitual free-living 
TEE, easy to administer 
Requires participant compliance to monitor 
wear and non-wear times, prediction equations 




Predicts EE based on the 
relationship between heart rate 
and V̇O2 
 
Flexible  Administration simple, unbiased Loss of data likely, individualised calibration 




Predicts EE based on the 
relationship between V̇O2 and EE 
Hours  Low-to-moderate cost, less 
sensitive to physical cofounders  
Not applicable in free-living, low to moderate 
accuracy and prevision  
 
EE, energy expenditure; TEE, total energy expenditure.  
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Indirect calorimetry calculates EE by measurement of the energy released by oxidisation of 
carbohydrate, fat and protein (Lam and Ravussin 2016). For accurate measurement, 
measurement of V̇O2, V̇CO2 and urinary nitrogen is required  (Westerterp 2019). Examples of 
equations used to calculate EE and substrate oxidation include Astrup (1990), Brouwer 
(1957), Frayn (1983), and Weir (1949). Differences relate to the chemical values used for 
assumptions on gaseous exchange and energy released from carbohydrate, fat and protein 
(Westerterp 2019). For this thesis (Chapter 4), the Brouwer equation was used due to its 
established significant agreement with direct calorimetry (Webb et al. 1988).  
 
Measurement of EE and substrate oxidation via indirect calorimetry can be undertaken using 
a number of systems. For short-term measurements, a metabolic cart using a facemask or 
ventilated hood to collect respiratory gases is often used  (Westerterp 2019). However, face 
masks can only be tolerated for a few hours, limiting measurement time (Westerterp 2019). 
To overcome this limitation, an open-circuit whole-room calorimeter (or respiration chamber) 
enables measurement of EE and substrate oxidation under free-living conditions for up to 
several days. Considered the gold standard for assessing minute-by-minute EE (Brychta et 
al. 2009), respiration chambers (Figure 2.5) are airtight thermally insulated living spaces 
(typically small), which give the impression of a hotel-type room, equipped with a bed, desk, 
chair, computer with internet and freezer toilet (Schoffelen et al. 1997, Westerterp 2019). 
Environmental conditions and consumption of food and drink can be controlled at all times.  
 
Air flow is controlled by either a push or pull system. In a push-type system, air is forced into 
the chamber to eliminate other sources of in-flow, whereas pull-type systems draw air out to 
eliminate other sources of outflow (Schoffelen and Plasqui 2018). Both systems have their 
specific advantages and disadvantages. For accurate results using a push-type system, all 
expired air must to be collected as the probability of air leaks with these systems with 
increasing chamber size is high. In contrast, in a pull-type system, even if the chamber is not 
perfectly sealed, air will not escape as it is pulled from the chamber into one outlet (Schoffelen 
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and Plasqui 2018). For this reason, pull-type calorimeters are the predominant technique used 
in today’s respiration chambers (Schoffelen and Plasqui 2018). Nevertheless, for both 
techniques, O2 consumption and CO2 production is calculated as the difference in gas 
composition between incoming and outgoing air (Schoffelen et al. 1997).  
 
Throughout the measurement period, physical activity can be monitored continuously via a 
radar system working on the Doppler principle (Schoffelen et al. 1997). Through continuous 
measurement of EE and physical activity, measurements of 24-h sedentary EE, AEE, SPA 
and DIT can be calculated (Ravussin et al. 1986), in addition to SMR (Schoffelen and 
Westerterp 2008). Unfortunately, measurement of AEE is limited due to the confined space of 
a respiration chamber and the subsequent inability to perform many forms of physical activity 




Figure 2.5 Example layout of a 
respiration chamber similar to that 
used in the present thesis. 1) TV; 2) 
chair; 3) sink; 4) deep-freeze toilet; 5; 
air lock for blood samples; 6) exercise 
step; 7) bed; 8) air locks (one for food 
and one for urine/biological samples). 







2.3.11 Effects of resistance exercise on fat mass and weight maintenance  
Decreases in FM have been reported in numerous studies in older adults following RE training; 
however, body mass generally remains stable due to a concomitant increase in FFM 
(Campbell et al. 1994, Englund et al. 2018, Hunter et al. 2000, Pratley et al. 1994, Treuth et 
al. 1995, Westcott 2012). Regionally, reductions in both visceral (Hunter et al. 2002, Ibañez 
et al. 2005, Treuth et al. 1994, 1995) and intramuscular adipose tissue have been observed 
(Moro et al. 2020). A major factor in the loss of FM following RE training is the RE-induced 
increase in EE, particularly RMR (Westcott 2012). Additionally, changes in appetite may also 
influence weight maintenance following RE training (Dorling et al. 2018). The effects of RE on 
EE and appetite will be reviewed in subsequent sections.  
 
2.3.12 Effects of resistance exercise on appetite and satiety 
Following an acute bout of RE, several studies have reported a brief suppression (~30-60 min) 
of subjective appetite (Broom et al. 2009, Freitas et al. 2020, Laan et al. 2010). Broom et al. 
(2009) also demonstrated a suppression of the orexigenic gut hormone acylated ghrelin. In 
contrast, others have not reported a suppression of either subjective appetite (Ballard et al. 
2009, Larsen et al. 2017, Madzima et al. 2018) or acylated ghrelin (Balaguera-Cortes et al. 
2011, Larsen et al. 2017). Disparities may be explained by the RE intensity, as differences in 
hunger have been reported following an acute bout of high and low intensity exercise (Freitas 
et al. 2020). Further, acute studies to date report either minimal or no changes in the 
anorexigenic hormones peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) (Balaguera-
Cortes et al. 2011, Broom et al. 2009, Larsen et al. 2017), and no compensatory reduction or 
significant increase in EI for the remainder of the day in either young (Ballard et al. 2009, 
Broom et al. 2009, Cadieux et al. 2014, Laan et al. 2010) or older adults (Maltais et al. 2018). 
The latter of these findings may have important implications for maintaining energy balance in 
older adults.  
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Regrettably, few studies have investigated the longitudinal effects of RE on subjective or 
hormonal appetite. Following 12 weeks of RE, no changes in subjective appetite or 
concentrations of active ghrelin, PYY or pancreatic polypeptide (PP) in either the fasted or 
post-prandial state have been reported in middle-aged men who were either overweight or 
with obesity (Guelfi, Donges, and Duffield 2013). In contrast, a study of male students who 
were overweight observed decreases and increases in fasting acylated ghrelin and PYY, 
respectively (Shakiba et al. 2019), and meta-analyses have also reported decreases in the 
appetite suppressants leptin (Fedewa et al. 2018) and insulin (Ashton et al. 2020). The authors 
in the study by Shakiba et al. (2019) concluded that changes in appetite hormones might be 
related to the increase in EE and subsequent loss of body mass following RE training. 
However, as the abovementioned longitudinal studies were conducted on young and middle-
aged adults, these findings may not translate to older adults.  
 
2.3.13 Effects of resistance exercise on energy expenditure 
A single bout of RE has been shown to expend ~120-500 kcal/h (Hunter et al. 2013), elevate 
RMR for up to 48 h post-exercise (Speakman and Selman 2003), and increase DIT (Denzer 
and Young 2003). Longitudinally, studies of 12-26 weeks in duration have reported ~7-8% 
increases in RMR (Hunter, McCarthy, and Bamman 2004), with increases of 87 kcal/d (Hunter 
et al. 2000), 108 kcal/d (Campbell et al. 1994), 109 kcal/d (Treuth et al. 1995) and 119 kcal/d 
(Pratley et al. 1994) reported. Despite increases in RMR, few studies have assessed the 
longitudinal effects on TEE in older adults. In the study by Hunter and colleagues (2000), the 
increase in RMR occurred alongside increases in AEE (120 kcal/d) and TEE (230 kcal/d) as 
measured by doubly labelled water (DLW). Rises in activity and TEE may be explained by 
improved metabolic efficiency of spontaneous activities, including walking economy (Valenti, 
Bonomi, and Westerterp 2016) and ease of movement (Taaffe et al. 1999), leading to an 
increase in PAL. Indeed, ease of movement positively correlates with SPA (Hunter et al. 2004, 
2015) and has been suggested as a mechanism to offset age-related increases in FM in older 
adults (Hunter et al. 2018). 
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Whilst improvements in RMR have often been reported, and Hunter et al. (2000) reported an 
increase in TEE, the majority of studies in the literature have reported either no change or a 
decrease in TEE following RE training in older adults (Bell et al. 2019, Hunter et al. 2013, 
Meijer, Westerterp, and Verstappen 1999, Treuth et al. 1995). These findings are often 
attributed to a reduction in AEE, particularly SPA (Westerterp 2018b). Although the 
mechanisms are not fully explained, it has been hypothesised that fatigue due to an increase 
in training frequency results in a compensatory decrease in non-exercise physical activity 
(Hunter et al. 2018). In support, Hunter et al. (2013) reported a 150 kcal/d decrease in SPA in 
older women who performed RE three times per week, but an increase of 200 kcal/d in those 
that trained twice weekly. Other studies that have also reported decreases in AEE likewise 
employed a three sessions per week training protocol (Bell et al. 2019, Treuth et al. 1995). 
These findings suggest training thrice weekly during the early phases (0-12 weeks) of RE in 
older adults may be the breakpoint which negatively impacts non-exercise physical activity. 
However, challenging this hypothesis, reductions in physical activity have been reported in 
participants training twice weekly (Meijer, Westerterp, and Verstappen 1999), suggesting 
additional factors also influence reductions in SPA. 
 
Indeed, SPA is a complex issue, controlled by a number of neuromodulating factors including 
orexin A (Kotz, Teske, and Billington 2008). Orexin A has been shown to drive activity, control 
energy balance and regulate adipose tissue (Kotz et al. 2017, Perez-Leighton, Billington, and 
Kotz 2014, Teske, Billington, and Kotz 2010). Consequently, reductions in SPA reported in 
older adults following RE may also partly be explained by decreases in orexin A to oppose the 
increase in RMR and reduction in FM frequently reported (Hunter, McCarthy, and Bamman 
2004). This hypothesis requires further investigation.  
 
 78 
2.3.14 Effects of resistance exercise on substrate oxidation and balance 
The effects of RE on substrate oxidation, particularly in older adults, has not been extensively 
studied. In young adults, decreased respiratory exchange ratio (RER) (indicating greater fat 
oxidation) immediately and up to 48-h post exercise has been observed following an acute 
bout of RE (Allman et al. 2019, Melby et al. 1993, Ormsbee et al. 2007, Schuenke, Mikat, and 
McBride 2002). Conversely, respiration chamber studies conducted by Melanson and 
colleagues have not reported similar effects (Melanson et al. 2002, 2005). Differences 
between chamber and non-chamber studies may be explained by exercise timing (i.e., prior 
to breakfast in the fasted state vs. following food consumption). Longitudinally, RE has been 
reported to decrease sleeping and resting RQ in young adults (Kirk et al. 2009), and increase 
both resting and 24-h fat oxidation in middle- and older-aged adults (Ho et al. 2012, Treuth et 
al. 1995). 
 
Regarding carbohydrate and glucose oxidation, increased 24-h carbohydrate oxidation in 
young adults has been observed following an acute bout of RE (Melanson et al. 2002, 2005). 
However, the longitudinal effects in both young and older adults report conflicting findings with 
no changes (Kirk et al. 2009, Miller et al. 1994), decreases (Treuth et al. 1995) and increases 
in carbohydrate/glucose oxidation all reported (Consitt et al. 2016, Sparks et al. 2013). 
Differences may be explained by measurement of rates of whole-body (Kirk et al. 2009, Miller 
et al. 1994, Treuth et al. 1995) versus skeletal muscle oxidation (Consitt et al. 2016, Sparks 
et al. 2013), suggesting the increase in glucose oxidation following RE may be muscle specific.  
 
In both young and older adults, decreases in 24-h nitrogen excretion and protein oxidation 
(Campbell et al. 1995, Iglay et al. 2007, Moore et al. 2007, Treuth et al. 1995), and 
improvements in nitrogen balance (Campbell et al. 1995, Moore et al. 2007) have been 
reported following RE training. These data are consistent with the accretion of FFM frequently 
reported (Peterson, Sen, and Gordon 2011), and suggest a greater retention of dietary protein 
in the trained state. Nevertheless, it is important to note that increased nitrogen balance does 
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not always translate to changes in FFM (Drummen et al. 2018), with studies in older adults 
reporting no change in nitrogen balance despite significant increases in FFM (Verdijk et al. 
2009a, Leenders et al. 2013). 
 
2.3.15 Effect of resistance exercise on metabolic flexibility 
At present, data on the effect of RE on metabolic flexibility in older adults is scarce. Meex et 
al. (2010) established RE once weekly in addition to twice weekly aerobic exercise (AE) 
improved metabolic flexibility in T2DM patients but not in healthy controls. More recently, 
Consitt et al. (2016) established impairments in skeletal muscle pyruvate dehydrogenase 
(PDH) phosphorylation and plasma lactate are indicative of metabolic flexibility, but can be 
reversed following RE in older adults. Together, these findings suggest RE may be an effective 
strategy to offset age-related metabolic inflexibility. Although research is in its infancy, 
increased metabolic flexibility may be explained by improvements in mitochondrial content 
and function (Goodpaster and Sparks 2017), which have been observed in older adults 
following RE training (Parry, Roberts, and Kavazis 2020). 
 
2.3.16 Effects of resistance exercise on glucose homeostasis  
In elderly individuals, several studies have demonstrated improvements in whole-body insulin 
sensitivity (~10-30%) and glycaemic control following RE training (Bell et al. 2017, Bucci et al. 
2016, Flack et al. 2011, Holwerda et al. 2018, Iglay et al. 2007, Leenders et al. 2013, Miller et 
al. 1994). These findings are perhaps not surprising considering skeletal muscle is the largest 
glucose storage depot in the human body (Scott, de Courten, and Ebeling 2016), with 
increased uptake observed following RE in older adults (Bucci et al. 2016). However, although 
skeletal muscle hypertrophy following RE is well-documented (Peterson, Sen, and Gordon 
2011), increases in SMM alone may not fully explain improvements in insulin sensitivity 
(Andersen et al. 2003, Holten et al. 2004, Miller et al. 1994). Improvements in skeletal muscle 
insulin signalling, specifically increased phosphorylation of Akt substrate of 160 kDa (AS160) 
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and expression of GLUT-4 likely contribute to the remaining unexplained improvements, which 
may require a reduction in FM in order to be observed (Consitt, Dudley, and Saxena 2019).  
 
2.3.17 Effects of dietary protein on fat mass and weight maintenance   
Numerous studies, as reviewed by Drummen and colleagues (2018), have demonstrated high 
protein diets are effective for weight maintenance and decreasing FM. For instance, meta-
analyses have reported a greater long-term reduction in FM following consumption of a high 
protein diet during weight loss compared to a normal protein diet (Clifton, Condo, and Keogh 
2014, Kim et al. 2016b). Additionally, in participants required to maintain a constant body mass 
for 12 weeks via an energy-controlled diet, Martens et al. (2015a) demonstrated a high protein 
diet (30% of EI) maintained energy balance and decreased FM by 0.4 kg. In contrast, a group 
consuming a high carbohydrate, low protein diet (5% of EI) gained 0.4 kg FM due to a resultant 
increased positive energy balance. These findings suggest a high protein diet may protect 
against a positive energy balance and increased adiposity whilst maintaining a constant body 
mass.  
 
2.3.18 Effects of dietary protein on appetite and satiety 
Several short-term studies in younger adults using energy balanced diets have demonstrated 
a greater satiating effect following consumption of a high compared to low protein diet 
(Bendtsen et al. 2013, Lejeune et al. 2006, Veldhorst, Westerterp-Plantenga, and Westerterp 
2009, Veldhorst et al. 2009). Mechanistically, these effects are regulated via several 
pathways, including increases in anorexigenic (e.g., GLP-1 and PYY) and decreases in 
orexigenic hormones (e.g., ghrelin and cortisol), rises in DIT and gluconeogenesis, 
aminostatic theory (i.e., AAs directly serving as satiety signals), and effects on digestion 
(Drummen et al. 2018). However, although satiating effects of a high protein diet may be 
beneficial for younger adults, the effect is potentially deleterious for older adults, as substantial 
declines in both daily energy and protein intake are contributors of age-related declines in 
SMM (Atalayer and Astbury 2013, Paddon-Jones et al. 2015).  
 81 
Interestingly, in contrast to data in younger adults, data in the elderly suggests ageing might 
blunt the suppression of appetite induced by dietary protein. For example, two acute studies 
conducted by the same research group reported a reduced suppression of appetite following 
intake of dietary protein in older compared to young adults (Giezenaar et al. 2017, 2020). 
Butterworth and colleagues (2019) also demonstrated acute ingestion of an EAA gel increased 
both protein and energy intake. Recently, a meta-analysis by Ben-Harchache et al. (2020) 
reported either a positive or no effect of longitudinal protein supplementation on total EI. These 
studies suggest dietary protein could be effective at maintaining energy and protein intake in 
the elderly, which in turn may aid attenuation of sarcopenia and age-related declines in EE. 
Furthermore, the ability for older adults to consume ample amounts of dietary protein might 
prevent the protein leverage hypothesis, that is, continually eating until protein needs are met, 
regardless of the energy and protein content (Martens, Lemmens, and Westerterp-Plantenga 
2013). Prevention of the protein leverage hypothesis may therefore also have implications for 
prevention of sarcopenic obesity. However, it is important to note that due to limited 
longitudinal data in older adults, the meta-analysis by Ben-Harchache et al. (2020) only 
included two studies that assessed the effects of protein supplementation on subjective 
appetite. These studies provided mixed findings; therefore, further research is needed to 
examine the long-term effects of dietary protein on subjective appetite ratings in older adults. 
 
2.3.19 Effects of dietary protein on energy expenditure  
Increased dietary protein has been promoted to increase EE via increases in resting, sleeping 
and postprandial metabolism (Leidy et al. 2015). Acutely, 24-h respiration chamber studies 
have reported increases in DIT (Hochstenbach-Waelen et al. 2009a, Sutton et al. 2016, 
Westerterp-Plantenga et al. 1999, Westerterp, Wilson, and Rolland 1999), SMR 
(Hochstenbach-Waelen et al. 2009a, 2009b, Lejeune et al. 2006, Mikkelsen, Toubro, and 
Astrup 2000), RMR (Mikkelsen, Toubro, and Astrup 2000, Veldhorst, Westerterp-Plantenga, 
and Westerterp 2009) and TEE (Hochstenbach-Waelen et al. 2009a, 2009b) following 
consumption of a high protein (25-30% of EI) diet. Longitudinal studies of up to 12 weeks in 
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duration have also observed increases in SMR and DIT (Bray et al. 2015, Martens et al. 2015a, 
Sutton et al. 2016), RMR (Bray et al. 2012) and TEE (Bray et al. 2012, 2015). Bray et al. (2015) 
also observed an adaptive thermogenesis, whereby TEE and SMR remained elevated above 
baseline values when protein intake was returned back to baseline intake. This higher level of 
EE could be a mechanism that supports long-term weight maintenance. However, although 
high protein diets elicit longitudinal increases in RMR and DIT, either no change (Drummen et 
al. 2020) or decreases (Apolzan et al. 2014, Lejeune et al. 2006, Martens et al. 2015a, 
Veldhorst, Westerterp-Plantenga, and Westerterp 2009) in AEE has been reported. These 
findings cannot be explained by changes in physical activity, as activity counts measured 
inside the respiration chamber in these studies did not change. Therefore, similar to that of 
RE, the aforementioned findings suggest high protein diets improve the metabolic efficiencies 
of spontaneous activities, leading to a decline in AEE if physical activity is not increased.  
 
Mechanistically, protein-induced increases in SMR can be explained by increased rates of 
MPS [which has an energetic cost of 0.86 kcal/g (Hall 2006)] and protein turnover, whilst 
increases in DIT can be explained by the adenosine-5'-triphosphate (ATP) required for 
metabolism and oxidation, including urea synthesis (Drummen et al. 2018). To explain the 
latter, dietary protein uses considerably more of its useable energy (~20-30%) to metabolise 
compared to carbohydrate (~5-10%) and fat (~0-3%) (Westerterp-Plantenga et al. 2009b). 
The metabolic efficiency of protein oxidation largely depends on the AA composition of the 
protein, with higher biological value AA producing a higher thermic effect (Drummen et al. 
2018). Gluconeogenesis due to a surplus of dietary protein also contributes (explaining ~42%) 
to the increases in EE observed (Veldhorst, Westerterp-Plantenga, and Westerterp 2009). 
Furthermore, although the ability of dietary protein per se to increase FFM is limited, gains in 
skeletal muscle and FFM, which have specific metabolic rates of 12.6 and 24 kcal/kg/d, 
respectively (Hall 2006, Wang et al. 2010), also partly explain protein-induced increases in 
EE.  
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Whilst previously cited studies have demonstrated increases in EE following a high protein 
diet, all these studies were conducted in young adults. Unfortunately, few studies have 
assessed the effects in older adults. Acute studies have reported no effects of either 40 g 
casein prior to sleep on RMR then next morning (Morehen et al. 2020), or 40 g whey protein 
on DIT (Hawley et al. 2020). The former of these null findings may be attributed to the time 
difference between protein consumption and RMR measurement [~9 hours (Morehen et al. 
2020)], which is longer than the acute pre-sleep protein-induced effect on DIT [~6 hours 
(Westerterp 2004)]. Additionally, use of an isonitrogenous pea protein supplement as a 
comparator control supplement might also explain these findings of Hawley et al. (2020). In 
contrast to these acute studies, a respiration chamber study by Drummen et al. (2020) 
established 34 months of a high protein diet (25% of EI) increased RMR, induced a negative 
energy balance and subsequently counteracted weight loss-induced adaptive thermogenesis 
34 months following weight loss compared to a typical protein diet (15% of EI). This important 
mechanistic study provides evidence to support the use of high protein diets to aid EE and 
oppose weight gain in older adults.  
 
However, whilst Drummen and colleagues (2020) reported a protein-induced increase in 
RMR, other longitudinal studies in older adults have not observed these effects (Luger et al. 
2013, Negro et al. 2019). Insufficient increases in dietary protein (≤0.1 g/kg/d) to stimulate 
changes in FFM and RMR may clarify these findings. In fact, due to weight loss, participants 
in the study by Luger et al. (2013) lost 0.8 kg of FFM, likely due to consumption of a suboptimal 
protein intake to maintain FFM during weight loss (~0.9 g/kg/d). As often cited in this literature 
review, a protein deviation of ≥0.4 g/kg/d may be required to stimulate gains in SMM in older 
adults (Park, Choi, and Hwang 2018). As FFM accounts for 50-70% of RMR (Gallagher et al. 
2000), of which SMM accounts for ~20% (Geisler and Müller 2017), further research 
increasing dietary protein intake by ≥0.4 g/kg/d is required to determine the effects on EE in 
older adults.  
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2.3.20 Effects of dietary protein on macronutrient oxidation and balance 
Intervention studies conducted in both young (Bray et al. 2015, Martens et al. 2015b, 
Pannemans et al. 1995, Robinson et al. 1990) and middle- to older-aged adults (Campbell et 
al. 1995, Drummen et al. 2020, Hays et al. 2009, Pannemans, Halliday, and Westerterp 1995, 
Pannemans et al. 1998) have established high protein diets increase 24-h protein oxidation 
and improve protein balance. Additionally, others have also demonstrated increases in 24-h 
fat oxidation (or decreased 24-h RQ) (Drummen et al. 2020, Lejeune et al. 2006, Martens et 
al. 2015b, Smeets, Janssens, and Westerterp-Plantenga 2013), a greater negative fat balance 
(Lejeune et al. 2006), and an exercise-induced increase in fat oxidation (Soenen et al. 2010). 
Protein-induced increase in fat oxidation is likely attributed to increased EE leading to rapid 
glycogen depletion, principally overnight (Smeets, Janssens, and Westerterp-Plantenga 
2013), and due to protein eliciting a negative energy balance which is known to increase fat 
oxidation (Westerterp 1993). Moreover, some (Drummen et al. 2020, Martens et al. 2015b), 
but not all of the abovementioned studies that observed increases in fat oxidation (Lejeune et 
al. 2006, Smeets, Janssens, and Westerterp-Plantenga 2013), also observed reductions in 
carbohydrate oxidation and balance. Though, these decreases were likely due to the fact 
carbohydrate was exchanged for dietary protein in these studies. Further, whilst studies have 
shown a protein-induced effect on fat oxidation, the majority [apart from Drummen et al. 
(2020)] were conducted on young adults. The findings therefore might not translate to the 
older population.   
 
2.3.21 Effect of dietary protein on metabolic flexibility  
The effect of dietary protein on metabolic flexibility is relatively unknown due to a paucity of 
published data. In the only study conducted to date to the author’s knowledge, Eelderink et al. 
(2019) reported no effects of high compared to low dairy consumption over 6 weeks in middle- 
and older-aged adults. These findings may be related to the short duration of the intervention 
and the lack of difference in protein intake between conditions (~20 g/d). Nevertheless, as 
dietary protein has been shown to increase SMM and fat oxidation [particularly in the overnight 
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fasted state (Smeets, Janssens, and Westerterp-Plantenga 2013)], reduce markers of 
systemic inflammation and decrease FM, all of which contribute to improved metabolic 
flexibility (Calçada et al. 2014, Smith et al. 2018), it might be hypothesised that dietary protein 
at a higher daily intake may improve metabolic flexibility in older adults. This hypothesis 
requires examining in future work.  
 
2.3.22 Effects of dietary protein on glucose homeostasis  
The effect of dietary protein on glucose homeostasis in middle- and older-aged adults is 
controversial (Drummen et al. 2018). Some studies have reported an increase in insulin 
sensitivity and/or a reduction in fasting glucose (Acheson et al. 2011, Amirani et al. 2020, 
Luger et al. 2013, Pal, Ellis, and Dhaliwal 2010, Promintzer and Krebs 2006), whereas others 
have reported either no change (Leenders et al. 2011), or increased whole-body insulin 
resistance (Linn et al. 2000, Hattersley et al. 2014, Weickert et al. 2011) and an elevated risk 
of developing T2DM (Tian et al. 2017). Deleterious effects reported in some studies may be 
related to the source of dietary protein (Drummen et al. 2018). In particular, associations 
between dietary protein and insulin resistance is most pronounced with high levels of red meat 
consumption (Sluijs et al. 2010). Additionally, it is thought that dietary protein may induce 
insulin resistance by activating mTOR and consequent phosphorylation of S6K1 (Weickert 
2012). However, these negative effects might be counteracted by reductions in FM, decreases 
in inflammation and increases in SMM observed following consumption of a high protein diet 
(Weickert 2012).  
 
2.3.23 Effects of resistance exercise combined with dietary protein on fat mass, energy 
metabolism, appetite and satiety, and metabolic health 
Based on the aforementioned cited evidence, RE combined with dietary protein may 
synergistically aid reductions in FM, increase components of EE, and improve metabolic 
health in older adults. Indeed, a meta-analysis of 15 RCTs reported augmented decreases in 
absolute and %FM following RE combined with protein supplementation (Liao et al. 2017). 
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More recent RCTs have also observed similar findings, reporting greater reductions in whole-
body (Bell et al. 2017) and intermuscular thigh FM (Englund et al. 2018). Of importance, data 
from Campbell and colleagues (2015) suggests intakes of ≥1.2 g protein/kg/d during RE 
training leads to greater declines in both absolute and %FM.  
 
From an appetite perspective, in one study, RE combined with whey protein supplementation 
(which increased daily protein intake from 1.24 g/kg/d to 1.40 g/kg/d) suppressed subjective 
hunger during the early stages of the intervention (weeks 1-3), but this was reversed at the 
end of the study (week 11) where hunger was increased (Ridge et al. 2018). However, it is 
important to note that participants were only supplemented with whey protein on training days, 
so it is unknown whether daily consumption of this dose would have affected appetite. In a 
more recent study, 12 weeks of RE combined with whey protein supplementation (which 
increased dietary protein intake from 1.2 g/kg/d to 1.4 g/kg/d) increased daily and ad libitum 
EI and postprandial subjective appetite in older adults (Johnson et al. 2021). The increase in 
ad libitum EI was associated with an increase in FFM. These findings suggest older adults 
may adapt to increased dietary protein intake over time. However, it must be noted that the 
dietary protein intake in these studies was lower than that reported by Morton et al. (2018a) 
to optimise SMM accretion during RE training (1.6 g/kg/d), and appetite was not compared 
against either RE or dietary protein alone.  
 
Moreover, despite reported synergistic effects of RE combined with dietary protein on FM, 
similar effects have not been observed on components of EE in older adults (Amamou et al. 
2017, Campbell et al. 1994, Maltais et al. 2016, Weinheimer et al. 2012). These findings may 
be explained by a lack of sample size (n = 6 per group) and statistical power (Campbell et al. 
1994), an inadequate increase in dietary protein (≤0.3 g/kg/d and less than 1.6 g/kg/d) to 
stimulate additive gains in SMM and EE (Amamou et al. 2017, Maltais et al. 2016), and an 
adequate (0.97-1.12 g/kg/d) habitual protein intake at baseline (Weinheimer et al. 2012).  
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Similar to the above, whilst studies have reported improvements in glucose homeostasis 
following RE training, no additive effects of dietary protein have been observed in the majority 
of studies (Holwerda et al. 2018, Iglay et al. 2007, Leenders et al. 2013, Maltais et al. 2016, 
Verdijk et al. 2009a, Weinheimer et al. 2012). Although, Bell et al. (2017) did report an 
augmented effect of a whey protein-based multi-ingredient supplement on glucose tolerance 
in healthy older men. In this study, dietary protein was increased from 1.1-1.6 g/kg/d, greater 
than that of previously cited studies [excluding Weinheimer et al. (2012)]. This synergistic 
effect was likely attributed to an augmented reduction in FM and decreases in markers of 
systemic inflammation (Bell et al. 2018). Of importance, the supplement investigated by Bell 
and colleagues contained additional ingredients such as omega 3 polyunsaturated fatty acids 
(n-3 PUFA), which has been shown to have insulin sensitising effects (Gao et al. 2017). 
Consequently, the addition of n-3 PUFA may have influenced the improvement in glucose 
tolerance. Based on the highlighted limitations of studies investigating the effects of RE 
combined with dietary protein on EE, appetite and glucose homeostasis, further research with 
an optimal dietary protein dosing regimen (i.e., 1.6 g/kg/d) is warranted.  
 
In parallel to the limitations of studies examining the synergistic effects of RE and dietary 
protein on FFM, strength and physical function reported in section 2.2.10.3.1, a significant 
limitation of studies investigating the synergistic effects on energy metabolism and glucose 
homeostasis was the failure to include a protein only group. The synergistic effects compared 
to each intervention alone are therefore unknown. Furthermore, studies investigating the 
effects on energy metabolism only captured RMR; consequently, the effects on 24-h energy 
metabolism are also unknown. As 24-h EE is not constant, varying based on numerous factors 
such as time of day and food consumption (Schoffelen and Plasqui 2018), collection of such 
data is important to further understand the individual and synergistic effects of these 
interventions on all components of EE (i.e., RMR, SMR, AEE, DIT and TEE). Finally, no study 
has investigated the synergistic effects on 24-h metabolic flexibility or appetite compared to 
both RE and dietary protein alone in older adults. The addition of this data would provide the 
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literature with comprehensive data on the effects of RE and dietary protein on metabolic health 
and energy balance, which might have important implications for attenuating sarcopenic 
obesity.   
 
2.4 Part 3: Cognitive function  
 
2.4.1 Introduction 
Ageing is associated with degeneration of a number of cognitive capacities, including memory, 
attention, reaction time and executive function (Hedden and Gabrieli 2004). Such declines can 
lead to mild cognitive impairment (MCI) and dementia, most commonly Alzheimer’s disease 
(Alzheimer’s Society 2014). At present, MCI affects 17.1% of adults aged ≥65 years in the 
United Kingdom, with reported rates of progression to dementia ranging from ~8-15% per 
annum (Petersen 2016). Dementia prevalence is currently estimated at ~50 million people 
worldwide and is projected to affect ~82 million people by 2030 (World Health Organisation 
2019). The impact of such conditions, both personally and economically, is extensive (Farina 
et al. 2017, Wimo et al. 2017). Personally, cognitive impairment is associated with physical 
impairment (Coppin et al. 2006, Demnitz et al. 2017) and poor quality of life (Woods et al. 
2015). Economically, the total cost of dementia in the United Kingdom has been calculated at 
£26.3 billion per annum (Alzheimer’s Society 2014). Identifying safe and effective strategies 
to prevent cognitive decline is therefore vital for public health.  
 
2.4.2 Age-related declines in cognitive function  
Across the human lifespan, increases in cognitive function are observed up until early 
adulthood, with gradual decreases seen from mid adulthood to older age (Daffner 2010). 
Generally, cognitive function can be partitioned into either fluid or crystallised intelligence. 
Fluid intelligence refers to basic processes that depend minimally on prior learning (e.g., 
problem solving ability), whereas crystallised intelligence refers to learned procedures and 
knowledge (e.g., general knowledge) (Deary et al. 2009, Salthouse 2009). The core fluid and 
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crystallised domains include memory, attention, executive function, language, visuospatial 
abilities and processing speed (Serper et al. 2014). Figure 2.6 displays estimates of age-
related changes in key cognitive domains from a number of studies including the Seattle 
Longitudinal Study (Hedden and Gabrieli 2004). These estimates suggest declines in all 
cognitive domains are evident from 55 years of age.   
Figure 2.6 Cross-sectional (A) and longitudinal (B) estimates of age-related declines in 
cognitive domains. Taken from Hedden and Gabrieli (2004). 
 
2.4.3 Mechanisms and risk factors 
Several mechanisms and risk factors contribute to age-related cognitive decline. These 
include structural and neurophysiological changes in the brain, genetic and lifestyle factors, 
chronic stress and systemic inflammation (Deary et al. 2009, Prince 2014). It is beyond the 
scope of this thesis to review the literature on the structural and genetic mechanisms of age-
related cognitive decline. Therefore, the following sections will briefly review the lifestyle, 






2.4.3.1 Lifestyle and cardiometabolic factors 
Numerous lifestyle and cardiometabolic factors, including obesity, hypertension, insulin 
resistance and T2DM, and physical inactivity/poor diet have been linked to cognitive decline 
and dementia (Biessels and Reagan 2015, Cunningham et al. 2020, Nguyen, Killcross, and 
Jenkins 2014, Stough et al. 2019, Walker, Power, and Gottesman 2017). For example, obesity 
has been associated with decreased brain volume and atrophy (Raji et al. 2010), and 
diagnosis of T2DM has been reported to increase the risk of developing dementia by 73% 
(Biessels et al. 2014). Mechanistically, hippocampal insulin resistance, which has deleterious 
effects on memory (De Felice, Lourenco, and Ferreira 2014), is understood to be the result of 
impaired insulin receptor signalling combined with reductions in insulin transport across the 
blood-brain barrier (Banks, Owen, and Erickson 2012). Hypertension is purported to 
negatively affect cognitive function by altering brain structure and function via cerebral vessel 
remodelling, leading to disturbances in cerebral autoregulation, reduced cerebral perfusion 
and limiting the ability of the brain to clear harmful proteins such as β-amyloid (Walker, Power, 
and Gottesman 2017). Lastly, data from some (Guure et al. 2017, Sofi et al. 2011), but not all 
studies (Blondell, Hammersley-Mather, and Veerman 2014), indicates physical inactivity may 
promote cognitive decline, which may be explained in part by the relationship between 
inactivity and sarcopenic muscle loss (Peng et al. 2020). 
 
2.4.3.2 Sarcopenia  
Several meta-analyses have reported an association between sarcopenia and cognitive 
impairment (Chang et al. 2016, Cipolli, Yassuda, and Aprahamian 2019, Peng et al. 2020). 
Common pathologies of both conditions, including chronic systemic inflammation, insulin 
resistance and reductions in growth factors might explain this relationship (Chang et al. 2016). 
For instance, associations have been observed between high concentrations of IL-6 and CRP 
with both parameters of sarcopenia (Alemán et al. 2011, Schaap et al. 2006) and increased 
risk of dementia (Engelhart et al. 2004). Others have also reported associations between low 
IGF-1 concentration and insulin resistance with decreased gait speed, low appendicular FFM 
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and sarcopenia (Gielen et al. 2015, Moon 2014), and cognitive impairment (Al-Delaimy, Von 
Muhlen, and Barrett-Connor 2009, Kim and Feldman 2015). Lastly, findings from 
neuroimaging studies suggests sarcopenic muscle loss leads to the presence of white matter 
and brain atrophy (Burns et al. 2010, Kohara et al. 2017). 
 
Sarcopenia had previously been considered a risk factor for cognitive impairment; however, 
the relationship may plausibly be bidirectional (Peng et al. 2020). It is also unknown whether 
the association is purely casual, and which parameter of sarcopenia (SMM, strength or 
physical function) correlates strongest with cognitive impairment (Cipolli, Yassuda, and 
Aprahamian 2019). Further longitudinal research is warranted to answer these vital questions.  
 
2.4.3.3 Neurobiological changes 
Prior work has established a number of growth and neurotrophic factors, in particular IGF-1 
and BDNF, both of which decline with age (Katoh-Semba et al. 2007, Veldhuis et al. 1995), 
play important roles in maintaining cognitive function. Insulin-like growth factor 1, which is 
produced both peripherally and locally in the brain (Van Dam et al. 2000), is an important 
regulator of neurogenesis (Lichtenwalner et al. 2001). Low (<75 ng/mL) and high (>106 ng/mL) 
peripheral concentrations have been associated with poorer and better cognitive function, 
respectively (Al-Delaimy, Von Muhlen, and Barrett-Connor 2009, Angelini et al. 2009, Dik et 
al. 2003).  
 
Brain-derived neurotrophic factor aids the development, preservation and function of 
neurones, and enhances long-term potentiation, strengthening synapses linked with memory 
and learning (Alderson et al. 1990, Bramham and Messaoudi 2005, Mattson, Maudsley, and 
Martin 2004). Declines in BDNF, which have been observed in individuals with MCI and 
dementia (Laske et al. 2007, Yasutake et al. 2006, Yu et al. 2008), has been associated with 
impaired memory and general cognitive function (Katoh-Semba et al. 2007, Paulsen et al. 
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2020). However, others have not observed decreases in individuals with Alzheimer’s disease 
compared to healthy controls (O’Bryant et al. 2011), and some have reported either no 
association (Ziegenhorn et al. 2007), or an association in the opposite direction (Angelucci et 
al. 2010), between BDNF and cognitive function. Likewise, longitudinal data is also mixed 
(Driscoll et al. 2012, Li et al. 2009, Nettiksimmons et al. 2014). Further work, particularly of 
longitudinal design, is required to determine the effects of BDNF on cognitive decline.  
 
2.4.3.4 Cortisol  
Psychological stress and the resulting dysregulation of the HPA axis has been linked with 
cognitive impairment (Lucassen et al. 2014). Over time, psychological stressors stimulate 
activity of the HPA axis, leading to alterations in diurnal cortisol secretion (Dickman et al. 
2020), which subsequently adversely affects cognitive function (Beluche et al. 2010, 
Dijckmans et al. 2017, Evans et al. 2011, 2012, Lee et al. 2007). For example, an attenuated 
decline in diurnal cortisol secretion (Beluche et al. 2010, Dijckmans et al. 2017, Evans et al. 
2011), a blunted CAR (Evans et al. 2011), and a high mean cortisol concentration (Lee et al. 
2007) have all been associated with poor cognitive function. However, not all studies have 
reported such associations (Harris et al. 2017, Peavy et al. 2009). Lack of association in these 
studies might be related to the method of cortisol measurement, such as unsupervised cortisol 
and cognitive testing (Harris et al. 2017), and inclusion of the CAR in mean daily 
concentrations (Peavy et al. 2009). Taken together, although the relationship between 
cognitive function and diurnal cortisol is not fully understood, current evidence suggests a 
flatter diurnal cortisol profile may contribute to cognitive decline. 
 
2.4.3.5 Inflammation  
Epidemiological data suggests systemic inflammation may contribute to brain atrophy 
(Jefferson et al. 2007, Satizabal et al. 2012, Wersching et al. 2010) and poorer cognitive 
performance (Marioni et al. 2009, Marsland et al. 2006, Rafnsson et al. 2007). In middle- and 
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older-aged adults, higher circulating concentrations of IL-6 and CRP have been associated 
with higher volumes of white matter hyperintensities, lower grey matter and hippocampal 
volumes, and poorer cognitive performance (Marsland et al. 2006, Satizabal et al. 2012). 
Mechanistically, systemic inflammation contributes to neurodegeneration and cognitive 
impairment by crossing the blood-brain barrier, switching primed microglia to an inflammatory 
phenotype, subsequently increasing the central inflammatory response (Marsland et al. 2015). 
 
2.4.4 Measurement of cognitve function  
Several psychological tools have been used in the literature to measure cognitive function 
(Table 2.6). These methods generally assess individual responses of specific cognitive 
domains in a relevant sample population (Cordell et al. 2013, Pase and Stough 2014). 
However, no single tool is considered the ‘gold standard’ for detecting changes in cognitive 
function (Cordell et al. 2013). Due to the plethora and diversity of tests used within the 
literature, interpretation and comparison between studies is challenging (Pase and Stough 
2014). Inconsistencies in the method of analysis and reporting of data (e.g., reporting raw 
scores or converting into z-scores) also makes comparison problematic (Pase and Stough 
2014). Furthermore, when conducting cognitive testing, several important methodological 
factors need to be considered. For example, room temperature, nutritional status and timing 
of cognitive testing may all potentially influence outcomes (Pase and Stough 2014). Adequate 
control and standardisation of these factors is therefore critical for accurate and reliable 
results. 
 
At present, the Cambridge Neuropsychological Test Automated Battery (CANTAB) is the most 
widely publicised testing battery with reports on test-retest reliability and clinical use (Zygouris 
and Tsolaki 2015). The CANTAB is a touchscreen, tablet-based testing battery, which 
assesses the cognitive domains memory, executive function, attention and psychomotor 
speed, and emotional and social cognition (Cambridge Cognition Ltd. 2020). In multiple health 
and disease states, studies have demonstrated the CANTAB to be sensitive to changes in 
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cognitive function (Blackwell et al. 2004, Chamberlain et al. 2011, De Luca et al. 2003). Validity 
and reliability have also been confirmed for detecting age-related cognitive impairment 
(Rabbitt and Lowe 2000, Wild et al. 2008). The advantages of the CANTAB include the 
comprehensive assessment of multiple domains of cognitive function, sensitivity for use in 
older adults, and the touch screen use (Cordell et al. 2013). However, the testing battery does 
have several limitations, such as difficulty and length of time to administer in addition to lack 
of normative data for a number of cognitive outcomes (Cordell et al. 2013).  
 
Table 2.6 Summary of cognitive assessment tools used in exercise and/or nutrition trials. 
Adapted from Cordell et al. (2013) and Pase and Stough (2014) 
Test Advantages Limitations 
7-Minute Screamer  Little/no education bias,  
primary care validated  
 




Simple administration, verbal only 
(no writing/drawing)  
Education/ethnicity bias, does not test key 











Test Automated Battery 
(CANTAB) 
 
Tests numerous cognitive domains, 
computer administrated, touch 
screen 
Long duration (depending on tests 
included), lack of normative data on some 
tests 
Digital span (forwards 
and backwards) 
Reliable and valid, effective 
method of measuring working 
memory 
 
More research needed on how the test 
translates into unfamiliar consequences of 






Primary care validated, no 
culture/education bias, available in 
multiple languages, useful 
informant component  
Little data on language/culture bias, 
informant-based responses only 
Mini-Cog  Primary care developed and 
validated, available in multiple 
languages, administration time 
short, no education/culture/race 
bias 
 





Verbal, little/no education bias  Does not test key cognitive domains (e.g., 
executive function 
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Table 2.6 continued 
 
Test Advantages Limitations 
Mini Mental State 
Exam (MMSE) 
Most widely used test worldwide, 
used as a criterion method against 
other methods, quick to administer  
Ceiling effect (cognitively able/highly 
educated individuals score nearly full 




Available in multiple languages, 
tests multiple cognitive domains, 
designed to assess MCI 
Education bias (<12 y), limited literature 
due to recently developed, long 
administration time 
Rey Auditory Verbal 
Learning Test 
(RAVLT) 
Simple word recall administration  Education bias  
 
Rey-Osterrieth 
Complex Figure test 
(ROCF) 
 
Tests numerous domains such as 
memory, attention, planning, 








Little/no education bias, designed 
for different cultures  
 
Limited published research due to recently 
developed  
 




Effective test for detecting 
dementia  
 
Memory not tested, lacks data on 
education/culture biases  
 
Short Blessed Test 
(SBT) 
 
Verbal only (no writing/drawing) 
 
Executive function not tested, scoring can 
be burdensome, education/culture bias 
 




Tests numerous cognitive domains, 
no education bias  
 
Limited published data  
 




Verbal only (no writing/drawing), 
quick to administer 
 
 
Education/culture/race bias, short-term 
memory not assessed, scoring can be 
burdensome  
 
Short Test of Mental 
Status (STMS) 
 
Primary care validated, numerous 
cognitive domains assessed  
 
Education bias - tested on well-educated 
individuals, race bias  
 
Stroop test  
 
Multiple variants for repeated 
measures, simple scoring, quick to 
administer  
 
Some education bias, potential gender 
bias  
 
Time and Change 
Test (T&C) 
 
Brief administration time (<1 min), 
no education bias  
 






Tests several cognitive domains, 
reliable and valid 
 
Typically requires trained psychological 
personnel to conduct, poor assessment of 
working memory 
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2.4.5 Effects of resistance exercise on cognitive function 
Epidemiological data suggests muscle strengthening exercises may improve executive 
functioning in older adults (Loprinzi 2016). Additionally, as shown in Table 2.7, a number of 
RCTs of 4-52 weeks in duration have shown improvements in multiple aspects of cognitive 
function following RE training (Anderson-Hanley, Nimon, and Westen 2010, Best et al. 2015, 
Cassilhas et al. 2007, Coelho-Júnior et al. 2020, Ikudome et al. 2017, Liu-Ambrose et al. 2010, 
2012, Smolarek et al. 2016, Singh et al. 2014, Yoon, Lee, and Song 2018). Results from these 
studies indicate RE is primarily beneficial for improving the cognitive domains executive 
function (Anderson-Hanley, Nimon, and Westen 2010, Best et al. 2015, Ikudome et al. 2017, 
Liu-Ambrose et al. 2010, Yoon, Lee, and Song 2018), memory (Best et al. 2015, Cassilhas et 
al. 2007, Coelho-Júnior et al. 2020, Ikudome et al. 2017, Marston et al. 2019c), and global 
cognitive function (Coelho-Júnior et al. 2020, Singh et al. 2014, Smolarek et al. 2016). 
Furthermore, although not analysed or reported universally, improvements in attention (Liu-
Ambrose et al. 2012) and processing speed (Yoon, Lee, and Song 2018) have also been 
reported. In contrast to these studies, cognitive benefits of RE have not been observed by all 
(Kimura et al. 2010, Lachman et al. 2006). An insufficient RE intensity (light-moderate) 
(Lachman et al. 2006) and lack of experimental control (high background noise) (Kimura et al. 
2010) might explain these findings.  
 
Whilst recommendations have been set by the ACSM (Chodzko-Zajko et al. 2009) and the 
NSCA (Fragala et al. 2019) for the optimal frequency (2-3 sessions/week) and intensity (60-
80% 1RM) of RE to optimise outcomes such as maintenance of SMM and strength, the optimal 
intensity to aid cognitive function is of debate. In an acute dose-response study (40-100% 
1RM), RE performed at 100% 1RM resulted in the greatest improvement in processing speed, 
but moderate intensity RE (70% 1RM) elicited superior improvements in executive function 
(Chang and Etnier 2009). Similarly, Engeroff et al. (2019) reported greater increases in lower 
cognitive functions, such as attention following high intensity RE (90% 1RM), but higher 
cognitive functions, including interference control, were improved by RE performed at 
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moderate intensity (60% 1RM). In contrast to these studies, Chang et al. (2017) did not 
observe any cognitive benefit of high intensity RE (80% 1RM), reporting worsening effects 
compared to RE performed at low intensity (30% 1RM). More recently, a meta-analysis 
conducted by Wilke et al. (2019) reported low (≤50% 1RM) and high intensity RE (75-100% 
1RM) elicited similar effects on cognitive function, but RE performed at moderate intensity (50-
75%1RM) produced greater improvements compared to both. The reasons for the 
abovementioned varying effects regarding RE intensity is not clear, but it is thought the dose-
response effects may be unique to the cognitive domain assessed (Engeroff et al. 2019). Also, 
it has been suggested that RE-induced improvements in cognitive function may be highly 
specific to the participants studied (Chang et al. 2017). Together, these findings suggest low, 
moderate and high intensity RE may be beneficial for different cognitive domains.  
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Table 2.7 Summary of intervention studies investigating the effects of resistance exercise on cognitive function in older adults  












RE: 2-3 times/week (primarily chair and 
standing exercises)* 
Control: Exercise waiting list 
*Intensity not defined  
RE ↑ executive function but not processing speed 
compared to control 
Best et al. 
(2015) 
155 older women (age: 
65-75 y) 
12-month RCT with 2-
year follow up 
Once weekly: 2 sets of 6-8 repetitions at 
7RM) 2 times/week 
Twice weekly: 2 sets of 6-8 repetitions at 
7RM) 2 times/week 
Control: balance and toning (twice weekly) 
 
Both RE frequencies ↑ executive function 
compared to control. Only twice weekly RE ↑ 
memory compared to control 
Cassilhas et 
al. (2007)  
62 sedentary men (age: 
65-75 y) 
24-week RCT  High intensity: whole-body RE (80%1RM) 3 
times/week 
Moderate intensity: whole-body RE (50% 
1RM) 3 times/week 
Control: warm-up and stretching 3 
times/week 
 
Both moderate and high intensity RE ↑ cognitive 
performance examining short-term memory, 
episodic memory and executive/digital span 
compared to control. No differences occurred 
between moderate and high intensity groups 
  
Coelho-
Júnior et al. 
(2020) 




assessed after 5 and 
14 weeks) 
Traditional RE: twice weekly RE (5-6/10 
RPE, 9 exercises, 8-10 repetitions per set, 3 
sets per exercise) 
Power training: twice weekly RE at 
moderate intensity (RPE 3), as quickly as 
possible, 8-10 repetitions per set, 3 sets per 
exercise  
Control: no exercise  
Both traditional and power RE ↑ global cognitive 
function, short-term memory, and dual-task 
performance. No changes in serum BDNF 
occurred in any group 




Table 2.7 continued 
Study Participants Duration and design Groups Key findings 
Ikudome et al. 
(2017)  
170 healthy older 
adults (age: 52-
81 y) 
12-week RCT  RE: home-based body mass RE (5 exercises, 16 
repetitions of each, 2-3 circuits/day) 
Control: maintain normal lifestyle  
RE ↑ working memory and inhibitory control 
(executive function), but not information 
processing, attention or timing ability compared 
to control group 
 




adults (age: >65 
y) 
12-week RCT Strength training: twice weekly RE at 60% 1RM, 
2-3 sets of 10 repetitions 
Health education: 1.5 hours of health education 
twice/month 
 
No differences in reaction time occurred 
between groups 








24-week RCT RE: elastic-band (TheraBand) RE (thin to heavy 
resistance 3 times/week) 
Control: waiting list (continue normal everyday 
activities) 
 
No differences occurred between groups for 
memory, but RE level was a significant predictor 
of memory change 
Liu-Ambrose 
et al. (2010) 
155 community-
dwelling women 
(age: 65-75 y) 
12-month RCT Once weekly: 2 sets of 6-8 repetitions whole-body 
RE at 7RM (once weekly) 
Twice weekly: 2 sets of 6-8 repetitions whole-body 
RE at 7RM (twice weekly) 
Control: balance and toning (twice weekly) 
 
Both RE groups ↑ Stroop test performance 
(executive function), selective attention and 




et al. (2012) 
*Same as above 
 
*Same as above 
 
*Same as above 
 
Twice weekly RE only ↑ selective attention and 
conflict resolution compared to control. No 






Table 2.7 continued 
Study Participants Duration and design Groups Key findings 
Marston et 
al. (2019c)  
45 healthy adults (age: 
41–69 y) 
12-week RCT  High load, long rest RE: 5 sets of 5 
repetitions at 85% 1RM twice weekly, 3 min 
between sets 
Moderate load, short rest RE: 3 sets of 10 
repetitions at 70% 1RM twice weekly, 60 s 
between sets 
Control: no exercise  
Delayed verbal memory performance ↑ greater in 
the RE groups when compared to the control 
group 
     
Singh et al. 
(2014)  
100 MCI participants 
(age: 70.1 ± 6.7) 
6 months RCT with 18 
months follow up 
RE: twice weekly RE (3 sets of 8 repetitions 
of 5-6 exercises at high intensity)  
CT: computer based cognitive function 
training  
Combined RE+CT: interventions above 
combined 
Control: sham cognition + sham exercise 
(stretching) 
 
RE ↑ global cognitive function compared to 
control at 6 months. RE maintained executive 




37 older women (age: 
65.9 ± 5.7y) 
12-week RCT Strength training: whole-body RE (60-70% 
1RM; 3 sets of 10 exercises) 3 times/week  
Control: maintained habitual physical activity 
Strength training ↑ global cognitive function 






43 cognitively frail older 
adults (age: 73.9 ± 4.3 y) 
16-week RCT  High-speed whole-body RE: 2-3 sets of 12-
15 repetitions [intensity based on RPE (12-13 
- somewhat hard)] 3 times/week 
Control: balance and resistance band 
stretching (3 times/week) 
RE ↑ processing speed and executive function 
compared to control. No differences in memory or 
working memory occurred between groups 
 
↑, increased; MCI, mild cognitive impairment; MoCA, Montreal Cognitive Assessment; RCT, randomised controlled trial; RE, resistance exercise. 
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2.4.6 Effects of dietary protein on cognitive function  
Epidemiological studies investigating the association between dietary protein and cognitive 
function have reported mixed findings with some (Lee et al. 2001, Nes et al. 1988, Roberts et 
al. 2012, Vizuete et al. 2010), but not all studies (Barberger-Gateau et al. 2007, Deschamps 
et al. 2002, Katsiardanis et al. 2013, Requejo et al. 2003, Velho et al. 2008, Vercambre et al. 
2009) reporting positive associations. Similarly, review articles also report inconsistent results 
(Koh et al. 2015, van de Rest, van der Zwaluw, and De Groot 2013). These disparities may 
be due to the relatively good health and nutritional status of participants, and differences in 
the range of dietary protein spread between participants.  
 
Consistent with the above, findings from intervention studies in older adults are also varied 
(Table 2.8). Several studies have reported beneficial effects of dietary protein on aspects of 
cognitive function (Charlton et al. 2016, Kaplan et al. 2001, Lefferts et al. 2020, van der Zwaluw 
et al. 2014), whilst others have failed to observe such effects (Bell et al. 2019, Moran et al. 
2018, Zajac et al. 2019). Acutely, improvements in memory have been observed following 
50.5 g whey protein supplementation (Kaplan et al. 2001). Longitudinal intervention studies of 
12-24 weeks have also reported improvements in reaction time (van der Zwaluw et al. 2014), 
memory (Charlton et al. 2016, Kita et al. 2019), attention (Kita et al. 2019) and emotion 
identification (Lefferts et al. 2020). Contrary to these studies, Bell et al. (2019) reported no 
improvement in any aspect of cognitive function in older adults consuming a whey protein- 
based multi-ingredient supplement twice daily for 6 weeks. Likewise, Moran et al. (2018) also 
reported no cognitive effects of 6 months consumption of a multi-ingredient supplement 
containing whey protein. More recently, twice daily consumption of 25 g whey protein for 8 
weeks elicited no effects on cognitive function in older adults, but improvements in reasoning 
speed and reaction time were observed following twice daily consumption of 25 g soy protein 
in older women only (Zajac et al. 2019). The authors concluded the latter of these findings 
may have been observed due to the positive impact of soy isoflavones in postmenopausal 
women (Kritz-Silverstein et al. 2003). It is also worth noting that although two previously cited 
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studies reported positive effects of protein supplementation on reaction time and emotion 
identification, respectively (Lefferts et al. 2020, van der Zwaluw et al. 2014), these studies 
observed no effects on memory or executive functioning, two key cognitive domains 
associated with ageing (Vaughan and Giovanello 2010, Peters 2006). 
 
The lack of protein-induced effects on cognitive function in several of the abovementioned 
studies might be related to an insufficient intervention duration and inadequate protein dose. 
To explain, two of these studies examined the effects over a 6-8-week duration (Bell et al. 
2019, Zajac et al. 2019), whereas studies that reported beneficial effects were conducted over 
at least 12 weeks (Kaplan et al. 2001, Lefferts et al. 2020, van der Zwaluw et al. 2014). 
Furthermore, while the multi-ingredient supplement investigated by Moran et al. (2018) 
contained 3000 mg n-3 PUFA, a dose previously reported to attenuate cognitive impairment 
(Zhang et al. 2016), the supplement only contained 8 g whey protein. As detailed in part 1 of 
this literature review (section 2.2.8.3), Moore et al. (2015) established the breakpoint for 
maximal stimulation of MPS in older adults to be 0.4 g protein/kg, which has led others to 
suggest this deviation of dietary protein might be required to stimulate gains in SMM in older 
adults (Park, Choi, and Hwang 2018). Given the association between sarcopenia and 
cognitive impairment previously reported (Peng et al. 2020), the findings of Moore et al. (2015) 
partly support the notion that 8 g whey protein over 6 months was likely insufficient to stimulate 
changes in SMM and cognitive function. Though, it must be acknowledged that no dose-
response study has been conducted to determine the optimal dose of dietary protein to 
stimulate cognitive benefits in older adults; therefore, this theory is purely speculative.  
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Table 2.8 Summary of intervention studies investigating the effects of dietary protein on cognitive function in older adults  
Study Participants Duration and design Groups Key findings 
Bell et al. 
(2019) 
49 healthy sedentary 
men (age: 73 ± 6 y) 
20-week double-blind 
RCT split into 2 
phases: 6-weeks 
nutrition only + 12-
weeks exercise + 
nutrition 
 
SUPP: 1500 mg n−3 PUFA, 30 g whey protein, 
2.5 g creatine, 500 IU vitamin D and 400 mg 
calcium (twice daily) 
CON: 22 g maltodextrin (twice daily) 
No changes in any aspect of cognitive function 
following phase 1 (6 weeks supplementation) 
occurred in any group. No changes in plasma BDNF 
occurred in any group 
Charlton et 
al. (2016)  
48 healthy older 




Pork: pork-containing meals 4 times/week 
(average protein per meal 28.1 ± 6.3 g) 
Chicken (control): chicken-containing meals 4 
times/week (average protein per meal 25.2 ± 
6.2 g) 
 
Chicken group ↑ verbal learning and 
memory at 6 weeks. Pork had no effect on any 
cognitive function test 
Kaplan et al. 
(2001) 
22 older adults (age: 




Protein: 260 mL water, 10 mL lemon juice, 
50.5 g whey protein isolate 
Fat: 248.9 mL water, 10 mL lemon juice, 41.1 
g safflower oil 
Carbohydrate: 260 mL water, 10 mL lemon 
juice and 50 g glucose 
Placebo: 290 mL water, 10 mL lemon juice 
and 23.7 mg sodium saccharin 
 
Whey protein ↑ delayed paragraph recall (memory) 
compared to placebo, but had no effect on attention 
or executive function 
Kita et al. 
(2019) 
114 healthy older 
adults (age: 50-75 y) 
12-week double-blind 
RCT 
Whey peptide: 1 g whey peptide tablet 
[containing 1.6 mg of β-lactopeptide of glycine-
thereonine-tryptophan-tyrosine (GTWY)] once 
daily 
Placebo: 1 g maltodextrin tablet 
 
Whey peptide ↑ associative learning memory and 
control of attention greater than placebo 
Lefferts et al. 
(2020) 
99 healthy older 
adults (age: 67 ± 6 
y) 
12-week parallel 
groups RCT  
Whey protein: 50 g/d (2 x 25 g) whey protein 
isolate  
Control: 50 g/d (2 x 25 g) carbohydrate 
(maltodextrin)  
Whey protein ↑ emotion identification compared to 
control, but no significant differences occurred 
between groups for working memory, attention, or 
impulsivity composite scores 
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Table 2.8 continued  
Study Participants Duration and design Groups Key findings 








Multi-ingredient nutrition supplement: 200 
mL liquid juice comprising 3000 mg n-3 PUFA 
[1500 mg docosahexaenoic acid (DHA) and 
1500 mg eicosapentaenoic acid (EPA)], 10 μg 
vitamin D3, 150 mg resveratrol and 8 g whey 
protein isolate 
Placebo: 200 mL juice only 
 
No significant differences in overall cognitive 
function or composite cognitive domain scores 
were observed between groups. Stroop colour-
word time ↓ in the multi-ingredient group only 
compared to the placebo, but this effect was 




65 frail or pre-frail 
elderly individuals 
(age: 78 ± 8 y in 
protein group, 81 ± 7 
y in placebo group) 
 
24-week double-blind 
parallel groups RCT 
Protein: 2 x 15 g protein supplement per day 
Control: 2 x matched placebo (0 g protein) per 
day 
Protein ↓ reaction time greater than the placebo 
group. No differences occurred between groups for 
global cognitive function, episodic memory, working 
memory, information processing or executive 
function 




participants (age: 60 
± 8.5 y) 
8-week randomised 
controlled crossover 
trial (16 weeks 
washout) 
Whey protein: 2 x 25 g whey protein isolate 
per day 
Soy protein: 2 x 25 g soy protein per day 
No effect of whey protein on any cognitive 
domains. Soy protein ↑ reasoning speed and 
reaction time in females only 
  
↑, increased; ↓, decreased; PUFA, polyunsaturated fatty acids; RCT, randomised controlled trial.  
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2.4.7 Effects of resistance exercise combined with dietary protein on cognitive function  
At present, only four studies have investigated the effects of RE combined with increased 
dietary protein intake on cognitive function in older adults (Bell et al. 2019, Formica et al. 2020, 
Rondanelli et al. 2020, van de Rest et al. 2014). van de Rest and colleagues (2014) 
demonstrated twice weekly RE performed at 75% 1RM combined with twice daily protein 
supplementation (15 g/serving) for 24 weeks improved information processing speed greater 
than protein supplementation alone. In contrast, the opposite effect was observed for verbal 
fluency, and no differences were observed between RE groups for any cognitive domain. More 
recently, Formica et al. (2020) demonstrated 24 weeks of multimodal exercise three times per 
week [including moderate-high intensity (5-8 on the 10-point Borg scale) aerobic + RE] 
enhanced global cognitive function and executive functioning, but consumption of lean red 
meat (2 x 80 g cooked weight on training days; ~45 g/d additional protein) did not augment 
these effects. Paradoxically, multimodal exercise alone improved working memory greater 
than exercise combined with lean red meat.   
 
Contrary to these studies, Rondanelli et al. (2020) demonstrated physical rehabilitation 
(including muscle strengthening exercises) combined with twice daily consumption of a whey 
protein-based nutritional supplement enriched with leucine and vitamin D, improved Trail 
making test performance (which assesses executive functioning, processing speed, mental 
flexibility and attention) greater than physical rehabilitation combined with a control 
supplement in sarcopenic older adults. Additionally,  Bell et al. (2019) established multimodal 
exercise, including twice weekly RE (80% 1RM) and once weekly high intensity interval 
training (HIIT) [10 x 60 s intervals at 90% max heart rate (HR)] combined with a twice daily 
whey protein-based multi-ingredient supplement (containing 30 g whey protein), elicited 
greater effect sizes on reaction time (d = -0.73 vs. -0.44) and MoCA performance (d = 0.53 
vs. 0.02) compared to RE combined with a control supplement. A within-group improvement 
for composite cognitive function was also only observed in the RE plus whey protein-based 
multi-ingredient supplement group. However, while differences in effect sizes were observed, 
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it must be noted that no significant between-group differences occurred. The authors attributed 
the lack of significant effects to a lack of statistical power.  
 
The disparities between the abovementioned studies may be related to the habitual intake, 
daily dose during the intervention, and deviation of dietary protein. Dietary intake data from 
participants in the study by van de Rest et al. (2014) published elsewhere (Tieland et al. 
2012b), reports dietary protein intake increased by 0.3 g/kg/d (1.0-1.3 g/kg/d). In the study by 
Formica and colleagues (2020), red meat was only consumed on exercise training days (3 
days/week); subsequently, protein intake was increased from 1.26 to 1.40 g/kg/d. In contrast, 
whilst Rondanelli et al. (2020) increased dietary protein by a similar amount to these studies 
(0.32 g/kg/d), habitual intake was considerably less (0.79 g/kg/d). Similar to that mentioned 
previously, the effect of dietary protein on cognitive function may be more profound in protein 
malnourished individuals. Furthermore, Bell et al. (2019) increased dietary protein by a notably 
greater amount (0.5 g/kg/d; 1.1-1.6 g/kg/d). Although further research is warranted, it may be 
that a protein dose of 1.6 g/kg/d (or a deviation of ~0.5 g/kg/d) may be required to stimulate 
additive effects on cognitive function in older adults habitually consuming adequate amounts 
of dietary protein. Interestingly, this intake mimics that suggested to maximally increase SMM 
during RE training (Morton et al. 2018a).  
 
Whilst data from Bell et al. (2019) and Rondanelli et al. (2020) provide preliminary evidence 
indicating that RE combined with dietary protein may synergistically improve cognitive function 
in the elderly, several methodological aspects of these studies warrant further discussion. 
Firstly, the supplements investigated in these studies contained vitamin D, and the supplement 
examined by Bell et al. (2019) also contained n-3 PUFA. Both of these ingredients have 
previously been shown to attenuate cognitive decline (Balion et al. 2012, Karr, Alexander, and 
Winningham 2011). As the isolated effects of dietary protein were not studied, it is unknown 
whether increased dietary protein per se stimulated the additive effects. Moreover, the 
exercise intervention in the study by Bell and colleagues (2019) included aerobic-based 
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exercise, which has been shown to aid cognitive function in older adults (Zheng et al. 2016). 
This was also the case in the study by Formica et al. (2020). Consequently, it is also unknown 
whether the combination of aerobic plus RE combined with the multi-ingredient supplement 
yielded the cognitive benefits. The true effects of RE combined with dietary protein on 
cognitive function in the elderly is therefore limited to that of van de Rest and colleagues 
(2014).  
 
2.4.8 Mechanisms underlying resistance exercise- and dietary protein-induced 
improvements in cognitive function 
Although previous work has indicated RE and dietary protein may slow or prevent cognitive 
decline, the mechanisms of action are relatively unknown (Macaulay, Fisher, and Schroeder 
2020, van de Rest, van der Zwaluw, and De Groot 2013). At present, changes to brain 
structure and function, alterations in various neurobiological and inflammatory markers, and 
improvements in vascular and muscle function, insulin sensitivity, and psychological factors 
such as mood and sleep quality are all purported to contribute to the cognitive benefits 
(Kovacevic et al. 2018, Macaulay, Fisher, and Schroeder 2020, van de Rest, van der Zwaluw, 
and De Groot 2013). The following sections will briefly review these mechanisms. 
 
2.4.1 Skeletal muscle mass and strength  
As previously reported in part 1 of this literature review (section 2.2.10.1.2), RE is well-known 
for its effects on FFM (Peterson, Sen, and Gordon 2011), muscular strength (Peterson et al. 
2010) and physical function (Arnarson et al. 2013, Oesen et al. 2015). Similarly, although 
research is mixed, dietary protein has also been shown to increase FFM, muscular strength 
and physical function in both healthy (Bell et al. 2017, Norton et al. 2016, ten Haaf et al. 2019) 
and sarcopenic/frail older adults (Bauer et al. 2015, Bo et al. 2019, Shahar et al. 2013, Tieland 
et al. 2012c). Some studies have also demonstrated synergistic effects of RE combined with 
dietary protein (Bell et al. 2017, Daly et al. 2014, Kang et al. 2019, Junior et al. 2018, 
Rondanelli et al. 2016, 2020, Tieland et al. 2012b, Verreijen et al. 2015, Yamada et al. 2019, 
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Zdzieblik et al. 2015). Therefore, given the previously mentioned association between 
sarcopenia and cognitive impairment (Chang et al. 2016, Cipolli, Yassuda, and Aprahamian 
2019, Peng et al. 2020), RE- and dietary protein-induced improvements in cognitive function 
may be partially explained by improvements in muscle function. In support of this hypothesis, 
Liu-Ambrose et al. (2010) reported an association between improvements in selective 
attention and conflict resolution with increases in gait speed following 12 months of RE. More 
recently, two studies established improvements in cognitive function following RE were 
mediated by increases in muscular strength (Forte et al. 2013, Mavros et al. 2017). 
Unfortunately, no study has examined whether protein-induced effects on SMM, strength or 
physical function are related to cognitive function in older adults.  
 
In addition, it is also unknown whether the relationship between RE-induced changes in 
muscle and cognitive function is purely casual or causative due to changes in common 
pathologies, such as systemic inflammation and insulin sensitivity. Recently, Macaulay, 
Fisher, and Schroeder (2020) proposed the association might be explained by shared 
supraspinal neural pathways.  
 
2.4.8.2 Brain structure and function 
Several studies have reported improvements in brain structure and function following RE 
training (Best et al. 2015, Herold et al. 2019, Liu-Ambrose et al. 2012, Suo et al. 2016). Studies 
employing morphometric imaging have demonstrated expanded grey matter in the posterior 
cingulate, reversed progression of white matter hyperintensities, and positive functional 
changes in hemodynamic activity in several areas of the brain (Liu-Ambrose et al. 2012, Suo 
et al. 2016). Regarding dietary protein, the AA tryptophan has been shown to enhance 
serotonin receptor activation, which plays a significant role in the regulation of sleep, mood 
and memory (Camfield et al. 2011, van de Rest, van der Zwaluw, and De Groot 2013). The 
AA tyrosine is also a precursor for a number of important neurotransmitters, including 
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norepinephrine, epinephrine and dopamine (Fernstrom and Fernstrom 2007). The latter of 
which is involved in working memory (Tarn and Roth 1997). 
 
2.4.8.3 Neurobiological markers  
 
2.4.8.3.1 Insulin-like growth factor 1 
As reported in section 2.2.10.4.1, several studies have reported increased circulating IGF-1 
concentration following both RE training (Cassilhas et al. 2010, de Souza Vale et al. 2009, 
Formica et al. 2020, Jiang et al. 2020, Singh et al. 1999) and increased dietary protein intake 
(Bauer et al. 2015, Bo et al. 2019, Mehlsen et al. 2017, Zhu et al. 2011). As IGF-1 can cross 
the blood-brain barrier, it may be that RE- and protein-induced increases in peripheral IGF-1 
concentration may influence brain IGF-1 concentration, potentially aiding cognitive function 
(Van Dam et al. 2000). In part support, Cassilhas and colleagues (2010) reported parallel 
increases in cognitive function and IGF-1 following RE training; however, no cause-and-effect 
relationship can be determined from this study. Further, no study has directly assessed the 
association between protein-induced changes in IGF-1 and cognitive function in older adults. 
Prospective studies are therefore required to determine whether there is a cause-and-effect 
relationship between RE- and protein-induced changes in IGF-1 and cognitive function in older 
adults. 
 
2.4.8.3.2 Brain-derived neurotrophic factor 
Increased circulating BDNF concentration following an acute bout of RE has been reported in 
some (Church et al. 2016, Marston et al. 2017, Vega et al. 2010, Yarrow et al. 2010) but not 
all studies (Correia et al. 2010, Goekint et al. 2010, Tsai et al. 2018). Discrepant findings might 
be explained by the intensity of RE, as previous work has demonstrated significant differences 
between the magnitude of BDNF increase (40% vs. 4%) following RE performed at high and 
low intensity (Vega et al. 2010). Similar to that of acute studies, findings from longitudinal 
studies are also equivocal with some (Coelho et al. 2012, Forti et al. 2015, Pereira et al. 2013), 
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but not all studies (Bell et al. 2019, Formica et al. 2020, Marston et al. 2019a), reporting 
increases in BDNF. However, in contrast to acute studies, intensity (or frequency) of RE does 
not seem to explain the disparities between studies as the interventions were all similar and 
appear adequate based on acute findings (Marston et al. 2019b). It is also unlikely that 
differences in the health status of participants and baseline BDNF concentration explain these 
conflicting findings as increases in BDNF have been observed in both frail and healthy elderly 
individuals (Coelho et al. 2012, Forti et al. 2015), and those with low and high baseline BDNF 
concentration (Coelho et al. 2012). Further research is warranted to explore the influence of 
different factors which may affect RE-induced changes in basal BDNF.  
 
The effect of dietary protein on circulating BDNF is relatively unknown due to a lack of 
published data. Bell et al. (2019) demonstrated 18 weeks of a whey protein-based multi-
ingredient supplement had no effect on basal plasma BDNF concentration. In support of these 
findings, Formica et al. (2020) reported no effect of multimodal exercise combined with 
consumption of lean red meat three times per week on basal BDNF concentration. Based on 
these findings, it appears that protein-induced increases in cognitive function are not related 
to changes in BDNF.  
 
2.4.8.4 Cortisol  
As previously noted in section 2.2.10.4.2, the effects of RE on the adaptive cortisol response 
is controversial. Disparities in the literature are likely due to cortisol being measured at only 
one time point at different times in the morning. Whilst the effect of RE on cortisol is unclear, 
several studies have reported changes in fasting cortisol (Kraemer et al. 1999, Häkkinen et al. 
2002, Izquierdo et al. 2003). Similarly, although findings from studies investigating the effects 
of dietary protein on cortisol secretion are also mixed, lower cortisol concentration following a 
high protein compared to a high carbohydrate meal/diet has been reported (Vicennati et al. 
2002, Martens et al. 2010). Thoeretically, as altered cortisol secretion contributes to cognitive 
decline with age (Beluche et al. 2010, Dijckmans et al. 2017, Evans et al. 2011, 2012, Lee et 
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al. 2007), changes following RE and dietary protein may explain improvements in cognitive 
function. Though, from a RE perspective, a recent acute study by Wang et al. (2019) disputes 
this hypothesis, reporting no correlation between RE-induced changes in cognitive function 
and cortisol secretion. This study was, however, conducted in young adults, which may explain 
these findings. Further longitudinal work is required to determine whether RE- and protein-
induced changes in cognitive function are mediated by changes in cortisol secretion in older 
adults.  
 
2.4.8.5 Inflammation  
As previous reviewed in section 2.2.10.4.5, RE may reduce systemic inflammation in older 
adults if the exercise stimulus elicits increases in SMM and reduces FM (Sardeli et al. 2018). 
It has been postulated that RE-induced decreases in systemic inflammation may improve 
cognitive function by supressing the activation of microglia, reducing neuroinflammation 
(Macaulay, Fisher, and Schroeder 2020). However, limited studies have assessed both 
cognitive function and inflammation in parallel following RE in older adults. In cognitively 
impaired older women, 28 weeks of RE significantly increased concentrations of the anti-
inflammatory cytokine interleukin-10 (IL-10), which occurred alongside increases in global 
cognitive function (Chupel et al. 2017). In contrast, Formica et al. (2020) observed 
improvements in cognitive function following 24 weeks of multimodal exercise incorporating 
RE, but no changes in inflammatory markers were observed.  
 
At present, no study has examined the relationship between protein-induced changes in 
inflammation and cognitive function. However, recent work has demonstrated dietary protein 
may induce anti-inflammatory effects in older adults (Bell et al. 2018, Liberman et al. 2019, 
Sugawara et al. 2012, Solerte et al. 2008). As systemic inflammation contributes to cognitive 
decline via increasing central nervous system (CNS) inflammation (Marsland et al. 2015), it 
may be hypothesised that dietary protein might improve cognitive function through reversing 
this mechanism. Taken together, it is currently unknown whether RE and protein-induced 
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improvements in cognitive function are related to a reduction in systemic inflammation. Further 
research is warranted to examine such association. 
 
2.4.8.6 Vascular function and blood pressure 
Both RE (Williams et al. 2007) and dietary protein, specifically whey protein (Camfield et al. 
2011, Pal and Ellis 2010), may improve cognitive function via improved cardiovascular health. 
Following RE training, decreased systolic and diastolic blood pressure (BP) (Ashton et al. 
2020), improved endothelial function (Ashor et al. 2015), and a greater resting cerebral 
perfusion leading to an increase in brain blood flow have been reported (Xu et al. 2014). Whey 
protein contains lactokinins, which are peptides that inhibit angiotensin converting enzyme 
(ACE) activity (FitzGerald and Meisel 1999), the key enzyme in the regulation of BP (Pal and 
Ellis 2010). Acutely, whey protein ingestion has been shown to improve endothelial function 
(Ballard et al. 2013). Longitudinally, improvements in BP and endothelial function, and reduced 
aortic stiffness have been observed (Fekete et al. 2016, Pal and Ellis 2010). Whey protein is 
also comprised of ~20% of its protein from milk, which may partially explain the associations 
between dairy consumption and reduced risk of hypertension (Hidayat et al. 2017) and arterial 
stiffness (Crichton et al. 2012a).  
 
2.4.8.7 Glucose homeostasis 
As previously discussed in part 2 of this literature review (section 2.3.16), RE is an effective 
stimulus for increasing insulin sensitivity and improving glycaemic control (Westcott 2012). 
Although the effects of dietary protein on insulin sensitivity are somewhat controversial 
(Drummen et al. 2018), there is evidence suggesting the BCAA leucine can stimulate insulin 
production (Yang et al. 2010). Consequently, RE and dietary protein may stimulate the 
abundance of insulin receptors in the brain (Frazier et al. 2019), improving local brain insulin 
sensitivity and altering key processes such as cerebral glucose metabolism, which is involved 
in learning and memory (Doyle et al. 1995).  
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2.5 Summary from the literature and justification for the research 
Based on the review of relevant literature, RE combined with adequate dietary protein may 
synergistically aid attenuation of sarcopenia and sarcopenic obesity, improve metabolic health 
and aid cognitive function in older adults. However, several questions remain unanswered, 
highlighting the need for further research.  
 
Firstly, as previously mentioned in section 2.3.23, only four studies have investigated the 
synergistic effects on components of EE, of which neither examined the effects on 24-h EE. 
Similarly, no studies have investigated the combined effects on 24-h metabolic flexibility or 
appetite compared to each intervention alone. Collection of such data is vital to understand 
whether these interventions elicit augmented effects on aspects of energy metabolism, energy 
balance and metabolic health in older adults.  
 
Secondly, whilst numerous studies have examined the combined effects of RE and dietary 
protein on SMM, strength and physical function, the majority of these studies, particularly in 
healthy older adults, employed an insufficient protein dose to elicit additive effects (see 
section 2.2.10.3.1). Furthermore, only a few studies have employed an experimental design 
with four intervention groups, of which none measured any hormonal or inflammatory markers 
related to sarcopenia. The biochemical mechanisms of how RE combined with dietary protein 
may attenuate sarcopenia is still therefore relatively unknown. Investigation of the synergistic 
effects employing a daily protein intake of 1.6 g/kg/d, and analysis of hormonal and 
inflammatory markers, is required to answer this question.  
 
Finally, due to a paucity of data, further research on the combined effects of RE and dietary 
protein on cognitive function and analysis of mechanisms of action is warranted to determine 





























3.1 Chapter overview 
This chapter details and justifies the methods used within this thesis. The overall aim is to 
provide a detailed account of the experimental design, participant recruitment, experimental 
interventions and outcome measures used in most/all experimental chapters. Study specific 
methods are detailed in relevant experimental chapters (Chapters 4, 5 and 6). 
 
3.2 Study design 
The study conducted within this thesis was a 12-week randomised, controlled, double-blind, 
4-arm parallel group trial that took place between October 2017 and June 2019. Individual 
results chapters are outcomes taken from the 12-week clinical trial. Participants are the same 
group throughout. Following screening (see section 3.4.2), eligible participants were 
randomly assigned to one of four experimental groups: control (CON), whey protein 
supplementation (PRO), RE + control (EX+CON) or RE + whey protein supplementation 
(EX+PRO). A coded (A, B, C or D) randomisation scheme was used. Randomisation was 
performed using the minimization allocation method with stratification for age (dichotomised 
as 60-63, 64-66, 67-70, 71-74, 75-77 and 78-80 y) and body mass index [(BMI); dichotomised 
as 18.5-20.4, 20.5-22.4, 22.5-24.4, 24.5-26.4, 26.5-28.4 and 28.5-30 kg/m2] using free online 
software (QMinim; http://rct.mui.ac.ir/q/). A key to the randomisation code was held by an 
investigator who was not directly involved with participant recruitment, exercise training, or 
testing. At both baseline and 12 weeks, participants completed two testing sessions. The first 
session involved 24-h metabolic testing where participants resided in respiration chambers, 
and the second (within 7 days of metabolic testing) involved strength and physical function 








Figure 3.1 Experimental design and sequence of testing. 
 
3.2.1 Justification for study design  
Double-blind RCTs are considered the ‘gold standard’ for intervention-based studies and, 
when well designed, provide the strongest possible evidence of causation (Misra 2012). In 
addition, a position paper by the European Society for Clinical and Economic Aspects of 
Osteoporosis and Osteoarthritis (ESCEO) also highlight the double-blind, placebo-controlled, 
parallel-arm design is the mainstay of regulatory design for clinical intervention trials 
investigating the effectiveness of interventions to treat or prevent sarcopenia (Reginster et al. 
2016). Alternative research designs such as cross-over and non-placebo-controlled were 
considered, however, these designs were not chosen for several reasons. Firstly, the time 
required to complete a cross-over design with significant wash-out was unfeasible. Secondly, 
non-placebo-controlled trials significantly increase the risk of bias (i.e., participants in the 
control groups changing their dietary behaviour, particularly increasing protein intake). Finally, 
a control product was necessary as differences in body mass may have occurred between 




24-h respiration chamber Strength and functional performance testing
3-day diet diary PA Accelerometry (physical activity monitoring)
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groups purely due to an increase in EI in the experimental groups. Consequently, this may 
have affected primary endpoints of the study (e.g., 24-h EE). A 4-arm RCT was chosen as few 
studies (de Carvalho Bastone et al. 2020, Gryson et al. 2014, Kim et al. 2012, Kirk et al. 2020, 
Kukuljan et al. 2009, Shahar et al. 2013, van de Rest et al. 2014, Verreijen et al. 2017) in the 
literature have employed such a research design of four experimental groups (control, protein, 
RE, RE + protein), and only two of these studies included a placebo or energy-matched control 
product (Gryson et al. 2014, van de Rest et al. 2014). Further, neither of these studies 
increased dietary protein to 1.6 g/kg/d, the suggested optimal intake to accrete SMM during 
RE training (Morton et al. 2018a). Thus, additional research utilising a 4-arm randomised 
controlled design and a protein intake of 1.6 g/kg/d was required to robustly determine both 
the individual and combined effects of RE and whey protein supplementation.  
 
Minimisation was used to randomise participants to ensure significant imbalances in baseline 
participant characteristics between groups did not occur (Taves 2010). Age and BMI were 
chosen a priori as stratification variables as previously published data has shown both 
significantly affect energy metabolism, a primary outcome of this thesis (Geisler and Müller 
2017, Manini 2010). Age also affects body composition (Janssen et al. 2000b, Shen et al. 
2005, St-Onge and Gallagher 2010), muscle strength (Clark and Manini 2008), cognitive 
function (Salthouse 2009) and appetite (Akimoto and Miyasaka 2010). Consequently, failure 
to control for this variable may have significantly affected differences between groups at 
baseline. 
 
An intervention period of 12 weeks was used as previous studies have reported clinically 
significant increases in FFM and/or muscle strength (Arnarson et al. 2013, Holwerda et al. 
2018, Rondanelli et al. 2016, Verdijk et al. 2009a), components of EE (Campbell et al. 1994), 
and improvements in cognitive function (Smolarek et al. 2016) following RE training of this 
duration either with or without additional protein supplementation in older adults. Studies in 
older adults have also reported significant increases in FFM (Bauer et al. 2013, Mitchell et al. 
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2017) and cognitive function (Charlton et al. 2016, Kita et al. 2018, Lefferts et al. 2020) 
following increased protein intake per se for 10-12 weeks. Furthermore, Churchward-Venne 
et al. (2015) established high interindividual variability in the adaptive response to RE training 
when changes in FFM, muscle fibre size and strength, and physical function were assessed 
in older adults. The level of responsiveness in this study was strongly influenced by the 
duration of the RE intervention, with 76.4% of participants displaying improvements in FFM 
following 12 weeks. Additionally, significant increases in leg press (33 ± 2 kg, P < 0.001) and 
leg extension 1RM (20 ± 1 kg, P < 0.001) were observed after 12 weeks. Based on the 
aforementioned studies, an intervention period of 12 weeks was deemed sufficient to detect 
significant changes in FFM, muscle strength, and components of EE and cognitive function 
following RE and/or whey protein supplementation.  
 
3.3 Ethical approval  
Ethical approval was granted by Coventry University Ethics Committee (Project reference: 
P59723, Appendix A). In addition, Governance Arrangements for Research Ethics 
Committees (GafREC) approval was granted by the Research & Development department at 
University Hospitals Coventry and Warwickshire (UHCW) NHS Trust for use of the respiration 
chambers within the Human Metabolism Research Unit (HMRU) (Appendix B). Following 
interest in participation, all participants were sent a participant information sheet (PIS) via 
email or through the post, which explained the research study and were asked to read its 
entirety (Appendix C). Participants were also informed of the nature of the study verbally. 
Informed consent was obtained in accordance with the Declaration of Helsinki by the chief 
investigator who had received NHS informed consent and good clinical practice (GCP) training 





Participants were recruited from Coventry, UK and surrounding areas between October 2017 
and February 2019 by several avenues, including newspaper advertisements, contact with 
local groups and organisations (e.g., parish councils, rambling groups, bridge/bowls clubs), 
word of mouth, social media, charity shops, libraries, coffee shops and leisure facilities. See 
Appendix E for the study recruitment poster.  
 
3.4.2 Screening and participant flow 
A total of 256 individuals responded to advertisements and were sent a PIS for consideration. 
From these, 85 individuals declined to participate, and 171 individuals were screened for 
consideration against the inclusion/exclusion criteria (see sections 3.4.2.1 and 3.4.2.2). 
Screening involved two stages. Firstly, participants completed a health and lifestyle 
questionnaire which screened for age, medical history, medication use and current levels of 
physical activity (Appendix F). Secondly, if participants were eligible following stage 1, at 
baseline metabolic testing, height and body mass were measured to check BMI, BP was 
measured, and blood was drawn and analysed for HbA1c, uric acid, brain natriuretic peptide 
(BNP) and estimated glomerular filtration rate (eGFR) by the pathology department at UHCW 
to screen for diabetes, susceptibility to gout, heart failure and kidney function. Blood was 
screened by Professor Martin O. Weickert (Consultant Endocrinologist, UHCW), who provided 
medical clearance and confirmed participant suitability to begin the intervention. Of the 171 
individuals who were screened, 132 did not meet the study eligibility criteria, so were therefore 
excluded. The remaining 39 individuals were included in the study. No participant had any 
cognitive impairment, which was assessed by the Mini-Mental State Examination (MMSE) 
(score >24) (Folstein, Folstein, and McHugh 1975). Of the 39 participants included in the 
study, three did not participate in respiration chamber assessments (Chapter 4) but completed 
all other aspects of the study (Chapters 5 and 6). Three participants also withdrew. As a 
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result, 33 participants completed metabolic testing and 36 participants completed all other 
measures. The flow of participants is shown diagrammatically in Figure 3.2. 
 
3.4.2.1 Inclusion criteria 
• Age >60 and <80 y  
• BMI between 18.5-30 kg/m2 
• Not participated in any form of RE within the last 6 months 
• Free from musculoskeletal injury 
 
3.4.2.2 Exclusion criteria   
• Age <60 or >80 y 
• Current smoker, or ex-smoker ceasing <6 months ago 
• BMI <18.5 or >30 kg/m2 
• Weight instability (±>3 kg change in body mass in previous 6 months) 
• Individuals participating in another research project within the last 6 months involving 
a dietary and/or exercise intervention 
• Existing or past medical history of cancer, diabetes, or vascular, neurological, kidney, 
pulmonary, digestive, or thyroidal disease, osteoporosis, or a history of falls 
• Currently taking protein/amino acid supplements  
• Currently prescribed non-steroidal anti-inflammatory medication, hormone 
replacement therapy (HRT), diabetic medication, beta-blockers, or statins 
• Uncontrolled BP (>160/100 mmHg) 
• Self-report lactose intolerance, or allergy to any ingredients within study products 
• Neuromuscular disorders or injuries or individuals with a pacemaker 






































Figure 3.2 Flow of participants throughout the study.  
 
Assessed for eligibility between October 2017 
and February 2019 (n = 256) 
Excluded (n = 217) 
¨   Did not meet inclusion criteria (n = 132) 
¨   Declined to participate (n = 85) 
 
Randomised (n = 39) 
Lost to follow-up 
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3.4.3 Justification for inclusion/exclusion criteria 
Although working groups suggest the target population for clinical trials investigating treatment 
and preventative interventions to mitigate sarcopenia should be individuals aged ≥65 years 
(Cruz-Jentoft et al. 2010, Reginster et al. 2016), the age range of 60-80 years was chosen for 
this preventative study as the onset of age-related declines in SMM, strength, EE and cognitive 
function are typically noticeable between 40-60 years (Beenakker et al. 2010, Hedden and 
Gabrieli 2004, Janssen et al. 2000b, Manini 2010). Recently published RE and protein 
supplementation intervention studies of similar nature have also employed a similar age range 
(Bell et al. 2017, Junior et al. 2018, Kirk et al. 2019, 2020). Women were excluded from this 
relatively small study based on data demonstrating sex differences in the age-related changes 
in body composition and EE, thus likely causing large variability in primary study endpoints 
(Geisler et al. 2016a, Geisler and Müller 2017). Also, men experience greater losses of FFM 
per annum (3% vs. 1.7%) and have a short life expectancy than women (Reid et al. 2008). 
However, as women account for a large proportion of older adults, the exclusion of women is 
recognised as a limitation of this thesis.  
 
Individuals with obesity (BMI >30 kg/m2) were also excluded as this study was designed as a 
preventative study and individuals with sarcopenic obesity display a significantly different 
metabolic profile to that of individuals without sarcopenic obesity (Perna et al. 2017). Obesity 
also exacerbates sarcopenia, with the EWGSOP2 advising that sarcopenic obesity should be 
investigated as a distinct condition (Cruz-Jentoft et al. 2019). Other exclusion criteria were set 
based upon likely effects on endpoints of the study (i.e., SMM, markers of metabolism) 
reported in previous studies. For example, intentional weight loss (Gallagher et al. 2000); 
diabetes mellitus (Ghanassia et al. 2006); current smokers (Rom et al. 2012); prescription of 
non-steroidal anti-inflammatory medication (Rieu et al. 2009), thyroid medication (Johannsen 
et al. 2012), or statins (Krishnan and Thompson 2010); RE trained (Ahtiainen et al. 2003); or 
regular supplementation of protein leading to a high baseline habitual protein intake (Phillips, 
Chevalier, and Leidy 2016). 
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3.4.4 Sample size  
The primary aim of this thesis was to investigate the individual and combined effects of RE 
and whey protein supplementation on aspects of 24-h energy metabolism measured in a 
respiration chamber (Chapter 4). As RMR is the largest component of TEE, accounting for 
60-80% (Geisler and Müller 2017), sample size was determined based on changes in this 
variable from a previous respiration chamber study that reported an increase of 109 kcal/d in 
older adults following 16 weeks of RE (Treuth et al. 1995). Using G*Power (Version 3.1.9.2; 
Dusseldorf, Germany), a minimum of 48 participants (12/group) were needed to observe a 
significant group-by-time interaction for a mixed-model analysis of covariance (ANCOVA) with 
one covariate (α = 0.05; β = 0.8; effect size [Cohen’s f2] = 0.5). However, due to time and 
budgetary constraints, only 33 participants had data for the primary outcome. A retrospective 
power analysis of the 33 participants who completed the study and the observed changes in 
RMR provided a β of 0.60.  
 
3.5 Experimental Interventions 
 
3.5.1 Nutritional Supplements   
Participants ingested one sachet of either whey protein isolate [(PRO) Instantized BiPRO; 
Agropur, Quebec, Canada] or an isocaloric control powder [(CON) Maltodextrin; Myprotein, 
Northwich, UK] twice daily, consumed directly after breakfast and lunch. The macronutrient 
and specific AA composition of the experimental supplements related to this thesis per serving 
can be seen in Table 3.1, and the full nutrient and AA composition (per 100 g) can be seen in 
Appendix G. Both supplements were similar in powder weight, unflavoured and were provided 
in opaque sachets in a double-blinded manner (Figure 3.3). Participants prepared their 
supplement beverages at home by mixing the contents of each sachet with ~200 mL of water 
combined with a double strength no-added sugar cordial of choice using a handheld shaker 
(Myprotein, Northwich, UK). Participants were provided with recommendations on cordial 
flavouring use, which was based on taste testing conducted prior to commencing the study. 
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However, cordial flavouring was not prescriptive. Compliance was assessed by the number of 
empty sachets returned by participants at the end of the study and through the use of a 
supplementation log (Appendix H). Empty sachets were counted by a postgraduate 
researcher not involved in any aspect of the study. To test the success of supplement blinding, 
participants completed an exit questionnaire on completion of the study. The questionnaire 
asked, ‘Do you know which supplement you were consuming during the intervention?’. The 
answers were either ‘protein’, ‘control’, or ‘don’t know’. Seven out of 36 participants (19.4%) 
answered correctly, 3/36 participants (8.4%) answered incorrectly, and 26/36 participants 
(72.2%) were not sure which supplement they were consuming. 
 
Table 3.1 Nutritional composition of experimental supplements (per serving)1 
Component 
 
Whey protein isolate (PRO)1 
25 g  
Control (CON) 
23.75 g 
Energy, kcal 95 95 
Carbohydrate, g 0 23.75 
Protein, g 22.8 0 
Leucine, g 2.9 0 
BCAA, g 5.4 0 
EAA, g 11.2  0 
Tryptophan, g 0.7 0 
Tyrosine, g 0.8 0 
Fat, g 0.4 0 
 
1Whey protein isolate also contained per serving: vitamin A (<25 IU), vitamin C (<0.5 mg), vitamin D 
(0.2 mcg), iron (0.25 mg), calcium (21.3 mg), phosphorus (85 mg), magnesium (2.5 mg) chloride (20 
mg), sodium (172.5 mg), potassium (17.5 mg). BCAA; branched-chain amino acids (leucine, isoleucine, 
and valine); EAA, essential amino acids. 
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Figure 3.3 Coded (A, B, C or D) supplement sachets provided to participants in a double-
blinded manner (Flexible Packaging Services Ltd, Wirral, UK).  
 
3.5.1.1 Justification for nutritional interventions 
As previously highlighted in sections 2.2.8.2 and 2.2.10.2.1, protein ingestion is a potent 
anabolic stimulus which transiently increases rates of MPS and supresses MPB via the effects 
of insulin, consequently resulting in a positive net protein balance (Rennie et al. 2004). The 
stimulation of MPS following protein ingestion is primarily attributed to hyperaminoacidemia of 
EAA (Volpi et al. 2003), most specifically, leucine (Kimball and Jefferson 2006). Of all dietary 
proteins, whey protein is considered the highest quality protein due to its high content of EAA, 
particularly leucine, and its rapid digestibility (Devries and Phillips 2015).  
 
The timing (breakfast and lunch daily) and dose (25 g, including ~3 g leucine) of whey protein 
used in this study was based on findings of previous work, as highlighted in section 2.2.10.2.2, 
that consistently report that older adults consume their daily protein intake in a skewed pattern 
(Tieland et al. 2012a, Farsijani et al. 2017, Smeuninx, Greig, and Breen 2020). Based on a 
hypothesised daily protein distribution similar to that reported by Smeuninx, Greig, and Breen 
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(2020) (~0.2, ~0.3 and ~0.5 g/kg at breakfast, lunch and dinner, respectively), plus a daily 
protein intake of  ~1 g/kg/d and a mean body mass of ~80 kg of the cohort used in this study 
to that of others (Bell et al. 2017, Kirk et al. 2019, Smeuninx, Greig, and Breen 2020), the dose 
of 25 g whey protein (~0.25 g/kg) at breakfast and lunch was postulated to yield a daily protein 
distribution of ~0.45 g/kg at breakfast, ~0.55 g/kg at lunch, and the evening meal remaining at 
~0.5 g/kg. Accordingly, this would ensure all meals met both the per meal protein (0.4 g/kg) 
and leucine (≥2.5 g) thresholds to maximally stimulate rates of MPS in older adults (Moore et 
al. 2015). In addition, it was hypothesised that this dose would increase daily dietary protein 
intake from ~1.0 to 1.6 g/kg/d, the intake recommended to curb sarcopenia (Phillips, Chevalier, 
and Leidy 2016) and maximise SMM accretion during RE training (Morton et al. 2018a). This 
deviation of daily dietary protein intake (~0.6 g/kg/d) would also surpass the suggested 
required deviation of 0.4 g/kg/d to stimulate gains in SMM in healthy older adults (Park, Choi, 
and Hwang 2018).  
 
Maltodextrin, a polysaccharide produced from grain, starch, corn, potatoes or rice, was used 
as the control supplement as previous studies have demonstrated carbohydrate intake of 100 
g (far greater than that used in this thesis) has a limited effect on rates of MPS (Børsheim et 
al. 2004). Previous RCTs have also reported no effects of carbohydrate as a control product 
on FFM in older adults (Bauer et al. 2015, Bell et al. 2017, Norton et al. 2016, Park, Choi, and 
Hwang 2018). The ingestion of 47.5 g/day of carbohydrate (maltodextrin) used in this study 
was therefore hypothesised based on previous data to have a minimal effect on SMM over 12 
weeks. Furthermore, from a safety perspective, previous RCTs have used similar amounts of 
maltodextrin (Bell et al. 2017) and glucose (Pal, Ellis, and Dhaliwal 2010) over a comparable 
intervention period as control products and have reported no significant negative effects on 
insulin sensitivity or body mass gain. Finally, the supplements were iso-caloric to ensure 
changes in study endpoints were due to differences in the macronutrient content of the 
supplements and not due to differences in EI. 
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Unflavoured products were chosen, and allowance of a no-added sugar cordial of choice for 
mixture and consumption was provided to participants based on adherence data from 
previously published RCTs investigating the effects of whey protein alone or combined with 
RE in older adults (Kirk et al. 2019, 2020, Norton et al. 2016). For example, Kirk et al. (2019) 
reported only 43% adherence of whey protein supplementation over 16 weeks, which may 
have significantly affected study endpoints. The authors reported undesirable taste and 
unpalatability of the supplement, which was reported by participants, was the reason for the 
poor compliance. Therefore, participants in the present study were provided flexibility in no-
added sugar (calorie-free) cordial flavouring to reduce flavour fatigue and increase 
supplement compliance. Participants were instructed no-added sugar cordial must be used to 
ensure the calorie content remained at 95 kcal per serving.  
 
The use of returned sachets (both used and unused) and a supplementation log were 
employed as methods of monitoring compliance as this method has been used by a number 
of recently published studies of similar nature in older adults (Bell et al. 2017, Holwerda et al. 
2018, Kirk et al. 2019, 2020). However, it should be noted that although these methods are 
easy to implement, inexpensive and are widely used within the literature, their reliability and 
validity are controversial (Farmer 1999). For example, some researchers have shown that 
these methods result in overestimation of adherence as participants tend to respond in a 
manner believed to be socially desirable (Teshome et al. 2018).  
 
3.5.2 Resistance exercise intervention 
Supervised, progressive whole-body RE was performed twice weekly at Coventry University 
Sports Centre during the 12-week intervention by participants in the EX+CON and EX+PRO 
groups only. All sessions were supervised by a qualified fitness instructor (Corbin Griffen), 
were 60-75 min in duration, and occurred at least 48 h apart. Each session consisted of a 5-
min warm-up on a cycle ergometer, followed by 3 sets of leg press, lateral row, hamstring curl, 
chest press, leg extension and shoulder press exercises on fixed RE machines (in that order) 
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(Life Fitness, Rosemont, Illinois, USA). During the first 4 weeks of training, exercise intensity 
began at 60% 1RM (10-12 repetitions per set) and was increased to 80% 1RM (8 repetitions 
per set), where it remained until the end of the intervention. The final set of each exercise was 
performed to volitional muscle failure (typically 8-12 repetitions), which was defined as the 
inability to perform an additional repetition with the correct form. The time under tension for 
each repetition was 6 s (3 s concentric, 3 s eccentric). Although not controlled, time under 
tension was practiced at the beginning of the intervention and was reinforced throughout. 
Resting periods of 60 s and 2-3 min were allocated between sets and exercises, respectively. 
Intensity was adjusted according to 1RM tests performed at baseline and during weeks 5 and 
9 using the guidelines of Kraemer et al. (2006), and when participants were able to complete 
>12 repetitions on the third set of each exercise. Sessions concluded with a 5 min cool-down 
on a cycle ergometer followed by static stretching. Session rate of perceived exertion (RPE) 
was also obtained (Borg 1998). Compliance and completion of repetitions was monitored by 
a training log (Appendix I).  
 
3.5.2.1 Exercise intervention justification 
 
3.5.2.1.1 Modality 
As previously highlighted in section 2.2.10.1.1, RE stimulates MPS and elicits a positive net 
protein balance for up to 48 h post exercise (Phillips et al. 1997, Wilkinson et al. 2014, Brook 
et al. 2015), leading to muscle mass accretion when performed over a chronic period of time 
(Phillips 2015). It has also been established that RE stimulates MPS to a greater effect and is 
the key exercise modality to elicit muscle hypertrophy compared to AE (Grgic et al. 2019). 
Thus, RE was used for this study aimed at increasing SMM in older adults. All sessions were 
supervised to facilitate optimal improvements in SMM, strength and physical function, and to 
maintain participant safety (Fragala et al. 2019). Machine-based exercises were chosen as 
participants in this study were naive to RE, and it has been suggested that novice lifters benefit 
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more from this exercise equipment (Fragala et al. 2019). Also, machine-based exercises are 
more suitable and recommended when training to volitional muscle failure to reduce the 
likelihood of injury (Schoenfeld and Grgic 2019).  
 
3.5.2.1.2 Intensity  
The intensity of RE employed was based upon literature cited in section 2.2.10.1.3.1. These 
data suggest RE performed at a high intensity (~70-80% 1RM) elicits the greatest effects on 
muscle strength (Borde, Hortobágyi, and Granacher 2015). Whilst RE performed at low and 
high intensity elicits similar effects on muscle hypertrophy when mechanical work is matched 
(Borde, Hortobágyi, and Granacher 2015), high intensity RE was chosen on the premise of 
maximally increasing muscle strength as the EWGSOP2 now consider muscle weakness as 
the main determinant of sarcopenia (Cruz-Jentoft et al. 2019). The NSCA also state that older 
adults should perform RE at 70-85% 1RM to optimise strength gains (Fragala et al. 2019). 
Furthermore, RE performed at high intensity has also been shown to elicit improvements in 
cognitive function (Wilke et al. 2019) and attenuate metabolic dysfunction (Liu et al. 2019). A 
familiarisation intensity of 60% 1RM was prescribed for the first four weeks of training to allow 
for exercise tolerance and to minimise the risk of injury in novice lifters (Fragala et al. 2019).  
 
3.5.2.1.3 Volume  
Training volume was chosen based on evidence cited in section 2.2.10.1.3.2. Based on the 
findings of two meta-analyses (Borde, Hortobágyi, and Granacher 2015, Peterson et al. 2010), 
2-3 sets per exercise and ~8 repetitions per set appears to elicit the greatest increases in 
muscle hypertrophy and strength in older adults. The final set was performed to volitional 
failure to induce a greater volume per exercise (~28 repetitions/exercise); however, failure 
was not performed for every set as older adults may experience slower post-exercise recovery 
compared to younger adults (Schoenfeld and Grgic 2019), and failure may not be necessary 
to achieve increases in SMM and strength in older adults (Fragala et al. 2019).  
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3.5.2.1.4 Progression  
Progressive overload is the gradual increase in stress placed on the body during RE training 
(Kraemer et al. 2002). The concern when designing RE interventions for elderly individuals 
with regards to progression is exercise tolerance and optimal recovery (Fragala et al. 2019). 
2019). However, progression is essential for continued adaptation (Fragala et al. 2019). 
Typically, hypertrophy, and changes in muscle fibre type and strength, are evident after a short 
period of training (~4-8 weeks) (Kraemer and Ratamess 2004); thus, 1RM was measured 
every 4 weeks and intensity was increased in accordance with each participant.  
 
3.5.2.1.5 Frequency  
A frequency of twice weekly RE was chosen based on literature cited in section 2.2.10.1.3.3. 
Based on findings from these studies, 2-3 sessions per week appears to elicit superior 
increases in muscle strength (Borde, Hortobágyi, and Granacher 2015, Steib, Schoene, and 
Pfeifer 2010) and hypertrophy (da Silva et al. 2017, Grgic, Schoenfeld, and Latella 2019, Stec 
et al. 2017). As no significant benefit seems apparent between two and three sessions per 
week (Borde, Hortobágyi, and Granacher 2015), and 26% of older adults have reported to 
prefer training twice per week compared to only 1% preferring to train three times per week 
(Foley, Hillier, and Barnard 2011), twice weekly RE was chosen to aid adherence.   
 
3.5.2.1.6 Exercises and order  
It has been recommended that RE interventions for older adults should include exercises that 
target major muscle groups using multi-joint movements (e.g., leg press, chest press, shoulder 
press, lateral row/pull down, leg extension) to stimulate whole-body increases in SMM and 
strength, and improve physical function (Fragala et al. 2019). Large muscle groups were 
exercised first (e.g., those used in leg press) and upper- and lower-body exercises were 
alternated to reduce fatigue. The exercise order was kept consistent to ensure this variable 
did not affect outcomes.  
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3.5.2.1.7 Rest allocation between sets and time under tension per repetition 
In the meta-analysis by Borde, Hortobàgyi, and Granacher (2015), 60 s rest between sets was 
the most effective at increasing SMM. This meta-analysis also reported the largest effect size 
for time under tension to increase SMM and strength to be 6 s. Three min was allocated 
between exercises as numerous studies within the literature, as reviewed by the NSCA 
(Fragala et al. 2019), have used 2-3 min between exercises, which appears to provide 
sufficient recovery for symptom-free progression in older adults.  
 
3.6 Outcome measures   
This section will outline outcome measures that are reported in all experimental chapters 
within this thesis. Within individual experimental study chapters, these outcomes will be briefly 
described and referred to this chapter. Outcome measures only measured in individual study 
chapters are detailed in those specific chapters. A list of the participant schedule of 
assessments can be seen in Table 3.2. 
 
3.6.1 Body composition 
Body composition (FM, kg; FFM, kg; SMM, kg) was assessed in the morning by BIA (BC-418 
MA; Tanita Corporation, Tokyo, Japan). Measurement occurred at the same time of day (±1 
h) and participants were asked to consume the same breakfast for both visits. Participants did 
not consume any food or drink in the 1 h before and voided their bladder prior to measurement. 
Minimal clothing was worn. Skeletal muscle mass (kg) was estimated using the formulae of 
Janssen et al. (2000a): 
 
 [(height2 / Ω x 0.401) + (sex x 3.825) + (age x -0.071)] + 5.102 
 
where height is in cm and sex = 1 for male. Impedance (Ω) was measured at a single frequency 
of 50 Hz. Whilst BIA has several limitations, as highlighted in section 2.2.9, prediction 
equations have been validated in the elderly and the method has been cross validated against 
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MRI for measurement of SMM in older adults (Janssen et al. 2000a). Waist and hip 
circumference were measured by an ergonomic circumference measuring tape (Seca 201; 
Seca, Malaysia). Waist circumference was measured at the midpoint between the lowest rib 
margin and the iliac crest. Hip circumference was measured at the widest portion of the hips. 
Both outcomes were measured to the nearest 0.1 cm.  
 
3.6.2 Dietary analysis  
Participants completed 3-day food records [2 weekdays and 1 weekend day (Appendix J)] at 
baseline (prior to commencing the intervention) and during weeks 6 and 12 to monitor changes 
in habitual dietary intake during the intervention. Prior to completion, participants were 
instructed on how to record the types and quantities of food and beverages. Participants were 
asked to use kitchen scales were possible. Following completion, the diaries were checked by 
the lead investigator for clarity and analysed using Nutritics dietary analysis online software 
(Version 5.097; Nutritics, Dublin, Ireland). An example analysis can be seen in Figure 3.4.  
 
Figure 3.4 Example dietary analysis (ID: 008; age: 72 y).  
 
Many methods are available to measure habitual dietary intake. These include food frequency 
questionnaires (FFQ), 24-h dietary recalls, technological methods such as ‘snap and send’, 
and biomarkers such as DLW and urinary nitrogen excretion (Shim, Oh, and Kim 2014). 
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However, the former methods (FFQ, 24-h dietary recalls) have several limitations, such as 
recall bias and large measurement error, and the latter methods (biomarkers) are of high cost. 
Although food records have a number of limitations, including large respondent burden and 
frequent underreporting, this method also has a number of strengths, including providing 
detailed information if completed correctly and minimal recall bias (Shim, Oh, and Kim 2014). 
Dietary records also have acceptable reproducibility [intraclass correlation coefficient (ICC): 
0.67-0.84 for total kcal, carbohydrate, fat and protein intake] (Tremblay et al. 1983) and have 
been used to monitor habitual intake by the majority of studies of similar nature cited in this 
thesis (e.g., Bell et al. 2017, Kirk et al. 2019, 2020). A recording period of three days was 
chosen for this study as periods longer than this are unsatisfactory, as reported intakes 
decrease due to respondent fatigue (Gersovitz, Madden, and Smiciklas-Wright 1978). Two 
weekdays and one weekend day was chosen as individuals typically modify their diet at 
weekends (Thompson and Subar 2017); therefore, incorporation of both provides a typical 
weekly dietary pattern. 
 
3.6.3 Habitual physical activity  
Habitual physical activity was measured at baseline and week 12 using a small (3.5 x 3.5 x 1 
cm), lightweight (14 g), tri-axial accelerometer (Actigraph GT9X; Actigraph, Pensacola, 
Florida, USA) sampled at 80 Hz. Participants wore the accelerometer on the dominant wrist 
for 7 days continuously and were asked to record when the monitor was not worn (e.g., when 
showering) using a compliance log (Appendix K). Time spent sedentary, and in light and 
moderate-vigorous physical activity (MVPA) was determined during wakening hours based on 
metabolic equivalent (MET) values using the cut-points of Freedson, Melanson, and Sirard 
(1998). Data were analysed in 60-s EPOCHs using ActiLife software (Version 6.13.4; 
Actigraph, Pensacola, Florida, USA). At least 5 d of ≥10 h wear time was required for data to 
be included in the final analysis (Schrack et al. 2016b). The wrist was chosen for 
accelerometery placement due to increased compliance reported compared to the traditionally 
used hip placement in older adults (Schrack et al. 2016a). Wrist placement has also been 
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validated against established methods for measurement of AEE (van Hees et al. 2011, White 
et al. 2016), and data from the UK Biobank Study (Doherty et al. 2017), which is the largest 
accelerometery study to date (including 96,600 participants), has also demonstrated dominant 
wrist accelerometery to be a valid method for measurement of physical activity.  
 
3.6.4 Blood and saliva collection and analysis  
All blood collection reported in this thesis was drawn from participants whilst residing in a 
respiration chamber for 24 h under highly controlled conditions (see Chapter 4) by a research 
nurse at UHCW. Blood was collected routinely (at 2130, 0815, 0900, 1230, 1355, 1715 and 
1835 h) via an indwelling cannula (Vasofix Safety 22G; B. Braun Medical, Sheffield, UK) 
inserted in an antecubital arm vein. The cannula was flushed after every blood draw with 0.9% 
sodium chloride (BD Posiflush XS 5 mL; BD, New Jersey, USA) to maintain cannula patency. 
Individual chapters within this thesis provides data on some, but not all time points, of which 
are clearly outlined in each experimental chapter. Blood samples were collected using 
ethylenediaminetetraacetic acid (EDTA), serum separator tube (SST) and heparin vacutainers 
(BD 3 mL vacutainers; BD, New Jersey, USA). A total of ~70 mL of whole blood (~9 mL per 
sample apart from the first fasted sample at 0815 h where ~12 mL was drawn) was drawn at 
both pre- and post-intervention visits. Whole blood was immediately centrifuged (Eppendorf 
5702R; Eppendorf UK Ltd, Stevenage, UK) at 1900 relative centrifugal force (x g) for 10 min 
at 4°C. Aliquots containing plasma and serum were then immediately stored at -80°C until 
analysis. Saliva samples were collected at 0650 (immediately upon awakening), 0805, 1225, 
1700 and 2000 h using a synthetic swab (Salivette; Sarstedt, Nümbrecht, Germany). Samples 
were immediately centrifuged at 1900 x g for 2 min and stored at -80°C until analysis. For 
analysis, plasma, serum, and saliva samples were analysed by enzyme-linked 
immunosorbent assay (ELISA). Specific assays measured in this thesis are detailed in each 
experimental chapter. The general ELISA methodology is detailed in section 3.6.5.  
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3.6.5 Enzyme-linked immunosorbent assay 
For all ELISA experiments, assay-specific protocols were followed according to the 
manufacturer’s procedures. Generally, each assay followed the procedures outlined below. 
 
3.6.5.1 Sample and reagent preparation  
All reagents and samples were brought to room temperature prior to use. Plasma and serum 
samples were thawed for ~1 h and vortexed thoroughly. Several steps were then followed. 
Firstly, a specific volume (per protocol) of wash buffer concentrate was added to a specific 
volume (per protocol) of deionized water to prepare a wash buffer. Secondly, a diluted 
calibrator diluent was created by mixing a specific volume (per protocol) of assay-specific 
calibrator diluent with a specific volume (per protocol) of deionized water. Thirdly, an assay-
specific standard was created by reconstituting the contents of the standard (recombinant 
human protein) with a specific volume (per protocol) of deionized water. The standard was 
then rested for a time as per each protocol’s procedure prior to use. Fourthly, a standard curve 
was created by pipetting a set volume (per protocol) of calibrator diluent into polypropylene 
tubes and using the stock solution to produce a dilution series (see Figure 3.5). Each tube 
was vortexed prior to transfer. Furthermore, a substrate solution was created by mixing two 
colour reagents (reagent A, stabilized hydrogen peroxide; and reagent B, 
tetramethylbenzidine) together 15 min prior to use. The substrate solution was protected from 
light at all times. Lastly, if samples required diluting, a specific dilution factor (per protocol) was 




Figure 3.5 Example dilution series for a standard curve (IL-6). Taken from R&D Systems 
(2018). 
 
3.6.5.2 Assay procedure  
To begin, a per protocol volume of assay-specific diluent was added to each well. A per 
protocol volume of standards, controls, and samples, which were assayed in duplicate, were 
subsequently added to specific wells outlined by the plate plan. The plate was then incubated 
at room temperature for a set time (as per protocols procedure). If a horizontal orbital plate 
shaker was required, the shaker (PHMP-4 Thermoshaker, Grant Bio, Chelmsford, UK) was 
set to 500 rpm. Following incubation, each cell was aspirated and washed with 400 μL of wash 
buffer four times using an autowasher (Autura 1000; Mikura, Sussex, UK). After the final wash, 
the plate was blotted against clean paper towels to ensure removal of wash buffer. A specific 
volume (per protocol) of assay-specific conjugate was then added to each well and incubated 
at room temperature for a set time (per protocol), either on the benchtop or using the plate 
shaker. Following the second incubation, the aforementioned washing procedure was 
repeated. A set volume of substrate solution (per protocol) was then added to each well and 
the plate was incubated for 30 min at room temperature with no light exposure. Succeeding 
the final incubation period, a set volume (per protocol) of stop solution was added to each well. 
The plate was then inserted into a microplate reader (Biotek, Epoch 2, Vermont, New England, 
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USA), which determined the optical density of each well using a wavelength of 450 nm and a 
correction factor of 540 nm. 
 
3.6.5.3 Calculation of results  
Duplicate readings were averaged, and the average zero optical density was subtracted from 
each. A standard curve was created using a curve fit recommended within the ELISA protocol 
using GraphPad Prism (Version 8.4.3; San Diego, California, USA). Unknown concentrations 
were interpolated from the standard curve. If samples were diluted, a dilution factor was 
applied.  
 
3.7 Statistical analysis  
Statistical analysis was performed using SPSS version 25 (IBM Corporation, New York, USA). 
Data are presented as means ± SE and significance was set at P < 0.05. All data were checked 
for normality using the Shapiro-Wilk test. Outliers (±>3 SD from mean) were identified and 
removed. Non-normally distributed data were transformed by log transformations. When 
transformation was unsuccessful, non-parametric tests were utilised. Baseline values were 
analysed by one-way ANOVA for parametric data and using the Mann-Whitney U test for non-
parametric data. A mixed-model ANCOVA with time as the within-subjects factor, group as 
the between-subjects factor, and respective baseline values as covariates was performed on 
outcome variables. Mauchly’s test of sphericity was used to check homogeneity of variance; 
where necessary, Greenhouse-Geisser adjustment was used to correct any violations of the 
assumption. Following significant group-by-time interactions, significant within- and between-
group differences were identified using post-hoc tests with a Bonferroni correction for multiple 
comparisons. 
 
For exploratory analyses comparing pooled groups (i.e., exercise and non-exercise groups, 
and whey protein and control groups), supplement consumed and RE participation were 
controlled for in the ANCOVA model, respectively. Non-normally distributed data were 
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analysed using the Scheirer-Ray-Hare two-way ANOVA of ranks test. Post-hoc analysis was 
conducted using the Mann-Whitney U test. Longitudinal changes within groups were analysed 
using 2-tailed paired samples t-tests for parametric data and the Wilcoxon signed ranks test 
for non-parametric data. Correlations were analysed using partial correlation (Pearson’s for 
parametric and Spearman’s rank-order coefficients for non-parametric data). Participants 
were pooled for correlation analyses. Age and intervention group were controlled for in 
baseline and Δbaseline correlations, respectively. 
 
For cognitive test scores only (Chapter 6), effect sizes (Cohen’s d) were calculated for 
longitudinal changes within groups. Effect sizes were computed as the mean difference 
between pre- and post-intervention scores divided by the pooled SDs (Cohen 1988). The 
standard definitions of Cohen’s d are as follows: very small, 0.01-0.19; small, 0.2-0.49; 








Table 3.2 Schedule of assessments 
 
1RM, one repetition maximum; 6MWT, 6-minute walk test; SPPB, short physical performance battery; VAS, visual analogue scales. Adverse events were 
monitored throughout the intervention period. 
 
 
 Metabolic testing (baseline and 
post-intervention) 
Strength and functional performance 
testing (baseline and post-intervention) 
Week 6 Week 12 
24-h (2 x 12-h) urine collection x    
3-d food diary  x (3-d following baseline only)  x x 
7-d physical activity monitoring (accelerometery) x (for 7-d following baseline only)   x 
Blood collection x    
Blood pressure  x    
Body composition x x   
Cognitive function x    
Continuous glucose monitoring  x    
Functional performance testing (6MWT, SPPB)  x   
Indirect calorimetry x    
Informed consent  x (baseline only)    
Mini-mental state examination   x (baseline only)   
Saliva collection x    
Strength testing (1RM, handgrip)   x   
Supplement exit questionnaire   x (post-intervention only)   
VAS appetite scales x    
 140 
Thesis map: Study 1 
Study Aims Key findings 
Study 1: Effects of resistance 
exercise and whey protein 
supplementation on 24-h 
energy expenditure, substrate 
oxidation and metabolic 
flexibility, body composition, 
appetite and glucose 
homeostasis in healthy older 
men 
• To investigate the individual and combined effects of RE and whey 
protein supplementation on components of 24-h EE, substrate 
oxidation and metabolic flexibility, body composition, appetite, and 
glucose homeostasis in healthy older men.  
 
Study 2: Effects of resistance 
exercise and whey protein 
supplementation on skeletal 
muscle mass, strength, 
physical function, and 
hormonal and inflammatory 
biomarkers in healthy older 
men 
• To investigate the individual and combined effects of RE and whey 
protein supplementation on SMM, strength, physical function, and 
hormonal and inflammatory biomarkers in healthy older men. 
• To determine whether changes in hormonal and inflammatory 
markers correlate with changes in SMM, strength and physical 
function.  
 
Study 3: Effects of resistance 
exercise and whey protein 
supplementation on cognitive 
function in healthy older men 
• To investigate the individual and combined effects of RE and whey 
protein supplementation on cognitive function and neurobiological, 
inflammatory and insulin sensitivity markers, diurnal salivary cortisol, 
and BP in healthy older men. 
• To determine whether changes in neurobiological, inflammatory and 
insulin sensitivity markers, and changes diurnal salivary cortisol, BP, 





CHAPTER 4 (Study 1): Effects of resistance exercise 
and whey protein supplementation on 24-h energy 
expenditure, substrate oxidation and metabolic 
flexibility, body composition, appetite, and glucose 






















4.1 Chapter overview  
Ageing is associated with declines in FFM and components of EE, which may result in energy 
imbalance, increased FM and sarcopenic obesity, and poor metabolic health. Previous studies 
have shown RE and increased dietary protein intake may mitigate age-related declines in 
these outcomes. In this chapter, the individual and combined effects of RE and whey protein 
supplementation on 24-h EE, substrate oxidation and metabolic flexibility, body composition, 
subjective appetite and glucose homeostasis were investigated in healthy older men. 
 
4.2 Introduction 
Increased FM and declines in FFM characterise age-related changes in body composition (St-
Onge 2005). Skeletal muscle, which accounts for ~45% of FFM (Geisler and Müller 2017), 
declines by ~0.5-1% per annum after ~45 years of age (Janssen 2010). When accompanied 
by concomitant declines in muscle strength and physical function, this gives rise to the 
phenomenon known as sarcopenia (Cruz-Jentoft et al. 2019). Contrary to SMM, FM has been 
shown to increase by ~0.2% per annum from 20 years of age (Imboden et al. 2017, Westerterp 
2018a). The coexistence of sarcopenia and obesity, termed sarcopenic obesity, is of great 
concern for the health of older adults as they act synergistically, exacerbating the negative 
effects of one another (Batsis et al. 2015, Lee et al. 2016, Scott et al. 2018).  
 
Body composition changes with age are ascribed to alterations in energy balance (St-Onge 
and Gallagher 2010). Regarding the EE component of the energy balance equation (rate of 
ES = rate of EI – rate of EE), ageing is associated with declines in all three major constituents: 
RMR, which accounts for 60-80%; AEE, which comprises ~20-50%; and DIT, which uses 5-
10% (Manini 2010). The decline in RMR occurs at a rate of ~1-2% per decade from the age 
of 30 (Elia, Ritz, and Stubbs 2000). Fat-free mass accounts for 50-70% of the variance (Bosy-
Westphal et al. 2003, Geisler et al. 2016a), of which SMM accounts for ~25% (Gallagher et 
al. 1998). Interventions that curb sarcopenia may mitigate age-related declines in components 
of EE, improve energy balance and attenuate adiposity in older adults. 
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Resistance exercise is a potent stimulus to mitigate sarcopenia (Phillips and Martinson 2019). 
Others have also reported increases in TEE (Hunter et al. 2000), RMR (Hunter, McCarthy, 
and Bamman 2004) and 24-h fat oxidation (Treuth et al. 1995), decreases in the energetic 
cost of walking (Valenti, Bonomi, and Westerterp 2016) and FM (Westcott 2012), and 
improvements in metabolic flexibility (Consitt et al. 2016) and glucose homeostasis (Bell et al. 
2017, Holwerda et al. 2018, Iglay et al. 2007, Leenders et al. 2013) following RE training in 
older adults. However, a potential caveat of RE in the elderly is the frequently reported 
compensatory reduction in AEE, particularly SPA (Westerterp 2018a, 2018b), which has been 
postulated to occur due to training-related fatigue (Hunter et al. 2018). This effect may be 
eliminated by performing RE twice as opposed to three times per week (Hunter et al. 2013). 
 
In addition to RE, a high protein diet may also assist in attenuating sarcopenia and age-related 
reductions in EE, alongside aiding body weight management (Drummen et al. 2018, Phillips 
and Martinson 2019). Meta-analyses have indicated increased dietary protein may augment 
decreases in both absolute and %FM (Liao et al. 2017) and amplify the adaptative RE-induced 
response of skeletal muscle (Cermak et al. 2012, Finger et al. 2015, Liao et al. 2017, Morton 
et al. 2018a). A high protein diet (25-30% of EI) has also been shown to increase TEE, RMR, 
SMR and DIT (Bray et al. 2012, Bray et al. 2015, Martens et al. 2015b, Sutton et al. 2016), 
improve metabolic efficiency of physical activity (Apolzan et al. 2014, Martens et al. 2015a), 
decrease 24-h RQ and elicit a greater negative fat balance (Lejeune et al. 2006, Martens et 
al. 2015b, Smeets, Janssens, and Westerterp-Plantenga 2013), and stimulate an adaptative 
thermogenic increase in TEE and SMR when dietary protein is returned to baseline intake 
(Bray et al. 2015).  
 
However, whilst the aforementioned meta-analyses suggest increased dietary protein might 
augment the effect of RE on body composition, the majority of intervention studies in older 
adults have been unable to replicate supplemental increases in skeletal muscle or FFM 
(Arnarson et al. 2013, Candow et al. 2006, Chalé et al. 2013, Dulac et al. 2020, Englund et al. 
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2018, Gryson et al. 2014, Holm et al. 2008, Holwerda et al. 2018, Kukuljan et al. 2009, 
Leenders et al. 2013, Maltais et al. 2016, Ottestad et al. 2017, Shahar et al. 2013, Thomson 
et al. 2016, Verdijk et al. 2009a, Verreijen et al. 2017). Similarly, studies investigating the 
combined effects on components of EE have also observed no additive effects (Amamou et 
al. 2017, Campbell et al. 1994, Maltais et al. 2016, Weinheimer et al. 2012). Null findings may 
be attributed to an insufficient increase in dietary protein intake from baseline (<0.4 g/kg/d) 
and a total dietary protein intake <1.6 g/kg/d, which, might be the breakpoints required to 
maximally augment increases in SMM and EE (Morton et al. 2018a, Park, Choi, and Hwang 
2018). Furthermore, to the authors knowledge, no study has investigated the synergistic 
effects on 24-h metabolic flexibility or appetite. This data is required to comprehensively 
determine the combined effects on energy balance and metabolic health in older adults.  
 
4.2.1 Aims and hypotheses  
 
Primary aim 
• To investigate the individual and combined effects of RE and whey protein 
supplementation (aimed to increase dietary protein intake by ≥0.4 g/kg/d to 1.6 g/kg/d) 
on components of 24-h EE in healthy older men.  
Secondary aims 
• To investigate the individual and combined effects on body composition, 24-h substrate 
oxidation and metabolic flexibility, glucose homeostasis, subjective appetite, fasting 
plasma leptin and diurnal salivary cortisol.  
Hypotheses 
• Resistance exercise combined with whey protein supplementation will augment 
increases in skeletal muscle and FFM, elevate rises in components of 24-h EE (e.g., 
RMR and SMR) and substrate oxidation (i.e., resting and 24-h fat oxidation), and 
enhance decreases in FM compared to each intervention alone. 
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• Resistance exercise and whey protein supplementation will synergistically increase 24-
h metabolic flexibility, reduce fasting plasma leptin, and have no adverse effects on 
diurnal salivary cortisol or subjective appetite. 
 
4.3 Methods  
 
4.3.1 Participants and experimental design  
Thirty-three healthy, community-dwelling older men [mean ± standard error (SE) age: 66.8 ± 
0.7 y] participated in this study. Measurements were taken at baseline and following the 12-
week intervention. As previously highlighted in section 3.2, participants were randomised to 
either control (CON, n = 8), whey protein (PRO, n = 8), RE + control (EX+CON, n = 8), or RE 
+ whey protein (EX+PRO, n = 9). Full details of the experimental design (section 3.2) and 
eligibility criteria (sections 3.4.2.1 and 3.4.2.2) have been previously described. Although not 
planned in the original study design, exploratory analyses were also conducted between 
pooled exercise (EX+CON and EX+PRO groups, n = 17) and non-exercise groups (CON and 
PRO groups, n = 16), and between pooled whey protein (PRO and EX+PRO groups, n = 17) 
and control groups (CON and EX+CON group, n = 16) to determine the effects of RE and 
whey protein with greater statistical power. All participants provided written informed consent 
approved by Coventry University Ethics Committee (project code: P59723). The flow of 
participants throughout the study has been previously presented and can be seen in Chapter 
3 (Figure 3.2).  
 
4.3.2 Exercise training and nutritional supplements 
Full details of the RE intervention completed by participants in the EX+CON and EX+PRO 
groups and nutritional supplements consumed by participants in all groups have been 
previously detailed (sections 3.5.1 and 3.5.2). Briefly, the RE intervention consisted of twice-
weekly supervised whole-body RE [including 3 sets of 8 repetitions of six exercises (leg press, 
lateral row, hamstring curl, chest press, leg extension and shoulder press)] performed at 80% 
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1RM. Participants in the PRO and EX+PRO groups consumed 25 g whey protein containing 
~3 g leucine, whereas participants in the CON and EX+CON groups consumed an energy-
matched carbohydrate control (maltodextrin). Supplements were consumed twice daily (at 
breakfast and lunch).  
 
4.3.3 Dietary intake and physical activity  
Participants completed 3-day food records (2 weekdays and 1 weekend day) at baseline (prior 
to commencing the intervention) and during weeks 6 and 12. Dietary records were analysed 
with the dietary supplements both included and excluded. Full details have been previously 
described (section 3.6.2). Analysis of dietary records exclusive of the dietary supplements 
was conducted to assess any compensatory effect on participants’ habitual dietary intake. To 
control for acute changes in dietary intake on energy metabolism, participants also completed 
a food record for the 3 days prior to baseline testing. Participants were provided a copy to 
replicate their dietary intake on the day of post-intervention metabolic testing. To control for 
changes in habitual physical activity that may have influenced study endpoints, participants 
wore a tri-axial accelerometer on the dominant wrist, as described in section 3.6.3, for 7 days 
at baseline and during the final week of the intervention.  
 
4.3.4 Body mass and composition  
Body mass and composition (FFM, FM and SMM) was measured in the morning by BIA. Full 
details have been previously described (section 3.6.1). Skeletal muscle mass (kg) was 
estimated using the formula of Janssen et al. (2000a). Participants did not consume any food 
or drink in the hour prior and voided their bladder before measurement. Minimal clothing was 
worn. 
 
4.3.5 Respiration chamber 
Participants resided in respiration chambers located at the HMRU, UHCW NHS Trust for 
measurement of 24-h EE, substrate oxidation and metabolic flexibility, interstitial glucose, 
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subjective appetite, and diurnal salivary cortisol concentration (Figure 4.1). Briefly, the 
respiration chamber is an airtight and thermally insulated living space (floor dimensions: 2.9 
m x 2.1 m) containing a bed, desk, chair, computer and freezer toilet (Schoffelen et al. 1997). 
Environmental conditions were controlled at all times (relative humidity: 57 ± 5%; temperature: 
24 ± 0.5 ˚C). Participants entered the chamber at ~1930 h and left at 2000 h the following 
evening. The first 30 min acted as a habituation period, and the 24-h measurement period, 
which is shown diagrammatically in Figure 4.2, occurred between 2000-2000 h. A full timeline 
of the 24-h assessment can be seen in Appendix L. Whilst residing in the chamber, 
participants were fed a study diet designed to provide energy balance. Food intake was 
partitioned into four separate meals provided at scheduled times (see Table 4.1 for example). 
The diet consisted of ~45% of energy from carbohydrate, ~20% of energy from protein, and 
~35% of energy from fat. This macronutrient composition mimicked that used in a recent  
respiration chamber study in older adults (Bush et al. 2018), and is similar to that habitually 
reported in healthy older men (Farsijani et al. 2016). Energy requirements for each participant 
were calculated from RMR multiplied by an activity factor of 1.47, obtained from pilot data 
(Appendix M). Participants were prohibited from consuming alcohol or caffeinated drinks 
inside the chamber, but water and non-caffeinated herbal teas were available ad libitum. 
Caffeine was prohibited due to its known effect on EE (Hursel et al. 2011).  
 
Participants completed three bouts of 30 min step exercise (Reebok Aerobic Step - height 150 
mm; Reebok, Boston, Massachusetts, USA) at a step rate of 75 steps/min. Exercise was 
performed at 0830 h (EX-1), 1445 h (EX-2) and 1915 h (EX-3). The first bout (EX-1) was 
performed prior to breakfast in a fasted state. Step rate was paced using a metronome 
(TempoPerfect, NCH Software, Canberra, Australia) and participants were visually monitored 
throughout. Step exercise was chosen due to its ease of performing inside a respiration 
chamber (Westerterp, Wilson, and Rolland 1999), and the exercise volume (~6,750 steps; 75 
steps/min x 90 min) was chosen to replicate the step count previously reported in free-living 
older men (age: 70-74 y; 6,798 steps/d) (Lohne-Seiler et al. 2014). Physical activity within the 
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chamber was continuously measured by a radar system working on the Doppler principle, and 
is expressed as a percentage of total time active (Ravussin et al. 1986). During the intervention 














Figure 4.1 Outside (left) and inside (right) of one of the respiration chambers used in this 
study. 
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Table 4.1 Example chamber diet (ID: 029_baseline)1 
 
1All products purchased from Tesco, UK (https://www.tesco.com/groceries/en-GB/). 
Meal/Ingredients Contents, g Carbohydrate, g Protein, g Fat, g Energy, kcal 
Evening meal (2000 h)      
Chicken tikka masala 427 56.0 33.7 25.2 587 
Breakfast (0915 h)       
Fruit and fibre cereal  85 57.4 7.9 4.5 302 
Semi-skimmed milk 156 7.5 5.6 2.8 78 
Lunch (1240 h)      
Lasagne 383 39.1 31.1 28.8 539 
Garlic bread 57 28.2 2.9 9.5 209 
Whole milk yoghurt, Yeo valley strawberry 125 13.1 12.0 4.7 143 
Snack (1720 h)      
Wholemeal bread 119 45.0 12.6 3.3 261 
Margarine, Lurpack spreadable  17 0.1 0.1 13.3 120 
Ham 23 0.3 5.1 0.5 25 
Banana (without skin) 136 31.6 1.6 0.4 136 
  Total, g Total, kcal 
  279 112.6 92.9 2400 
  % Energy intake  




Figure 4.2 Schematic of the 24-h respiration chamber protocol. Energy expenditure (y-axis) 
is plotted against time (x-axis bottom) for one participant (ID: 008_baseline; age: 72 y). The 
protocol is noted on top of the x-axis. Components of 24-h EE are illustrated with dashed lines. 
AEE, activity energy expenditure; DIT, diet-induced thermogenesis; EX-1, step exercise bout 
1; EX-2, step exercise bout 2; EX-3, step exercise bout 3; SMR, sleeping metabolic rate; SPA, 
spontaneous physical activity. 
 
4.3.6 Energy expenditure, substrate oxidation and metabolic flexibility  
Energy Expenditure and rates of carbohydrate and fat oxidation were calculated from 
continuous measurement of V̇O2 and V̇CO2 by indirect calorimetry corrected for protein 
oxidation using the equation of Brouwer (1957):  
 
EE (kcal/min) = 15.977 x V̇O2 (L) + 5.515 x V̇CO2 (L) - 1.352 x protein oxidation (g/d) / 4.184 




















































































Fat oxidation (g/d) = 1.718 x V̇O2 – 1.718 x V̇CO2 (L) – 0.315 x protein oxidation (g/d) 
Protein oxidation (g/d) = 6.25 x total nitrogen (g/d). 
 
The Brouwer equation was used due to its significant agreement with direct calorimetry (Webb 
et al. 1988). Protein oxidation was determined from urinary nitrogen excretion measured over 
12-h periods (overnight: 2000-0800 h; daytime: 0800-2000 h) (Bingham et al. 1988, Brouwer 
1957). Total nitrogen output was calculated by multiplying urinary nitrogen by 1.11 to account 
for normal losses via faeces and other miscellaneous losses (Bingham et al. 1988). 
Respiratory quotient, which is an expression of relative fuel utilisation, was calculated by 
dividing V̇CO2 by V̇O2. Non-protein respiratory quotient (npRQ) was calculated using the 
following formula: 
 
V̇CO2 (L) - 4.8 x urinary nitrogen (g) / V̇O2 (L) – 6 x urinary nitrogen (g). 
 
Twenty-four-hour metabolic flexibility was defined as the difference between awake npRQ 
(mean npRQ between 2000-2200 h and 0700-2000 h) and sleeping npRQ (mean npRQ during 
the defined SMR, as detailed below) (Peterson et al. 2017). Carbohydrate, fat, and protein 
balances were determined as the difference between intake and oxidation.  
 
Twenty-four-hour EE was partitioned into various components. Total EE represented the total 
EE between 2000-2000 h; SMR was determined as the lowest EE over a continuous 3 h period 
between 0000-0600 h (Schoffelen and Westerterp 2008); RMR was measured between 0700-
0800 h following awakening at 0650 h, with the participant supine, but awake. The first 20 and 
last 10 min were discarded, and RMR was calculated during the least restless consecutive 20 
min period between 0720-0750 h (Adriaens, Schoffelen, and Westerterp 2003). The energy 
cost of step exercise was determined as the mean EE whilst participants were in steady state, 
defined when EE reached a plateau and was maintained for a minimum of 15 min (McClave 
et al. 2003, Reeves et al. 2004). Other components of EE, including sedentary EE, AEE, SPA 
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and DIT were calculated using the intercept method, as shown in Figure 4.3 (Hall et al. 2016, 
Ravussin et al. 1986, Westerterp, Wilson, and Rolland 1999). This approach involved plotting 
EE against physical activity, both averaged over 30 min, over the non-exercise intervals of the 
24-h measurement period. The y-intercept (c) of the regression line represents EE in the 
inactive state, defined as sedentary EE, which consists of SMR and DIT. Activity EE was 
calculated by subtracting sedentary EE from TEE, and the difference between sedentary EE 
and SMR represented DIT. Spontaneous physical activity was determined as the slope (m) of 
the regression line and was extrapolated to 24-h values by multiplying by the mean chamber 
activity of the total non-exercise period (Ravussin et al. 1986). Physical activity level was 
determined by dividing TEE by RMR. Throughout this study, components of EE and substrate 
oxidation are expressed as raw values, as well as normalised to body mass and composition 








Figure 4.3 Calculation of sedentary EE, AEE, SPA and DIT using the intercept method for 
one participant (ID: 028_baseline) (Hall et al. 2016, Ravussin et al. 1986, Westerterp, Wilson, 
and Rolland 1999). Energy expenditure was plotted against physical activity, both averaged 
over 30 min intervals, over the non-exercise intervals (21.5 h) of the 24-h measurement period. 
The y-intercept (c) represents EE at zero activity (EE0), defined as sedentary EE (kcal/min), 
which consists of SMR and DIT. The slope (m) of the regression line represents SPA (kcal/min 
per % activity).   
 
For measurement of the abovementioned variables, the non-exercise periods of EE and 
activity (21.5 h) were used and extrapolated to 24-h values due to previous studies that have 
demonstrated physical activity within the chamber significantly affects the y-intercept (c) and 
the slope (x) of the regression line, leading to underestimation of DIT (Ravussin et al. 1986, 
Tataranni et al. 1995, Usui et al. 2015). Indeed, when including exercise periods within the 
analysis in this study, 8/33 (24.2%) and 9/33 (27.2%) of participants’ DIT was negative at 
baseline and 12 weeks, respectively. In contrast, 5/33 (15.2%) and 2/33 (6.1%) of participants’ 
DIT was negative at baseline and 12 weeks, respectively, when only the non-exercise data, 
as employed by Hall et al. (2016), was analysed. Furthermore, when both methods of DIT 
were statistically compared, significant differences were observed at 12 weeks (P = 0.001). 








y = 0.0194x + 0.89
Intercept (EE0; sedentary EE, kcal/min)
















Figure 4.4 Differences in the calculation of DIT for one participant (ID: 018_12 weeks) using 
only data in the non-exercise intervals (A) compared to inclusion of exercise (B). As shown in 
panel B, the extreme data point from the step exercise influenced the determination of the y-
intercept. As a result, DIT was underestimated compared to calculation without exercise (120 
vs. 240 kcal/d).  
 
4.3.7 Continuous glucose monitoring 
To measure 24-h interstitial glucose, participants wore a flash glucose monitor (FreeStyle 
Libre Flash; Abbott Diabetes Care, Witney, UK) whilst residing in the respiration chamber. The 
device was inserted subcutaneously in the posterior compartment of the upper arm and 
captured glucose from interstitial fluid every 15 min, which was transmitted to a receiver. 
Twenty-four-hour average interstitial glucose was calculated as the mean of all 15 min 
samples and 24-h interstitial glucose variability represented the CV (Hall et al. 2019).  
 







































4.3.8 Appetite profile  
Appetite profile was measured by means of visual analogue scales [(VAS), Appendix N] (Flint 
et al. 2000). These are paper based 100 mm scales with ‘not at all’ or ‘extremely’ anchored 
on either side, combined with questions on hunger, satiety, fullness, and desire to eat. 
Participants were asked to draw a line along the 100 mm scale relating to their perception of 
the question asked. The lines were then measured (in mm) and a sub-sample (n = 100) were 
measured by Professor Derek Renshaw. Validity and reproducibility of VAS to measure 
appetite have been previously confirmed (Flint et al. 2000). Participants completed the VAS 
nine times (at 1955 and 2130 h on day 1, and at 0805, 0900, 1225, 1355, 1720, 1835 and 
1955 h on day 2). Research staff within the laboratory did not consume food in sight of 
participants to eliminate a food cue, but participants did have access to the time of day during 
the 24-h period. The area under the curve (AUC) for appetite ratings was measured over the 
24-h measurement period using the trapezoidal method.  
 
4.3.9 Urine, fasting plasma and saliva measurements 
Urine samples were analysed enzymatically for urinary urea (UREA kit; Roche, Mannheim, 
Germany) and creatinine (CREA kit; Roche, Mannheim, Germany) using an automated clinical 
chemistry analyser (Cobas c702 Analyser; Roche, Mannheim, Germany). Venous blood was 
collected at 0815 h following the observed overnight fasting period (>10 h) via an indwelling 
cannula inserted in an antecubital arm vein. Whole blood was collected into EDTA coated 
vacutainers then centrifuged at 1900 x g for 10 min at 4°C (see section 3.6.4 for detailed 
blood collection methodology). Aliquots containing plasma were stored at -80°C until analysis. 
Due to difficulty in blood collection, blood was unable to be drawn from two participants (n = 1 
participant in both the CON and EX+CON groups). Therefore, n = 31 participants had full blood 
data. Samples were analysed for plasma glucose using a glucose analyser (Biosen C-Line 
Glucose and Lactate Analyser; EKF Diagnostics, Cardiff, UK). Plasma insulin (EIA-2935; DRG 
Instruments GmbH, Marburg, Germany) and leptin (DLP00; R&D Systems Inc., Abbington, 
UK) were analysed by ELISA. Insulin resistance (homeostatic model assessment of insulin 
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resistance; HOMA-IR), insulin sensitivity (quantitative insulin sensitivity check index; QUICKI) 
and beta-cell function (HOMA-beta) were calculated from fasting glucose and insulin 
concentrations using standard equations (Katz et al. 2000, Matthews et al. 1985): 
 
HOMA-IR = Fasting insulin (µU/mL) x fasting glucose (mmol/L) / 22.5 
QUICKI = 1/ [log(fasting insulin (µU/mL)) + log(fasting glucose (mmol/L))] 
HOMA-beta = 20 x fasting insulin (µU/mL) / fasting glucose (mmol/L) – 3.5. 
 
Saliva samples were collected immediately upon awakening at 0650 h, and at 0805, 1225, 
1700 and 2000 h using a synthetic swab (see section 3.6.4 for detailed methodology). 
Participants were asked to rinse their mouth with water prior to each collection. Samples were 
centrifuged at 1900 x g for 2 min and stored at -80°C. Samples were analysed for salivary 
cortisol by ELISA (Item No. 1-3002; Salimetrics, Pennsylvania, USA). Salivary cortisol AUC 
(nmol/L x 790 min) was calculated using the trapezoidal method. The CV for plasma glucose 
was 0.5% and the intra-assay CV was 9.5%, 8.3% and 9.0% for plasma insulin and leptin, and 
salivary cortisol, respectively.  
 
4.3.10 Statistical analysis  





4.4.1 Participants and compliance  
Thirty-nine older men were randomised: 33 completed the study and 6 withdrew. Reasons for 
withdrawal have been previously displayed and can be seen in Figure 3.2. Baseline 
characteristics of the 33 participants who completed the study are shown in Table 4.2. The 
mean attendance to the RE sessions was 98.0 ± 1.0% in the EX+CON group and 98.2 ± 1.2% 
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in the EX+PRO group, with no differences between groups (P = 0.98). All participants 
completed their prescribed repetitions for sets 1-2 of each exercise; during the final set (to 
volitional failure) the mean number of completed repetitions was 9.1 ± 0.3 in the EX+CON 
group and 9.1 ± 0.2 in the EX+PRO group, with no differences between groups (P = 0.94). 
The mean compliance with experimental supplements was 95.8 ± 0.6% and did not differ 
between groups (CON: 94.4 ± 1.3%; PRO: 96.9 ± 1.1%; EX+CON: 96.0 ± 1.1%; EX+PRO: 
96.1 ± 1.3%, P = 0.64). The majority of participants (80.6%) were unable to judge treatment 
allocation.
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Table 4.2 Baseline characteristics of participants1  
 CON PRO EX+CON EX+PRO P value3 Overall 
n 8 8 8 9 - 33 
Age, y 66.6 ± 1.8 66.3 ± 1.7 66.5 ± 1.2 67.8 ± 1.2 0.89 66.8 ± 0.7 
Height, m 1.78 ± 0.02 1.78 ± 0.02 1.77 ± 0.02 1.74 ± 0.03 0.63 1.76 ± 0.01 
Body mass, kg 80.5 ± 3.4 79.7 ± 3.0 76.1 ± 3.8 80.9 ± 4.0 0.77 79.3 ± 1.8 
BMI, kg/m2 25.5 ± 1.0 25.2 ± 0.6 24.4 ± 0.8 26.6 ± 0.8 0.31 25.4 ± 0.4 
FFM, kg 60.2 ± 1.6 60.9 ± 1.6 57.8 ± 2.8 60.5 ± 2.9 0.80 59.9 ± 1.9 
SMM, kg 26.8 ± 0.7 27.5 ± 0.6 25.6 ± 1.2 26.9 ± 1.3 0.62 26.7 ± 0.7 
FM, kg 20.3 ± 2.4 18.6 ± 1.8 18.2 ± 1.7 20.4 ± 1.5 0.78 19.4 ± 0.9 
FM, % 24.7 ± 2.1 23.2 ± 1.7 23.8 ± 1.6 25.1 ± 1.2 0.84 24.2 ± 0.8 
TEE, kcal/d 2417 ± 101 2529 ± 74 2460 ± 86 2454 ± 86 0.84 2465 ± 42 
RMR, kcal/d 1602 ± 80 1661 ± 63 1631 ± 66 1609 ± 68 0.94 1625 ± 33 
PAL 1.51 ± 0.03 1.53 ± 0.04 1.51 ± 0.05 1.53 ± 0.03 0.97 1.52 ± 0.02 
Fasting plasma glucose, mmol/L 5.6 ± 0.2 6.0 ± 0.3 5.9 ± 0.3 5.7 ± 0.2 0.72 5.8 ± 0.1 
HOMA-IR 2.4 ± 0.5 2.7 ± 0.5 2.3 ± 0.4 2.2 ± 0.4 0.85 2.4 ± 0.2 
Step count, steps/d  10,840 ± 668 12,396 ± 1,398 12,171 ± 1,153 11,346 ± 907 0.71 11,678 ± 516 
Time spent sedentary, min/d 275 ± 14 277 ± 41 285 ± 30 289 ± 20 0.98 282 ± 13 
Time spent in MVPA, min/d 109 ± 8 119 ± 14 126 ± 16 135 ± 10 0.52 123 ± 6 
 
1Values are means ± SE. 3P value refers to differences between groups analysed by one-way ANOVA. No significant differences in baseline characteristics 
occurred between either pooled exercise and non-exercise groups, or between pooled whey protein and control groups (data not shown). BMI, body mass 
index; FFM, fat-free mass; FM, fat mass; HOMA-IR, homeostatic model assessment of insulin resistance; MVPA, moderate-vigorous physical activity; PAL, 
physical activity level; RMR, resting metabolic rate; SMM, skeletal muscle mass; TEE, total energy expenditure.
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4.4.2 Dietary intake  
At baseline, no differences in carbohydrate, fat, protein or total EI occurred between groups. 
At weeks 6 and 12, protein intake increased in the PRO and EX+PRO groups greater than the 
CON and EX+CON groups (P < 0.001, Table 4.3). Carbohydrate intake increased in the 
EX+CON group greater than the EX+PRO group at weeks 6 and 12 (P < 0.05), and greater 
than the PRO group at week 12 only (P = 0.01). Total EI increased over time in the EX+PRO 
group at week 6 (P = 0.03) but not at week 12 (P = 0.75) and increased in the CON group at 
week 12 only (P = 0.001). When participants’ dietary intake was analysed excluding 
experimental supplements, total EI decreased over time in the PRO group at week 12 (P = 
0.02). Total EI also decreased to a greater extent over time when whey protein groups were 
pooled and compared to control supplement groups pooled (P = 0.01). Habitual carbohydrate 
intake decreased over time in the CON group at week 6 (P = 0.04), but not at week 12 (P = 
0.68). Fat intake decreased greater in the PRO compared to the CON group at week 12 (P = 
0.02). When whey protein supplement groups were pooled, fat intake decreased greater than 
control supplement groups pooled between weeks 6 and 12 (P = 0.004).
 160 
Table 4.3 Dietary intake (including and excluding experimental supplements) during the intervention period1 
 
1Values are means ± SE. Baseline values for individual groups are not shown but no significant differences occurred between groups for any dietary marker. 
2P value refers to respective group-by-time interaction.3Significant main effect of time, P < 0.05. *Significantly (P < 0.05) greater than CON group at respective 
time point. ‡Significantly greater than PRO group at respective time point. ¥Significantly greater than EX+CON group at respective time point. $Significantly 
greater than EX+PRO group at respective time point. #P < 0.05 from baseline value. ¢P < 0.05 from week 6. – indicates same value as diet. Diet = intake from 
habitual intake (excluding supplements). Total = intake from habitual diet plus experimental supplements. 
 Pooled CON PRO EX+CON EX+PRO  
 Baseline 6 weeks 12 weeks 6 weeks 12 weeks 6 weeks 12 weeks 6 weeks 12 weeks P value2 
Energy, kcal/d            
     Diet3 1999 ± 59 1822 ± 104 1920 ± 84 1878 ± 147 1741 ± 159#  1972 ± 93 2021 ± 128 2048 ± 97 1969 ± 141 0.08 
     Total3 - 1989 ± 116 2086 ± 89# 2069 ±147  1932 ± 159 2163 ± 93 2211 ± 128 2238 ± 97# 2159 ± 141 0.09 
Protein, g/d          
 Diet3 82 ± 2 77 ± 6 75 ± 4 82 ± 4 81 ± 5 86 ± 5 84 ± 5 85 ± 6 79 ± 3 0.87 
 Total3 - 77 ± 6 75 ± 4  128 ± 4*¥# 126 ± 5*¥# 86 ± 5  84 ± 5  131 ± 6*¥# 125 ± 3*¥# < 0.001 
Protein, g/kg/d           
 Diet3 1.0 ± 0.02 1.0 ± 0.1 0.9 ± 0.04 1.0 ± 0.03 1.0 ± 0.04 1.1 ± 0.1 1.1 ± 0.1 1.1 ± 0.05 1.0 ± 0.05 0.37 
 Total - 1.0 ± 0.1 0.9 ± 0.04 1.6 ± 0.04*¥# 1.5 ± 0.1*¥# 1.1 ± 0.1 1.1 ± 0.1 1.6 ± 0.1*¥# 1.6 ± 0.1*¥# < 0.001 
Protein, %           
 Diet 17 ± 0.4 17 ± 1 16 ± 1 18 ± 1 19 ± 1 18 ± 1 17 ± 1 17 ± 1 17 ± 1 0.47 
 Total3  - 16 ± 1 15 ± 1 25 ± 1*¥#  27 ± 2*¥# 16 ± 1 15 ± 1 24 ± 1*¥#  24 ± 1*¥# < 0.001 
Carbohydrate, g/d          
 Diet 234 ± 8 197 ± 9# 211 ± 18 196 ± 23 204 ± 18 224 ± 16 231 ± 12 221 ± 11 238 ± 16 0.87 
 Total3 - 239 ± 12 253 ± 17 196 ± 23 204 ± 18 272 ± 16$# 279 ± 12‡$# 221 ± 11 238 ± 16 0.02 
Carbohydrate, %            
 Diet3 48 ± 12 44 ± 2# 44 ± 3 42 ± 4 47 ± 2 46 ± 2 46 ± 2 44 ± 2 49 ± 2 0.69 
 Total - 48 ± 2‡ 48 ± 2 38 ± 4 42 ± 1 50 ± 2$ 51 ± 2‡# 40 ± 2 44 ± 2 0.001 
Fat, g/d          
 Diet 70 ± 3 69 ± 6  75 ± 4‡ 73 ±11  55 ± 8 71 ± 6  70 ± 9 77 ± 5 61 ± 8 0.02 
 Total -  69 ± 6  75 ± 4‡ 74 ±11  56 ± 9 71 ± 6  70 ± 9 78 ± 5 62 ± 8 0.03 
Fat, %            
 Diet 32 ± 1 34 ± 2  35 ± 1 35 ± 4 28 ± 2 32 ± 2 31 ± 2 34 ± 1 27 ± 2 0.21 
 Total3 - 31 ± 2 32 ± 1 32 ± 4 25 ± 2 29 ± 2 28 ± 2 31 ± 1  25 ± 2 0.08 
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4.4.3 Habitual physical activity  
No differences in any marker of habitual physical activity occurred between groups at baseline 
(Table 4.2). Following the intervention, daily step count (P = 0.52), time spent sedentary (P = 
0.48), and in light (P = 0.92) and MVPA (P = 0.80) did not differ between groups over time. No 
significant within-group changes occurred.  
 
4.4.4 Body mass and composition 
Body mass did not change over time in either the PRO or EX+PRO groups, whereas 
participants gained 0.9 ± 0.3 kg (P = 0.007) in the CON group and 1.3 ± 0.2 kg (P < 0.001) in 
the EX+CON group. When control supplement groups were pooled, body mass increased 
greater than whey protein groups pooled (P = 0.04, Figure 4.5A). Fat-free mass and SMM 
increased in only the EX+CON (FFM: 1.0 ± 0.4 kg, P = 0.06; SMM: 0.6 ± 0.2 kg, P = 0.042) 
and EX+PRO groups (FFM: 1.0 ± 0.4 kg, P = 0.05; SMM: 0.6 ± 0.3 kg, P = 0.06), but no 
differences occurred between groups. When exercise groups were pooled, FFM increased 
greater than non-exercise groups pooled (P = 0.04, Figure 4.5B). Fat mass significantly 
increased over time in the CON group (0.8 ± 0.3 kg, P = 0.02) and decreased, but not 
significantly, in the EX+PRO group (-0.9 ± 0.5 kg, P = 0.09). When whey protein supplement 
groups were pooled, both absolute (P = 0.03, Figure 4.5C) and %FM (P = 0.04) decreased 
greater than control supplement groups pooled. Body mass index increased greater in the 
pooled control supplement group compared to the pooled whey protein supplement group (P 














Figure 4.5 Changes in (A) body mass between pooled whey protein (n = 17) and control supplement groups (n = 16); (B) fat-free mass between 
pooled exercise (n = 17) and non-exercise groups (n = 16); and (C) fat mass between pooled whey protein and control supplement groups over 
the intervention period (means ± SE). Circles represent individual data points. Data were analysed using a mixed-model ANCOVA with baseline 
values and either exercise or non-exercise (for pooled whey protein vs. control groups, panels A and C), and supplement consumed (whey protein 


































































4.4.5 Energy expenditure and substrate oxidation  
 
4.4.5.1 Total EE 
Total EE decreased in all groups from baseline to 12 weeks, but only significantly in the PRO 
group (-78 ± 26 kcal/d, P = 0.02, Table 4.4). When normalised to both FFM and SMM, 
decreases in TEE over time in the CON, PRO and EX+PRO groups became significant (P < 
0.05). No differences were observed between groups (P = 0.26).  
 
4.4.5.2 24-h substrate oxidation  
Twenty-four-hour protein oxidation increased over time in the PRO and EX+PRO groups 
greater than the CON and EX+CON groups (P < 0.05, Figure 4.6A). The increase was driven 
by rises in overnight protein oxidation, which increased in the PRO (29 ± 6 g/d) and EX+PRO 
groups (30 ± 10 g/d) greater than the CON and EX+CON groups (P < 0.05, Figure 4.6B). No 
within- or between-group differences occurred for daytime protein oxidation. Protein balance 
was positive in all groups at baseline but decreased in the PRO and EX+PRO groups greater 
than the EX+CON group when protein intake was returned to the chamber diet at week 12 (P 
< 0.05, Figure 4.6C). No within- or between-group differences in 24-h oxidation or balance of 
carbohydrate or fat, or RQ, was observed over the course of the study (Table 4.4).  
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Table 4.4 Energy expenditure, 24-h macronutrient oxidation and balances, and appetite profile for each treatment group at baseline and 12 
weeks1  
 CON PRO EX+CON EX+PRO P value 
 Baseline 12 weeks Baseline 12 weeks Baseline 12 weeks Baseline 12 weeks Time Group x time 
TEE, kcal/d 2417 ± 101 2372 ± 95 2529 ± 74 2451 ± 85# 2460 ± 86 2413 ± 96 2455 ± 86 2439 ± 88 0.54 0.26 
Sedentary EE, kcal/d 1761 ± 81 1708 ± 80 1727 ± 78 1724 ± 77 1711 ± 47 1750 ± 75 1720 ± 75 1798 ± 64 0.19 0.17 
RMR, kcal/d 1602 ± 80 1586 ± 66 1661 ± 63 1598 ± 57 1631 ± 66 1670 ± 64 1609 ± 68 1643 ± 65 0.25 0.11 
SMR,2 kcal/d  1561 ± 73 1554 ± 68 1600 ± 56 1597 ± 62 1562 ± 79 1607 ± 78# 1598 ± 64 1643 ± 60# 0.40 0.15 
AEE, kcal/d 656 ± 38 664 ± 45 803 ± 42 727 ± 42# 748 ± 59 663 ± 30 735 ± 47 642 ± 41 0.008 0.41 
SPA, kcal/d 358 ± 30 346 ± 37 461 ± 41 384 ± 37# 421 ± 43 345 ± 16 407 ± 46 297 ± 33# 0.004 0.27 
DIT, kcal/d 143 ± 20 134 ± 27 126 ± 47 128 ± 47 153 ± 31 170 ± 20 122 ± 38 155 ± 25 0.001 0.79 
DIT, % of EI 6.1 ± 0.9 5.7 ± 1.1 4.9 ± 1.9 5.1 ± 1.9 6.7 ± 1.4 7.1 ± 0.9 4.9 ± 1.5 6.4 ± 1.1 0.001 0.80 
Protein oxidation, g/d 86 ± 8 80 ± 6 89 ± 5 108 ± 6*¥# 84 ± 6 80 ± 6 83 ± 6 102 ± 7*¥# 0.005 0.001 
Carbohydrate oxidation, g/d 267 ± 14 255 ± 12 243 ± 18 238 ± 23 240 ± 14 240 ± 14 253 ± 16 245 ± 7 0.008 0.95 
Fat oxidation, g/d 92 ± 9 96 ± 10 113 ± 52 99 ± 4 110 ± 7 106 ± 5 105 ± 6 97 ± 7 0.08 0.47 
RQ 0.86 ± 0.01 0.85 ± 0.01 0.84 ± 0.01 0.84 ± 0.01 0.84 ± 0.01 0.84 ± 0.01 0.84 ± 0.01 0.84 ± 0.01 0.01 0.99 
Protein balance, g/d 28 ± 8 24 ± 5 26 ± 8 5 ± 9¥# 31 ± 6 36 ± 4 28 ± 4 9 ± 5¥# 0.12 0.001 
Carbohydrate balance, g/d 37 ± 13 34 ± 15 52 ± 12 56 ± 14 56 ± 11 48 ± 9 41 ± 11 55 ± 12 0.001 0.63 
Fat balance, g/d 0 ± 7 -6 ± 8 -15 ± 7 -1 ± 7 -15 ± 9 -9 ± 6 -9 ± 9 -1 ± 7 0.55 0.28 
Energy balance, kcal/d 80 ± 70 30 ± 56 -12 ± 79 35 ± 62 44 ± 98 73 ± 74 37 ± 61 61 ± 37 0.57 0.82 
Hunger AUC, mm x 24 h 60,446±7521 61,418±6556 60,184±6703 62,553±6848 57,811±4103 69,608±2892 51,673±5803 57,880±5371 0.001 0.48 
Satiety AUC, mm x 24 h 75,625±5467 77,649±6341 72,501±6597 66,871±3779 69,285±3928 64,790±3779 79,107±6505 75,065±4101 0.07 0.42 
Fullness AUC, mm x 24 h 74,435±6782 78,329±6918 60,019±10201 59,579±9220 65,514±3363 63,951±5523 77,723±5719 71,901±3548 0.02 0.49 
Desire to eat AUC, mm x 24 h 69,471±8387 69,382±7112 80,207±10,688 71,250±7045 71,553±3876 77,956±3809 58,871±6325 64,534±4680 0.001 0.39 
 
1Values are means ± SE. Baseline values were not significantly different between groups. 2CON and EX+CON, n = 7 (n = 1 outlier, >3SD from mean removed 
from each group). AEE, activity energy expenditure; AUC, area under the curve; DIT, diet-induced thermogenesis; EI, energy intake; PAL, physical activity 
level; RMR, resting metabolic rate; RQ, respiratory quotient; SMR, sleeping metabolic rate; SPA, spontaneous physical activity. *Significantly (P < 0.05) 






Figure 4.6 Changes in (A) 24-h protein oxidation; (B) overnight and daytime protein oxidation; and (C) 24-h protein balance between groups 
(means ± SE). Circles represent individual data points. Data were analysed using a mixed-model ANCOVA with baseline values included as a 
covariate. ††Significant group-by-time interaction, P < 0.01. *Significantly greater than the CON group. ¥Significantly greater than EX+CON group.





























































































4.4.5.3 Resting, sedentary and sleeping EE and substrate oxidation 
No differences in RMR (P = 0.11) or sedentary EE (P = 0.17) occurred between groups over 
the course of the study. When exercise groups were pooled, both RMR (36 ± 14 kcal/d) and 
sedentary EE (60 ± 30 kcal/d) increased over time greater than non-exercise groups pooled 
(P < 0.05, Figure 4.7), but not when normalised to skeletal muscle or FFM. Resting fat 
oxidation decreased over time in the PRO group greater than the EX+CON group (P = 0.02), 
which remained significant when normalised to body composition variables (P < 0.05). No 
within- or between-group differences in resting carbohydrate oxidation or RQ were observed. 
 
 
Figure 4.7 Changes in resting metabolic rate (RMR), sedentary EE and sleeping metabolic 
rate (SMR) between pooled exercise (EX+CON and EX+PRO; n = 17 for RMR and sedentary 
EE; n = 16 for SMR) and non-exercise groups (CON and PRO; n = 16 for RMR and sedentary 
EE; n = 15 for SMR) over the intervention period (means ± SE). Circles represent individual 
data points. Data were analysed using a mixed-model ANCOVA with baseline values and 
supplement consumed (whey protein or control) included as covariates. †P < 0.05 between 





























Sleeping metabolic rate significantly increased over time in the EX+CON (45 ± 12 kcal/d, P = 
0.008) and EX+PRO groups (45 ± 9 kcal/d, P = 0.04), but not when normalised to FFM or 
SMM. No differences occurred between groups (P = 0.15). When exercise groups were 
pooled, SMR increased greater than non-exercise groups pooled (P < 0.001, Figure 4.7). No 
within- or between-group differences occurred for sleeping carbohydrate or fat oxidation.  
 
4.4.5.4 Activity EE and physical activity 
Activity EE significantly decreased over time in the PRO group (-76 ± 26 kcal/d, P = 0.02), and 
tended to decrease in the EX+CON (-85 ± 40 kcal/d, P = 0.07) and EX+PRO groups (-93 ± 43 
kcal/d, P = 0.06) (Figure 4.8A). When normalised to SMM, AEE significantly decreased in 
these groups (P < 0.05). Spontaneous physical activity decreased over time in the PRO (-77 
± 22 kcal/d, P = 0.01) and EX+PRO groups (-110 ± kcal/d, P = 0.045), and decreased, but not 
significantly, in the EX+CON group (-76 ± 38 kcal/d, P = 0.09) (Figure 4.8B). When normalised 
to body composition variables, SPA decreased over time in the PRO and EX+CON groups (P 
< 0.05), whereas in the EX+PRO group, SPA was no longer significantly decreased when 
normalised to FM only (P = 0.17). 
 
In the PRO and EX+CON groups, the decrease in SPA over the course of the study occurred 
due to a reduction in the energy cost of SPA per unit of activity, which significantly decreased 
in the PRO group (P = 0.03, Figure 4.8C). In contrast, the decline in SPA in the EX+PRO 
group occurred due to a notable reduction in chamber activity during the non-exercise periods, 
which decreased greater than the PRO group (P = 0.049, Figure 4.8D). Change in chamber 
activity negatively correlated with ΔRMR (r = -0.41, P = 0.02, Figure 4.8E). Physical activity 
level decreased over time in the EX+CON group (-0.06 ± 0.02, P = 0.02) and decreased, but 
not significantly, in the EX+PRO group (-0.04 ± 0.02, P = 0.09). No differences occurred 
between groups (P = 0.20); however, there was a trend towards a greater decrease in PAL 



















Figure 4.8 Changes in (A) AEE; (B) SPA (kcal/d); (C) SPA (kcal/d per % activity); and (D) chamber activity during the non-exercise periods for each 
treatment group over the intervention period (means ± SE); (E) correlation between ΔRMR and Δchamber activity; and (F) change in PAL between 
exercise and non-exercise groups (means ± SE). Individual data points are shown with circles (apart from panel E where different shapes represent 
participants in different experimental groups). AEE; activity energy expenditure; PAL, physical activity level; RMR, resting metabolic rate; SPA, 
spontaneous physical activity. †Significant group-by-time interaction, P < 0.05. ‡Significantly (P < 0.05) less than PRO group. #P < 0.05 from baseline.















































































r = -0.41, P = 0.02














































4.4.5.5 Exercise EE and substrate oxidation 
At baseline and 12 weeks, fat oxidation was significantly greater and carbohydrate oxidation 
was significantly less during the fasted step exercise bout (EX-1) than during both EX-2 (P < 
0.001) and EX-3 (P < 0.001, Figure 4.9). Energy expenditure did not differ between step 
exercise bouts at baseline. In contrast, at 12 weeks, EE during EX-1 (4.7 ± 0.1 kcal/min) was 
significantly less than during both EX-2 (4.9 ± 0.1 kcal/min, P < 0.001) and EX-3 (4.8 ± 0.1 
kcal/min, P < 0.001).  
 
 
Figure 4.9 Carbohydrate, fat and protein oxidation during the three step exercise bouts 
performed at 75 steps/min at baseline and 12 weeks (n = 33; means ± SE). EX-1, step exercise 
bout 1 (0830 h in the fasted state); EX-2, step exercise bout 2 (1445 h); EX-3, step exercise 
bout 3 (1915 h). Baseline and 12-week data were analysed by repeated measures ANOVA. 
*P < 0.001 compared to EX-2. †P < 0.001 compared to EX-3. 
 
Following the intervention, EE tended to decrease over time during EX-1 in the PRO group (-
0.3 ± 0.2 kcal/min, P = 0.06, Table 4.5), which became significant when normalised to SMM 





























Fat oxidation: P < 0.001
Carbohydrate oxidation: P < 0.001  
Fat oxidation: P < 0.001
Carbohydrate oxidation: P < 0.001  
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(P = 0.04). Energy expenditure also decreased over time during EX-1 in the EX+CON group 
when normalised to FFM (P = 0.047). Fat oxidation decreased over time during EX-1 in the 
PRO group (-71 ± 23 g/d, P = 0.02), which remained decreased when normalised to body 
composition variables (P < 0.05). During EX-2 (-0.1 ± 0.1 kcal/min, P = 0.049) and EX-3 (-0.2 
± 0.1 kcal/min, P = 0.02), modest, but significant decreases in EE occurred over the course of 
the study in the EX+CON group, which remained significant when normalised to body 
composition variables (P < 0.05). Neither EE, nor substrate oxidation changed over time 
during any step exercise bout in the CON or EX+PRO groups, and no differences occurred 
between groups.  
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Table 4.5 Step exercise energy expenditure and substrate oxidation for each treatment group at baseline and 12 weeks1 
 CON PRO EX+CON EX+PRO P value 
 Baseline 12 weeks Baseline 12 weeks Baseline 12 weeks Baseline 12 weeks Time Group x time 
EX-1            
EE, kcal/min 4.5 ± 0.3 4.6 ± 0.2 5.0 ± 0.2 4.7 ± 0.2 4.7 ± 0.2 4.6 ± 0.2 4.7 ± 0.2 4.8 ± 0.2 0.76 0.08 
Carbohydrate oxidation, g/d 649 ± 58 705 ± 47 661 ± 86 695 ± 95 693 ± 68 688 ± 54 760 ± 47 776 ± 47 0.02 0.96 
Fat oxidation, g/d 348 ± 38  335 ± 25  416 ± 24 344 ± 23# 351 ± 24  342 ± 22  328 ± 25  326 ± 26  0.009 0.50 
Protein oxidation, g/d 90 ± 8 84 ± 7 89 ± 5  100 ± 5 85 ± 9 85 ± 8  88 ± 7 92 ± 9 0.009 0.27 
RQ 0.84 ± 0.01 0.84 ± 0.01 0.82 ± 0.01 0.84 ± 0.01 0.84 ± 0.01 0.84 ± 0.01 0.85 ± 0.01 0.85 ± 0.01 0.02 0.79 
EX-2            
EE,2 kcal/min  4.6 ± 0.2 4.8 ± 0.2 5.0 ± 0.2 5.0 ± 0.2 4.8 ± 0.2 4.7 ± 0.3# 4.9 ± 0.2 4.9 ± 0.2 0.29 0.35 
Carbohydrate oxidation, g/d 1047 ± 71 1056 ± 70 1165 ± 69 1162 ± 93 1143 ± 80 1091 ± 68 1154 ± 58 1168 ± 54 0.19 0.71 
Fat oxidation, g/d 174 ± 33 203 ± 24  185 ± 21 179 ± 22 174 ± 20 191 ± 17 173 ± 12  190 ± 24 < 0.001 0.86 
Protein oxidation, g/d 90 ± 8 84 ± 7 89 ± 5  100 ± 5 85 ± 9 85 ± 8  88 ± 7 92 ± 9 0.009 0.27 
RQ 0.91 ± 0.01 0.90 ± 0.01 0.91 ± 0.01 0.91 ± 0.01 0.92 ± 0.01 0.91 ± 0.01  0.92 ± 0.01 0.91 ± 0.01 0.003 0.77 
           
EX-3            
EE,2 kcal/min  4.6 ± 0.2 4.7 ± 0.2 5.0 ± 0.2 4.9 ± 0.2 4.9 ± 0.2 4.7 ± 0.3# 4.9 ± 0.2 4.9 ± 0.2 0.09 0.26 
Carbohydrate oxidation, g/d 1075 ± 56 1067 ± 50 1164 ± 69  1159 ± 77  1133 ± 71  1152 ± 64 1172 ± 53  1219 ± 56  0.05 0.59  
Fat oxidation, g/d 166 ± 21 185 ± 23 184 ± 17 180 ± 19 179 ± 24  162 ± 19 170 ± 13 168 ± 14 0.02 0.47  
Protein oxidation, g/d 90 ± 8 84 ± 7 89 ± 5  100 ± 5 85 ± 9 85 ± 8  88 ± 7 92 ± 9 0.009 0.27 
RQ 0.92 ± 0.01  0.92 ± 0.01 0.91 ± 0.01 0.91 ± 0.01 0.92 ± 0.01  0.92 ± 0.01 0.91 ± 0.01 0.92 ± 0.01 0.04 0.47 
 
1Values are means ± SE. Baseline values were not significantly different between groups. 2EX+PRO, n = 8 (1 outlier removed, >3SD from mean). Protein 
oxidation data has been added for completeness but was obtained from one urine sample between 0800-2000 h. EE, energy expenditure; EX-1, step exercise 




4.4.5.6 Diet-induced thermogenesis  
Diet-induced thermogenesis was similar between groups at baseline (CON: 6.1 ± 0.9%; PRO: 
4.9 ± 1.9%; EX+CON: 6.7 ± 1.4%; EX+PRO: 4.9 ± 1.5%, P = 0.78). A high inter-individual 
variability was observed (range -3.1-12.5%). At 12 weeks when protein intake was returned to 
the baseline chamber diet, no within- or between-group differences in DIT (expressed as both 
kcal/d and % EI) occurred (Table 4.4).  
 
4.4.5.7 Metabolic flexibility 
Twenty-four-hour metabolic flexibility increased over time in only the EX+CON (P = 0.007) and 
EX+PRO groups (P = 0.01), but no significant differences occurred between groups (P = 0.06). 
When exercise groups were pooled, 24-h metabolic flexibility increased greater than non-
exercise groups pooled (P = 0.01, Figure 4.10). The increase in 24-h metabolic flexibility when 
exercise groups were pooled was driven by decreases in sleeping npRQ (-0.019 ± 0.007, P = 


























Figure 4.10 Change in 24-h metabolic flexibility between pooled exercise (n = 17) and non-
exercise groups (n = 16) (means ± SE). Circles represent individual data points. Data were 
analysed using a mixed-model ANCOVA with baseline values and supplement consumed 
(whey protein or control) included as covariates. npRQ, non-protein respiratory quotient. †P < 
0.05 between groups. 
 
4.4.6 Appetite profile  
No differences in hunger (P = 0.71), satiety (P = 0.66), fullness (P = 0.26) or desire to eat VAS 
AUC (P = 0.28) occurred between groups at baseline (Table 4.4). Following the intervention, 
increases in hunger AUC occurred in the EX+CON (11,798 mm x 24 h, P = 0.053) and 
EX+PRO groups (6,207 mm x 24 h, P = 0.052), which trended towards statistical significance. 
The increase became significant when exercise groups were pooled (P = 0.006); however, no 
significant differences in any appetite rating occurred between groups. When whey protein 
groups were pooled, no within- or between-group differences for any marker of subjective 










































4.4.7 Continuous glucose monitoring  
At baseline, 24-h average interstitial glucose concentration was 5.5 ± 0.4 mmol/L in the CON 
group, 5.1 ± 0.2 mmol/L in the PRO group, 5.5 ± 0.2 mmol/L in the EX+CON group, and 5.7 ± 
0.2 mmol/L in the EX+PRO group with no differences between groups (P = 0.36). After 12 
weeks, no differences in 24-h average interstitial glucose (P = 0.58) or interstitial glucose 
variability (P = 0.31) occurred between groups, and no significant within-group differences 
were observed for either variable (Table 4.6). 
 
4.4.8 Fasting plasma measurements and diurnal salivary cortisol  
Fasting plasma leptin (-1.2 ± 0.5 ng/mL, P = 0.045) and plasma glucose concentration (-0.3 ± 
0.1 mmol/L, P = 0.04) decreased over time in only the EX+PRO group, and fasting plasma 
insulin tended to decrease in both the EX+CON (-1.6 ± 0.7 mU/L, P = 0.06) and EX+PRO 
groups (-2.1 ± 1.1 mU/L, P = 0.09, Table 4.6). In the EX+PRO group, HOMA-IR significantly 
decreased (-0.6 ± 0.3, P = 0.04) and QUICKI increased over the duration of the study (0.02 ± 
0.01, P = 0.02). In the PRO and EX+CON groups, HOMA-IR tended to decrease (PRO: -0.6 
± 0.3, P = 0.07; EX+CON: -0.5 ± 0.2, P = 0.06), and QUICKI significantly increased in the PRO 
group (0.03 ± 0.01, P = 0.048) and tended to increase in the EX+CON group (0.02 ± 0.01, P 
= 0.05). No differences occurred between groups for either HOMA-IR (P = 0.25) or QUICKI (P 
= 0.23). When protein supplement groups were pooled, QUICKI tended to increase greater 
than control groups pooled (P = 0.06). No within- or between-group differences occurred for 
HOMA-beta over the course of the study.  
 
At baseline, no group-by-timepoint interaction (P = 0.79) or differences in the AUC (P = 0.28) 
for salivary cortisol occurred between groups. Following the intervention, no significant group-
by-time-by-time point interaction occurred for salivary cortisol (P = 0.57); however, awakening 
cortisol concentration (0650 h) increased, but not significantly, in the PRO (5.5 ± 2.9 nmol/L, 
P = 0.09) and EX+PRO groups (7.2 ± 4.1 nmol/L, P = 0.06). When these groups were pooled, 
the increase in awakening cortisol concentration was significantly greater than control 
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supplement groups pooled (P = 0.049, Figure 4.11). No within- or between-group changes 




























Figure 4.11 Change in awakening (0650 h) salivary cortisol concentration between pooled 
whey protein (n = 17) and control supplement groups (n = 16) (means ± SE). Circles represent 
individual data points. Data were analysed using the Scheirer-Ray-Hare two-way ANOVA of 

































Table 4.6 Fasting plasma, continuous glucose monitoring and salivary cortisol markers at baseline and 12 weeks for each treatment group1 
 CON PRO EX+CON EX+PRO P value 
 Baseline 12 weeks Baseline 12 weeks Baseline 12 weeks Baseline 12 weeks Time Group 
x time 
Plasma glucose,2 mmol/L 5.6 ± 0.2 5.7 ± 0.3 6.0 ± 0.3 5.7 ± 0.1 5.9 ± 0.3 5.6 ± 0.3 5.7 ± 0.2 5.4 ± 0.1# 0.09 0.64 
Plasma insulin,2 mU/L  10.6 ± 1.9 10.6 ± 2.3 10.2 ± 1.6 8.4 ± 2.3 9.0 ± 1.6 7.4 ± 1.4 8.8 ± 1.8 6.7 ± 1.3 0.20 0.16 
HOMA-IR2 2.6 ± 0.5 2.6 ± 0.5 2.7 ± 0.5 2.2 ± 0.6 2.3 ± 0.4 1.8 ± 0.4 2.2 ± 0.4 1.6 ± 0.3# 0.92 0.25 
HOMA-beta2 111 ± 21 111 ± 25 87 ± 16 74 ± 18 81 ± 15 72 ± 15 83 ± 18 76 ± 21 0.27 0.61 
QUICKI2 0.34 ± 0.01 0.34 ± 0.01 0.34 ± 0.01 0.37 ± 0.02# 0.34 ± 0.01 0.36 ± 0.01 0.35 ± 0.01 0.37 ± 0.01# 0.24 0.23 
24-h average interstitial glucose,3 mmol/L  5.5 ± 0.4 5.2 ± 0.3 5.1 ± 0.2 5.1 ± 0.2 5.5 ± 0.2 5.7 ± 0.2 5.7 ± 0.2 5.8 ± 0.2 0.64 0.58 
24-h interstitial glucose variability,3 %  22.3 ± 2.3 28.3 ± 2.2 22.2 ± 2.4 24.5 ± 2.8 28.9 ± 2.6 28.8 ± 2.5 21.1 ± 2.4 22.8 ± 2.8 0.06 0.31 
Plasma leptin,2 ng/mL  5.5 ± 1.0 5.5 ± 1.0 5.0 ± 1.4 5.1 ± 1.3 4.2 ± 1.1 4.2 ± 1.2 5.4 ± 1.0 4.2 ± 0.6# 0.07 0.43 
Salivary cortisol 0650 h, nmol/L 8.2 ± 1.6 9.4 ± 1.3 9.3 ± 1.5 14.8 ± 2.7 11.1 ± 1.7 13.0 ± 3.2 9.3 ± 1.9 17.2 ± 4.0 < 0.001 0.21 
Salivary cortisol AUC, nmol/L x 790 min 4067 ± 551 4349 ± 528 4088 ± 196 45450 ± 425 5588 ± 969 5326 ± 778 4127 ± 587 4530 ± 414 0.001 0.99 
 
1Values are means ± SE. Baseline values were not significantly different between groups. 2CON, n = 7; PRO, n = 8; EX+CON, n = 7; EX+PRO, n = 9. 3CON, n 
= 7; PRO, n = 8; EX+CON, n = 7; EX+PRO, n = 8. HOMA-beta, homeostatic model assessment of beta-cell function; HOMA-IR, homeostatic model assessment 





This study is unique in examining both the individual and combined effects of RE and whey 
protein supplementation on 24-h EE, substrate oxidation and metabolic flexibility, body 
composition, appetite, and glucose homeostasis in healthy older men. The main findings were:  
 
i) Resistance exercise significantly increased FFM, RMR, SMR and metabolic 
flexibility compared to non-exercise. Resistance exercise also elicited within-group 
increases in subjective hunger and insulin sensitivity.  
ii) Whey protein supplementation improved body weight maintenance, reduced FM, 
and increased insulin sensitivity compared to an isocaloric carbohydrate control; 
however, increased overnight protein oxidation and awakening cortisol secretion, 
and reduced 24-h protein balance.  
iii) Whey protein supplementation resulted in a compensatory decrease in habitual EI 
via a reduction in fat intake but had no adverse effect on total protein or EI, or 24-
h subjective appetite.  
iv) Resistance exercise alone, but not combined with whey protein supplementation, 
reduced the energy cost of step exercise and spontaneous activity.  
v) Whey protein supplementation alone reduced the energy cost of spontaneous 
activity and fasted step exercise. 
vi) Resistance exercise combined with whey protein supplementation did not 
significantly augment changes in body composition, 24-h EE, substrate oxidation 
or metabolic flexibility, or glucose homeostasis compared to either RE or whey 
protein supplementation alone.  
 
4.5.1 Effects on energy expenditure and physical activity  
Twelve weeks of RE resulted in combined mean increases in RMR (36 ± 14 kcal/d), sedentary 
EE (60 ± 30 kcal/d) and SMR (45 ± 7 kcal/d). It is likely muscle hypertrophy largely explained 
these increases. The increase in SMR is in line with those reported in elderly women (Treuth 
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et al. 1995); however, the rise in RMR in the present study was considerably less than others 
that have reported increases of ~7-9% (Hunter, McCarthy, and Bamman 2004). For example, 
increases of 87 kcal/d (Hunter et al. 2000), 108 kcal/d (Campbell et al. 1994), 109 kcal/d 
(Treuth et al. 1995), and 119 kcal/d (Pratley et al. 1994) have been reported following RE 
training in older adults. With the exception of the study by Hunter et al. (2000), whereby 
participants gained 2 kg of FFM following the RE intervention, it is unlikely that RE-induced 
changes in FFM explain the discrepancies between studies. Fat-free mass increased by 1.0 
± 0.3 kg in the present study, similar or greater than that reported by the remaining of these 
studies (0.5-1.4 kg) (Campbell et al. 1994, Pratley et al. 1994, Treuth et al. 1995). Also, when 
normalised to FFM, RMR remained significantly elevated in two of these studies (Pratley et al. 
1994, Treuth et al. 1995), contradictory to the findings of this study. Inconsistencies between 
studies are therefore likely due to alternative factors, including differences in participant 
training status, sex, rates of resting post-intervention MPS and sympathetic nervous system 
activity, and differences in the time of post-intervention RMR measurement relative to 
termination of the final RE session (Geisler et al. 2016b, Geisler and Müller 2017, Schutz 
2011, Speakman and Selman 2003). Consequently, although RE significantly increased and 
may offset age-related declines in RMR, the results from this study suggest the clinical 
significance in active healthy men is relatively small. 
 
The present study examined whether twice daily ingestion of a leucine-rich whey protein 
supplement would augment RE-induced increases in components of EE in healthy older men. 
Despite rises in RMR, SMR and sedentary EE following RE, the addition of whey protein 
supplementation did not further increase these EE components. Protein supplementation 
alone also had no effect on these EE constituents. These findings are in agreement with 
studies that demonstrated no synergistic effects of combined RE and increased dietary protein 
intake on RMR (Amamou et al. 2017, Campbell et al. 1994, Maltais et al. 2016, Weinheimer 
et al. 2012), and no effect of a high protein diet on either RMR (Luger et al. 2013, Negro et al. 
2019) or SMR in older adults (Drummen et al. 2020). However, the findings of the present 
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study are in contrast with studies in younger adults that demonstrated protein-induced 
increases in SMR (Bray et al. 2015, Martens et al. 2015b), RMR (Bray et al. 2012) and TEE 
(Bray et al. 2012, 2015). Further, the findings of this study also contradict those of Drummen 
et al. (2020), who reported an increase in RMR following 34 months of a high compared to a 
moderate protein diet in older adults. This study did, however, only measure RMR post-
intervention; therefore, it is unknown whether there was a group-by-time interaction.  
 
The lack of individual and augmented increase in EE following increased dietary protein intake 
in the present study and those previously mentioned (Amamou et al. 2017, Campbell et al. 
1994, Maltais et al. 2016, Weinheimer et al. 2012) is likely due to a lack of protein-induced 
increase in FFM. These findings are consistent with others that demonstrated no individual 
(Björkman et al. 2020, Kim et al. 2012, Kirk et al. 2020, Verreijen et al. 2017, Zhu et al. 2015) 
or synergistic effects (Arnarson et al. 2013, Candow et al. 2006, Dulac et al. 2020, Holm et al. 
2008, Holwerda et al. 2018, Kirk et al. 2020, Kukuljan et al. 2009, Leenders et al. 2013, 
Thomson et al. 2016, Verdijk et al. 2009a) of increased dietary protein on FFM in healthy older 
adults habitually consuming sufficient amounts (~1.0-1.2 g/kg/d) of dietary protein according 
to consensus groups (Bauer et al. 2013, Deutz et al. 2014). In contrast, studies conducted in 
older adults habitually consuming insufficient (≤1.0 g/kg/d) amounts of dietary protein have 
observed both individual (Bauer et al. 2015, Bo et al. 2019, Kang et al. 2020, Park, Choi, and 
Hwang 2018, ten Haaf et al. 2019) and augmented effects (Kang et al. 2019, Rondanelli et al. 
2016, 2020, Tieland et al. 2012b, Yamada et al. 2019, Zdzieblik et al. 2015). These findings 
suggest synergistic effects on EE may have been observed in the present study if participants 
were consuming insufficient (<1.0 g/kg/d) amounts of dietary protein.  
 
However, this study hypothesised, based on prior work that demonstrated increased dietary 
protein alone, or combined with RE, may increase FFM in older adults habitually consuming 
~1.0-1.2 g/kg/d of dietary protein if the deviation in dietary protein from baseline is sufficient 
(≥0.4 g/kg/d), and total daily protein intake reaches ~1.6 g/kg/d (Bell et al. 2017, Daly et al. 
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2014, Junior et al. 2018, Norton et al. 2016), additive effects on EE may still be observed. As 
the present study failed to detect individual and synergistic effects following consumption of 
1.6 g/kg/d (0.6 g/kg/d deviation from baseline), the findings suggest habitual protein intake 
may be the most important factor in determining the effectiveness of increased dietary protein 
intake on FFM and subsequent effects on EE in healthy older men. 
 
In the present study, although RE increased several components of EE, TEE decreased by 
30 ± 15 kcal/d. Resistance exercise also decreased PAL, an observation frequently seen in 
older adults (Westerterp 2018c). Furthermore, SPA decreased in both RE groups in addition 
to the PRO group. In the PRO and EX+CON groups, the decrease in SPA was the result of a 
reduction in the energetic cost of spontaneous activity. This was accompanied by modest 
decreases in the energetic cost of step exercise, but only in the fasted state in the PRO group. 
The improvement in metabolic efficiency in the EX+CON group is consistent with others that 
have demonstrated improvements in metabolic efficiency of locomotion and functional tasks 
in older adults following RE (Hunter et al. 1995, Valenti, Bonomi, and Westerterp 2016, Wang 
et al. 2017a). The enhancement in the PRO group is consistent with high protein intervention 
studies in younger adults (Apolzan et al. 2014, Martens et al. 2015a). Together, these findings 
are of clinical importance as less energy required for activity may prolong independence and 
aid quality of life (QOL) (Hunter et al. 2018).  
 
Unlike previous studies as reviewed by Hunter and colleagues (2018), the increase in 
metabolic efficiency in the PRO and EX+CON groups did not increase non-exercise activity, 
neither inside the respiration chamber, nor in free-living during week 12 as measured by 
accelerometry. As prior work has shown increasing AEE is an effective strategy in the defense 
against adiposity (Kotz et al. 2017), these findings somewhat question the use of these 
interventions to increase habitual physical activity. Nonetheless, it is important to note that the 
lack of increase in non-exercise activity may be due to participants being confined to 
respiration chambers, and due to the fact accelerometry was measured during week 12 as a 
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control measure when participants were instructed not to change their habitual activity. Future 
work should therefore explore the effects of RE and increased dietary protein on post-
intervention non-exercise physical activity in free-living conditions in this population.  
 
Contrary to the PRO and EX+CON groups, the decrease in SPA observed in the EX+PRO 
group was due to a reduction in non-exercise activity within the respiratory chamber, which 
decreased by 3.7 ± 1.0%. This equated to a 53 min (1440 min x 0.037) reduction in non-
exercise activity. This finding is not unique, as several studies have observed reductions in 
non-exercise activity in older adults following exercise interventions (Hunter et al. 2018, 
Melanson 2017). It has been suggested that fatigue due to an increase in training frequency 
may explain these findings (Hunter et al. 2018); however, this theory is unlikely in the present 
study as chamber activity in the EX+CON group, of whom completed the identical exercise 
intervention and had similar baseline characteristics, did not change. An alternative 
explanation may be a compensatory reduction in activity to maintain energy balance and 
oppose the reduction in FM, which was observed predominantly in the EX+PRO group (Hall 
et al. 2012). In support, spontaneous activity is regulated by neuromodulating factors including 
orexin A, which drives activity, controls energy balance and regulates adipose tissue (Kotz et 
al. 2017, Perez-Leighton, Billington, and Kotz 2014, Teske, Billington, and Kotz 2010).  
 
Diet-induced thermogenesis of participants in this study was similar to that reported in 
previous studies in older adults (Du et al. 2014, Morgan and York 1983). Likewise, consistent 
with others (Sutton et al. 2016, Tataranni et al. 1995, Watanabe et al. 2006), DIT when fed 
the same diet whilst residing in the same controlled environment was highly variable (range 
15.6%). This variability may be explained in part by the methodology used to calculate DIT in 
respiration chamber studies (Kumahara, Tanaka, and Schutz 2011). Additionally, although the 
acute and longitudinal effects of dietary protein on DIT are well known in younger adults 
(Westerterp-Plantenga et al. 2009b), a recently published study reported no effect in older 
adults (Drummen et al. 2020). Previous data in young adults has also established no metabolic 
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adaptation in DIT following a high protein diet when protein intake was returned back to 
baseline (Sutton et al. 2016). The findings of this study coincide with both these studies. 
 
4.5.2 Effects on body mass and composition 
Whilst whey protein supplementation had no effect on components of EE, maintenance of 
body mass and BMI, and reductions in absolute and %FM were observed compared to an 
isocaloric carbohydrate control. These findings coincide with others that have shown high 
protein diets effectively maintain energy balance and body mass, and decrease FM (Clifton, 
Condo, and Keogh 2014, Drummen et al. 2018, Kim et al. 2016b, Martens et al. 2015b). 
Compensatory reductions in habitual fat and EI observed in the whey protein supplementation 
groups might partially explain these results. Furthermore, although no significant augmented 
reduction in FM was observed compared to RE or dietary protein alone, a favourable decrease 
was observed compared to RE alone (-0.9 vs. 0.4 kg), a finding also reported by others (Bell 
et al. 2017, Liao et al. 2017). Taken together, these findings suggest increased dietary protein 
intake may protect against energy imbalance, and age-related increases in adiposity and 
sarcopenic obesity. 
 
4.5.3 Effects on appetite  
Although whey protein supplementation resulted in a compensatory reduction in fat and EI of 
the habitual diet, which was observed particularly in the PRO group between weeks 6-12, no 
adverse reduction in overall protein or EI occurred when dietary supplements were included 
in the analysis. Additionally, no adverse effect on 24-h subjective appetite was observed whilst 
residing in the respiration chamber under highly controlled conditions. These findings are in 
agreement with previous acute (Giezenaar et al. 2017, 2020) and longitudinal studies in older 
adults (Ben-Harchache et al. 2020, Johnson et al. 2021, Ridge et al. 2018, Tieland et al. 
2012c). In contrast, studies in younger adults have established a greater acute (Lejeune et al. 
2006, Veldhorst et al. 2009, Veldhorst, Westerterp-Plantenga, and Westerterp 2009) and 
chronic satiating effect of increased dietary protein (Martens et al. 2015a). Although the 
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mechanisms are currently unclear (Giezenaar et al. 2020), data from this study supports a 
blunted protein-induced suppression of appetite in older adults. However, it must be noted 
that participants in the present study were not fed a high protein diet in the respiratory chamber 
during post-intervention testing, which may confound these findings. This methodology was 
chosen as the primary aim of this study was to determine the combined effects of RE and 
whey protein supplementation on SMM and subsequent effects on energy metabolism. 
Nevertheless, as reductions in appetite and dietary protein intake may contribute to 
sarcopenia (Atalayer and Astbury 2013, Paddon-Jones et al. 2015), the blunted protein-
induced suppression of appetite in older adults may be of clinical importance and supports the 
role of protein supplementation to increase total protein intake without adverse effects on total 
EI.  
 
To add to the above, the present study also observed an increase in 24-h subjective hunger 
following RE. Regrettably, few studies have investigated the longitudinal effects of RE on 
appetite, and the present study, to the authors knowledge, is the first to assess the effects in 
older adults. In partial agreement with the findings of this study, meta-analyses have reported 
RE-induced decreases in two tonic appetite suppressants, leptin (Fedewa et al. 2018) and 
insulin (Ashton et al. 2020). However, others have reported no changes in subjective appetite 
(Guelfi, Donges, and Duffield 2013), and decreases in orexigenic and increases in obesogenic   
hormones (Shakiba et al. 2019). Inconsistent findings may be related to participant 
characteristics (i.e., normal BMI vs. obesity, age), changes in body composition, and due to 
differences in the RE intervention. As previously highlighted, since reduced appetite with age 
contributes to sarcopenia, the findings of this study suggest RE might be a beneficial strategy 
to indirectly mitigate sarcopenia by increasing perceived hunger. Though, only subjective 
appetite was measured; therefore, the longitudinal effects of RE and increased dietary protein 




4.5.4 Effects on substrate oxidation  
The present study observed greater rates of fat oxidation during the fasted step exercise bout 
compared to step exercise performed postprandially at 1445 h and 1915 h at both baseline 
and 12 weeks. These findings are similar to that of Edinburgh et al. (2020), who observed 
higher rates of fat oxidation following an acute bout of fasted exercise compared to exercise 
performed following consumption of breakfast. Edinburgh et al. (2020) also observed a greater 
sustained increase in fat oxidation when exercise was performed in the fasted state for 6 
weeks alongside improvements in insulin sensitivity. Based on these data, research 
investigating the longitudinal effects of fasted exercise in the elderly, of whom are at greater 
risk of metabolic dysfunction (Hunter et al. 2019), is warranted to determine the safety and 
effectiveness on mitigating age-related metabolic disease.  
 
The increase in 24-h protein oxidation following 12 weeks whey protein supplementation 
concurs with studies in both young (Bray et al. 2015, Martens et al. 2015b, Robinson et al. 
1990, Pannemans et al. 1995) and older adults (Drummen et al. 2020, Pannemans, Halliday, 
and Westerterp 1995, Pannemans et al. 1998). In the present study, raised overnight as 
opposed to daytime protein oxidation stimulated the 24-h increase, consistent with prior work 
that demonstrated diurnal differences in nitrogen excretion cycling following adaptation to a 
high protein diet (Price et al. 1994). Moreover, the present study also established when dietary 
protein intake (~25% of EI at 6 and 12 weeks in the PRO and EX+PRO groups) was returned 
to that of the chamber diet (~20% of EI), 24-h protein balance significantly reduced. This 
outcome is in agreement with others that established a significantly lower net protein balance 
in elderly men following habituation to a high protein diet (Højfeldt et al. 2020), and a reduced 
nitrogen balance following termination of a high protein diet until nitrogen output met the new 
level of intake (Waterlow 1999). These findings indicate a potential drawback of habitually 
ingesting high amounts of dietary protein in the elderly. Further, as a higher protein turnover 
increases protein requirements to maintain nitrogen balance (Gaine et al. 2006), the findings 
of the present study highlight that elderly individuals consuming high amounts of dietary 
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protein (~1.6 g/kg/d) should refrain from drastically reducing protein intake to minimise 
transient periods of reduced protein balance.  
 
4.5.5 Effects on metabolic flexibility and insulin sensitivity 
Growing evidence demonstrates metabolic flexibility - the ability to adjust rates of substrate 
oxidation to changes in fuel availability (Kelley and Mandarino 2000) - is impaired in the elderly 
(Smith et al. 2018). Accumulating evidence also links impairments in metabolic flexibility to 
obesity, insulin resistance and T2DM (Goodpaster and Sparks 2017). In the present study,  
24-h metabolic flexibility increased greater following RE compared to non-exercise, a finding 
which might be clinically relevant to the metabolic heath of older adults. In agreement, others 
have also reported increases in metabolic flexibility following RE in the elderly (Consitt et al. 
2016, Meex et al. 2010). Although not assessed in this study, several plausible mechanisms, 
including increased skeletal muscle mitochondrial biogenesis, content and function, and 
improved glucose transport via increased activation of the insulin signalling cascade, may 
explain these findings (Consitt, Dudley, and Saxena 2019, Goodpaster and Sparks 2017). 
Furthermore, both RE alone, and combined with whey protein supplementation, also 
increased insulin sensitivity, consistent with prior work in older adults (Bell et al. 2017, Bucci 
et al. 2016, Flack et al. 2011, Holwerda et al. 2018, Iglay et al. 2007, Leenders et al. 2013, 
Miller et al. 1994). Also, in agreement with others (Andersen et al. 2003, Holten et al. 2004, 
Miller et al. 1994), changes in SMM following RE did not explain improvements in insulin 
sensitivity. Therefore, the insulin sensitising effects of RE in this study might be explained by 
improvements in skeletal muscle insulin signalling, specifically phosphorylation of AS160 and 
expression of GLUT-4 (Consitt, Dudley, and Saxena 2019).  
 
Consistent with recent work that reported no effects of high compared to low dairy 
consumption over 6 weeks in middle- and older-aged adults (Eelderink et al. 2019), whey 
protein supplementation per se did not notably increase 24-h metabolic flexibility. However, 
when protein supplement groups were pooled, a significant increase in insulin sensitivity was 
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observed, coherent with previous studies (Acheson et al. 2011, Luger et al. 2013, Pal, Ellis, 
and Dhaliwal 2010). The protein-induced increase in insulin sensitivity but not metabolic 
flexibility may be due to changes in insulin sensitivity appearing before changes in metabolic 
flexibility, an observation also seen in participants exposed to 8 weeks of overfeeding 
(Peterson et al. 2017).  
 
4.5.6 Effects on salivary cortisol 
The present study investigated the effects of RE and whey protein supplementation on diurnal 
salivary cortisol concentration based on prior work that reported a relationship between stress 
and increased prevalence of obesity (Hewagalamulage et al. 2016), and increased cortisol 
and appetite (Horner et al. 2020). Others have also demonstrated dysfunction of the HPA axis 
in the elderly, that is, an attenuated diurnal decline in cortisol resulting in a higher evening 
nadir (Piazza et al. 2010). Previous studies have indicated the macronutrient composition of 
a meal might influence the magnitude of cortisol response. Two studies demonstrated 
elevated cortisol concentration following a high carbohydrate compared to a high protein/fat 
meal (Vicennati et al. 2002, Martens et al. 2010). In contrast, others have reported a protein-
induced increase in cortisol concentration (Slag et al. 1981, Gibson et al. 1999). More recently, 
no differences were observed between a high protein and high carbohydrate diet (Lemmens 
et al. 2011). In the present study, awakening salivary cortisol concentration (0650 h) increased 
following 12 weeks ingestion of whey protein, but no differences occurred at any other time 
point. This increase may have occurred due to an increase in nocturnal ureagenesis and 
gluconeogenesis, confirming dietary protein might have gone beyond a critical threshold for 
the nitrogen demands of these participants (Schutz 2011).   
 
4.5.7 Strengths and limitations 
To date, only a few studies of ≥4 weeks in duration have assessed the effects of either a 
dietary or exercise intervention on components of EE and substrate oxidation using respiration 
chambers in older adults (Bush et al. 2018, Drummen et al. 2020, Morio et al. 1998, Treuth et 
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al. 1995). Also, no study, to the authors knowledge, has investigated the individual and 
combined effects of RE and whey protein supplementation on 24-h metabolic flexibility and 
appetite in older adults. The investigation of both the individual and combined effects of a 
dietary and exercise intervention using a 4-arm experimental design over 12-weeks on these 
outcomes are key strengths and novel aspects of this study. Furthermore, unlike previous 
studies that have investigated the combined effects of these interventions (Amamou et al. 
2017, Campbell et al. 1994, Maltais et al. 2016, Weinheimer et al. 2012), multiple components 
of EE and substrate oxidation were measured over a 24-h period using gold standard 
methodology under highly controlled conditions. A limitation of this study is the relatively small 
number of participants; however, such a limitation is inherent in work of this nature. The 
sample size is also congruent with previous respiration chamber studies (Apolzan et al. 2014, 
Bray et al. 2015, Melanson et al. 2007, Westerterp-Plantenga et al. 2009a). Nevertheless, it 
is recognised that the sample achieved was underpowered to detect between-group 
differences on several outcome variables. Effect sizes (Cohen’s f2) obtained from changes in 
RMR (f2 = 0.50) and SMR (f2 = 0.47) between groups indicated a sample size of 48-56 
participants (12-14/group) would have been required to detect between-group differences in 
these variables. A second limitation is the inclusion of only men who were healthy and had a 
normal-to-overweight BMI. Women were excluded based on sex differences in the age-related 
decline in RMR (Geisler et al. 2016b). Individuals with obesity were excluded due to 
differences in metabolic profile (Perna et al. 2017), and due to the preventative nature of this 
study. Investigation of these groups, in addition to older adults with insufficient habitual protein 
intakes (<1 g/kg/d), should form future work.  
 
4.5.8 Conclusion 
Twelve weeks of RE significantly increased FFM and elicited modest, but significant increases 
in RMR, SMR, sedentary EE and 24-h metabolic flexibility in healthy older men compared to 
non-exercise. In addition, RE also resulted in within-group increases in the metabolic 
efficiency of step exercise and spontaneous activity, subjective hunger, and insulin sensitivity. 
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Based on these findings, RE should be promoted in older adults to aid metabolic health. Whey 
protein supplementation aided body weight maintenance, reduced FM, and improved insulin 
sensitivity, supporting the role of increased dietary protein intake to mitigate sarcopenic 
obesity. However, the results from this study suggest a potential caveat of older individuals 
habitually consuming a high protein diet is an increase in protein turnover in the overnight 
fasting period, which may have deleterious effects on protein balance. Resistance exercise 
combined with whey protein supplementation elicited no significant additive effects on any 
markers compared to either RE or dietary protein alone; though, a favourable decrease in FM 
was observed compared to RE alone.
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Thesis map: Study 2 
Study Aims Key findings 
Study 1: Effects of resistance 
exercise and whey protein 
supplementation on 24-h 
energy expenditure, substrate 
oxidation and metabolic 
flexibility, body composition, 
appetite, and glucose 
homeostasis in healthy older 
men 
• To investigate the individual and combined effects of 
RE and whey protein supplementation on components 
of 24-h EE, substrate oxidation and metabolic 
flexibility, body composition, appetite, and glucose 
homeostasis in healthy older men.  
• Resistance exercise significantly increased FFM, RMR, 
SMR, sedentary EE and 24-h metabolic flexibility compared 
to non-exercise. RE also resulted in within-group increases 
in subjective hunger and insulin sensitivity, and within-
group decreases in the energy cost of step exercise and 
spontaneous activity.  
• Whey protein supplementation improved body weight 
maintenance and reduced FM, and increased insulin 
sensitivity; however, resulted in an increase in overnight 
protein oxidation and awakening cortisol secretion, and 
reduced 24-h protein balance.  
• Whey protein supplementation had no adverse effects on 
total protein or EI, or 24-h subjective appetite. 
• Resistance exercise combined with whey protein 
supplementation did not significantly augment changes in 
body composition, 24-h EE, substrate oxidation or 
metabolic flexibility, or markers of glucose homeostasis 
compared to either RE or whey protein supplementation 
alone.  
Study 2: Effects of resistance 
exercise and whey protein 
supplementation on skeletal 
muscle mass, strength, 
physical function, and 
hormonal and inflammatory 
biomarkers in healthy older 
men 
• To investigate the individual and combined effects of 
RE and whey protein supplementation on SMM, 
strength, physical function, and hormonal and 
inflammatory biomarkers in healthy older men.  
• To determine whether changes in hormonal and 
inflammatory markers correlate with changes in SMM, 





Thesis map: Study 2 continued  
Study Aims Key findings 
Study 3: Effects of resistance 
exercise and whey protein 
supplementation on cognitive 
function in healthy older men 
• To investigate the individual and combined effects of 
RE and whey protein supplementation on cognitive 
function and neurobiological, inflammatory and insulin 
sensitivity markers, diurnal salivary cortisol, and BP in 
healthy older men. 
• To determine whether changes in neurobiological, 
inflammatory and insulin sensitivity markers, and 
changes diurnal salivary cortisol, BP, SMM, strength 






CHAPTER 5 (Study 2): Effects of resistance exercise 
and whey protein supplementation on skeletal 
muscle mass, strength, physical function, and 
hormonal and inflammatory biomarkers in healthy 























5.1 Chapter Overview 
Ageing is associated with declines in SMM, strength and physical function (sarcopenia). 
Previous studies have shown RE and increased dietary protein intake alone may mitigate age-
related sarcopenia. Meta-analyses also suggest increased dietary protein intake may augment 
the RE-induced response of skeletal muscle; however, most individual studies in older adults 
have failed to observe such effects. Null findings may be explained by an inadequate deviation 
of dietary protein from baseline (<0.4 g/kg/d) and an insufficient daily protein intake (<1.6 
g/kg/d) to augment the effects of RE. Furthermore, the biochemical mechanisms of how these 
interventions may synergistically mitigate sarcopenia are relatively unknown. In this chapter, 
the individual and combined effects of RE and whey protein supplementation (aimed to 
increase daily protein intake to 1.6 g/kg/d) on SMM, strength, physical function and multiple 
biochemical pathways related to sarcopenia were investigated in healthy older men.   
 
5.2 Introduction 
Age-related declines in SMM and strength, termed sarcopenia (Cruz-Jentoft et al. 2019), 
progress at rates of ~0.5-1% and ~1-3% per annum, respectively, manifesting around the fifth 
decade of life (Clark and Manini 2008, Janssen 2010). Sarcopenia is associated with various 
negative health outcomes, including an increased risk of falls and fractures, impairments in 
the ability to perform ADL (Beaudart et al. 2017), a greater risk of cardiovascular (Bahat and 
Ilhan 2016) and metabolic disease (Hunter et al. 2019), and an elevated mortality risk (de 
Buyser et al. 2016). In economic terms, in the United Kingdom alone, the annual cost 
associated with muscle weakness is estimated at £2.5 billion (Pinedo-Villanueva et al. 2019). 
Hence, interventions that attenuate sarcopenia are imperative.  
 
Resistance exercise is a potent stimulus to curb sarcopenia (Phillips and Martinson 2019). 
Meta-analyses have reported increases in FFM (Peterson, Sen, and Gordon 2011), muscular 
strength (Peterson et al. 2010) and physical function (Yoshimura et al. 2017) following RE 
training in older adults. Regarding the optimal RE intensity, meta-analyses suggest for 
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optimisation of muscle strength, which is considered the primary index of sarcopenia by the 
EWGSOP2 (Cruz-Jentoft et al. 2019), RE performed at high intensity (~70-80% 1RM) elicits 
the largest effects (Borde, Hortobágyi, and Granacher 2015, Steib, Schoene, and Pfeifer 
2010). Concerning RE frequency, comparable increases in parameters of sarcopenia have 
been observed between 2-3 sessions per week (da Silva et al. 2017, Grgic, Schoenfeld, and 
Latella 2019, Kneffel et al. 2020, Stec et al. 2017). As previous work has reported older adults 
prefer training twice compared to three times per week (Foley, Hillier, and Barnard 2011), RE 
performed twice weekly may be most beneficial to aid long-term adherence and mitigation of 
sarcopenia in this population.  
 
In addition to RE, increased dietary protein intake is also recommended to curb sarcopenia 
(Phillips and Martinson 2019). Observational data over a 3-year period has shown higher 
intakes of dietary protein is associated with a greater retention of FFM (Houston et al. 2008). 
Others have also presented data indicating higher quantities of dietary protein (>1 g/kg/d) may 
preserve muscle strength (McLean et al. 2016) and physical function (Mustafa et al. 2018). 
Furthermore, meta-analyses suggest increased dietary protein intake may augment the 
adaptive response of skeletal muscle to RE (Cermak et al. 2012, Finger et al. 2015, Liao et 
al. 2017, Morton et al. 2018a). However, whilst several individual studies in older adults have 
demonstrated greater increases in skeletal muscle and/or FFM, muscle strength, and physical 
function following combined RE and increased dietary protein intake compared to RE alone 
(Bell et al. 2017, Daly et al. 2014, Kang et al. 2019, Junior et al. 2018, Rondanelli et al. 2016, 
2020, Tieland et al. 2012b, Verreijen et al. 2015, Yamada et al. 2019, Zdzieblik et al. 2015), 
the majority of studies have not observed additive effects (Arnarson et al. 2013, Candow et 
al. 2006, Chalé et al. 2013, de Carvalho Bastone et al. 2020, Dulac et al. 2020, Englund et al. 
2018, Fielding et al. 2017, Gryson et al. 2014, Hofmann et al. 2016, Holm et al. 2008, Holwerda 
et al. 2018, Kim et al. 2012, Kirk et al. 2019, 2020, Kukuljan et al. 2009, Leenders et al. 2013, 
Maltais, Ladouceur, and Dionne 2016, Oesen et al. 2015, Ottestad et al. 2017, Shahar et al. 
2013, Thomson et al. 2016, Verdijk et al. 2009a, Verreijen et al. 2017).  
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Inconsistent findings may be explained by the population studied, habitual protein intake of 
participants, and characteristics of the protein intervention. Of note, studies in healthy older 
adults that have observed synergistic effects deviated dietary protein intake by 0.5-0.6 g/kg/d 
(Bell et al. 2017, Junior et al. 2018), which exceeds the proposed deviation required to elicit 
gains in SMM (≥0.4 g/kg/d) (Moore et al. 2015, Park, Choi, and Hwang 2018). In contrast, 
several studies that have failed to observe additive effects deviated dietary protein intake by 
≤0.3 g/kg/d (Arnarson et al. 2013, Dulac et al. 2020, Gryson et al. 2014, Hofmann et al. 2016, 
Holwerda et al. 2018, Kirk et al. 2019, 2020, Kukuljan et al. 2009, Leenders et al. 2013, 
Maltais, Ladouceur, and Dionne 2016, Verdijk et al. 2009a). Additionally, a meta-regression 
conducted by Morton et al. (2018a) also suggests ~1.6 g protein/kg/d might be required to 
maximally augment RE-induced gains in FFM. This level of dietary protein was only achieved 
by one of the aforementioned studies (Bell et al. 2017). Taken together, current evidence 
suggests a dietary modification of ≥0.4 g protein/kg/d and a total protein intake of 1.6 g/kg/d 
may be required to amplify RE-induced effects on SMM, strength and physical function in 
healthy older adults.  
 
A limitation of many of the aforementioned studies investigating the synergistic effects of RE 
and increased dietary protein intake in older adults was the failure to include a protein only 
group. In fact, only 7/33 studies cited examined the combined effects compared to both RE 
and dietary protein alone (de Carvalho Bastone et al. 2020, Gryson et al. 2014, Kim et al. 
2012, Kirk et al. 2020, Kukuljan et al. 2009, Shahar et al. 2013, Verreijen et al. 2017). In these 
studies, dietary protein intake was increased by ≤0.3 g/kg/d and total protein intake was <1.6 
g/kg/d. Consequently, the synergistic effects utilising the proposed optimal protein dose of 1.6 
g/kg/d compared to both interventions alone is currently unknown. As not all older adults are 
able or willing to perform RE (Dismore et al. 2020), collection of such data is vital to determine 
the effectiveness of this nutrient compared to both RE alone and combined with increased 
dietary protein. 
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Furthermore, several biochemical pathways are involved in the pathogenesis of sarcopenia, 
including chronic systemic inflammation (e.g., increases in IL-6, CRP and TNF-α) and changes 
in the hormonal milieu (e.g., reduced IGF-1, flattened diurnal cortisol secretion, and increased 
myostatin) (Beyer, Mets, and Bautmans 2012, McKee and Morley 2019, White and Lebrasseur 
2014). However, there is currently limited evidence on the synergistic effects of RE and 
increased dietary protein intake on these biomarkers, and no study has examined all of these 
biomarkers following these interventions alone and combined.  
 
5.2.1 Aims and hypotheses  
 
Primary aim 
• To investigate the individual and combined effects of RE and whey protein 
supplementation (aimed to increase dietary protein intake by ≥0.4 g/kg/d to ~1.6 g/kg/d) 
on SMM, strength and physical function in healthy older men.  
Secondary aims 
• To investigate the effects of these interventions on multiple hormonal and inflammatory 
biomarkers associated with sarcopenia, and to determine whether individual participant 
changes in these markers correlate with changes in SMM, strength and physical function.  
Hypotheses  
• Combined RE and whey protein supplementation will augment the effects on SMM, 
strength and physical function compared each intervention alone. 
• Resistance exercise and whey protein supplementation will synergistically increase IGF-
1, will augment decreases in myostatin and markers of systemic inflammation, and will 
amplify the salivary cortisol slope (i.e., increased awakening and decreased evening 
cortisol secretion).   
• Changes in SMM, strength and physical function will correlate with changes in hormonal 




5.3.1 Participants and experimental design  
Thirty-six healthy, community-dwelling older men (mean ± SE age: 66.9 ± 0.7 y) participated 
in this 4-arm, double-blind RCT. All measurements were assessed at baseline and following 
the 12-week intervention. As previously highlighted in section 3.2, participants were 
randomised to either control (CON, n = 9), whey protein (PRO, n = 9), RE + control (EX+CON, 
n = 9), or RE + whey protein (EX+PRO, n = 9). Full details of the experimental design (section 
3.2) and eligibility criteria (sections 3.4.2.1 and 3.4.2.2) have been previously described. To 
minimise diurnal variation, body composition, muscular strength and physical function 
measures were performed at the same time of day (± 1 h) at baseline and following the 12-
week intervention. Although not planned in the original study design, exploratory analyses 
were also conducted between pooled exercise (EX+CON and EX+PRO groups, n = 18) and 
non-exercise groups (CON and PRO groups, n = 18), and between pooled whey protein (PRO 
and EX+PRO groups, n = 18) and control groups (CON and EX+CON group, n = 18). All 
participants provided written informed consent in accordance with the Declaration of Helsinki. 
The protocol was approved by Coventry University Ethics Committee (project code: P59723). 
The flow of participants throughout the study has been previously presented and can be seen 
in Chapter 3 (Figure 3.1).  
 
5.3.2 Exercise training and nutritional supplements  
Participants in the EX+CON and EX+PRO groups participated in supervised whole-body RE 
twice weekly, which consisted of 3 sets of 8 repetitions on six exercise machines (leg press, 
lateral row, hamstring curl, chest press, leg extension and shoulder press) performed at 80% 
1RM (see section 3.5.2 for a detailed description of the RE intervention). Participants in the 
PRO and EX+PRO groups consumed 25 g whey protein supplementation containing ~3 g 
leucine, whereas participants in the CON and EX+CON groups consumed an energy-matched 
carbohydrate control supplement (maltodextrin). Supplements were consumed twice daily (at 
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breakfast and lunch). A full description of the nutritional interventions can be seen in section 
3.5.1. 
 
5.3.3 Dietary intake  
Participants completed 3-day food records (2 weekdays and 1 weekend day) at baseline (prior 
to commencing the intervention) and during weeks 6 and 12. Dietary records were analysed 
using Nutritics dietary analysis software (see section 3.6.2 for a detailed description). 
 
5.3.4 Habitual physical activity  
To control for changes in habitual physical activity levels that may have influenced outcome 
measures, participants wore a tri-axial accelerometer on the dominant wrist for 7 days at 
baseline and during the final week of the intervention (see section 3.6.3 for a detailed 
description). Time spent sedentary, and in light and MVPA was determined during waking 
hours (Freedson, Melanson, and Sirard 1998).  
 
5.3.5 Body composition  
Body composition (SMM, FFM and FM) was measured in the morning by BIA. Participants 
were asked to void their bladder prior to measurement. Full details have been previously 
described (see section 3.6.1). Skeletal muscle index (SMI, kg/m2) and fat mass index (FMI, 
kg/m2) were calculated by dividing SMM and FM by height squared, respectively. Waist 
circumference, which is a predictive measure of visceral adipose tissue (Janssen et al. 2002), 
was measured at the midpoint between the lowest rib margin and the iliac crest. Hip 
circumference was measured at the widest portion of the hips. Both outcomes were measured 
to the nearest 0.1 cm using a measuring tape (Seca 201; Seca GmbH, Hamburg, Germany).  
 
5.3.6 Muscle strength  
Maximal strength was assessed by 1RM tests on the leg press and leg extension machines 
(Life Fitness, Rosemont, Illinois, USA) using the guidelines of Kraemer et al. (2006). Proper 
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lifting technique was demonstrated and practiced by participants prior to baseline 1RM testing 
to minimise a potential learning effect (Levinger et al. 2009, Phillips et al. 2004). For 1RM 
testing, participants first completed 5-10 repetitions at 40-60% perceived 1RM followed by 3-
5 repetitions at 60-80% perceived 1RM. The load was then gradually increased, and 
participants performed one repetition at each increased load until they were unable to achieve 
a complete repetition. One repetition maximum was determined as the last successful lift prior 
to failure. Three min rest was allocated between each maximal lift. Test-retest reliability of  leg 
press 1RM has been previously confirmed in healthy older men [ICC = 0.95, 95% confidence 
interval (CI) (0.88–0.98)] (LeBrasseur et al. 2008). Strong correlations have also been 
reported in elderly individuals between leg press (r = 0.60, 95% CI 0.24-0.82) and leg 
extension 1RM (r = 0.75, 95% CI 0.49-0.89) and isokinetic peak torque (Verdijk et al. 2009b). 
Leg press and extension exercises were chosen for 1RM tests as lower extremity strength is 
strongly associated with functional limitations and disability (Puthoff and Nielsen 2007), and 
many combined RE and protein supplementation RCTs in older adults have assessed these 
outcomes (Bell et al. 2017, Holwerda et al. 2018, Leenders et al. 2013, Verdijk et al. 2009a); 
therefore, enabling comparison with previous work. 
 
Handgrip strength was measured using a JAMAR hydraulic handgrip dynamometer (Jamar 
5030J1; Sammons Preston, Bolingbrook, Illinois, USA) using standardised procedures 
(Roberts et al. 2011). Previous studies have shown handgrip dynamometry is a valid and 
reliable instrument for measurement of muscle strength in older adults (Mijnarends et al. 2013, 
Wang, Olson, and Protas 2002). A strong correlation with measurement of muscle strength by 
isokinetic dynamometry has also been reported  (Reed et al. 1993). Handgrip strength was 
assessed as previous studies have shown low grip strength is a powerful predictor of 
increased functional limitations, poor quality of life and mortality (Ibrahim et al. 2016, Leong et 
al. 2015).  
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5.3.7 Physical function  
Physical function was assessed by the SPPB and the 6MWT. The SPPB was conducted using 
standard procedures, which consisted of three timed tests: 4 m gait speed, time to perform 
five chair raises, and standing balance (feet together, semi-tandem and tandem) (Guralnik et 
al. 2000). Each test was scored equally between 0 and 4. The total score between 0 and 12 
was used for analysis. A recent meta-analysis showed poor performance (<10 points) on the 
SPPB is predictive of all-cause mortality (Pessini, Barbosa, and Trindade 2016). Reliability 
and validity has also been confirmed by numerous studies highlighted in a systematic review 
(Mijnarends et al. 2013). The 6MWT was performed adhering to guidelines set by the 
American Thoracic Society (Crapo et al. 2002). A 30 m indoor track was marked out with 
cones at either end. Participants were informed the aim of the test was to cover as much 
distance as possible in six min. Shorter distance on the 6MWT has been associated with an 
impaired ability to perform ADL, systemic inflammation and increased risk of CVD, and T2DM 
(Enright et al. 2003). A strong test-retest reliability (ICC = 0.88) for the 6MWT has been 
previously reported in elderly men (Rikli and Jones 1998).  
 
5.3.8 Blood and saliva collection and analysis  
Venous blood was collected following a >10 h overnight fast. Whole blood was collected into 
EDTA, heparin and SST vacutainers, then centrifuged at 1900 x g for 10 min at 4°C. Serum 
samples were rested for 30 min prior to centrifuging to allow for sufficient clotting. Aliquots 
containing plasma and serum were stored at -80°C until analysis (see section 3.6.4 for 
detailed blood collection methodology). Due to difficulty in blood collection, blood was unable 
to be drawn from two participants (n = 1 participant in both the CON and EX+CON groups). 
Therefore, 34 participants had full blood data. Commercially available ELISA’s were used to 
analyse plasma IL-6 [Item No. D6050 and HS600C (the latter for high sensitivity IL-6)], high 
sensitivity TNF-a (Item No. HSTA00E) and CRP (Item No. DCRP00), and serum IGF-1 (Item 
No. DB100B) and myostatin (Item No. DGDF80) (R&D Systems Inc., Abbington, UK). 
Estimated glomerular filtration rate was also analysed by the pathology department at UHCW. 
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Blood samples were collected >72 h following the final RE session to allow for biomarkers to 
return to basal concentrations (Schoenfeld 2012).  
 
Saliva samples were collected whilst participants (n = 33) resided in respiration chambers for 
24 h under highly controlled conditions, as previously described (see Chapter 4). Samples 
were collected immediately upon awakening at 0650 h, and at 0805, 1225, 1700 and 2000 h 
using a synthetic swab. Samples were centrifuged at 1900 x g for 2 min and stored at -80°C 
until analysis. Saliva samples were analysed for cortisol by ELISA (Item No. 1-3002; 
Salimetrics, Pennsylvania, USA). Salivary cortisol data (samples 1-5; 0650-200 h) was used 
to calculate two indices. Firstly, all five samples were used to calculate salivary cortisol AUC 
(nmol/L x 790 min) using the trapezoidal method. Secondly, cortisol slope (peak-to-evening) 
was calculated as the rate of salivary cortisol change from peak morning (0650 or 0805 h, 
depending on the highest concentration) to evening (2000 h) (Adam et al. 2017). The intra-
assay CV was 9.8%, 11.8%, 9.9%, 9.9%, 9.1%, 7.7% and 9% for plasma IL-6, high sensitivity 
IL-6, high sensitivity TNF-a and CRP, serum IGF-1 and myostatin, and salivary cortisol, 
respectively.  
 
5.3.9 Statistical analysis  






5.4.1 Participants and safety 
Thirty-nine older men were randomised: 36 completed the study and 3 withdrew. Reasons for 
withdrawal have been previously detailed and can be seen in Chapter 3 (Figure 3.1). Baseline 
characteristics of the 36 participants who completed the study are shown in Table 5.1. No 
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significant differences were observed for any outcome variable at baseline (P > 0.05). 
Resistance exercise participation was well tolerated with only one participant missing a single 
session due to muscle soreness. No other adverse events were reported following RE. 
Following whey protein supplementation, renal function was not adversely affected, confirmed 
by an eGFR of >60 mL/min/1.73m2 in all participants following the intervention. Two 
participants in the PRO group did, however, experience episodes of gout. 
  
5.4.2 Exercise and supplement adherence  
Participants in the EX+CON and EX+PRO groups attended 98.2 ± 1.0% and 98.2 ± 1.2% of 
their prescribed RE sessions, respectively. All participants completed their prescribed 
repetitions for sets 1 and 2 of each exercise. During the final set (to volitional failure), the mean 
number of completed repetitions was 9.1 ± 0.3 in the EX+CON group and 9.1 ± 0.2 in the 
EX+PRO group. No differences occurred between groups for either RE compliance (P = 0.63) 
or the mean number of repetitions completed during the final set (P = 0.97). Compliance with 
the dietary supplements was 94.1 ± 1.2%, 96.8 ± 1.0%, 96.1 ± 1.3% and 96.1 ± 1.3% in the 
CON, PRO, EX+CON and EX+PRO groups, respectively, with no differences between groups 
(P = 0.50). Eighty percent of participants were unable to judge treatment allocation based on 
the supplement exit questionnaire (see section 3.5.1). 
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Table 5.1 Baseline characteristics of participants1  
 CON PRO EX+CON EX+PRO P value3 Overall 
n 9 9 9 9 - 36 
Age, y 67.2 ± 1.7 65.6 ± 1.7  67.1 ± 1.3 67.8 ± 1.3 0.75 66.9 ± 0.7 
Height, m 1.77 ± 0.01 1.76 ± 0.03 1.77 ± 0.02 1.74 ± 0.03 0.71 1.76 ± 0.01 
Body mass, kg 79.0 ± 3.4  78.0 ± 3.1  78.2 ± 3.9  80.9 ± 4.0 0.94 79.0 ± 1.8 
BMI, kg/m2 25.1 ± 1.0 25.0 ± 0.6  25.1 ± 0.9 26.6 ± 0.8  0.50 25.5 ± 0.4 
FFM, kg 59.8 ± 1.5 60.0 ± 1.7 58.5 ± 2.6  60.5 ± 2.9 0.94 59.7 ± 1.1 
SMM, kg 26.7 ± 0.6  27.2 ± 0.7 25.9 ± 1.1 26.9 ± 1.3 0.79 26.7 ± 0.5 
SMI, kg/m2 8.5 ± 0.2 8.8 ± 0.2 8.3 ± 0.2 8.9 ± 0.3 0.19 8.6 ± 0.1  
FM, kg 19.2 ± 2.4 18.0 ± 1.7 19.6 ± 2.0 20.4 ± 1.5 0.85 19.3 ± 0.3 
FM, % 23.8 ± 2.0 22.7 ± 1.5  24.8 ± 1.7  25.1 ± 1.2  0.74 24.1 ± 0.8 
Handgrip strength, kg 41.8 ± 1.8 36.5 ± 2.5 39.9 ± 4.1 41.8 ± 2.1 0.37 40.1 ± 1.3 
Leg extension 1RM, kg 63 ± 6  58 ± 3 52 ± 5 59 ± 4 0.52 58 ± 2 
Leg press 1RM, kg 116 ± 9 107 ± 7  107 ± 9 118 ± 7 0.66 112 ± 4 
SPPB, points 11.7 ± 0.2 11.4 ± 0.2 11.2 ± 0.3 11.8 ± 0.1 0.38 11.5 ± 0.1 
Fasting plasma glucose, mmol/L 5.7 ± 0.2  5.9 ± 0.3 5.8 ± 0.3 5.7 ± 0.2 0.80  5.7 ± 0.1 
HOMA-IR4 2.6 ± 0.4 2.7 ± 0.4 2.9 ± 0.7 2.2 ± 0.4 0.85 2.6 ± 0.2 
Systolic BP, mmHg 127 ± 6 133 ± 6  133 ± 7 136 ± 4 0.57 132 ± 3 
Diastolic BP, mmHg 78 ± 2 76 ± 3 77 ± 4 77 ± 4 0.98 77 ± 1 
Step count, steps/d 10,766 ± 594 12,670 ± 1263 12,061 ± 1023 11,346 ± 907 0.55 11,710 ± 483 
MVPA, min/d 110 ± 8  127 ± 15 137 ± 18 135 ± 10 0.50 127 ± 7 
 
1Values are means ± SE. 3P value refers to differences between groups analysed by one-way ANOVA. No significant differences in baseline characteristics 
occurred between pooled exercise and non-exercise groups, or between pooled whey protein and control groups (data not shown). 4CON and EX+CON groups, 
n = 8. 1RM, one repetition maximum; BMI, body mass index; BP, blood pressure; FFM, fat-free mass; FM, fat mass; FMI, fat mass index; MVPA, moderate-
vigorous physical activity; SMI, skeletal muscle index; SMM, skeletal muscle mass; SPPB, short physical performance battery. 
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5.4.3 Dietary intake  
Significant group-by-time interactions were observed for dietary protein (expressed as g/d, 
g/kg/d, and % energy; P < 0.001) and carbohydrate intake (expressed as g/d and % energy; 
P < 0.05, Table 5.2). Protein intake increased over time in the PRO and EX+PRO groups 
greater than both the CON and EX+CON groups at weeks 6 (P < 0.001) and 12 (P < 0.001). 
Carbohydrate intake increased over time in the EX+CON group greater than the CON and 
EX+PRO groups at week 6 (P < 0.05), and greater than the PRO and EX+PRO groups at 
week 12 (P < 0.05). Total EI increased over time in the EX+PRO group at week 6 (P = 0.03) 




Table 5.2 Dietary intake during the intervention period (including supplements)1 
 
1Values are means ± SE. Baseline values for individual groups are not shown but no significant differences occurred between groups for any dietary marker. 
2P value refers to respective group-by-time interaction.3Significant main effect of time, P < 0.05. *Significantly (P < 0.05) greater than CON group at respective 
time point. ‡Significantly greater than PRO group at respective time point. ¥Significantly greater than EX+CON group at respective time point. $Significantly 
greater than EX+PRO group at respective time point. #P < 0.05 from baseline value.  
 
 Pooled CON PRO EX+CON EX+PRO  
 Baseline 6 weeks 12 weeks 6 weeks 12 weeks 6 weeks 12 weeks 6 weeks 12 weeks P value2 
Energy,3 kcal/d  1964 ± 59 1944 ± 111# 2013 ± 107# 2055 ± 130 1937 ± 140 2177 ± 83 2176 ± 118 2238 ± 97# 2159 ± 141 0.30 
Protein          
 g/d3 81 ± 2 77 ± 5  74 ± 4 129 ± 4*¥# 125 ± 5*¥# 86 ± 4 82 ± 5 131 ± 6*¥# 125 ± 3*¥# < 0.001 
 g/kg/d3 1.0 ± 0.02 1.0 ± 0.05 0.9 ± 0.03 1.6 ± 0.1*¥# 1.6 ± 0.1*¥# 1.1 ± 0.1 1.0 ± 0.1 1.6 ± 0.1*¥# 1.6 ± 0.1*¥# < 0.001 
 % 17 ± 0.4 16 ± 1 15 ± 1 26 ± 1*¥# 26 ± 1*¥# 16 ± 1 15 ± 1 24 ± 1*¥# 24 ± 1*¥# < 0.001 
Carbohydrate           
 g/d3 232 ± 8 207 ± 23 250 ± 15 200 ± 21 209 ± 16 279 ± 16*$# 280 ± 11‡$# 221 ± 11 238 ± 16 0.007 
 %3  48 ± 1 42 ± 4 50 ± 2 39 ± 4 43 ± 2 51 ± 2‡$ 52 ± 2‡$# 40 ± 2 44 ± 2 0.03 
Fat           
 g/d3 68 ± 3 68 ± 5 71 ± 6 71 ± 10 55 ± 8 70 ± 5 68 ± 8 78 ± 5 62 ± 8 0.06 
 %3 31 ± 1 31 ± 2 31 ± 1$ 31 ± 3 25 ± 2 29 ± 1 28 ± 2 31 ± 1  25 ± 2 0.08 
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5.4.4 Habitual physical activity  
At baseline, markers of habitual physical activity were similar between groups (Table 5.1). 
Following the intervention, no significant differences in daily step count (P = 0.61), or time 
spent sedentary (P = 0.45), or in light (P = 0.67) or in MVPA (P = 0.80) occurred between 
groups over time. No significant within-group differences occurred for any marker of habitual 
physical activity.  
 
5.4.5 Body composition  
No significant within- or between-group differences occurred over time for FFM; however, 
when RE groups were pooled, FFM increased over time greater than non-exercise groups 
pooled (0.9 ± 0.3 vs. 0.0 ± 0.2 kg, P = 0.045, Figure 5.1). Skeletal muscle mass increased by 
0.5 ± 0.2 kg and 0.6 ± 0.3 kg in the EX+CON and EX+PRO groups, respectively, both of which 
trended towards statistical significance (P = 0.06, Table 5.3). No differences occurred between 
groups (P = 0.35). Fat mass and BMI significantly increased over time in the CON group (P < 
0.05), and FM decreased, but not significantly, by -0.9 ± 0.5 kg (P = 0.09) in the EX+PRO 
group. Also, in only the EX+PRO group, waist circumference significantly decreased over time 
(P = 0.01). No significant differences in FM, FMI, BMI or waist circumference occurred 
between groups; although, %FM decreased greater in the EX+PRO group compared to the 






























Figure 5.1 Change in fat-free mass between pooled exercise (n = 18) and non-exercise 
groups (n = 18) (means ± SE). Circles represent individual participant changes. Data were 
analysed by mixed-model ANOVA with baseline values and supplement consumed (whey 

























Table 5.3 Body composition, muscle strength and physical function measures for each treatment group at baseline and 12 weeks1  
 
1Values are means ± SE. 1RM, one repetition maximum; 6MWT, 6-minute walk test; BMI, body mass index; FFM, fat-free mass; FM, fat mass; FMI, fat mass 
index; SMI, skeletal muscle index; SMM, skeletal muscle mass; SPPB, short physical performance battery. *Significantly (P < 0.05) greater than CON group. 
‡Significantly greater than PRO group. $Significantly greater than EX+PRO group. #P < 0.05 from baseline.
 CON PRO EX+CON EX+PRO P value 
 Baseline 12 weeks Baseline 12 weeks Baseline 12 weeks Baseline 12 weeks Time Group x 
time 
Body composition           
Body mass, kg 79.0 ± 3.4 79.8 ± 3.3# 78.0 ± 3.1 78.3 ± 3.3 78.2 ± 3.9 79.0 ± 3.8 80.9 ± 4.0 81.0 ± 4.1 0.48 0.74 
BMI, kg/m2 25.1 ± 1.0 25.3 ± 0.9# 25.0 ± 0.6 25.1 ± 0.7 25.1 ± 0.9 25.3 ± 0.9 26.6 ± 0.8 26.6 ± 0.8 0.45 0.80 
FFM, kg 59.8 ± 1.5 59.8 ± 1.6 60.0 ± 1.7 60.0 ± 1.9 58.5 ± 2.6 59.2 ± 2.5 60.5 ± 2.9 61.5 ± 2.9 0.92 0.23 
SMM, kg 26.7 ± 0.6 26.7 ± 0.7 27.2 ± 0.7 27.5 ± 0.8 25.9 ± 1.1 26.4 ± 1.1 26.9 ± 1.3 27.5 ± 1.3 0.99 0.35 
SMI, kg/m2 8.5 ± 0.2 8.5 ± 0.2 8.8 ± 0.2 8.9 ± 0.2 8.3 ± 0.2 8.4 ± 0.2 8.9 ± 0.3 9.1 ± 0.2 0.25 0.23 
FM, kg 19.2 ± 2.4 20.1 ± 2.2# 18.0 ± 1.7 18.3 ± 1.9 19.6 ± 2.0 19.8 ± 2.1 20.4 ± 1.5 19.5 ± 1.7 0.97 0.08 
FM, % 23.8 ± 2.0 24.7 ± 1.9#$ 22.7 ± 1.5 22.9 ± 1.7 24.8 ± 1.7 24.6 ± 2.0 25.1 ± 1.2 23.8 ± 1.5 0.72 0.04 
FMI, kg/m2 6.1 ± 0.7 6.4 ± 0.7# 5.7 ± 0.5 5.9 ± 0.6 6.3 ± 0.6 6.3 ± 0.6 6.7 ± 0.5 6.4 ± 0.5 0.89 0.07 
Waist circumference, cm 92.5 ± 2.6 92.8 ± 2.4 92.8 ± 3.0 93.1 ± 3.1 91.3 ± 3.5 91.7 ± 3.7 98.1 ± 3.4 97.0 ± 3.3# 0.82 0.44 
Waist:hip ratio 0.93 ± 0.02 0.92 ± 0.02 0.91 ± 0.02 0.91 ± 0.02 0.91 ± 0.02 0.91 ± 0.02 0.97 ± 0.02 0.96 ± 0.02 0.53 0.65 
Muscle strength           
Leg extension 1RM, kg 63 ± 6 65 ± 6 58 ± 3 64 ± 4 52 ± 5 72 ± 6#*‡ 59 ± 4 80 ± 4#*‡ 0.17 < 0.001 
Leg press 1RM, kg 116 ± 9 119 ± 9 107 ± 7 113 ± 6 107 ± 9 137 ± 8#*‡ 118 ± 7 157 ± 7#*‡ < 0.001 < 0.001 
Handgrip strength, kg  41.8 ± 1.7 43.0 ± 1.5 36.2 ± 2.2 38.7 ± 2.1 40.7 ± 3.7 42.0 ± 3.8 41.8 ± 2.1 43.4 ± 1.8 0.38 0.58 
Physical function            
6MWT, m 639 ± 21 636 ± 20 616 ± 18 626 ± 17 627 ± 30 648 ± 30# 591 ± 26 612 ± 24# 0.55 0.53 
SPPB, points 11.7 ± 0.2 11.8 ± 0.1 11.4 ± 0.2 11.8 ± 0.2 11.2 ± 0.3 11.6 ± 0.3 11.8 ± 0.1 12.0 ± 0 < 0.001 0.84 
4 m gait speed, m/s 1.09 ± 0.08 1.08 ± 0.06 1.13 ± 0.04 1.24 ± 0.06 1.14 ± 0.04 1.15 ± 0.04 1.22 ± 0.05 1.26 ± 0.03 0.001 0.043 
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5.4.6 Muscle strength 
Significant group-by-time interactions were observed for both leg extension (P < 0.001, Figure 
5.2A) and leg press 1RM (P < 0.001, Figure 5.2B). Leg extension 1RM increased over time 
by 38% (52 ± 5 to 72 ± 6 kg, P < 0.001) and 36% (59 ± 4 to 80 ± 4 kg, P < 0.001) in the 
EX+CON and EX+PRO groups, respectively. Leg press 1RM increased by 28% (107 ± 9 to 
137 ± 8 kg, P < 0.001) and 33% (118 ± 7 to 157 ± 7 kg, P < 0.001) in the EX+CON and 
EX+PRO groups, respectively. Post-hoc analysis revealed both variables in the EX+CON and 
EX+PRO groups increased over time greater than the CON and PRO groups (P < 0.001). No 
differences were observed between either the CON and PRO groups, or the EX+CON and 
EX+PRO groups. When whey protein supplement groups were pooled, there was a trend 
towards a greater increase in leg press 1RM compared to control supplements pooled (P = 
0.06). No significant within- or between-group differences in handgrip strength were observed 
(Table 5.3).  
 
5.4.7 Physical function  
A significant group-by-time interaction was observed for 4 m gait speed (P = 0.043, Table 5.3) 
but not SPPB (P = 0.84) or 6MWT distance (P = 0.53). In the PRO group, gait speed increased 
by 0.11 ± 0.06 m/s, which tended to increase over time greater than the CON group (P = 0.06). 
When whey protein supplement groups were pooled, 4 m gait speed increased greater than 
control groups pooled (P = 0.007, Figure 5.2C). Although no significant differences in 6MWT 
distance occurred between groups, significant within-group increases occurred in both the 
EX+CON (21 ± 7 m, P = 0.02) and EX+PRO groups (21 ± 6 m, P = 0.007). When RE groups 
were pooled, 6MWT increased greater than non-exercise groups pooled (P = 0.04, Figure 







Figure 5.2 Changes in (A) leg extension 1RM and (B) leg press 1RM between intervention 
groups; change in (C) 6MWT distance between pooled exercise and non-exercise groups; 
and (D) change in 4 m gait speed between pooled whey protein and control supplement 
groups (means ± SE). Circles represent individual data points. Analyses were performed using 
a mixed-model ANCOVA with baseline values only included as a covariate (for panels A and 
B), baseline values and supplement consumed (whey protein or control) included as 
covariates (for panel C only), and baseline values and exercise/non-exercise included as 
covariates (for panel D only). 1RM, one repetition maximum; 6MWT, 6 min walk test. †P < 0.05 
between groups. ††P < 0.01 between groups. *Significantly (P < 0.05) greater than CON group. 
‡Significantly greater than PRO group.






























































































5.4.8 Hormonal and inflammatory biomarkers 
At baseline, salivary cortisol AUC was significantly inversely correlated with SMI (ρ = -0.54, P 
= 0.001), handgrip strength (ρ = -0.36, P = 0.046), 6MWT distance (ρ = -0.46, P = 0.08) and 
leg press 1RM (ρ = -0.53, P = 0.002) (Figure 5.3). When each salivary cortisol time point was 
analysed separately, no significant correlations were observed with any of the 
abovementioned variables; however, the 2000 h time point was significantly correlated with 
leg press 1RM (ρ = -0.39, P = 0.03), and SPPB (ρ = 0.40, P = 0.03). No significant correlations 
were observed between baseline concentrations of plasma IL-6, TNF-a, or CRP, serum IGF-






Figure 5.3 Correlation between salivary cortisol AUC and (A) SMI; (B) handgrip strength; (C) 
6MWT distance; and (D) leg press 1RM at baseline (n = 33). Correlations were analysed by 
partial correlation (Spearman’s rank-order coefficients) controlled for age. 6MWT, 6-minute 
walk test; AUC, area under the curve; SMI, skeletal muscle index; SPPB, short physical 
performance battery. 
 
Changes in fasting hormonal and inflammatory biomarkers, and diurnal salivary cortisol 
indices over the intervention period can be seen in Table 5.4. Both plasma IL-6 and TNF-a 
significantly decreased over time in the EX+PRO group by 21% (-1.2 ± 0.6 pg/mL, P = 0.01) 
and 20% (-0.6 ± 0.2 pg/mL, P = 0.03), respectively. Similar decreases were also observed in 
the EX+CON group (plasma IL6: -25%, -0.8 ± 0.5 pg/mL; plasma TNF-a:  -20.6%, -0.7 ± 0.5 
pg/mL), but values did not significantly differ from baseline (P = 0.15; P = 0.21, respectively). 
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No differences occurred between groups for either variable (P = 0.13; P = 0.11, respectively). 
When RE groups were pooled, both IL-6 (P = 0.048) and TNF-a (P = 0.02) significantly 
decreased over time greater than non-exercise groups pooled (Figure 5.4). Salivary cortisol 
slope (peak morning to 2000 h) increased in the EX+PRO group by 92.1% (8.1 ± 2.8 nmol/L, 
P = 0.02), but no differences occurred between groups (P = 0.15). No significant within- or 
between-group differences were observed for plasma CRP, serum IGF-1 or myostatin, or any 
index of salivary cortisol. When whey protein groups were pooled, serum myostatin tended to 
increase greater than control supplement groups pooled (P = 0.05). No correlations were 
observed between changes in SMM, FM, muscle strength or physical function and changes 




Figure 5.4 Changes in (A) plasma IL-6 and (B) TNF-a between pooled exercise (n = 17) and 
non-exercise groups (n = 17) (means ± SE). Circles represent individual participant changes. 
Data were analysed by mixed-model ANCOVA with baseline values and supplement 
consumed (whey protein or control) included as covariates. †P < 0.05 between groups. IL-6, 




































































































Table 5.4 Fasted hormonal and inflammatory biomarkers, and salivary cortisol indices for each treatment group at baseline and 12 weeks1 
 
1Values are means ± SE. 2n = 34 (CON, n = 8; PRO, n = 9; EX+CON, n = 8; EX+PRO, n = 9). 3n = 33 (CON, n = 8; PRO, n = 8; EX+CON, n = 8; EX+PRO, n = 
9). AUC, area under the curve; CRP, C-reactive protein; IGF-1, insulin-like growth factor 1; IL-6, interleukin-6; TNF-a, tumor necrosis factor-alpha. #P < 0.05 









 CON PRO EX+CON EX+PRO P value 
 Baseline 12 weeks Baseline 12 weeks Baseline 12 weeks Baseline 12 weeks Time Group x 
time 
Serum IGF-1,2 ng/mL  152 ± 34 130 ± 29 119 ± 17  110 ± 14 137 ± 16 119 ± 12 118 ± 15 100 ± 10 0.07 0.86 
Serum myostatin,3 ng/mL  2.2 ± 0.5 2.0 ± 0.4 1.9 ± 0.3 2.2 ± 0.3 1.8 ± 0.3 1.6 ± 0.1 2.3 ± 0.2 2.4 ± 0.3 0.06 0.15 
Plasma IL-6,2 pg/mL 4.9 ± 1.2 5.8 ± 1.3 4.0 ± 1.0 4.0 ± 1.2 3.2 ± 0.9 2.4 ± 0.6 5.8 ± 1.8 4.6 ± 1.2# 0.09 0.13 
Plasma TNF-a,2 pg/mL  3.2 ± 0.3 3.0 ± 0.3 2.4 ± 0.3 3.0 ± 0.3 3.4 ± 0.6 2.7 ± 0.3 3.0 ± 0.4 2.4 ± 0.2# < 0.001 0.11 
Plasma CRP,2 ng/mL  2.4 ± 0.6 1.7 ± 0.3 1.6 ± 0.4  1.1 ± 0.5 0.8 ± 0.2 0.8 ± 0.2 2.0 ± 0.4 1.8 ± 0.2 0.18 0.18 
Salivary cortisol AUC,3 nmol/L x 790 min 4067 ± 551 4349 ± 528 4088 ± 196 45450 ± 425 5588 ± 969  5326 ± 778 4127 ± 587 4530 ± 414 0.001 0.99 
Salivary cortisol slope,3 nmol/L  9.6 ± 1.1  9.1 ± 1.4 10.6 ± 0.8 13.6 ± 2.4 12.5 ± 2.5 15.7 ± 2.7 8.8 ± 1.4 16.9 ± 3.5# 0.004 0.15 
Salivary cortisol (2000 h),3 nmol/L  2.1 ± 0.5  1.9 ± 0.5 1.9 ± 0.4 2.2 ± 0.6 2.2 ± 0.6 1.8 ± 0.7 2.1 ± 0.7 2.6 ± 0.6 0.009 0.64 
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5.5 Discussion 
This study investigated the individual and combined effects of RE and whey protein 
supplementation on skeletal muscle and FFM, muscle strength, physical function, and 
hormonal and inflammatory biomarkers associated with sarcopenia in healthy older men. The 
main findings were: 
 
i) Resistance exercise significantly increased FFM, muscle strength and physical function 
and decreased markers of systemic inflammation. 
ii) Whey protein supplementation alone did not increase skeletal muscle or FFM and tended 
to increase serum myostatin. When whey protein supplement groups were pooled, 
physical function (4 m gait speed) significantly increased, and muscle strength (leg press 
1RM) tended to increase greater than consuming an isocaloric carbohydrate control.   
iii) No synergistic effects of RE and whey protein supplementation occurred for any parameter 
of sarcopenia compared to RE or whey protein supplementation alone.  
iv) Changes in hormonal and inflammatory markers did not correlate with changes in SMM, 
muscle strength or physical function, but diurnal salivary cortisol secretion did significantly 
correlate with multiple parameters of sarcopenia at baseline. 
 
5.5.1 Effects on skeletal muscle and FFM, muscle strength and physical function 
Twelve weeks of progressive whole-body RE resulted in a combined mean increase of 0.9 ± 
0.3 kg FFM, of which 0.6 ± 0.2 kg was an increase in SMM. This corresponds to increases of 
1.2% and 2.3%, respectively. The magnitude of FFM increase in the present study is in line 
with previous studies that reported increases of ~1 kg following 12 weeks of RE in older adults 
(Campbell et al. 1995, Holwerda et al. 2018, Leenders et al. 2013, Verdijk et al. 2009a). The 
increase in FFM and SMM in the present study was accompanied by 36%, 31% and 3.4% 
increases in leg extension and leg press 1RM, and 6MWT distance, respectively. These 
findings add to the current body of literature that have reported similar increases in muscle 
strength (Arnarson et al. 2013, Bell et al. 2017, Holwerda et al. 2018, Kirk et al. 2019, Leenders 
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et al. 2013, Verdijk et al. 2009a) and physical function as measured by 6MWT distance 
following ≥12 weeks of RE training alone (Arnarson et al. 2013, Oesen et al. 2015), or 
combined with endurance-based training elements in older adults (Bell et al. 2017, Kirk et al. 
2019). Taken together, considering SMM, strength and physical function decline at rates of 
~0.5-1%, ~1-3%, and ~0.5% per annum around mid-life, respectively (Clark and Manini 2008, 
Janssen 2010, Daly et al. 2013), which are associated with numerous adverse effects on 
human health (Cruz-Jentoft et al. 2019), and increases the economic burden to healthcare 
services (Goates et al. 2019, Pinedo-Villanueva et al. 2019), the findings of the present study 
are both clinically and economically relevant.  
 
The lack of effect of whey protein supplementation on skeletal muscle and FFM is in 
agreement with some (Björkman et al. 2020, Cramer et al. 2016, de Carvalho Bastone et al. 
2020, Kim et al. 2012, Kirk et al. 2020, Kukuljan et al. 2009, Verreijen et al. 2017, Zhu et al. 
2015) but not all previous studies (Bauer et al. 2015, Bell et al. 2017, Bo et al. 2018, Kang et 
al. 2020, Mitchell et al. 2017, Negro et al. 2018, Norton et al. 2016, ten Haaf et al. 2019). It 
was hypothesised that disparities between previous studies may be partially explained by 
differences in the deviation of dietary protein from baseline (≥0.4 vs. <0.4 g/kg/d). Although, 
the findings of this study oppose this hypothesis as dietary protein was increased by 0.6 g/kg/d 
and observed no effect. This data is in contrast to others that increased dietary protein intake 
by 0.4-0.6 g/kg/d (Bell et al. 2017, Norton et al. 2016). Of note, the whey protein-based multi-
ingredient supplement consumed by participants in the study by Bell and colleagues (2017) 
contained vitamin D and n-3 PUFA. Both of these ingredients have been shown to aid muscle 
hypertrophy and function (Rosendahl-Riise et al. 2017, Smith et al. 2015). Also, the study by 
Norton and colleagues (2016) was double the duration of the present study, which might have 
provided a greater timeframe for protein-induced increases in FFM. These methodological 
differences may explain the inconsistent findings. Additionally, the decrease in protein 
balance, particularly in the overnight fasting period as reported in Chapter 4, might also 
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explain the lack of protein-induced increase in skeletal muscle and FFM following whey protein 
supplementation in the present study.  
 
Whilst whey protein supplementation elicited no effect on skeletal muscle or FFM, the present 
study observed a significantly greater increase in physical performance (4 m gait speed) and 
a trend towards a greater increase muscle strength (leg press 1RM) when whey protein 
supplement groups were pooled and compared to control supplement groups pooled. These 
outcomes are in agreement with others that have reported increases in muscle strength and/or 
physical function following increased dietary protein intake in older adults (Bauer et al. 2015, 
Bell et al. 2017, Kang et al. 2020, ten Haaf et al. 2019, Tieland et al. 2012b). As not all older 
adults are able or willing to perform RE (Dismore et al. 2020), these findings suggest higher 
intakes of dietary protein may be of clinical importance to attenuate declines in muscle function 
in these groups.  
 
This study tested the hypothesis that twice daily supplementation of a high leucine whey 
protein supplement would augment the effects of RE on SMM, strength and physical function. 
Despite gains in these outcomes following RE training alone, and an increase in physical 
function and a trend for an increase in muscle strength following whey protein 
supplementation, no synergistic effects were observed. These findings are consistent with the 
majority of previously published studies (Arnarson et al. 2013, Candow et al. 2006, Chalé et 
al. 2013, de Carvalho Bastone et al. 2020, Dulac et al. 2020, Englund et al. 2018, Fielding et 
al. 2017, Gryson et al. 2014, Hofmann et al. 2016, Holm et al. 2008, Holwerda et al. 2018, Kim 
et al. 2012, Kirk et al. 2019, 2020, Kukuljan et al. 2009, Leenders et al. 2013, Maltais, 
Ladouceur, and Dionne 2016, Oesen et al. 2015, Ottestad et al. 2017, Shahar et al. 2013, 
Thomson et al. 2016, Verdijk et al. 2009a, Verreijen et al. 2017). Similar to that of many of 
these studies, the population used in this study were non-frail, i.e., displayed high baseline 
physical function scores (SPPB: 11.5 ± 0.1; 6MWT: 618 ± 12 m), were already physically 
active (MVPA: 127 ± 7 min/d), and consumed sufficient but not optimal amounts of dietary 
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protein (1.0 ± 0.02 g/kg/d) at baseline according to the PROT-AGE and ESPEN consensus 
groups (Bauer et al. 2013, Deutz et al. 2014). 
 
In contrast to the present and abovementioned studies, other studies have reported 
synergistic effects of RE and increased dietary protein on parameters of sarcopenia (Bell et 
al. 2017, Daly et al. 2014, Kang et al. 2019, Junior et al. 2018, Rondanelli et al. 2016, 2020, 
Tieland et al. 2012b, Verreijen et al. 2015, Yamada et al. 2019, Zdzieblik et al. 2015). 
Participants in the majority of these studies were sarcopenic or frail older adults with habitual 
protein intakes ≤1 g/kg/d (Kang et al. 2019, Rondanelli et al. 2016, Tieland et al. 2012b, 
Yamada et al. 2019, Zdzieblik et al. 2015). Based on these comparisons, the findings of the 
present and previous studies imply a relatively good health status, and an adequate habitual 
dietary protein intake may mask the supplemental effects in older adults performing RE. 
However, it is important to note that augmented effects have been observed in healthy older 
adults habitually consuming adequate (1.0-1.1 g/kg/d) amounts of dietary protein (Bell et al. 
2017, Daly et al. 2014, Junior et al. 2018). Therefore, as the present study observed an effect 
of whey protein supplementation on muscle function when whey protein groups were pooled, 
it may be that the sample size of this study was insufficient to detect post-hoc differences 
between the EX+CON and EX+PRO groups. Additional RCTs including a substantially larger 
sample size to that of the present study are required to determine whether increased dietary 
protein (at a dose of ~1.6 g/kg/d) elicits additive effects during RE in healthy active older adults 
habitually consuming adequate amounts of dietary protein at baseline.  
 
5.5.2 Effects on hormonal and growth factors 
At baseline, no significant correlations were observed between SMM, strength or physical 
function and serum IGF-1 or myostatin. In contrast, significant inverse correlations were 
observed between diurnal salivary cortisol AUC [from 5 measurements across waking hours 
(0650, 0805, 1225, 1700 and 2000 h) under highly controlled conditions] and multiple 
parameters of sarcopenia [SMI, muscle strength (handgrip strength and leg press 1RM), and 
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physical function (6MWT distance)]. In agreement, previous studies have also observed 
elevated cortisol concentration in sarcopenic compared to non-sarcopenic elderly individuals 
(Waters et al. 2008), and inverse associations between atypical diurnal cortisol secretion 
(attenuated morning and elevated pre-sleep cortisol concentration) and poor physical 
performance in older adults (Gardner et al. 2011, Heaney, Phillips, and Carroll 2012, Sousa 
et al. 2017). However, although baseline data from this study, albeit in a small sample size, 
suggests measurement of diurnal salivary cortisol may be an effective method to identify 
sarcopenic individuals, the clinical application is somewhat limited due to both the cost and 
required participant compliance to gain such data. Unfortunately, not one single time point of 
salivary cortisol significantly inversely correlated with all components of sarcopenia similar to 
that of the diurnal profile; although, measurement at 2000 h did show some promise. 
Consistent with this observation, a recent study also reported an association between high 
salivary cortisol secretion at 2000 h and sarcopenia prevalence (Gonzalez et al. 2018).  
 
In addition to the above, no changes in salivary cortisol indices occurred following RE, despite 
improvements in parameters of sarcopenia being observed, further questioning the use of 
salivary cortisol as a potential biomarker of sarcopenia. Consistent with the present study, 
studies that have analysed the effects of RE on basal cortisol in both serum (Häkkinen et al. 
2001, 2002, Izquierdo et al. 2003) and saliva in older adults (Ahn and Kim 2018) have also 
reported no changes. It should be noted that two of these studies did report significant 
decreases in basal cortisol secretion at some point during the intervention, just not following 
(Häkkinen et al. 2002, Izquierdo et al. 2003). However, a significant limitation of these studies 
was the singular measurement of cortisol in the morning between 0800 and 1000 h. It is well 
known that cortisol secretion follows a diurnal rhythm, that is, high upon waking, surging 50-
60% 30-40 min after waking, decreasing rapidly in the subsequent hours following waking and 
then slowly declining until reaching a nadir in the late evening (Adam et al. 2017). The novel 
findings of present study are that RE does not decrease diurnal cortisol secretion, and RE-
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induced changes in SMM and strength are not associated with changes in diurnal salivary 
cortisol in healthy older men.  
 
The lack of decrease in serum myostatin following RE training is consistent with some 
(Hofmann et al. 2016, Kim et al. 2007, Planella-Farrugia et al. 2019) but not all studies 
(Bagheri et al. 2020, Binns et al. 2017, Negaresh et al. 2019, Shabani and Izaddoust 2018). 
It has been hypothesised that an insufficient RE intensity and high pre-post test myostatin 
variability amongst participants might explain the above null findings. In the present study, RE 
intensity was high (80% 1RM), and SMM increased by 0.6 ± 0.2 kg, similar to that of Bagheri 
and colleagues (2020) who reported a decrease in myostatin following RE in elderly women. 
This suggests that the intensity of RE and/or change in SMM in the present study does not 
explain the descrepancies with previous stuies. Instead, similar to that of Kim et al. (2007), the 
pre-post variability in serum myostatin was large (-1.7-1.1 ng/mL), which most likely explains 
the lack of decrease in the present study.  
 
The increase in serum myostatin following whey protein supplementation, which tended to 
increase greater than control supplement groups pooled, is in agreement with longitudinal 
data in younger adults (Paoli et al. 2015). Furthermore, an acute study in middle- and older-
aged men demonstrated dietary protein hindered the decrease in myostatin mRNA following 
RE (Hulmi et al. 2008). As reported in Chapter 4, whey protein supplementation led to a 
significant rise in nocturnal protein oxidation and a decrease in nocturnal protein balance. 
Consequently, the increase in fasting serum myostatin may have reflected an increase in 
protein breakdown in the overnight fasting period following 12 weeks of whey protein 
supplementation. 
 
However, it must be noted that the validity of myostatin as both a biomarker of sarcopenia and 
a method to monitor response to treatments has been questioned, making interpretation of 
data and comparisons with the literature difficult (Peng et al. 2018). For example, whilst the 
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muscle-wasting effect of myostatin is well-known (Elliott et al. 2012), evidence from studies 
investigating the relationship between myostatin and SMM is far from congruent. Some 
studies have reported an inverse relationship between myostatin and age-related declines in 
SMM (Ju and Chen 2012, Yarasheski et al. 2002), whilst others have reported associations 
between reduced SMM and low myostatin concentration (Christensen et al. 2013, Furihata et 
al. 2016, Lenk et al. 2012, Peng et al. 2018). Clearly, further research to clarify the potential 
of myostatin as a biomarker of sarcopenia is warranted.  
 
Previous studies have claimed that circulating hormones, including IGF-1, are mechanistically 
and directly related to RE-induced increases in SMM (Kraemer, Ratamess, and Nindl 2017, 
Mangine et al. 2017). Indeed, in older adults, intervention studies have reported 
accompanying elevated basal IGF-1 concentration with increased SMM following RE 
interventions (Chen et al. 2017, Cunha et al. 2020, Rondanelli et al. 2016). However, there is 
also substantial contrary evidence that suggests circulating systemic hormones at rest both in 
young (Mobley et al. 2018, Morton et al. 2016, 2018b) and older adults (Arnarson et al. 2015, 
Häkkinen et al. 2000, 2001, Holwerda et al. 2018, Nascimento et al. 2019, Shahar et al. 2013, 
Walsh et al. 2015) are not related to RE-induced increases in SMM. In agreement, although 
RE increased SMM in the present study, serum IGF-1 did not increase, and change in 
concentration did not correlate with change in SMM. Furthermore, in the previously cited study 
by Morton et al. (2018b), although neither circulating nor intramuscular hormones influenced 
or were related to skeletal muscle hypertrophy following RE in young men, intramuscular 
androgen receptor content was. These findings are supported by other studies that have also 
demonstrated increases in skeletal muscle androgen receptor content following RE training 
(Ahtiainen et al. 2011, Mitchell et al. 2013) and suggest that local intramuscular factors as 
opposed to changes in systemic hormonal concentrations might underpin increases in SMM 
following RE. Although, it should be noted that two recent studies have not observed an 
increase in intramuscular androgen receptor content following RE (Haun et al. 2019, Mobley 
et al. 2018). Whilst further research on the effects of RE on SMM and intramuscular androgen 
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receptor content is warranted, particularly in older adults, it is possible, although speculative, 
that the RE training programme in this study induced changes at the hormone receptor level, 
which in turn elicited increases in SMM.  
 
5.5.3 Effects on systemic inflammation  
A key finding of this study was the significant reduction in markers of systemic inflammation 
following RE training. Age-related, low-grade systemic inflammation, termed inflammaging 
(Franceschi et al. 2006), is associated with numerous adverse health outcomes, including 
CVD, insulin resistance and a higher risk of mortality (Calder et al. 2017). Inflammation is also 
often cited in the aetiology of sarcopenia (Beyer, Mets, and Bautmans 2012). In the present 
study, the pro-inflammatory cytokines IL-6 and TNF-a significantly reduced by ~20% in the 
EX+PRO group and decreased, but not significantly, by a similar magnitude in the EX+CON 
group. When RE groups were pooled, both IL-6 and TNF-a significantly decreased greater 
than non-exercise groups pooled. These reductions are consistent, but greater than the ~11-
12% declines in IL-6 and TNF-a following RE and HIIT combined with a whey protein-based 
multi-ingredient supplement in healthy older men (Bell et al. 2018). Additional studies in older 
adults have also reported reductions in markers of systemic inflammation following RE alone 
(Sardeli et al. 2018) and combined with whey protein supplementation (Rondanelli et al. 2016). 
Given that IL-6 in particular is strongly associated with advancing age, morbidity and mortality 
(Beavers et al. 2010, Ershler 1993), these findings illustrate the importance of performing RE 
in older age to delay degeneration of health in older adults. Furthermore, previous work has 
also shown IL-6 and TNF-a have important roles in the pathogenesis of insulin resistance 
(Kim et al. 2004, Plomgaard et al. 2005). These reductions may therefore also help explain 
the improvement in insulin sensitivity observed in both the EX+CON and EX+PRO groups 
reported in Chapter 4. 
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Contrary to the findings of the present and abovementioned studies, others have failed to 
report reductions in inflammatory markers following RE training alone (Hangelbroek et al. 
2018), or combined with either AE (Beavers et al. 2010, Grosicki et al. 2020) or protein 
supplementation (Shahar et al. 2013). Conflicting results may in part be related to the health 
status of the population studied. Participants in studies that have not reported a reduction in 
markers of systemic inflammation were sarcopenic/frail with reduced physical function (SPPB 
score of ≤10) (Hangelbroek et al. 2018, Grosicki et al. 2020, Shahar et al. 2013), whereas 
healthy, well-functioning older adults were used in the present study and that of Bell et al. 
(2018). Although, it is important to note that Rondanelli et al. (2016) reported a between-group 
difference in CRP between whey protein and placebo groups following 12 weeks physical 
activity in sarcopenic elderly; however, this finding was driven more by a within-group increase 
in the placebo group (0.44, 95% CI -0.02-0.90, P = 0.06) rather than a significant decrease 
following whey protein supplementation (-0.19, 95% CI -0.57-0.19, P = 0.33). Together, data 
from these studies suggests RE is not effective at reducing systemic inflammation in 
sarcopenic/frail older adults who are prone to systemic inflammation. In support, in a sub 
analysis of TNF-a in a meta-analysis conducted by Sardeli et al. (2018), only those studies 
that investigated healthy older adults demonstrated reduced TNF-a following RE 
interventions. Furthermore, it has been suggested that modulating inflammation is likely most 
effective at the early stage of health decline when the compensatory capacity is not completely 
exhausted (Ferrucci and Fabbri 2018), further supporting this hypothesis. 
 
In addition to the above, contradictory results of the aforementioned studies might also be 
related to changes in FM following RE training. In particular, changes in central (predominantly 
visceral) adiposity, which is a well-known causative factor of inflammaging (Beyer, Mets, and 
Bautmans 2012). In the combined RE and whey protein supplement groups in the present 
study and that of Bell et al. (2018), reductions in whole-body FM as well as proxy markers of 
visceral adipose tissue (waist circumference and trunk FM, respectively) were observed. In 
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contrast, no changes in FM occurred in studies that reported no changes in pro-inflammatory 
markers (Beavers et al. 2010, Hangelbroek et al. 2018). Furthermore, in the previously 
mentioned meta-analysis by Sardeli and colleagues (2018), only studies that demonstrated 
reductions in FM also reported reductions in TNF-a. However, it must be noted that no 
changes in FM or waist circumference were observed in the EX+CON group, suggesting 
change in FM cannot fully explain the decrease in systemic inflammation in the present study. 
 
Previous research has consistently reported inverse relationships between IL-6 and SMM, 
strength and physical function in older adults (Cesari et al. 2005, Grosicki et al. 2020, 
Hangelbroek et al. 2018, Visser et al. 2002). Conversely, the results from baseline data in the 
present study do not support these findings. The relatively good health status of participants 
in this study may explain this discrepancy. Furthermore, the present study also did not report 
any correlations between changes in markers of systemic inflammation and changes in 
parameters of sarcopenia. These findings are in contrast with Grosicki et al. (2020), who 
demonstrated an association between changes in IL-6 and physical function (gait speed) 
following a 6-month physical activity programme that included RE. Conversely, the findings of 
the present study are in agreement with Hangelbroek and colleagues (2018) who reported no 
significant correlations between changes in IL-6 and TNF-a, and changes in FFM and markers 
of muscle strength following 24 weeks RE in frail older adults. Inconsistencies might in part be 
related to the sample sizes between studies. Though, due to limited data, further research 
examining the relationship between changes systemic inflammation and parameters of 
sarcopenia is warranted to determine its role in curbing the disease.  
 
5.5.4 Safety and compliance  
In agreement with previous work as reviewed by Fragala et al. (2019), twice weekly RE was 
well tolerated in this population, confirmed by the high compliance (~98%) and no serious 
adverse events reported. Similarly, 12 weeks of whey protein supplementation was also well 
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accepted (compliance ~96%). It is postulated that the supervised nature of the RE programme 
(1-to-1 or 2-to-1 basis with a qualified exercise professional) was a key factor in the high 
compliance observed. Indeed, a recent meta-analysis reported greater effects of supervised 
compared to non-supervised RE in older adults (Lacroix et al. 2017). Furthermore, although 
not reported, it is believed that in addition to the supervision, the strong rapport built between 
the exercise professional and the participants was a key factor in the compliance seen. This 
hypothesis is based on verbal feedback from participants throughout the research study. 
Therefore, future research should investigate the role of the exercise professional and 
relationship with the exerciser on RE compliance in older adults. 
 
Consistent with the findings of a meta-analysis conducted by Devries and colleagues (2018), 
the high protein diet (1.6 g/kg/d) had no adverse effect on renal function as confirmed by eGFR 
(>60 mL/min/1.73m2 in all participants following the intervention). Based on these findings, a 
high protein diet does not adversely affect renal function in healthy older men. However, of 
note, two participants in the PRO group did experience episodes of gout during the 
intervention period. In agreement, although not often reported, increased uric acid, which is a 
causative factor of gout (Zhang et al. 2012), has been reported in elderly males consuming 
high amounts of dietary protein (Durainayagam et al. 2019). A recent animal model study has 
also reported similar findings (Hong et al. 2020). Therefore, although the present study could 
not directly determine the causality, further research into the effects of high protein diets and 
incidence of gout is warranted due to its known causative effects on hypertension, CVD and 
T2DM risk (Hong et al. 2020). 
 
5.5.5 Strengths and limitations 
The present study is only one of few that has investigated both the independent and combined 
effects of RE and increased dietary protein intake over a ≥10 week period on SMM, strength 
and physical function in older adults (de Carvalho Bastone et al. 2020, Gryson et al. 2014, 
Kim et al. 2012, Kirk et al. 2020, Kukuljan et al. 2009, Shahar et al. 2013, Verreijen et al. 
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2017). As such, the current research extends our understanding of this topic. In contrast to 
the above cited studies, the present study employed a double-blind, randomised, controlled 
design, increased dietary protein to the optimal dose (1.6 g/kg/d) to maximally augment RE-
induced increases in SMM (Morton et al. 2018a), and comprehensively measured multiple 
hormonal (serum IGF-1 and myostatin, and salivary cortisol) and inflammatory (plasma IL-6, 
TNF-a and CRP) biomarkers related to sarcopenia. These are novel aspects of this study.  
 
Limitations of this study include the small sample size per group and the inclusion of only men. 
The sample size in this study affected statistical power to determine between-group 
differences between the four intervention groups for SMM, physical function and markers of 
systemic inflammation. Retrospective power analysis revealed a sample size of 104 
(26/group), 72 (18/group) and 60 (15/group) participants would have been required to 
determine between-group differences in these outcomes, respectively. Further, due to the 
small effect observed between the CON and PRO, and EX+CON and EX+PRO groups, the 
sample size of this study was significantly underpowered to detect post-hoc differences 
between these groups. Although, it should be noted that the primary outcome of the overall 
trial was a change in RMR as detailed in Chapter 3, and this study was a secondary analysis 
of outcomes of interest related to sarcopenia. Women were excluded from this relatively small 
study to reduce the likelihood of high variability in outcome variables. Nevertheless, as women 
account for a large proportion of older adults, this is a major limitation of the study.  
 
5.5.6 Conclusion 
Twelve weeks of RE significantly increased FFM, muscle strength and physical function, 
tended to increase SMM and decreased circulation concentrations of markers of systemic 
inflammation in healthy older men. Whey protein supplementation alone was ineffective at 
increasing skeletal muscle or FFM, and tended to increase serum myostatin; however, a 
greater increase in physical function (gait speed) and a trend towards a greater increase in 
muscle strength (leg press 1RM) was observed when whey protein supplements were pooled 
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and compared to control supplements pooled. Despite these increases following RE and whey 
protein supplementation independently, no synergistic effects were observed for any 
parameter of sarcopenia compared to RE or whey protein supplementation alone. Data from 
this study also suggests changes in parameters of sarcopenia are not related to changes in 
hormonal or inflammatory markers, but diurnal salivary cortisol concentration did correlate with 
parameters of sarcopenia at baseline. 
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Thesis map: Study 3 
Study  Aims Key findings 
Study 1: Effects of resistance 
exercise and whey protein 
supplementation on 24-h 
energy expenditure, substrate 
oxidation and metabolic 
flexibility, body composition, 
appetite and glucose 
homeostasis in healthy older 
men 
• To investigate the individual and combined effects of RE 
and whey protein supplementation on components of 
24-h EE, substrate oxidation and metabolic flexibility, 
body composition, appetite, and glucose homeostasis in 
healthy older men.  
• Resistance exercise significantly increased FFM, RMR, 
SMR, sedentary EE and 24-h metabolic flexibility 
compared to non-exercise. RE also resulted in within-
group increases in subjective hunger and insulin 
sensitivity, and within-group decreases in the energy cost 
of step exercise and spontaneous activity.  
• Whey protein supplementation improved body weight 
maintenance and reduced FM, and increased insulin 
sensitivity; however, resulted in an increase in overnight 
protein oxidation and awakening cortisol secretion, and 
reduced 24-h protein balance.  
• Whey protein supplementation had no adverse effects on 
total protein or EI, or 24-h subjective appetite. 
• Resistance exercise combined with whey protein 
supplementation did not significantly augment changes in 
body composition, 24-h EE, substrate oxidation or 
metabolic flexibility, or markers of glucose homeostasis 
compared to either RE or whey protein supplementation 
alone. 
Study 2: Effects of resistance 
exercise and whey protein 
supplementation on skeletal 
muscle mass, strength, 
physical function, and 
hormonal and inflammatory 
biomarkers in healthy older 
men 
• To investigate the individual and combined effects of RE 
and whey protein supplementation on SMM, strength, 
physical function, and hormonal and inflammatory 
biomarkers in healthy older men.  
• To determine whether changes in hormonal and 
inflammatory biomarkers correlate with changes in 
SMM, strength and physical function.  
• Resistance exercise significantly increased FFM, muscle 
strength and physical function, and decreased markers of 
systemic inflammation. 
• Whey protein supplementation alone increased physical 
function (4 m gait speed) and muscle strength (leg press 
1RM).  
• No synergistic effects occurred for any parameter of 
sarcopenia compared to RE or whey protein alone.  
• Changes in hormonal and inflammatory biomarkers did 
not correlate with changes in parameters of sarcopenia, 
but diurnal salivary cortisol and sarcopenia indices did at 
baseline. 
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Thesis map: Study 3 continued 
Study Aims Key findings 
Study 3: Effects of resistance 
exercise and whey protein 
supplementation on cognitive 
function in healthy older men 
• To investigate the individual and combined effects of RE 
and whey protein supplementation on cognitive function 
and neurobiological, inflammatory and insulin sensitivity 
markers, diurnal salivary cortisol, and BP in healthy 
older men. 
• To determine whether changes in neurobiological, 
inflammatory and insulin sensitivity markers, and 
changes diurnal salivary cortisol, BP, SMM, strength and 
physical function are associated with changes in 
cognitive function. 
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6.1 Chapter overview 
Ageing is associated with declines in cognitive function. Previous studies have shown RE and 
increased dietary protein intake may mitigate age-related cognitive impairment. However, little 
work has investigated the synergistic effects of these interventions. In this chapter, the 
individual and combined effects of RE and whey protein supplementation on cognitive function 
were investigated in healthy older men. Blood and salivary markers, and measurement of BP, 
SMM, strength and physical function were also analysed to identify potential mechanisms of 
action.  
 
6.2 Introduction  
Ageing is associated with an increased risk of chronic conditions such as cognitive impairment 
and dementia (Daviglus et al. 2010). Currently, the worldwide prevalence of dementia is 
estimated at ~50 million people, which is expected to increase to ~82 million people by 2030 
(World Health Organisation 2019). The impact of such conditions, both personally and 
economically, is extensive (Farina et al. 2017, Wimo et al. 2017). Cognitive impairment 
decreases the ability of affected individuals to perform ADL (Giebel, Sutcliffe, and Challis 
2015) and increases the financial and psychological burden on families and caregivers 
(Kasper et al. 2015). Recently, meta-analyses have reported the age-related decline in SMM, 
strength and physical function, termed sarcopenia (Cruz-Jentoft et al. 2019), is associated 
with cognitive impairment (Chang et al. 2016, Cipolli, Yassuda, and Aprahamian 2019, Peng 
et al. 2020). Common pathologies of both conditions, including chronic systemic inflammation, 
insulin resistance and reductions in growth factors may explain this relationship (Chang et al. 
2016). Although the mechanisms require further investigation, it may be speculated that 
strategies that curb sarcopenia may also assist in attenuating age-related declines in cognitive 
function. 
 
Resistance exercise is well known for its attenuating sarcopenic effects (Phillips and Martinson 
2019). Additionally, several studies have also reported enhanced cognitive function following 
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RE, including improvements in executive function (Anderson-Hanley, Nimon, and Westen 
2010, Best et al. 2015, Ikudome et al. 2017, Liu-Ambrose et al. 2010, Yoon, Lee, and Song 
2018), memory (Best et al. 2015, Cassilhas et al. 2007, Coelho-Júnior et al. 2020, Ikudome et 
al. 2017, Marston et al. 2019c), and global cognitive function (Coelho-Júnior et al. 2020, Singh 
et al. 2014, Smolarek et al. 2016). Exercise-induced improvements in cognitive function are 
purported to be related to several factors, including structural changes in the brain, increases 
in circulating concentrations of various neurobiological markers such as BDNF and IGF-1, and 
decreases in cortisol secretion and inflammation (Ahlskog et al. 2011, Cassilhas et al. 2007, 
Liu-Ambrose et al. 2012, Tsai et al. 2014, 2015, Walsh et al. 2015). 
 
In addition to RE, it is recommended that older adults should consume higher intakes of dietary 
protein to attenuate sarcopenia (Phillips and Martinson 2019). Evidence also suggests 
increased dietary protein intake may play a role in delaying age-related cognitive impairment 
(van de Rest, van der Zwaluw, and De Groot 2013). For instance, previous studies have 
demonstrated acute improvements in memory (Kaplan et al. 2001) and longitudinal 
improvements in reaction time, memory and emotion identification following increased dietary 
protein intake in older adults (Charlton et al. 2016, Kita et al. 2019, Lefferts et al. 2020, van 
der Zwaluw et al. 2014). These improvements are purported to be due to protein-induced 
increases in IGF-1 and decreases in inflammation (Bordoni et al. 2017, Journel et al. 2012), 
amplified brain insulin receptor signalling stimulation (Frazier et al. 2019), and increased brain 
neurotransmitter availability (van de Rest, van der Zwaluw, and De Groot 2013).  
 
In addition to the singular effects of RE and whey protein supplementation on cognitive 
function, recent evidence also suggests these interventions may synergistically curb cognitive 
decline. Two studies have reported synergistic improvements in reaction time, executive 
function, memory, and processing speed (Bell et al. 2019, Rondanelli et al. 2020). However, 
it must be noted that others have not observed augmented effects (Formica et al. 2020, van 
de Rest et al. 2014); although, van de Rest and colleagues (2014) did report an additive effect 
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on information processing speed compared to protein supplementation alone. Inconsistencies 
might be related to the habitual protein intake of participants, and due to differences in the 
daily dose and deviation of dietary protein intake from baseline. To add, in both studies that 
reported null findings (Formica et al. 2020, van de Rest et al. 2014), habitual protein intake 
was sufficient (1.0-1.26 g/kg/d) according to consensus groups (Bauer et al. 2013, Deutz et 
al. 2014), and was increased by ≤0.3 g/kg/d during the intervention. In contrast, whilst 
Rondanelli et al. (2020) increased dietary protein intake by a similar amount to these studies 
(0.32 g/kg/d), habitual intake was considerably less (0.79 g/kg/d). Bell et al. (2019) also 
increased dietary protein intake by a notably greater amount to the aforementioned studies 
(0.5 g/kg/d; 1.1-1.6 g/kg/d). Although further research is required, it may be that in healthy 
older adults habitually consuming sufficient amounts of dietary protein (~1.0-1.2 g/kg/d), a 
dose of 1.6 g/kg/d (and a deviation of ~0.5 g/kg/d) might be required to stimulate additive 
effects on cognitive function. 
 
6.2.1 Aims and hypotheses 
 
Primary aim  
• To investigate the individual and combined effects of RE and whey protein 
supplementation (aimed to increase dietary protein intake to ~1.6 g/kg/d) on cognitive 
function in healthy older men. 
Secondary aims 
• To investigate the individual and synergistic effects on neurobiological, inflammatory and 
insulin sensitivity markers, diurnal salivary cortisol, and BP. 
• To determine whether changes in these markers in addition to changes in SMM, strength 
and physical function are associated with changes in cognitive function. 
Hypotheses  
• Combined RE and whey protein supplementation will enhance cognitive function to a 
greater extent than RE and whey protein supplementation alone. 
 233 
• Greater increases in circulating neurobiological biomarkers, and greater decreases in 
inflammatory biomarkers, diurnal salivary cortisol and BP will be observed following RE 
plus whey protein supplementation compared to each intervention alone.  
• Changes in neurobiological, inflammatory and insulin sensitivity markers, diurnal salivary 
cortisol in addition to changes in SMM, strength and physical function will be associated 




6.3.1 Participants and experimental design  
Thirty-six healthy older men [(mean ± SE) age: 66.9 ± 0.7 y] participated in this 12-week, 4-
arm, double-blind RCT. All measurements were taken at baseline and following the 12-week 
intervention. Participants were randomised to either control (CON, n = 9), whey protein (PRO, 
n = 9), RE + control (EX+CON, n = 9), or RE + whey protein (EX+PRO, n = 9). Full details of 
the experimental design and eligibility criteria have been detailed previously in Chapter 3 
(sections 3.2, 3.4.2.1 and 3.4.2.2). Although not planned in the original study design, 
exploratory analyses were also conducted between pooled exercise (EX+CON and EX+PRO 
groups, n = 18) and non-exercise groups (CON and PRO groups, n = 18), and between pooled 
whey protein (PRO and EX+PRO groups, n = 18) and control supplement groups (CON and 
EX+CON groups, n = 18). All participants provided written informed consent in accordance 
with the Declaration of Helsinki. Ethical approval was granted by Coventry University Ethics 
Committee (project code: P59723). The flow of participants throughout the study has been 
previously presented and can be seen in Chapter 3 (Figure 3.1).  
 
6.3.2 Exercise training and nutritional supplements  
Full details of the RE intervention completed by participants in the EX+CON and EX+PRO 
groups, and nutritional supplements consumed by all participants have been previously 
detailed (see Chapter 3 - sections 3.5.1 and 3.5.2). Briefly, participants in the PRO and 
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EX+PRO groups consumed 25 g whey protein containing ~3 g leucine, 0.7 g tryptophan and 
0.8 tyrosine, whereas participants in the CON and EX+CON groups consumed an energy-
matched carbohydrate control. Supplements were consumed twice daily (at breakfast and 
lunch). The RE intervention consisted of twice-weekly supervised whole-body RE. During 
each session, participants completed two sets of eight repetitions followed by one set to 
volitional failure on six exercise machines (leg press, lateral row, hamstring curl, chest press, 
leg extension and shoulder press). Resistance exercise was performed at 80% 1RM. 
 
6.3.3 Dietary intake and habitual physical activity  
Participants completed 3-day food records (2 weekdays and 1 weekend day) at baseline (prior 
to commencing the intervention), and during weeks 6 and 12. Prior to baseline measurements, 
participants also completed a 3-day dietary recall and were provided a copy to replicate their 
intake on the day before post-intervention cognitive testing. Habitual physical activity was 
assessed using a tri-axial accelerometer (Actigraph GT9X; Actigraph, Pensacola, Florida, 
USA) on the dominant wrist for 7 days at baseline and during the final week of the intervention. 
Full details of the dietary and accelerometery analyses have been previously described (see 
Chapter 3 - sections 3.6.2 and 3.6.3). 
 
6.3.4 Skeletal muscle mass, maximal strength and physical function  
Full details of the methods used to measure SMM, maximal strength and physical function 
have been previously described (see Chapter 3 – section 3.6.1 for SMM measurement, and 
Chapter 5 – sections 5.3.6 and 5.3.7 for maximal strength and functional performance 
assessments). Briefly, SMM was measured by BIA using the equation of Janssen et al. 
(2000a). Skeletal muscle index (SMI, kg/m2) was calculated by dividing SMM by height 
squared. Maximal strength (1RM) was assessed on the leg press and leg extension machines. 
Physical function was assessed by the SPPB and the 6MWT. The SPPB included 3 timed 
tests [4 m gait speed, time to perform five chair raises, and standing balance (feet together, 
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semi-tandem and tandem)]. Each test was scored equally (0-4), and the total score between 
0 and 12 was used for analysis. 
 
6.3.5 Cognitive function  
Cognitive function was assessed whilst participants resided in respiration chambers as 
previously detailed in Chapter 4. Testing was performed under highly controlled standardised 
environmental conditions (relative humidity: 57 ± 5%; temperature: 24 ± 0.5 ˚C). Participants 
were free from distractions at all times. To minimise diurnal variation, cognitive function was 
assessed at 1000 h at baseline and following the 12-week intervention. Prior to testing, 
participants were prohibited from consuming alcohol or caffeine for 24 h and consumed a 
standardised breakfast at 0900 h (Tesco fruit and fibre with semi-skimmed milk; Tesco PLC, 
Hertfordshire, UK). The quantity of breakfast was scaled for each participant, based on energy 
requirements to achieve energy balance within the respiration chamber. Three participants in 
this study (n = 1 participant in the CON, PRO and EX+CON groups) did not participate in 
respiration chamber experiments; however, testing procedures (i.e., testing environment, 
timing, breakfast consumption and alcohol/caffeine restrictions) remained consistent for these 
participants.  
 
At baseline only (outside of the respiration chamber), the Mini-Mental State Examination 
(MSSE) was performed to determine general cognitive status (Folstein, Folstein, and McHugh 
1975). At baseline and 12 weeks, participants completed a battery of neuropsychological tests 
(£10.46 per test) (CANTAB; Cambridge Cognition, Cambridge, UK) on a tablet computer (iPad 
Air 2; Apple Inc., California, USA). The CANTAB has previously been established as a valid 
and reliable method for detecting age-related cognitive impairments (Rabbitt and Lowe 2000, 
Wild et al. 2008). The testing battery assessed the cognitive domains working memory, 
episodic memory, executive function, recognition and mental response speed. These were 
analysed as previous work has demonstrated ageing typically affects these cognitive domains 
(Hedden and Gabrieli 2004). The age-related decline in these cognitive functions has also 
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been associated with reduced physical function (Coppin et al. 2006, Demnitz et al. 2017) and 
poor quality of life (Woods et al. 2015). The testing battery consisted of the following tests: 
Motor Screening Task (MOT), Reaction Time (RTI), Spatial Working Memory (SWM), Paired 
Associates Learning Test (PALT), Multitasking Test (MTT), and Delayed Matching to Sample 
(DMS). The order of cognitive tests was consistent for both visits. Full details of each test are 
detailed below. To eliminate a potential learning effect, participants were familiarised with the 
CANTAB interface prior to testing. A short familiarisation trial of each test was also performed 
immediately prior to the final assessment trial at both visits. The tablet computer was kept on 
a computer stand throughout cognitive testing to ensure the computer tablet height was 
consistent for both visits. Participants were asked to sit a comfortable distance from the 
screen; finger distance from the screen was recommended at enough room to easily touch 
the entire screen as quickly as possible.  
 
6.3.5.1 Motor Screening Task (MOT) (Familiarisation test) – 2 min 
The MOT was conducted to relax participants and familiarise them with the CANTAB interface. 
Participants were required to touch a flashing cross shown at different locations on the screen 
(Figure 6.1). The test measured the mean latency (ms) to correctly respond and touch the 
stimulus. The MOT provided a general assay of whether sensorimotor or comprehension 











Figure 6.1 Visual display of the Motor Screening Task. © Copyright 2018 Cambridge 
Cognition Limited. All rights reserved. 
 
6.3.5.2 Reaction Time (RTI) – 4 min 
The RTI test assessed motor and mental response speed, and movement and reaction time 
(Cambridge Cognition Ltd. 2020). Participants were instructed to hold down a touchscreen 
button at the bottom of the screen (Figure 6.2). A yellow spot then appeared inside one of the 
five circles; participants were required to release the touchscreen button and touch the yellow 
spot as quickly as possible with the same finger. This was repeated 30 times. The following 
outcomes were analysed: 
 
• Reaction time (ms) – the median time taken to release the response button after 
presentation of the target stimulus (for correct trials only). 
• Movement time (ms) – the median time taken to release the response button and select 










Figure 6.2 Visual display of the Reaction Time test. © Copyright 2018 Cambridge Cognition 
Limited. All rights reserved. 
 
6.3.5.3 Spatial Working Memory (SWM) – 6 min 
Spatial working memory assessed participants ability to retain and manipulate spatial 
information in working memory (Cambridge Cognition Ltd. 2020). The test also assessed 
notable executive function demands, including strategy. Participants were instructed to find a 
token hidden inside boxes and move the token into the column on the right-hand side of the 
screen (Figure 6.3). A token was never hidden in the same box twice; therefore, participants 
should not have returned to a box which had already contained a token. The test had three 
stages (6, 8 and 12 boxes). Outcomes analysed were: 
 
• Between errors (n) - the number of times a box was reopened in which a token had 
previously been found. This indicated a failure to recall (calculated for 6, 8 and 12 box 
stages, and all stages combined). 
• Strategy (n) - the number of times a new search began using the same box started 










Figure 6.3 Visual display of the Spatial Working Memory test. © Copyright 2018 Cambridge 
Cognition Limited. All rights reserved. 
 
6.3.5.4 Paired Associates Learning Test (PALT) – 12 min 
The PALT assessed visuospatial episodic memory (Cambridge Cognition Ltd. 2020). Boxes 
were displayed on the screen and were opened one-by-one in a randomised order to reveal 
patterns hidden inside (Figure 6.4). Patterns were then displayed in the middle of the screen 
one at a time. Participants were required to touch the box where the pattern was located. If 
the participant made an error, the patterns were re-presented to remind them of their locations. 
The following outcomes were analysed: 
 
• Total errors (n) – the number of times an incorrect box was chosen.  
• First attempt memory score (n) - the number of times the correct box was chosen on 











Figure 6.4 Visual display of the Paired Associates Learning Test. © Copyright 2018 
Cambridge Cognition Limited. All rights reserved. 
 
6.3.5.5 Multitasking Test (MTT) – 8 min 
The MTT assessed executive functioning. The test measured participants ability to use 
multiple sources of potentially conflicting information to guide behaviour (Cambridge Cognition 
Ltd. 2020). An arrow was displayed on either the right- or left-hand side of the screen and 
participants were required to make a right or left response. Participants learnt whether to 
respond either according to the arrow direction, or according to the side of the screen the 
arrow appeared, no matter what the direction was. During the assessment stage, a cue was 
presented prior to the presentation of the arrow indicating whether the participant should 
respond according to the arrow direction or side (Figure 6.5). In some sections of the test, the 
same rule was applied consistently, whereas in the final phase, the rules were intermixed in a 
random order. The direction and side of the arrow was also incongruent for some trials. 
Outcomes analysed were: 
 
• Total incorrect (n) – the number of trials the incorrect button within the response 
window was pressed. 
• Reaction latency (ms) – the median latency of response (from stimulus appearance to 
pressing the response button - calculated across all correct trials).  
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• Incongruency cost (ms) – the difference between the reaction latency on trials that 
were congruent versus trials that were incongruent. A higher incongruency cost 
indicates processing conflicting information takes a longer. 
• Multitasking cost (ms) – the difference between the reaction latency during trials in 
which both rules (direction and side) were used versus trials in which only a single rule 
(direction or side) was used. A positive score signifies a slower response during 










Figure 6.5 Visual display of the Multitasking Test. © Copyright 2018 Cambridge Cognition 
Limited. All rights reserved. 
 
6.3.5.6 Delayed Matching to Sample (DMS) – 7 min 
Delayed matching to sample measured short-term visual recognition memory (Cambridge 
Cognition Ltd. 2020). The test measured participants’ ability to match a complex visual pattern 
to four samples, both simultaneously, or after a brief delay (0, 4 or 12 s) (Figure 6.6). 
Participants were instructed to touch the pattern that matched the sample. The percentage 
(%) of correct trials (for 0, 4 and 12 s delays individually, and all delays combined) were used 










Figure 6.6 Visual display of the Delayed Matching to Sample test. © Copyright 2018 
Cambridge Cognition Limited. All rights reserved. 
 
6.3.5.7 Domain-specific z-scores 
In addition to analysis of individual cognitive function test scores, individual scores were 
transformed into z-scores [(value-mean)/SD] at baseline and 12 weeks, using the mean and 
SD of the total sample at baseline as the reference population (Formica et al. 2020). To remain 
consistent with other cognitive outcomes (i.e., a higher z-score indicating better cognitive 
performance), z-scores relating to reaction time and errors, where a lower score indicates 
better performance, were reversed (value x -1). Individual z-scores were clustered into 
compound scores for the following five cognitive domains:  
 
• Psychomotor/attention = (ZMOT mean latency + ZRTI reaction time + ZRTI movement time)/3 
• Executive function = (ZMTT total incorrect + ZMTT reaction latency + ZMTT incongruency cost + ZMTT 
multitasking cost + ZSWM strategy score)/5 
• Episodic memory = (ZPALT total errors + ZPALT first attempt memory score)/2 
• Working memory = [ZSWM between errors (all boxes) + ZSWM between errors (6 boxes) + ZSWM between errors (8 
boxes) + ZSWM between errors (12 boxes)]/4 
• Global cognitive function = (Zcomposite psychomotor/attention + Zcomposite executive function + Zcomposite 
episodic memory + Zcomposite working memory)/4 
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6.3.6 Blood pressure  
Blood pressure was measured at multiple times (at 2130, 0805, 0900, 1225, 1355, 1715, 1835 
and 1955 h) whilst participants (n = 33) resided in the respiration chamber for 24 h under 
highly controlled conditions (see Chapter 4). Measurements were taken whilst participants 
were rested in a seated position using a British and Irish Hypertension Society (BIHS) 
validated automated BP monitor (Omron M6; Omron Health Care Ltd., Milton Keynes, UK). 
Prior to entering the chamber, participants were trained how to correctly self-administer BP 
measurement. Systolic and diastolic BP measured in the morning (0805 h), and the average 
systolic and diastolic BP over the 8 measurements (2130-1955 h) were used as outcome 
measures. Blood pressure was assessed as previous studies have shown an association 
between hypertension and cognitive impairment in older adults (Kritz-Silverstein et al. 2017, 
McDonald et al. 2017). It has been suggested that this relationship might be mediated by 
vascular reserve impairment and microvascular disease (Novak and Hajjar 2010). 
 
6.3.7 Blood and saliva collection and analysis  
Venous blood was collected at 0815 h following a >10 h overnight fast. Whole blood was 
collected into EDTA, heparin and SST vacutainers then centrifuged at 1900 x g for 10 min at 
4°C. Serum samples were rested for 30 min prior to centrifuging to allow for sufficient clotting. 
Aliquots containing plasma and serum were stored at -80°C until analysis (see section 3.6.4 
for detailed blood collection methodology). Due to difficulty in blood collection, blood was 
unable to be drawn from two participants (n = 1 participant in the CON and EX+CON groups). 
Therefore, n = 34 participants had full blood data. Plasma glucose was analysed using a 
glucose analyser (Biosen C-Line Glucose and Lactate Analyser; EKF Diagnostics, Cardiff, 
UK). Commercially available ELISA kits were used to analyse serum total BDNF (Item No. 
DNBT00) and IGF-1 (Item No. DB100B), and plasma IL-6 [Item No. D6050 and HS600C (the 
latter for high sensitivity)], TNF-a (Item No. HSTA00E), CRP (Item No. DCRP00) (R&D 
Systems Inc., Abbington, UK), and insulin (EIA-2935; DRG Instruments GmbH, Marburg, 
Germany). Insulin resistance (HOMA-IR) and sensitivity (QUICKI) were calculated from fasting 
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glucose and insulin concentrations using standard equations (Katz et al. 2000, Matthews et 
al. 1985): 
 
HOMA-IR: Fasting insulin (µU/mL) x fasting glucose (mmol/L) / 22.5 
QUICKI: 1 / [log(fasting insulin (µU/mL)) + log(fasting glucose (mmol/L))]. 
 
The CV for plasma glucose was 0.5%, and the intra-assay CV was 9.5% for plasma insulin, 
8.5% for serum BDNF, 9.1% for serum IGF-1, 9.8% and 11.8% for plasma IL-6 and IL-6 high 
sensitivity, respectively, 9.9% for high sensitivity plasma TNF-a, and 9.9% for plasma CRP.  
 
Saliva samples were collected whilst participants resided in the respiration chamber. As 
previously mentioned, three participants (n = 1 participant from CON, PRO and EX+CON 
groups) in this study did not participate in respiration chamber measurements; therefore, 
saliva was collected from n = 33 participants. Samples were collected immediately upon 
waking at 0650 h, and at 0805, 1225, 1700 and 2000 h using a synthetic swab (Salivette; 
Sarstedt Nümbrecht, Germany). Samples were centrifuged at 1900 x g for 2 min and stored 
at -80°C until analysis. Samples were analysed for salivary cortisol by ELISA (Item No. 1-
3002; Salimetrics, Pennsylvania, USA). The intra-assay CV was 9%. Salivary cortisol data 
(samples 1-5; 0650-200 h) was used to calculate multiple indices. Firstly, all five samples were 
used to calculate salivary cortisol AUC (nmol/L x 790 min) using the trapezoidal method. 
Secondly, cortisol slope (peak-to-evening) was calculated as the rate of salivary cortisol 
change from the peak morning (0650 or 0805 h, whichever concentration was highest) to the 
evening (2000 h) (Adam et al. 2017). Thirdly, salivary cortisol at 2000 h was also analysed 
individually as elevated evening cortisol has been associated with poorer cognitive functioning 
(Geerlings et al. 2015).  
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6.3.8 Statistical analysis  
Statistical analysis performed in this chapter has previously been detailed and can be seen 




6.4.1 Participants and compliance  
Thirty-nine older men were randomised: 36 completed the study and 3 withdrew. Reasons for 
withdrawal have been previously detailed in Chapter 3 (see Figure 3.2). Participants were 
66.9 ± 0.7 years of age, had no cognitive impairments [assessed by the MMSE (29.4 ± 0.1 
points)], had 14.4 ± 0.5 years of full-time education and were slightly overweight according to 
BMI (25.5 ± 0.4 kg/m2). Baseline characteristics of the 36 participants who completed the study 
are shown in Table 6.1. Compliance was high for both consumption of the nutritional 
supplements (CON: 94.1 ± 1.2%; PRO: 96.8 ± 1.0%; EX+CON: 96.1 ± 1.3%; EX+PRO: 96.1 
± 1.3%) and attendance to the RE training programme (EX+CON: 98.2 ± 1.0%; EX+PRO: 
98.2 ± 1.2%). During the final set (to volitional failure) the mean number of completed 
repetitions was 9.1 ± 0.3 in the EX+CON group and 9.1 ± 0.2 in the EX+PRO group. No 
differences occurred between groups for supplement compliance (P = 0.50), or between RE 
groups for exercise compliance (P = 0.63) or the mean number of repetitions completed on 
the final set of each exercise (P = 0.97).
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Table 6.1 Baseline characteristics of participants1  
 CON PRO EX+CON EX+PRO P value3 Overall 
n 9 9 9 9 - 36 
Age, y 67.2 ± 1.7 65.6 ± 1.7  67.1 ± 1.3 67.8 ± 1.3 0.75 66.9 ± 0.7 
MSSE, points 29.6 ± 0.3 29.3 ± 0.3 29.4 ± 0.3 29.4 ± 0.3 0.88 29.4 ± 0.1 
Education, y 14.4 ± 0.9  14.0 ± 1.0 14.7 ± 1.2 14.4 ± 0.9 0.96 14.4 ± 0.5 
Height, m 1.77 ± 0.01 1.76 ± 0.03 1.77 ± 0.02 1.74 ± 0.03 0.71 1.76 ± 0.01 
Body mass, kg 79.0 ± 3.4  78.0 ± 3.1  78.2 ± 3.9  80.9 ± 4.0 0.94 79.0 ± 1.8 
BMI, kg/m2 25.1 ± 1.0 25.0 ± 0.6  25.1 ± 0.9 26.6 ± 0.8  0.50 25.5 ± 0.4 
SMM, kg 26.7 ± 0.6  27.2 ± 0.7 25.9 ± 1.1 26.9 ± 1.3 0.79 26.7 ± 0.5 
SMI, kg/m2 8.5 ± 0.2 8.8 ± 0.2 8.3 ± 0.2 8.9 ± 0.3 0.19 8.6 ± 0.1  
FM, kg 19.2 ± 2.4 18.0 ± 1.7 19.6 ± 2.0 20.4 ± 1.5 0.85 19.3 ± 0.3 
FM, % 23.8 ± 2.0 22.7 ± 1.5  24.8 ± 1.7  25.1 ± 1.2  0.74 24.1 ± 0.8 
Leg extension 1RM, kg 63 ± 6  58 ± 3 52 ± 5 59 ± 4 0.52 58 ± 2 
Leg press 1RM, kg 116 ± 9 107 ± 7  107 ± 9 118 ± 7 0.66 112 ± 4 
SPPB, points 11.7 ± 0.2 11.4 ± 0.2 11.2 ± 0.3 11.8 ± 0.1 0.38 11.5 ± 0.1 
6MWT, m 639 ± 21 616 ± 18 627 ± 30 591 ± 26 0.54 618 ± 12 
Gait speed, m/s 1.09 ± 0.08 1.13 ± 0.04 1.14 ± 0.04 1.22 ± 0.05 0.51 1.15 ± 0.02 
Systolic BP, mmHg 127 ± 6 133 ± 6  133 ± 7 136 ± 4 0.57 132 ± 3 
Diastolic BP, mmHg 78 ± 2 76 ± 3 77 ± 4 77 ± 4 0.98 77 ± 1 
 
1Values are means ± SE. 3P value refers to differences between groups analysed by one-way ANOVA. No significant differences in baseline characteristics 
occurred between pooled exercise and non-exercise groups, or between pooled whey protein and control supplement groups (data not shown). 1RM, one 
repetition maximum; BMI, body mass index; BP, blood pressure; FM, fat mass; MMSE, mini-mental state examination; SMM, skeletal muscle mass; SPPB, 
short physical performance battery. Education (y) refers to the total amount of full-time education attended from primary school up to postgraduate university 
level.
 247 
6.4.2 Habitual dietary intake and physical activity  
Dietary intake and habitual physical activity data during the intervention period has been 
previously reported in Chapter 5 (sections 5.4.3 and 5.4.4). Briefly, protein intake increased 
over time in the PRO and EX+PRO groups greater than both the CON and EX+CON groups 
at weeks 6 (P < 0.001) and 12 (P < 0.001). Carbohydrate intake increased over time in the 
EX+CON group greater than the CON and EX+PRO groups at week 6 (P < 0.05), and greater 
than the PRO and EX+PRO groups at week 12 (P < 0.05). Total EI increased over time in the 
EX+PRO group at week 6 (P = 0.03) and increased in the CON group at weeks 6 and 12 (P 
< 0.05). No within- or between-group differences occurred for time spent sedentary, or in light 
or MVPA.  
 
6.4.3 Skeletal muscle mass, maximal strength, and physical function  
Skeletal muscle mass, maximal strength, and physical function changes over the intervention 
period for each intervention group have previously been reported in detail in Chapter 5. Briefly, 
SMM increased over time in the EX+CON (0.5 ± 0.2 kg) and EX+PRO groups (0.6 ± 0.3 kg), 
both of which trended towards statistical significance (P = 0.06). When RE groups were 
pooled, increases in SMM over time became significant (0.6 ± 0.2 kg, P = 0.006) and SMI also 
significantly increased (0.2 ± 0.1 kg/m2, P = 0.007). Leg extension and leg press 1RM 
significantly increased in only the EX+CON (leg extension: +38%; 52 ± 5 to 72 ± 6 kg, P < 
0.001; leg press: +28%, 107 ± 9 to 137 ± 8 kg, P < 0.001) and EX+PRO groups (leg extension: 
+36%; 59 ± 4 to 80 ± 4 kg, P < 0.001; leg press: +33%, 118 ± 7 to 157 ± 7 kg, P < 0.001). 
Increases in both leg press and leg extension 1RM in the EX+CON and EX+PRO groups were 
greater than both the CON and PRO groups (P < 0.001). Six minute walk test distance also 
increased over time in only these groups (EX+CON: 21 ± 7 m, P = 0.02; EX+PRO: 21 ± 6 m, 
P = 0.007). When RE groups were pooled, 6MWT distance increased over time greater than 
non-exercise groups pooled (P = 0.04). Gait speed increased by 0.11 ± 0.06 m/s in the PRO 
group, which tended to increase over time greater than the CON group (P = 0.06). 
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6.4.4 Cognitive function 
 
6.4.4.1 Motor Screening Task (MOT)  
All participants completed the MOT to ensure familiarisation with the CANTAB interface. No 
participants displayed any sensorimotor or comprehension difficulties during the test at either 
baseline or 12 weeks. Data collected at both visits was therefore deemed valid for all 
participants. At baseline, mean latency was comparable between groups (P = 0.40, Table 
6.2). Mean latency significantly decreased over time in the PRO (-101.3 ± 32.6 ms, P = 0.02, 
d = -1.10), EX+CON (-80.3 ± 29.2 ms, P = 0.02, d = -1.22) and EX+PRO groups (-80.6 ± 24.2 
ms, P = 0.02, d = -1.42). No changes were observed in the CON group (27.0 ± 48.4 ms, P = 
0.47, d = 0.24).  When whey protein supplement groups were pooled, mean latency decreased 
over time greater than control supplement groups pooled (P = 0.03). The same effect was not 
observed between pooled exercise and non-exercise groups (P = 0.12).  
 
6.4.4.2 Reaction Time (RTI) 
Both reaction (P = 0.36) and movement time (P = 0.52) were similar between groups at 
baseline and no within- or between-group differences occurred for either variable over the 
course of the study. No differences occurred between pooled exercise and non-exercise 
groups (P = 0.91; P = 0.93, respectively), or between pooled whey protein and control 
supplement groups (P = 0.34; P = 0.61, respectively).  
 
6.4.4.3 Spatial Working Memory (SWM) 
Spatial working memory test scores were comparable between groups at baseline (P > 0.61). 
Following the intervention, between errors (12 boxes) decreased in only the PRO group by 
38% (-14.7 ± 4.9, P = 0.02, d = -1.0, Figure 6.7). Differences between groups were not 
significant (P = 0.09). No within- or between-group differences were observed for any other 
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SWM test score, and no differences occurred between pooled exercise and non-exercise 


















Figure 6.7 Change in between errors (12 box stage) on the Spatial Working Memory test for 
each treatment group over the intervention period (means ± SE). Circles represent individual 
data points. #P < 0.05 from baseline.




























Table 6.2 Cognitive function test scores for each treatment group at baseline and 12 weeks1 
1Values are means ± SE. 2CON (n = 8), n = 1 participants data removed (>3SD from mean). 3EX+PRO (n = 8), n = 1 participants data removed (>3 SD from 
mean). 4EX+CON (n = 8), n = 1 participants data removed (>3 SD from mean). #P < 0.05 from baseline.
 CON PRO EX+CON EX+PRO P value 
 Baseline 12 weeks Baseline 12 weeks Baseline 12 weeks Baseline 12 weeks Time Group 
x time 
Motor Screening Task           
Mean latency, ms 801.6 ± 25.1 827.8 ± 29.4 873.6 ± 43.6 772.3 ± 39.7# 883.2 ± 69.8 789.1 ± 63.1# 800.8 ± 49.0 720.2 ± 52.4# 0.05 0.06 
Reaction time           
5-choice reaction time, ms 364.1 ± 12.7 371.1 ± 10.1 386.8 ± 15.4 395.2 ± 17.0 400.0 ± 15.0 402.4 ± 19.6 388.3 ± 9.2 392.9 ± 9.5 0.36 0.98 
5-choice movement time, ms  303.7 ± 22.4 284.9 ± 21.3 322.9 ± 20.8 321.4 ± 18.9 282.3 ± 17.0 308.7 ± 14.2 293.5 ± 17.7 279.1 ± 10.5 < 0.001 0.30 
Spatial Working Memory            
Between errors (All boxes), n  13.5 ± 2.6 9.1 ± 3.0 15.6 ± 3.3 11.4 ± 3.0 16.3 ± 3.3 12.9 ± 2.6 14.2 ± 2.6 13.4 ± 3.4 0.21 0.75 
Between errors (6 boxes), n 3.2 ± 1.0 2.1 ± 0.9 4.4 ± 1.2 2.3 ± 0.9 4.8 ± 1.0 4.0 ± 1.0 3.3 ± 1.0 2.8 ± 1.2 0.02 0.87 
Between errors (8 boxes), n  10.8 ± 1.9 6.2 ± 1.9 10.0 ± 2.3 8.6 ± 2.1 10.8 ± 1.6 8.0 ± 1.7 10.2 ± 2.2 9.6 ± 2.3 0.007 0.72 
Between errors (12 boxes), n  35.4 ± 3.1 32.7 ± 3.0 38.7 ± 4.7 24.0 ± 3.9# 31.8 ± 2.4 31.7 ± 3.0 32.7 ± 5.1 32.1 ± 4.7 0.009 0.09 
Strategy score  8.1 ± 0.6 6.6 ± 1.1 7.4 ± 1.1 6.3 ± 1.1 8.6 ± 1.1 8.3 ± 0.8 8.7 ± 1.0 7.1 ± 1.1 0.01 0.61 
Paired Associates Learning           
Total errors, n 15.8 ± 4.2 15.9 ± 4.4 16.0 ± 3.5 17.1 ± 4.5 24.9 ± 3.9 21.1 ± 5.5 24.9 ± 5.9 11.9 ± 2.5# 0.77 0.37 
First attempt memory score, n 13.2 ± 1.1 11.8 ± 1.1 12.8 ± 1.0 12.6 ± 1.6 9.9 ± 1.1 11 .3 ± 1.6 10.7 ± 1.7 12.8 ± 1.4 0.03 0.54 
Multitasking Test            
Total incorrect,2 n  2.4 ± 0.8 1.6 ± 0.6 4.2 ± 1.5 2.1 ± 0.7 3.9 ± 1.8 2.3 ± 0.6 4.1 ± 1.9 1.8 ± 0.6 0.02 0.90 
Reaction latency, ms 724.2 ± 20.9 723.6 ± 20.7 741.9 ± 38.8 735.4 ± 32.0 698.2 ± 47.1 737.5 ± 38.2 715.4 ± 39.0 713.1 ± 39.8 0.002 0.71 
Incongruency cost,3 ms 87.2 ± 29.9 86.1 ± 20.8 81.3 ± 19.5 63.9 ± 16.6 82.6 ± 13.9 116.3 ± 17.6# 92.1 ± 14.8 98.6 ± 18.6 0.01 0.10 
Multitasking cost,3,4 ms  205.9 ± 40.0 202.5 ± 29.4 337.7 ± 64.4 219.9 ± 45.0# 324.8 ± 43.1 218.3 ± 34.9# 270.9 ± 64.3 233.5 ± 38.7 0.02 0.41 
Delayed Matching to Sample           
% correct (All delays) 85.1 ± 2.4 88.9 ± 2.1 81.4 ± 3.5 84.6 ± 3.3 86.6 ± 2.9 80.7 ± 4.5 84.4 ± 3.1 84.4 ± 3.7 0.001 0.77 
% correct (0 s delay) 84.4 ± 4.4 91.1 ± 3.5 82.2 ± 5.2 88.9 ± 6.8 91.1 ± 3.5 82.2 ± 7.0 95.6 ± 2.9 84.4 ± 6.5 < 0.001 0.98 
% correct (4 s delay) 86.7 ± 5.8 84.4 ± 5.6 80.0 ± 6.7 86.7 ± 5.8 84.4 ± 5.6 82.2 ± 4.0 80.0 ± 8.8 88.9 ± 4.8 < 0.001 0.67 
% correct (12 s delay) 84.4 ± 4.4 91.1 ± 4.8 82.2 ± 5.2 77.8 ± 6.2 84.4 ± 2.9 77.8 ± 6.2 77.8 ± 6.2 80.0 ± 5.8 0.001 0.33 
Domain specific z-scores           
Psychomotor/attention 0.23 ± 0.17 0.20 ± 0.19 -0.21 ± 0.22 -0.05 ± 0.25 -0.14 ± 0.24 -0.11 ± 0.28 0.09 ± 0.24 0.33 ± 0.16 0.12 0.50 
Executive function 0.15 ± 0.18 0.29 ± 0.15 -0.08 ± 0.26 0.30 ± 0.18# 0.03 ± 0.13 -0.07 ± 0.16 -0.24 ± 0.31 0.06 ± 0.27# 0.08 0.32 
Episodic memory  0.34 ± 0.29 0.15 ± 0.29 0.27 ± 0.24 0.21 ± 0.36 -0.41 ± 0.27 -0.09 ± 0.39 -0.32 ± 0.42 0.43 ± 0.26 0.047 0.46 
Working memory -0.10 ± 0.63 0.79 ± 0.55 -0.60 ± 0.86 1.80 ± 0.68# 0.29 ± 0.50 0.58 ± 0.48 0.37 ± 0.82 0.54 ± 0.82 0.001 0.10 
Global cognitive function 0.16 ± 0.27 0.36 ± 0.22 -0.15 ± 0.28 0.58 ± 0.24# -0.06 ± 0.22 0.08 ± 0.22 -0.03 ± 0.34 0.33 ± 0.31 < 0.001 0.15 
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6.4.4.4 Paired Associates Learning Test (PALT) 
At baseline, no differences in total errors (P = 0.25) or first attempt memory score (P = 0.35) 
occurred between groups. At 12 weeks, total errors decreased in the EX+PRO group by 52.2% 
(-13.0 ± 5.5, P = 0.045, d = -0.79, Figure 6.8A), but no differences occurred between groups 


















Figure 6.8 Change in total errors on the Paired Associates Learning Test between groups 
and (means ± SE). Circles represent individual data points. #P < 0.05 from baseline. 
 
6.4.4.5 Multitasking Test (MTT) 
Multitasking test scores were similar between groups at baseline (P > 0.25). Following the 
intervention, incongruency cost increased in the EX+CON group by 40.7% (33.8 ± 10.1 ms, P 
= 0.03, d = 1.17), but no significant differences occurred between groups (P = 0.10). When 
exercise groups were pooled, incongruency cost increased compared to non-exercise groups 














































in the PRO group (-117.8 ± 25.8 ms, P = 0.002, d = -1.50), and by 32.8% in the EX+CON (-
106.5 ± 32.9 ms, P = 0.01, d = -1.14). No differences occurred between groups (P = 0.41).  
 
 
Figure 6.9 Changes in (A) incongruency cost between pooled exercise (n = 17) and non-
exercise (n = 18) groups, and (B) multitasking cost between groups over the intervention 
period on the Multitasking Test (means ± SE). Circles represent individual data points. n = 1 
participant’s data removed from the pooled exercise group for incongruency cost, and n = 1 
participant’s data removed from the EX+CON and EX+PRO groups data for multitasking cost 
(>3 SD from mean). †Significant group x time interaction, P = 0.046. #P < 0.05 from baseline. 
 
6.4.4.6 Delated Matching to Samples (DMS)  
At baseline, no differences were observed between groups for any DMS test score and no 
within- or between-group differences occurred over the intervention period. No differences 
occurred between pooled exercise and non-exercise groups, or between pooled whey protein 
and control supplement groups for any DMS test score. 
 
6.4.4.7 Domain-specific composite z-scores  
Composite domain-specific z-scores were similar between groups at baseline (P > 0.22). For 













































executive function (0.38 ± 0.12 SD, P = 0.01, d = 1.05), working memory (2.4 ± 0.76 SD, P = 
0.01, d = 1.05) and global cognitive function (0.72 ± 0.24 SD, P = 0.02, d = 0.98). In the 
EX+PRO group, composite executive function z-score significantly increased over time by 
0.30 ± 0.12 SD (P = 0.04, d = 0.78). No significant changes over time for any domain-specific 
z-score was observed in either the CON or EX+CON groups, and no differences occurred 
between groups. When exercise groups were pooled, episodic memory z-score increased by 
0.53 ± 0.23 SD (P = 0.03, d = 0.54, Figure 6.10A), but the increase was not significantly 
greater than non-exercise groups pooled (P = 0.14). When whey protein groups were pooled, 
global cognitive function tended to increase greater than control supplement groups pooled 
(P = 0.06, Figure 6.10B).  
 
 
Figure 6.10 Changes in domain-specific z-scores for (A) episodic memory between pooled 
exercise (n = 18) and non-exercise groups (n = 18), and (B) global cognitive function between 
pooled whey protein (n = 18) and control supplement (n = 18) groups (means ± SE). Circles 



























































6.4.5 Blood pressure 
Morning (0805 h) and average systolic and diastolic BP (8 readings between 2130-1955 h) 
were similar between groups at baseline (P > 0.47, Table 6.1). At 12 weeks, morning systolic 
and diastolic BP decreased in only the PRO group by 6.4% (-8 ± 2 mmHg, P = 0.001) and 7% 
(-4 ± 2 mmHg, P = 0.02), respectively. No differences occurred between groups for any BP 
variable.  
 
6.4.6 Neurobiological, inflammatory, salivary cortisol and insulin sensitivity markers  
At baseline, no differences occurred between groups for any of the above markers (P > 0.08). 
Following the intervention, both plasma IL-6 and TNF-a significantly decreased in the 
EX+PRO group by 21% (-1.2 ± 0.6 pg/mL, P = 0.01) and 20% (-0.6 ± 0.2 pg/mL, P = 0.03), 
respectively (Table 6.3). No differences occurred between groups for either variable (P = 0.13; 
P = 0.11, respectively). As previously reported in Chapter 5 (see Figure 5.4), when RE groups 
were pooled, both IL-6 (P = 0.048) and TNF-a (P = 0.02) decreased greater than non-exercise 
groups pooled. Insulin resistance (HOMA-IR) decreased significantly over time in only the 
EX+PRO group (-0.5 ± 0.2, P = 0.04), and insulin sensitivity (QUICKI) increased in both the 
PRO (0.02 ± 0.01, P = 0.04) and EX+PRO groups (0.02 ± 0.01, P = 0.02). No differences 
occurred between groups for either variable (P = 0.23; P = 0.22, respectively). The slope of 
salivary cortisol from peak morning to evening increased in the EX+PRO group by 92.1% (8.1 
± 2.8 nmol/L, P = 0.02), but no differences occurred between groups (P = 0.15). No within- or 
between-group differences were observed for plasma CRP, serum total BDNF or IGF-1, or 




Table 6.3 Fasting neurobiological, inflammatory, insulin sensitivity and salivary cortisol markers for each treatment group at baseline and 12 
weeks1 
 
1Values are means ± SE. 2n = 34; CON (n = 8), PRO (n = 9), EX+CON (n = 8), EX+PRO (n = 9). 3n = 33; CON (n = 8), PRO (n = 8), EX+CON (n = 8), EX+PRO 
(n = 9). AUC, area under the curve; BDNF, brain-derived neurotrophic factor; CRP, C-reactive protein; HOMA-IR, homeostatic model assessment of insulin 
resistance; IGF-1, insulin-like growth factor 1; IL-6, interleukin-6; TNF-a, tumor necrosis factor-alpha; QUICKI, quantitative insulin-sensitivity check index. #P < 





 CON PRO EX+CON EX+PRO P value 
 Baseline 12 weeks Baseline 12 weeks Baseline 12 weeks Baseline 12 weeks Time Group x 
time 
Serum total BDNF,2 pg/mL  27.1 ± 3.2 19.8 ± 2.9  22.8 ± 1.4 25.7 ± 3.2 22.5 ± 2.9 28.6 ± 4.4 26.6 ± 1.1 25.2 ± 1.9 0.01 0.22 
Serum IGF-1,2 ng/mL  152 ± 34 130 ± 29 119 ± 17  110 ±14 137 ± 16 119 ± 12 118 ± 15 100 ± 10 0.07 0.86 
Plasma IL-6,2 pg/mL  4.9 ± 1.2 5.8 ± 1.3 4.0 ± 1.0 4.0 ± 1.2 3.2 ± 0.9 2.4 ± 0.6 5.8 ± 1.8 4.6 ± 1.2# 0.09 0.13 
Plasma TNF-a,2 pg/mL  3.2 ± 0.3 3.0 ± 0.3 2.4 ± 0.3 3.0 ± 0.3 3.4 ± 0.6 2.7 ± 0.3 3.0 ± 0.4 2.4 ± 0.2# < 0.001 0.11 
Plasma CRP,2 ng/mL  2.4 ± 0.6 1.7 ± 0.3 1.6 ± 0.4  1.1 ± 0.5 0.8 ± 0.2 0.8 ± 0.2 2.0 ± 0.4 1.8 ± 0.2 0.18 0.18 
Salivary cortisol AUC,3 nmol/L x 790 min  4067 ± 551 4349 ± 528 4088 ± 196 45450 ± 425 5588 ± 969  5326 ± 778 4127 ± 587 4530 ± 414 0.001 0.99 
Salivary cortisol (2000 h),3 nmol/L  2.1 ± 0.5  1.9 ± 0.5 1.9 ± 0.4 2.2 ± 0.6 2.2 ± 0.6 1.8 ± 0.7 2.1 ± 0.7 2.6 ± 0.6 0.009 0.64 
Salivary cortisol slope,3 nmol/L  9.6 ± 1.1  9.1 ± 1.4 10.6 ± 0.8 13.6 ± 2.4 12.5 ± 2.5 15.7 ± 2.7 8.8 ± 1.4 16.9 ± 3.5# 0.004 0.15 
HOMA-IR2 2.6 ± 0.4 2.6 ± 0.5 2.7 ± 0.4 2.3 ± 0.6  2.9 ± 0.7 2.4 ± 0.6 2.2 ± 0.4 1.6 ± 0.3# 0.15 0.23 
QUICKI2 0.34 ± 0.01 0.34 ± 0.01 0.34 ± 0.01 0.36 ± 0.02# 0.33 ± 0.01 0.35 ± 0.01 0.35 ± 0.01 0.37 ± 0.01# 0.18 0.22 
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6.4.7 Correlation analysis  
No significant correlations (baseline or Δbaseline) were observed between any 
neurobiological, inflammatory, salivary cortisol or insulin sensitivity marker and any domain 
specific cognitive function z-score. Similarly, no correlations (baseline or Δbaseline) were 
observed for morning or average systolic or diastolic BP and any cognitive domain z-score. In 
contrast, at baseline, leg extension 1RM positively correlated with global cognitive function z-
score (r = 0.34, P = 0.045, Figure 6.11A). Significant positive correlations were also observed 
between SPPB score and psychomotor/attention (ρ = 0.51, P = 0.002, Figure 6.11B) and 
episodic memory z-scores (ρ = 0.35, P = 0.04, Figure 6.11C), and between 6MWT distance 
and psychomotor/attention z-score (r = 0.39, P = 0.02, Figure 6.11D). Following the 
intervention, ΔSMI positively correlated with Δepisodic memory z-score (r = 0.34, P = 0.046, 
Figure 6.11E). No correlations were observed for changes in maximal strength or physical 


























Figure 6.11 Baseline correlations between (A) leg extension 1RM and global cognitive function z-score; (B) SPPB score and 
psychomotor/attention z-score; (C) SPPB score and episodic memory z-score; and (D) 6MWT distance and psychomotor/attention z-score. Panel 
E shows the correlation between ΔSMI and Δepisodic memory z-score following the intervention. 1RM, one repetition maximum; 6MWT, 6 min 
walk test; SMI, skeletal muscle index; SPPB, short physical performance battery.
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This 4-arm, double-blind RCT investigated the individual and combined effects of 12 weeks 
RE and whey protein supplementation on cognitive function in healthy older men. The present 
study also sought to determine the individual and combined effects of these interventions on 
various neurobiological, inflammatory, insulin sensitivity and diurnal salivary cortisol markers, 
and SMM, maximal strength and physical function to identify mechanisms of action. The main 
findings were: 
 
i) In both the main and exploratory analyses, no significant between-group differences 
occurred for any outcome variable. 
ii) Whey protein supplementation per se elicited a within-group improvement in global 
cognitive function, working memory and executive function. When whey protein 
supplement groups were pooled, there was also a trend towards a greater increase in 
global cognitive function compared to control supplement groups pooled. 
iii) Resistance exercise alone demonstrated a within-group improvement in multitasking 
efficiency but worsened processing speed. When RE groups were pooled, a within-
group increase in episodic memory was observed. 
iv) Resistance exercise plus whey protein supplementation elicited a within-group 
enhancement in executive functioning and tended to improve episodic memory and 
global cognitive function. However, no significant additive effects were observed 
compared to RE or whey protein supplementation alone.  
v) At baseline, parameters of sarcopenia (muscle strength and physical performance) 
positively correlated with cognitive function domains. 
vi) Changes in domain-specific z-scores did not correlate with changes in any 
neurobiological, inflammatory or insulin sensitivity marker, nor BP or salivary cortisol 
indices. However, an association was observed between changes in SMI and episodic 
memory. 
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6.5.1 Effects of whey protein supplementation on cognitive function 
Protein supplementation per se elicited large within-group effects on composite scores for the 
cognitive domains executive function, working memory and global cognitive function. Previous 
work has suggested a 0.5 SD improvement in cognitive function may be considered clinically 
meaningful in cognitively healthy adults (Crichton et al. 2012). In the present study, whey 
protein supplementation induced larger improvements than 0.5 SD in working memory and 
global cognitive function, suggesting these findings are of clinical importance. The 
improvement in working memory coincides with previous acute (Kaplan et al. 2001) and 
longitudinal studies (Charlton et al. 2016). Additionally, although not observed in the present 
study, longitudinal improvements in reaction time, memory and emotion identification have 
also been observed by others (Charlton et al. 2016, Kita et al. 2019, Lefferts et al. 2020, van 
der Zwaluw et al. 2014). Importantly, as not all older adults are able or willing to perform RE 
(Dismore et al. 2020), these findings are of particular importance and suggest that increased 
dietary protein alone may attenuate age-related declines in cognitive function in these 
individuals. However, contrary to these findings, cognitive benefits of increased dietary protein 
have not been observed in all studies (Bell et al. 2019, Moran et al. 2018, Zajac et al. 2019). 
Six weeks consumption of a whey protein-based multi-ingredient supplement did not elicit 
improvements in any domains of cognitive function in healthy older men (Bell et al. 2019). 
Similarly, others have also reported no effects of 8 weeks supplementation of whey protein 
(Zajac et al. 2019), or 6 months consumption of a multi-ingredient supplement containing whey 
protein (Moran et al. 2018). Furthermore, although two previously cited studies have reported 
improvements in either reaction time or emotion identification following protein 
supplementation (Lefferts et al. 2020, van der Zwaluw et al. 2014), these studies observed no 
improvements in memory or executive functioning, which is in contrast to the findings of this 
study.  
 
The disparities in findings between studies investigating the effects of increased dietary 
protein on cognitive function in the elderly might be due to differences in the duration of 
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intervention and the protein dose employed. In support, two previously cited studies that did 
not report positive benefits of increased dietary protein investigated the effects over a 6-8 
week duration (Bell et al. 2019, Zajac et al. 2019), which, based on prior research, was likely 
insufficient to stimulate longitudinal changes in cognitive function (Vellas et al. 2008). 
Moreover, the multi-ingredient supplement investigated by Moran and colleagues (2018) 
contained only 8 g whey protein, and dietary data from participants in the study by van der 
Zwaluw et al. (2014), published elsewhere (Tieland et al. 2012c), reported that protein intake 
increased by 0.4 g/kg/d (1.0-1.4 g/kg/kg/d). These deviations in protein intake were less than 
that of the present study (0.6 g/kg/d; 1.0-1.6 g/kg/d). The dose of protein supplemented in 
these studies may therefore have been insufficient to yield changes in cognitive function. 
However, at present, no dose-response study has been conducted to determine the optimal 
daily intake of protein to improve cognitive function in older adults. Therefore, this dosing 
hypothesis is purely speculative and should be examined in future work. It is difficult to explain 
why Lefferts and colleagues (2020) did not report improvements in memory or executive 
functioning following protein supplementation considering the dose (50 g/d) and the duration 
of study (12 weeks) was identical to that of the present study. A significant limitation of this 
study, however, was the failure to control for dietary intake; therefore, whether the daily dose 
of protein (in g/kg/d) before and the deviation from baseline during the study whilst consuming 
the protein supplement was similar to that of the present study is unknown.  
 
6.5.2 Effects of resistance exercise on cognitive function  
Consistent with previous research in older adults (Anderson-Hanley, Nimon, and Westen 
2010, Best et al. 2015, Cassilhas et al. 2007, Coelho-Júnior et al. 2020, Ikudome et al. 2017, 
Liu-Ambrose et al. 2010, Marston et al. 2019c, Yoon, Lee, and Song 2018), this study 
observed within-group improvements in memory and aspects of executive function following 
RE training. Specifically, the present study observed a large within-group effect on 
multitasking efficiency. When RE groups were pooled, a medium effect was also observed for 
the reduction in total errors on the PALT and an increase in composite episodic memory z-
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score. However, it must be noted that these increases were driven more by the EX+PRO as 
opposed to the EX+CON group. Nevertheless, these findings suggest RE with or without 
additional protein supplementation may improve the QOL of elderly individuals and delay age-
related cognitive impairment. For instance, episodic memory, which supports remembering 
past events [i.e., what, where and when certain events happened (Tulving 2002)], is 
considered the most age sensitive (Nyberg 2017) and is a common characteristic of the 
memory loss seen in individuals with Alzheimer’s disease (Peters 2006). Multitasking is the 
ability to complete several tasks within a limited time by efficiently switching between tasks 
(Kosowicz and MacPherson 2017). In everyday context, this translates to activities such as 
preparing a meal, shopping and driving (Phillips, Kliegel, and Martin 2006).  
 
Although RE elicited within-group improvements in certain aspects of executive functioning, 
other aspects, such as incongruency cost, which is the time required to process conflicting 
information, worsened. Furthermore, whilst episodic memory improved when RE groups were 
pooled, no effect was observed for working memory. These findings are in contrast with 
previous studies that observed improvements in these cognitive aspects following RE in older 
adults (Cassilhas et al. 2007, Ikudome et al. 2017, van de Rest et al. 2014, Yoon, Lee, and 
Song 2018). Other studies are, however, in agreement with the findings observed in this study, 
reporting no improvements in either processing speed (Anderson-Hanley, Nimon, and Westen 
2010, Bell et al. 2019) or working memory (Liu-Ambrose et al. 2010). The disparities between 
studies in the literature may be explained by the intensity of RE employed. To add, studies 
that have demonstrated improvements in working memory (Ikudome et al. 2017) and 
processing speed (van de Rest et al. 2014, Yoon, Lee, and Song 2018) employed an 
intervention of moderate intensity RE (≤70% 1RM). Contrastingly, the present study and 
others that did not observe improvements employed a higher RE intensity (Bell et al. 2019, 
Liu-Ambrose et al. 2010). Additionally, a recent systematic review by Herold and colleagues 
(2019) concluded that moderate compared to high intensity RE was more beneficial for 
improving working memory and processing speed. This conclusion is supported by a meta-
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analysis that reported greater effect sizes following moderate compared to high intensity RE 
in healthy adults (Wilke et al. 2019). However, it must be noted that the intensity of RE in the 
present study (80% 1RM) was chosen for the primary purpose of increasing skeletal muscle 
strength, which is the main determinant of sarcopenia and most predominantly associated 
with health-related outcomes (Cruz-Jentoft et al. 2019, Menant et al. 2017), and not 
speciifcally for the aim of improving cognitive function.  
 
6.5.3 Effects of combined resistance exercise and whey protein supplementation on 
cognitive function 
The present study reported no statistically significant augmented effects of RE plus whey 
protein supplementation on domains of cognitive function compared to RE or whey protein 
supplementation alone. The lack of significant synergistic effects compared to RE alone is in 
agreement with recently published data in older adults (Bell et al. 2019, Formica et al. 2020, 
van de Rest et al. 2014). In frail elderly individuals, protein supplementation combined with 
RE did not stimulate additive effects on episodic memory, attention and working memory, 
information processing speed, or executive functioning compared to RE alone (van de Rest 
et al. 2014). van de Rest et al. (2014) did, however, observe an additive effect on information 
processing speed compared to protein alone, but the opposite was reported for verbal fluency. 
Interestingly, the present study observed similar findings, whereby whey protein 
supplementation alone improved cognitive function to a greater extent on certain cognitive 
tests than performing RE with or without whey protein supplementation.  
 
More recently, Formica et al. (2020) established multimodal exercise (aerobic + RE) improved 
global cognitive function and executive function in community-dwelling older adults, but 
consumption of lean red meat (2 x 80 g cooked weight on training days; ~45 g/d additional 
protein) did not enhance these cognitive domains. Contrary to this, the present study observed 
within-group improvements in these domains in the EX+PRO but not the EX+CON group. 
Also, the EX+PRO group observed a significant within-group decrease in total errors on the 
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PALT, which assessed episodic memory. The effect size for the reduction in total errors was 
also considerably greater in the EX+PRO compared to the EX+CON group (d = -0.79 vs -
0.37). The lack of synergistic effects in the study by Formica and colleagues (2020) was likely 
due to red meat being consumed, and dietary intake increased, on only 3 days per week.  
 
Bell et al. (2019) established no significant synergistic effects of multimodal exercise (RE + 
HIIT) combined with twice daily consumption of a whey protein-based multi-ingredient 
supplement on cognitive function in healthy older men. Nevertheless, similar to the present 
study, within-group improvements in composite cognitive function in only the exercise + whey 
protein group and greater effect sizes on a number of individual cognitive function tests 
compared to exercise alone were reported. In agreement, Rondanelli et al. (2020) 
demonstrated physical rehabilitation (including muscle strengthening, balance and gait 
exercises) combined with twice daily consumption of a leucine- and vitamin D-enriched whey 
protein supplement improved Trail Making Test performance, which examines executive 
functioning, processing speed, visual search speed and mental flexibility. However, it must be 
noted that the whey protein supplements in both of the above studies contained vitamin D, 
and in the study by Bell et al. (2019), the supplement also contained n−3 PUFA. These 
ingredients have previously been shown to attenuate cognitive decline (Balion et al. 2012, 
Karr, Alexander, and Winningham 2011), questioning the sole synergistic effects. Further 
research with a larger sample size is required to confirm whether increased dietary protein 
augments RE-induced improvements in cognitive function.  
 
6.5.4 Mechanisms of action   
The mechanisms through which exercise and dietary protein are purported to improve 
cognitive function is via increases in various growth and neurotrophic factors, decreases in 
inflammation and cortisol secretion, and reductions in cardiovascular risk factors (Ahlskog et 
al. 2011, Camfield et al. 2011, Liu-Ambrose et al. 2012, Tsai et al. 2015, Walsh et al. 2015). 
However, in the present study, no changes in serum total BDNF or IGF-1 occurred in any 
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group. These findings coincide with recently published studies that also demonstrated no 
increases in peripheral concentrations of IGF-1 or BDNF following 12 weeks RE training in 
healthy adults (Bell et al. 2019, Marston et al. 2019a). Furthermore, a meta-analysis 
conducted by Dinoff and colleagues (2016) reported RE was not effective at increasing 
circulating concentrations of BDNF, but AE was. Consequently, research to date indicates that 
participation in regular AE may be required alongside RE to stimulate increases in BDNF.  
 
In parallel with the within-group improvements in cognitive function, the present study reported 
significant reductions in concentrations of markers of systemic inflammation and an increase 
in diurnal salivary cortisol slope in the EX+PRO group, improved insulin sensitivity in the PRO 
and EX+PRO groups, and a reduction in morning systolic and diastolic BP in only the PRO 
group. An important finding from this study is that although RE and whey protein 
supplementation produced favourable changes that support the purported mechanisms of 
improved cognitive function, changes were not associated with alterations in composite 
cognitive domain scores. Contrary to these findings, a significant positive correlation was 
observed between changes in SMI and episodic memory. Likewise, at baseline, associations 
were also observed between numerous parameters of sarcopenia (i.e., muscle strength and 
physical function) and domain-specific cognitive function z-scores. These findings are 
consistent with previous studies that reported associations between lower extremity strength 
and cognitive functioning (Frith and Loprinzi 2018), and changes in muscle strength and 
cognitive function following RE training (Mavros et al. 2017).  
 
6.5.5 Relationship between sarcopenia and cognitive function 
Data from the present study coincides with recent meta-analyses that reported associations 
between sarcopenia and cognitive impairment (Chang et al. 2016, Cipolli, Yassuda, and 
Aprahamian 2019, Peng et al. 2020). Collectively, these findings suggest that attenuating age-
related declines in SMM, strength and physical function may play a key role in mitigating 
cognitive decline in older adults. However, at present, whether this association is purely casual 
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is unknown (Cipolli, Yassuda, and Aprahamian 2019). Investigation into the mechanisms that 
govern this relationship should be prioritised in future work, as should mechanisms that 
explain improvements in cognitive function following RE and/or increased dietary protein.   
 
6.5.6 Strengths and limitations 
The strengths of this study include the 4-arm, double-blind, randomised controlled design and 
the comprehensive assessment of multiple domains of cognitive function, indices of 
sarcopenia, BP, and analysis of numerous neurobiological, inflammatory and insulin sensitivity 
markers. Also, this study assessed diurnal salivary cortisol secretion pre- and post-
intervention under highly controlled conditions. Collectively, this enabled investigation into the 
individual and combined effects of RE and whey protein supplementation on cognitive function 
in healthy older men and allowed exploration of potential mechanisms of action. In addition, 
compliance to both the RE intervention (98.2 ± 0.7%) and the protein supplementation (96.4 ± 
0.8%) was high, indicating these interventions are feasible strategies to curb cognitive decline 
in healthy older adults.   
 
This study also has several limitations that warrant further discussion. Firstly, only healthy 
volunteers who had high levels of physical functioning (SPPB: 11.5 ± 0.1; 6MWT: 618 ± 12 
m), habitually consumed sufficient amounts of dietary protein (1.0 ± 0.02 g/kg/d) (Bauer et al. 
2013, Deutz et al. 2014), and were generally well educated (14.4 ± 0.5 y) participated in this 
study. Inclusion of solely these participants may have limited the ability to detect greater 
exercise- and protein-induced improvements in cognitive function. A second limitation was the 
measurement of only basal concentrations of growth and neurotrophic factors >72 h following 
the final RE session and not also immediately following an acute bout of exercise pre- and 
post-intervention. Consequently, any longitudinal effects of RE and whey protein 
supplementation on acute exercise-induced changes in growth and neurotrophic factors were 
missed. Thirdly, this study was relatively short in duration (12 weeks), which although was 
sufficient to detect within-group RE- and protein-induced changes in cognitive function 
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domains, greater effects may have been observed over a longer intervention period (Vellas et 
al. 2008). Finally, although within-group differences in individual and composite cognitive 
function tests were observed, this study was underpowered to detect between-group 
differences. The results presented in this study should therefore be interpreted with caution. 
Post-hoc sample size calculations revealed the following number of participants would have 
been required to detect between-group differences in key domain-specific cognitive scores: 
executive function, 88 (22/group); episodic memory, 120 (30/group); working memory, 56 
(14/group); and global cognitive function, 64 (16/group). 
 
6.5.7 Conclusion 
The primary findings from this study demonstrate that RE and whey protein supplementation 
alone and combined do not elicit significant between-group differences compared to control. 
Nevertheless, this study does show twice daily ingestion of whey protein supplementation for 
12 weeks is an effective stimulus to elicit within-group improvements in multiple domains of 
cognitive function, including executive function, working memory and global cognitive function. 
Resistance exercise alone, and combined with whey protein supplementation, may also elicit 
within-group improvements in executive function and episodic memory, but whey protein does 
not stimulate significant additive effects on these outcomes. Nevertheless, as a 0.5 SD 
improvement in cognitive function has previously been deemed clinically meaningful (Crichton 
et al. 2012), which was observed particularly following whey protein supplementation, these 
findings may be of clinical importance to curb age-related declines in cognitive function. Lastly, 
change in cognitive function domains were not associated with changes in neurobiological or 
inflammatory markers, but change in SMI was associated with change in episodic memory. 
This finding highlights the importance of attenuating age-related declines in SMM to preserve 





Thesis map: Key findings 
 Study Aims Key findings 
Study 1: Effects of resistance 
exercise and whey protein 
supplementation on 24-h 
energy expenditure, substrate 
oxidation and metabolic 
flexibility, body composition, 
appetite and glucose 
homeostasis in healthy older 
men 
• To investigate the individual and combined effects of RE 
and whey protein supplementation on components of 
24-h EE, substrate oxidation and metabolic flexibility, 
body composition, appetite, and glucose homeostasis in 
healthy older men.  
• Resistance exercise significantly increased FFM, RMR, 
SMR, sedentary EE and 24-h metabolic flexibility 
compared to non-exercise. RE also resulted in within-
group increases in subjective hunger and insulin 
sensitivity, and within-group decreases in the energy cost 
of step exercise and spontaneous activity.  
• Whey protein supplementation improved body weight 
maintenance and reduced FM, and increased insulin 
sensitivity; however, resulted in an increase in overnight 
protein oxidation and awakening cortisol secretion, and 
reduced 24-h protein balance.  
• Whey protein supplementation had no adverses effect on 
total protein or EI, or 24-h subjective appetite. 
• Resistance exercise combined with whey protein 
supplementation did not significantly augment changes in 
body composition, 24-h EE, substrate oxidation or 
metabolic flexibility, or markers of glucose homeostasis 
compared to either RE or whey protein supplementation 
alone. 
Study 2: Effects of resistance 
exercise and whey protein 
supplementation on skeletal 
muscle mass, strength, 
physical function, and 
hormonal and inflammatory 
biomarkers in healthy older 
men 
• To investigate the individual and combined effects of RE 
and whey protein supplementation on SMM, strength, 
physical function, and hormonal and inflammatory 
biomarkers in healthy older men.  
• To determine whether changes in hormonal and 
inflammatory biomarkers correlate with changes in 
SMM, strength and physical function.  
• Resistance exercise significantly increased FFM, muscle 
strength and physical function, and decreased markers of 
systemic inflammation. 
• Whey protein supplementation alone increased physical 
function (4 m gait speed) and muscle strength (leg press 
1RM).  
• No synergistic effects occurred for any parameter of 
sarcopenia compared to RE or whey protein alone.  
• Changes in hormonal and inflammatory biomarkers did 
not correlate with changes in parameters of sarcopenia, 
but diurnal salivary cortisol and sarcopenia indices did at 
baseline. 
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Thesis map: Key findings continued  
Study Aims Key findings 
Study 3: Effects of resistance 
exercise and whey protein 
supplementation on cognitive 
function in healthy older men 
• To investigate the individual and combined effects of RE 
and whey protein supplementation on cognitive function 
and neurobiological, inflammatory and insulin sensitivity 
markers, diurnal salivary cortisol, and BP in healthy 
older men. 
• To determine whether changes in neurobiological, 
inflammatory and insulin sensitivity markers, and 
changes diurnal salivary cortisol, BP, SMM, strength and 
physical function are associated with changes in 
cognitive function. 
• Resistance exercise and whey protein supplementation 
alone and combined did not elicit significant between-
group differences compared to control. 
• Whey protein supplementation per se elicited within-group 
improvements in global cognitive function, working 
memory and executive function. When whey protein 
supplement groups were pooled, there was a trend 
towards a greater increase in global cognitive function 
compared control supplement groups pooled. 
• Resistance exercise alone elicited within-group 
improvements in multitasking efficiency but worsened 
processing speed. When RE groups were pooled, 
episodic memory significantly improved. 
• Resistance exercise plus whey protein supplementation 
elicited within-group enhancements in executive 
functioning and tended to improve episodic memory and 
global cognitive function. However, no significant additive 
effects were observed compared to RE or whey protein 
supplementation alone.  
• At baseline, parameters of sarcopenia (muscle strength 
and physical performance) positively correlated with 
several cognitive function domains. 
• Changes in domain-specific z-scores did not correlate with 
changes in any neurobiological, inflammatory or insulin 
sensitivity marker, nor BP or salivary cortisol indices. 
However, an association was observed between changes 


































This thesis investigated the individual and combined effects of RE and whey protein 
supplementation in healthy older men. To achieve this, a 12-week, 4-arm, double-blind RCT 
was conducted between October 2017 and May 2019. Participants ingested either 25 g whey 
protein supplementation (or an energy-matched control) twice daily with or without twice 
weekly supervised RE. Numerous outcome variables were assessed pre- and post-
intervention, including 24-h energy metabolism, parameters of sarcopenia, cognitive function 
and biomarkers relating to sarcopenia, metabolic health and cognitive decline. The following 
chapter will present a summary of the key findings presented in this thesis. Additionally, clinical 
and practical applications besides strengths and limitations of the thesis will be presented, 
and directions for future research will be proposed.   
 
7.2 Summary of key findings 
This thesis demonstrates as little as 12 weeks of RE in healthy older men is an effective 
stimulus to improve multiple health-related outcomes. Specifically, RE increased FFM, muscle 
strength and physical function, augmented multiple components of EE (i.e., RMR, SMR and 
sedentary EE) as well as 24-h metabolic flexibility and decreased markers of systemic 
inflammation compared to non-exercise. Additionally, RE also elicited within-group 
improvements in subjective hunger and insulin sensitivity, reduced the energetic cost of step 
exercise and stimulated within-group improvements in the cognitive functions multitasking 
efficiency and episodic memory. Whilst several of these outcomes have been reported 
previously in the literature, the original contribution of data in this thesis is the longitudinal 
effects of RE on 24-h metabolic flexibility and subjective hunger, and the effects on numerous 
biomarkers in older healthy older men. However, whilst RE improved many outcomes, PAL 
was in fact decreased and a within-group decrease in processing speed was observed. 
Although, the former of these may have been due to participants being confined to respiration 
chambers and not measured post-intervention in free-living.  
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In addition to RE, data presented in this thesis suggests whey protein supplementation may 
also be an effective stimulus to offset declines in health-related outcomes. For instance, twice 
daily whey protein supplementation for 12 weeks aided maintenance of body mass, reduced 
FM, decreased the energetic cost of spontaneous activities and step exercise in the fasted 
state, and increased insulin sensitivity compared to an isocaloric carbohydrate control. 
Furthermore, whey protein supplementation also increased gait speed, tended to increase 
muscle strength, and stimulated multiple within-group improvements in multiple components 
of cognitive function, including working memory, executive function, and global cognitive 
function. However, results from this thesis highlight a potential caveat of a longitudinal high 
protein diet via whey protein supplementation in the elderly. That is, an increase in protein 
oxidation in the overnight fasted state and subsequent decrease in overnight protein balance. 
Whilst this effect has been seen following a shorter duration in older adults by others (Højfeldt 
et al. 2020), data presented in this thesis adds original contribution to the literature that this 
effect is also observed after 12 weeks. 
 
Based on the findings of published meta-analyses (Cermak et al. 2012, Finger et al. 2015, 
Liao et al. 2017, Morton et al. 2018a) and RCTs (Bell et al. 2017, 2019, Daly et al. 2014, Junior 
et al. 2018, Rondanelli et al. 2016, 2020, Tieland et al. 2012b, Verreijen et al. 2015, Yamada 
et al. 2019, Zdzieblik et al. 2015), it was hypothesised that twice daily whey protein 
supplementation would augment the effects of RE on components of EE and metabolic health, 
and parameters of sarcopenia and cognitive function in healthy older men. However, the 
results of this thesis suggest that combined intervention does not significantly amplify the 
effects of any of the aforementioned markers compared to either RE or whey protein 
supplementation alone. Furthermore, only combined RE and whey protein supplementation 
and not either intervention individually had an adverse effect on spontaneous activity. It is 
hypothesised this decrease may be a compensatory mechanism to offset declines in FM (Hall 
et al. 2012).  
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Two interesting findings were observed from the baseline data within this thesis. Firstly, diurnal 
salivary cortisol secretion significantly inversely correlated with multiple parameters of 
sarcopenia; secondly, several components of cognitive function correlated with sarcopenia 
indices. For example, significant inverse correlations were observed between diurnal salivary 
cortisol secretion and SMI, muscle strength (handgrip strength and leg press 1RM) and 
physical function (6MWT distance). Whilst these findings suggest measurement of salivary 
cortisol may be a promising biomarker of sarcopenia, no changes in diurnal salivary cortisol 
occurred following RE, despite increases in parameters of sarcopenia observed, which 
questions its clinical application as a biomarker. Additionally, several cognitive domains (i.e., 
global cognitive function, psychomotor/attention, episodic memory) correlated with 
parameters of sarcopenia at baseline [i.e., muscle strength (leg extension 1RM) and physical 
performance (SPPB and 6MWT distance)]. These findings emphasise the importance of 
maintaining SMM and function in older age to offset age-related declines in cognitive function.  
 
An observation seen on numerous outcomes reported in this thesis is high interindividual 
variability. In particular, large interindividual variability occurred in bodyweight management 
outcomes. For example, following whey protein supplementation, change in body mass varied 
between -4.5 kg and 3.5 kg. This variance may be partially explained by interindividual 
differences in the effect of the high protein diet on EE outcomes, EI and physical activity. In 
support, Bray et al. (2012) observed interindividual variability in RMR (ranging from ~0-260 
kcal/d) following 8 weeks of overeating dietary protein. Thus, although not observed post-
intervention inside the respiration chamber when protein intake was returned to baseline 
levels, differences in EE may have occurred in free-living between participants randomised to 
whey protein supplementation groups whilst they were consuming the supplementation. 
Additionally, observed differences in EI and physical activity (step count) from baseline to 12 
weeks (-230 to 501 kcal/d for EI and -2307 to 5356 steps/d) was seen following whey protein 
supplementation. Together, as all the above outcomes influence body mass, it is likely that 
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interindividual differences in body mass following whey protein supplementation may be 
explained by physiological and environmental factors.  
 
In addition to change in body mass following whey protein supplementation, high 
interindividual variability (ranging from -1.5 to 2.7 kg) was seen in change in FFM following RE 
training. As FFM is strongly associated with EE (Manini 2010), this variability also likely 
contributed to the variability also seen in EE outcomes following RE. It has been proposed 
that differential responses in ribosome biogenesis and consequent MPS rate during RE 
explain some of the interindividual variance (Roberts et al. 2018). Additionally, high 
responders to RE have also been shown to experience greater satellite cell proliferation, 
higher intramuscular androgen receptor content, and express a muscle microRNA profile that 
enhanced IGF-1 during RE than low responders (Roberts et al. 2018). However, as the 
present study did not investigate these mechanistic outcomes and limited data is available in 
older adults examining the effects of high vs. low responders (Roberts et al. 2018), future 
research should investigate these mechanisms to aid identification of extrinsic factors (e.g., 
exercise dose) to aid maximal response in low responders.  
 
Following the intervention, no correlations were observed between changes in parameters of 
sarcopenia and changes in hormonal or inflammatory biomarkers. Similarly, changes in 
cognitive function were not correlated with any markers purported to be mechanistically 
associated with cognitive decline (i.e., neurobiological, inflammatory or insulin sensitivity 
markers, BP or cortisol secretion). Together, these findings suggest that changes in SMM, 
strength and physical function following RE and/or increased dietary protein intake are not 
explained by changes in hormonal or inflammatory pathways, and that changes in cognitive 
function are likely not explained by changes in inflammation, growth factors, insulin sensitivity, 
the HPA axis or BP.  
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7.3 Clinical and practical applications  
The findings of this thesis have a number of important applications for both the health of elderly 
individuals and also to healthcare services globally. Firstly, as age-related obesity, which has 
risen by ~35-60% in middle- and older-aged adults since 1980 (Flegal et al. 2012, Gutiérrez-
Fisac et al. 2012, Howel 2012, Oreopoulos et al. 2009), is heavily linked to metabolic disease 
(Wannamethee and Atkins 2015), the increase in components of EE, metabolic flexibility and 
insulin sensitivity following RE, and the maintenance of body mass, reduction in FM and 
enhanced insulin sensitivity following whey protein supplementation reported in study 1 
(Chapter 4), may offset sarcopenic obesity and age-related metabolic dysfunction. As a result, 
long-term use of these interventions may allow older adults to live their later years with 
improved weight maintenance and metabolic function, thereby mitigating their risk of metabolic 
disease. Also, these findings indicate RE and whey protein supplementation may also reduce 
the demand of healthcare services to provide clinical care and reduce the economic burden 
of age-related metabolic disease (König et al. 2015). 
 
Secondly, as RE elicited a within-group increase in 24-h subjective hunger and whey protein 
supplementation did not adversely affect appetite, the findings of  Chapter 4 may have clinical 
implications for reducing the anorexia of ageing, a condition characterised by reductions in 
appetite and increased satiety (Wysokiński et al. 2015), which affects ~20% of older adults 
(Atalayer and Astbury 2013). As reductions in energy and protein intake are two key 
contributors of sarcopenic muscle loss and frailty (Atalayer and Astbury 2013, Paddon-Jones 
et al. 2015), the increase in subjective hunger following RE may indirectly offset sarcopenic 
muscle loss via effects on appetite (i.e., consuming more energy and potentially protein 
intake). Also, as whey protein supplementation did not adversely affect appetite or overall EI, 
and may offer small but significant benefits over an isocaloric control for muscle strength, 
physical function and components of cognitive function (as reported in Chapter’s 5 and 6), 
these findings might also have significant implications as a strategy to offset age-related 
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declines in sarcopenia and cognitive function in those who are unable or unwilling to perform 
RE (Dismore et al. 2020).  
 
A third noteworthy implication of the present thesis is the clinically significant increases in 
SMM (2.3%), muscle strength (31-36%) and physical function (3.4%) following RE training as 
reported in Chapter 5. Previous work has demonstrated from ~45 years of age, SMM, strength 
and physical function decline at rates of ~0.5-1%, ~1-3%, and ~0.5% per annum, respectively 
(Clark and Manini 2008, Daly et al. 2013, Janssen 2010). The increases in these parameters 
following as little as 12 weeks of RE may theoretically offset 5-10 years of age-related declines 
in these parameters. Furthermore, age-related sarcopenia has been associated with an 
increased risk of falls, fractures and impairments in the ability to perform ADL (Beaudart et al. 
2017), cardiovascular (Bahat and Ilhan 2016) and metabolic disease (Hunter et al. 2019), and 
mortality (de Buyser et al. 2016). The notable improvements in sarcopenic parameters 
following RE training may therefore curb age-related prevalence of these outcomes.  
 
Additionally, if the above findings were replicated in a sarcopenic cohort, they might also offer 
practical implications in the everyday lives of older adults, such as improved physical function 
and QOL. Indeed, an increase in muscle strength has been associated with a reduced 
likelihood of impairments in the ability to perform ADL, increased functional independence, 
and a decreased need for family/friend support (Gopinath et al. 2017). Furthermore, similar to 
that as highlighted above regarding the logistical and economic burden of age-related 
metabolic disease, data published from the NHS has reported the incidence of falls in 2015/16 
was 204,269 (NHS 2017), with a financial burden estimated at £2.5 billion (Pinedo-Villanueva 
et al. 2019). As such, as improvements in muscle strength and physical function are 
associated with a reduction in the incidence of falls in older adults (Smee et al. 2012, Yang et 
al. 2018), improvements in these parameters may also have significant logistical and 
economic implications to healthcare services globally.  
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Alongside improvements in parameters of sarcopenia, the reduction in systemic inflammation 
following RE also offers numerous clinical and practical applications. As previously highlighted 
in this thesis (section 2.2.8.5), inflammaging is a condition characterised by low-grade 
systemic inflammation with age (Franceschi et al. 2006) and is associated with reduced 
physical function, muscle strength, CVD, insulin resistance and T2DM, cognitive decline and 
a higher risk of mortality (Calder et al. 2017). The decrease in systemic inflammation reported 
in Chapter 5 may therefore have significant clinical implications for attenuating these 
outcomes. Furthermore, reducing the incidence of the abovementioned conditions may also 
have financial implications. As examples, at present, CVD (NHS 2019) and T2DM (Diabetes 
UK 2014) are estimated to cost the NHS £7 billion and £8 billion per annum, respectively. 
Whilst the causes of these diseases are multifactorial (Colpani et al. 2018, Rawshani et al. 
2018), even a slight reduction in the prevalence via a reduction in inflammatory pathways may 
have a significant impact on disease incidence and progression.  
 
In addition to the effects of RE on parameters of sarcopenia, Chapter 5 also shows whey 
protein supplementation provided a significant greater effect on physical function and a trend 
for a greater increase in muscle strength compared to an isocaloric carbohydrate control. 
Whilst the effect was considerably less than that of RE, which has also been acknowledged 
by others (Phillips and Martinson 2019), these findings may have significant implications for 
older adults who are unable or unwilling to perform RE (Dismore et al. 2020). Indeed, as 
highlighted above, sarcopenia has both financial and health-related adverse effects. Whilst 
whey protein supplementation elicited no effect on SMM, recently published revised diagnostic 
criteria of sarcopenia by the EWGSOP2 emphasise muscle strength as the primary parameter 
due to research demonstrating a stronger association with adverse health outcomes (Cruz-
Jentoft et al. 2019). Therefore, even a small attenuation of muscle strength and physical 




Lastly, the within-group improvements in cognitive function following whey protein 
supplementation and RE reported in study 3 (Chapter 6) also offers clinical and practical 
applications. Whey protein supplementation resulted in improvements in working memory, 
executive functioning, and global cognitive function. Resistance exercise alone increased 
episodic memory, and RE combined with whey protein supplementation increased executive 
functioning. Working memory is the temporary storage of information prior to entering long-
term memory (Harada, Love, and Triebel 2013), and episodic memory is a person’s unique 
memory of a specific event (Peters 2006). Executive functioning includes planning, organising 
and problem-solving skills (Harada, Love, and Triebel 2013), and global cognitive function 
encompasses aspects of all cognitive domains. In older adults, a 0.5 SD improvement in 
cognitive function has been suggested to be clinically meaningful (Crichton et al. 2012). The 
magnitude of increase in working memory and global cognitive function following whey protein 
supplementation (2.4 ± 0.76 SD and 0.72 ± 0.24 SD, respectively), the increase in episodic 
memory following RE (0.74 ± 0.37 SD), and the increase in executive functioning following 
combined RE and whey protein supplementation (0.53 ± 0.23 SD), were all above this clinically 
meaningful change and can therefore be deemed significant findings.  
 
In practical terms, the improvements in cognitive function might have implications for the 
everyday lives of older adults, such as improved ability to follow and remember instructions, 
enhanced medication adherence, and superior capability to plan social activities, prepare 
meals and manage finances. Overall, this may aid autonomy, enhance inclusion in society, 
and improve overall QOL (Baars and Dohmen 2013). In clinical terms, MCI affects 17.1% of 
adults aged ≥65 years in the United Kingdom, with global prevalence of dementia estimated 
at ~50 million people (Petersen 2016, World Health Organisation 2019). Attenuation of 
cognitive decline either via RE or increased dietary protein intake may consequently reduce 
the overwhelming patient clinical need from healthcare professionals. On an economic level, 
a recent study in the United Kingdom reported a 30-50% reduction in cognitive decline would 
result in a total societal saving of £670-£1100 per person over 18 months (Lenox-Smith et al. 
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2018). Taking into account the high prevalence of dementia coupled with the economic cost 
in the United Kingdom (£26.3 billion per annum) (Alzheimer’s Society 2014), the findings from 
Chapter 6 might have significant economic implications to healthcare providers.  
 
7.4 Strengths of the thesis  
The series of studies presented in this thesis have numerous strengths that enhance the 
novelty of this work. These will be presented in subsequent sections. 
 
7.4.1 Study design 
The present thesis adopted a 4-arm, double-blind, randomised controlled experimental 
design. This contrasts with most previous studies cited in this thesis that investigated the 
synergistic effects of RE and whey protein supplementation on parameters of sarcopenia, 
metabolic health and cognitive function. Of note, many of these studies failed to include a 
protein only group and compared the synergistic effects against just RE alone. In fact, only 
8/39 studies cited in this thesis that investigated the combined effects of RE and increased 
dietary protein employed a 4-arm design which compared the synergistic effects to both 
interventions alone (de Carvalho Bastone et al. 2020, Gryson et al. 2014, Kim et al. 2012, Kirk 
et al. 2020, Kukuljan et al. 2009, Shahar et al. 2013, van de Rest et al. 2014, Verreijen et al. 
2017). As previously highlighted in this chapter, not all older adults are willing or able to 
perform RE (Dismore et al. 2020); therefore, analysis of the effects of whey protein 
supplementation alone also allowed for comparison with both RE alone, and RE combined 
with whey protein supplementation. Subsequently, this enabled investigation into the efficacy 
of this nutrient in those participants unable to perform RE.  
 
7.4.2 Use of an energy-matched control product  
Only two studies cited in this thesis that investigated the individual and combined effects of 
RE and dietary protein including four experimental groups supplemented participants in the 
control groups with a placebo or energy-matched control supplement  (Gryson et al. 2014, van 
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de Rest et al. 2014). The non-placebo/energy-matched methodological approach in the 
remaining six 4-arm studies cited in this thesis may have increased the risk of bias (i.e., 
participants in non-protein groups increasing their protein intake) (de Carvalho Bastone et al. 
2020, Kim et al. 2012, Kirk et al. 2020, Kukuljan et al. 2009, Shahar et al. 2013, Verreijen et 
al. 2017). For this reason, an expert working group has recommended the double-blind RCT 
as the mainstay of experimental design for trials investigating the effectiveness of 
interventions to treat or prevent sarcopenia (Reginster et al. 2016). As participants in control 
groups in the present thesis were supplemented with an isocaloric control product, it can be 
hypothesised with a higher degree of certainty than the majority of previous work that the 
findings presented are as a result of differences in macronutrient content and not due to 
differences in EI provided by the intervention feed.  
 
7.4.3 Optimal dietary protein intake 
It has been hypothesised that the lack of effect of increased dietary protein in many previous 
studies cited in this thesis was due to dietary protein being insufficiently increased during the 
intervention period (<0.4 g/kg/d) and total dietary protein intake being <1.6 g/kg/d, the reported 
intake required to maximally accrete SMM during RE (Park, Choi, and Hwang 2018, Morton 
et al. 2018a). In the present thesis, dietary protein intake of participants was increased via 
whey protein supplementation by >0.4 g/kg/d (from ~1.1 to 1.6 g/kg/d). Therefore, individual 
studies in the present thesis are novel in the fact they are only one of a few studies (Bell et al. 
2017, 2018, 2019, Norton et al. 2016, Weinheimer et al. 2012) that have investigated the 
individual and combined effects of RE and increased dietary protein intake in older adults 
employing the optimal dose of dietary protein. 
 
7.4.4 Multidisciplinary investigation and resistance exercise supervision 
The multidisciplinary nature of the present thesis and the supervision of RE sessions are also 
noteworthy strengths of this work. As ageing is a multifactorial concept, with many pathologies 
interlinking with one another (Lloyd-Sherlock et al. 2012), the multidisciplinary investigation 
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allowed for analysis of a wide range of topical areas observed during the ageing process. 
Consequently, the findings may aid in the holistic attenuation of age-related disease. 
Regarding the exercise supervision, each session was supervised on a 1-to-1 or 2-to-1 basis 
with a qualified exercise professional, ensuring the exercise intervention was conducted in a 
safe manner. Potentially, although speculative, the close supervision of the exercise 
intervention might have resulted in greater effects on primary outcomes measured. In support, 
a recent meta-analysis reported augmented effects of supervised compared to non-
supervised RE in older adults (Lacroix et al. 2017). Furthermore, the supervised nature of the 
RE intervention may have also contributed to the high compliance reported (98.2 ± 0.7%). 
Importantly, high compliance to RE is likely a key strategy to mitigate sarcopenic muscle loss; 
however, such supervision is not feasible in the long-term, highlighting the need for follow-up 
data in this population.  
 
7.4.5 Monitoring of dietary intake and habitual physical activity 
Both habitual dietary intake and physical activity were monitored throughout the intervention 
to control for potential changes which may have influenced key outcomes. Whilst most 
previous studies in the literature controlled for changes in dietary intake, few studies have 
controlled for changes in physical activity using accelerometery. This level of experimental 
control subsequently allowed for examination of the true individual and combined effects of 
RE and whey protein supplementation without questioning external factors which may have 
influenced findings. 
 
7.4.6 Use of gold standard methodology to measure 24-h energy metabolism  
A key strength of study 1 (Chapter 4) was the use of respiration chambers to measure 24-h 
energy metabolism. Respiration chambers allow for continuous measurement of EE and 
substrate utilisation under highly controlled conditions (e.g., controlling for dietary intake and 
physical activity) for 24 h up to serval days (Schoffelen and Plasqui 2018). As a result, they 
are also considered the gold standard instrument for measurement of minute-by-minute EE 
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(Brychta et al. 2009). Furthermore, whilst the number of respiration chambers globally is 
growing, there are still only a limited amount of research centres with such facilities (Schutz 
2018). Use of this instrumentation is a novel aspect of this thesis as it allowed for 
measurement of multiple components of 24-h EE (i.e., RMR, SMR, AEE, SPA, sedentary EE, 
TEE), besides 24-h metabolic flexibility and appetite whilst controlling for several confounding 
variables as highlighted above. This contrasts with many previous studies that investigated 
the combined effects of RE and increased dietary protein on EE in the elderly that typically 
only measured RMR (Amamou et al. 2017, Campbell et al. 1994, Maltais et al. 2016, 
Weinheimer et al. 2012). Therefore, as far as the author is aware, data presented in this thesis 
is the first in older adults to determine the individual and combined effects of RE and whey 
protein supplementation on multiple components of 24-h energy metabolism.  
 
7.4.7 Comprehensive assessment of markers associated with sarcopenia, metabolic 
health, and cognitive function  
The assessment of multiple biomarkers associated with sarcopenia (i.e., IGF-1, myostatin, 
cortisol, IL-6, TNF-a and CRP), metabolic health (i.e., fasting glucose, insulin, leptin and 24-h 
interstitial glucose) and cognitive function (i.e., BDNF and IGF-1) alongside parameters of 
sarcopenia, cognitive function, and metabolism are key strengths of this thesis. Whilst 
previous studies have analysed markers of systemic inflammation (Rondanelli et al. 2016, 
Shahar et al. 2013), myostatin (Bagheri et al. 2020) and IGF-1 (Bauer et al. 2015, Rondanelli 
et al. 2016) alongside parameters of sarcopenia following RE and increased dietary protein 
alone, or combined, no study, to the authors knowledge, has also comprehensively examined 
the array of biomarkers presented in this thesis. Similarly, although studies have investigated 
the combined effects of these interventions on insulin sensitivity (Bell et al. 2017, Holwerda et 
al. 2018, Iglay et al. 2007, Leenders et al. 2013, Maltais et al. 2016, Verdijk et al. 2009a, 
Weinheimer et al. 2012), no study has investigated the individual and combined effects of RE 
and whey protein supplementation on 24-h glucose control and glucose variability under highly 
controlled conditions using respiration chambers. Lastly, whilst two previous studies have 
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examined both cognitive function and BDNF following combined RE and dietary protein (Bell 
et al. 2019, Formica et al. 2020), the present thesis is the first to examine multiple markers 
associated with cognitive function (i.e., IGF-1, BDNF, insulin sensitivity, BP, cortisol) alongside 
a comprehensive assessment of cognitive function following both RE and whey protein 
supplementation alone, and combined. Collectively, these data are of novelty and add 
considerable insight to the literature that previously purported mechanisms are not associated 
with changes in parameters of sarcopenia and cognitive function following RE and whey 
protein supplementation in healthy older adults.  
 
7.5 Limitations of the thesis  
The present thesis has several limitations that warrant further discussion. These will be briefly 
outlined in the following subsections.  
 
7.5.1 Sample size   
In intensive studies of this nature, the trade-off between sample size, resource and completion 
is an inherent problem. Sample size was calculated a priori based on between-group changes 
in RMR (primary outcome) from a previous respiration chamber study that reported an 
increase of 109 kcal/d following 16 weeks of RE in older adults (Treuth et al. 1995). The 
resulting sample size calculation determined 52 participants were required to detect 
statistically significant between-group differences from a mixed-model ANCOVA with one 
covariate. However, due to time and budgetary constraints, only 33 participants completed the 
study for the primary outcome, and 36 participants completed all other measures. Whilst the 
sample size of the main study of this thesis (Chapter 4) in which the primary outcome was 
investigated was congruent with previous respiration chamber studies (Apolzan et al. 2014, 
Melanson et al. 2007, Westerterp-Plantenga et al. 2009a), the sample size was unable to 
detect between-group differences. Based on the reported between-group effect size for RMR, 
post-hoc power analysis revealed 48 participants would have been required to detect a 
significant group-by-time interaction. Furthermore, whilst between-group differences were 
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observed for muscle strength measures, key cognitive outcomes were also considerably 
underpowered to detect between-group differences (e.g., post-hoc power analysis revealed 
64 participants would have been required to detect between-group differences in global 
cognitive function). Consequently, only within-group differences could be compared, and as 
such, this data and subsequent conclusions should be interpreted cautiously.  
 
To overcome the lack of statistical power throughout this thesis, RE and whey protein 
supplementation groups were pooled and compared to pooled non-exercise and control 
groups, respectively. Whilst this analysis was not planned in the original statistical plan, 
analysis allowed for determination of the effects of RE and whey protein supplementation on 
key outcome measures with greater statistical power. However, this did not allow for analysis 
of whether RE combined with whey protein supplementation augments gains in parameters 
of sarcopenia, EE, body composition and cognitive function compared to RE alone, which was 
a key aim of the present thesis. The lack of statistical power may also be a key reason why a 
repeated theme of the thesis was that dietary protein does not augment gains in outcomes. In 
partial support, Chapter 4 demonstrated greater effects of whey protein supplementation 
versus control for body composition, and Chapter’s 5 and 6 established greater increases in 
muscle strength and a trend for a greater improvement in global cognitive function, 
respectively. Thus, it may be that a larger sample size similar to that used in previous studies 
that observed synergistic effects of RE and increased dietary compared to RE alone (Bell et 
al. 2017, Rondanelli et al. 2016, 2020, Tieland et al. 2012b) might have elicited synergistic 
effects on key outcomes in individual studies within this thesis. Though, this hypothesis is 
purely speculative and requires further examination.  
 
7.5.2 Inclusion of participants who habitually consumed sufficient amounts of dietary 
protein 
As with many previous studies (Björkman et al. 2020, Cramer et al. 2016, Dulac et al. 2020, 
Holm et al. 2008, Holwerda et al. 2018, Kim et al. 2012, Kirk et al. 2019, 2020, Kukuljan et al. 
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2009, Leenders et al. 2013, Verreijen et al. 2017, Zhu et al. 2015), a limitation of this thesis 
was the inclusion of participants who habitually consumed sufficient amounts of dietary protein 
(>1.0 g/kg/d) at baseline (Bauer et al. 2013, Deutz et al. 2014). It has been hypothesised 
based on the findings of these studies that a high habitual protein intake may mask the 
additional effects of increased dietary protein in older adults (Holwerda et al. 2018, Kirk et al. 
2019). Consequently, inclusion of only older adults who were protein malnourished at baseline 
in this thesis might have allowed for augmented effects of whey protein supplementation to be 
observed and may have made the findings more representative of the target population. 
 
In opposition of the aforementioned, two studies within the literature have observed positive 
effects of protein supplementation either alone (Norton et al. 2016), or combined with RE (Bell 
et al. 2017), in healthy older adults habitually consuming ample amounts of dietary protein at 
baseline (1.1-1.2 g/kg/d). In the present thesis, improvements in body weight maintenance, a 
reduction in FM, and increases in muscle strength and physical function were observed 
following whey protein supplementation. Interestingly, unlike many previous studies that failed 
to observe effects of increased dietary protein in those habitually consuming sufficient 
amounts (Arnarson et al. 2013, Candow et al. 2006, Chalé et al. 2013, de Carvalho Bastone 
et al. 2020, Dulac et al. 2020, Englund et al. 2018, Fielding et al. 2017, Gryson et al. 2014, 
Hofmann et al. 2016, Holm et al. 2008, Holwerda et al. 2018, Kim et al. 2012, Kirk et al. 2019, 
2020, Kukuljan et al. 2009, Leenders et al. 2013, Maltais, Ladouceur, and Dionne 2016, Oesen 
et al. 2015, Ottestad et al. 2017, Shahar et al. 2013, Thomson et al. 2016, Verdijk et al. 2009a, 
Verreijen et al. 2017), the present thesis, as well as those studies that reported beneficial 
effects (Bell et al. 2017, Norton et al. 2016), increased dietary protein intake to 1.6 g/kg/d and 
deviated dietary protein by ≥0.4 g/kg/d. Thus, whilst the inclusion of participants who habitually 
consumed sufficient amounts of dietary protein may be a limitation of this thesis, the findings 
highlight dietary protein may still be an effective strategy to attenuate adverse health outcomes 
with age in non-protein malnourished older adults if the dose provided is sufficient. 
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7.5.3 Investigation of only healthy older men 
Women were excluded from studies within this thesis due to the relatively small sample size 
and prior work establishing sex differences in primary outcomes, which would have likely 
resulted in large variability in primary study endpoints (Geisler et al. 2016a, Geisler and Müller 
2017). Men were studied due to reported greater annual declines in FFM per annum (3% vs. 
1.7%) and shorter life expectancy compared to women (Reid et al. 2008). However, due to 
the sex differences reported above, the findings presented in this thesis may not be applicable 
to female older adults. As women account for a large proportion of the older population [55% 
over 65 years (Office for National Statistics 2018)] and have a high prevalence of sarcopenia 
(Kim et al. 2016a), the exclusion of women is recognised as a limitation of this thesis.   
 
In addition to the above, the inclusion of only healthy men with a normal-overweight BMI must 
also be acknowledged as a limitation of this thesis. Individuals with obesity were excluded due 
to the preventative nature of this thesis, of which one aim was to determine the effectiveness 
of RE and whey protein supplementation as a strategy to mitigate sarcopenic obesity. Men 
with obesity were also excluded based on prior work establishing obesity exacerbates 
sarcopenia (Trouwborst et al. 2018). Furthermore, older adults with obesity display an altered 
metabolic profile to that of individuals without obesity (Perna et al. 2017), which may have led 
to large variability in metabolic parameters. For these reasons, the EWGSOP2 advise 
investigating sarcopenic obesity as a distinct condition (Cruz-Jentoft et al. 2019). However, 
due to the metabolic differences between older adults with and without obesity, the findings of 
this thesis do not necessarily translate to older adults with obesity, who make up ~20% of 
adults over 65 years (Peralta et al. 2018) and are at greater risk of metabolic dysfunction 
(Wannamethee and Atkins 2015).  
 
7.6 Recommendations for future research 
Following the results of this thesis, several identified areas warrant further research. These 
will be outlined in the subsequent subsections. 
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7.6.1 Investigation into the mechanism(s) of reduced activity energy expenditure 
following resistance exercise in older adults 
In study 1 (Chapter 4), combined RE and whey protein supplementation resulted in a 
reduction in spontaneous activity whilst participants resided in the respiration chamber. This 
reduction was hypothesised, based on previous work, to be a compensatory reduction 
controlled by the neuromodulating factor orexin A to oppose the reduction in FM (Kotz et al. 
2017, Perez-Leighton, Billington, and Kotz 2014, Teske, Billington, and Kotz 2010). However, 
orexin A was not measured in this study; thus, this theory is hypothetical. As the reduction in 
AEE observed in this thesis following RE is not unique (Hunter et al. 2018, Melanson 2017), 
further research into the potential mechanism(s) is warranted. Although, it may be that studies 
that have measured AEE following RE in the elderly are of too short duration for elderly 
individuals to adjust; therefore, research of longer duration (e.g., 6 months) is warranted to 
determine the longitudinal effect.  
 
7.6.2 Longitudinal effect of high protein diets on protein balance in older adults 
As highlighted in Chapter 4, a potential drawback of long-term increased dietary protein intake 
in the elderly is a reduction in protein balance, particularly in the overnight fasting period. 
Whilst these findings have also been observed by another recently published study (Højfeldt 
et al. 2020), this and the present study were of relatively short duration (3 and 12 weeks, 
respectively). Further research determining the effects of high intakes of dietary protein (~1.6 
g/kg/d) on overnight protein breakdown over a longer period is therefore warranted.  
 
7.6.3 Longitudinal effects of resistance exercise and whey protein supplementation on 
appetite-related hormones in older adults  
Whilst the present thesis observed a within-group increase in 24-h subjective hunger when 
RE groups were pooled and no changes in subjective ratings of appetite when whey protein 
groups were pooled, this thesis did not measure the diurnal response of key appetite-related 
hormones such as ghrelin, PYY or GLP-1. Further analysis of these biomarkers is therefore 
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warranted and will add considerable mechanistic value of the effects of RE and increased 
dietary protein on appetite in older adults.  
 
7.6.4 Longitudinal effects of resistance exercise combined with whey protein 
supplementation on energy expenditure in older adults 
As emphasised in Chapter 4, participants in whey protein supplementation groups were not 
fed a high protein diet whilst they resided in the respiration chamber during post-intervention 
testing. This methodology was chosen as the aim of this study was to examine the effects of 
RE and whey protein supplementation on skeletal muscle/FFM and subsequent effects on 
energy metabolism, which may have been cofounded if participants were fed a high protein 
diet whilst residing in the respiration chamber post-intervention. However, due to this, the 
study was unable to directly determine the long-term effects of a high protein diet in the elderly 
on 24-h EE, substrate oxidation and appetite. This should therefore be examined in future 
work. 
 
Moreover, whilst no additive effects of RE and whey protein supplementation occurred for any 
components of EE, as previously highlighted, the sample size was small and underpowered 
to observe such effects. Further research with a larger sample size is required to examine 
whether combined RE and whey protein supplementation augments EE in older adults. 
Although, as recruitment to respiration chamber studies is challenging due to the expense and 
time required to obtain such data, a multi-centre trial may be required. Lastly, as women were 
excluded from this thesis and make up the largest proportion of older adults, individual studies 
within the present thesis should also be replicated in elderly women. 
 
7.6.5 Relationship between salivary cortisol concentration and sarcopenia  
As reported in Chapter 5, significant inverse correlations were observed between diurnal 
salivary cortisol AUC and numerous parameters of sarcopenia at baseline. However, though 
these results highlight salivary cortisol may be a potential biomarker of sarcopenia, no 
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changes were observed following RE, despite increases in parameters of sarcopenia being 
observed, questioning its clinical use. Consequently, further research with a larger sample 
size is needed to determine whether salivary cortisol correlates with changes in parameters 
of sarcopenia in a wide range of older adults (i.e., heathy, pre-sarcopenic, sarcopenic). 
Collection of this data is needed to supplement the findings observed in this thesis to 
determine whether salivary cortisol may be a potential biomarker of sarcopenia. 
 
7.6.6 Effects of resistance exercise combined with increased dietary protein intake on 
parameters of sarcopenia and mechanisms of action in older adults  
Due to lack of statistical power, this thesis was unable to truly determine whether RE and whey 
protein supplementation synergistically attenuates sarcopenia. As whey protein 
supplementation alone elicited greater effects on physical function and muscle strength 
compared to an isocaloric carbohydrate control when whey protein supplement groups were 
pooled, which is in contrast to many studies that increased dietary protein by <0.4 g/kg/d 
(Björkman et al. 2020, Cramer et al. 2016, de Carvalho Bastone et al. 2020, Kim et al. 2012, 
Kirk et al. 2020, Kukuljan et al. 2009, Verreijen et al. 2017, Zhu et al. 2015), further research 
using the same experimental methodology (i.e., twice weekly RE combined with a dietary 
protein intake of 1.6 g/kg/d) with a larger sample size is justified to determine whether 
increased dietary protein augments RE-induced improvements in parameters of sarcopenia.  
 
Furthermore, it is important to note that most studies in the literature investigated the effects 
of protein supplementation to achieve a higher protein diet. However, consumption of protein 
supplements daily does not replicate the habitual eating behaviour of this population. It is also 
questionable whether older individuals would consume these supplements longitudinally. 
Additional research employing the recommended daily protein dosing regimen as previous 
described using food items that older adults habitually consume is needed to understand if 
consuming this level of dietary protein is feasible to attenuate sarcopenia. These areas of 
further research should be examined in both men and women.  
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Also, as no inflammatory or hormonal biomarkers correlated with changes in parameters of 
sarcopenia, further research into the mechanisms that govern RE and protein-induced 
changes in these outcomes in older adults is warranted. In particular, as Morton and 
colleagues (2018b) have established an association between intramuscular androgen 
receptor content and muscle hypertrophy following RE in young adults, examination in older 
adults may provide valuable mechanistic data. 
 
7.6.7 Effects of resistance exercise and whey protein supplementation on cognitive 
function and mechanisms of action  
The findings of Chapter 6 emphasise the need for further research into the effects of RE and 
dietary protein on cognitive function in older adults. At present, no dose-response study has 
been conducted to determine the optimal dose of dietary protein to aid specific cognitive 
domains. In the present thesis, the rationale for the dose employed was based on the 
association between cognitive decline and sarcopenia (Chang et al. 2016, Cipolli, Yassuda, 
and Aprahamian 2019, Peng et al. 2020). However, a longitudinal study in older adults utilising 
different dosing regimens would enhance our understanding of the dose-response effects. 
Furthermore, similar to that of previous experimental chapters highlighted, the sample size of 
the abovementioned study was too small to detect between-group differences. Therefore, a 
trial of similar methodological design with a larger sample size would enhance current 
knowledge of the individual and combined effects of RE and whey protein supplement on 
cognitive function in older adults. A final recommendation for future work investigating the 
effects of RE and increased dietary protein intake on cognitive function in older adults is to 
examine the mechanisms of action. As few trials have investigated the combined effects of 
these interventions on cognitive function in older adults (Bell et al. 2019, Formica et al. 2020, 
Rondanelli et al. 2020, van de Rest et al. 2014), and neither of these comprehensively 
assessed potential mechanisms of action, further research with a larger sample size than the 
present thesis is required to determine mechanistic pathways. Such data would be of value to 
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the literature to aid healthcare professionals to scientifically recommend RE and dietary 
protein to attenuate cognitive decline. 
 
7.7 Conclusion 
The evidence presented in this thesis supports the use of RE as the primary lifestyle 
intervention to mitigate age-related declines in EE and parameters of sarcopenia. For 
example, whilst RE resulted in small increases in aspects of EE such as RMR (36 ± 14 kcal/d), 
when extrapolated over a year, this would result in an increased EE of 13,140 kcal, which may 
be significant over time to prevent age-related declines in TEE and adiposity. Additionally, RE 
resulted in significant improvements in parameters of sarcopenia, including muscle strength 
(~30%), mass (2.3%), and physical function (3.4%). Considering these parameters decline by 
~1-3%, ~0.5-1%, and ~0.5% per annum around mid-life, respectively, and are associated with 
numerous adverse effects on heath, these improvements, if maintained, are significant and 
may offset several years of sarcopenia-associated deterioration of health. Consequently, RE 
throughout the lifespan, and particularly in those individuals in their later years, should be 
promoted by government and healthcare professionals globally.  
 
In addition to RE, increased dietary protein intake via whey protein supplementation may also 
be recommended as a safe method for older adults to alleviate declines in muscle strength, 
physical function and sarcopenic obesity, and aid aspects of cognitive functioning. Notably, 
increased dietary protein intake may be of particular importance to those unable to perform 
RE. For example, whey protein supplementation increased 4 m gait speed by ~0.08 m/s and 
decreased FM by ~0.5 kg. Since low physical function and increased adiposity are two key 
factors that drive age-related chronic disease, these findings are important to those groups. 
However, it should be noted that whey protein supplementation alone offers far inferior 
protective effects against sarcopenic muscle loss than performing RE.  
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Finally, the data in this thesis does not support the need for combined RE and whey protein 
supplementation to mitigate age-related sarcopenia, sarcopenic obesity, metabolic disease 
nor cognitive decline. Although, it should be noted that whey protein supplementation did not 
adversely affect any markers compared to RE alone. Due to the notably small effect between 
the two interventions and the lack of statistical power to detect post-hoc differences, further 
RCTs with a far larger sample size in participants with inadequate habitual protein intakes 
(~0.8 g/kg/d) is required to determine whether increased dietary protein augments the effects 
of RE on multiple health outcomes in older adults. Study of the mechanisms of how these 
interventions may attenuate age-related declines in these conditions is also warranted.  
 
7.8 Dissemination of PhD findings to research participants  
In line with ethical considerations and to improve public engagement in research, participants 
who participated in this study have received a 3-page individual result sheet from their 
participation in the research study, which includes baseline measures and their individual 
change after 12 weeks. Additionally, participants have also received a summary of the main 
research findings of the thesis and will be emailed when manuscripts that arise from this thesis 
are published.  
 
7.9 Personal PhD reflection  
Ever since completing my master’s degree in 2013, I wanted to continue in academia and 
pursue a PhD. I had enjoyed my research modules at undergraduate and postgraduate levels, 
so continuing further was always the right option for me. In the time between 2013 and starting 
this PhD in 2017, I had several unsuccessful attempts at securing a scholarship to conduct a 
PhD, which I found difficult, but this was not going to stop me pursuing my dream. Therefore, 
I spent this time gaining further research experience as a research assistant/associate at 
various academic institutions and was excited to start my journey once I had been made an 
offer to conduct a PhD in an area I was extremely interested in.  
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With the four years of research experience behind me prior to starting the PhD, I was slightly 
naïve in the early stages of the PhD programme and thought I would complete the PhD with 
no problems. However, how wrong I was, and I soon realised why such a small percentage of 
the population had completed a doctorate degree. Nevertheless, I knew that an important 
aspect of successfully running a clinical trial is planning. I had planned the research the best 
way I could, and I believe this helped the trial be the success it was. Furthermore, I knew 
communication skills and trust with research participants was a highly needed skill to run a 
research study, and I also believe the skills I gathered in previous roles contributed to the very 
high adherence to both the exercise and nutritional interventions.  
 
Looking back, there were, however, several areas I believe I could have made the programme 
easier, which I will take into my future career as a researcher. Firstly, I did not begin to explore 
the data, especially the respiration chamber data, until late into the PhD programme. The main 
reason for this was due to the double-blinded nature of the study design. However, this led to 
a significant amount of continuous data analysis to occur in one period of time. If I was to 
analyse this data as the research went on, trends and errors picked up along the way would 
have been identified earlier. Whilst this would not have impact the thesis findings, it would 
likely have eased the data processing time and allowed for further reading earlier around 
trends and issues I had seen.  
 
In addition, a significant lesson I learnt during the PhD process was the time required for 
research activities which are not observed in research papers or within this PhD thesis. For 
example, in this trial, over 250 men aged >60 years were formally screened; however, I was 
in contact with >750 men over email or telephone discussing this trial. Additionally, I was in 
regular communication with trial participants throughout the 1.5 years running this PhD trial. 
Together, this accounted for a significant number of hours every week, and by the time of the 
end of the PhD programme, I had experienced burnout and trial fatigue. Therefore, moving 
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forward and running a large trial in the future, I have learnt sufficient time and staffing is 
required to run such a study, and this will be factored into future research grants and planning.  
 
Lastly, in the latter stages of 2019, Coronavirus disease (COVID-19), which is a contagious 
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was 
identified in Wuhan, China. In Mach 2020, the disease was classified by the World Health 
Organisation as a global pandemic, which led to a national lockdown in the United Kingdom. 
As a result, the university laboratories were closed, which resulted in the final piece of data 
collection analysing appetite-related markers not being analysed. Consequently, a change 
thesis structure was therefore required, as in the originally thesis planning, a specific appetite 
chapter was planned. This was unfortunate, as appetite and anorexia of ageing is a particular 
interest of mine. Nevertheless, I learnt to adapt quickly, which led to the appetite data I had 
already analysed being amalgamated into the EE and body composition chapter and a new 
exploratory cognitive function chapter being created.  
 
Overall, the PhD experience was a fantastic journey which I pleasantly enjoyed, and I have 
developed many transferable skills which I will take with me into my future career. It’s a 
process I would highly recommend to any aspiring scientist looking to gain the required 
qualifications and skills needed to begin a journey into scientific research. To end, the best 
piece of advice I would provide to someone aspiring to complete a PhD is to ensure you 
choose a topic you are extremely passionate about and want to answer the research 
question(s) proposed, and to begin reading and writing early. Also, it’s important to ensure the 
PhD does not take over your personal life and to make sure you celebrate the successes 







Acheson, K.J., Blondel-Lubrano, A., Oguey-Araymon, S., Beaumont, M., Emady-Azar, S., 
Ammon-Zufferey, C., Monnard, I., Pinaud, S., Nielsen-Moennoz, C., and Bovetto, L. 
(2011) ‘Protein Choices Targeting Thermogenesis and Metabolism’. The American 
Journal of Clinical Nutrition 93 (3), 525–534 
Adam, E.K., Quinn, M.E., Tavernier, R., McQuillan, M.T., Dahlke, K.A., and Gilbert, K.E. 
(2017) ‘Diurnal Cortisol Slopes and Mental and Physical Health Outcomes: A 
Systematic Review and Meta-Analysis’. Psychoneuroendocrinology 83, 25–41 
Adriaens, M.P.E., Schoffelen, P.F.M., and Westerterp, K.R. (2003) ‘Intra-Individual Variation 
of Basal Metabolic Rate and the Influence of Daily Habitual Physical Activity before 
Testing’. British Journal of Nutrition 90 (2), 419–423 
Ahlskog, J.E., Geda, Y.E., Graff-Radford, N.R., and Petersen, R.C. (2011) ‘Physical 
Exercise as a Preventive or Disease-Modifying Treatment of Dementia and Brain 
Aging’. Mayo Clinic Proceedings 86 (9), 876-884 
Ahn, N. and Kim, K. (2018) ‘The Effects of Resistance Elastic Bands Exercises on Salivary 
Iga and Salivary Cortisol Levels in Elderly Women’. Biomedical Research 29 (5), 889–
894 
Ahtiainen, J.P., Hulmi, J.J., Kraemer, W.J., Lehti, M., Nyman, K., Selänne, H., Alen, M., 
Pakarinen, A., Komulainen, J., Kovanen, V., Mero, A.A., and Häkkinen, K. (2011) 
‘Heavy Resistance Exercise Training and Skeletal Muscle Androgen Receptor 
Expression in Younger and Older Men’. Steroids 76 (1–2), 183–192 
Ahtiainen, J.P., Pakarinen, A., Alen, M., Kraemer, W.J., and Häkkinen, K. (2003) ‘Muscle 
Hypertrophy, Hormonal Adaptations and Strength Development during Strength 
Training in Strength-Trained and Untrained Men’. European Journal of Applied 
Physiology 89 (6), 555–563 
Akimoto, S. and Miyasaka, K. (2010) ‘Age-Associated Changes of Appetite-Regulating 
Peptides’. Geriatrics and Gerontology International 10 (1), 107-119 
Al-Delaimy, W.K., Von Muhlen, D., and Barrett-Connor, E. (2009) ‘Insulinlike Growth Factor-
1, Insulinlike Growth Factor Binding Protein-1, and Cognitive Function in Older Men and 
Women’. Journal of the American Geriatrics Society 57 (8), 1441–1446 
Alderson, R.F., Alterman, A.L., Barde, Y.-A., and Lindsay, R.M. (1990) ‘Brain-Derived 
Neurotrophic Factor Increases Survival and Differentiated Functions of Rat Septal 
Cholinergic Neurons in Culture’. Neuron 5 (3), 297–306 
Alemán, H., Esparza, J., Ramirez, F.A., Astiazaran, H., and Payette, H. (2011) ‘Longitudinal 
Evidence on the Association between Interleukin-6 and C-Reactive Protein with the 
Loss of Total Appendicular Skeletal Muscle in Free-Living Older Men and Women’. Age 
and Ageing 40 (4), 469–475 
Ali, S. and Garcia, J.M. (2014) ‘Sarcopenia, Cachexia and Aging: Diagnosis, Mechanisms 
and Therapeutic Options-a Mini-Review’. Gerontology 60 (4), 294–305 
Allman, B.R., Morrissey, M.C., Kim, J.-S., Panton, L.B., Contreras, R.J., Hickner, R.C., and 
Ormsbee, M.J. (2019) ‘Fat Metabolism and Acute Resistance Exercise in Trained 
Women’. Journal of Applied Physiology 126 (3), 739–745 
Alzheimer’s Society (2014) Dementia UK Report [online] available from 
<https://www.alzheimers.org.uk/about-us/policy-and-influencing/dementia-uk-report> [8 
August 2020] 
Amamou, T., Normandin, E., Pouliot, J., Dionne, I.J., Brochu, M., and Riesco, E. (2017) 
‘Effect of a High-Protein Energy-Restricted Diet Combined with Resistance Training on 
Metabolic Profile in Older Individuals with Metabolic Impairments’. Journal of Nutrition, 
Health and Aging 21 (1), 67–74 
Amirani, E., Milajerdi, A., Reiner, Ž., Mirzaei, H., Mansournia, M.A., and Asemi, Z. (2020) 
‘Effects of Whey Protein on Glycemic Control and Serum Lipoproteins in Patients with 
 295 
Metabolic Syndrome and Related Conditions: A Systematic Review and Meta-Analysis 
of Randomized Controlled Clinical Trials’. Lipids in Health and Disease 19 (1), 1–18 
Andersen, J.L., Schjerling, P., Andersen, L.L., and Dela, F. (2003) ‘Resistance Training and 
Insulin Action in Humans: Effects of De-training’. The Journal of Physiology 551 (3), 
1049–1058 
Anderson-Hanley, C., Nimon, J.P., and Westen, S.C. (2010) ‘Cognitive Health Benefits of 
Strengthening Exercise for Community-Dwelling Older Adults’. Journal of Clinical and 
Experimental Neuropsychology 32 (9), 996-1001 
Anderson, T. and Wideman, L. (2017) ‘Exercise and the Cortisol Awakening Response: A 
Systematic Review’. Sports Medicine-Open 3 (1), 37 
Angelini, A., Bendini, C., Neviani, F., Bergamini, L., Manni, B., Trenti, T., Rovati, R., and 
Neri, M. (2009) ‘Insulin-like Growth Factor-1 (IGF-1): Relation with Cognitive 
Functioning and Neuroimaging Marker of Brain Damage in a Sample of Hypertensive 
Elderly Subjects’. Archives of Gerontology and Geriatrics 49, 5–12 
Angelucci, F., Spalletta, G., Iulio, F. D, Ciaramella, A., Salani, F., Varsi, A.E., Gianni, W., 
Sancesario, G., Caltagirone, C., and Bossu, P. (2010) ‘Alzheimer’s Disease (AD) and 
Mild Cognitive Impairment (MCI) Patients Are Characterized by Increased BDNF Serum 
Levels’. Current Alzheimer Research 7 (1), 15–20 
Anthony, J.C., Yoshizawa, F., Anthony, T.G., Vary, T.C., Jefferson, L.S., and Kimball, S.R. 
(2000) ‘Leucine Stimulates Translation Initiation in Skeletal Muscle of Postabsorptive 
Rats via a Rapamycin-Sensitive Pathway’. The Journal of Nutrition 130 (10), 2413–
2419 
Antunes, A.C., Araújo, D.A., Veríssimo, M.T., and Amaral, T.F. (2017) ‘Sarcopenia and 
Hospitalisation Costs in Older Adults: A Cross-sectional Study’. Nutrition & Dietetics 74 
(1), 46–50 
Apolzan, J.W., Bray, G.A., Smith, S.R., De Jonge, L., Rood, J., Han, H., Redman, L.M., and 
Martin, C.K. (2014) ‘Effects of Weight Gain Induced by Controlled Overfeeding on 
Physical Activity’. American Journal of Physiology - Endocrinology and Metabolism 307 
(11), 1030-1037 
Arnal, M.A., Mosoni, L., Boirie, Y., Houlier, M.L., Morin, L., Verdier, E., Ritz, P., Antoine, 
J.M., Prugnaud, J., and Beaufrère, B. (1999) ‘Protein Pulse Feeding Improves Protein 
Retention in Elderly Women’. The American Journal of Clinical Nutrition 69 (6), 1202–
1208 
Arnarson, A., Geirsdottir, O.G., Ramel, A., Jonsson, P. V., and Thorsdottir, I. (2015) ‘Insulin-
like Growth Factor-1 and Resistance Exercise in Community Dwelling Old Adults’. 
Journal of Nutrition, Health and Aging 19 (8), 856–860 
Arnarson, A., Gudny Geirsdottir, O., Ramel, A., Briem, K., Jonsson, P. V., and Thorsdottir, I. 
(2013) ‘Effects of Whey Proteins and Carbohydrates on the Efficacy of Resistance 
Training in Elderly People: Double Blind, Randomised Controlled Trial’. European 
Journal of Clinical Nutrition 67 (8), 821–826 
Ashor, A.W., Lara, J., Siervo, M., Celis-Morales, C., Oggioni, C., Jakovljevic, D.G., and 
Mathers, J.C. (2015) ‘Exercise Modalities and Endothelial Function: A Systematic 
Review and Dose–Response Meta-Analysis of Randomized Controlled Trials’. Sports 
Medicine 45 (2), 279–296 
Ashton, R.E., Tew, G.A., Aning, J.J., Gilbert, S.E., Lewis, L., and Saxton, J.M. (2020) 
‘Effects of Short-Term, Medium-Term and Long-Term Resistance Exercise Training on 
Cardiometabolic Health Outcomes in Adults: Systematic Review with Meta-Analysis’. 
British Journal of Sports Medicine 54 (6), 341–348 
Astrup, A., Thorbek, G., Lind, J., and Isaksson, B. (1990) ‘Prediction of 24-h Energy 
Expenditure and Its Components from Physical Characteristics and Body Composition 
in Normal-Weight Humans’. The American Journal of Clinical Nutrition 52 (5), 777–783 
Atalayer, D. and Astbury, N.M. (2013) ‘Anorexia of Aging and Gut Hormones’. Aging and 
Disease 4 (5), 264 
Atherton, P.J., Etheridge, T., Watt, P.W., Wilkinson, D., Selby, A., Rankin, D., Smith, K., and 
Rennie, M.J. (2010) ‘Muscle Full Effect after Oral Protein: Time-Dependent 
 296 
Concordance and Discordance between Human Muscle Protein Synthesis and 
MTORC1 Signaling’. The American Journal of Clinical Nutrition 92 (5), 1080–1088 
Azizbeigi, K., Azarbayjani, M.A., Atashak, S., and Stannard, S.R. (2015) ‘Effect of Moderate 
and High Resistance Training Intensity on Indices of Inflammatory and Oxidative 
Stress’. Research in Sports Medicine 23 (1), 73–87 
Baars, J. and Dohmen, J. (2013) Ageing, Meaning and Social Structure: Connecting Critical 
and Humanistic Gerontology. Bristol: Policy Press 
Bagheri, R., Moghadam, Babak Hooshmand, Church, D.D., Tinsley, G.M., Eskandari, M., 
Moghadam, Bizhan Hooshmand, Motevalli, M.S., Baker, J.S., Robergs, R.A., and 
Wong, A. (2020) ‘The Effects of Concurrent Training Order on Body Composition and 
Serum Concentrations of Follistatin, Myostatin and GDF11 in Sarcopenic Elderly Men’. 
Experimental Gerontology 133, 110869 
Bagheri, R., Rashidlamir, A., Motevalli, M.S., Elliott, B.T., Mehrabani, J., and Wong, A. 
(2019) ‘Effects of Upper-Body, Lower-Body, or Combined Resistance Training on the 
Ratio of Follistatin and Myostatin in Middle-Aged Men’. European Journal of Applied 
Physiology 119 (9), 1921–1931 
Bahat, G. and Ilhan, B. (2016) ‘Sarcopenia and the Cardiometabolic Syndrome: A Narrative 
Review’. European Geriatric Medicine 7 (3), 220–223 
Balaguera-Cortes, L., Wallman, K.E., Fairchild, T.J., and Guelfi, K.J. (2011) ‘Energy Intake 
and Appetite-Related Hormones Following Acute Aerobic and Resistance Exercise’. 
Applied Physiology, Nutrition, and Metabolism 36 (6), 958–966 
Balion, C., Griffith, L.E., Strifler, L., Henderson, M., Patterson, C., Heckman, G., Llewellyn, 
D.J., and Raina, P. (2012) ‘Vitamin D, Cognition, and Dementia; A Systematic Review 
and Meta-Analysis’. Neurology 79 (13), 1397-1405 
Ballard, K.D., Kupchak, B.R., Volk, B.M., Mah, E., Shkreta, A., Liptak, C., Ptolemy, A.S., 
Kellogg, M.S., Bruno, R.S., and Seip, R.L. (2013) ‘Acute Effects of Ingestion of a Novel 
Whey-Derived Extract on Vascular Endothelial Function in Overweight, Middle-Aged 
Men and Women’. British Journal of Nutrition 109 (5), 882–893 
Ballard, T.P., Melby, C.L., Camus, H., Cianciulli, M., Pitts, J., Schmidt, S., and Hickey, M.S. 
(2009) ‘Effect of Resistance Exercise, with or without Carbohydrate Supplementation, 
on Plasma Ghrelin Concentrations and Postexercise Hunger and Food Intake’. 
Metabolism 58 (8), 1191–1199 
Banks, W.A., Owen, J.B., and Erickson, M.A. (2012) ‘Insulin in the Brain: There and Back 
Again’. Pharmacology & Therapeutics 136 (1), 82–93 
Bano, G., Trevisan, C., Carraro, S., Solmi, M., Luchini, C., Stubbs, B., Manzato, E., Sergi, 
G., and Veronese, N. (2017) ‘Inflammation and Sarcopenia: A Systematic Review and 
Meta-Analysis’. Maturitas 96, 10–15 
Barberger-Gateau, P., Raffaitin, C., Letenneur, L., Berr, C., Tzourio, C., Dartigues, J.-F., and 
Alpérovitch, A. (2007) ‘Dietary Patterns and Risk of Dementia: The Three-City Cohort 
Study’. Neurology 69 (20), 1921–1930 
Barha, C.K., Davis, J.C., Falck, R.S., Nagamatsu, L.S., and Liu-Ambrose, T. (2017) ‘Sex 
Differences in Exercise Efficacy to Improve Cognition: A Systematic Review and Meta-
Analysis of Randomized Controlled Trials in Older Humans’. Frontiers in 
Neuroendocrinology 46, 71-85 
Basu, R., Breda, E., Oberg, A.L., Powell, C.C., Dalla Man, C., Basu, A., Vittone, J.L., Klee, 
G.G., Arora, P., and Jensen, M.D. (2003) ‘Mechanisms of the Age-Associated 
Deterioration in Glucose Tolerance: Contribution of Alterations in Insulin Secretion, 
Action, and Clearance’. Diabetes 52 (7), 1738–1748 
Batsis, J.A. and Buscemi, S. (2011) ‘Sarcopenia, Sarcopenic Obesity and Insulin 
Resistance’. in Medical Complications of Type 2 Diabetes. ed by Colleen Croniger. 
London: Intech Open Ltd, 233-256 
Batsis, J.A., Mackenzie, T.A., Lopez-Jimenez, F., and Bartels, S.J. (2015) ‘Sarcopenia, 
Sarcopenic Obesity, and Functional Impairments in Older Adults: National Health and 
Nutrition Examination Surveys 1999-2004’. Nutrition Research 35 (12), 1031-1039 
Batsis, J.A. and Villareal, D.T. (2018) ‘Sarcopenic Obesity in Older Adults: Aetiology, 
 297 
Epidemiology and Treatment Strategies’. Nature Reviews Endocrinology 14 (9), 513–
537 
Bauer, J., Biolo, G., Cederholm, T., Cesari, M., Cruz-Jentoft, A.J., Morley, J.E., Phillips, S., 
Sieber, C., Stehle, P., Teta, D., Visvanathan, R., Volpi, E., and Boirie, Y. (2013) 
‘Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: 
A Position Paper from the Prot-Age Study Group’. Journal of the American Medical 
Directors Association 14 (8), 542–559 
Bauer, J.M. and Morley, J.E. (2020) ‘Body Composition Measurements in Older Adults’. 
Current Opinion in Clinical Nutrition & Metabolic Care 23 (1), 1–3 
Bauer, J.M., Verlaan, S., Bautmans, I., Brandt, K., Donini, L.M., Maggio, M., McMurdo, 
M.E.T., Mets, T., Seal, C., Wijers, S.L., Ceda, G.P., De Vito, G., Donders, G., Drey, M., 
Greig, C., Holmbäck, U., Narici, M., McPhee, J., Poggiogalle, E., Power, D., Scafoglieri, 
A., Schultz, R., Sieber, C.C., and Cederholm, T. (2015) ‘Effects of a Vitamin D and 
Leucine-Enriched Whey Protein Nutritional Supplement on Measures of Sarcopenia in 
Older Adults, the PROVIDE Study: A Randomized, Double-Blind, Placebo-Controlled 
Trial’. Journal of the American Medical Directors Association 16 (9), 740–747 
Baumgartner, R.N. (2000) ‘Body Composition in Healthy Aging’. Annals of the New York 
Academy of Sciences 904 (1), 437–448 
Beaudart, C., Rizzoli, R., Bruyère, O., Reginster, J.-Y., and Biver, E. (2014) ‘Sarcopenia: 
Burden and Challenges for Public Health’. Archives of Public Health 72 (1), 45 
Beaudart, C., Rolland, Y., Cruz-Jentoft, A.J., Bauer, J.M., Sieber, C., Cooper, C., Al-Daghri, 
N., de Carvalho, I.A., Bautmans, I., and Bernabei, R. (2019) ‘Assessment of Muscle 
Function and Physical Performance in Daily Clinical Practice’. Calcified Tissue 
International 105, 1–14 
Beaudart, C., Zaaria, M., Pasleau, F., Reginster, J.Y., and Bruyère, O. (2017) ‘Health 
Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis’. PloS one 12 (1), 
e0169548 
Beavers, K.M., Hsu, F.C., Isom, S., Kritchevsky, S.B., Church, T., Goodpaster, B., Pahor, 
M., and Nicklas, B.J. (2010) ‘Long-Term Physical Activity and Inflammatory Biomarkers 
in Older Adults’. Medicine and Science in Sports and Exercise 42 (12), 2189–2196 
Beckwée, D., Delaere, A., Aelbrecht, S., Baert, V., Beaudart, C., Bruyère, O., de Saint-
Hubert, M., and Bautmans, I. (2019) ‘Exercise Interventions for the Prevention and 
Treatment of Sarcopenia. A Systematic Umbrella Review’. The Journal of Nutrition, 
Health & Aging 23 (6), 494–502 
Beenakker, K.G.M., Ling, C.H., Meskers, C.G.M., de Craen, A.J.M., Stijnen, T., Westendorp, 
R.G.J., and Maier, A.B. (2010) ‘Patterns of Muscle Strength Loss with Age in the 
General Population and Patients with a Chronic Inflammatory State’. Ageing Research 
Reviews 9 (4), 431–436 
Bell, K.E., Fang, H., Snijders, T., Allison, D.J., Zulyniak, M.A., Chabowski, A., Parise, G., 
Phillips, S.M., and Heisz, J.J. (2019) ‘A Multi-Ingredient Nutritional Supplement in 
Combination with Resistance Exercise and High-Intensity Interval Training Improves 
Cognitive Function and Increases n-3 Index in Healthy Older Men: A Randomized 
Controlled Trial’. Frontiers in Aging Neuroscience 11, 107 
Bell, K.E., Snijders, T., Zulyniak, M., Kumbhare, D., Parise, G., Chabowski, A., and Phillips, 
S.M. (2017) ‘A Whey Protein-Based Multi-Ingredient Nutritional Supplement Stimulates 
Gains in Lean Body Mass and Strength in Healthy Older Men: A Randomized 
Controlled Trial’. PloS one 12 (7), e0181387 
Bell, K.E., Snijders, T., Zulyniak, M.A., Kumbhare, D., Parise, G., Chabowski, A., and 
Phillips, S.M. (2018) ‘A Multi-Ingredient Nutritional Supplement Enhances Exercise 
Training-Related Reductions in Markers of Systemic Inflammation in Healthy Older 
Men’. Applied Physiology, Nutrition and Metabolism 43 (3), 299–302 
Beluche, I., Carrière, I., Ritchie, K., and Ancelin, M.-L. (2010) ‘A Prospective Study of Diurnal 
Cortisol and Cognitive Function in Community-Dwelling Elderly People’. Psychological 
Medicine 40 (6), 1039 
Ben-Harchache, S., Roche, H.M., Corish, C.A., and Horner, K.M. (2020) ‘The Impact of 
 298 
Protein Supplementation on Appetite and Energy Intake in Healthy Older Adults: A 
Systematic Review with Meta-Analysis’. Advances in Nutrition, 1-13. DOI: 
10.1093/advances/nmaa115 
Bendtsen, L.Q., Lorenzen, J.K., Bendsen, N.T., Rasmussen, C., and Astrup, A. (2013) 
‘Effect of Dairy Proteins on Appetite, Energy Expenditure, Body Weight, and 
Composition: A Review of the Evidence from Controlled Clinical Trials’. Advances in 
Nutrition 4 (4), 418-438 
Bergland, A. and Strand, B.H. (2019) ‘Norwegian Reference Values for the Short Physical 
Performance Battery (SPPB): The Tromsø Study’. BMC Geriatrics 19 (1), 216 
Best, J.R., Chiu, B.K., Liang Hsu, C., Nagamatsu, L.S., and Liu-Ambrose, T. (2015) ‘Long-
Term Effects of Resistance Exercise Training on Cognition and Brain Volume in Older 
Women: Results from a Randomized Controlled Trial’. Journal of the International 
Neuropsychological Society 21 (10), 745-756 
Best, J.R., Nagamatsu, L.S., and Liu-Ambrose, T. (2014) ‘Improvements to Executive 
Function during Exercise Training Predict Maintenance of Physical Activity over the 
Following Year’. Frontiers in Human Neuroscience 8, 353 
Beyer, I., Mets, T., and Bautmans, I. (2012) ‘Chronic Low-Grade Inflammation and Age-
Related Sarcopenia’. Current Opinion in Clinical Nutrition and Metabolic Care 15 (1), 
12–22 
Biessels, G.J. and Reagan, L.P. (2015) ‘Hippocampal Insulin Resistance and Cognitive 
Dysfunction’. Nature Reviews Neuroscience 16 (11), 660-671 
Biessels, G.J., Strachan, M.W.J., Visseren, F.L.J., Kappelle, L.J., and Whitmer, R.A. (2014) 
‘Dementia and Cognitive Decline in Type 2 Diabetes and Prediabetic Stages: Towards 
Targeted Interventions’. The Lancet Diabetes & Endocrinology 2 (3), 246–255 
Bingham, S.A., Williams, R., Cole, T.J., Price, C.P., and Cummings, J.H. (1988) ‘Reference 
Values for Analytes of 24-h Urine Collections Known to Be Complete’. Annals of Clinical 
Biochemistry 25 (6), 610–619 
Binns, A., Gray, M., Henson, A.C., and Fort, I.L. (2017) ‘Changes in Lean Mass and Serum 
Myostatin with Habitual Protein Intake and High-Velocity Resistance Training’. Journal 
of Nutrition, Health and Aging 21 (10), 1111–1117 
Biolo, G., Maggi, S.P., Williams, B.D., Tipton, K.D., and Wolfe, R.R. (1995) ‘Increased Rates 
of Muscle Protein Turnover and Amino Acid Transport after Resistance Exercise in 
Humans’. American Journal of Physiology-Endocrinology And Metabolism 268 (3), 
514–520 
Biolo, G., Tipton, K.D., Klein, S., and Wolfe, R.R. (1997) ‘An Abundant Supply of Amino 
Acids Enhances the Metabolic Effect of Exercise on Muscle Protein’. American Journal 
of Physiology-Endocrinology And Metabolism 273 (1), 122–129 
Björkman, M.P., Suominen, M.H., Kautiainen, H., Jyväkorpi, S.K., Finne-Soveri, H.U., 
Strandberg, T.E., Pitkälä, K.H., and Tilvis, R.S. (2020) ‘Effect of Protein 
Supplementation on Physical Performance in Older People With Sarcopenia–A 
Randomized Controlled Trial’. Journal of the American Medical Directors Association 21 
(2), 226-232 
Blackwell, A.D., Sahakian, B.J., Vesey, R., Semple, J.M., Robbins, T.W., and Hodges, J.R. 
(2004) ‘Detecting Dementia: Novel Neuropsychological Markers of Preclinical 
Alzheimer’s Disease’. Dementia and Geriatric Cognitive Disorders 17 (1–2), 42–48 
Bloesch, D., Schutz, Y., Breitenstein, E., Jequier, E., and Felber, J.P. (1988) ‘Thermogenic 
Response to an Oral Glucose Load in Man: Comparison between Young and Elderly 
Subjects.’ Journal of the American College of Nutrition 7 (6), 471–483 
Blondell, S.J., Hammersley-Mather, R., and Veerman, J.L. (2014) ‘Does Physical Activity 
Prevent Cognitive Decline and Dementia?: A Systematic Review and Meta-Analysis of 
Longitudinal Studies’. BMC Public Health 14 (1), 510 
Bo, Y., Liu, C., Ji, Z., Yang, R., An, Q., Zhang, X., You, J., Duan, D., Sun, Y., Zhu, Y., Cui, 
H., and Lu, Q. (2019) ‘A High Whey Protein, Vitamin D and E Supplement Preserves 
Muscle Mass, Strength, and Quality of Life in Sarcopenic Older Adults: A Double-Blind 
Randomized Controlled Trial’. Clinical Nutrition 38 (1), 159-164 
 299 
Bollwein, J., Diekmann, R., Kaiser, M.J., Bauer, J.M., Uter, W., Sieber, C.C., and Volkert, D. 
(2013) ‘Distribution but Not Amount of Protein Intake Is Associated with Frailty: A 
Cross-Sectional Investigation in the Region of Nürnberg’. Nutrition Journal 12 (1), 109 
Bonaldo, P. and Sandri, M. (2013) ‘Cellular and Molecular Mechanisms of Muscle Atrophy’. 
Disease Models & Mechanisms 6 (1), 25–39 
Borde, R., Hortobágyi, T., and Granacher, U. (2015) ‘Dose–Response Relationships of 
Resistance Training in Healthy Old Adults: A Systematic Review and Meta-Analysis’. 
Sports Medicine 45 (12), 1693–1720 
Bordoni, A., Danesi, F., Dardevet, D., Dupont, D., Fernandez, A.S., Gille, D., Nunes dos 
Santos, C., Pinto, P., Re, R., Rémond, D., Shahar, D.R., and Vergères, G. (2017) ‘Dairy 
Products and Inflammation: A Review of the Clinical Evidence’. Critical Reviews in 
Food Science and Nutrition 57 (12), 2497-2525  
Borg, G. (1998) Borg ́s Perceived Exertion and Pain Scales. Champaign, IL: Human Kinetics 
Borkan, G.A., Hults, D.E., Gerzof, S.G., Robbins, A.H., and Silbert, C.K. (1983) ‘Age 
Changes in Body Composition Revealed by Computed Tomography’. Journal of 
Gerontology 38 (6), 673–677 
Børsheim, E., Cree, M.G., Tipton, K.D., Elliott, T.A., Aarsland, A., and Wolfe, R.R. (2004) 
‘Effect of Carbohydrate Intake on Net Muscle Protein Synthesis during Recovery from 
Resistance Exercise’. Journal of Applied Physiology 96 (2), 674–678 
Borst, S.E. (2004) ‘Interventions for Sarcopenia and Muscle Weakness in Older People’. 
Age and Ageing 33 (6), 548–555 
Borst, S.E., De Hoyos, D. V, Garzarella, L., Vincent, K., Pollock, B.H., Lowenthal, D.T., and 
Pollock, M.L. (2001) ‘Effects of Resistance Training on Insulin-like Growth Factor-I and 
IGF Binding Proteins’. Medicine and Science in Sports and Exercise 33 (4), 648–653 
Bosy-Westphal, A., Eichhorn, C., Kutzner, D., Illner, K., Heller, M., and Müller, M.J. (2003) 
‘The Age-Related Decline in Resting Energy Expenditure in Humans Is Due to the Loss 
of Fat-Free Mass and to Alterations in Its Metabolically Active Components’. The 
Journal of Nutrition 133 (7), 2356–2362 
Bouillanne, O., Curis, E., Hamon-Vilcot, B., Nicolis, I., Chrétien, P., Schauer, N., Vincent, J.-
P., Cynober, L., and Aussel, C. (2013) ‘Impact of Protein Pulse Feeding on Lean Mass 
in Malnourished and At-Risk Hospitalized Elderly Patients: A Randomized Controlled 
Trial’. Clinical Nutrition 32 (2), 186–192 
Bourre, J.M. (2006) ‘Effects of Nutrients (in Food) on the Structure and Function of the 
Nervous System: Update on Dietary Requirements for Brain. Part 2: Macronutrients’. 
Journal of Nutrition, Health and Aging 10 (5), 386 
Bramham, C.R. and Messaoudi, E. (2005) ‘BDNF Function in Adult Synaptic Plasticity: The 
Synaptic Consolidation Hypothesis’. Progress in Neurobiology 76 (2), 99–125 
Bray, G.A., Redman, L.M., De Jonge, L., Covington, J., Rood, J., Brock, C., Mancuso, S., 
Martin, C.K., and Smith, S.R. (2015) ‘Effect of Protein Overfeeding on Energy 
Expenditure Measured in a Metabolic Chamber’. American Journal of Clinical Nutrition 
101 (3), 496–505 
Bray, G.A., Smith, S.R., De Jonge, L., Xie, H., Rood, J., Martin, C.K., Most, M., Brock, C., 
Mancuso, S., and Redman, L.M. (2012) ‘Effect of Dietary Protein Content on Weight 
Gain, Energy Expenditure, and Body Composition during Overeating: A Randomized 
Controlled Trial’. Journal of the American Medical Association 307 (1), 47-55 
Breen, L. and Phillips, S.M. (2011) ‘Skeletal Muscle Protein Metabolism in the Elderly: 
Interventions to Counteract the’anabolic Resistance’of Ageing’. Nutrition & Metabolism 
8 (1), 68 
British Nutrition Foundation (2018) Protein [online] available from 
<https://www.nutrition.org.uk/nutritionscience/nutrients-food-and-
ingredients/protein.html> [10 August 2020] 
Brook, M.S., Wilkinson, D.J., Mitchell, W.K., Lund, J.N., Szewczyk, N.J., Greenhaff, P.L., 
Smith, K., and Atherton, P.J. (2015) ‘Skeletal Muscle Hypertrophy Adaptations 
Predominate in the Early Stages of Resistance Exercise Training, Matching Deuterium 
Oxide-Derived Measures of Muscle Protein Synthesis and Mechanistic Target of 
 300 
Rapamycin Complex 1 Signaling’. The FASEB Journal 29 (11), 4485–4496 
Broom, D.R., Batterham, R.L., King, J.A., and Stensel, D.J. (2009) ‘Influence of Resistance 
and Aerobic Exercise on Hunger, Circulating Levels of Acylated Ghrelin, and Peptide 
YY in Healthy Males’. American Journal of Physiology-Regulatory, Integrative and 
Comparative Physiology 296 (1), 29-35 
Brouwer, E. (1957) ‘On Simple Formulae for Calculating the Heat Expenditure and the 
Quantities of Carbohydrate and Fat Oxidized in Metabolism of Men and Animals, from 
Gaseous Exchange (Oxygen Intake and Carbonic Acid Output) and Urine-N.’ Acta 
Physiologica et Pharmacologica Neerlandica 6, 795–802 
Bruyère, O., Beaudart, C., Reginster, J.-Y., Buckinx, F., Schoene, D., Hirani, V., Cooper, C., 
Kanis, J.A., Rizzoli, R., and McCloskey, E. (2016) ‘Assessment of Muscle Mass, Muscle 
Strength and Physical Performance in Clinical Practice: An International Survey’. 
European Geriatric Medicine 7 (3), 243–246 
Brychta, R.J., Rothney, M.P., Skarulis, M.C., and Chen, K.Y. (2009) Optimizing Energy 
Expenditure Detection in Human Metabolic Chambers. Annual International Conference 
of the IEEE Engineering in Medicine and Biology Society. held 2-6 September 2009. 
IEEE, 6864–6868 
Bucci, M., Huovinen, V., Guzzardi, M.A., Koskinen, S., Raiko, J.R., Lipponen, H., Ahsan, S., 
Badeau, R.M., Honka, M.-J., and Koffert, J. (2016) ‘Resistance Training Improves 
Skeletal Muscle Insulin Sensitivity in Elderly Offspring of Overweight and Obese 
Mothers’. Diabetologia 59 (1), 77–86 
Buch, A., Kis, O., Carmeli, E., Keinan-Boker, L., Berner, Y., Barer, Y., Shefer, G., Marcus, 
Y., and Stern, N. (2017) ‘Circuit Resistance Training Is an Effective Means to Enhance 
Muscle Strength in Older and Middle Aged Adults: A Systematic Review and Meta-
Analysis’. Ageing Research Reviews 37, 16-27 
Buckner, S.L., Jessee, M.B., Mattocks, K.T., Mouser, J.G., Counts, B.R., Dankel, S.J., and 
Loenneke, J.P. (2017) ‘Determining Strength: A Case for Multiple Methods of 
Measurement’. Sports Medicine 47 (2), 193–195 
Burd, N.A., Gorissen, S.H., and van Loon, L.J.C. (2013) ‘Anabolic Resistance of Muscle 
Protein Synthesis with Aging’. Exercise and Sport Sciences Reviews 41 (3), 169–173 
Burd, N.A., Yang, Y., Moore, D.R., Tang, J.E., Tarnopolsky, M.A., and Phillips, S.M. (2012) 
‘Greater Stimulation of Myofibrillar Protein Synthesis with Ingestion of Whey Protein 
Isolate v. Micellar Casein at Rest and after Resistance Exercise in Elderly Men’. British 
Journal of Nutrition 108 (6), 958–962 
Burns, J.M., Johnson, D.K., Watts, A., Swerdlow, R.H., and Brooks, W.M. (2010) ‘Reduced 
Lean Mass in Early Alzheimer Disease and Its Association with Brain Atrophy’. Archives 
of Neurology 67 (4), 428–433 
Bush, N.C., Resuehr, H.E.S., Goree, L.L., Locher, J.L., Bray, M.S., Soleymani, T., and 
Gower, B.A. (2018) ‘A High-Fat Compared with a High-Carbohydrate Breakfast 
Enhances 24-Hour Fat Oxidation in Older Adults’. Journal of Nutrition 148 (2), 220–226 
Butterworth, M., Lees, M., Harlow, P., Hind, K., Duckworth, L., and Ispoglou, T. (2019) 
‘Αcute Effects of Essential Amino Acid Gel-Based and Whey Protein Supplements on 
Appetite and Energy Intake in Older Women’. Applied Physiology, Nutrition, and 
Metabolism 44 (11), 1141–1149 
Cadieux, S., McNeil, J., Lapierre, M.P., Riou, M.-È., and Doucet, É. (2014) ‘Resistance and 
Aerobic Exercises Do Not Affect Post-Exercise Energy Compensation in Normal Weight 
Men and Women’. Physiology & Behavior 130, 113–119 
Calçada, D., Vianello, D., Giampieri, E., Sala, C., Castellani, G., de Graaf, A., Kremer, B., 
van Ommen, B., Feskens, E., and Santoro, A. (2014) ‘The Role of Low-Grade 
Inflammation and Metabolic Flexibility in Aging and Nutritional Modulation Thereof: A 
Systems Biology Approach’. Mechanisms of Ageing and Development 136, 138–147 
Calder, P.C., Bosco, N., Bourdet-Sicard, R., Capuron, L., Delzenne, N., Doré, J., 
Franceschi, C., Lehtinen, M.J., Recker, T., Salvioli, S., and Visioli, F. (2017) ‘Health 
Relevance of the Modification of Low Grade Inflammation in Ageing (Inflammageing) 
and the Role of Nutrition’. Ageing Research Reviews 40, 95–119 
 301 
Calles-Escandon, J., Arciero, P.J., Gardner, A.W., Bauman, C., and Poehlman, E.T. (1995) 
‘Basal Fat Oxidation Decreases with Aging in Women’. Journal of Applied Physiology 
78 (1), 266–271 
Cambridge Cognition Ltd. (2020) Product Overview: CANTAB Connect Research, version 
11.12. Cambridge: Cambridge Cogition Ltd 
Camfield, D.A., Owen, L., Scholey, A.B., Pipingas, A., and Stough, C. (2011) ‘Dairy 
Constituents and Neurocognitive Health in Ageing’. British Journal of Nutrition 106 (2), 
159–174 
Campbell, W.W., Crim, M.C., Young, V.R., and Evans, W.J. (1994) ‘Increased Energy 
Requirements and Changes in Body Composition with Resistance Training in Older 
Adults’. American Journal of Clinical Nutrition 60 (2), 167–175 
Campbell, W.W., Crim, M.C., Young, V.R., Joseph, L.J., and Evans, W.J. (1995) ‘Effects of 
Resistance Training and Dietary Protein Intake on Protein Metabolism in Older Adults’. 
American Journal of Physiology - Endocrinology and Metabolism 268 (6), 1143-1153 
Campbell, W.W., Kim, J.E., Amankwaah, A.F., Gordon, S.L., and Weinheimer-Haus, E.M. 
(2015) ‘Higher Total Protein Intake and Change in Total Protein Intake Affect Body 
Composition but Not Metabolic Syndrome Indexes in Middle-Aged Overweight and 
Obese Adults Who Perform Resistance and Aerobic Exercise for 36 Weeks’. The 
Journal of Nutrition 145 (9), 2076–2083 
Camps, S.G.J.A., Verhoef, S.P.M., and Westerterp, K.R. (2013) ‘Weight Loss, Weight 
Maintenance, and Adaptive Thermogenesis’. The American of Clinical Nutrition 97 (5), 
990–994 
Candow, D.G., Chilibeck, P.D., Facci, M., Abeysekara, S., and Zello, G.A. (2006) ‘Protein 
Supplementation before and after Resistance Training in Older Men’. European Journal 
of Applied Physiology 97 (5), 548-556 
Candow, D.G., Forbes, S.C., Little, J.P., Cornish, S.M., Pinkoski, C., and Chilibeck, P.D. 
(2012) ‘Effect of Nutritional Interventions and Resistance Exercise on Aging Muscle 
Mass and Strength’. Biogerontology 13 (4), 345-358 
Cao, L. and Morley, J.E. (2016) ‘Sarcopenia Is Recognized as an Independent Condition by 
an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-
CM) Code’. Journal of the American Medical Directors Association 17 (8), 675–677 
Carroll, T.J., Riek, S., and Carson, R.G. (2001) ‘Neural Adaptations to Resistance Training’. 
Sports Medicine 31 (12), 829–840 
Carvalho, A., Rea, I.M., Parimon, T., and Cusack, B.J. (2014) ‘Physical Activity and 
Cognitive Function in Individuals over 60 Years of Age: A Systematic Review’. Clinical 
Interventions in Aging 9, 661 
Cassilhas, R.C., Antunes, H.K.M., Tufik, S., and De Mello, M.T. (2010) ‘Mood, Anxiety, and 
Serum IGF-1 in Elderly Men given 24 Weeks of High Resistance Exercise’. Perceptual 
and Motor Skills 110 (1), 265–276 
Cassilhas, R.C., Viana, V.A.R., Grassmann, V., Santos, R.T., Santos, R.F., Tufik, S., and 
Mello, M.T. (2007) ‘The Impact of Resistance Exercise on the Cognitive Function of the 
Elderly’. Medicine and Science in Sports and Exercise 39 (8), 1401 
Cawthon, P.M., Blackwell, T.L., Cauley, J., Kado, D.M., Barrett-Connor, E., Lee, C.G., 
Hoffman, A.R., Nevitt, M., Stefanick, M.L., and Lane, N.E. (2015) ‘Evaluation of the 
Usefulness of Consensus Definitions of Sarcopenia in Older Men: Results from the 
Observational Osteoporotic Fractures in Men Cohort Study’. Journal of the American 
Geriatrics Society 63 (11), 2247–2259 
Cermak, N.M., Res, P.T., De Groot, L.C.P.G.M., Saris, W.H.M., and Van Loon, L.J.C. (2012) 
‘Protein Supplementation Augments the Adaptive Response of Skeletal Muscle to 
Resistance-Type Exercise Training: A Meta-Analysis’. American Journal of Clinical 
Nutrition 96 (6), 1454-1464 
Cesari, M., Fielding, R.A., Pahor, M., Goodpaster, B., Hellerstein, M., Van Kan, G.A., Anker, 
S.D., Rutkove, S., Vrijbloed, J.W., and Isaac, M. (2012) ‘Biomarkers of Sarcopenia in 
Clinical Trials—Recommendations from the International Working Group on 
Sarcopenia’. Journal of Cachexia, Sarcopenia and Muscle 3 (3), 181–190 
 302 
Cesari, M., Kritchevsky, S.B., Baumgartner, R.N., Atkinson, H.H., Penninx, B.W.H.J., 
Lenchik, L., Palla, S.L., Ambrosius, W.T., Tracy, R.P., and Pahor, M. (2005) 
‘Sarcopenia, Obesity, and Inflammation - Results from the Trial of Angiotensin 
Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors Study’. American 
Journal of Clinical Nutrition 82 (2), 428–434 
Chaborski, K., Bitterlich, N., Alteheld, B., Parsi, E., and Metzner, C. (2015) ‘Placebo-
Controlled Dietary Intervention of Stress-Induced Neurovegetative Disorders with a 
Specific Amino Acid Composition: A Pilot-Study’. Nutrition Journal 14 (1), 43 
Chalé, A., Cloutier, G.J., Hau, C., Phillips, E.M., Dallal, G.E., and Fielding, R.A. (2013) 
‘Efficacy of Whey Protein Supplementation on Resistance Exercise-Induced Changes 
in Lean Mass, Muscle Strength, and Physical Function in Mobility-Limited Older Adults’. 
Journals of Gerontology - Series A Biological Sciences and Medical Sciences 68 (6), 
682–690 
Chamberlain, S.R., Robbins, T.W., Winder-Rhodes, S., Müller, U., Sahakian, B.J., Blackwell, 
A.D., and Barnett, J.H. (2011) ‘Translational Approaches to Frontostriatal Dysfunction in 
Attention-Deficit/Hyperactivity Disorder Using a Computerized Neuropsychological 
Battery’. Biological Psychiatry 69 (12), 1192–1203 
Chang, H., Kim, K., Jung, Y.-J., and Kato, M. (2017) ‘Effects of Acute High-Intensity 
Resistance Exercise on Cognitive Function and Oxygenation in Prefrontal Cortex’. 
Journal of Exercise Nutrition & Biochemistry 21 (2), 1 
Chang, K.V., Hsu, T.H., Wu, W.T., Huang, K.C., and Han, D.S. (2016) ‘Association Between 
Sarcopenia and Cognitive Impairment: A Systematic Review and Meta-Analysis’. 
Journal of the American Medical Directors Association 17 (12), 1164-1167 
Chang, Y.-K. and Etnier, J.L. (2009) ‘Exploring the Dose-Response Relationship between 
Resistance Exercise Intensity and Cognitive Function’. Journal of Sport and Exercise 
Psychology 31 (5), 640–656 
Chang, Y.K., Pan, C.Y., Chen, F.T., Tsai, C.L., and Huang, C.C. (2012) ‘Effect of 
Resistance-Exercise Training on Cognitive Function in Healthy Older Adults: A Review’. 
in Journal of Aging and Physical Activity 20 (4), 497-517 
Charlton, K., Walton, K., Batterham, M., Brock, E., Langford, K., McMahon, A., Roodenrys, 
S., Koh, F., Host, A., Crowe, R., and Thornhill, K. (2016) ‘Pork and Chicken Meals 
Similarly Impact on Cognitive Function and Strength in Community-Living Older Adults: 
A Pilot Study’. Journal of Nutrition in Gerontology and Geriatrics 35 (2), 124-145 
Chee, C., Shannon, C.E., Burns, A., Selby, A.L., Wilkinson, D., Smith, K., Greenhaff, P.L., 
and Stephens, F.B. (2016) ‘Relative Contribution of Intramyocellular Lipid to Whole-
Body Fat Oxidation Is Reduced with Age but Subsarcolemmal Lipid Accumulation and 
Insulin Resistance Are Only Associated with Overweight Individuals’. Diabetes 65 (4), 
840–850 
Chen, H.T., Chung, Y.C., Chen, Y.J., Ho, S.Y., and Wu, H.J. (2017) ‘Effects of Different 
Types of Exercise on Body Composition, Muscle Strength, and IGF-1 in the Elderly with 
Sarcopenic Obesity’. Journal of the American Geriatrics Society 65 (4), 827–832 
Chen, L.K., Woo, J., Assantachai, P., Auyeung, T.W., Chou, M.Y., Iijima, K., Jang, H.C., 
Kang, L., Kim, M., Kim, S., Kojima, T., Kuzuya, M., Lee, J.S.W., Lee, S.Y., Lee, W.J., 
Lee, Y., Liang, C.K., Lim, J.Y., Lim, W.S., Peng, L.N., Sugimoto, K., Tanaka, T., Won, 
C.W., Yamada, M., Zhang, T., Akishita, M., and Arai, H. (2020) ‘Asian Working Group 
for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment’. 
Journal of the American Medical Directors Association 21 (3), 300-307 
Chesley, A., MacDougall, J.D., Tarnopolsky, M.A., Atkinson, S.A., and Smith, K. (1992) 
‘Changes in Human Muscle Protein Synthesis after Resistance Exercise’. Journal of 
Applied Physiology 73 (4), 1383–1388 
Chodzko-Zajko, W.J., Proctor, D.N., Singh, M.A.F., Minson, C.T., Nigg, C.R., Salem, G.J., 
and Skinner, J.S. (2009) ‘Exercise and Physical Activity for Older Adults’. Medicine & 
Science in Sports & Exercise 41 (7), 1510–1530 
Christensen, H.M., Kistorp, C., Schou, M., Keller, N., Zerahn, B., Frystyk, J., Schwarz, P., 
and Faber, J. (2013) ‘Prevalence of Cachexia in Chronic Heart Failure and 
 303 
Characteristics of Body Composition and Metabolic Status’. Endocrine 43 (3), 626–634 
Chupel, M.U., Direito, F., Furtado, G.E., Minuzzi, L.G., Pedrosa, F.M., Colado, J.C., Ferreira, 
J.P., Filaire, E., and Teixeira, A.M. (2017) ‘Strength Training Decreases Inflammation 
and Increases Cognition and Physical Fitness in Older Women with Cognitive 
Impairment’. Frontiers in Physiology 8, 377 
Church, D.D., Hoffman, J.R., Mangine, G.T., Jajtner, A.R., Townsend, J.R., Beyer, K.S., 
Wang, R., La Monica, M.B., Fukuda, D.H., and Stout, J.R. (2016) ‘Comparison of High-
Intensity vs. High-Volume Resistance Training on the BDNF Response to Exercise’. 
Journal of Applied Physiology 121 (1), 123-128 
Churchward-Venne, T.A., Tieland, M., Verdijk, L.B., Leenders, M., Dirks, M.L., de Groot, 
L.C.P.G.M., and van Loon, L.J.C. (2015) ‘There Are No Nonresponders to Resistance-
Type Exercise Training Inolder Men and Women’. Journal of the American Medical 
Directors Association 16 (5), 400–411 
Cipolli, C., Yassuda, S., and Aprahamian, I. (2019) ‘Sarcopenia Is Associated with Cognitive 
Impairment in Older Adults: A Systematic Review and Meta-Analysis’. Journal of 
Nutrition, Health and Aging 23 (6), 525-531 
Clark, B.C. and Manini, T.M. (2008) ‘Sarcopenia ≠ Dynapenia’. Journals of Gerontology - 
Series A Biological Sciences and Medical Sciences 63 (8), 829–834 
Clegg, A., Young, J., Iliffe, S., Rikkert, M.O., and Rockwood, K. (2013) ‘Frailty in Elderly 
People’. The Lancet 381 (9868), 752–762 
Clifton, P.M., Condo, D., and Keogh, J.B. (2014) ‘Long Term Weight Maintenance after 
Advice to Consume Low Carbohydrate, Higher Protein Diets - A Systematic Review 
and Meta Analysis’. Nutrition, Metabolism and Cardiovascular Diseases 24 (3), 224-235 
Coelho-Júnior, H.J., Oliveira Gonçalves, I. de, Sampaio, R.A.C., Sampaio, P.Y.S., Lusa 
Cadore, E., Calvani, R., Picca, A., Izquierdo, M., Marzetti, E., and Uchida, M.C. (2020) 
‘Effects of Combined Resistance and Power Training on Cognitive Function in Older 
Women: A Randomized Controlled Trial’. International Journal of Environmental 
Research and Public Health 17 (10), 3435 
Coelho, F.M., Pereira, D.S., Lustosa, L.P., Silva, J.P., Dias, J.M.D., Dias, R.C.D., Queiroz, 
B.Z., Teixeira, A.L., Teixeira, M.M., and Pereira, L.S.M. (2012) ‘Physical Therapy 
Intervention (PTI) Increases Plasma Brain-Derived Neurotrophic Factor (BDNF) Levels 
in Non-Frail and Pre-Frail Elderly Women’. Archives of Gerontology and Geriatrics 54 
(3), 415–420 
Cohen, J. (1988) Statistical Power for the Social Sciences. Hillsdale, NJ: Laurence Erlbaum 
and Associates 
Colpani, V., Baena, C.P., Jaspers, L., Van Dijk, G.M., Farajzadegan, Z., Dhana, K., 
Tielemans, M.J., Voortman, T., Freak-Poli, R., and Veloso, G.G. V (2018) 'Lifestyle 
Factors, Cardiovascular Disease and All-Cause Mortality in Middle-Aged and Elderly 
Women: A Systematic Review and Meta-Analysis'. European Journal of Epidemiology 
33 (9), 831-845 
Consitt, L.A. and Clark, B.C. (2018) ‘The Vicious Cycle of Myostatin Signaling in Sarcopenic 
Obesity: Myostatin Role in Skeletal Muscle Growth, Insulin Signaling and Implications 
for Clinical Trials’. The Journal of Frailty & Aging 7 (1), 21–27 
Consitt, L.A., Dudley, C., and Saxena, G. (2019) ‘Impact of Endurance and Resistance 
Training on Skeletal Muscle Glucose Metabolism in Older Adults’. Nutrients 11 (11), 
2636 
Consitt, L.A., Saxena, G., Saneda, A., and Houmard, J.A. (2016) ‘Age-Related Impairments 
in Skeletal Muscle PDH Phosphorylation and Plasma Lactate Are Indicative of 
Metabolic Inflexibility and the Effects of Exercise Training’. American Journal of 
Physiology - Endocrinology and Metabolism 311 (11), 145-156 
Coon, P.J., Rogus, E.M., Drinkwater, D., Muller, D.C., and Goldberg, A.P. (1992) ‘Role of 
Body Fat Distribution in the Decline in Insulin Sensitivity and Glucose Tolerance with 
Age’. The Journal of Clinical Endocrinology & Metabolism 75 (4), 1125–1132 
Cooper, C., Fielding, R., Visser, M. V, Van Loon, L.J., Rolland, Y., Orwoll, E., Reid, K., 
Boonen, S., Dere, W., and Epstein, S. (2013) ‘Tools in the Assessment of Sarcopenia’. 
 304 
Calcified Tissue International 93 (3), 201–210 
Coppin, A.K., Shumway-Cook, A., Saczynski, J.S., Patel, K. V., Ble, A., Ferrucci, L., and 
Guralnik, J.M. (2006) ‘Association of Executive Function and Performance of Dual-Task 
Physical Tests among Older Adults: Analyses from the InChianti Study’. Age and 
Ageing 35 (6), 619-624 
Cordell, C.B., Borson, S., Boustani, M., Chodosh, J., Reuben, D., Verghese, J., Thies, W., 
Fried, L.B., and Workgroup, M.D. of C.I. (2013) ‘Alzheimer’s Association 
Recommendations for Operationalizing the Detection of Cognitive Impairment during 
the Medicare Annual Wellness Visit in a Primary Care Setting’. Alzheimer’s & Dementia 
9 (2), 141–150 
Correia, P.R., Pansani, A., Machado, F., Andrade, M., Silva, A.C. da, Scorza, F.A., 
Cavalheiro, E.A., and Arida, R.M. (2010) ‘Acute Strength Exercise and the Involvement 
of Small or Large Muscle Mass on Plasma Brain-Derived Neurotrophic Factor Levels’. 
Clinics 65 (11), 1123–1126 
Cramer, J.T., Cruz-Jentoft, A.J., Landi, F., Hickson, M., Zamboni, M., Pereira, S.L., Hustead, 
D.S., and Mustad, V.A. (2016) ‘Impacts of High-Protein Oral Nutritional Supplements 
Among Malnourished Men and Women with Sarcopenia: A Multicenter, Randomized, 
Double-Blinded, Controlled Trial’. Journal of the American Medical Directors 
Association 17 (11), 1044–1055 
Crapo, R.O., Casaburi, R., Coates, A.L., Enright, P.L., MacIntyre, N.R., McKay, R.T., 
Johnson, D., Wanger, J.S., Zeballos, R.J., Bittner, V., and Mottram, C. (2002) ‘ATS 
Statement: Guidelines for the Six-Minute Walk Test’. American Journal of Respiratory 
and Critical Care Medicine 166 (1), 111–117 
Crichton, G.E., Elias, M.F., Dore, G.A., Abhayaratna, W.P., and Robbins, M.A. (2012a) 
‘Relations between Dairy Food Intake and Arterial Stiffness: Pulse Wave Velocity and 
Pulse Pressure’. Hypertension 59 (5), 1044–1051 
Crichton, G.E., Murphy, K.J., Howe, P.R.C., Buckley, J.D., and Bryan, J. (2012b) ‘Dairy 
Consumption and Working Memory Performance in Overweight and Obese Adults’. 
Appetite 59 (1), 34-40 
Critchley, M. (1931) ‘The Neurology of Old Age.’ The Lancet 217 (5623), 1221–1231 
Cruz-Jentoft, A.J., Baeyens, J.P., Bauer, J.M., Boirie, Y., Cederholm, T., Landi, F., Martin, 
F.C., Michel, J.P., Rolland, Y., Schneider, S.M., Topinková, E., Vandewoude, M., and 
Zamboni, M. (2010) ‘Sarcopenia: European Consensus on Definition and Diagnosis’. 
Age and Ageing 39 (4), 412–423 
Cruz-Jentoft, A.J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., 
Landi, F., Rolland, Y., Sayer, A.A., Schneider, S.M., Sieber, C.C., Topinkova, E., 
Vandewoude, M., Visser, M., Zamboni, M., Bautmans, I., Baeyens, J.P., Cesari, M., 
Cherubini, A., Kanis, J., Maggio, M., Martin, F., Michel, J.P., Pitkala, K., Reginster, J.Y., 
Rizzoli, R., Sánchez-Rodríguez, D., and Schols, J. (2019) ‘Sarcopenia: Revised 
European Consensus on Definition and Diagnosis’. Age and Ageing 48 (1), 16–31 
Cruz-Jentoft, A.J., Landi, F., Schneider, S.M., Zúñiga, C., Arai, H., Boirie, Y., Chen, L.-K., 
Fielding, R.A., Martin, F.C., and Michel, J.-P. (2014) ‘Prevalence of and Interventions 
for Sarcopenia in Ageing Adults: A Systematic Review. Report of the International 
Sarcopenia Initiative (EWGSOP and IWGS)’. Age and Ageing 43 (6), 748–759 
Csapo, R. and Alegre, L.M. (2016) ‘Effects of Resistance Training with Moderate vs Heavy 
Loads on Muscle Mass and Strength in the Elderly: A Meta-Analysis’. Scandinavian 
Journal of Medicine & Science in Sports 26 (9), 995–1006 
Cunha, P.M., Nunes, J.P., Tomeleri, C.M., Nascimento, M.A., Schoenfeld, B.J., Antunes, M., 
Gobbo, L.A., Teixeira, D., and Cyrino, E.S. (2020) ‘Resistance Training Performed With 
Single and Multiple Sets Induces Similar Improvements in Muscular Strength, Muscle 
Mass, Muscle Quality, and IGF-1 in Older Women: A Randomized Controlled Trial’. 
Journal of Strength and Conditioning Research 34 (4), 1008–1016 
Cunningham, C., O’Sullivan, R., Caserotti, P., and Tully, M.A. (2020) ‘Consequences of 
Physical Inactivity in Older Adults: A Systematic Review of Reviews and Meta-
analyses’. Scandinavian Journal of Medicine & Science in Sports 30 (5), 816–827 
 305 
Cuthbertson, D., Smith, K., Babraj, J., Leese, G., Waddell, T., Atherton, P., Wackerhage, H., 
Taylor, P.M., and Rennie, M.J. (2005) ‘Anabolic Signaling Deficits Underlie Amino Acid 
Resistance of Wasting, Aging Muscle’. The FASEB Journal 19 (3), 1–22 
Daffner, K.R. (2010) ‘Promoting Successful Cognitive Aging: A Comprehensive Review’. 
Journal of Alzheimer’s Disease 19 (4), 1101–1122 
Daly, R.M., O’Connell, S.L., Mundell, N.L., Grimes, C.A., Dunstan, D.W., and Nowson, C.A. 
(2014) ‘Protein-Enriched Diet, with the Use of Lean Red Meat, Combined with 
Progressive Resistance Training Enhances Lean Tissue Mass and Muscle Strength 
and Reduces Circulating IL-6 Concentrations in Elderly Women: A Cluster Randomized 
Controlled Trial’. The American Journal of Clinical Nutrition 99 (4), 899–910 
Daly, R.M., Rosengren, B.E., Alwis, G., Ahlborg, H.G., Sernbo, I., and Karlsson, M.K. (2013) 
‘Gender Specific Age-Related Changes in Bone Density, Muscle Strength and 
Functional Performance in the Elderly: A-10 Year Prospective Population-Based Study’. 
in BMC Geriatrics 13 (1), 71 
Dankel, S.J., Kang, M., Abe, T., and Loenneke, J.P. (2019) ‘Resistance Training Induced 
Changes in Strength and Specific Force at the Fiber and Whole Muscle Level: A Meta-
Analysis’. European Journal of Applied Physiology 119 (1), 265–278 
da Silva, R.G., da Silva, D.R.P., Pina, F.L.C., do Nascimento, M.A., Ribeiro, A.S., and 
Cyrino, E.S. (2017) ‘Effect of Two Different Weekly Resistance Training Frequencies on 
Muscle Strength and Blood Pressure in Normotensive Older Women’. Revista Brasileira 
de Cineantropometria & Desempenho Humano 19 (1), 118-127 
Davidson, M.B. and Schriger, D.L. (2010) ‘Effect of Age and Race/Ethnicity on HbA1c Levels 
in People without Known Diabetes Mellitus: Implications for the Diagnosis of Diabetes’. 
Diabetes Research and Clinical Practice 87 (3), 415–421 
Daviglus, M.L., Bell, C.C., Berrettini, W., Bowen, P.E., Connolly, E.S., Cox, N.J., Dunbar-
Jacob, J.M., Granieri, E.C., Hunt, G., McGarry, K., Patel, D., Potosky, A.L., Sanders-
Bush, E., Silberberg, D., and Trevisan, M. (2010) ‘National Institutes of Health State-of-
the-Science Conference Statement: Preventing Alzheimer Disease and Cognitive 
Decline’. Annals of Internal Medicine 153 (3), 176-181 
Davy, K.P., Horton, T., Davy, B.M., Bessessen, D., and Hill, J.O. (2001) ‘Regulation of 
Macronutrient Balance in Healthy Young and Older Men’. International Journal of 
Obesity 25 (10), 1497–1502 
de Aguilar-Nascimento, J.E., Silveira, B.R.P., and Dock-Nascimento, D.B. (2011) ‘Early 
Enteral Nutrition with Whey Protein or Casein in Elderly Patients with Acute Ischemic 
Stroke: A Double-Blind Randomized Trial’. Nutrition 27 (4), 440–444 
Deary, I.J., Corley, J., Gow, A.J., Harris, S.E., Houlihan, L.M., Marioni, R.E., Penke, L., 
Rafnsson, S.B., and Starr, J.M. (2009) ‘Age-Associated Cognitive Decline’. British 
Medical Bulletin 92 (1), 135–152 
de Buyser, S.L., Petrovic, M., Taes, Y.E., Toye, K.R.C., Kaufman, J.M., Lapauw, B., and 
Goemaere, S. (2016) ‘Validation of the FNIH Sarcopenia Criteria and SOF Frailty Index 
as Predictors of Long-Term Mortality in Ambulatory Older Men’. Age and Ageing 45 (5), 
603–609 
de Carvalho Bastone, A., Nobre, L.N., de Souza Moreira, B., Rosa, I.F., Ferreira, G.B., 
Santos, D.D.L., Monteiro, N.K.S.S., Alves, M.D., Gandra, R.A., and de Lira, E.M. (2020) 
‘Independent and Combined Effect of Home-Based Progressive Resistance Training 
and Nutritional Supplementation on Muscle Strength, Muscle Mass and Physical 
Function in Dynapenic Older Adults with Low Protein Intake: A Randomized Controlled 
Trial’. Archives of Gerontology and Geriatrics 89, 104098 
DeFronzo, R.A. (1981) ‘Glucose Intolerance and Aging’. Diabetes Care 4 (4), 493–501 
DeFronzo, R.A. (1979) ‘Glucose Intolerance and Aging: Evidence for Tissue Insensitivity to 
Insulin’. Diabetes 28 (12), 1095–1101 
Degens, H. (2010) ‘The Role of Systemic Inflammation in Age-related Muscle Weakness 
and Wasting’. Scandinavian Journal of Medicine & Science in Sports 20 (1), 28–38 
Dela, F., Ploug, T., Handberg, A., Petersen, L.N., Larsen, J.J., Mikines, K.J., and Galbo, H. 
(1994) ‘Physical Training Increases Muscle GLUT4 Protein and MRNA in Patients with 
 306 
NIDDM’. Diabetes 43 (7), 862–865 
Delmonico, M., Harris, T., Visser, M., Park, S.W., Velasquez-Mieyer, P., Boudreau, R., 
Manini, T., Nevitt, M., Newman, A.B., and Goodpaster, B. (2009) ‘Longitudinal Study of 
Muscle Strength, Quality, and Adipose Tissue Infiltration’. The American Journal of 
Clinical Nutrition 90 (6), 1579–1585 
De Luca, C.R., Wood, S.J., Anderson, V., Buchanan, J.-A., Proffitt, T.M., Mahony, K., and 
Pantelis, C. (2003) ‘Normative Data from the CANTAB. I: Development of Executive 
Function over the Lifespan’. Journal of Clinical and Experimental Neuropsychology 25 
(2), 242–254 
Demerath, E.W., Rogers, N.L., Reed, D., Lee, M., Choh, A.C., Siervogel, R.M., Chumlea, 
W.C., Towne, B., and Czerwinski, S.A. (2011) ‘Significant Associations of Age, 
Menopausal Status and Lifestyle Factors with Visceral Adiposity in African-American 
and European-American Women’. Annals of Human Biology 38 (3), 247–256 
Demerath, E.W., Sun, S.S., Rogers, N., Lee, M., Reed, D., Choh, A.C., Couch, W., 
Czerwinski, S.A., Cameron Chumlea, W., Siervogel, R.M., and Towne, B. (2007) 
‘Anatomical Patterning of Visceral Adipose Tissue: Race, Sex, and Age Variation’. 
Obesity 15 (12), 2984–2993 
Demnitz, N., Zsoldos, E., Mahmood, A., Mackay, C.E., Kivimäki, M., Singh-Manoux, A., 
Dawes, H., Johansen-Berg, H., Ebmeier, K.P., and Sexton, C.E. (2017) ‘Associations 
between Mobility, Cognition, and Brain Structure in Healthy Older Adults’. Frontiers in 
Aging Neuroscience 9, 155 
Denzer, C.M. and Young, J.C. (2003) ‘The Effect of Resistance Exercise on the Thermic 
Effect of Food’. International Journal of Sport Nutrition and Exercise Metabolism 13 (3), 
396–402 
Deschamps, V., Astier, X., Ferry, M., Rainfray, M., Emeriau, J.P., and Barberger-Gateau, P. 
(2002) ‘Nutritional Status of Healthy Elderly Persons Living in Dordogne, France, and 
Relation with Mortality and Cognitive or Functional Decline’. European Journal of 
Clinical Nutrition 56 (4), 305–312 
de Souza Vale, R.G., de Oliveira, R.D., Pernambuco, C.S., da Silva Novaes, J., and de 
Andrade, A. de F.D. (2009) ‘Effects of Muscle Strength and Aerobic Training on Basal 
Serum Levels of IGF-1 and Cortisol in Elderly Women’. Archives of Gerontology and 
Geriatrics 49 (3), 343–347 
Deutz, N.E.P., Bauer, J.M., Barazzoni, R., Biolo, G., Boirie, Y., Bosy-Westphal, A., 
Cederholm, T., Cruz-Jentoft, A., Krznariç, Z., Nair, K.S., Singer, P., Teta, D., Tipton, K., 
and Calder, P.C. (2014) ‘Protein Intake and Exercise for Optimal Muscle Function with 
Aging: Recommendations from the ESPEN Expert Group’. Clinical Nutrition 33 (6), 
929–936 
Devries, M.C. and Phillips, S.M. (2015) ‘Supplemental Protein in Support of Muscle Mass 
and Health: Advantage Whey’. Journal of Food Science 80 (1), 8–15 
Devries, M.C. and Phillips, S.M. (2014) ‘Creatine Supplementation during Resistance 
Training in Older Adults - A Meta-Analysis’. Medicine and Science in Sports and 
Exercise 46 (6), 1194–1203 
Devries, M.C., Sithamparapillai, A., Brimble, K.S., Banfield, L., Morton, R.W., and Phillips, 
S.M. (2018) ‘Changes in Kidney Function Do Not Differ between Healthy Adults 
Consuming Higher-Compared with Lower-or Normal-Protein Diets: A Systematic 
Review and Meta-Analysis’. The Journal of Nutrition 148 (11), 1760–1775 
Diabetes UK (2014) The Cost of Diabetes [online] available from < 
https://www.diabetes.org.uk/resources-s3/2017-
11/diabetes%20uk%20cost%20of%20diabetes%20report.pdf> [12 June 2020] 
Dickman, K.D., Thomas, M.C., Anderson, B., Manuck, S.B., and Kamarck, T.W. (2020) 
‘Social Integration and Diurnal Cortisol Decline: The Role of Psychosocial and 
Behavioral Pathways’. Psychosomatic Medicine 82 (6), 568–576 
Dijckmans, B., Tortosa-Martínez, J., Caus, N., González-Caballero, G., Martínez-Pelegrin, 
B., Manchado-Lopez, C., Cortell-Tormo, J.M., Chulvi-Medrano, I., and Clow, A. (2017) 
‘Does the Diurnal Cycle of Cortisol Explain the Relationship between Physical 
 307 
Performance and Cognitive Function in Older Adults?’ European Review of Aging and 
Physical Activity 14 (1), 6 
Dik, M.G., Pluijm, S.M.F., Jonker, C., Deeg, D.J.H., Lomecky, M.Z., and Lips, P. (2003) 
‘Insulin-like Growth Factor I (IGF-I) and Cognitive Decline in Older Persons’. 
Neurobiology of Aging 24 (4), 573–581 
Dinoff, A., Herrmann, N., Swardfager, W., Liu, C.S., Sherman, C., Chan, S., and Lanctôt, 
K.L. (2016) ‘The Effect of Exercise Training on Resting Concentrations of Peripheral 
Brain-Derived Neurotrophic Factor (BDNF): A Meta-Analysis’. PloS one 11 (9), 
e0163037 
Dismore, L., Hurst, C., Sayer, A., Stevenson, E., Aspray, T., and Granic, A. (2020) ‘Study of 
the Older Adults’ Motivators and Barriers Engaging in a Nutrition and Resistance 
Exercise Intervention for Sarcopenia: An Embedded Qualitative Project in the MIlkMAN 
Pilot Study’. Gerontology & Geriatric Medicine 6, 1-9 
Doherty, A., Jackson, D., Hammerla, N., Plötz, T., Olivier, P., Granat, M.H., White, T., Van 
Hees, V.T., Trenell, M.I., Owen, C.G., Preece, S.J., Gillions, R., Sheard, S., Peakman, 
T., Brage, S., and Wareham, N.J. (2017) ‘Large Scale Population Assessment of 
Physical Activity Using Wrist Worn Accelerometers: The UK Biobank Study’. PloS one 
12 (2), e0169649 
Dorling, J., Broom, D.R., Burns, S.F., Clayton, D.J., Deighton, K., James, L.J., King, J.A., 
Miyashita, M., Thackray, A.E., Batterham, R.L., and Stensel, D.J. (2018) ‘Acute and 
Chronic Effects of Exercise on Appetite, Energy Intake, and Appetite-Related 
Hormones: The Modulating Effect of Adiposity, Sex, and Habitual Physical Activity’. 
Nutrients 10 (9), 1140 
Doyle, P., Cusin, I., Rohner-Jeanrenaud, F., and Jeanrenaud, B. (1995) ‘Four-Day 
Hyperinsulinemia in Euglycemic Conditions Alters Local Cerebral Glucose Utilization in 
Specific Brain Nuclei of Freely Moving Rats’. Brain Research 684 (1), 47–55 
Driscoll, I., Martin, B., An, Y., Maudsley, S., Ferrucci, L., Mattson, M.P., and Resnick, S.M. 
(2012) ‘Plasma BDNF Is Associated with Age-Related White Matter Atrophy but Not 
with Cognitive Function in Older, Non-Demented Adults’. PloS one 7 (4), e35217 
Drummen, M., Tischmann, L., Gatta-Cherifi, B., Adam, T., and Westerterp-Plantenga, M.S. 
(2018) ‘Dietary Protein and Energy Balance in Relation to Obesity and Co-Morbidities’. 
Frontiers in Endocrinology 9, 443 
Drummen, M., Tischmann, L., Gatta-Cherifi, B., Fogelholm, M., Raben, A., Adam, T.C., and 
Westerterp-Plantenga, M.S. (2020) ‘High Compared with Moderate Protein Intake 
Reduces Adaptive Thermogenesis and Induces a Negative Energy Balance during 
Long-Term Weight-Loss Maintenance in Participants with Prediabetes in the Postobese 
State: A PREVIEW Study’. Journal of Nutrition 150 (3), 458–463 
Drummond, M.J., Dickinson, J.M., Fry, C.S., Walker, D.K., Gundermann, D.M., Reidy, P.T., 
Timmerman, K.L., Markofski, M.M., Paddon-Jones, D., and Rasmussen, B.B. (2012) 
‘Bed Rest Impairs Skeletal Muscle Amino Acid Transporter Expression, MTORC1 
Signaling, and Protein Synthesis in Response to Essential Amino Acids in Older 
Adults’. American Journal of Physiology-Endocrinology and Metabolism 302 (9), 1113–
1122 
Drummond, M.J., Dreyer, H.C., Pennings, B., Fry, C.S., Dhanani, S., Dillon, E.L., Sheffield-
Moore, M., Volpi, E., and Rasmussen, B.B. (2008) ‘Skeletal Muscle Protein Anabolic 
Response to Resistance Exercise and Essential Amino Acids Is Delayed with Aging’. 
Journal of Applied Physiology 104 (5), 1452–1461 
Du, S., Rajjo, T., Santosa, S., and Jensen, M.D. (2014) ‘The Thermic Effect of Food Is 
Reduced in Older Adults’. Hormone and Metabolic Research 46 (5), 365–369 
Dubé, J.J., Broskey, N.T., Despines, A.A., Stefanovic-Racic, M., Toledo, F.G.S., 
Goodpaster, B.H., and Amati, F. (2016) ‘Muscle Characteristics and Substrate 
Energetics in Lifelong Endurance Athletes’. Medicine and Science in Sports and 
Exercise 48 (3), 472 
Dubowitz, N., Xue, W., Long, Q., Ownby, J.G., Olson, D.E., Barb, D., Rhee, M.K., Mohan, A. 
V, Watson-Williams, P.I., and Jackson, S.L. (2014) ‘Aging Is Associated with Increased 
 308 
HbA1c Levels, Independently of Glucose Levels and Insulin Resistance, and Also with 
Decreased HbA1c Diagnostic Specificity’. Diabetic Medicine 31 (8), 927–935 
Dulac, M.C., Pion, C.H., Lemieux, F.C., Carvalho, L.P., El Hajj Boutros, G., Bélanger, M., 
Gaudreau, P., Chevalier, S., Morais, J.A., Noirez, P., Gouspillou, G., and Aubertin-
Leheudre, M. (2020) ‘Effects of Slow versus Fast-Digested Protein Supplementation 
Combined with Mixed Power Training on Muscle Function and Functional Capacities in 
Older Men’. British Journal of Nutrition, 1-17. DOI: 10.1017/S0007114520001932 
Durainayagam, B., Mitchell, C.J., Milan, A.M., Zeng, N., Sharma, P., Mitchell, S.M., Ramzan, 
F., Knowles, S., Sjödin, A., and Wagner, K.-H. (2019) ‘Impact of a High Protein Intake 
on the Plasma Metabolome in Elderly Males: 10 Week Randomised Dietary 
Intervention.’ Frontiers in Nutrition 6, 180. DOI: 10.3389/fnut.2019.00180 
Edinburgh, R.M., Bradley, H.E., Abdullah, N.-F., Robinson, S.L., Chrzanowski-Smith, O.J., 
Walhin, J.-P., Joanisse, S., Manolopoulos, K.N., Philp, A., and Hengist, A. (2020) ‘Lipid 
Metabolism Links Nutrient-Exercise Timing to Insulin Sensitivity in Men Classified as 
Overweight or Obese’. The Journal of Clinical Endocrinology & Metabolism 105 (3), 
660–676 
Eelderink, C., Rietsema, S., van Vliet, I.M.Y., Loef, L.C., Boer, T., Koehorst, M., Nolte, I.M., 
Westerhuis, R., Singh-Povel, C.M., and Geurts, J.M.W. (2019) ‘The Effect of High 
Compared with Low Dairy Consumption on Glucose Metabolism, Insulin Sensitivity, and 
Metabolic Flexibility in Overweight Adults: A Randomized Crossover Trial’. The 
American Journal of Clinical Nutrition 109 (6), 1555–1568 
Eisenstein, J., Roberts, S.B., Dallal, G., and Saltzman, E. (2002) ‘High-Protein Weight-Loss 
Diets: Are They Safe and Do They Work? A Review of the Experimental and 
Epidemiologic Data’. Nutrition Reviews 60 (7), 189–200 
Elia, M. (1992) Organ and Tissue Contribution to Metabolic Rate. in Energy Metabolism, 
Tissue Determinants and Cellular Corollaries. ed. by Kinney, J.M. and Tucker. H.N. 
New York, USA: Raven Press, 61–80 
Elia, M., Ritz, P., and Stubbs, R.J. (2000) ‘Total Energy Expenditure in the Elderly’. 
European Journal of Clinical Nutrition 54, 92–103 
Elliott, B., Renshaw, D., Getting, S., and Mackenzie, R. (2012) ‘The Central Role of 
Myostatin in Skeletal Muscle and Whole Body Homeostasis’. Acta Physiologica 205 (3), 
324–340 
Engelhart, M.J., Geerlings, M.I., Meijer, J., Kiliaan, A., Ruitenberg, A., van Swieten, J.C., 
Stijnen, T., Hofman, A., Witteman, J.C.M., and Breteler, M.M.B. (2004) ‘Inflammatory 
Proteins in Plasma and the Risk of Dementia: The Rotterdam Study’. Archives of 
Neurology 61 (5), 668–672 
Engeroff, T., Niederer, D., Vogt, L., and Banzer, W. (2019) ‘Intensity and Workload Related 
Dose-Response Effects of Acute Resistance Exercise on Domain-Specific Cognitive 
Function and Affective Response–a Four-Armed Randomized Controlled Crossover 
Trial’. Psychology of Sport and Exercise 43, 55–63 
Englund, D.A., Kirn, D.R., Koochek, A., Zhu, H., Travison, T.G., Reid, K.F., Von Berens, Å., 
Melin, M., Cederholm, T., Gustafsson, T., and Fielding, R.A. (2018) ‘Nutritional 
Supplementation with Physical Activity Improves Muscle Composition in Mobility-
Limited Older Adults, the VIVE2 Study: A Randomized, Double-Blind, Placebo-
Controlled Trial’. Journals of Gerontology 73 (1), 95-101 
Enright, P.L., McBurnie, M.A., Bittner, V., Tracy, R.P., McNamara, R., Arnold, A., and 
Newman, A.B. (2003) ‘The 6-Min Walk Test: A Quick Measure of Functional Status in 
Elderly Adults’. Chest 123 (2), 387–398 
Ershler, W.B. (1993) ‘Interleukin-6: A Cytokine for Gerontolgists’. Journal of the American 
Geriatrics Society 41 (2), 176–181 
Evans, P., Hucklebridge, F., Loveday, C., and Clow, A. (2012) ‘The Cortisol Awakening 
Response Is Related to Executive Function in Older Age’. International Journal of 
Psychophysiology 84 (2), 201–204 
Evans, P.D., Fredhoi, C., Loveday, C., Hucklebridge, F., Aitchison, E., Forte, D., and Clow, 
A. (2011) ‘The Diurnal Cortisol Cycle and Cognitive Performance in the Healthy Old’. 
 309 
International Journal of Psychophysiology 79 (3), 371–377 
Evans, W.J. (1995) ‘Exercise, Nutrition, and Aging’. Clinics in Geriatric Medicine 11 (4), 725–
734 
Farina, N., Page, T.E., Daley, S., Brown, A., Bowling, A., Basset, T., Livingston, G., Knapp, 
M., Murray, J., and Banerjee, S. (2017) ‘Factors Associated with the Quality of Life of 
Family Carers of People with Dementia: A Systematic Review’. Alzheimer’s and 
Dementia 13 (5), 572-581 
Farmer, K.C. (1999) ‘Methods for Measuring and Monitoring Medication Regimen 
Adherence in Clinical Trials and Clinical Practice’. Clinical Therapeutics 21 (6), 1074–
1090 
Farsijani, S., Morais, J.A., Payette, H., Gaudreau, P., Shatenstein, B., Gray-Donald, K., and 
Chevalier, S. (2016) ‘Relation between Mealtime Distribution of Protein Intake and Lean 
Mass Loss in Free-Living Older Adults of the NuAge Study’. American Journal of 
Clinical Nutrition 104 (3), 694-703 
Farsijani, S., Payette, H., Morais, J.A., Shatenstein, B., Gaudreau, P., and Chevalier, S. 
(2017) ‘Even Mealtime Distribution of Protein Intake Is Associated with Greater Muscle 
Strength, but Not with 3-y Physical Function Decline, in Free-Living Older Adults: The 
Quebec Longitudinal Study on Nutrition as a Determinant of Successful Aging (NuAge 
Study)’. American Journal of Clinical Nutrition 106 (1), 113–124 
Fedewa, M. V, Hathaway, E.D., Ward-Ritacco, C.L., Williams, T.D., and Dobbs, W.C. (2018) 
‘The Effect of Chronic Exercise Training on Leptin: A Systematic Review and Meta-
Analysis of Randomized Controlled Trials’. Sports Medicine 48 (6), 1437–1450 
Fekete, A.A., Giromini, C., Chatzidiakou, Y., Givens, D.I., and Lovegrove, J.A. (2016) ‘Whey 
Protein Lowers Blood Pressure and Improves Endothelial Function and Lipid 
Biomarkers in Adults with Prehypertension and Mild Hypertension: Results from the 
Chronic Whey2Go Randomized Controlled Trial’. The American Journal of Clinical 
Nutrition 104 (6), 1534–1544 
Feldman, H.A., Longcope, C., Derby, C.A., Johannes, C.B., Araujo, A.B., Coviello, A.D., 
Bremner, W.J., and McKinlay, J.B. (2002) ‘Age Trends in the Level of Serum 
Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the 
Massachusetts Male Aging Study’. The Journal of Clinical Endocrinology & Metabolism 
87 (2), 589–598 
De Felice, F.G., Lourenco, M. V, and Ferreira, S.T. (2014) ‘How Does Brain Insulin 
Resistance Develop in Alzheimer’s Disease?’ Alzheimer’s & Dementia 10, 26–32 
Fenton, T.R., Lyon, A.W., Eliasziw, M., Tough, S.C., and Hanley, D.A. (2009) ‘Phosphate 
Decreases Urine Calcium and Increases Calcium Balance: A Meta-Analysis of the 
Osteoporosis Acid-Ash Diet Hypothesis’. Nutrition Journal 8 (1), 41 
Fenton, T.R., Tough, S.C., Lyon, A.W., Eliasziw, M., and Hanley, D.A. (2011) ‘Causal 
Assessment of Dietary Acid Load and Bone Disease: A Systematic Review & Meta-
Analysis Applying Hill’s Epidemiologic Criteria for Causality’. Nutrition Journal 10 (1), 41 
Fernández-Celemín, L., Pasko, N., Blomart, V., and Thissen, J.-P. (2002) ‘Inhibition of 
Muscle Insulin-like Growth Factor I Expression by Tumor Necrosis Factor-α’. American 
Journal of Physiology-Endocrinology and Metabolism 283 (6), 1279–1290 
Fernstrom, J.D. and Fernstrom, M.H. (2007) ‘Tyrosine, Phenylalanine, and Catecholamine 
Synthesis and Function in the Brain’. The Journal of Nutrition 137 (6), 1539-1547 
Ferrannini, E., Vichi, S., Beck-Nielsen, H., Laakso, M., Paolisso, L., Smith, G., and 
Resistance, E.G. for the S. of I. (1996) ‘Insulin Action and Age: European Group for the 
Study of Insulin Resistance (EGIR)’. Diabetes 45 (7), 947–953 
Ferrucci, L. and Fabbri, E. (2018) ‘Inflammageing: Chronic Inflammation in Ageing, 
Cardiovascular Disease, and Frailty’. Nature Reviews Cardiology 15 (9), 505–522 
Fiatarone, M.A., O’Neill, E.F., Ryan, N.D., Clements, K.M., Solares, G.R., Nelson, M.E., 
Roberts, S.B., Kehayias, J.J., Lipsitz, L.A., and Evans, W.J. (1994) ‘Exercise Training 
and Nutritional Supplementation for Physical Frailty in Very Elderly People’. New 
England Journal of Medicine 330 (25), 1769–1775 
Fielding, R.A., Travison, T.G., Kirn, D.R., Koochek, A., Reid, K.F., von Berens, Å., Zhu, H., 
 310 
Folta, S.C., Sacheck, J.M., and Nelson, M.E. (2017) ‘Effect of Structured Physical 
Activity and Nutritional Supplementation on Physical Function in Mobility-Limited Older 
Adults: Results from the VIVE2 Randomized Trial’. The Journal of Nutrition, Health & 
Aging 21 (9), 936–942 
Fielding, R.A., Vellas, B., Evans, W.J., Bhasin, S., Morley, J.E., Newman, A.B., van Kan, 
G.A., Andrieu, S., Bauer, J., and Breuille, D. (2011) ‘Sarcopenia: An Undiagnosed 
Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and 
Consequences. International Working Group on Sarcopenia’. Journal of the American 
Medical Directors Association 12 (4), 249–256 
Finger, D., Goltz, F.R., Umpierre, D., Meyer, E., Rosa, L.H.T., and Schneider, C.D. (2015) 
‘Effects of Protein Supplementation in Older Adults Undergoing Resistance Training: A 
Systematic Review and Meta-Analysis’. Sports Medicine 45 (2), 254-255 
Fisher, S.R., Kuo, Y., Graham, J.E., Ottenbacher, K.J., and Ostir, G. V (2010) ‘Early 
Ambulation and Length of Stay in Older Adults Hospitalized for Acute Illness’. Archives 
of Internal Medicine 170 (21), 1942–1943 
FitzGerald, R.J. and Meisel, H. (1999) ‘Lactokinins: Whey Protein-derived ACE Inhibitory 
Peptides’. Food/Nahrung 43 (3), 165–167 
Flack, K.D., Davy, K.P., Hulver, M.W., Winett, R.A., Frisard, M.I., and Davy, B.M. (2011) 
‘Aging, Resistance Training, and Diabetes Prevention’. Journal of Aging Research 2011 
Flegal, K.M., Carroll, M.D., Kit, B.K., and Ogden, C.L. (2012) ‘Prevalence of Obesity and 
Trends in the Distribution of Body Mass Index among US Adults, 1999-2010’. JAMA 
307 (5), 491–497 
Flint, A., Raben, A., Blundell, J.E., and Astrup, A. (2000) ‘Reproducibility, Power and Validity 
of Visual Analogue Scales in Assessment of Appetite Sensations in Single Test Meal 
Studies’. International Journal of Obesity 24 (1), 38-48 
Foley, A.L., Hillier, S., and Barnard, R. (2011) ‘Effectiveness of Once-Weekly Gym-Based 
Exercise Programmes for Older Adults Post Discharge from Day Rehabilitation: A 
Randomised Controlled Trial’. British Journal of Sports Medicine 45 (12), 978–986 
Folland, J.P. and Williams, A.G. (2007) ‘Morphological and Neurological Contributions to 
Increased Strength’. Sports Medicine 37 (2), 145–168 
Folstein, M.F., Folstein, S.E., and McHugh, P.R. (1975) ‘“Mini-Mental State”. A Practical 
Method for Grading the Cognitive State of Patients for the Clinician’. Journal of 
Psychiatric Research 12 (3), 189–198 
Formica, M.B., Gianoudis, J., Nowson, C.A., Connell, S.L.O., Milte, C., and Ellis, K.A. (2020) 
'Effect of Lean Red Meat Combined with a Multicomponent Exercise Program on 
Muscle and Cognitive Function in Older Adults : A 6-Month Randomized Controlled 
Trial'. The American Journal of Clinical Nutrition 112 (1), 113-128 
Forte, R., Boreham, C.A.G., Leite, J.C., De Vito, G., Brennan, L., Gibney, E.R., and Pesce, 
C. (2013) ‘Enhancing Cognitive Functioning in the Elderly: Multicomponent vs 
Resistance Training’. Clinical Interventions in Aging 8, 19 
Forti, L.N., Van Roie, E., Njemini, R., Coudyzer, W., Beyer, I., Delecluse, C., and Bautmans, 
I. (2015) ‘Dose-and Gender-Specific Effects of Resistance Training on Circulating 
Levels of Brain Derived Neurotrophic Factor (BDNF) in Community-Dwelling Older 
Adults’. Experimental Gerontology 70, 144–149 
Fouque, D., Wang, P.H., Laville, M., and Boissel, J.P. (2000) ‘Low Protein Diets for Chronic 
Renal Failure in Non Diabetic Adults’. Cochrane Database of Systematic Reviews (4). 
DOI: 10.1002/14651858.CD001892 
Fragala, M.S., Cadore, E.L., Dorgo, S., Izquierdo, M., Kraemer, W.J., Peterson, M.D., and 
Ryan, E.D. (2019) ‘Resistance Training for Older Adults: Position Statement From the 
National Strength and Conditioning Association’. Journal of Strength and Conditioning 
Research 33 (8), 2019–2052 
Franceschi, C., Bonafe, M., Valensin, S., Olivieri, F., De Luca, M., Ottaviani, E., and De 
Benefictis, G. (2006) ‘Inflamm-Aging: An Evolutionary Perspective on 
Immunosenescence’. Annals of the New York Academy of Sciences 908 (1), 244–254 
Frayn, K.N. (1983) ‘Calculation of Substrate Oxidation Rates in Vivo from Gaseous 
 311 
Exchange’. Journal of Applied Physiology 55 (2), 628–634 
Frazier, H.N., Ghoweri, A.O., Anderson, K.L., Lin, R.L., Porter, N.M., and Thibault, O. (2019) 
‘Broadening the Definition of Brain Insulin Resistance in Aging and Alzheimer’s 
Disease’. Experimental Neurology 313, 79-87 
Freedson, P.S., Melanson, E., and Sirard, J. (1998) ‘Calibration of the Computer Science 
and Applications, Inc. Accelerometer’. Medicine and Science in Sports and Exercise 30 
(5), 777–781 
Freitas, M.C., Panissa, V.L.G., Lenquiste, S.A., Serra, F. de M., Figueiredo, C., Lira, F.S., 
and Rossi, F.E. (2020) ‘Hunger Is Suppressed after Resistance Exercise with 
Moderate-Load Compared to High-Load Resistance Exercise: The Potential Influence 
of Metabolic and Autonomic Parameters’. Applied Physiology, Nutrition, and 
Metabolism 45 (2), 180–186 
Frith, E. and Loprinzi, P.D. (2018) ‘The Association between Lower Extremity Muscular 
Strength and Cognitive Function in a National Sample of Older Adults’. Journal of 
Lifestyle Medicine 8 (2), 99  
Furihata, T., Kinugawa, S., Fukushima, A., Takada, S., Homma, T., Masaki, Y., Abe, T., 
Yokota, T., Oba, K., Okita, K., and Tsutsui, H. (2016) ‘Serum Myostatin Levels Are 
Independently Associated with Skeletal Muscle Wasting in Patients with Heart Failure’. 
International Journal of Cardiology 220, 483–487 
Gaine, P.C., Pikosky, M.A., Martin, W.F., Bolster, D.R., Maresh, C.M., and Rodriguez, N.R. 
(2006) ‘Level of Dietary Protein Impacts Whole Body Protein Turnover in Trained Males 
at Rest’. Metabolism: Clinical and Experimental 55 (4), 501–507 
Gallagher, D., Belmonte, D., Deurenberg, P., Wang, Z., Krasnow, N., Pi-Sunyer, F.X., and 
Heymsfield, S.B. (1998) ‘Organ-Tissue Mass Measurement Allows Modeling of Ree 
and Metabolically Active Tissue Mass’. American Journal of Physiology - Endocrinology 
and Metabolism 275 (20), 249-258 
Gallagher, D. and Heymsfield, S.B. (1998) ‘Muscle Distribution: Variations with Body Weight, 
Gender, and Age’. Applied Radiation and Isotopes 49 (5–6), 733–734 
Gallagher, D., Ruts, E., Visser, M., Heshka, S., Baumgartner, R.N., Wang, J., Pierson, R.N., 
Pi-Sunyer, F.X., and Heymsfield, S.B. (2000) ‘Weight Stability Masks Sarcopenia in 
Elderly Men and Women’. American Journal of Physiology - Endocrinology and 
Metabolism 279 (2), 366-375 
Gao, H., Geng, T., Huang, T., and Zhao, Q. (2017) ‘Fish Oil Supplementation and Insulin 
Sensitivity: A Systematic Review and Meta-Analysis’. Lipids in Health and Disease 16 
(1), 131 
Gardner, M.P., Lightman, S.L., Gallacher, J., Hardy, R., Kuh, D., Ebrahim, S., Bayer, A., and 
Ben-shlomo, Y. (2011) ‘Diurnal Cortisol Patterns Are Associated with Physical 
Performance in the Caerphilly Prospective Study’. International Journal of Epidemiology 
40 (6), 1693–1702 
Geerlings, M.I., Sigurdsson, S., Eiriksdottir, G., Garcia, M.E., Harris, T.B., Gudnason, V., 
and Launer, L.J. (2015) ‘Salivary Cortisol, Brain Volumes, and Cognition in Community-
Dwelling Elderly without Dementia’. Neurology 85 (11), 976-983 
Geisler, C., Braun, W., Pourhassan, M., Schweitzer, L., Glüer, C.C., Bosy-Westphal, A., and 
Müller, M.J. (2016a) ‘Age-Dependent Changes in Resting Energy Expenditure (REE): 
Insights from Detailed Body Composition Analysis in Normal and Overweight Healthy 
Caucasians’. Nutrients 8 (6), 322 
Geisler, C., Braun, W., Pourhassan, M., Schweitzer, L., Glüer, C.C., Bosy-Westphal, A., and 
Müller, M.J. (2016b) ‘Gender-Specific Associations in Age-Related Changes in Resting 
Energy Expenditure (REE) and MRI Measured Body Composition in Healthy 
Caucasians’. Journals of Gerontology - Series A Biological Sciences and Medical 
Sciences 71 (7), 941–946 
Geisler, C. and Müller, M.J. (2017) ‘Impact of Fat-Free Mass Quality and Detailed Body 
Composition on Changes of Resting Energy Expenditure with Age’. Current Nutrition 
Reports 6 (2), 111–121 
Gersovitz, M., Madden, J.P., and Smiciklas-Wright, H. (1978) ‘Validity of the 24-Hr. Dietary 
 312 
Recall and Seven-Day Record for Group Comparisons.’ Journal of the American 
Dietetic Association 73 (1), 48–55 
Ghanassia, E., Brun, J.F., Fedou, C., Raynaud, E., and Mercier, J. (2006) ‘Substrate 
Oxidation during Exercise: Type 2 Diabetes Is Associated with a Decrease in Lipid 
Oxidation and an Earlier Shift towards Carbohydrate Utilization’. Diabetes and 
Metabolism 32 (6), 604–610 
Gibson, E.L., Checkley, S., Papadopoulos, A., Poon, L., Daley, S., and Wardle, J. (1999) 
‘Increased Salivary Cortisol Reliably Induced by a Protein-Rich Midday Meal’. 
Psychosomatic Medicine 61 (2), 214–224 
Giebel, C.M., Sutcliffe, C., and Challis, D. (2015) ‘Activities of Daily Living and Quality of Life 
across Different Stages of Dementia: A UK Study’. Aging and Mental Health 19 (1), 63-
71 
Gielen, E., O’Neill, T.W., Pye, S.R., Adams, J.E., Wu, F.C., Laurent, M.R., Claessens, F., 
Ward, K.A., Boonen, S., and Bouillon, R. (2015) ‘Endocrine Determinants of Incident 
Sarcopenia in Middle-aged and Elderly European Men’. Journal of Cachexia, 
Sarcopenia and Muscle 6 (3), 242–252 
Giezenaar, C., Lange, K., Hausken, T., Jones, K.L., Horowitz, M., Chapman, I., and Soenen, 
S. (2020) ‘Effects of Age on Acute Appetite-Related Responses to Whey-Protein 
Drinks, Including Energy Intake, Gastric Emptying, Blood Glucose, and Plasma Gut 
Hormone Concentrations—A Randomized Controlled Trial’. Nutrients 12 (4), 1008 
Giezenaar, C., Trahair, L.G., Luscombe-Marsh, N.D., Hausken, T., Standfield, S., Jones, 
K.L., Lange, K., Horowitz, M., Chapman, I., and Soenen, S. (2017) ‘Effects of 
Randomized Whey-Protein Loads on Energy Intake, Appetite, Gastric Emptying, and 
Plasma Gut-Hormone Concentrations in Older Men and Women’. American Journal of 
Clinical Nutrition 106 (3), 865-877 
Giustina, A. and Veldhuis, J.D. (1998) ‘Pathophysiology of the Neuroregulation of Growth 
Hormone Secretion in Experimental Animals and the Human’. Endocrine Reviews 19 
(6), 717–797 
Goates, S., Du, K., Arensberg, M.B., Gaillard, T., Guralnik, J., and Pereira, S.L. (2019) 
‘Economic Impact of Hospitalizations in US Adults with Sarcopenia’. The Journal of 
Frailty & Aging 8 (2), 93–99 
Goekint, M., De Pauw, K., Roelands, B., Njemini, R., Bautmans, I., Mets, T., and Meeusen, 
R. (2010) ‘Strength Training Does Not Influence Serum Brain-Derived Neurotrophic 
Factor’. European Journal of Applied Physiology 110 (2), 285–293 
Gonzalez, R.E., Papadakis, G., Vollenweider, P., Preisig, M., Waeber, G., Hans, D., 
Marques-Vidal, P., and Lamy, O. (2018) ‘Relationship between Salivary Cortisol 
Circadian Rhythm and Body Composition in the Postmenopausal Women of the 
Population Cohort OsteoLaus’. Endocrine Abstracts 56, 681 
Goodman, C.A., McNally, R.M., Hoffmann, F.M., and Hornberger, T.A. (2013) ‘Smad3 
Induces Atrogin-1, Inhibits MTOR and Protein Synthesis, and Promotes Muscle Atrophy 
in Vivo’. Molecular Endocrinology 27 (11), 1946–1957 
Goodpaster, B.H., Park, S.W., Harris, T.B., Kritchevsky, S.B., Nevitt, M., Schwartz, A. V, 
Simonsick, E.M., Tylavsky, F.A., Visser, M., and Newman, A.B. (2006) ‘The Loss of 
Skeletal Muscle Strength, Mass, and Quality in Older Adults: The Health, Aging and 
Body Composition Study’. The Journals of Gerontology Series A: Biological Sciences 
and Medical Sciences 61 (10), 1059–1064 
Goodpaster, B.H. and Sparks, L.M. (2017) ‘Metabolic Flexibility in Health and Disease’. Cell 
Metabolism 25 (5), 1027–1036 
Gopinath, B., Kifley, A., Liew, G., and Mitchell, P. (2017) ‘Handgrip Strength and Its 
Association with Functional Independence, Depressive Symptoms and Quality of Life in 
Older Adults’. Maturitas 106, 92–94 
Gregory, S.M., Spiering, B.A., Alemany, J.A., Tuckow, A.P., Rarick, K.R., Staab, J.S., 
Hatfield, D.L., Kraemer, W.J., Maresh, C.M., and Nindl, B.C. (2013) ‘Exercise-Induced 
Insulin-like Growth Factor I System Concentrations after Training in Women.’ Medicine 
and Science in Sports and Exercise 45 (3), 420–428 
 313 
Grgic, J., Lazinica, B., Schoenfeld, B.J., and Pedisic, Z. (2020) ‘Test–Retest Reliability of the 
One-Repetition Maximum (1RM) Strength Assessment: A Systematic Review’. Sports 
Medicine 6 (1), 1–16 
Grgic, J., Mcllvenna, L.C., Fyfe, J.J., Sabol, F., Bishop, D.J., Schoenfeld, B.J., and Pedisic, 
Z. (2019) ‘Does Aerobic Training Promote the Same Skeletal Muscle Hypertrophy as 
Resistance Training? A Systematic Review and Meta-Analysis’. Sports Medicine 49 (2), 
233–254 
Grgic, J., Schoenfeld, B.J., and Latella, C. (2019) ‘Resistance Training Frequency and 
Skeletal Muscle Hypertrophy: A Review of Available Evidence’. Journal of Science and 
Medicine in Sport 22 (3), 361-370 
Grosicki, G.J., Barrett, B.B., Englund, D.A., Liu, C., Travison, T.G., Cederholm, T., Koochek, 
A., von Berens, Gustafsson, T., Benard, T., Reid, K.F., and Fielding, R.A. (2020) 
‘Circulating Interleukin-6 Is Associated with Skeletal Muscle Strength, Quality, and 
Functional Adaptation with Exercise Training in Mobility-Limited Older Adults’. The 
Journal of Frailty & Aging 9 (1), 57–63 
Gryson, C., Ratel, S., Rance, M., Penando, S., Bonhomme, C., Le Ruyet, P., Duclos, M., 
Boirie, Y., and Walrand, S. (2014) ‘Four-Month Course of Soluble Milk Proteins 
Interacts With Exercise to Improve Muscle Strength and Delay Fatigue in Elderly 
Participants’. Journal of the American Medical Directors Association 15 (12), 958.e1-
958.e9 
Guelfi, K.J., Donges, C.E., and Duffield, R. (2013) ‘Beneficial Effects of 12 Weeks of Aerobic 
Compared with Resistance Exercise Training on Perceived Appetite in Previously 
Sedentary Overweight and Obese Men’. Metabolism 62 (2), 235–243 
Guralnik, J.M., Ferrucci, L., Pieper, C.F., Leveille, S.G., Markides, K.S., Ostir, G. V., 
Studenski, S., Berkman, L.F., and Wallace, R.B. (2000) ‘Lower Extremity Function and 
Subsequent Disability: Consistency across Studies, Predictive Models, and Value of 
Gait Speed Alone Compared with the Short Physical Performance Battery’. Journals of 
Gerontology - Series A Biological Sciences and Medical Sciences 55 (4), 221-231 
Gutiérrez-Fisac, J.L., Guallar-Castillón, P., León-Muñoz, L.M., Graciani, A., Banegas, J.R., 
and Rodríguez-Artalejo, F. (2012) ‘Prevalence of General and Abdominal Obesity in the 
Adult Population of Spain, 2008–2010: The ENRICA Study’. Obesity Reviews 13 (4), 
388–392 
Guure, C.B., Ibrahim, N.A., Adam, M.B., and Said, S.M. (2017) ‘Impact of Physical Activity 
on Cognitive Decline, Dementia, and Its Subtypes: Meta-Analysis of Prospective 
Studies’. BioMed Research International 2017. DOI: 10.1155/2017/9016924 
Häkkinen, K., Kraemer, W.J., Pakarinen, A., Triplett-McBride, T., McBride, J.M., Häkkinen, 
A., Alen, M., McGuigan, M.R., Bronks, R., and Newton, R.U. (2002) ‘Effects of Heavy 
Resistance/Power Training on Maximal Strength, Muscle Morphology, and Hormonal 
Response Patterns in 60-75-Year-Old Men and Women’. Canadian Journal of Applied 
Physiology 27 (3), 213–231 
Häkkinen, K., Pakarinen, A., Kraemer, W, J., Newton, R., and Alen, M. (2000) ‘Basal 
Concentrations and Acute Responses of Serum Hormones Andstrength Development 
during Heavy Resistance Training in Middle-Aged Andelderly Men and Women’. The 
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 55 (2), 95-
105 
Häkkinen, K., Pakarinen, A., Kraemer, W.J., Häkkinen, A., Valkeinen, H., and Alen, M. 
(2001) ‘Selective Muscle Hypertrophy, Changes in EMG and Force, and Serum 
Hormones during Strength Training in Older Women’. Journal of Applied Physiology 91 
(2), 569–580 
Hall, K.D. (2006) ‘Computational Model of in Vivo Human Energy Metabolism during 
Semistarvation and Refeeding’. American Journal of Physiology-Endocrinology and 
Metabolism 291 (1), 23–37 
Hall, K.D., Ayuketah, A., Brychta, R., Cai, H., Cassimatis, T., Chen, K.Y., Chung, S.T., 
Costa, E., Courville, A., Darcey, V., Fletcher, L.A., Forde, C.G., Gharib, A.M., Guo, J., 
Howard, R., Joseph, P. V., McGehee, S., Ouwerkerk, R., Raisinger, K., Rozga, I., 
 314 
Stagliano, M., Walter, M., Walter, P.J., Yang, S., and Zhou, M. (2019) ‘Ultra-Processed 
Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized 
Controlled Trial of Ad Libitum Food Intake’. Cell Metabolism 30 (1), 67-77 
Hall, K.D., Chen, K.Y., Guo, J., Lam, Y.Y., Leibel, R.L., Mayer, L.E.S., Reitman, M.L., 
Rosenbaum, M., Smith, S.R., Walsh, B.T., and Ravussin, E. (2016) ‘Energy 
Expenditure and Body Composition Changes after an Isocaloric Ketogenic Diet in 
Overweight and Obese Men’. American Journal of Clinical Nutrition 104 (2), 324–333 
Hall, K.D., Heymsfield, S.B., Kemnitz, J.W., Klein, S., Schoeller, D.A., and Speakman, J.R. 
(2012) ‘Energy Balance and Its Components: Implications for Body Weight Regulation’. 
American Journal of Clinical Nutrition 95 (4), 989-994 
Han, D., Chen, Y., Lin, S., Chang, H., Huang, T., Chi, Y., and Yang, W. (2011) ‘Serum 
Myostatin Levels and Grip Strength in Normal Subjects and Patients on Maintenance 
Haemodialysis’. Clinical Endocrinology 75 (6), 857–863 
Hangelbroek, R.W.J., Knuiman, P., Tieland, M., and de Groot, L.C.P.G.M. (2018) 
‘Attenuated Strength Gains during Prolonged Resistance Exercise Training in Older 
Adults with High Inflammatory Status’. Experimental Gerontology 106, 154–158 
Harada, C.N., Love, M.C.N., and Triebel, K.L. (2013) ‘Normal Cognitive Aging’. Clinics in 
Geriatric Medicine 29 (4), 737–752 
Harris, M.A., Cox, S.R., Brett, C.E., Deary, I.J., and MacLullich, A.M.J. (2017) ‘Cognitive 
Ability across the Life Course and Cortisol Levels in Older Age’. Neurobiology of Aging 
59, 64–71 
Harvey, J.A., Chastin, S.F.M., and Skelton, D.A. (2015) ‘How Sedentary Are Older People? 
A Systematic Review of the Amount of Sedentary Behavior’. Journal of Aging and 
Physical Activity 23 (3), 471–487 
Hattersley, J.G., Pfeiffer, A.F.H., Roden, M., Petzke, K.-J., Hoffmann, D., Rudovich, N.N., 
Randeva, H.S., Vatish, M., Osterhoff, M., and Goegebakan, Ö. (2014) ‘Modulation of 
Amino Acid Metabolic Signatures by Supplemented Isoenergetic Diets Differing in 
Protein and Cereal Fiber Content’. The Journal of Clinical Endocrinology & Metabolism 
99 (12), 2599–2609 
Haun, C.T., Vann, C.G., Mobley, C.B., Osburn, S.C., Mumford, P.W., Roberson, P.A., 
Romero, M.A., Fox, C.D., Parry, H.A., Kavazis, A.N., Moon, J.R., Young, K.C., and 
Roberts, M.D. (2019) ‘Pre-Training Skeletal Muscle Fiber Size and Predominant Fiber 
Type Best Predict Hypertrophic Responses to 6 Weeks of Resistance Training in to 
Previously Trained Young Men’. Frontiers in Physiology 10, 297 
Hawley, A.L., Gbur, E., Tacinelli, A.M., Walker, S., Murphy, A., Burgess, R., and Baum, J.I. 
(2020) ‘The Short-Term Effect of Whey Compared with Pea Protein on Appetite, Food 
Intake, and Energy Expenditure in Young and Older Men’. Current Developments in 
Nutrition 4 (2) 
Hayes, L., Sculthorpe, N., Cunniffe, B., and Grace, F.M. (2016) ‘Salivary Testosterone and 
Cortisol Measurement in Sports Medicine: A Narrative Review and User’s Guide for 
Researchers and Practitioners’. International Journal of Sports Medicine 37 (13), 1007–
1018 
Hays, N.P., Kim, H., Wells, A.M., Kajkenova, O., and Evans, W.J. (2009) ‘Effects of Whey 
and Fortified Collagen Hydrolysate Protein Supplements on Nitrogen Balance and Body 
Composition in Older Women’. Journal of the American Dietetic Association 109 (6), 
1082–1087 
He, Q., Heshka, S., Albu, J., Boxt, L., Krasnow, N., Elia, M., and Gallagher, D. (2009) 
‘Smaller Organ Mass with Greater Age, except for Heart’. Journal of Applied Physiology 
106 (6), 1780–1784 
Heaney, J.L.J., Phillips, A.C., and Carroll, D. (2012) ‘Aging, Health Behaviors, and the 
Diurnal Rhythm and Awakening Response of Salivary Cortisol’. Experimental Aging 
Research 38 (3), 295–314 
Hedden, T. and Gabrieli, J.D.E. (2004) ‘Insights into the Ageing Mind: A View from Cognitive 
Neuroscience’. Nature Reviews Neuroscience 5 (2), 87-96 
Herold, F., Törpel, A., Schega, L., and Müller, N.G. (2019) ‘Functional and/or Structural 
 315 
Brain Changes in Response to Resistance Exercises and Resistance Training Lead to 
Cognitive Improvements - A Systematic Review’. European Review of Aging and 
Physical Activity 16 (1), 10 
Hewagalamulage, S.D., Lee, T.K., Clarke, I.J., and Henry, B.A. (2016) ‘Stress, Cortisol, and 
Obesity: A Role for Cortisol Responsiveness in Identifying Individuals Prone to Obesity’. 
Domestic Animal Endocrinology 56, 112–120 
Heymsfield, S.B., Gonzalez, M.C., Lu, J., Jia, G., and Zheng, J. (2015) ‘Skeletal Muscle 
Mass and Quality: Evolution of Modern Measurement Concepts in the Context of 
Sarcopenia’. Proceedings of the Nutrition Society 74 (4), 355–366 
Hidayat, K., Du, H.-Z., Yang, J., Chen, G.-C., Zhang, Z., Li, Z.-N., and Qin, L.-Q. (2017) 
‘Effects of Milk Proteins on Blood Pressure: A Meta-Analysis of Randomized Control 
Trials’. Hypertension Research 40 (3), 264–270 
Ho, S.S., Dhaliwal, S.S., Hills, A.P., and Pal, S. (2012) ‘The Effect of 12 Weeks of Aerobic, 
Resistance or Combination Exercise Training on Cardiovascular Risk Factors in the 
Overweight and Obese in a Randomized Trial’. BMC Public Health 12 (1), 704 
Hochstenbach-Waelen, A., Veldhorst, M.A.B., Nieuwenhuizen, A.G., Westerterp-Plantenga, 
M.., and Westerterp, K.R. (2009a) ‘Comparison of 2 Diets with Either 25% or 10% of 
Energy as Casein on Energy Expenditure, Substrate Balance, and Appetite Profile’. 
The American Journal of Clinical Nutrition 89 (3), 831–838 
Hochstenbach-Waelen, A., Westerterp-Plantenga, M.S., Veldhorst, M.A.B., and Westerterp, 
K.R. (2009b) ‘Single-Protein Casein and Gelatin Diets Affect Energy Expenditure 
Similarly but Substrate Balance and Appetite Differently in Adults’. The Journal of 
Nutrition 139 (12), 2285–2292 
Hodson, N., West, D.W.D., Philp, A., Burd, N.A., and Moore, D.R. (2019) ‘Molecular 
Regulation of Human Skeletal Muscle Protein Synthesis in Response to Exercise and 
Nutrients: A Compass for Overcoming Age-Related Anabolic Resistance’. American 
Journal of Physiology-Cell Physiology 317 (6), 1061–1078 
Hofmann, M., Halper, B., Oesen, S., Franzke, B., Stuparits, P., Tschan, H., Bachl, N., 
Strasser, E.-M., Quittan, M., and Ploder, M. (2015) ‘Serum Concentrations of Insulin-
like Growth Factor-1, Members of the TGF-Beta Superfamily and Follistatin Do Not 
Reflect Different Stages of Dynapenia and Sarcopenia in Elderly Women’. Experimental 
Gerontology 64, 35–45 
Hofmann, M., Schober-Halper, B., Oesen, S., Franzke, B., Tschan, H., Bachl, N., Strasser, 
E.M., Quittan, M., Wagner, K.H., and Wessner, B. (2016) ‘Effects of Elastic Band 
Resistance Training and Nutritional Supplementation on Muscle Quality and Circulating 
Muscle Growth and Degradation Factors of Institutionalized Elderly Women: The 
Vienna Active Ageing Study (VAAS)’. European Journal of Applied Physiology 116 (5), 
885–897 
Højfeldt, G., Bülow, Jacob, Agergaard, J., Asmar, A., Schjerling, P., Simonsen, L., Bülow, 
Jens, van Hall, G., and Holm, L. (2020) ‘Impact of Habituated Dietary Protein Intake on 
Fasting and Postprandial Whole-Body Protein Turnover and Splanchnic Amino Acid 
Metabolism in Elderly Men: A Randomized, Controlled, Crossover Trial’. The American 
Journal of Clinical Nutrition. DOI: 10.1093/ajcn/nqaa201 
Holm, L., Olesen, J.L., Matsumoto, K., Doi, T., Mizuno, M., Alsted, T.J., Mackey, A.L., 
Schwarz, P., and Kjær, M. (2008) ‘Protein-Containing Nutrient Supplementation 
Following Strength Training Enhances the Effect on Muscle Mass, Strength, and Bone 
Formation in Postmenopausal Women’. Journal of Applied Physiology 105 (1), 274-281 
Holten, M.K., Zacho, M., Gaster, M., Juel, C., Wojtaszewski, J.F.P., and Dela, F. (2004) 
‘Strength Training Increases Insulin-Mediated Glucose Uptake, GLUT4 Content, and 
Insulin Signaling in Skeletal Muscle in Patients with Type 2 Diabetes’. Diabetes 53 (2), 
294–305 
Holwerda, A.M., Kouw, I.W.K., Trommelen, J., Halson, S.L., Wodzig, W.K.W.H., Verdijk, 
L.B., and van Loon, L.J.C. (2016) ‘Physical Activity Performed in the Evening Increases 
the Overnight Muscle Protein Synthetic Response to Presleep Protein Ingestion in 
Older Men’. The Journal of Nutrition 146 (7), 1307–1314 
 316 
Holwerda, A.M., Overkamp, M., Paulussen, K.J.M., Smeets, J.S.J., Van Kranenburg, J., 
Backx, E.M.P., Gijsen, A.P., Goessens, J.P.B., Verdijk, L.B., and Van Loon, L.J.C. 
(2018) ‘Protein Supplementation after Exercise and before Sleep Does Not Further 
Augment Muscle Mass and Strength Gains during Resistance Exercise Training in 
Active Older Men’. Journal of Nutrition 148 (11), 1723–1732 
Hong, F., Zheng, A., Xu, P., Wang, J., Xue, T., Dai, S., Pan, S., Guo, Y., Xie, X., and Li, L. 
(2020) ‘High-Protein Diet Induces Hyperuricemia in a New Animal Model for Studying 
Human Gout’. International Journal of Molecular Sciences 21 (6), 2147 
Hong, S.H. and Choi, K.M. (2020) ‘Sarcopenic Obesity, Insulin Resistance, and Their 
Implications in Cardiovascular and Metabolic Consequences’. International Journal of 
Molecular Sciences 21 (2), 494 
Horner, K., Hopkins, M., Finlayson, G., Gibbons, C., and Brennan, L. (2020) ‘Biomarkers of 
Appetite: Is There a Potential Role for Metabolomics?’ Nutrition Research Reviews, 1–
41 
Houston, D.K., Nicklas, B.J., Ding, J., Harris, T.B., Tylavsky, F.A., Newman, A.B., Jung, S.L., 
Sahyoun, N.R., Visser, M., and Kritchevsky, S.B. (2008) ‘Dietary Protein Intake Is 
Associated with Lean Mass Change in Older, Community-Dwelling Adults: The Health, 
Aging, and Body Composition (Health ABC) Study’. American Journal of Clinical 
Nutrition 87 (1), 150–155 
Houston, D.K., Nicklas, B.J., and Zizza, C.A. (2009) ‘Weighty Concerns: The Growing 
Prevalence of Obesity among Older Adults’. Journal of the American Dietetic 
Association 109 (11), 1886–1895 
Howel, D. (2012) ‘Waist Circumference and Abdominal Obesity among Older Adults: 
Patterns, Prevalence and Trends’. PloS one 7 (10), e48528 
Hulmi, J.J., Kovanen, V., Lisko, I., Selänne, H., and Mero, A.A. (2008) ‘The Effects of Whey 
Protein on Myostatin and Cell Cycle-Related Gene Expression Responses to a Single 
Heavy Resistance Exercise Bout in Trained Older Men’. European Journal of Applied 
Physiology 102 (2), 205–213 
Hulmi, J.J., Tannerstedt, J., Selanne, H., Kainulainen, H., Kovanen, V., and Mero, A.A. 
(2009) ‘Resistance Exercise with Whey Protein Ingestion Affects MTOR Signaling 
Pathway and Myostatin in Men’. Journal of Applied Physiology 106 (5), 1720–1729 
Hunter, G.R., Bickel, C.S., Fisher, G., Neumeier, W.H., and McCarthy, J.P. (2013) 
‘Combined Aerobic and Strength Training and Energy Expenditure in Older Women’. 
Medicine and Science in Sports and Exercise 45 (7) 
Hunter, G.R., Bryan, D.R., Wetzstein, C.J., Zuckerman, P.A., and Bamman, M.M. (2002) 
‘Resistance Training and Intra-Abdominal Adipose Tissue in Older Men and Women’. 
Medicine and Science in Sports and Exercise 34 (6), 1023-1028 
Hunter, G.R., Fisher, G., Neumeier, W.H., Carter, S.J., and Plaisance, E.P. (2015) ‘Exercise 
Training and Energy Expenditure Following Weight Loss’. Medicine and Science in 
Sports and Exercise 47 (9), 1950 
Hunter, G.R., McCarthy, J.P., and Bamman, M.M. (2004) ‘Effects of Resistance Training on 
Older Adults’. Sports Medicine 34 (5), 329–348 
Hunter, G.R., Plaisance, E.P., Carter, S.J., and Fisher, G. (2018) ‘Why Intensity Is Not a Bad 
Word: Optimizing Health Status at Any Age’. Clinical Nutrition 37 (1), 56–60 
Hunter, G.R., Singh, H., Carter, S.J., Bryan, D.R., and Fisher, G. (2019) ‘Sarcopenia and Its 
Implications for Metabolic Health’. Journal of Obesity 2019 
Hunter, G.R., Treuth, M.S., Weinsier, R.L., Kekes-Szabo, T., Kell, S.H., Roth, D.L., and 
Nicholson, C. (1995) ‘The Effects of Strength Conditioning on Older Women’s Ability to 
Perform Daily Tasks’. Journal of the American Geriatrics Society 43 (7), 756–760 
Hunter, G.R., Weinsier, R.L., Zuckerman, P.A., and Darnell, B.E. (2004) ‘Aerobic Fitness, 
Physiologic Difficulty and Physical Activity in Black and White Women’. International 
Journal of Obesity 28 (9), 1111–1117 
Hunter, G.R., Wetzstein, C.J., Fields, D.A., Brown, A., and Bamman, M.M. (2000) 
‘Resistance Training Increases Total Energy Expenditure and Free-Living Physical 
Activity in Older Adults’. Journal of Applied Physiology 89 (3), 977–984 
 317 
Hursel, R., Viechtbauer, W., Dulloo, A.G., Tremblay, A., Tappy, L., Rumpler, W., and 
Westerterp-Plantenga, M.S. (2011) ‘The Effects of Catechin Rich Teas and Caffeine on 
Energy Expenditure and Fat Oxidation: A Meta-Analysis’. Obesity Reviews 12 (7), 573-
581 
Ibañez, J., Izquierdo, M., Argüelles, I., Forga, L., Larrión, J.L., García-Unciti, M., Idoate, F., 
and Gorostiaga, E.M. (2005) ‘Twice-Weekly Progressive Resistance Training 
Decreases Abdominal Fat and Improves Insulin Sensitivity in Older Men with Type 2 
Diabetes’. Diabetes Care 28 (3), 662-667 
Ibrahim, K., May, C., Patel, H.P., Baxter, M., Sayer, A.A., and Roberts, H. (2016) ‘A 
Feasibility Study of Implementing Grip Strength Measurement into Routine Hospital 
Practice (GRImP): Study Protocol’. Pilot and Feasibility Studies 2 (1), 27 
Iglay, H.B., Thyfault, J.P., Apolzan, J.W., and Campbell, W.W. (2007) ‘Resistance Training 
and Dietary Protein: Effects on Glucose Tolerance and Contents of Skeletal Muscle 
Insulin Signaling Proteins in Older Persons’. American Journal of Clinical Nutrition 85 
(4), 1005-1013 
Ikudome, S., Mori, S., Unenaka, S., Kawanishi, M., Kitamura, T., and Nakamoto, H. (2017) 
‘Effect of Long-Term Body-Mass-Based Resistance Exercise on Cognitive Function in 
Elderly People’. Journal of Applied Gerontology 36 (12), 1519-1533 
Imboden, M.T., Welch, W.A., Swartz, A.M., Montoye, A.H.K., Finch, H.W., Harber, M.P., and 
Kaminsky, L.A. (2017) ‘Reference Standards for Body Fat Measures Using GE Dual 
Energy X-Ray Absorptiometry in Caucasian Adults’. PloS one 12 (4), e0175110 
Institute of Medicine (2005) Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, 
Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, DC, USA: National 
Academy Press 
Izquierdo, M., Häkkinen, K., Ibañez, J., Antón, A., Garrués, M., Ruesta, M., and Gorostiaga, 
E.M. (2003) ‘Effects of Strength Training on Submaximal and Maximal Endurance 
Performance Capacity in Middle-Aged and Older Men’. Journal of Strength and 
Conditioning Research 17 (1), 129–139 
Jakobsen, L.H., Kondrup, J., Zellner, M., Tetens, I., and Roth, E. (2011) ‘Effect of a High 
Protein Meat Diet on Muscle and Cognitive Functions: A Randomised Controlled 
Dietary Intervention Trial in Healthy Men’. Clinical Nutrition 30 (3), 303-311 
Janssen, I. (2010) ‘Evolution of Sarcopenia Research’. Applied Physiology, Nutrition and 
Metabolism 35 (5), 707–712 
Janssen, I., Heymsfield, S.B., Allison, D.B., Kotler, D.P., and Ross, R. (2002) ‘Body Mass 
Index and Waist Circumference Independently Contribute to the Prediction of 
Nonabdominal, Abdominal Subcutaneous, and Visceral Fat’. American Journal of 
Clinical Nutrition 75 (4), 683–688 
Janssen, I., Heymsfield, S.B., Baumgartner, R.N., and Ross, R. (2000a) ‘Estimation of 
Skeletal Muscle Mass by Bioelectrical Impedance Analysis’. Journal of Applied 
Physiology 89 (2), 465–471 
Janssen, I., Heymsfield, S.B., Wang, Z.M., and Ross, R. (2000b) ‘Skeletal Muscle Mass and 
Distribution in 468 Men and Women Aged 18-88 Yr’. Journal of Applied Physiology 89 
(1), 81–88 
Janssen, I. and Ross, R. (2005) ‘Linking Age-Related Changes in Skeletal Muscle Mass and 
Composition with Metabolism and Disease’. Journal of Nutrition Health and Aging 9 (6), 
408 
Janssen, I., Shepard, D.S., Katzmarzyk, P.T., and Roubenoff, R. (2004) ‘The Healthcare 
Costs of Sarcopenia in the United States’. Journal of the American Geriatrics Society 
52 (1), 80–85 
Jefferis, B.J., Sartini, C., Lee, I.-M., Choi, M., Amuzu, A., Gutierrez, C., Casas, J.P., Ash, S., 
Lennnon, L.T., and Wannamethee, S.G. (2014) ‘Adherence to Physical Activity 
Guidelines in Older Adults, Using Objectively Measured Physical Activity in a 
Population-Based Study’. BMC Public Health 14 (1), 382 
Jefferson, A.L., Massaro, J.M., Wolf, P.A., Seshadri, S., Au, R., Vasan, R.S., Larson, M.G., 
Meigs, J.B., Keaney, J.F., and Lipinska, I. (2007) ‘Inflammatory Biomarkers Are 
 318 
Associated with Total Brain Volume: The Framingham Heart Study’. Neurology 68 (13), 
1032–1038 
Jiang, Q., Lou, K., Hou, L., Lu, Y., Sun, L., Tan, S.C., Low, T.Y., Kord-Varkaneh, H., and 
Pang, S. (2020) ‘The Effect of Resistance Training on Serum Insulin-like Growth Factor 
1 (IGF-1): A Systematic Review and Meta-Analysis’. Complementary Therapies in 
Medicine. DOI: 10.1016/j.ctim.2020.102360 
Joanisse, S., Lim, C., McKendry, J., Mcleod, J.C., Stokes, T., and Phillips, S.M. (2020) 
‘Recent Advances in Understanding Resistance Exercise Training-Induced Skeletal 
Muscle Hypertrophy in Humans’. F1000Research 9, 141 
Johannsen, D.L., Galgani, J.E., Johannsen, N.M., Zhang, Z., Covington, J.D., and Ravussin, 
E. (2012) ‘Effect of Short-Term Thyroxine Administration on Energy Metabolism and 
Mitochondrial Efficiency in Humans’. PloS one 7 (7), e40837 
Johnson, K., Holliay, A., Misttry, N., Cunnife, A., Howard, K., Stanger, N., and Ispoglou, T., 
(2021) 'An Increase in Fat-Free Mass is Associated with Higher Appetite and Energy 
Intake in Older Adults: A Randomised Control Trial' Nutrients 13(1), 141 
Jones, P.P., Van Pelt, R.E., Johnson, D.G., and Seals, D.R. (2004) ‘Role of Sympathetic 
Neural Activation in Age- and Habitual Exercise-Related Differences in the Thermic 
Effect of Food’. Journal of Clinical Endocrinology and Metabolism 89 (10), 5138–5144 
Journel, M., Chaumontet, C., Darcel, N., Fromentin, G., and Tomé, D. (2012) ‘Brain 
Responses to High-Protein Diets’. Advances in Nutrition 3 (3), 322-329 
Ju, C.R. and Chen, R.C. (2012) ‘Serum Myostatin Levels and Skeletal Muscle Wasting in 
Chronic Obstructive Pulmonary Disease’. Respiratory Medicine 106 (1), 102–108 
Junior, P., Ribeiro, A., Nabuco, H., Fernandes, R., Tomeleri, C., Cunha, P., Venturini, D., 
Barbosa, D., Schoenfeld, B., and Cyrino, E. (2018) ‘Effects of Whey Protein 
Supplementation Associated with Resistance Training on Muscular Strength, 
Hypertrophy, and Muscle Quality in Preconditioned Older Women’. International Journal 
of Sport Nutrition and Exercise Metabolism 28 (5), 528–535 
Jyväkorpi, S.K., Urtamo, A., Kivimäki, M., and Strandberg, T.E. (2020) ‘Associations of 
Protein Source, Distribution and Healthy Dietary Pattern with Appendicular Lean Mass 
in Oldest-old Men: The Helsinki Businessmen Study (HBS)’. European Geriatric 
Medicine 11 (4), 699-704 
Kang, L., Gao, Y., Liu, X., Liang, Yinghui, Chen, Y., Liang, Yanhong, Zhang, L., Chen, W., 
Pang, H., and Peng, L.-N. (2019) ‘Effects of Whey Protein Nutritional Supplement on 
Muscle Function among Community-Dwelling Frail Older People: A Multicenter Study in 
China’. Archives of Gerontology and Geriatrics 83, 7–12 
Kang, Y., Kim, N., Choi, Y.J., Lee, Y., Yun, J., Park, S.J., Park, H.S., Chung, Y.S., and Park, 
Y.K. (2020) ‘Leucine-Enriched Protein Supplementation Increases Lean Body Mass in 
Healthy Korean Adults Aged 50 Years and Older: A Randomized, Double-Blind, 
Placebo-Controlled Trial’. Nutrients 12 (6), 1816 
Kaplan, R.J., Greenwood, C.E., Winocur, G., and Wolever, T.M.S. (2001) ‘Dietary Protein, 
Carbohydrate, and Fat Enhance Memory Performance in the Healthy Elderly’. 
American Journal of Clinical Nutrition 74 (5), 687-693 
Karakelides, H., Irving, B.A., Short, K.R., O’Brien, P., and Nair, K.S. (2010) ‘Age, Obesity, 
and Sex Effects on Insulin Sensitivity and Skeletal Muscle Mitochondrial Function’. 
Diabetes 59 (1), 89–97 
Karr, J.E., Alexander, J.E., and Winningham, R.G. (2011) ‘Omega-3 Polyunsaturated Fatty 
Acids and Cognition throughout the Lifespan: A Review.’ Nutritional Neuroscience 14 
(5), 216-225 
Kasper, J.D., Freedman, V.A., Spillman, B.C., and Wolff, J.L. (2015) ‘The Disproportionate 
Impact of Dementia on Family and Unpaid Caregiving to Older Adults’. Health Affairs 34 
(10), 1642-1649 
Katoh-Semba, R., Wakako, R., Komori, T., Shigemi, H., Miyazaki, N., Ito, H., Kumagai, T., 
Tsuzuki, M., Shigemi, K., and Yoshida, F. (2007) ‘Age-Related Changes in BDNF 
Protein Levels in Human Serum: Differences between Autism Cases and Normal 
Controls’. International Journal of Developmental Neuroscience 25 (6), 367–372 
 319 
Katsanos, C.S., Kobayashi, H., Sheffield-Moore, M., Aarsland, A., and Wolfe, R.R. (2006) ‘A 
High Proportion of Leucine Is Required for Optimal Stimulation of the Rate of Muscle 
Protein Synthesis by Essential Amino Acids in the Elderly’. American Journal of 
Physiology-Endocrinology and Metabolism 291 (2), 381–387 
Katsiardanis, K., Diamantaras, A.-A., Dessypris, N., Michelakos, T., Anastasiou, A., 
Katsiardani, K.-P., Kanavidis, P., Papadopoulos, F.C., Stefanadis, C., and 
Panagiotakos, D.B. (2013) ‘Cognitive Impairment and Dietary Habits among Elders: 
The Velestino Study’. Journal of Medicinal Food 16 (4), 343–350 
Katz, A., Nambi, S.S., Mather, K., Baron, A.D., Follmann, D.A., Sullivan, G., and Quon, M.J. 
(2000) ‘Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for 
Assessing Insulin Sensitivity in Humans’. Journal of Clinical Endocrinology and 
Metabolism 85 (7), 2402–2410 
Kelley, D.E. and Mandarino, L.J. (2000) ‘Fuel Selection in Human Skeletal Muscle in Insulin 
Resistance: A Reexamination’. Diabetes 49 (5), 677–683 
Kelly, M.E., Loughrey, D., Lawlor, B.A., Robertson, I.H., Walsh, C., and Brennan, S. (2014) 
‘The Impact of Exercise on the Cognitive Functioning of Healthy Older Adults: A 
Systematic Review and Meta-Analysis’. Ageing Research Reviews 16, 12-31 
Kim, B. and Feldman, E.L. (2015) ‘Insulin Resistance as a Key Link for the Increased Risk of 
Cognitive Impairment in the Metabolic Syndrome’. Experimental & Molecular Medicine 
47 (3), 149–149 
Kim, H., Hirano, H., Edahiro, A., Ohara, Y., Watanabe, Y., Kojima, N., Kim, M., Hosoi, E., 
Yoshida, Y., and Yoshida, H. (2016) ‘Sarcopenia: Prevalence and Associated Factors 
Based on Different Suggested Definitions in Community-dwelling Older Adults’. 
Geriatrics & Gerontology International 16, 110–122 
Kim, H.J., Higashimori, T., Park, S.Y., Choi, H., Dong, J., Kim, Y.J., Noh, H.L., Cho, Y.R., 
Cline, G., Kim, Y.B., and Kim, J.K. (2004) ‘Differential Effects of Interleukin-6 and -10 
on Skeletal Muscle and Liver Insulin Action In Vivo’. Diabetes 53 (4), 1060–1067 
Kim, H.K., Suzuki, T., Saito, K., Yoshida, H., Kobayashi, H., Kato, H., and Katayama, M. 
(2012) ‘Effects of Exercise and Amino Acid Supplementation on Body Composition and 
Physical Function in Community-Dwelling Elderly Japanese Sarcopenic Women: A 
Randomized Controlled Trial’. Journal of the American Geriatrics Society 60 (1), 16–23 
Kim, J.E., O’Connor, L.E., Sands, L.P., Slebodnik, M.B., and Campbell, W.W. (2016) ‘Effects 
of Dietary Protein Intake on Body Composition Changes after Weight Loss in Older 
Adults: A Systematic Review and Meta-Analysis’. Nutrition Reviews 74 (3), 210-224 
Kim, J.S., Petrella, J.K., Cross, J.M., and Bamman, M.M. (2007) ‘Load-Mediated 
Downregulation of Myostatin MRNA Is Not Sufficient to Promote Myofiber Hypertrophy 
in Humans: A Cluster Analysis’. Journal of Applied Physiology 103 (5), 1488–1495 
Kimball, S.R. and Jefferson, L.S. (2006) ‘Signaling Pathways and Molecular Mechanisms 
through Which Branched-Chain Amino Acids Mediate Translational Control of Protein 
Synthesis’. The Journal of Nutrition 136 (1), 227-231 
Kimura, K., Obuchi, S., Arai, T., Nagasawa, H., Shiba, Y., Watanabe, S., and Kojima, M. 
(2010) ‘The Influence of Short-Term Strength Training on Health-Related Quality of Life 
and Executive Cognitive Function’. Journal of Physiological Anthropology 29 (3), 95–
101 
Kirk, B., Mooney, K., Amirabdollahian, F., and Khaiyat, O. (2019) ‘Exercise and Dietary-
Protein as a Countermeasure to Skeletal Muscle Weakness: Liverpool Hope University 
- Sarcopenia Aging Trial (LHU-SAT)’. Frontiers in Physiology 10, 445 
Kirk, B., Mooney, K., Cousins, R., Angell, P., Jackson, M., Pugh, J.N., Coyles, G., 
Amirabdollahian, F., and Khaiyat, O. (2020) ‘Effects of Exercise and Whey Protein on 
Muscle Mass, Fat Mass, Myoelectrical Muscle Fatigue and Health-Related Quality of 
Life in Older Adults: A Secondary Analysis of the Liverpool Hope University—
Sarcopenia Ageing Trial (LHU-SAT)’. European Journal of Applied Physiology 120 (2), 
493–503 
Kirk, E.P., Donnelly, J.E., Smith, B.K., Honas, J., LeCheminant, J.D., Bailey, B.W., 
Jacobsen, D.J., and Washburn, R.A. (2009) ‘Minimal Resistance Training Improves 
 320 
Daily Energy Expenditure and Fat Oxidation’. Medicine and Science in Sports and 
Exercise 41 (5), 1122 
Kita, M., Kobayashi, K., Obara, K., Koikeda, T., Umeda, S., and Ano, Y. (2019) 
‘Supplementation with Whey Peptide Rich in β-Lactolin Improves Cognitive 
Performance in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled 
Study’. Frontiers in Neuroscience 13, 399 
Kita, M., Obara, K., Kondo, S., Umeda, S., and Ano, Y. (2018) ‘Effect of Supplementation of 
a Whey Peptide Rich in Tryptophan-Tyrosine-Related Peptides on Cognitive 
Performance in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled 
Study’. Nutrients 10 (7), 899 
Kneffel, Z., Murlasits, Z., Reed, J., and Krieger, J. (2020) ‘A Meta-Regression of the Effects 
of Resistance Training Frequency on Muscular Strength and Hypertrophy in Adults over 
60 Years of Age’. Journal of Sports Sciences. DOI: 10.1080/02640414.2020.1822595 
Koh, F., Charlton, K., Walton, K., and McMahon, A.-T. (2015) ‘Role of Dietary Protein and 
Thiamine Intakes on Cognitive Function in Healthy Older People: A Systematic 
Review’. Nutrients 7 (4), 2415–2439 
Kohara, K., Okada, Y., Ochi, M., Ohara, M., Nagai, T., Tabara, Y., and Igase, M. (2017) 
‘Muscle Mass Decline, Arterial Stiffness, White Matter Hyperintensity, and Cognitive 
Impairment: Japan Shimanami Health Promoting Program Study’. Journal of Cachexia, 
Sarcopenia and Muscle 8 (4), 557–566 
König, H.-H., Lehnert, T., Brenner, H., Schöttker, B., Quinzler, R., Haefeli, W.E., 
Matschinger, H., and Heider, D. (2015) ‘Health Service Use and Costs Associated with 
Excess Weight in Older Adults in Germany’. Age and Ageing 44 (4), 616–623 
Kosowicz, M. and MacPherson, S.E. (2017) ‘Improving Multitasking Assessment in Healthy 
Older Adults Using a Prop-Based Version of the Breakfast Task’. Applied 
Neuropsychology:Adult 24 (3), 252-263  
Kotz, C.M., Perez-Leighton, C.E., Teske, J.A., and Billington, C.J. (2017) ‘Spontaneous 
Physical Activity Defends Against Obesity’. Current Obesity Reports 6 (4), 362–370 
Kotz, C.M., Teske, J.A., and Billington, C.J. (2008) ‘Neuroregulation of Nonexercise Activity 
Thermogenesis and Obesity Resistance’. American Journal of Physiology-Regulatory, 
Integrative and Comparative Physiology 294 (3), 699–710 
Kovacevic, A., Mavros, Y., Heisz, J.J., and Singh, M.A.F. (2018) ‘The Effect of Resistance 
Exercise on Sleep: A Systematic Review of Randomized Controlled Trials’. Sleep 
Medicine Reviews 39, 52–68 
Kraemer, W.J., Adams, K., Cafarelli, E., Dudley, G.A., Dooly, C., Feigenbaum, M.S., Fleck, 
S.J., Franklin, B., Fry, A.C., Hoffman, J.R., Newton, R.U., Potteiger, J., Stone, M.H., 
Ratamess, N.A., and Triplett-McBride, T. (2002) ‘Progression Models in Resistance 
Training for Healthy Adults’. Medicine and Science in Sports and Exercise 34 (2), 364–
380 
Kraemer, W.J., Häkkinen, K., Newton, R.U., Nindl, B.C., Volek, J.S., Mccormick, M., 
Gotshalk, L.A., Gordon, S.E., Fleck, S.J., Campbell, W.W., Putukian, M., and Evans, 
W.J. (1999) ‘Effects of Heavy-Resistance Training on Hormonal Response Patterns in 
Younger vs. Older Men’. Journal of Applied Physiology 87 (3), 982–992 
Kraemer, W.J., Marchitelli, L., Gordon, S.E., Harman, E., Dziados, J.E., Mello, R., Frykman, 
P., McCurry, D., and Fleck, S.J. (1990) ‘Hormonal and Growth Factor Responses to 
Heavy Resistance Exercise Protocols’. Journal of Applied Physiology 69 (4), 1442–
1450 
Kraemer, W.J., Ratamess, N., Fry, A., and French, D. (2006) Strength Training: 
Development and Evaluation of Methodology. in Physiological Assessment of Human 
Fitness 2nd Edition. ed. Maud, P. and Foster. C. Champaign, IL: Human Kinetics, 119–
150 
Kraemer, W.J. and Ratamess, N.A. (2004) ‘Fundamentals of Resistance Training: 
Progression and Exercise Prescription’. Medicine and Science in Sports and Exercise 
36 (4), 674–688 
Kraemer, W.J., Ratamess, N.A., and Nindl, B.C. (2017) ‘Recovery Responses of 
 321 
Testosterone, Growth Hormone, and IGF-1 after Resistance Exercise’. Journal of 
Applied Physiology 122 (3), 549–558 
Krishnan, G.M. and Thompson, P.D. (2010) ‘The Effects of Statins on Skeletal Muscle 
Strength and Exercise Performance’. Current Opinion in Lipidology 21 (4), 324–328 
Kritz-Silverstein, D., Laughlin, G.A., McEvoy, L.K., and Barrett-Connor, E. (2017) ‘Sex and 
Age Differences in the Association of Blood Pressure and Hypertension with Cognitive 
Function in the Elderly: The Rancho Bernardo Study’. The Journal of Prevention of 
Alzheimer’s Disease 4 (3), 165 
Kritz-Silverstein, D., Von Mühlen, D., Barrett-Connor, E., and Bressel, M.A.B. (2003) 
‘Isoflavones and Cognitive Function in Older Women: The SOy and Postmenopausal 
Health In Aging (SOPHIA) Study’. Menopause 10 (3), 196–202 
Kukuljan, S., Nowson, C.A., Sanders, K., and Daly, R.M. (2009) ‘Effects of Resistance 
Exercise and Fortified Milk on Skeletal Muscle Mass, Muscle Size, and Functional 
Performance in Middle-Aged and Older Men: An 18-Mo Randomized Controlled Trial’. 
Journal of Applied Physiology 107 (6), 1864-1873 
Kumahara, H., Tanaka, H., and Schutz, Y. (2011) ‘Inconspicuous Assessment of Diet-
Induced Thermogenesis Using Whole-Body Indirect Calorimetry’. Applied Physiology, 
Nutrition and Metabolism 36 (5), 758-763 
Kumar, A., Takada, Y., Boriek, A.M., and Aggarwal, B.B. (2004) ‘Nuclear Factor-ΚB: Its Role 
in Health and Disease’. Journal of Molecular Medicine 82 (7), 434–448 
Kumar, V., Atherton, P., Smith, K., and Rennie, M.J. (2009a) ‘Human Muscle Protein 
Synthesis and Breakdown during and after Exercise’. Journal of Applied Physiology 106 
(6), 2026–2039 
Kumar, V., Selby, A., Rankin, D., Patel, R., Atherton, P., Hildebrandt, W., Williams, J., Smith, 
K., Seynnes, O., and Hiscock, N. (2009b) ‘Age-related Differences in the Dose–
Response Relationship of Muscle Protein Synthesis to Resistance Exercise in Young 
and Old Men’. The Journal of Physiology 587 (1), 211–217 
Laan, D.J., Leidy, H.J., Lim, E., and Campbell, W.W. (2010) ‘Effects and Reproducibility of 
Aerobic and Resistance Exercise on Appetite and Energy Intake in Young, Physically 
Active Adults’. Applied Physiology, Nutrition, and Metabolism 35 (6), 842–847 
Lachman, M.E., Neupert, S.D., Bertrand, R., and Jette, A.M. (2006) ‘The Effects of Strength 
Training on Memory in Older Adults’. Journal of Aging and Physical Activity 14 (1), 59-
73 
Lacroix, A., Hortobagyi, T., Beurskens, R., and Granacher, U. (2017) ‘Effects of Supervised 
vs. Unsupervised Training Programs on Balance and Muscle Strength in Older Adults: 
A Systematic Review and Meta-Analysis’. Sports Medicine 47 (11), 2341–2361 
Lam, Y.Y. and Ravussin, E. (2016) ‘Analysis of Energy Metabolism in Humans: A Review of 
Methodologies’. Molecular Metabolism 5 (11), 1057–1071 
Landrigan, J.F., Bell, T., Crowe, M., Clay, O.J., and Mirman, D. (2019) ‘Lifting Cognition: A 
Meta-Analysis of Effects of Resistance Exercise on Cognition’. Psychological Research 
84, 1-17 
Larsen, P.S., Donges, C.E., Guelfi, K.J., Smith, G.C., Adams, D.R., and Duffield, R. (2017) 
‘Effects of Aerobic, Strength or Combined Exercise on Perceived Appetite and Appetite-
Related Hormones in Inactive Middle-Aged Men’. International Journal of Sport 
Nutrition and Exercise Metabolism 27 (5), 389–398 
Laske, C., Stransky, E., Leyhe, T., Eschweiler, G.W., Maetzler, W., Wittorf, A., Soekadar, S., 
Richartz, E., Koehler, N., and Bartels, M. (2007) ‘BDNF Serum and CSF 
Concentrations in Alzheimer’s Disease, Normal Pressure Hydrocephalus and Healthy 
Controls’. Journal of Psychiatric Research 41 (5), 387–394 
LeBrasseur, N.K., Bhasin, S., Miciek, R., and Storer, T.W. (2008) ‘Tests of Muscle Strength 
and Physical Function: Reliability and Discrimination of Performance in Younger and 
Older Men and Older Men with Mobility Limitations’. Journal of the American Geriatrics 
Society 56 (11), 2118–2123 
Lee, B.K., Glass, T.A., McAtee, M.J., Wand, G.S., Bandeen-Roche, K., Bolla, K.I., and 
Schwartz, B.S. (2007) ‘Associations of Salivary Cortisol with Cognitive Function in the 
 322 
Baltimore Memory Study’. Archives of General Psychiatry 64 (7), 810–818 
Lee, J., Hong, Y.P., Shin, H.J., and Lee, W. (2016) ‘Associations of Sarcopenia and 
Sarcopenic Obesity with Metabolic Syndrome Considering Both Muscle Mass and 
Muscle Strength’. Journal of Preventive Medicine and Public Health 49 (1), 35 
Lee, L., Kang, S.A., Lee, H.O., Lee, B.H., Park, J.S., Kim, J.H., Jung, I.K., Park, Y.J., and 
Lee, J.E. (2001) ‘Relationships between Dietary Intake and Cognitive Function Level in 
Korean Elderly People’. Public Health 115 (2), 133–138 
Leenders, M., Verdijk, L.B., van der Hoeven, L., van Kranenburg, J., Hartgens, F., Wodzig, 
W.K.W.H., Saris, W.H.M., and van Loon, L.J.C. (2011) ‘Prolonged Leucine 
Supplementation Does Not Augment Muscle Mass or Affect Glycemic Control in Elderly 
Type 2 Diabetic Men’. The Journal of Nutrition 141 (6), 1070–1076 
Leenders, M., Verdijk, L.B., Van Der Hoeven, L., Van Kranenburg, J., Nilwik, R., Wodzig, 
W.K.W.H., Senden, J.M.G., Keizer, H.A., and Van Loon, L.J.C. (2013) ‘Protein 
Supplementation during Resistance-Type Exercise Training in the Elderly’. Medicine 
and Science in Sports and Exercise 45 (3), 542–552 
Lefferts, W.K., Augustine, J.A., Spartano, N.L., Hughes, W.E., Babcock, M.C., Heenan, B.K., 
and Heffernan, K.S. (2020) ‘Effects of Whey Protein Supplementation on Aortic 
Stiffness, Cerebral Blood Flow, and Cognitive Function in Community-Dwelling Older 
Adults: Findings from the ANCHORS A-WHEY Clinical Trial’. Nutrients 12 (4), 1054 
Léger, B., Derave, W., De Bock, K., Hespel, P., and Russell, A.P. (2008) ‘Human 
Sarcopenia Reveals an Increase in SOCS-3 and Myostatin and a Reduced Efficiency of 
Akt Phosphorylation’. Rejuvenation Research 11 (1), 163-175 
Leidy, H.J., Clifton, P.M., Astrup, A., Wycherley, T.P., Westerterp-Plantenga, M.S., 
Luscombe-Marsh, N.D., Woods, S.C., and Mattes, R.D. (2015) ‘The Role of Protein in 
Weight Loss and Maintenance’. The American Journal of Clinical Nutrition 101 (6), 
1320-1329 
Lejeune, M.P.G.M., Westerterp, K.R., Adam, T.C.M., Luscombe-Marsh, N.D., and 
Westerterp-Plantenga, M.S. (2006) ‘Ghrelin and Glucagon-like Peptide 1 
Concentrations, 24-h Satiety, and Energy and Substrate Metabolism during a High-
Protein Diet and Measured in a Respiration Chamber’. American Journal of Clinical 
Nutrition 83 (1), 89-94 
Lemmens, S.G., Born, J.M., Martens, E.A., Martens, M.J., and Westerterp-Plantenga, M.S. 
(2011) ‘Influence of Consumption of a High-Protein vs. High- Carbohydrate Meal on the 
Physiological Cortisol and Psychological Mood Response in Men and Women’. PloS 
one 6 (2), e16826 
Lenk, K., Erbs, S., Höllriegel, R., Beck, E., Linke, A., Gielen, S., Winkler, S.M., Sandri, M., 
Hambrecht, R., Schuler, G., and Adams, V. (2012) ‘Exercise Training Leads to a 
Reduction of Elevated Myostatin Levels in Patients with Chronic Heart Failure’. 
European Journal of Preventive Cardiology 19 (3), 404–411 
Lenox-Smith, A., Reed, C., Lebrec, J., Belger, M., and Jones, R.W. (2018) ‘Potential Cost 
Savings to Be Made by Slowing Cognitive Decline in Mild Alzheimer’s Disease 
Dementia Using a Model Derived from the UK GERAS Observational Study’. BMC 
Geriatrics 18 (1), 57 
Leong, D.P., Teo, K.K., Rangarajan, S., Lopez-Jaramillo, P., Avezum, A., Orlandini, A., 
Seron, P., Ahmed, S.H., Rosengren, A., Kelishadi, R., Rahman, O., Swaminathan, S., 
Iqbal, R., Gupta, R., Lear, S.A., Oguz, A., Yusoff, K., Zatonska, K., Chifamba, J., 
Igumbor, E., Mohan, V., Anjana, R.M., Gu, H., Li, W., and Yusuf, S. (2015) ‘Prognostic 
Value of Grip Strength: Findings from the Prospective Urban Rural Epidemiology 
(PURE) Study’. The Lancet 386 (9990), 266–273 
Levadoux, E., Morio, B., Montaurier, C., Puissant, V., Boirie, Y., Fellmann, N., Picard, B., 
Rousset, P., Beaufrere, B., and Ritz, P. (2001) ‘Reduced Whole-Body Fat Oxidation in 
Women and in the Elderly’. International Journal of Obesity 25 (1), 39–44 
Levey, A.S., Greene, T., Beck, G.J., Caggiula, A.W., Kusek, J.W., Hunsicker, L.G., and 
Klahr, S. (1999) ‘Dietary Protein Restriction and the Progression of Chronic Renal 
Disease: What Have All of the Results of the MDRD Study Shown?’ Journal of the 
 323 
American Society of Nephrology 10 (11), 2426–2439 
Levin, O., Netz, Y., and Ziv, G. (2017) ‘The Beneficial Effects of Different Types of Exercise 
Interventions on Motor and Cognitive Functions in Older Age: A Systematic Review’. 
European Review of Aging and Physical Activity 14 (1), 20 
Levine, J.A. (2005) ‘Measurement of Energy Expenditure’. Public Health Nutrition 8 (7), 
1123–1132 
Levinger, I., Goodman, C., Hare, D.L., Jerums, G., Toia, D., and Selig, S. (2009) ‘The 
Reliability of the 1RM Strength Test for Untrained Middle-Aged Individuals’. Journal of 
Science and Medicine in Sport 12 (2), 310–316 
Li, G., Peskind, E.R., Millard, S.P., Chi, P., Sokal, I., Yu, C.-E., Bekris, L.M., Raskind, M.A., 
Galasko, D.R., and Montine, T.J. (2009) ‘Cerebrospinal Fluid Concentration of Brain-
Derived Neurotrophic Factor and Cognitive Function in Non-Demented Subjects’. PloS 
one 4 (5), e5424 
Li, H., Malhotra, S., and Kumar, A. (2008) ‘Nuclear Factor-Kappa B Signaling in Skeletal 
Muscle Atrophy’. Journal of Molecular Medicine 86 (10), 1113–1126 
Liao, C. De, Tsauo, J.Y., Wu, Y.T., Cheng, C.P., Chen, Hui Chuen, Huang, Y.C., Chen, 
Hung Chou, and Liou, T.H. (2017) ‘Effects of Protein Supplementation Combined with 
Resistance Exercise on Body Composition and Physical Function in Older Adults: A 
Systematic Review and Meta-Analysis’. American Journal of Clinical Nutrition 106 (4), 
1078–1091 
Liberman, K., Njemini, R., Luiking, Y., Forti, L.N., Verlaan, S., Bauer, J.M., Memelink, R., 
Brandt, K., Donini, L.M., Maggio, M., Mets, T., Wijers, S.L.J., Sieber, C., Cederholm, T., 
and Bautmans, I. (2019) ‘Thirteen Weeks of Supplementation of Vitamin D and 
Leucine-Enriched Whey Protein Nutritional Supplement Attenuates Chronic Low-Grade 
Inflammation in Sarcopenic Older Adults: The PROVIDE Study’. Aging Clinical and 
Experimental Research 31 (6), 845–854 
Lichtenwalner, R.J., Forbes, M.E., Bennett, S.A., Lynch, C.D., Sonntag, W.E., and Riddle, 
D.R. (2001) ‘Intracerebroventricular Infusion of Insulin-like Growth Factor-I Ameliorates 
the Age-Related Decline in Hippocampal Neurogenesis’. Neuroscience 107 (4), 603-
613 
Linn, T., Santosa, B., Grönemeyer, D., Aygen, S., Scholz, N., Busch, M., and Bretzel, R.G. 
(2000) ‘Effect of Long-Term Dietary Protein Intake on Glucose Metabolism in Humans’. 
Diabetologia 43 (10), 1257–1265 
Litwack, G. (2018) Protein Biosynthesis. in Human Biochemistry. Los Angeles, CA, USA: 
Academic Press, 319–336 
Liu-Ambrose, T., Nagamatsu, L.S., Graf, P., Beattie, B.L., Ashe, M.C., and Handy, T.C. 
(2010) ‘Resistance Training and Executive Functions: A 12-Month Randomized 
Controlled Trial’. Archives of Internal Medicine 170 (2), 170-178 
Liu-Ambrose, T., Nagamatsu, L.S., Voss, M.W., Khan, K.M., and Handy, T.C. (2012) 
‘Resistance Training and Functional Plasticity of the Aging Brain: A 12-Month 
Randomized Controlled Trial’. Neurobiology of Aging 33 (8), 1690-1698 
Liu, Y., Ye, W., Chen, Q., Zhang, Y., Kuo, C.-H., and Korivi, M. (2019) ‘Resistance Exercise 
Intensity Is Correlated with Attenuation of HbA1c and Insulin in Patients with Type 2 
Diabetes: A Systematic Review and Meta-Analysis’. International Journal of 
Environmental Research and Public Health 16 (1), 140 
Lloyd-Sherlock, P., McKee, M., Ebrahim, S., Gorman, M., Greengross, S., Prince, M., 
Pruchno, R., Gutman, G., Kirkwood, T., and O’Neill, D. (2012) ‘Population Ageing and 
Health’. The Lancet 379 (9823), 1295–1296 
Loenneke, J.P., Loprinzi, P.D., Murphy, C.H., and Phillips, S.M. (2016) ‘Per Meal Dose and 
Frequency of Protein Consumption Is Associated with Lean Mass and Muscle 
Performance’. Clinical Nutrition 35 (6), 1506–1511 
Lohne-Seiler, H., Hansen, B.H., Kolle, E., and Anderssen, S.A. (2014) ‘Accelerometer-
Determined Physical Activity and Self-Reported Health in a Population of Older Adults 
(65-85 Years): A Cross-Sectional Study’. BMC Public Health 14 (1), 1–10 
Loprinzi, P.D. (2016) ‘Epidemiological Investigation of Muscle-Strengthening Activities and 
 324 
Cognitive Function among Older Adults’. Chronic Illness 12 (2), 157–162 
Lucassen, P.J., Pruessner, J., Sousa, N., Almeida, O.F.X., Van Dam, A.M., Rajkowska, G., 
Swaab, D.F., and Czéh, B. (2014) ‘Neuropathology of Stress’. Acta Neuropathologica 
127 (1), 109–135 
Luger, M., Holstein, B., Schindler, K., Kruschitz, R., and Ludvik, B. (2013) ‘Feasibility and 
Efficacy of an Isocaloric High-Protein Vsstandard Diet on Insulin Requirement, Body 
Weight and Metabolic Parameters in Patients with Type 2 Diabetes on Insulin Therapy’. 
Experimental and Clinical Endocrinology and Diabetes 121 (5), 286-294 
Lynch, N.A., Metter, E.J., Lindle, R.S., Fozard, J.L., Tobin, J.D., Roy, T.A., Fleg, J.L., and 
Hurley, B.F. (1999) ‘Muscle Quality. I. Age-Associated Differences between Arm and 
Leg Muscle Groups’. Journal of Applied Physiology 86 (1), 188–194 
Maass, A., Düzel, S., Brigadski, T., Goerke, M., Becke, A., Sobieray, U., Neumann, K., 
Lövdén, M., Lindenberger, U., and Bäckman, L. (2016) ‘Relationships of Peripheral 
IGF-1, VEGF and BDNF Levels to Exercise-Related Changes in Memory, Hippocampal 
Perfusion and Volumes in Older Adults’. Neuroimage 131, 142–154 
Macaulay, T.R., Fisher, B.E., and Schroeder, E.T. (2020) ‘Potential Indirect Mechanisms of 
Cognitive Enhancement After Long-Term Resistance Training in Older Adults’. Physical 
Therapy 100 (6), 907-916 
Madzima, T.A., Black, J.R., Melanson, J.T., Nepocatych, S., and Hall, E.E. (2018) ‘Influence 
of Resistance Exercise on Appetite and Affect Following Pre-Sleep Feeding’. Sports 6 
(4), 172 
Malone, J.J., Bassami, M., Waldron, S.C., Campbell, I.T., Hulton, A., Doran, D., and 
MacLaren, D.P. (2019) ‘Carbohydrate Oxidation and Glucose Utilisation under 
Hyperglycaemia in Aged and Young Males during Exercise at the Same Relative 
Exercise Intensity’. European Journal of Applied Physiology 119 (1), 235–245 
Maltais, M., Du Bois-Dit-Bonclaude, M., Amamou, T., Riesco, E., and Dionne, I.J. (2018) 
‘The Impact of Post-Resistance Exercise Protein Consumption on Subsequent Appetite 
and Daily Energy Intake of Sarcopenic Older Men: A Pilot Study’. Aging Clinical and 
Experimental Research 30 (9), 1087–1092 
Maltais, M.L., Ladouceur, J.P., and Dionne, I.J. (2016) ‘The Effect of Resistance Training 
and Different Sources of Postexercise Protein Supplementation on Muscle Mass and 
Physical Capacity in Sarcopenic Elderly Men’. Journal of Strength and Conditioning 
Research 30 (6), 1680–1687 
Maltais, M.L., Perreault, K., Courchesne-Loyer, A., Lagacé, J.C., Barsalani, R., and Dionne, 
I.J. (2016) ‘Effect of Resistance Training and Various Sources of Protein 
Supplementation on Body Fat Mass and Metabolic Profile in Sarcopenic Overweight 
Older Adult Men: A Pilot Study’. International Journal of Sport Nutrition and Exercise 
Metabolism 26 (1), 71–77 
Mangano, K.M., Sahni, S., and Kerstetter, J.E. (2014) ‘Dietary Protein Is Beneficial to Bone 
Health under Conditions of Adequate Calcium Intake: An Update on Clinical Research’. 
Current Opinion in Clinical Nutrition and Metabolic Care 17 (1), 69 
Mangine, G.T., Hoffman, J.R., Gonzalez, A.M., Townsend, J.R., Wells, A.J., Jajtner, A.R., 
Beyer, K.S., Boone, C.H., Wang, R., Miramonti, A.A., Lamonica, M.B., Fukuda, D.H., 
Witta, E.L., Ratamess, N.A., and Stout, J.R. (2017) ‘Exercise-Induced Hormone 
Elevations Are Related to Muscle Growth’. Journal of Strength and Conditioning 
Research 31 (1), 45–53 
Manini, T.M. (2010) ‘Energy Expenditure and Aging’. Ageing Research Reviews 9 (1), 1–11 
Manini, T.M. and Clark, B.C. (2012) ‘Dynapenia and Aging: An Update’. Journals of 
Gerontology Series A: Biomedical Sciences and Medical Sciences 67 (1), 28–40 
Manoy, P., Anomasiri, W., Yuktanandana, P., Tanavalee, A., Ngarmukos, S., Tanpowpong, 
T., and Honsawek, S. (2017) ‘Elevated Serum Leptin Levels Are Associated with Low 
Vitamin D, Sarcopenic Obesity, Poor Muscle Strength, and Physical Performance in 
Knee Osteoarthritis’. Biomarkers 22 (8), 723–730 
Marioni, R.E., Stewart, M.C., Murray, G.D., Deary, I.J., Fowkes, F.G.R., Lowe, G.D.O., 
Rumley, A., and Price, J.F. (2009) ‘Peripheral Levels of Fibrinogen, C-Reactive Protein, 
 325 
and Plasma Viscosity Predict Future Cognitive Decline in Individuals without Dementia’. 
Psychosomatic Medicine 71 (8), 901 
Marsland, A.L., Gianaros, P.J., Kuan, D.C.-H., Sheu, L.K., Krajina, K., and Manuck, S.B. 
(2015) ‘Brain Morphology Links Systemic Inflammation to Cognitive Function in Midlife 
Adults’. Brain, Behavior, and Immunity 48, 195–204 
Marsland, A.L., Petersen, K.L., Sathanoori, R., Muldoon, M.F., Neumann, S.A., Ryan, C., 
Flory, J.D., and Manuck, S.B. (2006) ‘Interleukin-6 Covaries Inversely with Cognitive 
Performance among Middle-Aged Community Volunteers’. Psychosomatic Medicine 68 
(6), 895–903 
Marston, K.J., Brown, B.M., Rainey-Smith, S.R., Bird, S., Wijaya, L., Teo, S.Y.M., Laws, 
S.M., Martins, R.N., and Peiffer, J.J. (2019a) ‘Twelve Weeks of Resistance Training 
Does Not Influence Peripheral Levels of Neurotrophic Growth Factors or Homocysteine 
in Healthy Adults: A Randomized-Controlled Trial’. European Journal of Applied 
Physiology 119 (10), 2167-2176 
Marston, K.J., Brown, B.M., Rainey-Smith, S.R., and Peiffer, J.J. (2019b) ‘Resistance 
Exercise-Induced Responses in Physiological Factors Linked with Cognitive Health’. 
Journal of Alzheimer’s Disease 68 (1), 39–64 
Marston, K.J., Newton, M.J., Brown, B.M., Rainey-Smith, S.R., Bird, S., Martins, R.N., and 
Peiffer, J.J. (2017) ‘Intense Resistance Exercise Increases Peripheral Brain-Derived 
Neurotrophic Factor’. Journal of Science and Medicine in Sport 20 (10), 899–903 
Marston, K.J., Peiffer, J.J., Rainey-Smith, S.R., Gordon, N., Teo, S.Y., Laws, S.M., Sohrabi, 
H.R., Martins, R.N., and Brown, B.M. (2019c) ‘Resistance Training Enhances Delayed 
Memory in Healthy Middle-Aged and Older Adults: A Randomised Controlled Trial’. 
Journal of Science and Medicine in Sport 22 (11), 1226–1231 
Martens, E.A., Gonnissen, H.K., Gatta-Cherifi, B., Janssens, P.L., and Westerterp-
Plantenga, M.S. (2015a) ‘Maintenance of Energy Expenditure on High-Protein vs. High-
Carbohydrate Diets at a Constant Body Weight May Prevent a Positive Energy 
Balance’. Clinical Nutrition 34 (5), 968–975 
Martens, E.A., Gonnissen, H.K., Gatta-Cherifi, B., Janssens, P.L., and Westerterp-
Plantenga, M.S. (2015b) ‘Maintenance of Energy Expenditure on High-Protein vs. High-
Carbohydrate Diets at a Constant Body Weight May Prevent a Positive Energy 
Balance’. Clinical Nutrition 34 (5), 968–975 
Martens, E.A., Lemmens, S.G., and Westerterp-Plantenga, M.S. (2013) ‘Protein Leverage 
Affects Energy Intake of High-Protein Diets in Humans’. The American Journal of 
Clinical Nutrition 97 (1), 86–93 
Martens, M.J.I., Rutters, F., Lemmens, S.G.T., Born, J.M., and Westerterp-Plantenga, M.S. 
(2010) ‘Effects of Single Macronutrients on Serum Cortisol Concentrations in Normal 
Weight Men’. Physiology and Behavior 101 (5), 563–567 
Martins, W.R., de Oliveira, R.J., Carvalho, R.S., de Oliveira Damasceno, V., da Silva, 
V.Z.M., and Silva, M.S. (2013) ‘Elastic Resistance Training to Increase Muscle Strength 
in Elderly: A Systematic Review with Meta-Analysis’. Archives of Gerontology and 
Geriatrics 57 (1), 8–15 
Martone, A.M., Lattanzio, F., Marie Abbatecola, A., La Carpia, D., Tosato, M., Marzetti, E., 
Calvani, R., Onder, G., and Landi, F. (2015) ‘Treating Sarcopenia in Older and Oldest 
Old’. Current Pharmaceutical Design 21 (13), 1715–1722 
Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., and Turner, R.C. 
(1985) ‘Homeostasis Model Assessment: Insulin Resistance and β-Cell Function from 
Fasting Plasma Glucose and Insulin Concentrations in Man’. Diabetologia 28 (7), 412–
419 
Mattson, M.P., Maudsley, S., and Martin, B. (2004) ‘BDNF and 5-HT: A Dynamic Duo in 
Age-Related Neuronal Plasticity and Neurodegenerative Disorders’. Trends in 
Neurosciences 27 (10), 589–594 
Mavros, Y., Gates, N., Wilson, G.C., Jain, N., Meiklejohn, J., Brodaty, H., Wen, W., Singh, 
N., Baune, B.T., Suo, C., Baker, M.K., Foroughi, N., Wang, Y., Sachdev, P.S., 
Valenzuela, M., and Fiatarone Singh, M.A. (2017) ‘Mediation of Cognitive Function 
 326 
Improvements by Strength Gains After Resistance Training in Older Adults with Mild 
Cognitive Impairment: Outcomes of the Study of Mental and Resistance Training’. 
Journal of the American Geriatrics Society 65 (3), 550–559 
Mavros, Y., Kay, S., Simpson, K.A., Baker, M.K., Wang, Y., Zhao, R.R., Meiklejohn, J., 
Climstein, M., O’Sullivan, A.J., and De Vos, N. (2014) ‘Reductions in C-Reactive 
Protein in Older Adults with Type 2 Diabetes Are Related to Improvements in Body 
Composition Following a Randomized Controlled Trial of Resistance Training’. Journal 
of Cachexia, Sarcopenia and Muscle 5 (2), 111–120 
McClave, S.A., Spain, D.A., Skolnick, J.L., Lowen, C.C., Kleber, M.J., Wickerham, P.S., 
Vogt, J.R., and Looney, S.W. (2003) ‘Achievement of Steady State Optimizes Results 
When Performing Indirect Calorimetry’. Journal of Parenteral and Enteral Nutrition 27 
(1), 16–20 
McDonald, C., Pearce, M.S., Kerr, S.R.J., and Newton, J.L. (2017) ‘Blood Pressure 
Variability and Cognitive Decline in Older People: A 5-Year Longitudinal Study’. Journal 
of Hypertension 35 (1), 140–147 
McKee, A. and Morley, J.E. (2019) ‘Hormones and Sarcopenia’. Current Opinion in 
Endocrine and Metabolic Research 9, 34–39 
McLean, R.R., Mangano, K.M., Hannan, M.T., Kiel, D.P., and Sahni, S. (2016) ‘Dietary 
Protein Intake Is Protective Against Loss of Grip Strength Among Older Adults in the 
Framingham Offspring Cohort’. Journals of Gerontology - Series A Biological Sciences 
and Medical Sciences 71 (3), 356–361 
Mcleod, J.C., Stokes, T., and Phillips, S.M. (2019) ‘Resistance Exercise Training as a 
Primary Countermeasure to Age-Related Chronic Disease’. Frontiers in Physiology 10, 
645 
McPherron, A.C., Lawler, A.M., and Lee, S.-J. (1997) ‘Regulation of Skeletal Muscle Mass in 
Mice by a New TGF-p Superfamily Member’. Nature 387 (6628), 83–90 
Meex, R.C.R., Schrauwen-Hinderling, V.B., Moonen-Kornips, E., Schaart, G., Mensink, M., 
Phielix, E., van de Weijer, T., Sels, J.-P., Schrauwen, P., and Hesselink, M.K.C. (2010) 
‘Restoration of Muscle Mitochondrial Function and Metabolic Flexibility in Type 2 
Diabetes by Exercise Training Is Paralleled by Increased Myocellular Fat Storage and 
Improved Insulin Sensitivity’. Diabetes 59 (3), 572–579 
Mehlsen, J.L., Pedersen, S.B., Nørgaard, K.I., Langdahl, B.L., Møller, N., and Richelsen, B. 
(2017) ‘Effect of Leucine-Rich Whey Protein as Compared to Soy Protein on Muscle 
Function in Elderly Individuals with Osteopenia. A Four Month Randomized Study’. 
Journal of Aging Research and Clinical Practice 6, 200–209 
Meijer, E.P., Goris, A.H.C., Wouters, L., and Westerterp, K.R. (2001) ‘Physical Inactivity as a 
Determinant of the Physical Activity Level in the Elderly’. International Journal of 
Obesity 25 (7), 935–939 
Meijer, E.P., Westerterp, K.R., and Verstappen, F.T.J. (1999) ‘Effect of Exercise Training on 
Total Daily Physical Activity in Elderly Humans’. European Journal of Applied 
Physiology and Occupational Physiology 80 (1), 16–21 
Melanson, E.L. (2017) ‘The Effect of Exercise on Non-Exercise Physical Activity and 
Sedentary Behavior in Adults’. Obesity Reviews 18, 40–49 
Melanson, E.L., Donahoo, W.T., Grunwald, G.K., and Schwartz, R. (2007) ‘Changes in 24-h 
Substrate Oxidation in Older and Younger Men in Response to Exercise’. Journal of 
Applied Physiology 103 (5), 1576-1582 
Melanson, E.L., Sharp, T.A., Seagle, H.M., and Donahoo, W.T. (2005) ‘Twenty-Four-Hour 
Metabolic Responses to Resistance Exercise in Women’. Journal of Strength and 
Conditioning Research 19 (1), 61 
Melanson, E.L., Sharp, T.A., Seagle, H.M., Donahoo, W.T., Grunwald, G.K., Peters, J.C., 
Hamilton, J., and Hill, J.O. (2002) ‘Resistance and Aerobic Exercise Have Similar 
Effects on 24-h Nutrient Oxidation’. Medicine & Science in Sports & Exercise 34 (11), 
1793–1800 
Melby, C., Scholl, C., Edwards, G., and Bullough, R. (1993) ‘Effect of Acute Resistance 
Exercise on Postexercise Energy Expenditure and Resting Metabolic Rate’. Journal of 
 327 
Applied Physiology 75 (4), 1847–1853 
Menant, J.C., Weber, F., Lo, J., Sturnieks, D.L., Close, J.C., Sachdev, P.S., Brodaty, H., and 
Lord, S.R. (2017) ‘Strength Measures Are Better than Muscle Mass Measures in 
Predicting Health-Related Outcomes in Older People: Time to Abandon the Term 
Sarcopenia?’ Osteoporosis International 28 (1), 59-70 
Mijnarends, D.M., Meijers, J.M.M., Halfens, R.J.G., Ter Borg, S., Luiking, Y.C., Verlaan, S., 
Schoberer, D., Cruz Jentoft, A.J., Van Loon, L.J.C., and Schols, J.M.G.A. (2013) 
‘Validity and Reliability of Tools to Measure Muscle Mass, Strength, and Physical 
Performance in Community-Dwelling Older People: A Systematic Review’. Journal of 
the American Medical Directors Association 14 (3), 170–178 
Mijnarends, D.M., Schols, J., Halfens, R.J.G., Meijers, J.M.M., Luiking, Y.C., Verlaan, S., 
and Evers, S. (2016) ‘Burden-of-Illness of Dutch Community-Dwelling Older Adults with 
Sarcopenia: Health Related Outcomes and Costs’. European Geriatric Medicine 7 (3), 
276–284 
Mikkelsen, P.B., Toubro, S., and Astrup, A. (2000) ‘Effect of Fat-Reduced Diets on 24-h 
Energy Expenditure: Comparisons between Animal Protein, Vegetable Protein, and 
Carbohydrate’. The American Journal of Clinical Nutrition 72 (5), 1135–1141 
Miller, J.P., Pratley, R.E., Goldberg, A.P., Gordon, P., Rubin, M., Treuth, M.S., Ryan, A.S., 
and Hurley, B.F. (1994) ‘Strength Training Increases Insulin Action in Healthy 50-to 65-
Yr-Old Men’. Journal of Applied Physiology 77 (3), 1122–1127 
Mishra, S., Goldman, J.D., Sahyoun, N.R., and Moshfegh, A.J. (2018) ‘Association between 
Dietary Protein Intake and Grip Strength among Adults Aged 51 Years and over: What 
We Eat in America, National Health and Nutrition Examination Survey 2011-2014’. PloS 
one 13 (1), e0191368 
Misra, S. (2012) ‘Randomized Double Blind Placebo Control Studies, the “Gold Standard” in 
Intervention Based Studies’. Indian Journal of Sexually Transmitted Diseases 33 (2), 
131–134 
Mitchell, C.J., Churchward-Venne, T.A., Bellamy, L., Parise, G., Baker, S.K., and Phillips, 
S.M. (2013) ‘Muscular and Systemic Correlates of Resistance Training-Induced Muscle 
Hypertrophy’. PloS one 8 (10), e78636 
Mitchell, C.J., Milan, A.M., Mitchell, S.M., Zeng, N., Ramzan, F., Sharma, P., Knowles, S.O., 
Roy, N.C., Sjödin, A., Wagner, K.H., and Cameron-Smith, D. (2017) ‘The Effects of 
Dietary Protein Intake on Appendicular Lean Mass and Muscle Function in Elderly Men: 
A 10-Wk Randomized Controlled Trial’. American Journal of Clinical Nutrition 106 (6), 
1375–1383 
Mobley, C.B., Haun, C.T., Roberson, P.A., Mumford, P.W., Kephart, W.C., Romero, M.A., 
Osburn, S.C., Vann, C.G., Young, K.C., Beck, D.T., Martin, J.S., Lockwood, C.M., and 
Roberts, M.D. (2018) ‘Biomarkers Associated with Low, Moderate, and High Vastus 
Lateralis Muscle Hypertrophy Following 12 Weeks of Resistance Training’. PloS one 13 
(4), e0195203 
Moon, J.H. (2014) ‘Prevalence of Sarcopenia and Its Association with Metabolic Syndrome 
in Korean Cancer Survivors’. Journal of Geriatric Oncology 5, 52 
Moore, D.R., Del Bel, N.C., Nizi, K.I., Hartman, J.W., Tang, J.E., Armstrong, D., and Phillips, 
S.M. (2007) ‘Resistance Training Reduces Fasted-and Fed-State Leucine Turnover and 
Increases Dietary Nitrogen Retention in Previously Untrained Young Men’. The Journal 
of Nutrition 137 (4), 985–991 
Moore, D.R., Churchward-Venne, T.A., Witard, O., Breen, L., Burd, N.A., Tipton, K.D., and 
Phillips, S.M. (2015) ‘Protein Ingestion to Stimulate Myofibrillar Protein Synthesis 
Requires Greater Relative Protein Intakes in Healthy Older versus Younger Men’. 
Journals of Gerontology - Series A Biological Sciences and Medical Sciences 70 (1), 
57–62 
Moore, D.R., Robinson, M.J., Fry, J.L., Tang, J.E., Glover, E.I., Wilkinson, S.B., Prior, T., 
Tarnopolsky, M.A., and Phillips, S.M. (2009a) ‘Ingested Protein Dose Response of 
Muscle and Albumin Protein Synthesis after Resistance Exercise in Young Men’. The 
American Journal of Clinical Nutrition 89 (1), 161–168 
 328 
Moore, D.R., Tang, J.E., Burd, N.A., Rerecich, T., Tarnopolsky, M.A., and Phillips, S.M. 
(2009b) ‘Differential Stimulation of Myofibrillar and Sarcoplasmic Protein Synthesis with 
Protein Ingestion at Rest and after Resistance Exercise’. The Journal of Physiology 587 
(4), 897–904 
Moran, C., Scotto di Palumbo, A., Bramham, J., Moran, A., Rooney, B., De Vito, G., and 
Egan, B. (2018) ‘Effects of a Six-Month Multi-Ingredient Nutrition Supplement 
Intervention of Omega-3 Polyunsaturated Fatty Acids, Vitamin D, Resveratrol, and 
Whey Protein on Cognitive Function in Older Adults: A Randomised, Double-Blind, 
Controlled Trial.’ The Journal of Prevention of Alzheimer’s Disease 5 (3), 175–183 
Morehen, S., Smeuninx, B., Perkins, M., Morgan, P., and Breen, L. (2020) ‘Pre-Sleep 
Casein Protein Ingestion Does Not Impact Next-Day Appetite, Energy Intake and 
Metabolism in Older Individuals’. Nutrients 12 (1), 90 
Morgan, J.B. and York, D.A. (1983) ‘Thermic Effect of Feeding in Relation to Energy 
Balance in Elderly Men’. Annals of Nutrition and Metabolism 27 (1), 71–77 
Morio, B., Montaurier, C., Pickering, G., Ritz, P., Fellmann, N., Coudert, J., Beaufrère, B., 
and Vermorel, M. (1998) ‘Effects of 14 Weeks of Progressive Endurance Training on 
Energy Expenditure in Elderly People’. British Journal of Nutrition 80 (6), 511–519 
Morley, J.E. and Perry, H.M. (2003) 'Androgens and Women at the Menopause and Beyond' 
The Journals of Gerontology 58 (5), 409-416 
Moro, T., Brightwell, C.R., Volpi, E., Rasmussen, B.B., and Fry, C.S. (2020) ‘Resistance 
Exercise Training Promotes Fiber Type-Specific Myonuclear Adaptations in Older 
Adults’. Journal of Applied Physiology 128 (4), 795-804 
Morris, E.P., Rivas, D.A., and Fielding, R.A. (2010) 'Increased Intramuscular Triglycerides 
Are Associated with Increased AMPK Alpha1 and Cleaved SREBP1 in Aged Skeletal 
Muscle'. Federation of American Societies for Experimental Biology 24 (S1), 677 
Morton, R.W., Murphy, K.T., McKellar, S.R., Schoenfeld, B.J., Henselmans, M., Helms, E., 
Aragon, A.A., Devries, M.C., Banfield, L., Krieger, J.W., and Phillips, S.M. (2018a) ‘A 
Systematic Review, Meta-Analysis and Meta-Regression of the Effect of Protein 
Supplementation on Resistance Training-Induced Gains in Muscle Mass and Strength 
in Healthy Adults’. British Journal of Sports Medicine 52 (6), 376–384 
Morton, R.W., Oikawa, S.Y., Wavell, C.G., Mazara, N., McGlory, C., Quadrilatero, J., 
Baechler, B.L., Baker, S.K., and Phillips, S.M. (2016) ‘Neither Load nor Systemic 
Hormones Determine Resistance Training-Mediated Hypertrophy or Strength Gains in 
Resistance-Trained Young Men’. Journal of Applied Physiology 121 (1), 129–138 
Morton, R.W., Sato, K., Gallaugher, M.P.B., Oikawa, S.Y., McNicholas, P.D., Fujita, S., and 
Phillips, S.M. (2018b) ‘Muscle Androgen Receptor Content but Not Systemic Hormones 
Is Associated with Resistance Training Induced Skeletal Muscle Hypertrophy in 
Healthy, Young Men’. Frontiers in Physiology 9, 1373 
Müller, M.J., Enderle, J., and Bosy-Westphal, A. (2016) ‘Changes in Energy Expenditure 
with Weight Gain and Weight Loss in Humans’. Current Obesity Reports 5 (4), 413–423 
Müller, M.J., Wang, Z., Heymsfield, S.B., Schautz, B., and Bosy-Westphal, A. (2013) 
‘Advances in the Understanding of Specific Metabolic Rates of Major Organs and 
Tissues in Humans’. Current Opinion in Clinical Nutrition and Metabolic Care 16 (5), 
501–508 
Murphy, C.H., Oikawa, S.Y., and Phillips, S.M. (2016) ‘Dietary Protein to Maintain Muscle 
Mass in Aging: A Case for per-Meal Protein Recommendations’. J Frailty Aging 5 (1), 
49–58 
Mustafa, J., Ellison, R.C., Singer, M.R., Bradlee, M.L., Kalesan, B., Holick, M.F., and Moore, 
L.L. (2018) ‘Dietary Protein and Preservation of Physical Functioning among Middle-
Aged and Older Adults in the Framingham Offspring Study’. American Journal of 
Epidemiology 187 (7), 1411–1419 
Nabuco, H.C.G., Tomeleri, C.M., Sugihara Junior, P., Fernandes, R.R., Cavalcante, E.F., 
Antunes, M., Ribeiro, A.S., Teixeira, D.C., Silva, A.M., Sardinha, L.B., and Cyrino, E.S. 
(2018) ‘Effects of Whey Protein Supplementation Pre- or Post-Resistance Training on 
Muscle Mass, Muscular Strength, and Functional Capacity in Pre-Conditioned 
 329 
Olderwomen: A Randomized Clinical Trial’. Nutrients 10 (5), 563 
Nahas, E.A., Maestá, N., and Burini, R.C. (2014) ‘Effects of Resistance Training Frequency 
on Body Composition and Metabolics and Inflammatory Markers in Overweight 
Postmenopausal Women.’ The Journal of Sports Medicine and Physical Fitness 54 (3), 
317–325 
Narici, M. V. and Maffulli, N. (2010) ‘Sarcopenia: Characteristics, Mechanisms and 
Functional Significance’. British Medical Bulletin 95 (1), 139–159 
Nascimento, M.A. Do, Gerage, A.M., Silva, D.R.P. Da, Ribeiro, A.S., Machado, D.G.D.S., 
Pina, F.L.C., Tomeleri, C.M., Venturini, D., Barbosa, D.S., Mayhew, J.L., and Cyrino, 
E.S. (2019) ‘Effect of Resistance Training with Different Frequencies and Subsequent 
Detraining on Muscle Mass and Appendicular Lean Soft Tissue, IGF-1, and 
Testosterone in Older Women’. European Journal of Sport Science 19 (2), 199–207 
Negaresh, R., Ranjbar, R., Baker, J., Habibi, A., Mokhtarzade, M., Gharibvand, M., and 
Fokin, A. (2019) ‘Skeletal Muscle Hypertrophy, Insulin-like Growth Factor 1, Myostatin 
and Follistatin in Healthy and Sarcopenic Elderly Men: The Effect of Whole-Body 
Resistance Training’. International Journal of Preventive Medicine 10 (1) 
Negro, M., Perna, S., Spadaccini, D., Castelli, L., Calanni, L., Barbero, M., Cescon, C., 
Rondanelli, M., and D’Antona, G. (2019) ‘Effects of 12 Weeks of Essential Amino Acids 
(EAA)-Based Multi-Ingredient Nutritional Supplementation on Muscle Mass, Muscle 
Strength, Muscle Power and Fatigue in Healthy Elderly Subjects: A Randomized 
Controlled Double-Blind Study’. Journal of Nutrition, Health and Aging 23 (5), 414–424 
Nes, M., Sem, S.W., Rousseau, B., Bjørneboe, G.E., Engedal, K., Trygg, K., and Pedersen, 
J.I. (1988) ‘Dietary Intakes and Nutritional Status of Old People with Dementia Living at 
Home in Oslo.’ European Journal of Clinical Nutrition 42 (7), 581 
Nettiksimmons, J., Simonsick, E.M., Harris, T., Satterfield, S., Rosano, C., and Yaffe, K. 
(2014) ‘The Associations between Serum Brain-Derived Neurotrophic Factor, Potential 
Confounders, and Cognitive Decline: A Longitudinal Study’. PloS one 9 (3), e91339 
Nguyen, J.C.D., Killcross, A.S., and Jenkins, T.A. (2014) ‘Obesity and Cognitive Decline: 
Role of Inflammation and Vascular Changes’. Frontiers in Neuroscience 8, 375 
NHS (2019) The Long Term Plan Is a Game Changer [online] available from < 
https://www.england.nhs.uk/blog/long-term-plan-will-be-a-game-changer/> [13 October 
2020] 
NHS (2017) The Incidence and Costs of Inpatient Falls in Hospitals [online] available from 
<https://improvement.nhs.uk/documents/1471/Falls_report_July2017.v2.pdf> [13 
October 2020] 
Nilwik, R., Snijders, T., Leenders, M., Groen, B.B.L., van Kranenburg, J., Verdijk, L.B., and 
van Loon, L.J.C. (2013) ‘The Decline in Skeletal Muscle Mass with Aging Is Mainly 
Attributed to a Reduction in Type II Muscle Fiber Size’. Experimental Gerontology 48 
(5), 492–498 
Northey, J.M., Cherbuin, N., Pumpa, K.L., Smee, D.J., and Rattray, B. (2018) ‘Exercise 
Interventions for Cognitive Function in Adults Older than 50: A Systematic Review with 
Meta-Analysis’. British Journal of Sports Medicine 52 (3), 154-160 
Norton, C., Toomey, C., McCormack, W.G., Francis, P., Saunders, J., Kerin, E., and 
Jakeman, P. (2016) ‘Protein Supplementation at Breakfast and Lunch for 24 Weeks 
beyond Habitual Intakes Increases Whole-Body Lean Tissue Mass in Healthy Older 
Adults’. Journal of Nutrition 146 (1), 65-69 
Nunes, P.R.P., Barcelos, L.C., Oliveira, A.A., Júnior, R.F., Martins, F.M., Orsatti, C.L., 
Resende, E.A.M.R., and Orsatti, F.L. (2016) ‘Effect of Resistance Training on Muscular 
Strength and Indicators of Abdominal Adiposity, Metabolic Risk, and Inflammation in 
Postmenopausal Women: Controlled and Randomized Clinical Trial of Efficacy of 
Training Volume’. Age 38 (2), 40 
Nyberg, L. (2017) ‘Functional Brain Imaging of Episodic Memory Decline in Ageing’. Journal 
of Internal Medicine 281 (1), 65-74 
O’Bryant, S.E., Hobson, V.L., Hall, J.R., Barber, R.C., Zhang, S., Johnson, L., and Diaz-
Arrastia, R. (2011) ‘Serum Brain-Derived Neurotrophic Factor Levels Are Specifically 
 330 
Associated with Memory Performance among Alzheimer’s Disease Cases’. Dementia 
and Geriatric Cognitive Disorders 31 (1), 31–36 
Oesen, S., Halper, B., Hofmann, M., Jandrasits, W., Franzke, B., Strasser, E.M., Graf, A., 
Tschan, H., Bachl, N., Quittan, M., Wagner, K.H., and Wessner, B. (2015) ‘Effects of 
Elastic Band Resistance Training and Nutritional Supplementation on Physical 
Performance of Institutionalised Elderly - A Randomized Controlled Trial’. Experimental 
Gerontology 72, 99–108 
Office for National Statistics (2018) Living Longer: How Our Population Is Changing and 




Ogawa, K., Sanada, K., Machida, S., Okutsu, M., and Suzuki, K. (2010) ‘Resistance 
Exercise Training-Induced Muscle Hypertrophy Was Associated with Reduction of 
Inflammatory Markers in Elderly Women’. Mediators of Inflammation 2010. DOI: 
10.1155/2010/171023 
Onder, G., Della Vedova, C., and Landi, F. (2009) ‘Validated Treatments and Therapeutics 
Prospectives Regarding Pharmacological Products for Sarcopenia’. JNHA-The Journal 
of Nutrition, Health and Aging 13 (8), 746–756 
Oreopoulos, A., McAlister, F.A., Kalantar-Zadeh, K., Padwal, R., Ezekowitz, J.A., Sharma, 
A.M., Kovesdy, C.P., Fonarow, G.C., and Norris, C.M. (2009) ‘The Relationship 
between Body Mass Index, Treatment, and Mortality in Patients with Established 
Coronary Artery Disease: A Report from APPROACH’. European Heart Journal 30 (21), 
2584–2592 
Ormsbee, M.J., Thyfault, J.P., Johnson, E.A., Kraus, R.M., Choi, M.D., and Hickner, R.C. 
(2007) ‘Fat Metabolism and Acute Resistance Exercise in Trained Men’. Journal of 
Applied Physiology 102 (5), 1767-1772 
Ottestad, I., Løvstad, A.T., Gjevestad, G.O., Hamarsland, H., Šaltytė Benth, J., Andersen, 
L.F., Bye, A., Biong, A.S., Retterstøl, K., Iversen, P.O., Raastad, T., Ulven, S.M., and 
Holven, K.B. (2017) ‘Intake of a Protein-Enriched Milk and Effects on Muscle Mass and 
Strength. A 12-Week Randomized Placebo Controlled Trial among Community-
Dwelling Older Adults’. Journal of Nutrition, Health and Aging 21 (10), 1160-1169 
Overend, T.J., Cunningham, D.A., Paterson, D.H., and Lefcoe, M.S. (1992) ‘Thigh 
Composition in Young and Elderly Men Determined by Computed Tomography’. 
Clinical Physiology 12 (6), 629–640 
Paddon-Jones, D., Campbell, W.W., Jacques, P.F., Kritchevsky, S.B., Moore, L.L., 
Rodriguez, N.R., and Van Loon, L.J.C. (2015) ‘Protein and Healthy Aging’. The 
American Journal of Clinical Nutrition 101 (6), 1339-1345 
Pal, S. and Ellis, V. (2010) ‘The Chronic Effects of Whey Proteins on Blood Pressure, 
Vascular Function, and Inflammatory Markers in Overweight Individuals’. Obesity 18 
(7), 1354–1359 
Pal, S., Ellis, V., and Dhaliwal, S. (2010) ‘Effects of Whey Protein Isolate on Body 
Composition, Lipids, Insulin and Glucose in Overweight and Obese Individuals’. British 
Journal of Nutrition 104 (5), 716–723 
Pannemans, D.L.E., Halliday, D., and Westerterp, K.R. (1995) ‘Whole-Body Protein 
Turnover in Elderly Men and Women: Responses to Two Protein Intakes’. American 
Journal of Clinical Nutrition 61 (1), 33–38 
Pannemans, D.L.E., Halliday, D., Westerterp, K.R., and Kester, A.D.M. (1995) ‘Effect of 
Variable Protein Intake on Whole-Body Protein Turnover in Young Men and Women’. 
American Journal of Clinical Nutrition 61 (1), 69–74 
Pannemans, D.L.E., Wagenmakers, A.J.M., Westerterp, K.R., Schaafsma, G., and Halliday, 
D. (1998) ‘Effect of Protein Source and Quantity on Protein Metabolism in Elderly 
Women’. American Journal of Clinical Nutrition 68 (6), 1228–1235 
Paoli, A., Pacelli, Q.F., Neri, M., Toniolo, L., Cancellara, P., Canato, M., Moro, T., Quadrelli, 
M., Morra, A., and Faggian, D. (2015) ‘Protein Supplementation Increases Postexercise 
 331 
Plasma Myostatin Concentration after 8 Weeks of Resistance Training in Young 
Physically Active Subjects’. Journal of Medicinal Food 18 (1), 137–143 
Papa, E. V, Dong, X., and Hassan, M. (2017) ‘Resistance Training for Activity Limitations in 
Older Adults with Skeletal Muscle Function Deficits: A Systematic Review’. Clinical 
Interventions in Aging 12, 955 
Park, Y., Choi, J.E., and Hwang, H.S. (2018) ‘Protein Supplementation Improves Muscle 
Mass and Physical Performance in Undernourished Prefrail and Frail Elderly Subjects: 
A Randomized, Double-Blind, Placebo-Controlled Trial’. American Journal of Clinical 
Nutrition 108 (5), 1026–1033 
Park, Y., Park, H.-Y., Kim, J., Hwang, H., Jung, Y., Kreider, R., and Lim, K. (2019) ‘Effects of 
Whey Protein Supplementation Prior to, and Following, Resistance Exercise on Body 
Composition and Training Responses: A Randomized Double-Blind Placebo-Controlled 
Study’. Journal of Exercise Nutrition & Biochemistry 23 (2), 34 
Parry, H.A., Roberts, M.D., and Kavazis, A.N. (2020) ‘Human Skeletal Muscle Mitochondrial 
Adaptations Following Resistance Exercise Training’. International Journal of Sports 
Medicine 41 (6), 349–359 
Pase, M.P. and Stough, C. (2014) ‘An Evidence-Based Method for Examining and Reporting 
Cognitive Processes in Nutrition Research’. Nutrition Research Reviews 27 (2), 232–
241 
Patel, H.P., Al-Shanti, N., Davies, L.C., Barton, S.J., Grounds, M.D., Tellam, R.L., Stewart, 
C.E., Cooper, C., and Sayer, A.A. (2014) ‘Lean Mass, Muscle Strength and Gene 
Expression in Community Dwelling Older Men: Findings from the Hertfordshire 
Sarcopenia Study (HSS)’. Calcified Tissue International 95 (4), 308–316 
Patel, H.P., Syddall, H.E., Jameson, K., Robinson, S., Denison, H., Roberts, H.C., Edwards, 
M., Dennison, E., Cooper, C., and Aihie Sayer, A. (2013) ‘Prevalence of Sarcopenia in 
Community-Dwelling Older People in the UK Using the European Working Group on 
Sarcopenia in Older People (EWGSOP) Definition: Findings from the Hertfordshire 
Cohort Study (HCS)’. Age and Ageing 42 (3), 378–384 
Paulsen, A.J., Schubert, C.R., Pinto, A., Carlsson, C.M., Chappell, R.J., Fischer, M.E., Klein, 
B.E.K., Klein, R., Tsai, M.Y., and Cruickshanks, K.J. (2020) ‘Neuroprotective 
Biomarkers and Cognitive Function in a Long-Term Prospective Population-Based 
Study of Aging US Adults’. Alzheimer Disease & Associated Disorders 34 (1), 31–39 
Peavy, G.M., Salmon, D.P., Jacobson, M.W., Hervey, A., Gamst, A.C., Wolfson, T., 
Patterson, T.L., Goldman, S., Mills, P.J., and Khandrika, S. (2009) ‘Effects of Chronic 
Stress on Memory Decline in Cognitively Normal and Mildly Impaired Older Adults’. 
American Journal of Psychiatry 166 (12), 1384–1391 
Peng, L.N., Lee, W.J., Liu, L.K., Lin, M.H., and Chen, L.K. (2018) ‘Healthy Community-Living 
Older Men Differ from Women in Associations between Myostatin Levels and Skeletal 
Muscle Mass’. Journal of Cachexia, Sarcopenia and Muscle 9 (4), 635–642 
Peng, T.C., Chen, W.L., Wu, L.W., Chang, Y.W., and Kao, T.W. (2020) ‘Sarcopenia and 
Cognitive Impairment: A Systematic Review and Meta-Analysis’. Clinical Nutrition 39 
(9), 2695-2701 
Pennings, B., Koopman, R., Beelen, M., Senden, J.M.G., Saris, W.H.M., and Van Loon, 
L.J.C. (2011) ‘Exercising before Protein Intake Allows for Greater Use of Dietary 
Protein–Derived Amino Acids for de Novo Muscle Protein Synthesis in Both Young and 
Elderly Men’. The American Journal of Clinical Nutrition 93 (2), 322–331 
Peralta, M., Ramos, M., Lipert, A., Martins, J., and Marques, A. (2018) ‘Prevalence and 
Trends of Overweight and Obesity in Older Adults from 10 European Countries from 
2005 to 2013’. Scandinavian Journal of Public Health 46 (5), 522–529 
Pereira, D.S., de Queiroz, B.Z., Miranda, A.S., Rocha, N.P., Felício, D.C., Mateo, E.C., 
Favero, M., Coelho, F.M., Jesus-Moraleida, F., and Pereira, D.A.G. (2013) ‘Effects of 
Physical Exercise on Plasma Levels of Brain-Derived Neurotrophic Factor and 
Depressive Symptoms in Elderly Women—a Randomized Clinical Trial’. Archives of 
Physical Medicine and Rehabilitation 94 (8), 1443–1450 
Perez-Leighton, C.E., Billington, C.J., and Kotz, C.M. (2014) ‘Orexin Modulation of Adipose 
 332 
Tissue’. Biochimica et Biophysica Acta - Molecular Basis of Disease 1842 (3), 440–445 
Perna, S., Peroni, G., Anna, F.M., Bartolo, A., Naso, M., Miccono, A., and Rondanelli, M. 
(2017) ‘Sarcopenia and Sarcopenic Obesity in Comparison: Prevalence, Metabolic 
Profile, and Key Differences. A Cross-Sectional Study in Italian Hospitalized Elderly’. 
Aging Clinical and Experimental Research 29 (6), 1–10 
Pessini, J., Barbosa, A.R., and Trindade, E.B.S. de M. (2016) ‘Chronic Diseases, 
Multimorbidity, and Handgrip Strength among Older Adults from Southern Brazil’. 
Revista de Nutricao 29 (1), 43–52 
Peters, R. (2006) ‘Ageing and the Brain’. Postgraduate Medical Journal 82 (964), 84–88 
Petersen, R.C. (2016) ‘Mild Cognitive Impairment’. CONTINUUM: Lifelong Learning in 
Neurology 22 (2 Dementia), 404-418 
Peterson, C.M., Zhang, B., Johannsen, D.L., and Ravussin, E. (2017) ‘Eight Weeks of 
Overfeeding Alters Substrate Partitioning without Affecting Metabolic Flexibility in Men’. 
International Journal of Obesity 41 (6), 887–893 
Peterson, M.D., Rhea, M.R., Sen, A., and Gordon, P.M. (2010) ‘Resistance Exercise for 
Muscular Strength in Older Adults: A Meta-Analysis’. Ageing Research Reviews 9 (3), 
226–237 
Peterson, M.D., Sen, A., and Gordon, P.M. (2011) ‘Influence of Resistance Exercise on 
Lean Body Mass in Aging Adults: A Meta-Analysis’. Medicine and Science in Sports 
and Exercise 43 (2), 249 
Phillips, L.H., Kliegel, M., and Martin, M. (2006) ‘Age and Planning Tasks: The Influence of 
Ecological Validity’. International Journal of Aging and Human Development 62 (2), 
175-184 
Phillips, S.M. (2015) ‘Nutritional Supplements in Support of Resistance Exercise to Counter 
Age-Related Sarcopenia’. Advances in Nutrition 6 (4), 452–460 
Phillips, S.M., Chevalier, S., and Leidy, H.J. (2016) ‘Protein “Requirements” beyond the 
RDA: Implications for Optimizing Health’. Applied Physiology, Nutrition, and Metabolism 
41 (5), 565–572 
Phillips, S.M. and Martinson, W. (2019) ‘Nutrient-Rich, High-Quality, Protein-Containing 
Dairy Foods in Combination with Exercise in Aging Persons to Mitigate Sarcopenia’. 
Nutrition Reviews 77 (4), 216–229 
Phillips, S.M., Tipton, K.D., Aarsland, A., Wolf, S.E., and Wolfe, R.R. (1997) ‘Mixed Muscle 
Protein Synthesis and Breakdown after Resistance Exercise in Humans’. American 
Journal of Physiology - Endocrinology and Metabolism 273 (1), 99-107 
Phillips, W.T., Batterham, A.M., Valenzuela, J.E., and Burkett, L.N. (2004) ‘Reliability of 
Maximal Strength Testing in Older Adults’. Archives of Physical Medicine and 
Rehabilitation 85 (2), 329–334 
Piazza, J.R., Almeida, D.M., Dmitrieva, N.O., and Klein, L.C. (2010) ‘Frontiers in the Use of 
Biomarkers of Health in Research on Stress and Aging’. Journals of Gerontology - 
Series B Psychological Sciences and Social Sciences 65 (5), 513–525 
Piber, D., Olmstead, R., Cho, J.H.-J., Witarama, T., Perez, C., Dietz, N., Seeman, T.E., 
Breen, E.C., Cole, S.W., and Irwin, M.R. (2019) ‘Inflammaging: Age and Systemic, 
Cellular, and Nuclear Inflammatory Biology in Older Adults’. The Journals of 
Gerontology: Series A 74 (11), 1716–1724 
Pinedo-Villanueva, R., Westbury, L.D., Syddall, H.E., Sanchez-Santos, M.T., Dennison, 
E.M., Robinson, S.M., and Cooper, C. (2019) ‘Health Care Costs Associated With 
Muscle Weakness: A UK Population-Based Estimate’. Calcified Tissue International 
104 (2), 137–144 
Planella-Farrugia, C., Comas, F., Sabater-Masdeu, M., Moreno, M., Moreno-Navarrete, J.M., 
Rovira, O., Ricart, W., and Fernández-Real, J.M. (2019) ‘Circulating Irisin and 
Myostatin as Markers of Muscle Strength and Physical Condition in Elderly Subjects’. 
Frontiers in Physiology 10, 871 
Plomgaard, P., Bouzakri, K., Krogh-Madsen, R., Mittendorfer, B., Zierath, J.R., and 
Pedersen, B.K. (2005) ‘Tumor Necrosis Factor-α Induces Skeletal Muscle Insulin 
Resistance in Healthy Human Subjects via Inhibition of Akt Substrate 160 
 333 
Phosphorylation’. Diabetes 54 (10), 2939–2945 
Pratley, R., Nicklas, B., Rubin, M., Miller, J., Smith, A., Smith, M., Hurley, B., and Goldberg, 
A. (1994) ‘Strength Training Increases Resting Metabolic Rate and Norepinephrine 
Levels in Healthy 50- to 65-Yr-Old Men’. Journal of Applied Physiology 76 (1), 133–137 
Price, G.M., Halliday, D., Pacy, P.J., Quevedo, M.R., and Millward, D.J. (1994) ‘Nitrogen 
Homoeostasis in Man: Influence of Protein Intake on the Amplitude of Diurnal Cycling of 
Body Nitrogen’. Clinical Science 86 (1), 91–102 
Prince, M.J. (2014) World Alzheimer Report 2014: Dementia and Risk Reduction: An 
Analysis of Protective and Modifiable Factors [online] available from < 
https://www.alzint.org/u/WorldAlzheimerReport2014.pdf> [10 May 2020] 
Promintzer, M. and Krebs, M. (2006) ‘Effects of Dietary Protein on Glucose Homeostasis’. 
Current Opinion in Clinical Nutrition & Metabolic Care 9 (4), 463–468 
Puthoff, M.L. and Nielsen, D.H. (2007) ‘Relationships Among Impairments in Lower-
Extremity Strength and Power, Functional Limitations, and Disability in Older Adults’. 
Physical Therapy 87 (10), 1334–1347 
Qiang, W., Weiqiang, K., Qing, Z., Pengju, Z., and Yi, L. (2007) ‘Aging Impairs Insulin-
Stimulated Glucose Uptake in Rat Skeletal Muscle via Suppressing AMPKα’. 
Experimental & Molecular Medicine 39 (4), 535–543 
R&D Systems (2018) Human IL-6 Immunoassay [online] available from 
<https://resources.rndsystems.com/pdfs/datasheets/d6050.pdf> [8 August 2020] 
Rabbitt, P. and Lowe, C. (2000) ‘Patterns of Cognitive Ageing’. Psychological Research 63 
(3-4), 308-316 
Rafii, M., Chapman, K., Owens, J., Elango, R., Campbell, W.W., Ball, R.O., Pencharz, P.B., 
and Courtney-Martin, G. (2015) ‘Dietary Protein Requirement of Female Adults> 65 
Years Determined by the Indicator Amino Acid Oxidation Technique Is Higher than 
Current Recommendations’. The Journal of Nutrition 145 (1), 18–24 
Rafnsson, S.B., Deary, I.J., Smith, F.B., Whiteman, M.C., Rumley, A., Lowe, G.D.O., and 
Fowkes, F.G.R. (2007) ‘Cognitive Decline and Markers of Inflammation and 
Hemostasis: The Edinburgh Artery Study’. Journal of the American Geriatrics Society 
55 (5), 700–707 
Raji, C.A., Ho, A.J., Parikshak, N.N., Becker, J.T., Lopez, O.L., Kuller, L.H., Hua, X., Leow, 
A.D., Toga, A.W., and Thompson, P.M. (2010) ‘Brain Structure and Obesity’. Human 
Brain Mapping 31 (3), 353–364 
Ratkevicius, A., Joyson, A., Selmer, I., Dhanani, T., Grierson, C., Tommasi, A.M., DeVries, 
A., Rauchhaus, P., Crowther, D., and Alesci, S. (2011) ‘Serum Concentrations of 
Myostatin and Myostatin-Interacting Proteins Do Not Differ between Young and 
Sarcopenic Elderly Men’. Journals of Gerontology Series A: Biomedical Sciences and 
Medical Sciences 66 (6), 620–626 
Ravussin, E., Lillioja, S., Anderson, T.E., Christin, L., and Bogardus, C. (1986) ‘Determinants 
of 24-Hour Energy Expenditure in Man. Methods and Results Using a Respiratory 
Chamber’. Journal of Clinical Investigation 78 (6), 1568–1578 
Rawshani, Aidin, Rawshani, Araz, Franzén, S., Sattar, N., Eliasson, B., Svensson, A.-M., 
Zethelius, B., Miftaraj, M., McGuire, D.K., and Rosengren, A. (2018) ‘Risk Factors, 
Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes’. New 
England Journal of Medicine, 633-644 
Reed, R.L., Den Hartog, R., Yochum, K., Pearlmutter, L., Ruttinger, A.C., and Mooradian, 
A.D. (1993) ‘A Comparison of Hand-Held Isometric Strength Measurement with 
Isokinetic Muscle Strength Measurement in the Elderly’. Journal of the American 
Geriatrics Society 41 (1), 53–56 
Reeves, M.M., Davies, P.S.W., Bauer, J., and Battistutta, D. (2004) ‘Reducing the Time 
Period of Steady State Does Not Affect the Accuracy of Energy Expenditure 
Measurements by Indirect Calorimetry’. Journal of Applied Physiology 97 (1), 130–134 
Reginster, J.Y., Cooper, C., Rizzoli, R., Kanis, J.A., Appelboom, G., Bautmans, I., Bischoff-
Ferrari, H.A., Boers, M., Brandi, M.L., Bruyère, O., Cherubini, A., Flamion, B., Fielding, 
R.A., Gasparik, A.I., Van Loon, L., McCloskey, E., Mitlak, B.H., Pilotto, A., Reiter-
 334 
Niesert, S., Rolland, Y., Tsouderos, Y., Visser, M., and Cruz-Jentoft, A.J. (2016) 
‘Recommendations for the Conduct of Clinical Trials for Drugs to Treat or Prevent 
Sarcopenia’. Aging Clinical and Experimental Research 28 (1), 47–58 
Reid, K.F., Callahan, D.M., Carabello, R.J., Phillips, E.M., Frontera, W.R., and Fielding, R.A. 
(2008) ‘Lower Extremity Power Training in Elderly Subjects with Mobility Limitations: A 
Randomized Controlled Trial’. Aging Clinical and Experimental Research 20 (4), 337-
343 
Rennie, M.J., Wackerhage, H., Spangenburg, E.E., and Booth, F.W. (2004) ‘Control of the 
Size of the Human Muscle Mass’. Annual Review of Physiology 66 (1), 799–828 
Requejo, A.M., Ortega, R.M., Robles, F., Navia, B., Faci, M., and Aparicio, A. (2003) 
‘Influence of Nutrition on Cognitive Function in a Group of Elderly, Independently Living 
People’. European Journal of Clinical Nutrition 57 (1), 54–57 
Ridge, A., Devine, A., Lyons-Wall, P., Conlon, J., and Lo, J. (2018) ‘The Impact of Whey 
Protein Supplementation in Older Adults on Nutrient Intakes and Satiety over an 11-
Week Exercise Intervention’. Food Quality and Preference 68, 72–79 
Rieu, I., Magne, H., Savary-Auzeloux, I., Averous, J., Bos, C., Peyron, M.A., Combaret, L., 
and Dardevet, D. (2009) ‘Reduction of Low Grade Inflammation Restores Blunting of 
Postprandial Muscle Anabolism and Limits Sarcopenia in Old Rats’. Journal of 
Physiology 587 (22), 5483–5492 
Rikli, R.E. and Jones, C.J. (1998) ‘The Reliability and Validity of a 6-Minute Walk Test as a 
Measure of Physical Endurance in Older Adults’. Journal of Aging and Physical Activity 
6 (4), 363–375 
Roberts, H.C., Denison, H.J., Martin, H.J., Patel, H.P., Syddall, H., Cooper, C., and Sayer, 
A.A. (2011) ‘A Review of the Measurement of Grip Strength in Clinical and 
Epidemiological Studies: Towards a Standardised Approach’. Age and Ageing 40 (4), 
423–429 
Roberts, M.D., Haun, C.T., Mobley, C.B., Mumford, P.W., Romero, M.A., Roberson, P.A., 
Vann, C.G. and McCarthy, J.J. (2018) 'Physiological differences between low versus 
high skeletal muscle hypertrophic responders to resistance exercise training: current 
perspectives and future research directions'. Frontiers in physiology 9, 834. 
Roberts, R.O., Roberts, L.A., Geda, Y.E., Cha, R.H., Pankratz, V.S., O’Connor, H.M., 
Knopman, D.S., and Petersen, R.C. (2012) ‘Relative Intake of Macronutrients Impacts 
Risk of Mild Cognitive Impairment or Dementia’. Journal of Alzheimer’s Disease 32 (2), 
329–339 
Roberts, S.B., Fuss, P., Heyman, M.B., and Young, V.R. (1995) ‘Influence of Age on Energy 
Requirements’. The American Journal of Clinical Nutrition 62 (5), 1053-1058 
Roberts, S.B. and Rosenberg, I. (2006) ‘Nutrition and Aging: Changes in the Regulation of 
Energy Metabolism with Aging’. Physiological Reviews 86 (2), 651–667 
Robinson, S.M., Jaccard, C., Persaud, C., Jackson, A.A., Jequier, E., and Schutz, Y. (1990) 
‘Protein Turnover and Thermogenesis in Response to High-Protein and High-
Carbohydrate Feeding in Men’. American Journal of Clinical Nutrition 52 (1), 72–80 
Rom, O., Kaisari, S., Aizenbud, D., and Reznick, A.Z. (2012) ‘Identification of Possible 
Cigarette Smoke Constituents Responsible for Muscle Catabolism’. Journal of Muscle 
Research and Cell Motility 33 (3–4), 199–208 
Rondanelli, M., Cereda, E., Klersy, C., Faliva, M.A., Peroni, G., Nichetti, M., Gasparri, C., 
Iannello, G., Spadaccini, D., and Infantino, V. (2020) ‘Improving Rehabilitation in 
Sarcopenia: A Randomized-controlled Trial Utilizing a Muscle-targeted Food for Special 
Medical Purposes’. Journal of Cachexia, Sarcopenia and Muscle: DOI: 
10.1002/jcsm.12532 
Rondanelli, M., Klersy, C., Terracol, G., Talluri, J., Maugeri, R., Guido, D., Faliva, M.A., 
Solerte, B.S., Fioravanti, M., Lukaski, H., and Perna, S. (2016) ‘Whey Protein, Amino 
Acids, and Vitamin D Supplementation with Physical Activity Increases Fat-Free Mass 
and Strength, Functionality, and Quality of Life and Decreases Inflammation in 
Sarcopenic Elderly’. American Journal of Clinical Nutrition 103 (3), 830–840 
Rosenberg, I.H. (1989) ‘Summary Comments’. The American Journal of Clinical Nutrition 50 
 335 
(5), 1231–1233 
Rosendahl-Riise, H., Spielau, U., Ranhoff, A.H., Gudbrandsen, O.A., and Dierkes, J. (2017) 
‘Vitamin D Supplementation and Its Influence on Muscle Strength and Mobility in 
Community-dwelling Older Persons: A Systematic Review and Meta-analysis’. Journal 
of Human Nutrition and Dietetics 30 (1), 3–15 
Ryall, J.G., Schertzer, J.D., and Lynch, G.S. (2008) ‘Cellular and Molecular Mechanisms 
Underlying Age-Related Skeletal Muscle Wasting and Weakness’. Biogerontology 9 (4), 
213–228 
Rynders, C.A., Blanc, S., DeJong, N., Bessesen, D.H., and Bergouignan, A. (2018) 
‘Sedentary Behaviour Is a Key Determinant of Metabolic Inflexibility’. The Journal of 
Physiology 596 (8), 1319–1330 
Sakuma, K., Aoi, W., and Yamaguchi, A. (2017) ‘Molecular Mechanism of Sarcopenia and 
Cachexia: Recent Research Advances’. Pflügers Archiv-European Journal of 
Physiology 469 (5–6), 573–591 
Salthouse, T.A. (2009) ‘When Does Age-Related Cognitive Decline Begin?’ Neurobiology of 
Aging 30 (4), 507–514 
Sardeli, A.V., Tomeleri, C.M., Cyrino, E.S., Fernhall, B., Cavaglieri, C.R., and Chacon-
Mikahil, M.P.T. (2018) ‘Effect of Resistance Training on Inflammatory Markers of Older 
Adults: A Meta-Analysis’. Experimental Gerontology 111, 188–196 
Satizabal, C.L., Zhu, Y.C., Mazoyer, B., Dufouil, C., and Tzourio, C. (2012) ‘Circulating IL-6 
and CRP Are Associated with MRI Findings in the Elderly: The 3C-Dijon Study’. 
Neurology 78 (10), 720–727 
Sattler, F.R. (2013) ‘Growth Hormone in the Aging Male’. Best Practice & Research Clinical 
Endocrinology & Metabolism 27 (4), 541–555 
Sawilowsky, S.S. (2009) ‘New Effect Size Rules of Thumb’. Journal of Modern Applied 
Statistical Methods 8 (2), 26 
Schaap, L.A., Pluijm, S.M.F., Deeg, D.J.H., Harris, T.B., Kritchevsky, S.B., Newman, A.B., 
Colbert, L.H., Pahor, M., Rubin, S.M., and Tylavsky, F.A. (2009) ‘Higher Inflammatory 
Marker Levels in Older Persons: Associations with 5-Year Change in Muscle Mass and 
Muscle Strength’. Journals of Gerontology Series A: Biomedical Sciences and Medical 
Sciences 64 (11), 1183–1189 
Schaap, L.A., Pluijm, S.M.F., Deeg, D.J.H., and Visser, M. (2006) ‘Inflammatory Markers 
and Loss of Muscle Mass (Sarcopenia) and Strength’. The American Journal of 
Medicine 119 (6), 526-529 
Schoeller, D.A., Shay, K., and Kushner, R.F. (1997) ‘How Much Physical Activity Is Needed 
to Minimize Weight Gain in Previously Obese Women?’ The American Journal of 
Clinical Nutrition 66 (3), 551–556 
Schoenfeld, B.J. (2012) ‘Does Exercise-Induced Muscle Damage Play a Role in Skeletal 
Muscle Hypertrophy?’ Journal of Strength and Conditioning Research 26 (5), 1441–
1453 
Schoenfeld, B.J. and Grgic, J. (2019) ‘Does Training to Failure Maximize Muscle 
Hypertrophy?’ Strength and Conditioning Journal 41 (5), 108–113 
Schoffelen, P.F.M. and Plasqui, G. (2018) ‘Classical Experiments in Whole-Body 
Metabolism: Open-Circuit Respirometry—Diluted Flow Chamber, Hood, or Facemask 
Systems’.European Journal of Applied Physiology 118 (1), 33-49 
Schoffelen, P.F.M. and Westerterp, K.R. (2008) ‘Intra-Individual Variability and Adaptation of 
Overnight- and Sleeping Metabolic Rate’. Physiology and Behavior 94 (2), 158–163 
Schoffelen, P.F.M., Westerterp, K.R., Saris, W.H.M., and Ten Hoor, F. (1997) ‘A Dual-
Respiration Chamber System with Automated Calibration’. Journal of Applied 
Physiology 83 (6), 2064–2072 
Schrack, J.A., Cooper, R., Koster, A., Shiroma, E.J., Murabito, J.M., Rejeski, W.J., Ferrucci, 
L., and Harris, T.B. (2016a) ‘Assessing Daily Physical Activity in Older Adults: 
Unraveling the Complexity of Monitors, Measures, and Methods’. Journals of 
Gerontology - Series A Biological Sciences and Medical Sciences 71 (8), 1039–1048 
Schrack, J.A., Simonsick, E.M., Chaves, P.H.M., and Ferrucci, L. (2012) ‘The Role of 
 336 
Energetic Cost in the Age-related Slowing of Gait Speed’. Journal of the American 
Geriatrics Society 60 (10), 1811–1816 
Schrack, J.A., Simonsick, E.M., and Ferrucci, L. (2010) ‘The Energetic Pathway to Mobility 
Loss: An Emerging New Framework for Longitudinal Studies on Aging’. Journal of the 
American Geriatrics Society 58, 329–336 
Schrack, J.A., Zipunnikov, V., Simonsick, E.M., Studenski, S., and Ferrucci, L. (2016b) 
‘Rising Energetic Cost of Walking Predicts Gait Speed Decline with Aging’. Journals of 
Gerontology Series A: Biomedical Sciences and Medical Sciences 71 (7), 947–953 
Schuenke, M.D., Mikat, R.P., and McBride, J.M. (2002) ‘Effect of an Acute Period of 
Resistance Exercise on Excess Post-Exercise Oxygen Consumption: Implications for 
Body Mass Management’. European Journal of Applied Physiology 86 (5), 411–417 
Schulte, J.N. and Yarasheski, K.E. (2001) ‘Effects of Resistance Training on the Rate of 
Muscle Protein Synthesis in Frail Elderly People’. International Journal of Sport 
Nutrition and Exercise Metabolism 11 (1), 111–118 
Schutz, Y. (2018) ‘Respiration Chamber Calorimetry and Doubly Labeled Water: Two 
Complementary Aspects of Energy Expenditure?’ European Journal of Clinical Nutrition 
72 (9), 1310–1313 
Schutz, Y. (2011) ‘Protein Turnover, Ureagenesis and Gluconeogenesis’. International 
Journal for Vitamin and Nutrition Research 81 (2–3), 101–107 
Schwartz, R.S., Jaeger, L.F., and Veith, R.C. (1990) ‘The Thermic Effect of Feeding in Older 
Men: The Importance of the Sympathetic Nervous System’. Metabolism 39 (7), 733–
737 
Scott, D., de Courten, B., and Ebeling, P.R. (2016) ‘Sarcopenia: A Potential Cause and 
Consequence of Type 2 Diabetes in Australia’s Ageing Population?’ Medical Journal of 
Australia 205 (7), 329–333 
Scott, D., Cumming, R., Naganathan, V., Blyth, F., Le Couteur, D.G., Handelsman, D.J., 
Seibel, M., Waite, L.M., and Hirani, V. (2018) ‘Associations of Sarcopenic Obesity with 
the Metabolic Syndrome and Insulin Resistance over Five Years in Older Men: The 
Concord Health and Ageing in Men Project’. Experimental Gerontology 108, 99-105 
Seals, D.R., Justice, J.N., and LaRocca, T.J. (2016) ‘Physiological Geroscience: Targeting 
Function to Increase Healthspan and Achieve Optimal Longevity’. The Journal of 
Physiology 594 (8), 2001–2024 
Serper, M., Patzer, R.E., Curtis, L.M., Smith, S.G., O’Conor, R., Baker, D.W., and Wolf, M.S. 
(2014) ‘Health Literacy, Cognitive Ability, and Functional Health Status among Older 
Adults’. Health Services Research 49 (4), 1249–1267 
Shabani, R. and Izaddoust, F. (2018) ‘Effects of Aerobic Training, Resistance Training, or 
Both on Circulating Irisin and Myostatin in Untrained Women’. Acta Gymnica 48 (2), 
47–55 
Shafiee, G., Keshtkar, A., Soltani, A., Ahadi, Z., Larijani, B., and Heshmat, R. (2017) 
‘Prevalence of Sarcopenia in the World: A Systematic Review and Meta-Analysis of 
General Population Studies’. Journal of Diabetes & Metabolic Disorders 16 (1), 21 
Shahar, S., Kamaruddin, N.S., Badrasawi, M., Mohamed Sakian, N.I., Manaf, Z.A., Yassin, 
Z., and Joseph, L. (2013) ‘Effectiveness of Exercise and Protein Supplementation 
Intervention on Body Composition, Functional Fitness, and Oxidative Stress among 
Elderly Malays with Sarcopenia’. Clinical Interventions in Aging 8, 1365–1375 
Shakiba, E., Sheikholeslami-Vatani, D., Rostamzadeh, N., and Karim, H. (2019) ‘The Type 
of Training Program Affects Appetite-Regulating Hormones and Body Weight in 
Overweight Sedentary Men’. Applied Physiology, Nutrition, and Metabolism 44 (3), 
282–287 
Shen, W., Liu, H., Punyanitya, M., Chen, J., and Heymsfield, S.B. (2005) ‘Pediatric Obesity 
Phenotyping by Magnetic Resonance Methods’. Current Opinion in Clinical Nutrition 
and Metabolic Care 8 (6), 595–601 
Shim, J.-S., Oh, K., and Kim, H.C. (2014) ‘Dietary Assessment Methods in Epidemiologic        
Studies’. Epidemiology and Health 36, e2014009 
Shimokata, H., Muller, D.C., Fleg, J.L., Sorkin, J., Ziemba, A.W., and Andres, R. (1991) ‘Age 
 337 
as Independent Determinant of Glucose Tolerance’. Diabetes 40 (1), 44–51 
Shook, R.P., Hand, G.A., O’Connor, D.P., Thomas, D.M., Hurley, T.G., Hébert, J.R., 
Drenowatz, C., Welk, G.J., Carriquiry, A.L., and Blair, S.N. (2018) ‘Energy Intake 
Derived from an Energy Balance Equation, Validated Activity Monitors, and Dual X-Ray 
Absorptiometry Can Provide Acceptable Caloric Intake Data among Young Adults’. The 
Journal of Nutrition 148 (3), 490–496 
Sial, S., Coggan, A.R., Carroll, R., Goodwin, J., and Klein, S. (1996) ‘Fat and Carbohydrate 
Metabolism during Exercise in Elderly and Young Subjects’. American Journal of 
Physiology-Endocrinology And Metabolism 271 (6), 983–989 
Siervo, M., Lara, J., Celis-Morales, C., Vacca, M., Oggioni, C., Battezzati, A., Leone, A., 
Tagliabue, A., Spadafranca, A., and Bertoli, S. (2016) ‘Age-Related Changes in Basal 
Substrate Oxidation and Visceral Adiposity and Their Association with Metabolic 
Syndrome’. European Journal of Nutrition 55 (4), 1755–1767 
Singh, M.A.F., Ding, W., Manfredi, T.J., Solares, G.S., O’Neill, E.F., Clements, K.M., Ryan, 
N.D., Kehayias, J.J., Fielding, R.A., and Evans, W.J. (1999) ‘Insulin-like Growth Factor I 
in Skeletal Muscle after Weight-Lifting Exercise in Frail Elders’. American Journal of 
Physiology-Endocrinology And Metabolism 277 (1), 135–143 
Singh, M.A.F., Gates, N., Saigal, N., Wilson, G.C., Meiklejohn, J., Brodaty, H., Wen, W., 
Singh, N., Baune, B.T., and Suo, C. (2014) ‘The Study of Mental and Resistance 
Training (SMART) Study—Resistance Training and/or Cognitive Training in Mild 
Cognitive Impairment: A Randomized, Double-Blind, Double-Sham Controlled Trial’. 
Journal of the American Medical Directors Association 15 (12), 873–880 
Slag, M.F., Ahmed, M., Gannon, M.C., and Nuttall, F.Q. (1981) ‘Meal Stimulation of Cortisol 
Secretion: A Protein Induced Effect’. Metabolism 30 (11), 1104–1108 
Sluijs, I., Beulens, J.W.J., Spijkerman, A.M.W., Grobbee, D.E., and van der Schouw, Y.T. 
(2010) ‘Dietary Intake of Total, Animal, and Vegetable Protein and Risk of Type 2 
Diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-
NL Study’. Diabetes Care 33 (1), 43–48 
Smee, D.J., Anson, J.M., Waddington, G.S., and Berry, H.L. (2012) ‘Association between 
Physical Functionality and Falls Risk in Community-Living Older Adults’. Current 
Gerontology and Geriatrics Research 2012 
Smeets, A.J., Janssens, P.L.H.R., and Westerterp-Plantenga, M.S. (2013) ‘Addition of 
Capsaicin and Exchange of Carbohydrate with Protein Counteract Energy Intake 
Restriction Effects on Fullness and Energy Expenditure’. Journal of Nutrition 143 (4), 
442-447 
Smeuninx, B., Greig, C.A., and Breen, L. (2020) ‘Amount, Source and Pattern of Dietary 
Protein Intake Across the Adult Lifespan: A Cross-Sectional Study’. Frontiers in 
Nutrition 7, 25 
Smith, G.I., Julliand, S., Reeds, D.N., Sinacore, D.R., Klein, S., and Mittendorfer, B. (2015) 
‘Fish Oil-Derived n-3 PUFA Therapy Increases Muscle Mass and Function in Healthy 
Older Adults’. American Journal of Clinical Nutrition 102 (1), 115–122 
Smith, R.L., Soeters, M.R., Wüst, R.C.I., and Houtkooper, R.H. (2018) ‘Metabolic Flexibility 
as an Adaptation to Energy Resources and Requirements in Health and Disease’. 
Endocrine Reviews 39 (4), 489–517 
Smolarek, A. de C., Boiko Ferreira, L.H., Gomes Mascarenhas, L.P., McAnulty, S.R., Varela, 
K.D., Dangui, M.C., de Barros, M.P., Utter, A.C., and Souza-Junior, T.P. (2016) ‘The 
Effects of Strength Training on Cognitive Performance in Elderly Women’. Clinical 
Interventions in Aging 11, 749 
Snijders, T., Verdijk, L.B., McKay, B.R., Smeets, J.S.J., van Kranenburg, J., Groen, B.B.B., 
Parise, G., Greenhaff, P., and van Loon, L.J.C. (2014) ‘Acute Dietary Protein Intake 
Restriction Is Associated with Changes in Myostatin Expression after a Single Bout of 
Resistance Exercise in Healthy Young Men’. The Journal of Nutrition 144 (2), 137–145 
Soenen, S., Plasqui, G., Smeets, A.J., and Westerterp-Plantenga, M.. (2010) ‘Protein Intake 
Induced an Increase in Exercise Stimulated Fat Oxidation during Stable Body Weight’. 
Physiology & Behavior 101 (5), 770–774 
 338 
Sofi, F., Valecchi, D., Bacci, D., Abbate, R., Gensini, G.F., Casini, A., and Macchi, C. (2011) 
‘Physical Activity and Risk of Cognitive Decline: A Meta-analysis of Prospective 
Studies’. Journal of Internal Medicine 269 (1), 107–117 
Solerte, S.B., Gazzaruso, C., Bonacasa, R., Rondanelli, M., Zamboni, M., Basso, C., 
Locatelli, E., Schifino, N., Giustina, A., and Fioravanti, M. (2008) ‘Nutritional 
Supplements with Oral Amino Acid Mixtures Increases Whole-Body Lean Mass and 
Insulin Sensitivity in Elderly Subjects with Sarcopenia’. The American Journal of 
Cardiology 101 (11), 69–77 
Solomon, T.P.J., Marchetti, C.M., Krishnan, R.K., Gonzalez, F., and Kirwan, J.P. (2008) 
‘Effects of Aging on Basal Fat Oxidation in Obese Humans’. Metabolism 57 (8), 1141–
1147 
Sousa, A.C.P. de A., Marchand, A., Garcia, A., Gomez, J.F., Ylli, A., Guralnik, J.M., 
Zunzunegui, M.V., and Guerra, R.O. (2017) ‘Cortisol and Physical Performance in 
Older Populations: Findings from the International Mobility in Aging Study (IMIAS)’. 
Archives of Gerontology and Geriatrics 71, 50–58 
Sousa, A.S., Guerra, R.S., Fonseca, I., Pichel, F., Ferreira, S., and Amaral, T.F. (2016) 
‘Financial Impact of Sarcopenia on Hospitalization Costs’. European Journal of Clinical 
Nutrition 70 (9), 1046–1051 
Soysal, P., Bulut, E.A., Yavuz, I., and Isik, A.T. (2019) ‘Decreased Basal Metabolic Rate Can 
Be an Objective Marker for Sarcopenia and Frailty in Older Males’. Journal of the 
American Medical Directors Association 20 (1), 58–63 
Sparks, L.M., Johannsen, N.M., Church, T.S., Earnest, C.P., Moonen-Kornips, E., Moro, C., 
Hesselink, M.K.C., Smith, S.R., and Schrauwen, P. (2013) ‘Nine Months of Combined 
Training Improves Ex Vivo Skeletal Muscle Metabolism in Individuals with Type 2 
Diabetes’. The Journal of Clinical Endocrinology & Metabolism 98 (4), 1694–1702 
Speakman, J.R. and Selman, C. (2003) ‘Physical Activity and Resting Metabolic Rate’. 
Proceedings of the Nutrition Society 62 (3), 621–634 
St-Onge, M.P. (2005) ‘Relationship between Body Composition Changes and Changes in 
Physical Function and Metabolic Risk Factors in Aging’. Current Opinion in Clinical 
Nutrition and Metabolic Care 8 (5), 523-528 
St-Onge, M.P. and Gallagher, D. (2010) ‘Body Composition Changes with Aging: The Cause 
or the Result of Alterations in Metabolic Rate and Macronutrient Oxidation?’ Nutrition 26 
(2), 152–155 
Stec, M.J., Thalacker-Mercer, A., Mayhew, D.L., Kelly, N.A., Tuggle, C.S., Merritt, E.K., 
Brown, C.J., Windham, S.T., Dell’Italia, L.J., Bickel, S.C., Roberts, B.M., Vaughn, K.M., 
Isakova-Donahue, I., Many, G.M., and Bamman, M.M. (2017) ‘Randomized, Four-Arm, 
Dose-Response Clinical Trial to Optimize Resistance Exercise Training for Older Adults 
with Age-Related Muscle Atrophy’. Experimental Gerontology 99, 98-109 
Steib, S., Schoene, D., and Pfeifer, K. (2010) ‘Dose-Response Relationship of Resistance 
Training in Older Adults: A Meta-Analysis’. Medicine and Science in Sports and 
Exercise 42 (5), 902–914 
Stein, A.M., Silva, T.M.V., Coelho, F.G. de M., Arantes, F.J., Costa, J.L.R., Teodoro, E., and 
Santos-Galduróz, R.F. (2018) ‘Physical Exercise, IGF-1 and Cognition A Systematic 
Review of Experimental Studies in the Elderly’. Dementia & Neuropsychologia 12 (2), 
114–122 
Stough, C., Pipingas, A., Camfield, D., Nolidin, K., Savage, K., Deleuil, S., and Scholey, A. 
(2019) ‘Increases in Total Cholesterol and Low Density Lipoprotein Associated with 
Decreased Cognitive Performance in Healthy Elderly Adults’. Metabolic Brain Disease 
34 (2), 477–484 
Straight, C.R., Fedewa, M. V, Toth, M.J., and Miller, M.S. (2020) ‘Improvements in Skeletal 
Muscle Fiber Size with Resistance Training Are Age-Dependent in Older Adults: A 
Systematic Review and Meta-Analysis’. Journal of Applied Physiology 129 (2), 392–403 
Su, Y., Hirayama, K., Han, T., Izutsu, M., and Yuki, M. (2019) ‘Sarcopenia Prevalence and 
Risk Factors among Japanese Community Dwelling Older Adults Living in a Snow-
Covered City According to EWGSOP2’. Journal of Clinical Medicine 8 (3), 291 
 339 
Suetta, C., Frandsen, U., Jensen, L., Jensen, M.M., Jespersen, J.G., Hvid, L.G., Bayer, M., 
Petersson, S.J., Schrøder, H.D., and Andersen, J.L. (2012) ‘Aging Affects the 
Transcriptional Regulation of Human Skeletal Muscle Disuse Atrophy’. PloS one 7 (12), 
e51238 
Sugawara, K., Takahashi, H., Kashiwagura, T., Yamada, K., Yanagida, S., Homma, M., 
Dairiki, K., Sasaki, H., Kawagoshi, A., and Satake, M. (2012) ‘Effect of Anti-
Inflammatory Supplementation with Whey Peptide and Exercise Therapy in Patients 
with COPD’. Respiratory Medicine 106 (11), 1526–1534 
Suo, C., Singh, M.F., Gates, N., Wen, W., Sachdev, P., Brodaty, H., Saigal, N., Wilson, 
G.C., Meiklejohn, J., and Singh, N. (2016) ‘Therapeutically Relevant Structural and 
Functional Mechanisms Triggered by Physical and Cognitive Exercise’. Molecular 
Psychiatry 21 (11), 1633–1642 
Sutton, E.F., Bray, G.A., Burton, J.H., Smith, S.R., and Redman, L.M. (2016) ‘No Evidence 
for Metabolic Adaptation in Thermic Effect of Food by Dietary Protein’. Obesity 24 (8), 
1639–1642 
Taaffe, D.R., Duret, C., Wheeler, S., and Marcus, R. (1999) ‘Once-weekly Resistance 
Exercise Improves Muscle Strength and Neuromuscular Performance in Older Adults’. 
Journal of the American Geriatrics Society 47 (10), 1208–1214 
Tang, M., McCabe, G.P., Elango, R., Pencharz, P.B., Ball, R.O., and Campbell, W.W. (2014) 
‘Assessment of Protein Requirement in Octogenarian Women with Use of the Indicator 
Amino Acid Oxidation Technique’. The American Journal of Clinical Nutrition 99 (4), 
891–898 
Tarn, S.-Y. and Roth, R.H. (1997) ‘Mesoprefrontal Dopaminergic Neurons: Can Tyrosine 
Availability Influence Their Functions?’ Biochemical Pharmacology 53 (4), 441–453 
Tataranni, P.A., Larson, D.E., Snitker, S., and Ravussin, E. (1995) ‘Thermic Effect of Food in 
Humans: Methods and Results from Use of a Respiratory Chamber’. American Journal 
of Clinical Nutrition 61 (5), 1013-1019 
Taves, D.R. (2010) ‘The Use of Minimization in Clinical Trials’. Contemporary Clinical Trials 
31 (2), 180–184 
ten Haaf, D.S.M., Van Dongen, E.J.I., Nuijten, M.A.H., Eijsvogels, T.M.H., De Groot, L.C., 
and Hopman, M.T.E. (2018a) ‘Protein Intake and Distribution in Relation to Physical 
Functioning and Quality of Life in Community-Dwelling Elderly People: Acknowledging 
the Role of Physical Activity’. Nutrients 10 (4), 506 
ten Haaf, D.S.M., Eijsvogels, T.M.H., Bongers, C.C.W.G., Horstman, A.M.H., Timmers, S., 
de Groot, L.C.P.G.M., and Hopman, M.T.E. (2019) ‘Protein Supplementation Improves 
Lean Body Mass in Physically Active Older Adults: A Randomized Placebo-Controlled 
Trial’. Journal of Cachexia, Sarcopenia and Muscle 10 (2), 298-310 
ten Haaf, D.S.M., De Regt, M.F., Visser, M., Witteman, B.J.M., De Vries, J.H.M., Eijsvogels, 
T.M.H., and Hopman, M.T.E. (2018b) ‘Insufficient Protein Intake Is Highly Prevalent 
among Physically Active Elderly’. The Journal of Nutrition, Health & Aging 22 (9), 1112–
1114 
Teshome, E.M., Oriaro, V.S., Andango, P.E.A., Prentice, A.M., and Verhoef, H. (2018) 
‘Adherence to Home Fortification with Micronutrient Powders in Kenyan Pre-School 
Children: Self-Reporting and Sachet Counts Compared to an Electronic Monitoring 
Device’. BMC Public Health 18 (1), 205 
Teske, J.A., Billington, C.J., and Kotz, C.M. (2010) ‘Hypocretin/Orexin and Energy 
Expenditure’. Acta Physiologica 198 (3), 303–312 
Thomas, D.K., Quinn, M.A., Saunders, D.H., and Greig, C.A. (2016) ‘Protein 
Supplementation Does Not Significantly Augment the Effects of Resistance Exercise 
Training in Older Adults: A Systematic Review’. Journal of the American Medical 
Directors Association 17 (10), 959 
Thompson, F.E. and Subar, A.F. (2017) Dietary Assessment Methodology. in Nutrition in the 
Prevention and Treatment of Disease. ed. by Coulston, A. and Boshey, L., Ferruzini, M. 
and Delahanty, L. Massachusetts, USA: Academinc Press, 5–48 
Thomson, R.L., Brinkworth, G.D., Noakes, M., and Buckley, J.D. (2016) ‘Muscle Strength 
 340 
Gains during Resistance Exercise Training Are Attenuated with Soy Compared with 
Dairy or Usual Protein Intake in Older Adults: A Randomized Controlled Trial’. Clinical 
Nutrition 35 (1), 27-33 
Tian, S., Xu, Q., Jiang, R., Han, T., Sun, C., and Na, L. (2017) ‘Dietary Protein Consumption 
and the Risk of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Cohort 
Studies’. Nutrients 9 (9), 982 
Tieland, M., Borgonjen-Van Den Berg, K.J., Van Loon, L.J.C., and De Groot, L.C.P.G.M. 
(2012a) ‘Dietary Protein Intake in Community-Dwelling, Frail, and Institutionalized 
Elderly People: Scope for Improvement’. European Journal of Nutrition 51 (2), 173–179 
Tieland, M., Dirks, M.L., van der Zwaluw, N., Verdijk, L.B., van de Rest, O., de Groot, 
L.C.P.G.M., and van Loon, L.J.C. (2012b) ‘Protein Supplementation Increases Muscle 
Mass Gain During Prolonged Resistance-Type Exercise Training in Frail Elderly 
People: A Randomized, Double-Blind, Placebo-Controlled Trial’. Journal of the 
American Medical Directors Association 13 (8), 713–719 
Tieland, M., van de Rest, O., Dirks, M.L., van der Zwaluw, N., Mensink, M., van Loon, L.J.C., 
and de Groot, L.C.P.G.M. (2012c) ‘Protein Supplementation Improves Physical 
Performance in Frail Elderly People: A Randomized, Double-Blind, Placebo-Controlled 
Trial’. Journal of the American Medical Directors Association 13 (8), 720–726 
Tieland, M., Verdijk, L.B., de Groot, L.C., and van Loon, L.J.C. (2015) ‘Handgrip Strength 
Does Not Represent an Appropriate Measure to Evaluate Changes in Muscle Strength 
during an Exercise Intervention Program in Frail Older People’. International Journal of 
Sport Nutrition and Exercise Metabolism 25 (1), 27–36 
Tipton, K.D., Elliott, T.A., Cree, M.G., Aarsland, A.A., Sanford, A.P., and Wolfe, R.R. (2007) 
‘Stimulation of Net Muscle Protein Synthesis by Whey Protein Ingestion before and 
after Exercise’. American Journal of Physiology-Endocrinology and Metabolism, 71-76 
Tolea, M.I. and Galvin, J.E. (2015) ‘Sarcopenia and Impairment in Cognitive and Physical 
Performance’. Clinical Interventions in Aging 10, 663 
Tomeleri, C.M., Cavaglieri, C.R., de Souza, M.F., Cavalcante, E.F., Antunes, M., Nabbuco, 
H.C.G., Venturini, D., Barbosa, D.S., Silva, A.M., and Cyrino, E.S. (2018) ‘Phase Angle 
Is Related with Inflammatory and Oxidative Stress Biomarkers in Older Women’. 
Experimental Gerontology 102, 12–18 
Tomeleri, C.M., Ribeiro, A.S., Souza, M.F., Schiavoni, D., Schoenfeld, B.J., Venturini, D., 
Barbosa, D.S., Landucci, K., Sardinha, L.B., and Cyrino, E.S. (2016) ‘Resistance 
Training Improves Inflammatory Level, Lipid and Glycemic Profiles in Obese Older 
Women: A Randomized Controlled Trial’. Experimental Gerontology 84, 80–87 
Tosato, M., Marzetti, E., Cesari, M., Savera, G., Miller, R.R., Bernabei, R., Landi, F., and 
Calvani, R. (2017) ‘Measurement of Muscle Mass in Sarcopenia: From Imaging to 
Biochemical Markers’. Aging Clinical and Experimental Research 29 (1), 19–27 
Toth, M.J., Matthews, D.E., Tracy, R.P., and Previs, M.J. (2005) ‘Age-Related Differences in 
Skeletal Muscle Protein Synthesis: Relation to Markers of Immune Activation’. 
American Journal of Physiology-Endocrinology and Metabolism 288 (5), 883–891 
Tremblay, A., Sévigny, J., Leblanc, C., and Bouchard, C. (1983) ‘The Reproducibility of a 
Three-Day Dietary Record’. Nutrition Research 3 (6), 819–830 
Treuth, M.S., Hunter, G.R., Weinsier, R.L., and Kell, S.H. (1995) ‘Energy Expenditure and 
Substrate Utilization in Older Women after Strength Training: 24-h Calorimeter Results’. 
Journal of Applied Physiology 78 (6), 2140–2146 
Treuth, M.S., Ryan, A.S., Pratley, R.E., Rubin, M.A., Miller, J.P., Nicklas, B.J., Sorkin, J., 
Harman, S.M., Goldberg, A.P., and Hurley, B.F. (1994) ‘Effects of Strength Training on 
Total and Regional Body Composition in Older Men’. Journal of Applied Physiology 77 
(2), 614-620 
Trouwborst, I., Verreijen, A., Memelink, R., Massanet, P., Boirie, Y., Weijs, P., and Tieland, 
M. (2018) ‘Exercise and Nutrition Strategies to Counteract Sarcopenic Obesity’. 
Nutrients 10 (5), 605 
Tsai, C.-L., Ukropec, J., Ukropcová, B., and Pai, M.-C. (2018) ‘An Acute Bout of Aerobic or 
Strength Exercise Specifically Modifies Circulating Exerkine Levels and Neurocognitive 
 341 
Functions in Elderly Individuals with Mild Cognitive Impairment’. NeuroImage: Clinical 
17, 272–284 
Tsai, C.L., Wang, C.H., Pan, C.Y., and Chen, F.C. (2015) ‘The Effects of Long-Term 
Resistance Exercise on the Relationship between Neurocognitive Performance and 
GH, IGF-1, and Homocysteine Levels in the Elderly’. Frontiers in Behavioral 
Neuroscience 9, 23 
Tsai, C.L., Wang, C.H., Pan, C.Y., Chen, F.C., Huang, T.H., and Chou, F.Y. (2014) 
‘Executive Function and Endocrinological Responses to Acute Resistance Exercise’. 
Frontiers in Behavioral Neuroscience 8, 262 
Tulving, E. (2002) ‘Episodic Memory: From Mind to Brain’. Annual Review of Psychology 53, 
1-5 
Usui, C., Ando, T., Ohkawara, K., Miyake, R., Oshima, Y., Hibi, M., Oishi, S., Tokuyama, K., 
and Tanaka, S. (2015) ‘Validity and Reproducibility of a Novel Method for Timecourse 
Evaluation of Diet-Induced Thermogenesis in a Respiratory Chamber’. Physiological 
Reports 3 (5), e12410 
Valenti, G., Bonomi, A.G., and Westerterp, K.R. (2016) ‘Multicomponent Fitness Training 
Improves Walking Economy in Older Adults’. Medicine and Science in Sports and 
Exercise 48 (7), 1365–1370 
Van Dam, P.S., Aleman, A., De Vries, W.R., Deijen, J.B., Van der Veen, E.A., De Haan, 
E.H.F., and Koppeschaar, H.P.F. (2000) ‘Growth Hormone, Insulin-like Growth factor I 
and Cognitive Function in Adults’. Growth Hormone & IGF Research 10 (2), 69–73 
van de Rest, O., van der Zwaluw, N.L., and De Groot, L.C.P.G.M. (2013) ‘Literature Review 
on the Role of Dietary Protein and Amino Acids in Cognitive Functioning and Cognitive 
Decline’. Amino Acids 45 (5), 1035-1045 
van de Rest, O., van der Zwaluw, N.L., Tieland, M., Adam, J.J., Hiddink, G.J., van Loon, 
L.J.C., and de Groot, L.C.P.G.M. (2014) ‘Effect of Resistance-Type Exercise Training 
with or without Protein Supplementation on Cognitive Functioning in Frail and Pre-Frail 
Elderly: Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial’. 
Mechanisms of Ageing and Development 136, 85-93 
van der Zwaluw, N.L., van de Rest, O., Tieland, M., Adam, J.J., Hiddink, G.J., Van Loon, 
L.J.C., and De Groot, L.C.P.G.M. (2014) ‘The Impact of Protein Supplementation on 
Cognitive Performance in Frail Elderly’. European Journal of Nutrition 53 (3), 803-812 
van Hees, V.T., Renström, F., Wright, A., Gradmark, A., Catt, M., Chen, K.Y., Löf, M., Bluck, 
L., Pomeroy, J., Wareham, N.J., Ekelund, U., Brage, S., and Franks, P.W. (2011) 
‘Estimation of Daily Energy Expenditure in Pregnant and Non-Pregnant Women Using a 
Wrist-Worn Tri-Axial Accelerometer’. PloS one 6 (7), e22922 
Vaughan, L. and Giovanello, K. (2010) ‘Executive Function in Daily Life: Age-Related 
Influences of Executive Processes on Instrumental Activities of Daily Living.’ 
Psychology and Aging 25 (2), 343 
Vaughan, L., Zurlo, F., and Ravussin, E. (1991) ‘Aging and Energy Expenditure’. The 
American Journal of Clinical Nutrition 53 (4), 821–825 
Vega, S.R., Knicker, A., Hollmann, W., Bloch, W., and Strüder, H.K. (2010) ‘Effect of 
Resistance Exercise on Serum Levels of Growth Factors in Humans’. Hormone and 
Metabolic Research 42 (13), 982–986 
Veldhorst, M.A.B., Nieuwenhuizen, A.G., Hochstenbach-Waelen, A., Westerterp, K.R., 
Engelen, M.P.K.J., Brummer, R.J.M., Deutz, N.E.P., and Westerterp-Plantenga, M.S. 
(2009) ‘Effects of High and Normal Soyprotein Breakfasts on Satiety and Subsequent 
Energy Intake, Including Amino Acid and “satiety” Hormone Responses’. European 
Journal of Nutrition 48 (2), 92 
Veldhorst, M.A.B., Westerterp-Plantenga, M.S., and Westerterp, K.. (2009) 
‘Gluconeogenesis and Energy Expenditure after a High-Protein, Carbohydrate-Free 
Diet’. American Journal of Clinical Nutrition 90 (3), 519–526 
Veldhuis, J.D., Liem, A.Y., South, S., Weltman, A., Weltman, J., Clemmons, D.A., Abbott, R., 
Mulligan, T., Johnson, M.L., and Pincus, S. (1995) ‘Differential Impact of Age, Sex 
Steroid Hormones, and Obesity on Basal versus Pulsatile Growth Hormone Secretion 
 342 
in Men as Assessed in an Ultrasensitive Chemiluminescence Assay’. The Journal of 
Clinical Endocrinology & Metabolism 80 (11), 3209–3222 
Velho, S., Marques-Vidal, P., Baptista, F., and Camilo, M.E. (2008) ‘Dietary Intake Adequacy 
and Cognitive Function in Free-Living Active Elderly: A Cross-Sectional and Short-Term 
Prospective Study’. Clinical Nutrition 27 (1), 77–86 
Vellas, B., Andrieu, S., Sampaio, C., Coley, N., and Wilcock, G. (2008) ‘Endpoints for Trials 
in Alzheimer’s Disease: A European Task Force Consensus’. The Lancet Neurology 7 
(5), 436-450 
Vercambre, M.-N., Boutron-Ruault, M.-C., Ritchie, K., Clavel-Chapelon, F., and Berr, C. 
(2009) ‘Long-Term Association of Food and Nutrient Intakes with Cognitive and 
Functional Decline: A 13-Year Follow-up Study of Elderly French Women’. British 
Journal of Nutrition 102 (3), 419–427 
Verdijk, L.B., Jonkers, R.A.M., Gleeson, B.G., Beelen, M., Meijer, K., Savelberg, H.H.C.M., 
Wodzig, K.W.H.W., Dendale, P., and Van Loon, L.J.C. (2009a) ‘Protein 
Supplementation before and after Exercise Does Not Further Augment Skeletal Muscle 
Hypertrophy after Resistance Training in Elderly Men’. American Journal of Clinical 
Nutrition 89 (2), 608–616 
Verdijk, L.B., Van Loon, L., Meijer, K., and Savelberg, H.H.C.M. (2009b) ‘One-Repetition 
Maximum Strength Test Represents a Valid Means to Assess Leg Strength in Vivo in 
Humans’. Journal of Sports Sciences 27 (1), 59–68 
Verreijen, A.M., Engberink, M.F., Memelink, R.G., Van der Plas, S.E., Visser, M., and Weijs, 
P.J.M. (2017) ‘Effect of a High Protein Diet and/or Resistance Exercise on the 
Preservation of Fat Free Mass during Weight Loss in Overweight and Obese Older 
Adults: A Randomized Controlled Trial’. Nutrition Journal 16 (1), 1–8 
Verreijen, A.M., Verlaan, S., Engberink, M.F., Swinkels, S., de Vogel-van den Bosch, J., and 
Weijs, P.J.M. (2015) ‘A High Whey Protein–, Leucine-, and Vitamin D–Enriched 
Supplement Preserves Muscle Mass during Intentional Weight Loss in Obese Older 
Adults: A Double-Blind Randomized Controlled Trial’. The American Journal of Clinical 
Nutrition 101 (2), 279–286 
Vicennati, V., Ceroni, L., Gagliardi, L., Gambineri, A., and Pasquali, R. (2002) ‘Response of 
the Hypothalamic Pituitary-Adrenocortical Axis to High-Protein/Fat and High-
Carbohydrate Meals in Women with Different Obesity Phenotypes’. Journal of Clinical 
Endocrinology and Metabolism 87 (8), 3984–3988 
Visser, M., Deurenberg, P., van Staveren, W.A., and Hautvast, J.G.A.J. (1995) ‘Resting 
Metabolic Rate and Diet-Induced Thermogenesis in Young and Elderly Subjects: 
Relationship with Body Composition, Fat Distribution, and Physical Activity Level’. The 
American Journal of Clinical Nutrition 61 (4), 772–778 
Visser, M., Pahor, M., Taaffe, D.R., Goodpaster, B.H., Simonsick, E.M., Newman, A.B., 
Nevitt, M., and Harris, T.B. (2002) ‘Relationship of Interleukin-6 and Tumor Necrosis 
Factor-α with Muscle Mass and Muscle Strength in Elderly Men and Women: The 
Health ABC Study’. Journals of Gerontology - Series A Biological Sciences and Medical 
Sciences 57 (5), 326-332 
Vitale, G., Cesari, M., and Mari, D. (2016) ‘Aging of the Endocrine System and Its Potential 
Impact on Sarcopenia’. European Journal of Internal Medicine 35, 10–15 
Vitale, G., Salvioli, S., and Franceschi, C. (2013) ‘Oxidative Stress and the Ageing 
Endocrine System’. Nature Reviews Endocrinology 9 (4), 228–240 
Vizuete, A.A., Robles, F., Rodríguez-Rodríguez, E., López-Sobaler, A.M., and Ortega, R.M. 
(2010) ‘Association between Food and Nutrient Intakes and Cognitive Capacity in a 
Group of Institutionalized Elderly People’. European Journal of Nutrition 49 (5), 293–
300 
Voelcker-Rehage, C. and Niemann, C. (2013) ‘Structural and Functional Brain Changes 
Related to Different Types of Physical Activity across the Life Span’. Neuroscience and 
Biobehavioral Reviews 37 (9), 2268-2295 
Volpato, S., Bianchi, L., Cherubini, A., Landi, F., Maggio, M., Savino, E., Bandinelli, S., 
Ceda, G.P., Guralnik, J.M., and Zuliani, G. (2014) ‘Prevalence and Clinical Correlates 
 343 
of Sarcopenia in Community-Dwelling Older People: Application of the EWGSOP 
Definition and Diagnostic Algorithm’. Journals of Gerontology Series A: Biomedical 
Sciences and Medical Sciences 69 (4), 438–446 
Volpi, E., Kobayashi, H., Sheffield-Moore, M., Mittendorfer, B., and Wolfe, R.R. (2003) 
‘Essential Amino Acids Are Primarily Responsible for the Amino Acid Stimulation of 
Muscle Protein Anabolism in Healthy Elderly Adults’. American Journal of Clinical 
Nutrition 78 (2), 250–258 
Walker, K.A., Power, M.C., and Gottesman, R.F. (2017) ‘Defining the Relationship between 
Hypertension, Cognitive Decline, and Dementia: A Review’. Current Hypertension 
Reports 19 (3), 24 
Wall, B.T., Dirks, M.L., and van Loon, L.J.C. (2013) ‘Skeletal Muscle Atrophy during Short-
Term Disuse: Implications for Age-Related Sarcopenia’. Ageing Research Reviews 12 
(4), 898–906 
Wall, B.T., Dirks, M.L., Snijders, T., van Dijk, J.-W., Fritsch, M., Verdijk, L.B., and van Loon, 
L.J.C. (2016) ‘Short-Term Muscle Disuse Lowers Myofibrillar Protein Synthesis Rates 
and Induces Anabolic Resistance to Protein Ingestion’. American Journal of Physiology-
Endocrinology and Metabolism 310 (2), 137-147 
Wall, B.T., Dirks, M.L., Snijders, T., Senden, J.M.G., Dolmans, J., and Van Loon, L.J.C. 
(2014) ‘Substantial Skeletal Muscle Loss Occurs during Only 5 Days of Disuse’. Acta 
Physiologica 210 (3), 600–611 
Walsh, J.J., Scribbans, T.D., Bentley, R.F., Mikhail Kellawan, J., Gurd, B., and Tschakovsky, 
M.E. (2015) ‘Neurotrophic Growth Factor Responses to Lower Body Resistance 
Training in Older Adults’. Applied Physiology, Nutrition and Metabolism 41 (3), 315-323 
Wanderley, F.A.C., Moreira, A., Sokhatska, O., Palmares, C., Moreira, P., Sandercock, G., 
Oliveira, J., and Carvalho, J. (2013) ‘Differential Responses of Adiposity, Inflammation 
and Autonomic Function to Aerobic versus Resistance Training in Older Adults’. 
Experimental Gerontology 48 (3), 326–333 
Wang, A., Luan, H.H., and Medzhitov, R. (2019) ‘An Evolutionary Perspective on 
Immunometabolism’. Science 363 (6423) 
Wang, C.Y., Olson, S.L., and Protas, E.J. (2002) ‘Test-Retest Strength Reliability: Hand-
Held Dynamometry in Community-Dwelling Elderly Fallers’. Archives of Physical 
Medicine and Rehabilitation 83 (6), 811–815 
Wang, E., Nyberg, S.K., Hoff, J., Zhao, J., Leivseth, G., Tørhaug, T., Husby, O.S., Helgerud, 
J., and Richardson, R.S. (2017a) ‘Impact of Maximal Strength Training on Work 
Efficiency and Muscle Fiber Type in the Elderly: Implications for Physical Function and 
Fall Prevention’. Experimental Gerontology 91, 64–71 
Wang, J., Leung, K.-S., Chow, S.K.-H., and Cheung, W.-H. (2017b) ‘Inflammation and Age-
Associated Skeletal Muscle Deterioration (Sarcopaenia)’. Journal of Orthopaedic 
Translation 10, 94–101 
Wang, Z., Ying, Z., Bosy-Westphal, A., Zhang, J., Schautz, B., Later, W., Heymsfield, S.B., 
and Müller, M.J. (2010) ‘Specific Metabolic Rates of Major Organs and Tissues across 
Adulthood: Evaluation by Mechanistic Model of Resting Energy Expenditure’. The 
American Journal of Clinical Nutrition 92 (6), 1369–1377 
Wannamethee, S.G. and Atkins, J.L. (2015) ‘Muscle Loss and Obesity: The Health 
Implications of Sarcopenia and Sarcopenic Obesity’. Proceedings of the Nutrition 
Society 74 (4), 405–412 
Watanabe, T., Nomura, M., Nakayasu, K., Kawano, T., Ito, S., and Nakaya, Y. (2006) 
‘Relationships between Thermic Effect of Food, Insulin Resistance and Autonomic 
Nervous Activity’. Journal of Medical Investigation 53 (1–2), 153–158 
Waterlow, J.C. (1999) ‘The Mysteries of Nitrogen Balance’. Nutrition Research Reviews 12 
(1), 25–54 
Waters, D.L., Qualls, C.R., Dorin, R.I., Veldhuis, J.D., and Baumgartner, R.N. (2008) ‘Altered 
Growth Hormone, Cortisol, and Leptin Secretion in Healthy Elderly Persons with 
Sarcopenia and Mixed Body Composition Phenotypes’. Journals of Gerontology - 
Series A Biological Sciences and Medical Sciences 63 (5), 536–541 
 344 
Waters, D.L., Ward, A.L., and Villareal, D.T. (2013) ‘Weight Loss in Obese Adults 65 Years 
and Older: A Review of the Controversy’. Experimental Gerontology 48 (10), 1054-1061 
Webb, P., Saris, W.H.M., Schoffelen, P.F.M., Schenau, G.J.V.I., and Hoor, F. Ten (1988) 
‘The Work of Walking: A Calorimetric Study’. Medicine and Science in Sports and 
Exercise 20 (4), 331-337 
Weickert, M.O. (2012) ‘What Dietary Modification Best Improves Insulin Sensitivity and 
Why?’ Clinical Endocrinology 77 (4), 508–512 
Weickert, M.O., Roden, M., Isken, F., Hoffmann, D., Nowotny, P., Osterhoff, M., Blaut, M., 
Alpert, C., Gögebakan, Ö., and Bumke-Vogt, C. (2011) ‘Effects of Supplemented 
Isoenergetic Diets Differing in Cereal Fiber and Protein Content on Insulin Sensitivity in 
Overweight Humans’. The American Journal of Clinical Nutrition 94 (2), 459–471 
Weinheimer, E.M., Conley, T.B., Kobza, V.M., Sands, L.P., Lim, E., Janle, E.M., and 
Campbell, W.W. (2012) ‘Whey Protein Supplementation Does Not Affect Exercise 
Training-Induced Changes in Body Composition and Indices of Metabolic Syndrome in 
Middle-Aged Overweight and Obese Adults’. Journal of Nutrition 142 (8), 1532-1539 
Weinsier, R.L., Hunter, G.R., Desmond, R.A., Byrne, N.M., Zuckerman, P.A., and Darnell, 
B.E. (2002) ‘Free-Living Activity Energy Expenditure in Women Successful and 
Unsuccessful at Maintaining a Normal Body Weight’. The American Journal of Clinical 
Nutrition 75 (3), 499–504 
Weir, J.B. de V (1949) ‘New Methods for Calculating Metabolic Rate with Special Reference 
to Protein Metabolism’. The Journal of Physiology 109 (1–2), 1 
Welch, A.A., Hayhoe, R.P.G., and Cameron, D. (2020) ‘The Relationships between 
Sarcopenic Skeletal Muscle Loss during Ageing and Macronutrient Metabolism, Obesity 
and Onset of Diabetes’. Proceedings of the Nutrition Society 79 (1), 158–169 
Wersching, H., Duning, T., Lohmann, H., Mohammadi, S., Stehling, C., Fobker, M., Conty, 
M., Minnerup, J., Ringelstein, E.B., and Berger, K. (2010) ‘Serum C-Reactive Protein Is 
Linked to Cerebral Microstructural Integrity and Cognitive Function’. Neurology 74 (13), 
1022–1029 
West, D.W.D., Burd, N.A., Churchward-Venne, T.A., Camera, D.M., Mitchell, C.J., Baker, 
S.K., Hawley, J.A., Coffey, V.G., and Phillips, S.M. (2012) ‘Sex-Based Comparisons of 
Myofibrillar Protein Synthesis after Resistance Exercise in the Fed State’. Journal of 
Applied Physiology 112 (11), 1805–1813 
West, D.W.D., Burd, N.A., Coffey, V.G., Baker, S.K., Burke, L.M., Hawley, J.A., Moore, D.R., 
Stellingwerff, T., and Phillips, S.M. (2011) ‘Rapid Aminoacidemia Enhances Myofibrillar 
Protein Synthesis and Anabolic Intramuscular Signaling Responses after Resistance 
Exercise’. The American Journal of Clinical Nutrition 94 (3), 795–803 
Westcott, W.L. (2012) ‘Resistance Training Is Medicine: Effects of Strength Training on 
Health’. Current Sports Medicine Reports 11 (4), 209–216 
Westerterp-Plantenga, M.S., Lejeune, M.P.G.M., Smeets, A.J.P.G., and Luscombe-Marsh, 
N.D. (2009a) ‘Sex Differences in Energy Homeostatis Following a Diet Relatively High 
in Protein Exchanged with Carbohydrate, Assessed in a Respiration Chamber in 
Humans’. Physiology and Behavior 97 (3-4), 414-419 
Westerterp-Plantenga, M.S., Nieuwenhuizen, A., Tomé, D., Soenen, S., and Westerterp, 
K.R. (2009b) ‘Dietary Protein, Weight Loss, and Weight Maintenance’. Annual Review 
of Nutrition 29, 21-41 
Westerterp-Plantenga, M.S., Rolland, V., Wilson, S.A.J., and Westerterp, K.R. (1999) 
‘Satiety Related to 24 h Diet-Induced Thermogenesis during High Protein/Carbohydrate 
vs High Fat Diets Measured in a Respiration Chamber’. European Journal of Clinical 
Nutrition 53 (6), 495–502 
Westerterp, K.R. (2019) Measurement of Energy Expenditure. in Translational Research 
Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. ed. by Krentz, A., 
Weyer, C. and Hompesch, C. New York, USA: Springer, 101–119 
Westerterp, K.R. (2018a) ‘Changes in Physical Activity over the Lifespan: Impact on Body 
Composition and Sarcopenic Obesity’ Obesity Reviews 19, 8–13 
Westerterp, K.R. (2018b) ‘Exercise, Energy Balance and Body Composition’. European 
 345 
Journal of Clinical Nutrition 72 (9), 1246-1250 
Westerterp, K.R. (2018c) ‘Exercise, Energy Expenditure and Energy Balance, as Measured 
with Doubly Labelled Water’. Proceedings of the Nutrition Society 77 (1), 4-10 
Westerterp, K.R. (2013) ‘Physical Activity and Physical Activity Induced Energy Expenditure 
in Humans: Measurement, Determinants, and Effects’. Frontiers in Physiology 4, 90 
Westerterp, K.R. (2004) ‘Diet Induced Thermogenesis’. Nutrition & Metabolism 1 (1), 1–5 
Westerterp, K.R. (2000) ‘Daily Physical Activity and Ageing’. Current Opinion in Clinical 
Nutrition & Metabolic Care 3 (6), 485–488 
Westerterp, K.R. (1993) ‘Food Quotient, Respiratory Quotient, and Energy Balance’. The 
American Journal of Clinical Nutrition 57 (5), 759-765 
Westerterp, K.R. and Meijer, E.P. (2001) ‘Physical Activity and Parameters of Aging: A 
Physiological Perspective’. The Journals of Gerontology Series A: Biological Sciences 
and Medical Sciences 56 (2), 7–12 
Westerterp, K.R., Wilson, S.A.J., and Rolland, V. (1999) ‘Diet Induced Thermogenesis 
Measured over 24 h in a Respiration Chamber: Effect of Diet Composition’. 
International Journal of Obesity 23 (3), 287–292 
Weststrate, J.A. (1993) ‘Resting Metabolic Rate and Diet-Induced Thermogenesis: A 
Methodological Reappraisal’. The American Journal of Clinical Nutrition 58 (5), 592–
601 
White, T., Westgate, K., Wareham, N.J., and Brage, S. (2016) ‘Estimation of Physical 
Activity Energy Expenditure during Free-Living from Wrist Accelerometry in UK Adults’. 
PloS one 11 (12), e0167472 
White, T.A. and Lebrasseur, N.K. (2014) ‘Myostatin and Sarcopenia: Opportunities and 
Challenges - A Mini-Review’. Gerontology 60 (4), 289–293 
Wijsman, C.A., Van Heemst, D., Hoogeveen, E.S., Slagboom, P.E., Maier, A.B., De Craen, 
A.J.M., Van Der Ouderaa, F., Pijl, H., Westendorp, R.G.J., and Mooijaart, S.P. (2013) 
‘Ambulant 24-h Glucose Rhythms Mark Calendar and Biological Age in Apparently 
Healthy Individuals’. Aging Cell 12 (2), 207–213 
Wild, K., Howieson, D., Webbe, F., Seelye, A., and Kaye, J. (2008) ‘Status of Computerized 
Cognitive Testing in Aging: A Systematic Review’. Alzheimer’s and Dementia 4 (6), 
428-437 
Wilke, J., Giesche, F., Klier, K., Vogt, L., Herrmann, E., and Banzer, W. (2019) ‘Acute 
Effects of Resistance Exercise on Cognitive Function in Healthy Adults: A Systematic 
Review with Multilevel Meta-Analysis’. Sports Medicine 49 (6), 905-916 
Wilkinson, D.J., Franchi, M. V., Brook, M.S., Narici, M. V., Williams, J.P., Mitchell, W.K., 
Szewczyk, N.J., Greenhaff, P.L., Atherton, P.J., and Smith, K. (2014) ‘A Validation of 
the Application of D2O Stable Isotope Tracer Techniques for Monitoring Day-to-Day 
Changes in Muscle Protein Subfraction Synthesis in Humans’. American Journal of 
Physiology - Endocrinology and Metabolism 306 (5), 571-579 
Wilkinson, D.J., Piasecki, M., and Atherton, P.J. (2018) ‘The Age-Related Loss of Skeletal 
Muscle Mass and Function: Measurement and Physiology of Muscle Fibre Atrophy and 
Muscle Fibre Loss in Humans’. Ageing Research Reviews 47, 123–132 
Williams, M.A., Haskell, W.L., Ades, P.A., Amsterdam, E.A., Bittner, V., Franklin, B.A., 
Gulanick, M., Laing, S.T., and Stewart, K.J. (2007) ‘Resistance Exercise in Individuals 
with and without Cardiovascular Disease: 2007 Update: A Scientific Statement from the 
American Heart Association Council on Clinical Cardiology and Council on Nutrition, 
Physical Activity, and Metabolism’. Circulation 116 (5), 572–584 
Wilson, D., Jackson, T., Sapey, E., and Lord, J.M. (2017) ‘Frailty and Sarcopenia: The 
Potential Role of an Aged Immune System’. Ageing Research Reviews 36, 1–10 
Wimo, A., Guerchet, M., Ali, G.C., Wu, Y.T., Prina, A.M., Winblad, B., Jönsson, L., Liu, Z., 
and Prince, M. (2017) ‘The Worldwide Costs of Dementia 2015 and Comparisons with 
2010’. Alzheimer’s and Dementia 13 (1), 1-7 
Winett, R.A. and Carpinelli, R.N. (2001) ‘Potential Health-Related Benefits of Resistance 
Training’. Preventive Medicine 33 (5), 503–513 
Winter, E.M. and Fowler, N. (2009) ‘Exercise Defined and Quantified According to the 
 346 
Systeme International d’Unites’. Journal of Sports Sciences 27 (5), 447–460 
Wirth, J., Hillesheim, E., and Brennan, L. (2020) ‘The Role of Protein Intake and Its Timing 
on Body Composition and Muscle Function in Healthy Adults: A Systematic Review and 
Meta-Analysis of Randomized Controlled Trials’. The Journal of Nutrition 150 (6), 1443–
1460 
Witard, O.C., McGlory, C., Hamilton, D.L., and Phillips, S.M. (2016) ‘Growing Older with 
Health and Vitality: A Nexus of Physical Activity, Exercise and Nutrition’. Biogerontology 
17 (3), 529–546 
Withrow, D. and Alter, D.A. (2011) ‘The Economic Burden of Obesity Worldwide: A 
Systematic Review of the Direct Costs of Obesity’. Obesity Reviews 12 (2), 131–141 
Wolfe, R.R. (2006) ‘The Underappreciated Role of Muscle in Health and Disease’. The 
American Journal of Clinical Nutrition 84 (3), 475–482 
Wolfe, R.R. and Miller, S.L. (2008) ‘The Recommended Dietary Allowance of Protein: A 
Misunderstood Concept’. Jama 299 (24), 2891–2893 
Woods, S.P., Weinborn, M., Li, Y.R., Hodgson, E., Ng, A.R.J., and Bucks, R.S. (2015) ‘Does 
Prospective Memory Influence Quality of Life in Community-Dwelling Older Adults?’ 
Aging, Neuropsychology, and Cognition 22 (6), 679-692 
World Health Organisation (2019) Dementia [online] available from 
<https://www.who.int/news-room/fact-sheets/detail/dementia> [7 May 2020] 
World Health Organisation (2018) Ageing and Health [online] available from 
<https://www.who.int/news-room/fact-sheets/detail/ageing-and-health> [7 May 2020] 
Wright, C.S., Zhou, J., Sayer, R.D., Kim, J.E., and Campbell, W.W. (2018) ‘Effects of a High-
Protein Diet Including Whole Eggs on Muscle Composition and Indices of 
Cardiometabolic Health and Systemic Inflammation in Older Adults with Overweight or 
Obesity: A Randomized Controlled Trial’. Nutrients 10 (7), 946 
Wysokiński, A., Sobów, T., Kłoszewska, I., and Kostka, T. (2015) ‘Mechanisms of the 
Anorexia of Aging—a Review’. Age 37 (4), 81 
Xia, Z., Cholewa, J., Zhao, Y., Shang, H.-Y., Yang, Y.-Q., Araújo Pessôa, K., Su, Q.-S., 
Lima-Soares, F., and Zanchi, N.E. (2017) ‘Targeting Inflammation and Downstream 
Protein Metabolism in Sarcopenia: A Brief up-Dated Description of Concurrent Exercise 
and Leucine-Based Multimodal Intervention’. Frontiers in Physiology 8, 434 
Xu, X., Jerskey, B.A., Cote, D.M., Walsh, E.G., Hassenstab, J.J., Ladino, M.E., Clark, U.S., 
Labbe, D.R., Gunstad, J.J., and Poppas, A. (2014) ‘Cerebrovascular Perfusion among 
Older Adults Is Moderated by Strength Training and Gender’. Neuroscience Letters 
560, 26–30 
Xue, Q.-L., Bandeen-Roche, K., Mielenz, T.J., Seplaki, C.L., Szanton, S.L., Thorpe, R.J., 
Kalyani, R.R., Chaves, P.H.M., Dam, T.-T.L., and Ornstein, K. (2012) ‘Patterns of 12-
Year Change in Physical Activity Levels in Community-Dwelling Older Women: Can 
Modest Levels of Physical Activity Help Older Women Live Longer?’ American Journal 
of Epidemiology 176 (6), 534–543 
Yamada, M., Kimura, Y., Ishiyama, D., Nishio, N., Otobe, Y., Tanaka, T., Ohji, S., Koyama, 
S., Sato, A., and Suzuki, M. (2019) ‘Synergistic Effect of Bodyweight Resistance 
Exercise and Protein Supplementation on Skeletal Muscle in Sarcopenic or Dynapenic 
Older Adults’. Geriatrics & Gerontology International 19 (5), 429–437 
Yang, J., Chi, Y., Burkhardt, B.R., Guan, Y., and Wolf, B.A. (2010) ‘Leucine Metabolism in 
Regulation of Insulin Secretion from Pancreatic Beta Cells’. Nutrition Reviews 68 (5), 
270-279 
Yang, N.-P., Hsu, N.-W., Lin, C.-H., Chen, H.-C., Tsao, H.-M., Lo, S.-S., and Chou, P. 
(2018) ‘Relationship between Muscle Strength and Fall Episodes among the Elderly: 
The Yilan Study, Taiwan’. BMC Geriatrics 18 (1), 90 
Yang, Y., Breen, L., Burd, N.A., Hector, A.J., Churchward-Venne, T.A., Josse, A.R., 
Tarnopolsky, M.A., and Phillips, S.M. (2012a) ‘Resistance Exercise Enhances 
Myofibrillar Protein Synthesis with Graded Intakes of Whey Protein in Older Men’. 
British Journal of Nutrition 108 (10), 1780–1788 
Yang, Y., Churchward-Venne, T.A., Burd, N.A., Breen, L., Tarnopolsky, M.A., and Phillips, 
 347 
S.M. (2012b) ‘Myofibrillar Protein Synthesis Following Ingestion of Soy Protein Isolate 
at Rest and after Resistance Exercise in Elderly Men’. Nutrition and Metabolism 9 (1), 
1-9 
Yarasheski, K.E., Bhasin, S., Sinha-Hikim, I., Pak-Loduca, J., and Gonzalez-Cadavid, N.F. 
(2002) ‘Serum Myostatin-Immunoreactive Protein Is Increased in 60-92 Year Old 
Women and Men with Muscle Wasting’. Journal of Nutrition, Health and Aging 6 (5), 
343–348 
Yarrow, J.F., White, L.J., McCoy, S.C., and Borst, S.E. (2010) ‘Training Augments 
Resistance Exercise Induced Elevation of Circulating Brain Derived Neurotrophic 
Factor (BDNF)’. Neuroscience Letters 479 (2), 161–165 
Yasuda, J., Tomita, T., Arimitsu, T., and Fujita, S. (2020) ‘Evenly Distributed Protein Intake 
over 3 Meals Augments Resistance Exercise–Induced Muscle Hypertrophy in Healthy 
Young Men’. The Journal of Nutrition 150 (7), 1845-1851 
Yasutake, C., Kuroda, K., Yanagawa, T., and Okamura, T. (2006) ‘Serum BDNF, TNF-Alpha 
and IL-1beta Levels 462 in Dementia Patients: Comparison between Alzheimer’s 463 
Disease and Vascular Dementia’. Eur Arch Psychiatry Clin 464 Neurosci 256, 402–406 
Yoon, D.H., Lee, J.Y., and Song, W. (2018) ‘Effects of Resistance Exercise Training on 
Cognitive Function and Physical Performance in Cognitive Frailty: A Randomized 
Controlled Trial’. Journal of Nutrition, Health and Aging 22 (8), 944-951 
Yoshimura, Y., Wakabayashi, H., Yamada, M., Kim, H., Harada, A., and Arai, H. (2017) 
‘Interventions for Treating Sarcopenia: A Systematic Review and Meta-Analysis of 
Randomized Controlled Studies’. Journal of the American Medical Directors Association 
18 (6), 553 
Yu, H., Zhang, Z., Shi, Y., Bai, F., Xie, C., Qian, Y., Yuan, Y., and Deng, L. (2008) 
‘Association Study of the Decreased Serum BDNF Concentrations in Amnestic Mild 
Cognitive Impairment and the Val66Met Polymorphism in Chinese Han.’ The Journal of 
Clinical Psychiatry 69 (7), 1104–1111 
Zajac, I.T., Herreen, D., Bastiaans, K., Dhillon, V.S., and Fenech, M. (2019) ‘The Effect of 
Whey and Soy Protein Isolates on Cognitive Function in Older Australians with Low 
Vitamin B 12 : A Randomised Controlled Crossover Trial’. Nutrients 11 (1), 19 
Zanker, J., Scott, D., Reijnierse, E.M., Brennan-Olsen, S.L., Daly, R.M., Girgis, C.M., 
Grossmann, M., Hayes, A., Henwood, T., Hirani, V., Inderjeeth, C.A., Iuliano, S., 
Keogh, J.W.L., Lewis, J.R., Maier, A.B., Pasco, J.A., Phu, S., Sanders, K.M., Sim, M., 
Visvanathan, R., Waters, D.L., Yu, S.C.Y., and Duque, G. (2019) ‘Establishing an 
Operational Definition of Sarcopenia in Australia and New Zealand: Delphi Method 
Based Consensus Statement’. Journal of Nutrition, Health and Aging 23 (1), 105-110 
Zdzieblik, D., Oesser, S., Baumstark, M.W., Gollhofer, A., and König, D. (2015) ‘Collagen 
Peptide Supplementation in Combination with Resistance Training Improves Body 
Composition and Increases Muscle Strength in Elderly Sarcopenic Men: A Randomised 
Controlled Trial’. British Journal of Nutrition 114 (8), 1237–1245 
Zhang, X.-W., Hou, W.-S., Li, M., and Tang, Z.-Y. (2016) ‘Omega-3 Fatty Acids and Risk of 
Cognitive Decline in the Elderly: A Meta-Analysis of Randomized Controlled Trials’. 
Aging Clinical and Experimental Research 28 (1), 165–166 
Zhang, Y., Chen, C., Choi, H., Chaisson, C., Hunter, D., Niu, J., and Neogi, T. (2012) 
‘Purine-Rich Foods Intake and Recurrent Gout Attacks’. Annals of the Rheumatic 
Diseases 71 (9), 1448–1453 
Zheng, G., Xia, R., Zhou, W., Tao, J., and Chen, L. (2016) ‘Aerobic Exercise Ameliorates 
Cognitive Function in Older Adults with Mild Cognitive Impairment: A Systematic 
Review and Meta-Analysis of Randomised Controlled Trials’. British Journal of Sports 
Medicine 50 (23), 1443-1450 
Zhu, K., Kerr, D.A., Meng, X., Devine, A., Solah, V., Binns, C.W., and Prince, R.L. (2015) 
‘Two-Year Whey Protein Supplementation Did Not Enhance Muscle Mass and Physical 
Function in Well-Nourished Healthy Older Postmenopausal Women’. The Journal of 
Nutrition 145 (11), 2520–2526 
Zhu, K., Meng, X., Kerr, D.A., Devine, A., Solah, V., Binns, C.W., and Prince, R.L. (2011) 
 348 
‘The Effects of a Two-year Randomized, Controlled Trial of Whey Protein 
Supplementation on Bone Structure, IGF-1, and Urinary Calcium Excretion in Older 
Postmenopausal Women’. Journal of Bone and Mineral Research 26 (9), 2298–2306 
Ziaaldini, M.M., Marzetti, E., Picca, A., and Murlasits, Z. (2017) ‘Biochemical Pathways of 
Sarcopenia and Their Modulation by Physical Exercise: A Narrative Review’. Frontiers 
in Medicine 4, 167 
Ziegenhorn, A.A., Schulte-Herbrüggen, O., Danker-Hopfe, H., Malbranc, M., Hartung, H.-D., 
Anders, D., Lang, U.E., Steinhagen-Thiessen, E., Schaub, R.T., and Hellweg, R. (2007) 
‘Serum Neurotrophins—a Study on the Time Course and Influencing Factors in a Large 
Old Age Sample’. Neurobiology of Aging 28 (9), 1436–1445 
Zurlo, F., Lillioja, S., Esposito-Del Puente, A., Nyomba, B.L., Raz, I., Saad, M.F., Swinburn, 
B.A., Knowler, W.C., Bogardus, C., and Ravussin, E. (1990) ‘Low Ratio of Fat to 
Carbohydrate Oxidation as Predictor of Weight Gain: Study of 24-h RQ’. American 
Journal of Physiology-Endocrinology And Metabolism 259 (5), 650–657 
Zygouris, S. and Tsolaki, M. (2015) ‘Computerized Cognitive Testing for Older Adults: A 














































































































































Effects of 12 weeks resistance training and whey protein supplementation on 
multiple indices of sarcopenia in older men 
 
This is to certify that the above named applicant has completed the Coventry 
University Ethical Approval process and their project has been confirmed and 




Date of approval: 
    31 August 2017 
 












































Some content has been removed on data protection grounds
 354 
 
































Participant Information Sheet (Version 3.0) 
 
Study title: Effects of 12 weeks resistance exercise and whey protein supplementation 
on multiple indices of sarcopenia in older men 
 
You are being invited to take part in a research study. Before you decide, it is important for 
you to understand why the research is being done and what it will involve. Please take time 
to read the following information carefully and discuss it with others if you wish. Ask us if 
there is anything that is not clear, or if you would like more information please do not 
hesitate to contact us. 
 
Principle Investigator: Corbin Griffen (PhD Student, Centre for Applied Biological & Exercise 
Sciences, Coventry University) 
 
Other scientists working on the study: Professor Derek Renshaw (Professor of 
Translational Physiology, Coventry University), Dr John Hattersley (Head of Human 
Metabolism Research Unit, University Hospitals Coventry & Warwickshire) and Professor 
Michael Duncan (Professor of Sport and Exercise Science, Coventry University). 
 
What is the study about?  
This study will investigate whether participating in twice weekly supervised resistance exercise 
(weighted exercise) and increasing protein intake (through twice daily supplementation), for 
12 weeks has beneficial effects on multiple measurements related to sarcopenia. Sarcopenia 
is defined as the loss of muscle mass, strength and reduction in the ability to perform everyday 











Why is this study important? 
After the age of 50, individuals lose between 0.5-1% of their muscle mass and 3% of their 
muscle strength each year. Over time, these losses can lead to sarcopenia, which affects 
approximately 10% of individuals over the age of 60 years globally. Sarcopenia has been 
associated with an increased risk of falls, cardiovascular disease, type 2 diabetes, 
hospitalisation and a reduction in cognitive function. This highlights the need for research on 
interventions which can slow the rate of muscle loss due to ageing. Both resistance exercise 
and increasing daily protein intake are two strategies shown to improve outcomes related to 
sarcopenia in older adults. However, further research investigating the combined effects of 
resistance exercise and increasing protein intake on multiple outcomes related to sarcopenia 
is required. 
What is still unclear is: 
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• IF the effects of combined resistance exercise and increasing protein intake improves 
multiple outcomes related to sarcopenia?  
• HOW these benefits occur? 
• WHETHER the effects of combined resistance exercise and increasing protein intake 
improves metabolic health and cognitive function? 
 
We’d like your help to find this out. 
 
Who can enter the study? 
We are looking for 52 men who are aged between 60 and 80 years.  
 
Unfortunately, you will NOT be able to volunteer for this study if:  
• You are a current smoker or ex-smoker who ceased smoking less than 6 months ago 
• Your body mass index (BMI) is less than 18.5 kg/m2 (underweight) or greater than 30 
kg/m2 (obese)  
• You currently participate in resistance exercise (using weights) regularly  
• You are not weight stable (lost or gained more than 3 kg in the last 6 months)  
• You are currently, or have previously taken part in another research project within the 
last 6 months involving a dietary and/or exercise intervention 
• You are currently taking protein or amino acid supplements 
• Your GP has told you that you have a disease related to your heart, kidneys, lungs, 
gut, blood, brain, thyroid, or have been diagnosed with cancer or diabetes 
• You are predisposed to gout, or have a recent history of gout within the last 2 years  
• You have high blood pressure which is not controlled  
• You are prescribed (daily) non-steroidal anti-inflammatory medication, hormonal 
medication, cholesterol lowering medication, diabetic medication, or beta blockers  
• You are lactose intolerant or allergic to wheat or potatoes  
• You have a history of falls  
• You have muscular disorders or injuries, or are unable to walk unaided  
 
We will check your eligibility for the study by asking you to complete a health and 
lifestyle questionnaire. However, if you are in doubt about whether or not you are 
suitable to volunteer, please do not hesitate in contacting the principal investigator of 
the study. 
 
What do we aim to do? 
Our aim is to determine whether participating in supervised resistance exercise twice a week, 
in addition to consuming a 25 g whey protein supplement immediately after breakfast and 
lunch daily for 12 weeks has beneficial effects on muscle mass, strength and physical, 
metabolic and cognitive function in men aged 60-80 years. We will also assess a number of 
markers found in blood and saliva that are linked to sarcopenia and metabolism.  
 
Our study design will help us to understand whether combining resistance exercise and 
increasing protein intake is more beneficial to our study outcomes than participating in 
resistance exercise alone, increasing protein intake alone or not altering physical activity 
levels or daily protein intake.  
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Therefore, if you are eligible for this study, you will be allocated to one of the following four 
groups: 
 
1. Resistance exercise and protein supplementation  
The resistance exercise and whey protein supplementation group will perform 
supervised resistance exercise two times per week for between 45-60 minutes in 
duration for 12 weeks. Participants randomised to this group will also be required to 
consume a 25 g powdered whey protein supplement to be consumed after breakfast 
and lunch daily for 12 weeks. 
 
2. Resistance exercise and placebo supplementation 
The resistance exercise and placebo supplementation group will perform supervised 
resistance exercise two times per week for between 45-60 minutes in duration for 12 
weeks. Participants randomised to this group will also be required to consume 23.75 
g of placebo powder (containing no protein) to be consumed immediately after 
breakfast and lunch daily for 12 weeks.  
 
3. Protein supplementation only  
The protein supplementation only group will be required to consume a 25 g powdered 
whey protein supplement to be consumed immediately after breakfast and lunch daily 
for the 12-week intervention. 
 
4. Control group  
The control group will be required to consume 23.75 g of placebo powder (containing 
no protein) to be consumed immediately after breakfast and lunch daily for the 12-
week intervention. 
 
The test foods used in this study will appear and taste similar. We will provide recipes of how 
to consume your test foods, but you will be given freedom to choose to your own particular 
taste. You will be randomly allocated to one of these groups and, you will therefore be unable 
to request which group you will be allocated to. We will ask that you do not change your 
normal physical activity and dietary habits throughout the study. 
 
What do I have to do? 
You will be asked to attend visits at Coventry University and University Hospitals Coventry & 
Warwickshire Human Metabolism Research Unit on 4 occasions (in total) during the study. 
We will send you maps and information of where each visit will take place.  
 
• Visit 1: Metabolic assessment (Human Metabolism Research Unit, University 
Hospitals Coventry & Warwickshire) - at the beginning of the study  
• Visit 2: Strength and functional performance testing (Coventry University) – at the 
beginning of the study 
• Visit 3: Metabolic assessment (Human Metabolism Research Unit, University 
Hospitals Coventry & Warwickshire) – after the 12-week intervention  
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• Visit 4: Strength and functional performance testing (Coventry University) – after the 
12-week intervention 
 
You will be required to avoid strenuous exercise 48 hours before each testing visit. Parking at 
University Hospitals Coventry & Warwickshire will be covered by the Human Metabolism 
Research Unit and free parking will also be available for visits to Coventry University. 
 
In addition to the above testing visits, if you are randomised to either of the resistance exercise 
groups, you will be required to attend Coventry University two times per week for 12 weeks 
for supervised resistance exercise sessions with a qualified gym instructor.  
 
The measurements that will be taken during the study are detailed below.  
 
Strength and Functional Performance Assessment (Coventry University) 
 
The following assessments will be taken at each strength and functional performance testing 
visit. 
 
• Body composition – You will be asked to stand on a plate which will assess your 
total muscle and fat mass. 
• Handgrip strength – You will be asked to sit on a chair and grip a handgrip 
dynamometer as hard as you can for no more than 5 seconds.  
• Muscle strength – You will be asked to perform a strength test on your legs 
• Short Physical Performance Battery – You will be asked to perform 3 different tests. 
These will include: 
- Time to rise from a chair and return 5 times 
- Normal walking speed over 4 metres   
- 3 different balance tests including feet together and feet apart.  
• 6-meter usual walking speed – You will be timed walking 6 meters at your normal 
walking speed twice.  
• 6-minute walk test – You will walk at your normal walking speed for 6 minutes. 
• Questionnaires – During the study duration we will ask you to complete 
questionnaires assessing your physical activity levels and dietary patterns. 
• Physical Activity Monitor – We will ask you to wear an accelerometer for 7 days 
(which looks like a watch on your wrist). 
Metabolic assessment (Human Metabolism Research Unit, University Hospitals 
Coventry and Warwickshire NHS Trust)  
You will be required to stay in a whole-body calorimeter for 24 hours to enable measurement 
of a number of markers related to metabolic health and sarcopenia. Research staff will be 
present within the unit throughout the day, and nursing staff will check hourly throughout the 
night. Before entering the calorimeter, we will assess your muscle content by asking you to sit 
inside a small pod. For this assessment, tight clothing (e.g. cycling shorts or swimming trunks) 
and a cap will be required to be worn. 
Calorimeters are “bedsit” style rooms; each has a desk, chair, fold-down bed, toilet, sink, 
telephone and an internet connected computer/television. There is an intercom to speak to 
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the resident in the second room, as well as the staff in the containing laboratory. The rooms 
have 3 windows; 1 with an outside view, 1 to the neighbouring room and 1 in the door facing 
the researchers. There are three 2-way hatches that are air locked which are used for passing 
food/personal items, samples and taking blood tests. The unit is situated within the heart of 
the University Hospitals Coventry & Warwickshire, next to a 24-hour ward with the full security 
and medical safety. 
You will be left to live freely within the calorimeter with the exception of set times for meals, 
light exercise, blood and saliva collection, cognitive function tests and rest. All meals will be 
provided to you by the research team. Unrestricted access to drinking water will be provided; 
however, no alcohol, tea, coffee or other caffeinated beverages will be allowed to be 
consumed as these may affect the study outcomes. Fruit teas are allowed to be consumed 
and will be provided by the unit. 
Before entering the calorimeter, a qualified nurse will insert a cannula into a suitable vein for 
repeated blood samples to measure markers related to both metabolic health and sarcopenia 
over the 24 hours. Approximately 115 ml (22 teaspoons) of blood will be taken from the 
cannula at each 24-hour visit. You will also be asked to wear a continuous glucose monitor to 




Whole-body calorimeter at the Human Metabolism 
Research Unit, University Hospitals Coventry & 





During the metabolic assessment, you will also be asked to perform a battery of cognitive tests 
which will assess your reaction time and how you process tasks. The test will last for 
approximately 30-40 minutes on a tablet device. 
Please note, only 40 out of the final 52 participants will complete the 24-hour metabolic 
assessment for this study. Priority will be given to the first 40 participants. Participants who do 
not perform the 24-hour metabolic assessment will be required to attend a 3-hour visit at 
University Hospitals Coventry and Warwickshire NHS trust for a fasted blood test, a muscle 
mass measurement and a cognitive function test.  
What are the benefits of taking part? 
We cannot guarantee that taking part in this study will benefit you individually. However, we 
hope that the results of this study will inform guidelines of an intervention that can slow the 
rate of muscle loss in men aged 60-80 years. Through taking part in this study, you will receive 
a thorough examination of your metabolic health and performance of a range of 
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exercise/functional performance tests in relation to the general population by exercise and 
metabolism specialists. The metabolic assessment will use a state-of-the-art scientific 
instrument, which is only available in two locations in the UK. This data will be provided to you 
in the form of a mini health MOT form at the end of the study. Participants randomised to the 
exercise intervention will also receive free supervised exercise sessions at Coventry 
University gym by a qualified exercise professional. All participants who complete the 12-week 
study will also receive a £20 Waterstones voucher as a thank you for participating. 
Are there any side effects or risks of taking part in the study? 
The protein and placebo supplements used in this study will be provided by commercial and 
reputable companies and are fit for human consumption. Both the protein and placebo 
supplements will be given in a dose that can be achieved from your normal diet (95 kcal per 
supplement). In this respect, we do not anticipate any side effects. The supplements may 
contain very small traces of egg, gluten, soy and milk as they are produced in laboratories 
with other nutritional products. Therefore, if you are highly sensitive to these, we recommend 
you do not participate in this study.  
The exercise sessions will be conducted in accordance with guidelines set by the American 
College of Sports Medicine (ACSM) for older adults. There is a potential risk of injury and 
discomfort from participating in resistance exercise. These risks will be minimised thorough 
familiarisation of each exercise, warm up and cool down procedures before and after each 
session, monitoring of your perceived exertion and supervision of all exercise sessions by 
qualified exercise professionals. 
The continuous glucose monitor fitted during the metabolic assessment is a minimally invasive 
device that is attached to the skin; there is a small risk of skin irritation from the adhesive 
plaster and minor discomfort from a number of finger pricks to calibrate the device. It is normal 
that you may feel some discomfort whilst a blood sample is taken, and the cannula is inserted, 
and there is a slight risk of bruising. Only experienced nursing staff and trained research 
scientists will conduct cannulation and blood drawing to minimises these risks. 
Will my details be confidential? 
Any personal information (e.g., name, address, contact details) supplied by you during the 
study, will be handled by trained research staff and will be treated as strictly confidential (e.g. 
stored in locked filing cabinets, within a room with restricted access). All participants will be 
assigned a random 3-digit number when enrolled onto the study, and all paperwork, samples 
and results related to the study will be coded with this number to protect your identity.  
Do I have to take part? 
It is up to you to decide whether or not to take part. If you decide to take part, you are still free 
to withdraw at any time and without giving a reason. If you chose not to take part in the study, 
or withdraw from the study at any time, this will not affect your future healthcare. An expression 
of interest does not commit you to participation. 
 
What will happen to the results of the research study? 
The results of this research study will be published in scientific journals and presented at 
national and international scientific conferences. You will not be identified personally in any 
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output related to this study and you will be provided with a summary of the research findings 
after the data has been analysed.  
 
Who has reviewed this study?  
This study has been reviewed and approved by the Ethics Committee at Coventry University 
and by Research & Development at University Hospitals Coventry & Warwickshire NHS Trust. 
The procedures in place for the study adhere to the Code of Conduct of the British Association 
of Sport and Exercise Sciences. 
What if I have more questions?  
If you have any further questions please get in touch with the principal researcher for the study, 
Corbin Griffen, e-mail: griffenc@uni.coventry.ac.uk or telephone    
What happens next? 
If you would like to proceed with the study, please complete the health and lifestyle 
questionnaire attached and return via email to griffenc@uni.coventry.ac.uk.  























































Informed Consent Form 
 
Volunteer study ID: 
 
Study title:  Effects of 12 weeks resistance training and whey protein supplementation on 
multiple indices of sarcopenia in older men 
    Please initial 
 




2. I have been given the opportunity to ask questions about the study 
and my participation. 
 
3. I understand that my participation is voluntary and that I am free to 




4. I understand that all the information I provide will be treated in 
confidence. I understand that any data gained may be used in scientific 
publication but that the data will be anonymous. 
 





(Name in BLOCK Letters:): 
…………………………………………………………………………………….. 
 
Signature of volunteer  ………………………………………………………………. 
 
 D D M M M Y Y Y Y 
DATE:          















Scientist/researcher taking consent (I confirm that the volunteer above has been given a full 
verbal and written explanation of the study) 
Name of researcher (PRINT): ………………………………………………….. 
Signature of researcher: ……………………………………....................... 
 D D M M M Y Y Y Y 
DATE:          
E.g. 0 1 J A N 2 0 1 7 
 
PLEASE PROVIDE A PHOTOCOPY OF THIS SHEET TO THE PARTICIPANT AND RETAIN 




















Interested in finding out more? Please contact Corbin Griffen
Are you a generally healthy male 
aged 60-80 years?
Benefits of participating:
x Opportunity for 12 weeks free 
exercise sessions with a qualified 
personal trainer 
x You will receive a unique and 
detailed health assessment and 
metabolic profile using state-of-
the-art scientific equipment
x £20 Waterstones voucher on 
completion of the study 
If so, you are being invited to participate in a cutting-edge 
research study investigating the impact of a 12 week 
exercise and/or nutrition intervention on outcomes related 
to healthy ageing. 
Volunteers will need to: Attend 4 test visits over 3 
months (2 x 2 hour visits at Coventry University & 2 x 24
hour metabolic assessments at University Hospitals 
Coventry & Warwickshire NHS Trust) Provide blood, 
ali a & ine am le  Have body composition, 
muscular strength & performance + metabolic & 
cognitive function assessed. 

















































HEALTH AND LIFESTYLE QUESTIONNAIRE 
 
The following questionnaire will help us to determine if you are eligible to participate 




 DAY MONTH YEAR 
Date questionnaire completed          
Example 1 0 J U N 2 0 1 7 












Mobile telephone number: 
 





Date of Birth:  
Age today:  
Approximately how tall are you?  BMI: 
 




Q1. Do you smoke? If you are an ex-smoker, when did you stop? 
A. (if previous smoker, please give further details of approximate no. of cigarettes smoked per day and 







BRIEF MEDICAL HISTORY 
(please be aware that we do NOT have access to your medical notes and any relevant 
information you can provide is very helpful) 
 
For the following questions, please tell us if your GP has diagnosed you with existing or 
previous history of: 
 
Q2. Heart disease (e.g. Angina), stroke or any other disease of the circulation (such as Reynaud’s 
disease)?  






Q3. Diabetes (either type 1 or type 2)?  






Q4. Cancer   






Q5. A liver or kidney complaint / disease?  
IF yes please give further details 
 
 
Has your weight changed in the last 3 







Q6. A digestive disease (such as Chron’s, coeliac irritable bowel, colitis)?  








Q7. Neurological disorder, severe muscular injuries or a thyroid condition?  







Q8. Respiratory conditions, including asthma:   





Q9. Any other illness or conditions we need to be aware of?  





Q11. Has your doctor diagnosed you as having high cholesterol?  





Q12. Has your doctor diagnosed you as having high blood pressure?  







Q13. Do you have any known food intolerances (e.g. lactose intolerance), food allergies, or other 
allergies?  



























Q16. Have you been prescribed blood pressure medications (e.g. alpha blockers, beta blockers, 







Q17. Have you been prescribed anti-diabetic medications (e.g. insulin, exenatide, liraglutide) or 









Q18. Are you currently on any long-term medication; including aspirin / steroids, antihistamines, 
anti-inflammatory medication, pain relief? 






Q19. Do you regularly take non prescribed pain relief, anti-inflammatory? 






Q20. Are you currently prescribed hormone replacement therapy?  
Q21. Do you currently take any other medications? 
 
DIETARY OR SUPPLEMENT USE 
 
Q22. Are you on a therapeutic diet? or ‘dieting’ with the intention of substantial weight loss?  








Q23. Do you currently consume protein and/or amino acid supplements, or any other nutritional 
supplements?  





Q24. Have you been involved in an exercise or dietary intervention trial in the last 6 months? If 







EXERCISE AND PHYSICAL ACTIVITY  
 





























OFFICE USE ONLY – OFFICE USE ONLY – OFFICE USE ONLY 
 
Is the volunteer eligible to proceed in the trial?  
 
YES  NO 
 
 
Name of scientist / research nurse (PRINT): ……………………………………. 
 
 
Signature of the scientist / research nurse: ……………………………………… 
 D D M M M Y Y Y Y 














































Some materials have been removed from this thesis due to Third Party Copyright. Pages where material has been 
removed are clearly marked in the electronic version. The unabridged version of the thesis can be viewed at the 
Lanchester Library, Coventry University
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Appendix H: Supplement log 
 
CRF 10. Missed sachet sheet 
 
Please complete the table of any missed sachets throughout the 12 weeks. 
 

























































































Resistance exercise log – Sarcopenia study 
 
 










Session Number  Date  Attended? 
1) 1RM (1) – W0   
2) RT Session 2 – W1   
3) RT Session 3 – W2   
4) RT Session 4 – W2   
5) RT Session 5 – W3   
6) RT Session 6 – W3   
7) RT Session 7 – W4   
8) RT Session 8 – W4   
9) 1RM (2) – W5   
10) RT Session 10 – W5   
11) RT Session 11 – W6   
12) RT Session 12 – W6   
13) RT Session 13 – W7   
14) RT Session 14 – W7   
15) RT Session 15 – W8   
16) RT Session 16 – W8   
17) 1RM (3)    
18) RT Session 18 – W9   
19) RT Session 19 – W10   
20) RT Session 20 – W10   
21) RT Session 21 – W11   
22) RT Session 22 – W11   
23) RT Session 23 – W12    
24) RT Session 24 – W12   
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Warm up Machine set up Heaviest weight (1RM) Comments RPE 
Bike – 5 minutes  
 
 50 rpm    
Whole-body dynamic 
exercises – 5 minutes 
 
    
Main session     
Leg Press  
 
    
Chest Press  
 
    
Leg extension  
 
    
Shoulder Press  
 
    
Hamstring Curl  
 
    
Lat row  
 
 
    
Cool Down     
5 minute of bike – 
self-selected pace 
 
    
Whole body static 
exercises  
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Session 2) Resistance training session (60% 1RM). 







Warm up Machine set up Intensity/Weight Target reps Sets Reps completed Comments 
Bike – 5 minutes  
 
 50 rpm      
Whole-body 
dynamic exercises – 
5 minutes 
 
      
Main session       
Leg Press  
 
  12-15 (final set 
failure) 
3   
Chest Press  
 
  12-15 (final set 
failure) 
3   
Leg extension  
 
  12-15 (final set 
failure) 
3   
Shoulder Press  
 
  12-15 (final set 
failure) 
3   
Hamstring Curl  
 
  12-15 (final set 
failure) 
3   
Lat row  
 
 
  12-15 (final set 
failure) 
3   
Cool Down       
5 minute of bike – 
self-selected pace 
 
      
Whole body static 
exercises  
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Warm up Machine set up Intensity/Weight Target reps Sets Reps completed Comments RPE  
Bike – 5 minutes  
 
 50 rpm       
Whole-body 
dynamic exercises – 
5 minutes 
 
       
Main session        
Leg Press  
 
  12-15 (final set 
failure) 
3    
Chest Press  
 
  12-15 (final set 
failure) 
3    
Leg extension  
 
  12-15 (final set 
failure) 
3    
Shoulder Press  
 
  12-15 (final set 
failure) 
3    
Hamstring Curl  
 
  12-15 (final set 
failure) 
3    
Lat row  
 
 
  12-15 (final set 
failure) 
3    
Cool Down        
5 minute of bike – 
self-selected pace 
 
       
Whole body static 
exercises  
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Warm up Machine set up Intensity/Weight Target reps Sets Reps completed Comments RPE  
Bike – 5 minutes  
 
 50 rpm       
Whole-body 
dynamic exercises – 
5 minutes 
 
       
Main session        
Leg Press  
 
  12-15 (final set 
failure) 
3    
Chest Press  
 
  12-15 (final set 
failure) 
3    
Leg extension  
 
  12-15 (final set 
failure) 
3    
Shoulder Press  
 
  12-15 (final set 
failure) 
3    
Hamstring Curl  
 
  12-15 (final set 
failure) 
3    
Lat row  
 
 
  12-15 (final set 
failure) 
3    
Cool Down        
5 minute of bike – 
self-selected pace 
 
       
Whole body static 
exercises  
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Warm up Machine set up Intensity/Weight Target reps Sets Reps completed Comments RPE  
Bike – 5 minutes  
 
 50 rpm       
Whole-body 
dynamic exercises – 
5 minutes 
 
       
Main session        
Leg Press  
 
  12-15 (final set 
failure) 
3    
Chest Press  
 
  12-15 (final set 
failure) 
3    
Leg extension  
 
  12-15 (final set 
failure) 
3    
Shoulder Press  
 
  12-15 (final set 
failure) 
3    
Hamstring Curl  
 
  12-15 (final set 
failure) 
3    
Lat row  
 
 
  12-15 (final set 
failure) 
3    
Cool Down        
5 minute of bike – 
self-selected pace 
 
       
Whole body static 
exercises  
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Warm up Machine set up Intensity/Weight Target reps Sets Reps completed Comments RPE  
Bike – 5 minutes  
 
 50 rpm       
Whole-body 
dynamic exercises – 
5 minutes 
 
       
Main session        
Leg Press  
 
  8 (final set 
failure) 
3    
Chest Press  
 
  8 (final set 
failure) 
3    
Leg extension  
 
  8 (final set 
failure) 
3    
Shoulder Press  
 
  8 (final set 
failure) 
3    
Hamstring Curl  
 
  8 (final set 
failure) 
3    
Lat row  
 
 
  8 (final set 
failure) 
3    
Cool Down        
5 minute of bike – 
self-selected pace 
 
       
Whole body static 
exercises  
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Warm up Machine set up Intensity/Weight Target reps Sets Reps completed Comments RPE  
Bike – 5 minutes  
 
 50 rpm       
Whole-body 
dynamic exercises – 
5 minutes 
 
       
Main session        
Leg Press  
 
  8 (final set 
failure) 
3    
Chest Press  
 
  8 (final set 
failure) 
3    
Leg extension  
 
  8 (final set 
failure) 
3    
Shoulder Press  
 
  8 (final set 
failure) 
3    
Hamstring Curl  
 
  8 (final set 
failure) 
3    
Lat row  
 
 
  8 (final set 
failure) 
3    
Cool Down        
5 minute of bike – 
self-selected pace 
 
       
Whole body static 
exercises  
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Warm up Machine set up Intensity/Weight Target reps Sets Reps completed Comments RPE  
Bike – 5 minutes  
 
 50 rpm       
Whole-body 
dynamic exercises – 
5 minutes 
 
       
Main session        
Leg Press  
 
  8 (final set 
failure) 
3    
Chest Press  
 
  8 (final set 
failure) 
3    
Leg extension  
 
  8 (final set 
failure) 
3    
Shoulder Press  
 
  8 (final set 
failure) 
3    
Hamstring Curl  
 
  8 (final set 
failure) 
3    
Lat row  
 
 
  8 (final set 
failure) 
3    
Cool Down        
5 minute of bike – 
self-selected pace 
 
       
Whole body static 
exercises  
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3-day dietary record 
 
Please complete a dietary record of everything you eat and drink for 3 days (2 days during the week and 1 weekend day). Please be as 
accurate and as honest as possible. If you need more space, please use back of piece of paper. 
 
Example 
VOL_ID: Date: 29 JULY 2017                                         Day of week (circle below) Typical? (circle) Other important detail: 
 







location Food item – identify full description, 














Breakfast 07:30 Home Cornflakes 
Milk 
Orange Juice 
Coffee, milk, 1 sugar 
 50g bowl 






Snack 10:45  Coffee 
shop 
Coffee, milk, 1 sugar 
Chocolate muffin 
 
 50ml milk 
1 medium 
1 bag- 25g 
NO  
Lunch   Ham sandwiches, crisps (salt and 
vinegar), Kit Kat, Glass of orange cordial  













VOL_ID: Date:                                          Day 1)                  Day of week (circle below) Typical? (circle) Other important detail: 
 








location Food item – identify full 
description, brand, type (i.e. low 
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VOL_ID: Date:                                          Day 2)                  Day of week (circle below) Typical? (circle) Other important detail: 
 








location Food item – identify full 
description, brand, type (i.e. low 
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VOL_ID: Date:                                          Day 3)                  Day of week (circle below) Typical? (circle) Other important detail: 
 








location Food item – identify full 
description, brand, type (i.e. low 
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Actigraph Instruction Sheet 
Please wear this monitor on your dominant wrist for the next 7 days. The monitor is an 
accelerometer and it will monitor your activity levels. Please carry on your week as normal 
and do not adjust your activity levels due to wearing the monitor. The monitor should be 
worn both during the day and overnight. The monitor should be placed snug to the wrist to 















When you take the monitor off (e.g. for showering or swimming), please write down the 
approximate time you took it off and put it back on in the table below. This will help us to 
determine any periods of non-wear when the data is analysed. Please also write down the 
final time the monitor was taken off. Finally, please bring this piece of paper back with you 
when your return the monitor at your next visit. 
 
Day Time taken off  Time put back on Normal day activity? 
(yes/no) – if no why? 
1    
    
    
2    
    
    
3    
    
    
4    
    
    
5    
    
    
    
6    
    
    
7    
Please note: The 
accelerometer will not 
display any information 
during the study period  
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Blood  Pressure and Hunger/ Sleep Scales
  sample 7 
sample 5 





 sample 1 & 8 
Prepare for RMR 
0700 Resting on bed  for 60min 
0805  
 sample 2 
Exchange Urine bottle and weigh 
Blood  Pressure and Hunger/ Sleep Scales 
0815   sample 1 (and 8) Prepare for Exercise 
0830 Start step 75 bpm for 30m   
0900   sample 2  Blood  Pressure and Hunger/ Sleep Scales  
0915   
1000  
1225 
Blood  Pressure and Hunger/ Sleep Scales 
 sample 3
1230 Sample 3 
1240   
1355 Blood  Pressure and Hunger/ Sleep Scales Sample 4
 396 
 
2005  Exit Room 
 (Remove cannula)  
Remove CGM  
 
 
1445 Start step 75 bpm for 30min 
1700  sample 4 
1715 Blood Pressure and Hunger/ Sleep Scales sample 5
1720    
1835 Blood Pressure and Hunger/ Sleep Scales sample 6 
1915 Start at 75 bpm for 30min 
1955 
Urine container exchange and weigh 
Blood Pressure and Hunger/ Sleep Scales
 
2000  sample 6 
 397 
 
Appendix M: Pilot chamber data 
 
Vol RMR (kcal/d) Total EE (kcal) PAL 
1 1837 2559 1.39 
2 1562 2373 1.52 
3 1295 1900 1.47 
4 1343 2088 1.55 
5 1604 2317 1.44 
  Mean 1.47 
  SD 0.06 
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Satiety Visual Analogue Scale 
 
 










I am not   How hungry do you feel?            I have never  
hungry at all ____________________________________________________  been             




I am  How satisfied do you feel?          I cannot eat  
completely ____________________________________________________  another     
empty                                                                                           bite 
 
Fullness 
   How full do you feel?    
Not at all full ____________________________________________________  Totally    
                                                                                                     full 
 
Appetite 
               How much do you think you can eat?    
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